Link,Title,Description,Original_title,news_id,Rating,Reviewers,Category,Tags,Img,Criteria,News_Source,Our_review_summary,Source_link,Why_this_matters,
https://www.healthnewsreview.org/review/a-little-more-context-would-have-boosted-already-strong-healthday-story-on-drug-for-hot-flashes/,A little more context would have boosted already-strong HealthDay story on drug for hot flashes,Did the study findings really earn a label of ‚Äúgame-changing?‚Äù, Incontinence Drug May Cut Hot Flashes in Breast Cancer Survivors,story_reviews_00004,5,"['Sue Rochman', 'Karen Carlson, MD', 'Joy Victory']",HealthDay,"['breast cancer', 'hot flashes']",https://consumer.healthday.com/women-s-health-information-34/menopause-and-postmenopause-news-472/incontinence-drug-may-cut-hot-flashes-in-breast-cancer-survivors-740325.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Using the lead researcher as a source, the article states that most insurers cover oxybutynin; that a month‚Äôs supply can range fr",Health Day,"The San Antonio Breast Cancer Symposium typically generates extensive media coverage of new research studies. However, not all of the studies presented are of the same caliber and some will never undergo the peer review that will lead them to be published","https://www.healthnewsreview.org/wp-content/uploads/2018/12/GettyImages-973159304-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/12/GettyImages-973159304.jpg 724w",Many breast cancer treatments are known to cause hot flashes. Some premenopausal women have treatments that put them into immediate menopause; others enter menopause naturally while they are being treated for breast cancer; and still others are postmenopa,
https://www.healthnewsreview.org/review/props-to-npr-for-highlighting-the-need-for-balanced-decision-making-around-statins/,Props to NPR for highlighting the need for balanced decision-making around statins,"This story could have provided a bit more on costs, alternatives, and how this study was performed.","Before Starting A Statin, Talk It Over With Your Doctor",story_reviews_00005,4,"['Alan Cassels', 'Doug Campos-Outcalt, MD, MPA', 'Mary Chris Jaklevic']",NPR,['statins'],https://www.npr.org/sections/health-shots/2018/12/03/672990317/before-starting-a-statin-talk-it-over-with-your-doctor,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There‚Äôs no discussion of cost, even to mention that statins are relatively inexpensive these days and are mostly generically ",NPR,"The story reports on a study that re-assessed who benefits from taking a statin to prevent heart disease, with different risk thresholds based on sex, age group, and statin type.
It reports the view that current guidelines ‚Äúhaven‚Äôt adequately consider",nan,"Statins are among the most widely prescribed drugs, with their use encouraged under guidelines such as those of the American Heart Association of the American College of Cardiology.
However, data isn‚Äôt crystal clear on the benefits and harms of statins ",
https://www.healthnewsreview.org/review/cnn-delivers-a-balanced-report-on-peanut-allergy-treatment/,CNN delivers a balanced report on peanut allergy treatment,One girl‚Äôs story illustrates harms as well as benefits.,"Experimental treatment helps 2 out of 3 peanut allergy sufferers, study finds",story_reviews_00009,5,"['Jill U. Adams', 'Dan Mayer, MD', 'Mary Chris Jaklevic']",CNN,"['allergies', 'peanuts']",https://www.cnn.com/2018/11/18/health/peanut-allergy-treatment-study/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention costs ‚Äî particularly important since the treatment might have to be taken for life. It‚Äôs reporte",CNN,"This CNN News story describes a new treatment for kids with peanut allergy called AR101, which could help protect against severe reactions to small amounts of peanut ingestion. It‚Äôs one of two stories we reviewed about this important and newsworthy stud","https://www.healthnewsreview.org/wp-content/uploads/2018/11/GettyImages-911706562-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/11/GettyImages-911706562-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Peanut allergy is one of the most common food allergies. It typically presents early in life, is known for severe reactions, and is rarely outgrown. There currently are no treatments for peanut allergy, besides emergency care in the event of a reaction. S",
https://www.healthnewsreview.org/review/thoughtful-and-thorough-ap-story-looks-at-growing-trend-of-using-ketamine-for-depression/,"Thoughtful and thorough, AP story looks at growing trend of using ketamine for depression","When it comes to ketamine, people with depression and their families should be informed of the unclear benefits and risks.",High hopes & hype for experimental depression drug ketamine,story_reviews_00015,5,"['Mary Chris Jaklevic', 'Susan Molchan, MD, MA', 'Joy Victory']",Associated Press,['ketamine'],https://www.apnews.com/8f1a189bfde14cbf91179a60b900a81a,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story said one woman paid $3,000 ‚Äúso far‚Äù for her treatments and ‚Äúscrambles to find a way to pay for another one‚Äù as th",Associated Press,"This story explained how the drug ketamine is coming into vogue as a treatment for depression and suicidal behavior. It‚Äôs not focused on one new study but rather the topic in general, describing how ‚Äúdesperate patients are shelling out thousands of do","https://www.healthnewsreview.org/wp-content/uploads/2018/11/GettyImages-635810582-300x238.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/11/GettyImages-635810582.jpg 664w","Whenever a treatment takes hold ahead of the evidence, it‚Äôs the news media‚Äôs job to cast a critical eye. In this case, depression is a major public health problem, and ketamine or some derivative of it with longer lasting benefits could prove to be an",
https://www.healthnewsreview.org/review/new-york-times-warns-readers-that-new-flu-drug-is-no-miracle-cure/,New York Times warns readers that new flu drug ‚Äòis no miracle cure‚Äô,The story provides people with the fundamental details they need to be informed patients.,F.D.A. Approves New Drug for Flu,story_reviews_00017,4,"['Matt Shipman', 'Elizabeth Russo, MD', 'Joy Victory']",New York Times,['influenza'],https://www.nytimes.com/2018/10/24/health/flu-pill-xofluza.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story devotes its second paragraph to cost, including how that cost may differ depending on whether patients have insurance. We",The New York Times,"This story is one of two we are reviewing that focuses on FDA‚Äôs approval of a drug designed to speed patient recovery from flu symptoms (the second story is from ABC News). The drug is baloxavir marboxil, marketed under the trade name Xofluza. This New ","https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-891341512-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-891341512.jpg 724w","The criteria that we use at HealthNewsReview.org to review health-related news stories were not developed in a vacuum. Rather, these are the criteria we feel are essential to allow patients and health care providers to make informed decisions about diagno",
https://www.healthnewsreview.org/review/inquirers-look-at-using-facebook-to-screen-for-depression-emphasizes-research-is-still-in-very-early-stages/,Inquirer‚Äôs look at using Facebook to screen for depression emphasizes research ‚Äòis still in very early stages‚Äô,"It would have been helpful if the story had explored who would pay for this kind of screening, and what we know about depression screening in general: Is it effective?",Depression often goes undiagnosed. Researchers are turning to Facebook to change that.,story_reviews_00021,4,"['Matt Shipman', 'Susan Molchan, MD, MA', 'Joy Victory']",Philadelphia Inquirer,"['depression', 'screening']",http://www2.philly.com/philly/health/facebook-predict-depression-mental-health-penn-study-20181015.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This work is early in its development and the story makes that clear.\nHowever, it would still be worthwhile to raise some questi",The Philadelphia Inquirer,"
This Philadelphia Inquirer story focuses on the early development of a computer model that uses Facebook posts to identify people with depression.
It makes clear that the technology is in its preliminary stages and is not close to being used in a clinica","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000067356463_Small-300x217.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000067356463_Small.jpg 814w","Depression affects quality of life for millions of people around the world. This story is appropriately cautious about how far this technology is from real-world application, though a number of questions remain unanswered.",
https://www.healthnewsreview.org/review/ap-offers-strong-reporting-about-the-evidence-for-a-drug-treatment-for-moderate-bone-loss/,AP offers strong reporting about the evidence for a drug treatment for moderate bone loss,This story did a good job of explaining the findings and the quality of evidence.,Study suggests more older women may benefit from bone drugs,story_reviews_00024,5,"['Sue Rochman', 'Karen Carlson, MD', 'Mary Chris Jaklevic']",Associated Press,"['osteoporosis', 'Reclast']",https://abcnews.go.com/Health/wireStory/study-suggests-older-women-benefit-bone-drugs-58209993?cid=clicksource_26_4_article%20roll_articleroll_hed,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article states that a generic version of Reclast costs $200 to $500 per infusion, ‚Äúdepending on insurance and other factors.‚",Associated Press,"This article covers a six-year study of 2,000 women in New Zealand ages 65 or older who had a scan indicating osteopenia, or moderate bone loss. Half received up to four infusions of the bisphosphonate zoledronate acid (brand name Reclast), administered i","https://www.healthnewsreview.org/wp-content/uploads/2018/10/GettyImages-808704868-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/10/GettyImages-808704868-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Bone breaks and fractures become more common as people age. At age 65, most women receive their first DEXA scan, a test that uses low-dose X-rays to measure the amount of calcium and other minerals inside the bone. The test results score bone as normal th",
https://www.healthnewsreview.org/review/newsweek-story-on-zika-vaccine-to-zap-brain-cancer-is-fascinating-but-needed-more-caution-about-mouse-research/,Newsweek story on Zika vaccine to zap brain cancer is fascinating‚Äìbut needed more caution about mouse research,"The story does express some limitations of the study findings, which we appreciate.",GLIOBLASTOMA: ZIKA VIRUS COULD DESTROY BRAIN CANCER THAT KILLED JOHN MCCAIN,story_reviews_00030,4,"['Ann Miller, PhD', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",Newsweek,"['vaccines', 'Zika virus']",https://www.newsweek.com/glioblastoma-zika-virus-could-destroy-brain-cancer-killed-john-mccain-1125530,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This is a report of the results of a clinical trial in mice. It‚Äôs too early to estimate costs for human treatment. However, som",Newsweek,"This story reports results from a study in which researchers deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice.¬†Glioblastoma is¬†the most common and malignant form of primar","https://www.healthnewsreview.org/wp-content/uploads/2018/09/GettyImages-827580730-300x169.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/09/GettyImages-827580730-768x432.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Any new ideas about cancer treatment are exciting. The idea of using the ‚Äúbad side‚Äù of viruses for good purposes is intriguing. However, as the story states, it‚Äôs not yet known if this virus is safe for use in humans, and finding that out is likely ",
https://www.healthnewsreview.org/review/healthday-story-describes-a-randomized-controlled-trial-as-if-its-an-observational-study/,"Fish oil during pregnancy led to ‚Äòstronger kids,‚Äô but was the difference clinically meaningful?","The story included multiple independent sources to provide perspective, and it included a few key details about the study.","Fish Oil Pills During Pregnancy Might Mean Stronger, Healthier Kids",story_reviews_00034,4,"['Earle Holland', 'Karen Carlson, MD', 'Joy Victory']",HealthDay,"['fish oil', 'Pregnancy']",https://consumer.healthday.com/vitamins-and-nutrition-information-27/nutritional-supplements-health-news-504/fish-oil-pills-during-pregnancy-might-mean-stronger-healthier-kids-737405.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This story doesn‚Äôt mention the costs of the fish oil supplements it appears to support. However, the cost of such supplements i",Health Day,"This HealthDay story describes a study published in the British Medical Journal that looked at whether pregnant women who took fish oil supplements in their third trimester¬†produced healthier children based on their growth statistics and body mass index,","https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-655371326-300x198.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-655371326-768x506.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","There is great interest in understanding the effects of interventions during pregnancy on the health of the offspring, but such studies are difficult to conduct, since assessing outcomes that occur years following the pregnancy can be a challenge.
Althoug",
https://www.healthnewsreview.org/review/when-n1-its-easy-to-jump-to-conclusions-about-a-therapy-working/,"When n=1, it‚Äôs easy to jump to conclusions about a therapy working",Was it the hyperbaric treatment or something else that helped a patient profiled in a Philadelphia Inquirer story?,Hyperbaric oxygen: The mysterious therapy that saved a cancer survivor from radiation side effects,story_reviews_00043,4,"['Mandy Stahre, PhD', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",Philadelphia Inquirer,"['cancer', 'radiation therapy']",http://www.philly.com/philly/health/hyperbaric-oxygen-saved-him-from-radiation-injury-20180808.html?__vfz=medium%3Dsharebar,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article discussed that Medicare covers the treatment at $450 for a two-hour session. There wasn‚Äôt a discussion about whether ",The Philadelphia Inquirer,"This well-written article discusses a patient suffering from delayed effects of radiation who received hyperbaric therapy treatment. The patient noticed improvements in pain levels and mobility, but doctors in the story warn that this treatment is unprove","https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-160736406-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-160736406.jpg 726w",Overuse of unproven medical technologies poses risks to patients and adds to rising healthcare costs. An N of 1 does not prove that a technology works since there are so many other factors that could contribute to a patient seeing improvement over time.,
https://www.healthnewsreview.org/review/abc-doesnt-oversell-early-research-on-blood-test-for-depression/,ABC News doesn‚Äôt oversell early research on blood test for depression,"However, parts of the story might confuse readers by suggesting a benefit to taking LAC for depression even though, as the story points out, there‚Äôs as yet no evidence that LAC can effectively treat depression.",Could a blood test lead to new treatments for depression?,story_reviews_00046,4,"['Mary Chris Jaklevic', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",ABC News,['depression'],https://abcnews.go.com/Health/blood-test-lead-treatments-depression/story?id=56896507,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Because of the early stage of this research, we‚Äôll rate this N/A.\nBut it‚Äôs worth noting that a new test used in the diagnost",ABCNews.com,"This story reported a study that showed an amino acid called acetyl-L-carnitine (LAC) is lower in people with clinical depression, suggesting it might be used as a biomarker to guide treatment decisions.
We applaud the story‚Äôs generally cautious tone an","https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_81485663_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_81485663_MEDIUM-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2","A biomarker could be a useful tool to develop treatments for depression or to target those at risk for early diagnosis and interventions. However, news stories have to maintain a cautious tone because identifying appropriate biomarkers and translating the",
https://www.healthnewsreview.org/review/but-it-comes-with-some-big-caveats-vox-is-clear-about-drawbacks-of-new-endometriosis-drug/,‚ÄòBut it comes with some big caveats:‚Äô Vox is clear about drawbacks of new endometriosis drug,One clinical trial detail we think should have been included: The measured benefits for both the drug group ,Women with endometriosis experience terrible pain. There‚Äôs finally a new treatment.,story_reviews_00047,4,"['Sharon Dunwoody, PhD', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",Vox,['endometriosis'],https://www.vox.com/2018/7/24/17608984/endometriosis-pain-symptoms-treatments-elagolix-orilissa,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does a good job of describing the monthly cost ($850) for women who do not have health insurance. The inference is that i",Vox,"The recent approval of a drug for the treatment of endometriosis pain is shared in this story in a way that satisfies many of our review site criteria.¬† The story is carefully written, with lots of detailed explanations of the drug‚Äôs potential benefits","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_17854778_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_17854778_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Endometriosis, a condition in which tissue migrates from the uterus into the abdomen of women, is relatively common and can be debilitatingly painful. While there is no cure at present, efforts to control the pain include hormonal treatments and even surg",
https://www.healthnewsreview.org/review/healthday-provides-needed-details-on-side-effects-of-pot-derived-drug-studied-for-alzheimers-agitation/,HealthDay provides needed details on side effects of THC-based drug studied for Alzheimer‚Äôs agitation,"However, the story didn‚Äôt provide any supporting numbers for the touted benefits.",Could Pot-Linked Drug Help Ease Agitation in Alzheimer's?,story_reviews_00048,4,"['Michael Joyce, MD', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",HealthDay,"[""alzheimer's disease"", 'dementia', 'marijuana']",https://consumer.healthday.com/cognitive-health-information-26/alzheimer-s-news-20/could-pot-linked-drug-help-ease-agitation-in-alzheimer-s-736075.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of nabilone is not mentioned.\nAccording to drugs.com:\nThe cost for Cesamet (nabilone) 1 mg capsules is around $2,054",Health Day,This story summarizes the findings of a small Canadian study investigating whether a synthetic form of THC (the psychoactive ingredient in marijuana) helps calm agitation in people with Alzheimer‚Äôs disease. It‚Äôs unpublished work that was presented thi,"https://www.healthnewsreview.org/wp-content/uploads/2018/07/GettyImages-673695060-300x203.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/07/GettyImages-673695060.jpg 719w","As lucidly communicated in this story, treating Alzheimer‚Äôs patients for agitation is a common challenge. Existing approaches aren‚Äôt very effective and can lead to significant side effects.
As this story makes clear new approaches, even when helpful, ",
https://www.healthnewsreview.org/review/its-way-too-soon-to-know-if-melanoma-blood-test-will-save-thousands-of-lives/,It‚Äôs way too soon to know if melanoma blood test will save ‚Äòthousands of lives‚Äô,"Early on the CNN story makes a bold claim that the test could save thousands of lives, yet in many cases, early detection of cancer does not guarantee a longer, healthier life.","Experimental blood test could detect melanoma skin cancer early, study finds",story_reviews_00049,4,"['Harold J. DeMonaco, MS', 'Richard Hoffman, MD', 'Joy Victory']",CNN,['melanoma'],https://www.cnn.com/2018/07/17/health/melanoma-skin-cancer-blood-test-intl/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This test, since it involves ten separate autoantibody antigens is likely to be expensive. \xa0A test to determine breast cance",CNN,"The story provides a review of early research examining an experimental blood test for the detection of melanoma.¬† The addition of the comments from an unaffiliated expert place the research into context and provide important caveats to the study.
But ea","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000046237340_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000046237340_Small.jpg 849w","Melanoma is the most dangerous form of skin cancer. Early detection is essential for good clinical outcomes. A blood test to easily detect the disease would be a welcome addition especially in those areas with a high prevalence of the disorder. However, t",
https://www.healthnewsreview.org/review/wsj-offers-caution-early-and-often-in-coverage-of-latest-experimental-alzheimers-drug/,WSJ offers caution early and often in coverage of latest experimental Alzheimer‚Äôs drug,This article demonstrates it‚Äôs not only desireable but also possible to write objectively and temper expectations when writing for a business audience.,Drugmakers Call Experimental Alzheimer‚Äôs Drug Study Positive,story_reviews_00053,5,"['Mary Chris Jaklevic', 'Susan Molchan, MD, MA', 'Kathlyn Stone']",Alzheimer's,['BAN2401'],https://www.wsj.com/articles/drugmakers-call-experimental-alzheimers-drug-study-outcome-positive-1530897640,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story frames the discussion in terms of income to the company, but doesn‚Äôt address the costs to patients or society. The stor",The Wall Street Journal,"This story covered the announcement of ‚Äúpositive‚Äù early results for an experimental Alzheimer‚Äôs drug called BAN2401, an antibody that attacks beta-amyloid clumps, and which appeared to trigger a surge in the stock prices of two companies developing ","https://www.healthnewsreview.org/wp-content/uploads/2018/03/Alzheimer-300x210.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/03/Alzheimer.jpg 400w","Business stories about unproven treatments must explain the news driving investors without creating false hopes for patients. That can be a tall order.
Alzheimer‚Äôs ‚Äî which has no cure or treatment to stop its progression ‚Äî is a particularly good exa",
https://www.healthnewsreview.org/review/stat-suggests-flu-drug-could-upend-treatment-but-theres-plenty-to-question-about-this-claim/,"STAT suggests flu drug could ‚Äòupend treatment,‚Äô but there‚Äôs plenty to question about this claim","But we laud the story for how well it covered how much the drug might cost, if approved.",A flu drug ‚Äî shown to reduce the duration of symptoms ‚Äî could upend treatment in U.S.,story_reviews_00055,4,"['Sue Rochman', 'Preeti N. Malani, MD, MSJ', 'Joy Victory']",STAT,['influenza'],https://www.statnews.com/2018/06/27/flu-drug-single-pill/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story makes clear the ‚Äúbig unknown‚Äù remains the price and ‚Äúhow much people are willing to spend to cut a day or so off of",STAT,This story‚Äôs headline makes a bold statement: ‚ÄúA flu drug‚Äîshown to reduce duration of symptoms‚Äîcould upend treatment in U.S.‚Äù The next two paragraphs ramp up the excitement regarding the FDA‚Äôs announcement that it has granted priority review t,"https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_63545303_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_63545303_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","As Genentech noted in its news release about the FDA granting priority review for its new drug, the flu is responsible for up to 650,000 deaths worldwide each year. It would be great if there was a drug that reduced deaths from the flu. Genentech has prov",
https://www.healthnewsreview.org/review/npr-deftly-summarizes-results-of-early-study-using-polio-vaccine-for-brain-cancer/,"NPR deftly summarizes results of early study using polio vaccine for brain cancer, except industry conflicts of interest",The only thing the story lacked was disclosing that seven of the researchers on the study reported financial interests in the company that holds the license for the treatment.,Doctors Try Genetically Modified Poliovirus As Experimental Brain Cancer Treatment,story_reviews_00056,4,"['Mary Chris Jaklevic', 'Elizabeth Russo, MD', 'Joy Victory']",NPR,['glioblastoma'],https://www.npr.org/sections/health-shots/2018/06/26/622610333/doctors-try-genetically-modified-poliovirus-as-experimental-brain-cancer-treatme,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There‚Äôs no mention of how much this might cost, but we‚Äôll rate this N/A since the story makes it clear that this is early res",NPR,"This is one of two stories we reviewed about an early-phase trial of the use of a modified poliovirus for glioblastoma, a fatal brain cancer. The other review covers an NBC News story. Results of the study were published in the New England Journal of Medi","https://www.healthnewsreview.org/wp-content/uploads/2012/07/brain-MRI-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2012/07/brain-MRI.jpg 400w","Stories about experimental treatments for fatal conditions such as glioblastoma serve the public when they exercise discretion and avoid raising false hopes.
Journalists should also strive to give some perspective on the breadth of ongoing research. Notab",
https://www.healthnewsreview.org/review/highly-atypical-patient-anecdote-throws-off-mostly-well-reported-nbc-news-story-on-experimental-brain-cancer-treatment/,Atypical patient anecdote throws off well-reported NBC News story on experimental brain cancer treatment,The story delves into the harms of the treatment and refrains from disease-mongering.,Modified polio vaccine helps fight deadly brain tumors,story_reviews_00057,4,"['Mary Chris Jaklevic', 'Elizabeth Russo, MD', 'Joy Victory']",NBC News,['glioblastoma'],https://www.nbcnews.com/health/health-news/modified-polio-vaccine-helps-fight-deadly-brain-tumors-n886486,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There‚Äôs no mention of how much this might cost, but we‚Äôll rate this N/A since the story makes it clear that this concept stil",NBCNews.com,"This is one of two stories we reviewed that cover results of a phase 1 trial to study the use of a modified poliovirus to fight glioblastoma, a fatal brain cancer. The results of the study were published in the New England Journal of Medicine. The story d","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-472135395-225x300.jpg 225w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-472135395.jpg 512w","Stories about experimental treatments for fatal conditions such as glioblastoma should shy away from cause-and-effect framing and overly positive anecdotes in order to avoid raising false hopes.
You can hear a podcast that describes the emotional pain tha",
https://www.healthnewsreview.org/review/small-diabetes-vaccine-study-stat-provides-lots-of-useful-numbers-for-readers/,Small ‚Äòdiabetes vaccine‚Äô study: STAT provides lots of useful numbers for readers,But it could have gone further sourcing the story and exploring the ‚Äòcontroversial‚Äô claim made by the headline.,Controversial researcher‚Äôs diabetes vaccine causes improvement in small study,story_reviews_00059,4,"['Kim Walsh-Childers, PhD', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",STAT,['type 1 diabetes'],https://www.statnews.com/2018/06/21/type-1-diabetes-vaccine-denise-faustman/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes that the BCG vaccine costs less than $1 per dose, though it remains to be seen if the cost will remain the same if ",STAT,"This story from STAT met most of our criteria in describing the results of a study that examined how two doses of the generic bacillus Calmette Gu√©rin (BCG) vaccine, used for nearly a century against tuberculosis, affected blood sugar levels Type 1 diabe","https://www.healthnewsreview.org/wp-content/uploads/2017/08/GettyImages-822417776-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/08/GettyImages-822417776-768x513.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","According to the American Diabetes Association, about 1.25 million Americans have Type 1 diabetes, an autoimmune disease in which the pancreas stops producing insulin. Scientists do not know what causes Type 1 diabetes, and management of the disease requi",
https://www.healthnewsreview.org/review/buzzfeed-warns-readers-a-lot-more-work-to-be-done-to-find-out-if-experimental-blood-test-can-predict-preterm-birth/,BuzzFeed warns readers ‚Äòa lot more work to be done‚Äô to find out if experimental blood test can predict preterm birth,"The story would have benefited from an outside expert weighing on the study and its potential ramifications and ‚Äî more importantly ‚Äî the potential harms of a false-positive test, which are not insignificant.",This Blood Test Could Help Predict If A Pregnancy Is At Risk For Premature Labor,story_reviews_00063,4,"['Dave Mosher', 'Karen Carlson, MD', 'Joy Victory']",BuzzFeed,"['Pregnancy', 'premature babies']",https://www.buzzfeed.com/theresatamkins/pregnancy-blood-test-premature-preterm-labor?utm_term=.ohZW7qKl6#.qjjbg23Kj,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Experimental\xa0health\xa0tests\xa0don‚Äôt\xa0have public price tags. However,\xa0this\xa0story\xa0gives\xa0readers\xa0a rare and h",BuzzFeed,"This BuzzFeed News story reports on early-stage research into an experimental blood test that aims to predict whether or not a pregnancy is at risk for premature birth. To determine that risk, the test looks for specific pieces of RNA generated by the bab","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000060942786_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000060942786_Medium-1024x682.jpg 1024w","According to the CDC, preterm birth affects about one in every 10 infants born in the US. Significant advances to lower preterm birth rates are certainly newsworthy‚Äìbut this is an idea that‚Äôs been tested and failed before (see novelty, below) and read",
https://www.healthnewsreview.org/review/deep-brain-stimulation-diabetes/,LA Times provides careful take on early brain/diabetes research‚Äìexcept for the headline,The headline undermines the overall message of the story with phrasing suggesting a new treatment option: ‚Äúmay offer treatment‚Äù,"Deep brain stimulation may offer treatment for type 2 diabetes, study suggests",story_reviews_00067,4,"['Jill U. Adams', 'Elizabeth Russo, MD', 'Kevin Lomangino']",Los Angeles Times,"['deep brain stimulation', 'diabetes']",http://www.latimes.com/science/sciencenow/la-sci-sn-brain-stimulation-diabetes-20180526-story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Even though deep brain stimulation (DBS) is not close to being recommended for diabetes, it is a current therapy for Parkinson‚",Los Angeles Times,"
This Los Angeles Times story reports on a study with some tantalizing new information about connections between the brain and the body‚Äôs metabolism. The research is novel, very preliminary, and more about introducing a new avenue of study for researche","https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-527548482-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-527548482.jpg 724w","Type 2 diabetes is a chronic metabolic disease that affects 1 in 10 Americans and continues to increase. The disease is the leading cause of kidney failure, limb amputation, and blindness and the seventh leading cause of death in the US. We know many of t",
https://www.healthnewsreview.org/review/a-study-that-may-help-reduce-overtreatment-of-breast-cancer-gets-solid-write-up-by-bloomberg/,A study that may help reduce overtreatment of breast cancer gets solid write-up by Bloomberg,"The story also makes clear that this finding is not robust enough to change treatment guidelines yet and that other outcomes, such as quality of life improvement are still being analyzed.",Study Finds More Isn't Better for Roche Breast Cancer Drug,story_reviews_00069,4,"['Jill U. Adams', 'Kevin Lomangino', 'Joy Victory']",Bloomberg,['breast cancer'],https://www.bloomberg.com/news/articles/2018-05-16/study-finds-more-isn-t-better-for-widely-used-breast-cancer-drug,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentions that currently Herceptin costs $76,700 for 12-month treatment. Presumably that cost would be reduced with 6-mont",Bloomberg,"This Bloomberg story reports study findings that show the targeted breast cancer drug Herceptin may be as effective with a six-month treatment period as it is with the currently recommended 12-month treatment period.
The results, slated to be presented at","https://www.healthnewsreview.org/wp-content/uploads/2015/12/Breast-MRI-300x170.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/12/Breast-MRI-1024x581.jpg 1024w","Herceptin has been a hugely successful drug, both for patients with a particular type of breast cancer (tumors with HER-2 receptors, which occur in about 20% of all breast cancers) and for the drug‚Äôs maker, Roche. Approved 20 years ago, doctors are stil",
https://www.healthnewsreview.org/review/laughing-gas-makes-a-comeback-for-women-in-labor-like-kate-middleton/,Inquirer delivers well-rounded report on using laughing gas for labor pain‚Äìexcept for two things,"This story never cites a specific study, nor does it provide links to several existing studies documenting benefits and harms.", Laughing gas makes a comeback for women in labor - like Kate Middleton,story_reviews_00071,4,"['Michael Joyce, MD', 'Virginia A. Moyer, MD', 'Joy Victory']",Philadelphia Inquirer,['birth'],http://www.philly.com/philly/health/nitrous-oxide-laughing-gas-child-birth-labor-kate-middleton-20180516.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The cost of nitrous oxide for use during labor in one facility ($250) is included. It‚Äôs also mentioned that most insurance plans ",The Philadelphia Inquirer,"Is nitrous oxide (‚Äúlaughing gas‚Äù) ‚Äî which is frequently used to treat labor pain in other countries ‚Äî gaining more acceptance in the U.S., where more aggressive pain management has traditionally been the norm?
In answering this question this story","https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-112260168-199x300.jpg 199w, https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-112260168.jpg 481w","The U.S. approach to labor and delivery is arguably one of the most expensive, high-tech, and medicalized in the world. According to a New York Times analysis, the charges for delivering babies in this country have tripled since 1996, and maternity and ne",
https://www.healthnewsreview.org/review/gene-test-for-depression-treatment-realistic-patient-story-helps-keep-wsj-article-grounded/,Gene test for depression treatment: Realistic patient story helps keep WSJ article grounded,"But the story did not do enough to establish that the research is still preliminary ‚Äî it has not been published nor peer-reviewed, and everyone is relying on just a little bit of data released by the company.",Which Anti-Depressant is Right for You? Your DNA Can Shed Some Light,story_reviews_00074,4,"['Joann Rodgers, MS', 'Susan Molchan, MD, MA', 'Joy Victory']",Wall Street Journal,"['depression', 'genetic testing']",https://www.wsj.com/articles/which-anti-depressant-is-right-for-you-your-dna-can-shed-some-light-1525622524,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story makes clear that the test is expensive and that Medicare and some other insurance plans cover it.'}, {'question': 'Does t",The Wall Street Journal,"This Wall Street Journal article describes results of an unpublished, non-peer-reviewed study of a gene-based test designed to help physicians prescribe antidepressants in people with moderate-to-severe depression who have failed on at least one of the dr","https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing.jpg 410w",Federally-funded surveys of mental health in the U.S. consistently estimate that around 15 to 20 million adult Americans have moderate-to-severe depression that warrants treatment. The good news is that there are dozens of antidepressant drugs approved by,
https://www.healthnewsreview.org/review/independent-viewpoint-helps-round-out-healthday-story-on-impact-of-earlier-mammograms/,Independent viewpoint helps round out HealthDay story on impact of earlier mammograms,But the story would have been stronger had it described the findings using absolute rather than relative numbers.,Earlier Mammograms May Mean Less Need for Aggressive Treatments,story_reviews_00075,4,"['Jill U. Adams', 'Elizabeth Russo, MD', 'Joy Victory']",HealthDay,"['breast cancer', 'mammography', 'screening']",https://consumer.healthday.com/cancer-information-5/mammography-news-460/earlier-mammograms-may-mean-less-need-for-aggressive-treatments-733522.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article did not discuss costs. Screening mammograms impose a significant cost on the U.S. health care system and insurers, ",Health Day,"This HealthDay news story reports on findings among women diagnosed with breast cancer: those who had longer intervals between mammograms end up getting more aggressive treatments, including chemotherapy and surgery.
The story would have been stronger had","https://www.healthnewsreview.org/wp-content/uploads/2015/04/iStock_000016019343XSmall-mammogram-images-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/04/iStock_000016019343XSmall-mammogram-images.jpg 425w","Mammograms are the primary screening method for detecting breast cancer. However, when to start getting mammograms and how often to get screened have been subjects of controversy for the past decade. That‚Äôs because the data on how to balance risk of dev",
https://www.healthnewsreview.org/review/thank-you-new-york-times-for-asking-who-is-behind-these-studies-where-does-the-money-come-from/,"Thank you, New York Times, for asking ‚ÄòWho is behind these studies? Where does the money come from?‚Äô","The article makes effective use of a question-and-answer format to discuss previous research in this area, and other aspects of the research.",Ecstasy as PTSD Relief for Soldiers: ‚ÄòI Was Able to Forgive Myself‚Äô,story_reviews_00076,4,"['Michael Joyce, MD', 'Susan Molchan, MD, MA', 'Joy Victory']",New York Times,['ptsd'],https://www.nytimes.com/2018/05/01/us/ecstasy-molly-ptsd-mdma.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health&region=stream&module=stream_unit&version=latest&contentPlacement=2&pgtype=sectionfront,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of MDMA is not mentioned, and likely difficult to forecast.\nHowever, the associated therapy is fairly intensive, and ",The New York Times,"The study highlighted in this well-written article adds to a growing body of research into whether using the synthetic, psychoactive drug MDMA¬† (street names ‚ÄúEcstasy‚Äù or ‚ÄúMolly‚Äù) in conjunction with psychotherapy, can improve outcomes in PTSD.
T","https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-686316102-300x169.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-686316102-768x432.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","The National Institute of Mental Health (NIMH) estimates the lifetime prevalence of PTSD to be about 7%. The duration and severity can vary widely, and successful treatment is a challenge.
MDMA and psychotherapy to treat PTSD is just one example of an eme",
https://www.healthnewsreview.org/review/in-comparison-of-clot-busting-drugs-healthday-gets-props-for-being-clear-on-costs-and-harms/,"In comparison of clot-busting drugs, HealthDay gets props for being clear on costs and harms","On the flipside, it missed significant limitations to the evidence, the most significant one being that¬†there is ",A Better Clot-Buster Drug for Strokes?,story_reviews_00078,4,"['Mary Chris Jaklevic', 'Christopher Labos, MD', 'Joy Victory']",HealthDay,['stroke'],https://consumer.healthday.com/cardiovascular-health-information-20/heart-stroke-related-stroke-353/a-better-clot-buster-drug-for-strokes-733291.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explained that tenecteplase costs about $5,800 in the U.S. compared with about $8,000 for alteplase.'}, {'question': 'Doe",Health Day,"This story reported on a study that compared a newer clot-buster to treat strokes involving a blocked artery ‚Äî the most common kind ‚Äî to the current standard drug, alteplase (also known as tPA).
The story included cost data on the two drugs, mentioned","https://www.healthnewsreview.org/wp-content/uploads/2018/04/GettyImages-653408520-300x242.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/04/GettyImages-653408520.jpg 659w","An editorial accompanying this study says tenecteplase has the potential to provide an alternative for some stroke patients to alteplase, possibly lowering costs and reducing the number of surgeries to remove blood clots. However, it says, changes to prac",
https://www.healthnewsreview.org/review/diagnosing-alzheimers-using-biomarkers-ap-makes-it-clear-theres-little-benefits-to-patients/,Diagnosing Alzheimer‚Äôs using biomarkers‚ÄìAP makes it clear that there is no benefit to patients,"Still, we would have liked to see comment from an independent source on how this news might be misconstrued, especially by readers worried about their own risk for developing the disease.",New way of defining Alzheimer's aims to find disease sooner,story_reviews_00084,4,"['Jill U. Adams', 'Susan Molchan, MD, MA', 'Joy Victory']",Associated Press,"[""alzheimer's disease""]",http://abcnews.go.com/Health/wireStory/defining-alzheimers-aims-find-disease-sooner-54354122,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentions costs ‚Äî up to $6,000 for a brain scan ‚Äî and that diagnostic tests would not be covered by insurance because ",Associated Press,"This AP story covers the publication of new research guidelines for diagnosing Alzheimer‚Äôs disease.
The story did a lot of things well ‚Äî chiefly, it makes it clear for readers that the guidelines are for research purposes only, and will not be used in","https://www.healthnewsreview.org/wp-content/uploads/2017/10/Brain-Mental-Health-Neurology-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/Brain-Mental-Health-Neurology-768x576.jpg 768w, https://www.healthnewsreview.org/wp-con","Anything to do with Alzheimer‚Äôs disease is newsworthy, because of the ever growing numbers of Americans who have the condition (currently at 5.7 million). A change in diagnostic guidelines that will bump numbers of those diagnosed with the disease is ca",
https://www.healthnewsreview.org/review/inquirer-provides-balanced-and-complete-summary-of-debate-over-kratom-an-herbal-opioid/,"Inquirer provides balanced and complete summary of debate over kratom, an herbal opioid",It prioritizes reputable published science over unpublished research commissioned by kratom advocates.,Is kratom a safe herbal remedy or a dangerous opioid?,story_reviews_00092,5,"['Kevin Lomangino', 'Michael Bierer MD, MPH', 'Joy Victory']",Philadelphia Inquirer,"['kratom', 'opioids']",http://www.philly.com/philly/health/kratom-opioid-fda-cdc-herbal-coffee-20180320.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states, ‚ÄúTen one-gram capsules of kratom cost $20, while 30 grams of powder is $34.99.‚Äù\n(However, it‚Äôs not clear h",The Philadelphia Inquirer,"Many stories about kratom, an herbal product often promoted as an alternative to opioid drugs, give undue weight to statements from kratom advocates and pay insufficient attention to the science. This Philadelphia Inquirer piece is not one of those storie","https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-857996854-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-857996854.jpg 724w","We‚Äôre in the midst of an opioid epidemic, and kratom is being touted by many advocates as a potential non-addictive tool to manage withdrawal from opioid drugs. That sounds like a great benefit, and many desperate people might be tempted to use kratom b",
https://www.healthnewsreview.org/review/a-pat-on-the-back-to-cnn-for-its-well-written-story-on-barbershops-and-blood-pressure/,A pat on the back to CNN for its well-written story on barbershops and blood pressure,"The story is strong and scores well because it discusses critical data from the study, offers comments from independent sources and provides information on limitations.",How barbershops could help lower blood pressure,story_reviews_00098,5,"['Earle Holland', 'Christopher Labos, MD', 'Joy Victory']",CNN,['high blood pressure'],https://www.cnn.com/2018/03/12/health/blood-pressure-barbershop-study/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There was no mention of costs in this story although the costs of some antihypertensive drugs can be moderately high. Neither did",CNN,This well-written CNN story describes a multi-year study that looked at whether providing blood pressure screening and access to pharmacists in black-owned barber shops might be effective in reducing high blood pressure among the African-American men who ,"https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-502352690-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-502352690.jpg 724w","This was a unique choice for a study presented at the ACC conference. Often, the studies presented at the conference are industry-funded and focus on specific (and often very expensive) drugs or devices. We were heartened to see the news media give this s",
https://www.healthnewsreview.org/review/vox-thoroughly-covers-study-on-treatment-alternatives-to-alcoholics-anonymous/,Vox thoroughly covers study on treatment alternatives to Alcoholics Anonymous,"But do these programs have any downsides and what do they cost? Readers would have benefited from hearing those specifics, but the omissions are relatively minor considering the broad scope of the coverage.",Alcoholics Anonymous works for some people. A new study suggests the alternatives do too.,story_reviews_00100,5,"['Kevin Lomangino', 'Michael Bierer MD, MPH', 'Joy Victory']",Vox,['alcohol use disorder'],https://www.vox.com/science-and-health/2018/3/5/17071690/alcoholics-anonymous-aa-smart-lifering-study,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story does not discuss costs associated with either AA or the alternative addiction treatment groups. That would be useful in",Vox,This is excellent coverage of a study suggesting that Alcoholics Anonymous (AA) and similar 12-step programs aren‚Äôt the only worthwhile support groups for those recovering from alcohol use disorders. Alternative programs that (unlike AA) aren‚Äôt based ,"https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-481711236-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/03/GettyImages-481711236.jpg 724w","The story does an admirable job of explaining the scope of the addiction problem in the U.S. and why it‚Äôs important to have alternatives to traditional 12-step programs. Here‚Äôs the key text:
Based on¬†federal data, more than 20 million people in the U",
https://www.healthnewsreview.org/review/emerging-migraine-treatments-npr-story-deftly-weighs-the-good-the-bad-and-the-unknowns/,"Emerging migraine treatments: NPR story deftly weighs the good, the bad and the unknowns","We applaud how this story provided history, context, potential benefits but potential pitfalls (costs and side effects) of new drugs now being studied for migraine relief. Lots to like in this one.",Gone With A Shot? Hopeful New Signs Of Relief For Migraine Sufferers,story_reviews_00112,4,"['Mary Chris Jaklevic', 'Gary Schwitzer', 'Joy Victory']",NPR,['migraines'],https://www.npr.org/sections/health-shots/2018/02/03/581092093/gone-with-a-shot-hopeful-new-signs-of-relief-for-migraine-sufferers,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says these treatments could cost ‚Äúanywhere from $8,000 to $18,000 a year.‚Äù'}, {'question': 'Does the story adequately",NPR,"This highly readable first-person story by a writer who suffers from migraine headaches describes new antibody treatments that are under FDA review. The story effectively conveys the risks of trying monoclonal antibodies, describes how they work, and expl","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000066416125_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000066416125_Medium-1024x682.jpg 1024w","There is clearly a big need for effective new treatments for migraine. ¬†This story paints a clear picture of the history of past attempts, accidental discoveries, the range of symptoms that migraines present in different people, and the possibilities, co",
https://www.healthnewsreview.org/review/cautious-independent-voices-help-round-out-nprs-look-at-experimental-test-for-cancer/,"Cautious, independent voices help round out NPR‚Äôs look at experimental blood test for cancer","The story places the study evidence, benefits vs. risks, and important limitations in a real-world context.",Scientists Edge Closer To A Blood Test To Detect Cancers,story_reviews_00120,5,"['Michael Joyce, MD', 'Andrae Vandross, MD', 'Joy Victory']",NPR,['cancer test'],https://www.npr.org/sections/health-shots/2018/01/18/578620342/scientists-edge-closer-to-a-blood-test-to-detect-cancers,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story makes it clear that cost of the test is currently speculative (‚Äúcould cost about $500‚Äù) and goes even further to caut",NPR,"This story is an overview of a preliminary, experimental test to screen for eight types of cancer.
Not only does this story use clear language in discussing the relevance of both false positives and false negatives in screening, it also thoughtfully inclu","https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-905792042-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-905792042.jpg 724w","The search for noninvasive, accurate, and affordable cancer screening is an important, emerging focus in cancer research. It‚Äôs a topic that will likely continue to generate significant media attention and, therefore, careful reporting is essential.
¬†",
https://www.healthnewsreview.org/review/nprs-story-on-weight-loss-surgery-in-teens-cost-info-would-have-improved-a-well-reported-story/,NPR‚Äôs story on weight loss surgery in teens: Cost info would have improved a well-reported story,"The story did a good job describing the study, the potential harms of the intervention, and limitations to the findings.",Bariatric Surgery Helps Teens With Severe Obesity Reduce Heart Disease Risk,story_reviews_00124,4,"['Mary Chris Jaklevic', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",NPR,"['bariatric surgery', 'weight loss']",https://www.npr.org/sections/health-shots/2018/01/08/575977290/bariatric-surgery-helps-teens-with-severe-obesity-reduce-heart-disease-risk,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There‚Äôs no mention of the cost of these procedures or whether they are covered by insurance. The average cost of gastric bypa",NPR,"This story covers an observational study showing cardiovascular risk factors improved after three years for teens who underwent weight-loss surgery. The story does a good job describing the study, the potential harms of the intervention, and limitations t","https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-508625853-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-508625853.jpg 724w","This isn‚Äôt the first research to suggest that bariatric surgery might help teens with severe obesity, who are at risk of developing health problems in their 30s and 40s. Yet one recent review asserted that while weight-loss surgeries are increasingly be",
https://www.healthnewsreview.org/review/reuters-health-story-on-glaucoma-and-drinking-hot-tea-skims-over-study-limitations/,Reuters Health story on glaucoma and drinking hot tea skims over study limitations,"But the story had several independent sources, and did a good job describing the study‚Äôs design.",Drinking hot tea linked to lowered glaucoma risk,story_reviews_00126,4,"['Michael Joyce, MD', 'Susan Wei, PhD', 'Joy Victory']",Reuters Health,['glaucoma'],https://www.reuters.com/article/us-health-glaucoma-hot-tea/drinking-hot-tea-linked-to-lowered-glaucoma-risk-idUSKBN1EQ17H,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Tea is widely available and relatively affordable compared to other prepared drinks.'}, {'question': 'Does the story adequately q",Reuters Health,"Getty Images
This Reuters story reports on an observational study showing a possible association between drinking caffeinated hot tea and lowering the risk of glaucoma.
The story does a good job describing the study design and the lack of treatment option",nan,"Glaucoma is one of the leading causes of blindness in the world and affects over 55 million people globally. Because vision lost to glaucoma can‚Äôt be recovered, much of the research focuses on either slowing progression once it is diagnosed, or preventi",
https://www.healthnewsreview.org/review/la-times-provides-strong-overview-on-study-showing-vitamin-d-and-calcium-supplements-dont-prevent-fractures/,LA Times provides strong overview on study showing vitamin D and calcium supplements don‚Äôt prevent fractures,"The story would have been stronger if it had included some commentary from experts in the field who were not associated with the study, though.",Do you take calcium and vitamin D to protect your bones? A new study says it doesn't help,story_reviews_00128,4,"['Jill U. Adams', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",Los Angeles Times,"['calcium', 'osteoporosis', 'Vitamin D']",http://beta.latimes.com/science/sciencenow/la-sci-sn-vitamins-bone-fractures-20171226-story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Given that the premise of the story is explaining there is no benefit to taking these supplements, we‚Äôll rate this N/A. That sa",Los Angeles Times,"Getty Images
Reporting on a large review study, this Los Angeles Times article walks readers through the conflicting advice and evidence about calcium and vitamin D supplements. Both compounds play roles in bone health and the routinely accepted claim is ",nan,"More than two million so-called fragility fractures ‚Äî breaks that wouldn‚Äôt happen in a younger person, often related to the bone loss of osteoporosis‚Äìoccur every year in the US. Preventing fragility means attending to bone health, which currently ce",
https://www.healthnewsreview.org/review/gene-therapy-and-hemophilia-washington-post-wisely-tells-readers-the-study-has-some-limitations/,Gene therapy and hemophilia: Washington Post wisely tells readers ‚Äòthe study has some limitations‚Äô,Whether this particular treatment revolutionizes the landscape for hemophilia B sufferers will remain an open question for some years‚Äìand the story should have emphasized that more.,Gene therapy makes a big advance treating hemophilia B blood disorder,story_reviews_00134,4,"['Sharon Dunwoody, PhD', 'Preeti N. Malani, MD, MSJ', 'Joy Victory']",Washington Post,"['drug costs', 'gene therapy']",https://www.washingtonpost.com/news/to-your-health/wp/2017/12/06/a-cut-could-have-killed-him-then-he-got-experimental-gene-therapy-for-hemophilia/?utm_term=.d04f3b3879fc,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Although this therapy is not yet available for patient use, the story makes a point of noting that the cost may well be ‚Äústratosp",The Washington Post,"iStock / Getty Images Plus
A small, early-stage study published in the New England Journal of Medicine found that a single intravenous infusion of a novel bioengineered gene therapy treatment helped spare nine of 10 hemophilia B sufferers from repeated in",nan,People who have inherited the hemophilia B bleeding disorder face a lifetime of replacement therapy: injecting clotting factor when life deals them a stumble or a scrape. Gene therapy research appears to be on the cusp of offering an alternate treatment t,
https://www.healthnewsreview.org/review/fecal-transplant-via-a-pill-newsweeks-coverage-points-out-possible-selection-bias-of-study-participants/,Fecal transplant via a pill? Newsweek‚Äôs coverage points out possible selection bias of study participants,"However, the story should have avoided using the word ‚Äúcure‚Äù in the headline, since we don‚Äôt know the long-term results yet.",Fecal transplant via a pill? Newsweek‚Äôs coverage points out possible selection bias of study participants,story_reviews_00139,4,"['Earle Holland', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",Newsweek,['fecal transplant'],http://www.newsweek.com/poop-pill-cure-deadly-and-common-hospital-infection-724329,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does a good job of pointing out one advantage of the pill approach compared to delivery via colonoscopy‚Äìthe reduced cos",Newsweek,"This Newsweek story reports on the results of a small study published in the Journal of the American Medical Association. The study compared two methods of delivering a fecal microbiota transplant (FMT), via a colonoscopy or with an oral pill, to treat¬†C","https://www.healthnewsreview.org/wp-content/uploads/2017/12/GettyImages-848488428-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/12/GettyImages-848488428.jpg 724w","As the story points out, Clostridium difficile infections in hospital patients is a serious public health problem, infecting ‚Äúhalf a million people in the United States per year¬†and killing 15,000 people‚Äù annually.¬† Fecal microbiota transplant (FMT)",
https://www.healthnewsreview.org/review/spit-test-for-concussion-detection-cnn-story-includes-some-important-caveats/,Spit test for concussion detection: CNN story includes some important caveats,"However, the story could have provided more information on the potential harms of screening tests, as well as expected costs.","Spit test may diagnose, predict duration of concussion in kids",story_reviews_00142,4,"['Kim Walsh-Childers, PhD', 'Virginia A. Moyer, MD', 'Joy Victory']",CNN,['concussions'],http://www.cnn.com/2017/11/20/health/spit-test-concussion-children-study/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story provides no discussion of how much this test might cost if and when it comes to market.'}, {'question': 'Does the sto",CNN,CNN‚Äôs story describes a study that identified microRNA markers in the saliva of children and teens who‚Äôve sustained a concussion; five of these biomarkers could be used in an algorithm to predict whether or not the youngsters‚Äô concussions symptoms w,"https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-649313952-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-649313952.jpg 724w","Concussions are a hot medical topic, as we explain in¬†Communicating effectively about concussion research: 6 tips for writers. When it comes to screening tools, however, news outlets sometimes overlook the nuances. This CNN story, for example, didn‚Äôt d",
https://www.healthnewsreview.org/review/nyt-dives-deep-into-potential-impact-of-stent-study-but-needed-more-specifics-on-what-was-measured/,"NYT dives deep into potential impact of stent study, but needed more specifics on what was measured","That said, the story contains lots of helpful detail on the limitations of the study.",‚ÄòUnbelievable‚Äô: Heart Stents Fail to Ease Chest Pain,story_reviews_00148,4,"['Jill U. Adams', 'Christopher Labos, MD', 'Joy Victory']",New York Times,"['angina', 'heart disease', 'stent']",https://www.nytimes.com/2017/11/02/health/heart-disease-stents.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says the procedure to insert stents costs from $11,000 to $41,000 in the U.S.'}, {'question': 'Does the story adequately ",The New York Times,"This New York Times story describes startling news that a very common procedure‚Äìinserting a stent to open a blocked blood vessel‚Äìdoes not add benefit over medication in patients with angina. Angina is chest pain due to blocked heart arteries, and is c","https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-150868702-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-150868702.jpg 683w","Heart disease is still the leading killer of Americans so any news about treating aspects of heart disease, such as blocked arteries, is newsworthy. In addition, this story suggests that stenting ‚Äî common, but expensive ‚Äî is a prime example of over-tr",
https://www.healthnewsreview.org/review/wsjs-look-at-stent-study-solid-reporting-with-room-for-more-detail-on-costs-and-risks/,"WSJ‚Äôs look at stent study: Solid reporting, with room for more detail on costs and risks",A robust discussion of what the study measured was a strong point of this story.,Study Raises Questions About Stents in Some Heart Patients,story_reviews_00149,4,"['Jill U. Adams', 'Christopher Labos, MD', 'Joy Victory']",Wall Street Journal,"['angina', 'heart disease', 'stent']",https://www.wsj.com/articles/study-raises-questions-about-stents-in-some-heart-patients-1509661402,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention the cost of stent insertion, which can run into the tens of thousands of dollars.'}, {'question': 'D",The Wall Street Journal,This Wall Street Journal story describes surprising news that a very common procedure‚Äì inserting a stent to open a blocked blood vessel ‚Äî does not add benefit over medication in patients with angina.¬†Angina is chest pain due to blocked heart arteries,"https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-182157308-300x193.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-182157308.jpg 737w","Heart disease is still the leading killer of Americans so any news about treating aspects of heart disease, such as blocked arteries, is newsworthy. In addition, this story suggests that stenting ‚Äî common, but expensive ‚Äî is a prime example of over-tr",
https://www.healthnewsreview.org/review/first-test-anti-epilepsy-surgeries-children-shows-dramatic-benefit/,‚ÄòDramatic benefit‚Äô of surgery in kids with epilepsy‚Äìpotential harms clearly outlined,The story also discusses the potential hurdles in getting insurance coverage for the procedure.,First test of anti-epilepsy surgeries in children shows dramatic benefit,story_reviews_00150,4,"['Joann Rodgers, MS', 'Virginia A. Moyer, MD', 'Joy Victory']",Reuters Health,['Epilepsy'],http://www.reuters.com/article/us-health-epilepsy-kids-surgery/first-test-of-anti-epilepsy-surgeries-in-children-shows-dramatic-benefit-idUSKBN1CU33K,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article does an outstanding job of noting the cost of surgery, although the article could have been stronger if it had pointed ",Reuters Health,"This article describes results of a randomized trial of neurosurgical procedures designed to eliminate seizures in children under 18 years of age whose epilepsy is resistant to drug therapy.
Importantly, the story notes significant side effects attributab","https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-157313890-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-157313890.jpg 725w","Surgical approaches to intractable seizure disorders ‚Äî with some children and adults experiencing hundreds of significant seizures a day ‚Äî have been shown to improve quality of life and maintain cognitive health, particularly in young children for who",
https://www.healthnewsreview.org/review/u-s-news-world-report-story-on-copd-and-vitamin-a-left-us-wondering-whats-the-news/,U.S. News & World Report story on COPD and vitamin A left us wondering ‚Äòwhat‚Äôs the news?‚Äô,"The headline specifically targets people with COPD who are likely to be searching for treatment information, whereas the text itself fails to make the case that there is relevant news for these patients.",Can Vitamin A Help With My COPD?,story_reviews_00151,4,"['Kevin Lomangino', 'Saurabh Jha, MBBS', 'Joy Victory']",U.S. News & World Report,"['COPD', 'vitamins']",https://health.usnews.com/health-care/patient-advice/articles/2017-10-27/can-vitamin-a-help-with-my-copd,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story doesn‚Äôt discuss the costs associated with vitamin A. However, since the vitamin is readily available in foods and rel",US News & World Report,"The headline of this story asks, ‚ÄúCan vitamin A help with my COPD?‚Äù ‚Äî which suggests that there might be good reason to think that popping a supplement or eating a lot of vitamin A-rich foods would be helpful for those with this condition (more form","https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-508011138-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-508011138.jpg 724w",The bottom line message here ‚Äî there‚Äôs ‚Äúnot enough evidence‚Äù to support vitamin A supplements for COPD ‚Äî is a good one. And the story includes good information about the physiologic effects of vitamin A and the risks of an overdose. Our main con,
https://www.healthnewsreview.org/review/plenty-of-context-but-evidence-was-awol-in-wsj-story-on-uterine-fibroid-treatment/,"Plenty of context, but evidence was AWOL in WSJ story on uterine fibroid treatment",The story offers good background on how the drug works but no facts on benefits or evidence.,New Treatment for Fibroids Without Surgery,story_reviews_00153,4,"['Joann Rodgers, MS', 'Karen Carlson, MD', 'Kathlyn Stone']",Wall Street Journal,"['fibroids', 'UA', 'uliprital acetate']",https://www.wsj.com/articles/new-treatment-for-fibroids-without-surgery-1508772724?tesla=y,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article does not offer any cost information.'}, {'question': 'Does the story adequately quantify the benefits of the treatm",The Wall Street Journal,"This Wall Street Journal article describes the advent of a new¬†oral medication,¬†uliprital acetate, or UA, to treat severe bleeding and other symptoms associated with uterine fibroids. Although the article does a good¬†job of putting Allergan‚Äôs new ora","https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-851837058-300x244.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-851837058-768x624.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","As the article aptly points out, uterine fibroids are a source of significant pain, bleeding, anemia, infertility and disability in tens of millions of women, most of them in their childbearing years. The symptoms and complications can seriously interfere",
https://www.healthnewsreview.org/review/readers-will-be-swept-in-by-newsweeks-story-on-pending-muscular-dystrophy-drug-but-what-does-the-evidence-show/,"Readers will be swept in by Newsweek‚Äôs story on pending muscular dystrophy drug, but what does the evidence show?","Given the vividness of anecdotal accounts, the research details in a story like this must be a dominant and detailed part of the story.",MUSCULAR DYSTROPHY: HEARTBROKEN FAMILY AWAITS FDA DECISION ON EXPERIMENTAL DRUG,story_reviews_00156,4,"['Sharon Dunwoody, PhD', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",Newsweek,['muscular dystrophy'],http://www.newsweek.com/muscular-dystrophy-heartbroken-family-awaits-fda-decision-experimental-drug-681835,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Cost plays an important role in this story, as the drug (should it come to market) would be expensive and there is considerable unc",Newsweek,"This story focuses on a family tragedy‚Äîthree young boys in a single family with a fatal genetic disorder called Duchenne muscular dystrophy‚Äîand the family‚Äôs hope that an experimental drug, which the three boys have been taking as part of a clinical ","https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-477750750-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-477750750.jpg 724w","Letting the emotional intensity of anecdotal information duke it out with systematic research findings is a proven reader-grabber. But selecting this narrative route requires dedication to a story line that never lets the reader forget that good, systemat",
https://www.healthnewsreview.org/review/wise-wsj-reporting-on-ebola-vaccine-it-is-unknown-what-antibody-levels-are-needed-to-protect-patients/,WSJ wisely reports on Ebola vaccines: ‚ÄòIt is unknown‚Ä¶what antibody levels are needed to protect patients‚Äô,"That said, we think the story would have been stronger had it been more clear on the industry connections behind the study, and if it had discussed availability of the vaccine‚Äìespecially if a new outbreak occurs.",Ebola Vaccines Show Promise in New Study,story_reviews_00157,4,"['Earle Holland', 'Preeti N. Malani, MD, MSJ', 'Joy Victory']",Wall Street Journal,"['Ebola', 'vaccine']",https://www.wsj.com/articles/ebola-vaccines-show-promise-in-new-study-1507755629,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Vaccine pricing is complicated and prices are unknown at this point in development (pre-clinical). The story could have address",The Wall Street Journal,"This Wall Street Journal story reports on a New England Journal of Medicine-published study of the trial of two potential vaccines against Ebola disease. Overall, it‚Äôs a brief¬†but well-constructed article on a much anticipated study of two Ebola candid","https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-507067097-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-507067097-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/201","Vaccine development for Ebola would be a big step forward in combatting a deadly infection. And it can be tempting for journalists to get caught up in the exciting research developments, but as we‚Äôve discussed, journalists and consumers need to immunize",
https://www.healthnewsreview.org/review/new-york-times-is-upfront-about-risk-of-absolutely-crazy-prices-for-gene-therapy-treatment/,New York Times is upfront about risk of ‚Äòabsolutely crazy‚Äô prices for gene therapy treatment,"But the story left out some outstanding questions that remain about the treatment, such as the fact that we don‚Äôt know if the benefits are temporary.","In a First, Gene Therapy Halts a Fatal Brain Disease",story_reviews_00160,4,"['Matt Shipman', 'Virginia A. Moyer, MD', 'Joy Victory']",New York Times,"['ALD', 'gene therapy', ""Lorenzo's oil""]",https://www.nytimes.com/2017/10/05/health/gene-therapy-brain-disease.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health&region=rank&module=package&version=highlights&contentPlacement=1&pgtype=sectionfront&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story tackles this issue head on, though what they report may not be comforting for those affected. Here‚Äôs how they address t",The New York Times,This story is one of two that we are reviewing (the other is from the Associated Press) that focuses on a recent paper published in the New England Journal of Medicine. At issue is a novel gene therapy used to limit or eliminate symptoms related to the di,"https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-547435764-300x169.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-547435764-768x432.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Left untreated, ALD often leads to death within 1-10 years of diagnosis. And there are precious few treatment options available. What‚Äôs more, the primary treatment, bone marrow transplantation, relies on the availability of a donor ‚Äî and poses signifi",
https://www.healthnewsreview.org/review/ap-makes-it-clear-that-gene-therapy-has-uncertain-future-for-treating-ald/,AP makes it clear that gene therapy has uncertain future for treating ALD,"However, the story appears to mischaracterize current treatment options for the disease, and overlooked the potential harms of gene therapy.",Gene therapy helps boys with 'Lorenzo's Oil' disease,story_reviews_00161,4,"['Matt Shipman', 'Virginia A. Moyer, MD', 'Joy Victory']",Associated Press,"['ALD', 'gene therapy', ""Lorenzo's oil""]",http://abcnews.go.com/Health/wireStory/gene-therapy-helps-boys-lorenzos-oil-disease-50285402?cid=clicksource_26_4_article%20roll_articleroll_hed,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not discuss cost, but it does at least acknowledge that cost may be an issue. As the story notes: ‚ÄúThe main qu",Associated Press,This story is one of two that we are reviewing (the other is from the New York Times) that focuses on a recent paper published in the New England Journal of Medicine. At issue is a novel gene therapy used to limit or eliminate symptoms related to the dise,"https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-504703084-279x300.jpg 279w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-504703084.jpg 570w","Left untreated, ALD often leads to death within 1-10 years of diagnosis. And there are precious few treatment options available. What‚Äôs more, the primary treatment, bone marrow transplantation, relies on the availability of a donor ‚Äî and poses signifi",
https://www.healthnewsreview.org/review/study-limitations-needed-more-attention-in-inquirers-look-at-whooping-cough-vaccine-study/,Study limitations needed more attention in Inquirer‚Äôs look at whooping cough vaccine study,"It would have helped to see the study‚Äôs results characterized in more absolute terms, and the quality of its evidence discussed in slightly more detail.",Study: Whooping cough vaccination during pregnancy protects newborns,story_reviews_00164,4,"['Dave Mosher', 'Ranit Mishori, MD, MHS, FAAFP', 'Joy Victory']",Philadelphia Inquirer,['vaccines'],http://www.philly.com/philly/health/kids-families/study-whooping-cough-vaccination-during-pregnancy-protects-newborns-20170928.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of a Tdap vaccine for mothers isn‚Äôt noted, and it should be: It‚Äôs free under any insurance plan, per the Affordabl",The Philadelphia Inquirer,A Philadelphia Inquirer story covers the latest Centers for Disease Control and Prevention study that asked how much pregnant mothers‚Äô vaccines for pertussis ‚Äî more commonly called whooping cough ‚Äî helped their babies in the first 2 months of life. ,"https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-182178151-300x226.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-182178151.jpg 681w","Pertussis, or whooping cough, can be a deadly disease for non-immunized infants. Because infections are increasing in the U.S., it is important to look at various public health interventions to prevent new cases from occurring. This information is newswor",
https://www.healthnewsreview.org/review/cnn-speculates-about-benefits-of-preliminary-research-finding-on-potential-cte-biomarker/,CNN speculates about benefits of preliminary research finding on potential CTE biomarker,"Many news outlets covered this research, which could leave readers with the impression the finding is closer to clinical use than it really is.",Researchers identify CTE biomarker that may lead to diagnosis while alive,story_reviews_00165,4,"['Matt Shipman', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",CNN,['concussions'],http://www.cnn.com/2017/09/26/health/researchers-identify-cte-biomarker-that-may-lead-to-diagnosis-while-alive/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The relevant research finding is so far removed from a clinical diagnostic tool ‚Äî and the story makes that clear ‚Äî that it‚Äô",CNN,The story focuses on a recent journal article that reported finding higher levels of the protein CCL11 in individuals who were posthumously diagnosed with chronic traumatic encephalopathy (CTE) than was found in healthy individuals or in those who had bee,"https://www.healthnewsreview.org/wp-content/uploads/2017/09/GettyImages-841091310-300x261.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/09/GettyImages-841091310.jpg 634w","CTE has been a huge news topic lately because of its association with professional football players. For this reason, research related to CTE is likely to get a lot of attention from readers. This one certainly did, garnering coverage from several large n",
https://www.healthnewsreview.org/review/independent-source-bolsters-nprs-report-on-oral-food-challenges-for-allergies/,Independent source bolsters NPR‚Äôs report on oral food challenges for allergies,"The story would have scored stronger if it had better described what kind of research this was, and what made it novel.",This Test Can Determine Whether You've Outgrown A Food Allergy,story_reviews_00166,4,"['Ann Miller, PhD', 'Adam Cifu, MD', 'Joy Victory']",NPR,['allergies'],http://www.npr.org/sections/thesalt/2017/09/25/552959006/a-test-confirms-if-you-ve-outgrown-allergies,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention the cost of oral food challenges. That‚Äôs too bad because the economics of food challenges are part",NPR,"This story reports the results of a study of 6,300 oral food challenges, or medically supervised allergy tests, to determine whether patients have outgrown their food allergies.
The story did a good job discussing how oral food challenges work, and includ","https://www.healthnewsreview.org/wp-content/uploads/2017/09/GettyImages-165073957-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/09/GettyImages-165073957.jpg 724w","It‚Äôs important to determine the effectiveness of oral food challenges because food allergies affect¬†up to 6 million people,¬†and cost in the aggregate¬†$24 billion annually in medical and food costs and lost labor productivity. At a family level, findi",
https://www.healthnewsreview.org/review/sleep-deprivation-for-depression-philadelphia-inquirer-gives-readers-needed-context-on-study-limitations/,Sleep deprivation for depression: Philadelphia Inquirer gives readers needed context on study limitations,The story also makes it clear that the researchers are still trying to understand the connection between depression and sleep.,Strange but true: Sleep deprivation can help depression. Penn scientists want to know why,story_reviews_00167,4,"['Sally James', 'Susan Molchan, MD, MA', 'Joy Victory']",Philadelphia Inquirer,['depression'],http://www.philly.com/philly/health/health-news/penn-scientists-probe-the-mysterious-relationship-between-sleep-deprivation-and-depression-20170922.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release does not mention costs. One may assume there is no cost to sleep deprivation but the deprivation in the studies was",The Philadelphia Inquirer,"The story reports on a University of Pennsylvania research study that probed 66 other studies, in what is known as a meta-analysis. Researchers examined how sleep deprivation ‚Äî anything from three to four hours of sleep followed by 20 to 21 hours awake ","https://www.healthnewsreview.org/wp-content/uploads/2017/09/GettyImages-493155910-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/09/GettyImages-493155910.jpg 724w","Depression is a major cause of disability in the US and around the world, with estimates that 16.1 million adults in the US had an episode in 2015, according to the National Institute of Mental Health. The most common treatment for depression is drugs, an",
https://www.healthnewsreview.org/review/aps-story-on-cancer-immunotherapy-quickly-mentions-low-success-rate/,AP‚Äôs story on cancer immunotherapy quickly mentions low success rate,"However, readers may ignore those facts and instead only remember the two very positive patient anecdotes, which, while inspiring, don‚Äôt reflect the reality of how many people benefit.",The big question: Will cancer immune therapy work for me?,story_reviews_00169,4,"['Chioma Ihekweazu, PhD, MPH', 'Andrae Vandross, MD', 'Joy Victory']",Associated Press,['immunotherapy'],http://www.sfgate.com/news/science/article/The-big-question-Will-cancer-immune-therapy-work-12213681.php,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Apart from describing the treatment as ‚Äúexpensive,‚Äù readers aren‚Äôt given any additional information about the absolute co",Associated Press,This AP news story discusses immune therapy (or immunotherapy) and the various tests that cancer specialists are using to identify good and bad candidates for this kind of treatment. We appreciated the discussion around the evolving understanding of how t,"https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_42502802_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_42502802_MEDIUM-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2","As noted in the story, immune therapy has a low success rate if not targeted at the right patients, and even then benefits can be short-lived. This is vital context for readers that we don‚Äôt often see in stories about immunotherapy.",
https://www.healthnewsreview.org/review/solid-report-from-nyt-on-new-peanut-product-that-claims-to-reduce-allergy-risk/,Solid report from NYT on peanut product that claims to reduce allergy risk,"The story was strong on many points, though we wished it had better explained what a qualified health claim is, and why changing guidelines based on one study can be risky.",New Product Is First to Claim It May Reduce Peanut Allergies,story_reviews_00171,5,"['Jill U. Adams', 'Allison Dostal, PhD, RD', 'Joy Victory']",New York Times,"['allergies', 'peanuts']",https://www.nytimes.com/2017/09/14/well/family/new-product-is-first-to-claim-it-may-reduce-peanut-allergies.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health&region=stream&module=stream_unit&version=latest&contentPlac,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story cites the product‚Äôs cost: $25 for the introduction kit and and $20 for the maintenance kit, which lasts for about three",The New York Times,"This New York Times story covers the health claims of Hello, Peanut!, a powdered peanut product that allows parents to gradually expose their infants to peanuts, in accordance with pediatricians‚Äô and allergists‚Äô advice that the practice reduces the ri",nan,"While the story details the study that the qualified health claim is based on, it does not help readers understand how to interpret that limited evidence.",
https://www.healthnewsreview.org/review/reuters-health-deftly-reports-new-data-on-hormone-therapy-for-menopause/,Reuters Health deftly reports new data on hormone therapy for menopause,A discussion of the costs would have made it even stronger.,Menopause hormone therapy not linked to premature death,story_reviews_00172,5,"['Sally James', 'Karen Carlson, MD', 'Joy Victory']",Reuters Health,"['HRT', 'menopause']",https://www.reuters.com/article/us-health-menopause-hormones/menopause-hormone-therapy-not-linked-to-premature-death-idUSKCN1BN2LQ,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No information is given on the cost of a typical course of treatment.'}, {'question': 'Does the story adequately quantify the b",Reuters Health,"This is a story about a study that follows-up on the¬†long-term effects of hormone therapy on the risk of death.¬† The findings show that women who took combined hormone therapy (estrogen and progesterone) for approximately 5 years, or who took estrogen a","https://www.healthnewsreview.org/wp-content/uploads/2015/06/menopause-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/menopause.jpg 849w","The subject of women and menopause and hormone therapy has been debated for decades. This new study, which shows no significant difference in death rates for women who did or did not take hormone replacement, is important. But the take-home message, which",
https://www.healthnewsreview.org/review/healthday-cautiously-reports-results-of-opdivo-melanoma-study/,HealthDay cautiously reports results of Opdivo melanoma study,The story would have been stronger if it had mentioned the steep costs of these drugs., Immune-Focused Drug May Be New Weapon Against Advanced Melanoma,story_reviews_00175,4,"['Matt Shipman', 'Andrae Vandross, MD', 'Joy Victory']",HealthDay,"['ipilimumab', 'melanoma', 'Opdivo']",https://consumer.healthday.com/cancer-information-5/skin-cancer-news-108/immune-focused-drug-may-be-new-weapon-against-advanced-melanoma-726353.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not addressed. That‚Äôs a significant oversight given that treatment with Opdivo can reach well into the tens of thousa",Health Day,"The story focuses on a recent study that found the drug nivolumab (sold under the trade name Opdivo) is superior to the drug ipilimumab (sold as Yervoy) in preventing recurrence of Stage 3 and Stage 4 melanoma after surgery, at least when it comes to recu","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-184922903-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-184922903.jpg 724w","Study results related to new drugs are often overhyped, raising hopes in cancer patients without giving patients (and their loved ones) the information they need to place the new research findings in context. This story uses fairly cautious language and a",
https://www.healthnewsreview.org/review/stat-provides-readers-with-necessary-details-to-make-sense-of-new-psa-screening-study/,STAT provides readers with necessary details to make sense of new PSA screening study,"A thorough, nuanced and balanced examination of a re-analysis of two major PSA trials show the complexities involved in PSA screening research and underscores the difficulty physicians and patients face when it comes prostate cancer prevention.",A new study claims prostate cancer screenings significantly reduce deaths. Not everyone agrees,story_reviews_00176,4,"['Alan Cassels', 'Virginia A. Moyer, MD', 'Joy Victory']",STAT,['prostate cancer'],https://www.statnews.com/2017/09/04/prostate-cancer-analysis/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The lack of any cost information is one flaw to this article. Reminding the readers of the costs of PSA screening programs‚Äìin",STAT,This examination of two new mathematical modeling studies on the value of PSA testing accurately nails the problems in interpreting research of this nature and why it is difficult to draw firm conclusions. The reader is left with a broader understanding o,"https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-593309604-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-593309604.jpg 724w","PSA testing is a highly controversial, polarizing subject whereby those who promote it, as well as those men who have been treated based on raised prostate specific antigen levels, become evangelists for early detection. Others who examine the randomized ",
https://www.healthnewsreview.org/review/washington-posts-otherwise-well-reported-story-on-ecstasy-for-ptsd-skirts-evidence-discussion/,Washington Post‚Äôs otherwise well-reported story on ecstasy for PTSD skirts evidence discussion,"Given the long clinical trial road ahead, despite MDMA‚Äôs ‚Äúbreakthrough‚Äù status designation, much could change.","Ecstasy could be ‚Äòbreakthrough‚Äô therapy for soldiers, others suffering from PTSD",story_reviews_00179,4,"['Sharon Dunwoody, PhD', 'Susan Molchan, MD, MA', 'Joy Victory']",Washington Post,['ptsd'],https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html?utm_term=.6083790a8a15,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not discussed. Since the drug of interest‚ÄîMDMA‚Äîis banned in the US as a Schedule 1 substance, cost estimates may be",The Washington Post,"Post-traumatic stress disorder is difficult to treat.¬† Over the course of the past decade, evidence has been accumulating that the compound 3,4-methylenedioxymethamphetamine (MDMA), better known as ecstasy, may be more effective than current drugs such a","https://www.healthnewsreview.org/wp-content/uploads/2017/03/GettyImages-638959836-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/03/GettyImages-638959836.jpg 724w","The substance MDMA may meet all evidentiary challenges and emerge at some point in the future as an effective part of the treatment regimen for PTSD.¬† But drumming up enthusiasm for the drug before it is officially available, as this story may do, runs t",
https://www.healthnewsreview.org/review/in-coverage-of-anti-inflammatory-heart-drug-from-novartis-reuters-keeps-it-real/,"In coverage of anti-inflammatory heart drug from Novartis, Reuters keeps it real","In contrast to a TIME article on this study, and some others, the Reuters piece is appropriately skeptical.","Novartis hopeful for novel heart drug, despite 'modest' benefit",story_reviews_00181,4,"['Joann Rodgers, MS', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",Reuters,"['Canakinumab', 'cancer', 'heart attacks', 'Ilaris']",http://www.reuters.com/article/us-novartis-heart-drug-idUSKCN1B70AY,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This article does a great job of noting the cost and pricing issues inherent in the drug company‚Äôs efforts to develop, test and m",Reuters,"In contrast to the TIME article on this study (which we reviewed), and some others, the Reuters piece is appropriately skeptical and far more business-oriented, paying substantial detail to costs, harms, and regulatory challenges and cautions. It is skimp",nan,"The anti-inflammatory scientific arc is littered with the consequences of less-than-stellar clinical results, overblown expectations and pharmaceutical industry high-stakes business gambles. That makes it especially important for news organizations to cov",
https://www.healthnewsreview.org/review/nbc-news-doesnt-back-away-from-shortcomings-of-new-blood-test-for-early-cancer-detection/,NBC News doesn‚Äôt back away from shortcomings of new blood test for early cancer detection,"It outlines some of the potential risks as well as the benefits of the proposed test, and adequately explains that it is not yet ready for prime time.",Blood Test Finds Cancer Before Symptoms Start,story_reviews_00185,5,"['Earle Holland', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",NBC News,"['blood tests', 'cancer']",http://www.nbcnews.com/health/health-news/blood-test-finds-cancer-symptoms-start-n793181,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This story gets a satisfactory in this category by including, ‚ÄúThe genetic sequencing is also expensive right now ‚Äì on the orde",NBCNews.com,"This NBC News story reports on¬†a new approach to a blood test that might reveal early-stage cancers by detecting altered DNA floating in the bloodstream. Researchers reported an impressive success rate in finding markers that indicate cancer, although th","https://www.healthnewsreview.org/wp-content/uploads/2012/07/cancer-cells-dividing-410x301-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2012/07/cancer-cells-dividing-410x301.jpg 410w","Cancer screening (by definition, in asymptomatic patients) is complex and costly. It requires fairly complex tracking by physicians and practices, and for patients to undergo often unpleasant procedures. Because we screen for many cancers in healthy adult",
https://www.healthnewsreview.org/review/strong-recap-on-cancer-blood-test-should-have-challenged-survival-claims/,Strong recap on cancer blood test should have challenged survival claims,"Limitations of the research and the rarity of nasopharyngeal carcinoma would have been helpful to include, too.",Silicon Valley Startup Grail Sees Hope for Cancer Blood Test,story_reviews_00186,4,"['Andrew Holtz, MPH', 'Richard Hoffman, MD', 'Kathlyn Stone']",Bloomberg,"['blood test', 'nasopharyngeal carcinoma']",https://www.bloomberg.com/news/articles/2017-08-09/silicon-valley-startup-grail-sees-hope-for-cancer-blood-test,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story reports not only the cost of the blood test ($60), but the cost to detect one case (including follow-up), which the resea",Bloomberg,This story about a blood test for nasopharyngeal carcinoma focuses on the business angles of the research as much as on the potential health contributions of a new screening test. It clearly reports that there is much work to be done before such a test co,nan,Stories about medical studies should never proclaim findings that the studies were not designed to produce. This story includes several cautious descriptions of the study as a proof-of-concept and something that provides a ‚Äúglimpse of evidence‚Äù that a,
https://www.healthnewsreview.org/review/cautious-tone-underpins-healthdays-story-on-experimental-treatment-to-reduce-kidney-transplant-rejection/,Cautious tone underpins HealthDay‚Äôs story on experimental treatment to reduce kidney transplant rejection,"The article includes most of the needed cautions, shortcomings and barriers to clinical use of what remains an experimental treatment.",Novel Procedure Improves Kidney Transplant Success,story_reviews_00191,4,"['Joann Rodgers, MS', 'Clarissa Diamantidis, MD, MHS', 'Joy Victory']",HealthDay,['kidney donation'],https://consumer.healthday.com/diseases-and-conditions-information-37/misc-kidney-problem-news-432/novel-procedure-improves-kidney-transplant-success-725211.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the article notes that current desensitization efforts involving time-consuming immune system drug infusions to stifle",Health Day,"This news article describes a small clinical trial of an enzyme engineered to remove sensitizing antibodies from a patient about to undergo kidney transplantation within a few hours, increasing the chances of transplant success for potentially thousands o","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-537645661-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-537645661-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStoc","Any strategy that can safely, effectively, more easily and at lower cost improve successful transplant rates will be newsworthy to thousands seeking donor organs. But these hopeful patients also deserve to know the hurdles that stand in the way before the",
https://www.healthnewsreview.org/review/stat-puts-950-dna-based-fertility-test-under-the-microscope/,STAT puts $950 DNA-based fertility test under the microscope,The story does a thorough job of describing the test and bringing home the crucial point that the type of risk information may be more anxiety-producing than helpful.,Can a genetic test really boost your odds of becoming pregnant?,story_reviews_00192,5,"['Sharon Dunwoody, PhD', 'Kevin Lomangino', 'Joy Victory']",STAT,"['genetic testing', 'infertility', 'Pregnancy']",https://www.statnews.com/2017/08/02/infertility-genetic-test-fertilome/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Cost‚Äîsince the test is not covered by insurance‚Äîgets a prominent spot in this story. Well done.'}, {'question': 'Does the story",STAT,"Tests for genetic variants associated with problems linked to infertility are becoming increasingly available, and this story characterizes a new battery of those tests, marketed under the name Fertilome, that professes to be the latest in fertility manag","https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing.jpg 410w","It is tempting to look for genetic variants that might underlie disease, in part because we now can.¬† But this kind of information‚Äîwhether intended to inform infertility problems or other health risks‚Äîhas meaning only within contexts that illuminate ",
https://www.healthnewsreview.org/review/stem-cell-brain-implants-what-could-go-wrong-guardian-doesnt-say/,Stem cell brain implants‚Äìwhat could go wrong? Guardian doesn‚Äôt say,The bottom line is: We are talking about approximately 20 male mice.,"Stem cell brain implants could 'slow ageing and extend life', study shows",story_reviews_00195,4,"['Earle Holland', 'Ranit Mishori, MD, MHS, FAAFP', 'Joy Victory']",,"['mice studies', 'stem cell therapy', 'stem cells']",https://www.theguardian.com/science/2017/jul/26/stem-cell-brain-implants-could-slow-ageing-and-extend-life-study-shows,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We‚Äôll give the story a ‚ÄúN/A‚Äù in this category since it makes clear early on that this research is in the earliest of stages",The Guardian,"This story describes some interesting but very early research into the mechanisms of aging and how they might be altered.
The story made it clear that this was mouse-level research and has several hurdles to go before it‚Äôs ever tested in people. One wea","https://www.healthnewsreview.org/wp-content/uploads/2012/07/mice-story-homepage-300x203.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2012/07/mice-story-homepage.jpg 400w",The desire to somehow combat aging seems inherent in humans. If there is a fairly straightforward ‚Äúswitch‚Äù that can control the aging process ‚Äî and this story suggests so ‚Äî then this would be a major advance. Yet we are looking at decades before t,
https://www.healthnewsreview.org/review/vox-says-experimental-hiv-vaccine-is-promising-but-is-it/,Vox says experimental HIV vaccine is ‚Äòpromising.‚Äô But is it?,There‚Äôs far too much uncertainty in medicine to describe early results such as these as ‚Äúpromising.‚Äù,There's a promising new HIV vaccine candidate in the pipeline,story_reviews_00196,4,"['Alan Cassels', 'Kevin Lomangino', 'Joy Victory']",Vox,"['HIV/AIDS', 'vaccines']",https://www.vox.com/science-and-health/2017/7/24/16019590/hiv-vaccine-international-aids-society-conference,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While it might be premature to speculate about the exact costs of an experimental vaccine, offering no discussion at all is a m",Vox,"This story about an experimental HIV vaccine gets off on the wrong foot by describing the research as ‚Äúpromising,‚Äù which we‚Äôve previously flagged as one of 7 words that shouldn‚Äôt be used in medical news.¬†Why not? As our publisher, Gary Schwitzer,","https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-529904023-300x270.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-529904023-768x691.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","This new vaccine approach, if proven ultimately to be effective, safe and affordable, could make a major difference in resource-poor settings around the world. ¬†But, as we‚Äôve written about,¬†the field of vaccine research related to HIV is littered with",
https://www.healthnewsreview.org/review/to-taper-or-not-to-taper-off-opioids-vox-lays-out-strengths-and-weaknesses-of-new-study/,To taper or not to taper off opioids? Vox lays out strengths and weaknesses of new study,"Readers are expertly walked through the study‚Äôs weaknesses as well as an important related issue: The troubles of¬†trying to treat people for chronic pain without using opioids, and how access to such care is problematic.",A new study suggests it‚Äôs possible to get people off opioids and improve their pain,story_reviews_00198,5,"['Dave Mosher', 'Susan Molchan, MD, MA', 'Joy Victory']",Vox,"['opioids', 'painkiller addiction']",https://www.vox.com/science-and-health/2017/7/20/15988524/opioid-pain-outcomes-study,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Tapering is presumably free in and of itself, since it‚Äôs a slow and gradual lessening of opioids (which a person might already ",Vox,"This¬†story tackles a study that rounded up dozens of small studies to probe the¬†effectiveness¬†of painkiller ‚Äútapering:‚Äù a slow, gradual weaning of opioid painkillers for those who are addicted to the drugs. The story is much more than that, however","https://www.healthnewsreview.org/wp-content/uploads/2017/04/GettyImages-638310014-265x300.jpg 265w, https://www.healthnewsreview.org/wp-content/uploads/2017/04/GettyImages-638310014-768x871.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Finding better strategies to help wean people off opioid drugs is critical, so any method (especially a cheap and effective one) could help turn the tide as researchers find and introduce effective alternatives to opioid prescription drugs.",
https://www.healthnewsreview.org/review/despite-misleading-headline-newsweek-presents-balanced-account-of-a-familys-unconventional-struggle-with-cancer/,Newsweek presents a mostly balanced account of family‚Äôs unconventional cancer journey,"This story leaned in the direction of anecdote-over-evidence, but only slightly.",CANCER AND KIDS: IS MEDICAL MARIJUANA THE ANSWER?,story_reviews_00200,4,"['Andrew Holtz, MPH', 'Virginia A. Moyer, MD', 'Joy Victory']",Newsweek,"['cancer', 'leukemia', 'medical marijuana']",http://www.newsweek.com/2017/07/28/medical-marijuana-pediatric-cancer-637676.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no discussion of the cost of the cannabis treatment.'}, {'question': 'Does the story adequately quantify the benefits ",Newsweek,"We commend this story for making it clear that there is scanty evidence to support cannabis oil as a primary cancer treatment. Nevertheless, many readers will get the impression that the oil was responsible for the patient‚Äôs cancer remission and improve","https://www.healthnewsreview.org/wp-content/uploads/2017/05/GettyImages-590158202-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/05/GettyImages-590158202.jpg 723w","The emotional power of a personal anecdote is essential to good storytelling. But that emotional power must then be put into context with the evidence, so that readers can see the distinction between personal beliefs and objective facts. When stories focu",
https://www.healthnewsreview.org/review/washington-post-wisely-lets-readers-known-new-cancer-therapy-may-cost-at-least-300000/,"Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000",But the story needed more information on the clinical trial behind the findings.,First gene therapy ‚Äî ‚Äòa true living drug‚Äô ‚Äî on the cusp of FDA approval,story_reviews_00202,4,"['Matt Shipman', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",Washington Post,"['cancer', 'FDA', 'gene therapy', 'immunotherapy', 'leukemia']",https://www.washingtonpost.com/national/health-science/first-gene-therapy--a-true-living-drug--on-the-cusp-of-fda-approval/2017/07/11/bd7872a0-618a-11e7-a4f7-af34fc1d9d39_story.html?utm_term=.00bb4335a844,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story tackles this issue head on, as here: ‚ÄúNovartis has not disclosed the price for its therapy, but analysts are predicting",The Washington Post,"The story focuses on a treatment called CAR T-cell therapy, which is under review by the FDA for use in treating children with leukemia who are not responding to standard treatments.
The story does a good job of describing the treatment, how it‚Äôs differ","https://www.healthnewsreview.org/wp-content/uploads/2017/07/GettyImages-485339219-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/07/GettyImages-485339219.jpg 683w","This story looks specifically at using an immunotherapy treatment to tackle treatment-resistant leukemia in young people. And while childhood leukemia is rare, it is the most common form of cancer in children and adolescents. That alone makes the subject ",
https://www.healthnewsreview.org/review/vaccine-shows-protection-against-gonorrhea-stat-reports-but-what-about-the-costs-and-potential-harms/,"Vaccine shows protection against gonorrhea, STAT reports. But what about the costs and potential harms?","This industry-sponsored study received broad coverage, much of which downplayed the lack of safety and efficacy data while raising an alarm about antibiotic-resistant gonorrhea and neglecting other strategies to combat the disease.","Vaccine shows protection against gonorrhea for first time, study says",story_reviews_00203,4,"['Mary Chris Jaklevic', ""A'ndrea Elyse Messer, MS, PhD"", 'Joy Victory']",STAT,"['gonorrhea', 'sexually transmitted', 'vaccines']",https://www.statnews.com/2017/07/10/gonorrhea-vaccine-study/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There‚Äôs no mention of how much a gonorrhea vaccine might cost. In the U.S. meningitis B vaccine Bexsero, which contains manuf",STAT,"This story reports on a New Zealand study that suggests a vaccine that protects against a strain of meningitis may also offer some protection against gonorrhea. The research, published in the Lancet, estimated that a meningitis B vaccine administered to t","https://www.healthnewsreview.org/wp-content/uploads/2012/07/vaccine-410-x-410-300x300.png 300w, https://www.healthnewsreview.org/wp-content/uploads/2012/07/vaccine-410-x-410-150x150.png 150w, https://www.healthnewsreview.org/wp-content/uploads/2012/07/vac","Gonorrhea is common worldwide, with an estimated 820,000 new infections annually in the U.S. Untreated, it can cause infertility and lead to infections in other parts of the body. Yet journalists should use caution when reporting on the potential for a va",
https://www.healthnewsreview.org/review/two-big-studies-bolster-claim-coffee-even-decaf-good/,‚ÄúGood for you‚Äù or not? Mixed messages in LA Times coverage of coffee studies,"If the studies ‚Äúweren‚Äôt designed to show that drinking more coffee caused people to live longer,‚Äù why suggest that drinking more coffee may ‚Äúextend your life‚Äù?",Two big studies bolster the claim that coffee ‚Äì even decaf ‚Äì is good for you,story_reviews_00204,4,"['Jill U. Adams', 'Edward Ward, MD', 'Kevin Lomangino']",limits of observational studies,['coffee'],http://www.latimes.com/science/sciencenow/la-sci-sn-coffee-health-20170710-story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There‚Äôs little need to discuss costs of a substance as well known as coffee.'}, {'question': 'Does the story adequately quantif",Los Angeles Times,"This Los Angeles Times story was one of many news outlets to report on a pair of large epidemiological studies on coffee-drinking and mortality. And like many of those other stories, this piece seems to assume that coffee really is healthy, although that ","https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000048278610_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000048278610_Small.jpg 849w","As the article states, ‚Äú2.25 billion cups of coffee are consumed‚Äù each day around the world. Coffee is widely consumed and many people drink multiple cups per day. The potential health benefits and risks of coffee, like its consumption cousins wine an",
https://www.healthnewsreview.org/review/its-misleading-to-call-results-from-phase-1-trials-with-6-and-13-patients-a-cancer-breakthrough/,It‚Äôs misleading to call results from phase 1 trials with 6 and 13 patients a ‚Äòcancer breakthrough‚Äô,"Although the two trials profiled in the Newsweek article are phase 1 safety trials, the article barely mentions safety and calls it a breakthrough ‚Äî quite prematurely.",CANCER BREAKTHROUGH: PERSONALIZED MELANOMA VACCINES ‚ÄòSAFE AND EFFECTIVE‚Äô IN FIRST HUMAN CLINICAL TRIALS,story_reviews_00205,4,"['Chioma Ihekweazu, PhD, MPH', 'Mandy Stahre, PhD', 'Kathlyn Stone']",Newsweek,"['immunotherapy', 'melanoma', 'vaccine']",http://www.newsweek.com/cancer-vaccine-personalized-medicine-clinical-trial-632196,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This story doesn‚Äôt discuss how much the vaccines cost. Therefore, readers can‚Äôt compare the affordability of these vaccines",Newsweek,"Ungrounded speculation or reasonable caution? Both are present in this Newsweek story on two very early trials of immunotherapy drugs being developed to protect against melanoma. While the headline calls the research ‚Äúa cancer breakthrough,‚Äù quotes fr","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-526212629-300x247.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-526212629.jpg 651w","Results from small, preliminary studies like these involving six and 13 volunteers should be viewed cautiously.
Information about the effectiveness of a treatment is of limited consequence if patients cannot afford the treatment. There needs to be a discu",
https://www.healthnewsreview.org/review/emailed-help-for-smoking-cessation/,U.S. News takes careful look at emailed help for smoking cessation,"An informative, detailed description of a smoking cessation study that places the results nicely in context.",You‚Äôve Got Mail About Quitting Smoking,story_reviews_00206,5,"['Dave Mosher', 'Michael Bierer MD, MPH', 'Kevin Lomangino']",U.S. News & World Report,['smoking cessation'],http://health.usnews.com/health-care/patient-advice/articles/2017-07-06/youve-got-mail-about-quitting-smoking,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost isn‚Äôt provided, since the work is not available to the public. But like most other digital aids for smoking cessation,",US News & World Report,"This story by U.S. News & World Report highlights the results of a trial of a digital aid to quit smoking: tailored emails. Researchers sent multiple encouraging messages, which also included links to information on how to quit, to willing smokers, then f","https://www.healthnewsreview.org/wp-content/uploads/2017/07/GettyImages-586936498-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/07/GettyImages-586936498-768x513.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Smoking kills nearly half a million Americans every year, according to the CDC, and dependence on tobacco products is seen by many medical professionals today as a chronic disease. Any new tool to help smokers quit and reduce their risks for disabling and",
https://www.healthnewsreview.org/review/washington-post-deftly-examines-lack-of-evidence-for-a-fuzzy-area-of-psychiatry-animal-therapy/,Washington Post deftly examines lack of evidence for a fuzzy area of psychiatry: animal therapy,The story effectively conveys the lack of scientific consensus regarding how effective therapy animals are at reducing stress.,Therapy animals are everywhere. Proof that they help is not.,story_reviews_00207,5,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",Washington Post,['therapy'],https://www.washingtonpost.com/news/animalia/wp/2017/07/02/therapy-animals-are-everywhere-proof-that-they-help-is-not/?utm_term=.cd3259dfb785,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not discussed, but this is an important factor to consider when evaluating any intervention‚Äìand especially one that c",The Washington Post,"The story focuses on the lack of evidence supporting the fundamental concept of ‚Äútherapy animals‚Äù ‚Äî that interacting with animals can reduce stress or distress in humans.
The story includes input from an array of expert sources and offers a broad (i",nan,"Tackling the efficacy of therapy animals is a challenging subject, given that the story evaluates an absence of conclusive evidence. However, it‚Äôs an important subject. For example, therapy dogs can be expensive, which means a family may spend a great d",
https://www.healthnewsreview.org/review/preeclampsia-and-aspirin-healthday-does-solid-job-covering-new-study-findings/,Preeclampsia and aspirin: HealthDay does solid job covering new study findings,We especially liked that the story gave us the absolute risk reduction so we see a more accurate assessment of the intervention‚Äôs benefits.,Can an Aspirin a Day Keep a Pregnancy Complication Away?,story_reviews_00209,5,"['Earle Holland', 'Virginia A. Moyer, MD', 'Joy Victory']",HealthDay,"['heart disease', 'Pregnancy']",https://consumer.healthday.com/diseases-and-conditions-information-37/pre-eclampsia-994/can-an-aspirin-a-day-keep-a-pregnancy-complication-away-724086.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We‚Äôll consider this N/A since generic aspirin is very affordable. Still, we never think it‚Äôs a bad idea to acknowledge the co",Health Day,"This story from HealthDay does a good job of explaining the benefits, harms and quality of the evidence from the study, which assessed aspirin‚Äôs ability to prevent preeclampsia in certain women who are deemed high risk.
However, we wish the story had¬†m","https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000070337539_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000070337539_Small.jpg 849w",Preeclampsia is one of the top global causes of maternal and infant mortality. If taking a low dose of a readily available and inexpensive drug during pregnancy can reduce the risk of pre-term complications among high-risk women ‚Äî as this story and stud,
https://www.healthnewsreview.org/review/buzzfeed-offers-refreshing-candor-in-explainer-piece-on-female-condom/,Buzzfeed offers refreshing candor in explainer piece on female condom,"This story provides details about the price, exact mechanics of use and about effectiveness.",Here's What You Need To Know About The Female Condom,story_reviews_00210,5,"['Sally James', 'Karen Carlson, MD', 'Joy Victory']",BuzzFeed,['contraceptives'],https://www.buzzfeed.com/caseygueren/13-things-you-need-to-know-about-the-female-condom?utm_term=.xyBXr6P8Lv#.xaPXJ5kYv2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Hooray for details on cost, including nuances about ‚Äúfree‚Äù but only with prescription. We also believe the details on availabil",BuzzFeed,"Credit: Anka Grzywacz
This is a well-rounded ‚Äúexplainer‚Äù story looking at female condoms, a less frequently used form of contraception compared to male condoms. The story is not directly tied to a specific research study, but does include numbers for ",nan,"Women can be at a cultural disadvantage in asking for birth-control prevention at the time of intercourse, and are at risk for sexually transmitted diseases, including HIV because of exposure. Female condoms could be a relatively low-cost answer to this p",
https://www.healthnewsreview.org/review/wsjs-look-at-digital-therapy-covers-a-lot-of-ground-except-potential-downsides/,WSJ‚Äôs look at digital therapy covers a lot of ground‚Äìexcept potential downsides,"The story hits a lot of the right notes, employing independent sources, making clear that efficacy studies are still relatively sparse, and giving readers access to actual study texts.","To Treat Depression, Try a Digital Therapist",story_reviews_00211,4,"['Sharon Dunwoody, PhD', 'Dan Mayer, MD', 'Joy Victory']",Wall Street Journal,['depression'],https://www.wsj.com/articles/to-treat-depression-try-a-digital-therapist-1498227092,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôre rating this one a cautious ‚ÄúSatisfactory.‚Äù\xa0 The story offers no information about the cost to a patient of a digital",The Wall Street Journal,"This story heralds the evolution of internet-based therapies for treating mild to moderate depression.¬† It summarizes several recent studies, which find that a combination of interacting with both a ‚Äúsmart‚Äù internet app and human therapists competes ","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000065995387_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000065995387_Small.jpg 849w","Initial research suggests that internet-based approaches to therapy can work for individuals with minor or moderate mental health problems.¬† If that good news continues to hold over the course of further studies, such a strategy would be a boon in areas ",
https://www.healthnewsreview.org/review/though-light-on-data-u-s-news-world-report-story-covers-lack-of-evidence-for-arthroscopic-knee-surgery/,"Though light on data, U.S. News & World Report story looks at lack of evidence for arthroscopic knee surgery",The article overall leaves thoughtful readers with a ‚Äúthink twice or thrice‚Äù take home message if they are considering arthroscopy.,The Case Against ‚Äì and for ‚Äì Arthroscopic Knee Surgery,story_reviews_00213,4,"['Joann Rodgers, MS', 'James Rickert, MD', 'Joy Victory']",U.S. News & World Report,['knee osteoarthritis'],http://health.usnews.com/health-care/patient-advice/articles/2017-06-22/the-case-against-and-for-arthroscopic-knee-surgery,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the article puts an overall price tag on arthroscopy nationwide, the reader will not learn what a typical arthroscopy ",US News & World Report,"This news story uses a recent meta-analysis of already-published research as the news hook to review the pros and cons of arthroscopic knee surgery to treat both acute and chronic knee pain.
The article overall leaves thoughtful readers with a ‚Äúthink tw","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_79889613_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_79889613_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Given the rare but potentially serious risks of arthroscopy (infection and blood clots, for example, as noted in the article) and the lengthy recovery and rehab (around six weeks of limitation and therapy), stories like this one are important to help the ",
https://www.healthnewsreview.org/review/o-shot-incontinence-fix-inquirer-clearly-sets-out-lack-of-scientific-support-for-procedure/,‚ÄòO-Shot‚Äô incontinence fix: Inquirer sets out lack of scientific support for procedure,Sometimes it‚Äôs a good idea to bring a claim out of the shadows of website marketing and lone-wolf clinics and use the skills of reporting to inform¬†a fairly wide audience what‚Äôs what with an unproven therapy.,The O-Shot: Incontinence fix or empty promise?,story_reviews_00217,5,"['Joann Rodgers, MS', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",Philadelphia Inquirer,['urinary incontinence'],http://www.philly.com/philly/health/health-news/the-o-shot-incontinence-fix-or-empty-promise-20170618.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does a good job of not only giving the price of the O-shots, but leaving the reader with the clear understanding that the",The Philadelphia Inquirer,"This story about the use of an unproven treatment‚Äìcalled ‚ÄúO-shot‚Äù‚Äìto stop urinary leakage in women does a lot of things well. Specifically, it:
Two ways the story could have been stronger? If it had included a patient anecdote that wasn‚Äôt quite ","https://www.healthnewsreview.org/wp-content/uploads/2017/06/GettyImages-625387182-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/06/GettyImages-625387182.jpg 724w","As the story makes clear, urinary ‚Äústress‚Äù incontinence is a significant clinical problem for millions of women, interfering with active lifestyles and quality of life. Current surgical, medical and lifestyle treatments work but not always reliably, a",
https://www.healthnewsreview.org/review/small-unpublished-study-on-new-knee-pain-procedure-needed-more-scrutiny-from-nbc-news/,"Small, unpublished study on new knee pain procedure needed more scrutiny from NBC News","From what we can tell, there‚Äôs really not much high-quality data on this procedure‚Äìdespite the FDA approval.",‚ÄòCool‚Äô New Knee Procedure Eases Arthritis Pain Without Surgery,story_reviews_00218,4,"['Sharon Dunwoody, PhD', 'Edward Ward, MD', 'Joy Victory']",NBC News,['knee osteoarthritis'],http://www.nbcnews.com/health/health-news/cool-new-knee-procedure-eases-arthritis-pain-without-surgery-n771221,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Costs are indeed addressed.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedur",NBCNews.com,"Knees crippled by osteoarthritis sideline millions of Americans. While most folks seeking help are offered such treatments¬†as physical therapy and steroid injections, this story describes another option: using radio frequency to ‚Äúmute‚Äù the nerves in ","https://www.healthnewsreview.org/wp-content/uploads/2015/11/knee-pain-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/knee-pain-1024x682.jpg 1024w","The FDA approved this treatment earlier this spring, and that means its use could spread rapidly, making accurate stories about it all the more important. (Approval is no guarantee of safety of effectiveness.)",
https://www.healthnewsreview.org/review/time-takes-cautious-approach-with-probiotics-for-depression-study/,TIME takes cautious approach with probiotics and depression study,"However, we think the story would have been stronger if it had dug into the measured benefits a bit more: How were symptoms measured and by how much did they decrease?",How Probiotics May Help Depression,story_reviews_00223,4,"['Chioma Ihekweazu, PhD, MPH', 'Susan Molchan, MD, MA', 'Joy Victory']",TIME,"['depression', 'Probiotics']",http://time.com/4801842/probiotics-mood-depression-ibs/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Readers aren‚Äôt given information about\xa0how much the probiotic might cost.'}, {'question': 'Does the story adequately quant",Time,"Depression and irritable bowel syndrome (IBS) are both common conditions in the US. Consequently, so any treatment that can effectively¬†manage both conditions is an attractive one. This story about a new study looking at probiotics for depression does a ","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000051951024_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000051951024_Small.jpg 849w","People hear a lot about probiotics and it‚Äôs important they be tested systematically and in controlled trials. It‚Äôs just as important that media coverage highlights the limitations of the trials‚Äìand this story did.
¬†",
https://www.healthnewsreview.org/review/bloomberg-offers-up-balanced-recap-of-new-breast-cancer-therapy/,Bloomberg offers up balanced recap of new breast cancer therapy,"The downsides (cost, side effects and minimal benefit) received as much attention in the article as did the optimism offered by the researchers and drug sponsors.",Roche's Pricey New Breast-Cancer Combo Barely Beats Old Drug,story_reviews_00224,5,"['Susan Wei, PhD', 'Mandy Stahre, PhD', 'Kathlyn Stone']",Bloomberg,"['Bloomberg', 'breast cancer', 'Herceptin', 'Perjeta']",https://www.bloomberg.com/news/articles/2017-06-05/roche-s-pricey-new-breast-cancer-combo-barely-beat-its-old-drug,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We are told the new combo treatment will double the monthly costs of just Herceptin from $6,100 to $12,200.'}, {'question': 'Does t",Bloomberg,"The latest result¬†on Roche‚Äôs new combo therapy for breast cancer occurs as a disappointment to investors, though it is one that‚Äôs unsurprising to medical researchers. This Bloomberg article receives high marks for reporting the cost, harms and perhap","https://www.healthnewsreview.org/wp-content/uploads/2017/04/breastcancer1-300x240.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/04/breastcancer1.jpg 661w","The article suggests that though Herceptin has been a potent treatment for women with aggressive HER2-positive breast cancer for decades, apparently one in four women will eventually relapse. Thus, new therapies that reduce¬†the risk of relapsing are desi",
https://www.healthnewsreview.org/review/cannabidiol-slashes-seizures-kids-rare-epilepsy-study-finds/,CNN deftly reports on results of trial of cannabis-derived drug for severe epilepsy,The story would have been even stronger if it¬†had discuss the potential costs of the treatment.,"Cannabidiol slashes seizures in kids with rare epilepsy, study finds",story_reviews_00227,5,"['William Heisel', 'Karen Carlson, MD', 'Joy Victory']",CNN,['Epilepsy'],http://www.cnn.com/2017/05/24/health/cannabidiol-epilepsy-study/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was not a discussion of costs for this intervention‚Äìthis was the weak spot in the story.'}, {'question': 'Does the stor",CNN,"Whenever we see a verb like ‚Äúslashes‚Äù in a headline, our skepticism meter starts to buzz. In this case, the headline does not do the story justice. The story appropriately brings to light the current state of evidence around medical use of marijuana f","https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000033205626_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000033205626_Medium-1024x682.jpg 1024w","Quantitative reporting of evidence, unaffiliated expert commentary, and context setting‚Äìthese are the details that help accurately explain the implications of new research and truly inform readers.",
https://www.healthnewsreview.org/review/cautions-and-caveats-help-buoy-guardian-story-on-using-high-platelet-count-for-cancer-detection/,Cautions and caveats help buoy Guardian story on using high platelet count for cancer detection,"The story‚Äôs headline‚Äì‚ÄúHigh Blood Platelet Count ‚ÄòAs Good A Cancer Predictor as a Lump in the Breast‚Äù‚Äìis unfortunate, though, because it suggests to the reader that the blood test is a test for breast cancer (it isn‚Äôt a test for any specific ","High blood platelet count 'as good a cancer predictor as a lump in the breast,‚Äô",story_reviews_00229,4,"['Joann Rodgers, MS', 'Mandy Stahre, PhD', 'Joy Victory']",The Guardian,"['cancer', 'cancer test']",https://www.theguardian.com/science/2017/may/23/high-blood-platelet-count-as-good-a-cancer-predictor-as-a-lump-in-the-breast,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Blood testing costs vary widely, but can run to hundreds of dollars, even for those covered by national or private health insur",The Guardian,"With the exception of a misleading and somewhat¬†hyped headline,¬†this¬†British newspaper story¬†fairly describes results of some¬†data-mining research that adds strength to previously observed associations between a form of seriously elevated blood plate","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_38649484_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_38649484_MEDIUM-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2","In general ‚Äî albeit with caveats ‚Äî the earlier cancers are diagnosed the more likely treatments are to be appropriate and effective. But early detection remains a challenge for scientific reasons but also for reasons related to costs of care, access t",
https://www.healthnewsreview.org/review/could-an-expensive-chemotherapy-drug-treat-severe-asthma-its-too-soon-to-ask/,Could an expensive chemotherapy drug treat severe asthma? It‚Äôs too soon to know,"Considering how preliminary this trial is, there‚Äôs not a lot of news value to lay readers who are hoping for new asthma treatment options.",Could Cancer Drug Gleevec Help With Severe Asthma?,story_reviews_00230,4,"['Mary Chris Jaklevic', 'Clarissa Diamantidis, MD, MHS', 'Joy Victory']",HealthDay,['asthma'],https://consumer.healthday.com/cancer-information-5/gleevec-news-834/could-cancer-drug-gleevec-help-with-severe-asthma-722902.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We were glad the story addressed costs, but actual figures would have been more helpful. It says imatinib ‚Äúmight provide a relati",Health Day,"A headline that ends in a question mark can¬†often be answered with the word no. That adage applies here, in a story about a 62-person trial that tested whether leukemia drug imatinib, sold by Novartis and marketed as Gleevec, could be used to treat sever","https://www.healthnewsreview.org/wp-content/uploads/2017/05/GettyImages-501776757-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/05/GettyImages-501776757-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Millions of adult asthma patients have uncontrolled asthma, associated with lower quality of life and more healthcare use, according to the CDC. There has not been a significant shift in the availability of effective asthma therapies in recent decades. St",
https://www.healthnewsreview.org/review/bloomberg-story-provides-clear-eyed-view-of-trendy-neurofeedback-brain-training-clinics/,Bloomberg story provides clear-eyed view of trendy neurofeedback brain-training clinics,Expert sources and a review of the scientific literature ground the story and help balance the anecdotes.,Neurofeedback Could Fight Depression‚Äìor Just Empty Your Wallet,story_reviews_00232,5,"['Ann Miller, PhD', 'Susan Molchan, MD, MA', 'Joy Victory']",Bloomberg,['depression'],https://www.bloomberg.com/news/articles/2017-05-18/neurofeedback-could-fight-depression-or-just-empty-your-wallet,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story\xa0states the cost of a session of neurofeedback at Neurocore. The story would have been stronger if it had clarified whe",Bloomberg,"This story discusses the state of evidence for neurofeedback for treating depression, ADD, anxiety, and a number of other issues. Readers are introduced to the topic through the experience of the writer, who went for a $250 diagnostic session at the offic","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_32711818_SMALL-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_32711818_SMALL-768x576.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","As the title of the story indicates, neurofeedback is an expensive treatment option. People dealing with a range of conditions that¬†have not been amenable to other treatments might be tempted to try neurofeedback despite the cost, impressed by the scient",
https://www.healthnewsreview.org/review/except-for-needing-more-sources-reuters-health-story-on-graves-disease-is-well-reported/,"Except for needing more sources, Reuters Health story on Graves‚Äô disease is well-reported","The story does a lot of things well‚Äìit adequately quantifies the benefits from use of the drug, as well as outlining the potential risks associated with it.","Experimental drug reduces thyroid-associated ‚ÄòGraves' eyes,‚Äô",story_reviews_00237,4,"['Earle Holland', 'Kevin Lomangino', 'Joy Victory']",Reuters Health,['thyroid'],http://www.reuters.com/article/us-health-graves-eyes-drug-idUSKBN18523X,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of the potential price of teprotumumab, an important piece of context for the story. Will patients be able ",Reuters Health,"This Reuters story reports on a clinical trial testing the use of a new experimental drug, teprotumumab, to relieve Graves‚Äô ophthalmopathy, the bulging eyes that often affect patients with Graves‚Äô disease.
The story does a lot of things well‚Äìit adeq","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000025411579_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000025411579_Medium-1024x682.jpg 1024w","According to the National Institute of Diabetes and Digestive and Kidney Diseases, Graves‚Äô disease is the most common form of hyperthyroidism in the United States and between 25 and 30 percent of those patients may go on to develop the bulging eye sympt",
https://www.healthnewsreview.org/review/marijuana-and-memory-newsweek-writes-about-mouse-research-but-is-at-least-upfront-about-it/,Marijuana and memory: Newsweek writes about mouse research‚Äìbut is at least upfront about it,"The story goes into some detail about the substantial barriers to studying similar effects in people and offers explicit, attributed cautionary statements about marijuana‚Äôs potential adverse effects.",CAN MARIJUANA RESTORE MEMORY? NEW STUDY SHOWS CANNABIS CAN REVERSE COGNITIVE DECLINE IN MICE,story_reviews_00238,4,"['Joann Rodgers, MS', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",Newsweek,"['marijuana', 'medical marijuana', 'mice studies']",http://www.newsweek.com/cannabis-marijuana-restores-memory-learning-cognitive-decline-596160,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the story describes mouse experiments, it draws parallels to human marijuana use and some mention of the cost of its u",Newsweek,"This Newsweek article describes a study designed to find and measure the effects of marijuana‚Äôs active chemical ingredient on learning and memory in mammals. In this case, it‚Äôs mice fed an indeterminate (from the story itself) amount of cannabinoid TH","https://www.healthnewsreview.org/wp-content/uploads/2017/05/GettyImages-590158202-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/05/GettyImages-590158202.jpg 723w","With the boom in the relatively easy availability of recreational and medicinal availability of marijuana in the U.S and elsewhere, stories about studies on the positive and negative effects of marijuana use‚Äìespecially long-term, chronic use‚Äìare flood",
https://www.healthnewsreview.org/review/a-pat-on-the-back-to-healthday-for-thorough-report-on-ulcerative-colitis-drug/,A pat on the back to HealthDay for thorough report on ulcerative colitis drug,All it was missing was the cost of the drug.,Arthritis Drug Shows Promise for Ulcerative Colitis,story_reviews_00240,5,"['Matt Shipman', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",HealthDay,"['biologic drugs', 'ulcerative colitis']",https://consumer.healthday.com/gastrointestinal-information-15/inflammatory-bowel-disease-news-78/arthritis-drug-shows-promise-for-ulcerative-colitis-722330.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story doesn‚Äôt mention cost. This is a significant oversight, given that a glance at online pricing guides indicate the dr",Health Day,"The story reports on a journal article published in the New England Journal of Medicine (NEJM), regarding several clinical trials that found the arthritis drug tofacitinib (marketed under the name Xeljanz) was an effective treatment for ulcerative colitis","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000051951024_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000051951024_Small.jpg 849w","Those with ulcerative colitis, and their loved ones, are likely eager for news of new treatment options, particularly if they have exhausted other drug treatment options. That makes it particularly important to present related research findings in context",
https://www.healthnewsreview.org/review/stats-cautious-story-provides-interesting-insights-into-challenges-of-alzheimers-research/,STAT‚Äôs cautious story provides interesting insights into challenges of Alzheimer‚Äôs research,"This piece shows that you can provide the right note of caution while reporting on a scientific study without over-hyping, promising a cure-all, or throwing all caveats out the window.","In small Alzheimer‚Äôs study, hints of modest benefit from unusual drug",story_reviews_00243,5,"['William Heisel', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",STAT,"[""alzheimer's disease""]",https://www.statnews.com/2017/05/01/alzheimers-neurotrope-results/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There are no mentions of costs in the piece. Ordinarily, we expect to see some discussion of what the cost may be‚Äìespecially wh",STAT,"Reviewers for¬†HealthNewsReview.org sometimes get asked, ‚ÄúWhat do you want, a totally boring story?‚Äù This piece shows that you can provide the right note of caution while reporting on a scientific study without over-hyping, promising a cure-all, or th","https://www.healthnewsreview.org/wp-content/uploads/2015/08/Brain-mysteries-410x286-300x209.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/Brain-mysteries-410x286.jpg 410w",This piece highlights a novel agent that in an early-stage study showed small benefits of a short duration that weren‚Äôt even definitely proven to be related to the medicine. The fact that this study‚Äìnot even published or presented at a meeting‚Äìgener,
https://www.healthnewsreview.org/review/cnn-avoids-making-slimy-claims-about-preliminary-study-using-frog-peptides-to-kill-flu-viruses/,CNN avoids slimy claims about using frog peptides to kill flu viruses,"On the flip side, the story is not helped by the headline, which leaves the question of applicability to humans quite open.",Researchers use frog mucus to fight the flu,story_reviews_00247,5,"['Sharon Dunwoody, PhD', 'Edward Ward, MD', 'Joy Victory']",CNN,['flu shot'],http://www.cnn.com/2017/04/18/health/frog-flu-virus-study/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This story describes basic research that has not even reached the human clinical test stage. Because it makes this clear and adds",CNN,"Credit: Sanil George + Jessica Shartouny
Humans have long known that frogs come equipped with protective chemicals to maintain froggy health.¬† This story describes a study of a single peptide from the mucus of a frog from India that lays waste to the H1 ",nan,"The risk of flu pandemics, however low, is now a permanent feature of the human landscape, and many worry about how to cope when a crisis outpaces the development of vaccines. ¬†This story about basic research into the antiviral potency of peptides in fro",
https://www.healthnewsreview.org/review/ap-story-on-trans-fat-ban-strong-on-sourcing-but-left-out-important-detail-about-study-findings/,"AP story on trans fats ban: Strong on sourcing, but left out key detail about study findings","Although the headline admirably opted for¬†the term ‚Äúlinked,‚Äù the story lede translates that into a causal statement.",TRANS FATS BAN LINKED WITH FEWER NY HEART ATTACKS & STROKES,story_reviews_00251,5,"['Sharon Dunwoody, PhD', 'Yoni Freedhoff, MD', 'Joy Victory']",Associated Press,"['diet studies', 'trans fats']",http://www.detroitnews.com/story/life/wellness/2017/04/12/fats-ban-heart/100376810/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'While there may be costs associated with different food ingredients (i.e., different types of fats), that does not seem relevant ",Associated Press,A¬†group of researchers took advantage of a ‚Äúnatural‚Äù field study by examining records of hospitalization for heart attacks or stroke among New York residents living in counties that had implemented restrictions on the use of trans fats in restaurant ,"https://www.healthnewsreview.org/wp-content/uploads/2015/06/trans-fat-label-214x300.jpg 214w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/trans-fat-label.jpg 585w","According to the CDC, some 610,000 people die of heart disease annually in the United States; it is the leading cause of death for both men and women.¬† The FDA plans a nationwide restriction of trans fats beginning in 2018, so understanding the impact of",
https://www.healthnewsreview.org/review/that-finding-could-be-due-to-chance-reuters-health-uses-caution-to-explain-study-on-trans-fats-ban/,‚ÄòThat finding could be due to chance:‚Äô Reuters Health uses caution to explain study on trans fats ban,One weak point for the story was the lack of independent sources.,Hospitalizations drop where laws restrict trans fats,story_reviews_00252,5,"['Sharon Dunwoody, PhD', 'Yoni Freedhoff, MD', 'Joy Victory']",Reuters Health,"['diet studies', 'trans fats']",http://www.reuters.com/article/us-health-heart-trans-regulations-idUSKBN17E2TR,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'While there might be an aggregate, societal cost to this change in food ingredients, it is not clear that individuals will incur ",Reuters Health,"This story does a good job describing a recent study that looked at the association between a ban on trans fats in food, and New York hospital admissions related to heart disease.¬†The study found a modest reduction in hospitalizations for heart attacks i","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-91684813-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-91684813-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-","According to the CDC, some 610,000 people die of heart disease annually in the United States; it is the leading cause of death for both men and women.¬† The FDA plans a nationwide restriction of trans fats beginning in 2018, so understanding the impact of",
https://www.healthnewsreview.org/review/lack-of-independent-sources-hinders-ap-story-on-new-drug-that-treats-side-effect-caused-by-antipsychotics/,Lack of independent sources hinders AP story on new drug that treats side effect caused by antipsychotics,More sourcing would have better answered: Is the evidence for the drug as solid as the company is saying it is?,1st drug OK'd for movement disorder caused by certain meds,story_reviews_00253,4,"['Jill U. Adams', 'Susan Molchan, MD, MA', 'Joy Victory']",Associated Press,"['bipolar disorder', 'FDA']",http://abcnews.go.com/Health/wireStory/1st-drug-okd-movement-disorder-caused-meds-46737548?cid=clicksource_26_null_articleroll_hed,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Although there‚Äôs no cost estimate, the story informs readers that the\xa0newly approved drug doesn‚Äôt have a market price yet, b",Associated Press,"This¬†Associated Press story highlights FDA approval of a new drug‚Äìthe first medication approved specifically for treating tardive dyskinesia. A new drug that promises to alleviate a¬†previously intractable movement disorder is good news. However, even ","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-519562875-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-519562875.jpg 683w","Tardive dyskinesia is a serious movement disorder that emerges as a consequence of long-term treatment with certain drugs used to treat schizophrenia and gastrointestinal conditions. It affects¬†about 20% of people taking antipsychotic drugs. Presently, d",
https://www.healthnewsreview.org/review/walk-or-run-for-exercise-vox-provides-informative-look-at-risks-and-benefits-of-both/,Walk or run for exercise? Vox provides informative look at risks and benefits of both,"In particular, the story does a great job quantifying the potential risks of running and of comparing the likelihood of injury from running to those for walking.",Should you walk or run for exercise? Here's what the science says.,story_reviews_00256,5,"['Kim Walsh-Childers, PhD', 'Allison Dostal, PhD, RD', 'Joy Victory']",Vox,['exercise'],http://www.vox.com/2015/8/4/9091093/walking-versus-running,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story does not mention costs,\xa0but both walking and running are inexpensive and widely accessible, so we‚Äôll rate this N/A",Vox,"Vox‚Äôs story competently¬†compares the risks and benefits of walking vs. running, using multiple high-quality studies as the basis for its conclusions.¬†In particular, the story does a great job quantifying the potential risks of running and of comparing","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-488352958-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-488352958-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStoc","The United States is facing an epidemic of overweight and obesity, with more than one-third of U.S. adults now qualifying as obese. Increasing the amount of exercise we get can play a major role in reducing overweight and obesity, and both running and wal",
https://www.healthnewsreview.org/review/lack-of-independent-sources-weaken-nbcs-look-at-pricey-eczema-drug/,Lack of independent sources weaken NBC‚Äôs look at pricey eczema drug,"While it correctly portrays eczema as a potentially debilitating condition, the story¬†unnecessarily hypes the drug dupilumab‚Äôs benefits with video of a glowing celebrity anecdote and left out any meaningful discussion about the evidence¬†behind the app",New Eczema Drug Dupixent wins FDA Approval,story_reviews_00260,4,"['Mary Chris Jaklevic', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",NBC News,"['eczema', 'monoclonal antibody drugs']",http://www.nbcnews.com/health/health-news/new-eczema-drug-dupixent-wins-fda-approval-n739611,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This is a barely passing satisfactory rating‚Äìthe story did disclose the cost of $37,000, but overlooked some important details wh",NBCNews.com,"This story touts the FDA‚Äôs approval of a pricey injection to treat serious cases of chronic skin inflammation known as eczema. While it correctly portrays eczema as a potentially debilitating condition, it left out any meaningful discussion about the ev","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_000022362380_Small-300x198.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_000022362380_Small.jpg 852w",High costs for prescription drugs are one driver hobbling the U.S. healthcare system. Stories that portray the benefits of blockbuster drugs using selective patient anecdotes may prompt patients who aren‚Äôt as likely to benefit to pressure doctors into p,
https://www.healthnewsreview.org/review/throw-away-your-reading-glasses-informative-times-report-on-brain-training-for-vision-doesnt-quite-back-up-the-headline/,Throw away your reading glasses? Informative Times report on ‚Äòbrain-training‚Äô for vision doesn‚Äôt quite back up the headline,The coverage was solid in most respects and is based on the author‚Äôs thorough evaluation of a brain-training app. But we wanted to see more proof for the implied headline claim about eliminating the need for glasses.,Training Your Brain So That You Don‚Äôt Need Reading Glasses,story_reviews_00261,5,"['Joann Rodgers, MS', 'Kevin Lomangino', 'Joy Victory']",New York Times,['vision loss'],https://www.nytimes.com/2017/03/27/upshot/training-your-brain-so-that-you-dont-need-reading-glasses.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The column provides\xa0clear\xa0information about the cost of the app tried by the writer. It would have been strengthened by infor",The New York Times,"This¬†column is a thorough first-person account of undergoing a form of app-based ‚Äúbrain training‚Äù designed to compensate for the loss of age-related¬†eye lens elasticity and the resulting difficulty of¬†reading small print, especially in low light.
T","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_80199127_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_80199127_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","To be sure, glasses and especially bifocals, transitional lenses, or ‚Äúreaders‚Äù can be annoying and inconvenient. And nearly everyone will need them as they age. Therefore, new apps¬†that claim to make reading glasses a thing of the past deserve close ",
https://www.healthnewsreview.org/review/online-counseling-for-high-blood-pressure-washington-post-wisely-includes-the-caveats/,Online counseling for high blood pressure: Washington Post wisely includes caveats,We also appreciated the discussion of how common high blood pressure is and why it‚Äôs so important to treat.,"Web-based counseling reduces blood pressure, according to a new study",story_reviews_00265,4,"['Earle Holland', 'Christopher Labos, MD', 'Joy Victory']",Washington Post,['high blood pressure'],https://www.washingtonpost.com/news/to-your-health/wp/2017/03/18/web-based-counseling-reduces-blood-pressure-according-to-a-new-study/?utm_term=.6a893e3ffc18,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story didn‚Äôt mention the estimated cost; we think that would have been a useful detail to both patients and healthcare pr",The Washington Post,"This story describes a study comparing two groups of people with high blood pressure¬†who either received standard online information on lowering blood pressure, or ‚Äúe-Counseling,‚Äù a progressive, more interactive online program¬†that closely mimicked ","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000062354770_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000062354770_Medium-1024x682.jpg 1024w","High blood pressure is serious problem for a multitude of people and the story rightfully points out that one in three Americans suffer from it. Therefore, any new treatments‚Äìparticularly those that involve non-drug interventions‚Äìare likely to be of w",
https://www.healthnewsreview.org/review/10-foods-to-eat/,Can these 10 foods really ‚Äòcut risk of early death‚Äô? NPR overstates the evidence,"Despite cautioning readers about some of the limits of observational studies, this story makes many claims that observational data just can‚Äôt support.",Eating More ‚Äî Or Less ‚Äî Of 10 Foods May Cut Risk Of Early Death,story_reviews_00272,4,"['Kevin Lomangino', 'Alan Cassels', 'Gary Schwitzer']",NPR,"['diabetes', 'diet studies', 'heart disease']",http://www.npr.org/sections/thesalt/2017/03/11/519443324/eating-more-or-less-of-10-foods-may-cut-risk-of-death-from-heart-disease,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story addresses cost at both the individual and societal level, noting that poor diets are ‚Äúlinked to billions of dollars in ",NPR,"This NPR story is about a study, published in the Journal of the American Medical Association, which attempts to estimate the percentage of deaths from heart disease and diabetes associated with 10 specific dietary factors ‚Äî things like too much sodium ","https://www.healthnewsreview.org/wp-content/uploads/2017/03/GettyImages-172640330-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/03/GettyImages-172640330.jpg 724w",Overstatement of evidence from nutrition studies is rampant. And it‚Äôs one of the factors that contributes to diet news whiplash ‚Äî where what‚Äôs good for you or bad for you seemingly changes from week to week and study to study. ¬†We published a broad,
https://www.healthnewsreview.org/review/reuters-health-carefully-hedges-the-benefits-of-mild-shocks-to-the-arm-for-migraine-pain/,Reuters Health carefully hedges results of study on mild shocks for migraines,"However, we do wish the projected cost of the treatment had been included, as well as a discussion on migraine treatments in general.",Mild electric shocks on the arm might help ease migraine pain,story_reviews_00274,4,"['Dave Mosher', 'Edward Ward, MD', 'Joy Victory']",Reuters Health,['migraines'],http://www.reuters.com/article/us-health-migraine-electric-stimulation-idUSKBN1685PG,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This was one downside to the story: There‚Äôs no information about the cost, either for the Nerivio Migra or\xa0similar treatme",Reuters Health,"This Reuters story pulls readers in with the idea that, one day, people might reduce migraine pain with a smartphone-connected tool. The report¬†highlights a new Neurology journal study of¬†Nerivio Migra, a battery-powered device that uses low-intensity e","https://www.healthnewsreview.org/wp-content/uploads/2015/05/migraine-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/migraine.jpg 849w","There‚Äôs no totally effective treatment or way to prevent migraines, and sufferers will be eager to read news about potential new treatments. For this reason, any news stories on this treatment must be cautious and not oversell the benefits, which are st",
https://www.healthnewsreview.org/review/vitamins-delivered-via-iv-stat-wisely-asks-wheres-the-evidence/,Vitamins delivered via IV: STAT wisely asks ‚Äòwhere‚Äôs the evidence?‚Äô,This story helps squelch some of the hype around vitamin IV infusions by taking a look at the evidence for its use.,Vitamin IVs promise to erase jet lag and clear your mind. Where‚Äôs the evidence?,story_reviews_00279,5,"['Sally James', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",STAT,"['jet lag', 'vitamins']",https://www.statnews.com/2017/02/23/vitamin-iv-infusion/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story provides the retail price for the supplements described in the story.\xa0 (Between $325 and $875 for an infusion.)\xa0Tha",STAT,"This short story shines a bright light on a health fad in which¬†nutritional vitamin supplements are delivered directly to people via an intravenous drip.
The story was well-sourced and took a critical look at a health fad that‚Äôs trending. We appreciate","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000025346493_Medium-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000025346493_Medium-1024x768.jpg 1024w, https://www.healthnewsreview.org/wp-content","Claims about supplements fuel a a big industry in the United States, and this story helps squelch some of the hype around vitamin IV infusions by taking a look at the evidence for its use.",
https://www.healthnewsreview.org/review/philadelphia-inquirer-is-clear-about-the-underwhelming-benefits-of-testosterone-therapy-in-older-men/,Philadelphia Inquirer is clear about the underwhelming benefits of testosterone therapy in older men,"This story makes it clear that knowledge about many of the potential benefits of testosterone is still in flux, and other claims just¬†don‚Äôt bear up under the weight of scientific scrutiny.",Major study finds testosterone therapy is no fountain of youth,story_reviews_00281,5,"['Ann Miller, PhD', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",Philadelphia Inquirer,['testosterone'],http://www.philly.com/philly/health/Major-study-finds-testosterone-therapy-is-no-fountain-of-youth.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although this article\xa0mentioned that rub-on testosterone products are readily available, it did not explicitly mention the c",The Philadelphia Inquirer,"Testosterone therapy has become increasingly popular for older men over the past two decades or so, but scientific evidence has lagged behind popular practice.
This story¬†describes results of a group of coordinated trials with men over 64 years old. The ","https://www.healthnewsreview.org/wp-content/uploads/2015/10/testosterone-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/testosterone.jpg 849w","Testosterone therapy is one among a number of popular treatments to minimize the effects of aging. With a whole range of anti-aging regimens available, it is important to weigh the pros and cons of health fads against the weight of scientific evidence. Th",
https://www.healthnewsreview.org/review/time-is-upfront-about-new-psoriasis-drugs-black-box-warning-for-suicidal-behavior-risk/,TIME is upfront about new psoriasis drug‚Äôs black box warning for suicidal behavior risk,"Given the suicide risk, news stories ideally emphasize that it remains unclear how this new treatment will compare in terms of effectiveness and safety to existing medicines.",How a New Psoriasis Drug Is Different From Others,story_reviews_00283,4,"['Earle Holland', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",TIME,"['biologic drugs', 'Psoriasis']",http://time.com/4673630/new-psoriasis-drug-siliq/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôll give this story credit for mentioning cost, when it states\xa0‚Äúpricing information is not available at this time.‚Äù Howe",Time,"
This Time magazine story reports on the FDA approval of a new drug‚ÄìSiliq‚Äìfor the treatment of psoriasis, an autoimmune skin disorder.
The story does a good job of outlining the risks of the new drug, citing its link to suicide among users, as well as","https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000076587881_Medium-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000076587881_Medium-1024x680.jpg 1024w","Given the suicide risk linked to this drug, it remains unclear how this new treatment will compare in terms of effectiveness and safety to existing medicines when used for longer periods of time in the general population.",
https://www.healthnewsreview.org/review/in-story-on-experimental-blood-test-cnn-goes-where-few-dare-to-go-the-tests-sensitivity-and-specificity/,"In story on experimental blood test, CNN goes where few dare‚Äìthe test‚Äôs sensitivity and specificity","Readers of this story will be given a mostly thorough, non-hyped account of what a new study found.","Blood test might make Parkinson's diagnosis easier, study says",story_reviews_00287,4,"['Joann Rodgers, MS', 'Preeti N. Malani, MD, MSJ', 'Joy Victory']",CNN,"[""Parkinson's""]",http://www.cnn.com/2017/02/08/health/parkinsons-disease-blood-test-study/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs are not included. Presumably a blood test would be cheaper than a test of spinal fluid, which requires a lumbar puncture.",CNN,This CNN story describes the results of a newly published study designed to see if a protein that can be measured in a blood sample accurately distinguishes between Parkinson‚Äôs Disease and a group of a rarer ‚Äî but generally more rapidly disabling ‚Äî¬,"https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000052682424_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000052682424_Small.jpg 849w","The advent of a simple blood test that can, with significant accuracy, help primary care physicians as well as specialists achieve a more accurate diagnosis is newsworthy. Readers of this story will be given a mostly thorough, non-hyped account of what th",
https://www.healthnewsreview.org/review/an-app-a-day-keeps-the-baby-away-buzzfeeds-look-at-natural-cycles-app-gets-a-gold-star/,An app a day keeps pregnancy away? BuzzFeed‚Äôs informative look at Natural Cycles app gets a gold star,"The story is balanced, provides an excellent summary of the research on the app‚Äôs effectiveness for preventing pregnancy, and makes clear the limits of the evidence.","This App Says It‚Äôs As Good As The Pill At Preventing Pregnancy, But Experts Want More¬†Evidence",story_reviews_00288,5,"['Jill U. Adams', 'Karen Carlson, MD', 'Joy Victory']",BuzzFeed,['contraceptives'],https://www.buzzfeed.com/kellyoakes/contraceptive-app?utm_term=.fo4j9nZE9Y#.ihKBXjAQX0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The\xa0story states that the app requires a monthly or yearly subscription, which implies it‚Äôs not free. But there is no ment",BuzzFeed,"BuzzFeed‚Äôs take on an app to aid in birth control ends up being a very informative piece on the plusses and minuses of a variety of birth control methods. With the context provided, readers learn a bit about a woman‚Äôs monthly cycle and how so-called n","https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-598912704-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-598912704-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Women have strong preferences about birth control methods and need a range of choices. Natural family planning (sometimes known as the rhythm method) has been around for years, but is not highly regarded because it is relatively ineffective compared to me",
https://www.healthnewsreview.org/review/usa-today-story-on-diet-for-ibs-gives-readers-plenty-to-bite-on/,USA Today story on ‚ÄòFODMAP‚Äô diet for tummy troubles gives readers plenty to bite on,"While we appreciate the cautionary signals sent by this story, we would have moved¬†them much higher in the text.",Low-FODMAP diet catches on among people with digestive misery,story_reviews_00289,4,"['Sharon Dunwoody, PhD', 'Allison Dostal, PhD, RD', 'Joy Victory']",USA Today,['diet studies'],http://www.usatoday.com/story/life/2017/02/05/low-fodmap-diet-catches-among-people-digestive-misery/97239910/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story notes that health insurance is unlikely to cover the costs of a clinic visit with a dietitian to discuss the proper i",USA Today,"This story focuses on a¬†dietary pattern that has been around for years but is experiencing increased awareness and clinical use: the low-FODMAP diet. ‚ÄúFODMAP‚Äù stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols, types ","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_60904904_SMALL-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_60904904_SMALL-768x510.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Millions of people wrestle with abdominal pain, bloating, and changes in their bowel movement patterns and will be actively interested in lifestyle modifications to improve their symptoms. This story made it clear that the evidence is mixed.",
https://www.healthnewsreview.org/review/ny-times-deftly-describes-findings-of-study-on-using-hormone-blockers-for-prostate-cancer-recurrence/,NY Times deftly describes findings of study on using hormone blockers for prostate cancer recurrence,This was a complex study and the story did a good job in presenting it to readers.,Hormone Blockers Can Prolong Life if Prostate Cancer Recurs,story_reviews_00290,4,"['Dave Mosher', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",New York Times,['prostate cancer'],https://www.nytimes.com/2017/02/01/health/prostate-cancer-hormone-blockers.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No treatment costs are discussed. According to a 2015 study in the journal Future\xa0Oncology, the average cost per hospital st",The New York Times,"The New York Times covers a study of a treatment for prostate cancer that comes back after prostate removal surgery.¬†The treatment is hormone blocking, or androgen deprivation therapy. In this review, we‚Äôll occasionally compare the coverage to STAT‚Äôs","https://www.healthnewsreview.org/wp-content/uploads/2015/07/prostate-cancer-300x108.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/prostate-cancer-1024x369.jpg 1024w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/prost","For men who have had prostate cancer return after surgery, this study‚Äôs findings will help them make more informed decisions when choosing a treatment path. But it‚Äôs a complicated study with plenty of nuances, and this news story did a solid job disti",
https://www.healthnewsreview.org/review/reuters-health-provides-balanced-look-at-review-of-studies-on-alternative-remedies-for-premature-ejaculation/,Reuters Health provides balanced look at alternative remedies for premature ejaculation,"The story made clear that there were limitations to the data, and that the placebo effect could have played a big role.",Alternative medicine might help treat premature ejaculation,story_reviews_00294,4,"['Alan Cassels', 'Edward Ward, MD', 'Joy Victory']",Reuters Health,['premature ejaculation'],http://www.reuters.com/article/us-health-cam-premature-ejaculation-idUSKBN15B2GF,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There were no discussions of cost here, apart from the fact that the products in question would likely be available without a p",Reuters Health,"This report of a systematic review of complementary medicine to treat premature ejaculation is fairly complete and includes important limitations of the research.
Some additional¬†context would have been helpful, including information about¬†prescribed tr","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-509372692-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-509372692.jpg 724w","While the problem itself‚Äìhow exactly one defines ‚Äúpremature‚Äù may be open to debate and discussion‚Äìit is clear that this is an issue that many men may experience, yet may not want to consult their clinician about. Many may turn to alternative remed",
https://www.healthnewsreview.org/review/guardians-look-at-weekend-warrior-study-why-no-mention-of-plentiful-study-limitations/,Guardian‚Äôs look at weekend warrior study: Why no mention of (plentiful) limitations?,"But, we were pleased¬†to see the inclusion of an independent source, who helped establish what was novel about the study findings.","Weekend workouts can benefit health as much as a week of exercise, say researchers",story_reviews_00302,4,"['Harold J. DeMonaco, MS', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",The Guardian,['exercise'],https://www.theguardian.com/science/2017/jan/09/weekend-workouts-nearly-as-good-as-whole-week-of-excercise-researchers-say,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We don‚Äôt think that cost is relevant here.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/te",The Guardian,"
This story looks at an observational study comparing frequency of exercise vs no exercise on early risk of death, with an emphasis placed on ‚Äúweekend warrior‚Äù style exercise.
Like we saw in our review of Newsweek‚Äôs take on this study, this story fr","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-613030648-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-613030648.jpg 724w","Many people struggle to get enough exercise, and if the study‚Äôs findings are verifiable, then this is good news for people who can only exercise on the weekends. However, news stories shouldn‚Äôt overstate the findings nor¬†mislead people about just how",
https://www.healthnewsreview.org/review/newsweek-confuses-association-with-causation-in-weekend-warrior-exercise-story/,Newsweek confuses association with causation in ‚Äòweekend warrior‚Äô exercise story,Researchers saw an association with physical activity and reduced risk of death when looking at data‚Äìthey did not prove it‚Äôs a direct cause-and-effect relationship.,‚ÄòWEEKEND WARRIOR‚Äô WORKOUTS ARE BENEFICIAL AS JUST 20 MINUTES OF EXERCISE A DAY,story_reviews_00303,4,"['Harold J. DeMonaco, MS', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",Newsweek,['exercise'],http://www.newsweek.com/weekend-warrior-recommended-daily-exercise-workouts-20-minutes-540467,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Given the nature of the study we don‚Äôt think that this issue is relevant.'}, {'question': 'Does the story adequately quantify t",Newsweek,"This story¬†highlights the findings of a large, longitudinal study conducted in England and Scotland. However, ‚Äúlarge‚Äù doesn‚Äôt mean ‚Äúconclusive,‚Äù which this story seems to indicate.
As we saw in our review of The Guardian‚Äôs take on the same st","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-498344640-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-498344640.jpg 724w","If getting a lot of activity is only plausible on the weekends, and research shows it‚Äôs useful at reducing early death risk, then that‚Äôs perhaps newsworthy. However, the findings should not be overstated as conclusive, which was done in this story. Re",
https://www.healthnewsreview.org/review/reuters-health-succinctly-and-accurately-summarizes-study-looking-at-bystander-cpr-and-survivor-rates/,Reuters Health succinctly and accurately summarizes study looking at bystander CPR and survivor rates,"The story did a good job providing exact numbers on what the researchers measured, and it mentioned a few limitations to the study.",Bystander CPR may boost survival odds when ambulance delayed,story_reviews_00304,5,"['Ann Miller, PhD', 'Christopher Labos, MD', 'Joy Victory']",Reuters Health,['CPR'],http://www.reuters.com/article/us-health-cpr-bystanders-idUSKBN14Q2BV,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There is no direct cost to bystander CPR, so this category is not applicable.'}, {'question': 'Does the story adequately quantify",Reuters Health,"Bystander CPR (cardiopulmonary resuscitation) remains an underutilized resource for victims of cardiac arrest. This story adds to evidence¬†about¬†how important it may¬†be for observers to step in quickly¬†when someone near them collapses, without waiting","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-161335366-300x193.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-161335366.jpg 595w",Studies like the one reported in this article are important for building understanding among the lay public about¬†the benefits‚Äìand limits‚Äìof CPR.,
https://www.healthnewsreview.org/review/by-including-independent-viewpoints-stat-takes-a-more-measured-approach-to-coverage-of-brain-cancer-treatment/,"By including independent viewpoints, STAT takes a more measured approach to coverage of brain cancer immunotherapy","When reporting on a single case study, journalists should use abundant caution to avoid overselling the research.",CAR-T therapy makes early inroads in treating brain cancer,story_reviews_00306,4,"['Joann Rodgers, MS', 'Dan Mayer, MD', 'Joy Victory']",STAT,"['brain cancer', 'immunotherapy']",https://www.statnews.com/2016/12/28/car-t-brain-cancer/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'As we noted in our review of TIME Magazine‚Äôs story as well: Although there may not yet be any accurate prediction of the cost",STAT,"This story¬†in STAT, like the one in TIME.com that we also reviewed, describes the successful, and apparently first positive response of a glioblastoma brain tumor to CAR-T therapy. This is an experimental immunotherapy that depends on on injections of mo","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-472135395-225x300.jpg 225w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-472135395.jpg 512w","Unlike the TIME story (see our review), this story included important voices of caution to help keep expectations in check. Starting with the headline, readers of this story are likely to come away with a more realistic perspective on this treatment. (Mea",
https://www.healthnewsreview.org/review/bravo-new-york-times-using-absolute-risk-reduction-numbers-story-fish-oil-asthma/,"Bravo, New York Times, for using absolute risk reduction numbers in story on fish oil for asthma",This story did a lot of things well. The main shortcoming is the story‚Äôs failure to disclose relevant conflicts of interest.,Taking Fish Oil During Pregnancy Is Found to Lower Child‚Äôs Asthma Risk,story_reviews_00308,4,"['Joy Victory', 'Karen Carlson, MD', 'Kevin Lomangino']",New York Times,"['fish oil', 'supplements']",http://www.nytimes.com/2016/12/28/health/fish-oil-asthma-pregnancy.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health&region=rank&module=package&version=highlights&contentPlacement=2&pgtype=sectionfront&_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story did not discuss cost. There are dozens of fish oil supplements on the market and their cost varies widely. The story ",The New York Times,"This New York Times story looks at a new study showing a reduced risk of asthma in¬†the children of mothers who took high doses of fish oil during the last trimester of pregnancy.
The story was strong‚Äìit did a lot of things well. We were especially plea","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-452259387-200x300.jpg 200w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-452259387.jpg 483w","Other than avoidance of smoking by the mother, there is currently no known way to prevent asthma from developing in a child, and the World Health Organization defines its global health¬†and economic impact as ‚Äúsevere.‚Äù
Given how common this disease is",
https://www.healthnewsreview.org/review/experimental-heart-failure-drug-by-how-much-did-it-help-healthday-story-doesnt-say/,Experimental heart failure drug: By how much did it help? HealthDay story doesn‚Äôt say,The story would have been stronger if it had detailed exactly what the researchers were measuring when they concluded the drug worked better than placebo.,Heart Failure Drug Shows Promise in First Human Trial,story_reviews_00309,4,"['Earle Holland', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",HealthDay,['heart failure'],https://consumer.healthday.com/circulatory-system-information-7/heart-failure-news-753/heart-failure-drug-shows-promise-in-first-human-trial-718100.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of the cost for the tested drug, cimaglermin, in this story.\xa0 The costs for regularly prescribed drugs f",Health Day,"This HealthDay story reports on the very early results of a phase one trial of a drug, cimaglermin, intended to improve the left ventricular function among patients with a type of heart failure known as ‚Äúsevere left ventricular systolic dysfunction.‚Äù
","https://www.healthnewsreview.org/wp-content/uploads/2016/12/GettyImages-530199842-300x257.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/GettyImages-530199842.jpg 639w","Obviously, if a new drug is found that works effectively to thwart this kind of heart disease, then that‚Äôs good news all around, especially if the drug is needed less frequently and is well tolerated, as the story suggests.¬† But care needs to be taken ",
https://www.healthnewsreview.org/review/vox-notes-limitations-of-meta-analysis-on-starting-school-later-albeit-not-until-end-of-story/,"Vox notes limitations of meta-analysis on starting school later, albeit not until end of story","But, no sources appear to have been interviewed for this story, though it contains a lot of citations to studies and quotes used in past stories.",Starting school later might really help sleep-deprived teens,story_reviews_00312,4,"['Sharon Dunwoody, PhD', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",Vox,"['sleep problems', 'teens']",http://www.vox.com/science-and-health/2016/12/17/13981152/school-start-time-teens,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Although specific, numerical costs are not mentioned, the story does a good job of reflecting on the kinds of costs that school dis",Vox,"It is clear that too little sleep is bad for humans, and health officials have long recommended that teenagers get eight to nine hours of sleep a night, a suggestion made difficult by early start times (often before 8 a.m.) in America‚Äôs schools. But how","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-166674154-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-166674154.jpg 724w","America‚Äôs schools are under pressure to establish later start times, a change that will be complex and potentially expensive to implement.¬† Such a modification needs to be grounded in good evidence that teenagers will, in fact, benefit from it.¬†News s",
https://www.healthnewsreview.org/review/melanoma-survivors-friends-can-help-spot-new-moles/,Reuters Health briefly but aptly reports survey findings of partner-assisted skin exams for melanoma survivors,One downside to this story is the lack of independent sources.,Melanoma survivors' friends can help spot new moles,story_reviews_00313,4,"['Jill U. Adams', 'Edward Ward, MD', 'Joy Victory']",Reuters Health,['melanoma'],http://www.reuters.com/article/us-health-cancer-melanoma-idUSKBN1452U1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Although presumably there is\xa0a cost associated with training people to\xa0recognize melanomas, having a partner help check for",Reuters Health,"This is a bite-size but informative story from Reuters Health reporting new research that assessed the confidence levels and feelings of embarrassment in people helping melanoma survivors to look for suspicious moles in hard-to-see body parts.
One downsid","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-184922903-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-184922903.jpg 724w","Over a million people in the United States alone are at high risk of secondary melanomas after having treatment¬†to remove a malignant tumor. Barriers to finding secondary tumors, such as feelings of embarrassment or a lack of confidence in people helping",
https://www.healthnewsreview.org/review/solid-but-single-sourced-stats-coverage-of-alzheimers-drugs-needed-an-independent-voice/,Solid but single-sourced: STAT‚Äôs coverage of Alzheimer‚Äôs drugs needed an independent voice,This story wisely explains that there is still no scientific consensus that amyloid plaque¬†is the right target for drugs that treat Alzheimer‚Äôs disease.,Why Biogen is breathing a sigh of relief with the latest Alzheimer‚Äôs data,story_reviews_00317,4,"['Joann Rodgers, MS', 'Susan Molchan, MD, MA', 'Joy Victory']",STAT,"[""alzheimer's disease""]",https://www.statnews.com/2016/12/08/biogen-lilly-alzheimers/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'It‚Äôs too early to discuss\xa0how much one of these experimental drugs might cost. But the article could have reported something",STAT,"This¬†STAT story is a contextual view of not only the status of doomed¬†scientific efforts so far to delay or halt Alzheimer‚Äôs dementia¬†at its biological sources, but also of Big Pharma‚Äôs persistence at chasing an anti-amyloid cure.
The reporting mak","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-151645089-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-151645089.jpg 683w","Given the devastating magnitude of Alzheimer‚Äôs disease, reports like the one in STAT are intensely searched for and read by not only those with personal knowledge of the disease, but by the worried well.
¬†",
https://www.healthnewsreview.org/review/exercise-leads-to-better-sperm-time-story-doesnt-tell-us-by-how-much/,Exercise leads to ‚Äòbetter‚Äô sperm? TIME story doesn‚Äôt tell us by how much,And it left out a very important limitation of the study: It didn‚Äôt look at whether these changes had any impact on fertility.,Exercise May Be the Key to Better Sperm,story_reviews_00320,4,"['Earle Holland', 'Yoni Freedhoff, MD', 'Joy Victory']",TIME,"['exercise', 'fertility', ""men's health""]",http://time.com/4591307/exercise-sperm-count/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There was no mention of the cost of the methodology used in this study. Yes, in general exercise is free via walking or jogging, ",Time,"This short Time magazine story describes a study that looked at whether the quality of semen could be improved through one of three different exercise approaches, compared to that of men who did not exercise.
The story did a good job establishing what mad","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-488357906-300x226.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-488357906.jpg 681w","The story rightfully points to semen quality as a major factor for couples facing infertility problems‚Äìbut the study under discussion wasn‚Äôt designed to test if exercise has any impact on pregnancy rates. To not mislead readers, any connections drawn ",
https://www.healthnewsreview.org/review/reuters-health-story-on-light-therapy-for-drivers-is-a-shining-example-of-solid-medical-writing/,Reuters Health story on light therapy for drivers is a shining example of solid medical journalism,"Ample independent researchers were included, and the measured benefits of the intervention are stated clearly.",Driving home from night shift may be safer with light therapy,story_reviews_00321,5,"['Sharon Dunwoody, PhD', 'Dan Mayer, MD', 'Joy Victory']",Reuters Health,"['light therapy', 'sleep problems']",http://www.reuters.com/article/us-health-driving-sleepiness-idUSKBN13R2LU,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Cost information is not provided, but\xa0the cost of a bright light is presumably reasonable.'}, {'question': 'Does the story ade",Reuters Health,"The U. S. National Highway Traffic Safety Administration (NHTSA), which conducts research on driver behavior and traffic safety, estimates that drowsy driving causes at least 100,000 auto crashes each year.¬† This Reuters story describes a recent study th","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-543841716-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-543841716.jpg 724w","Sleep deprivation is common among folks who work night shifts, and even among the general public. ¬†While societal calls for getting a good 7 to 8 hours‚Äô¬†sleep‚Äîstill the only proven remedy for the problem‚Äîare growing, both the sleep-deprived and th",
https://www.healthnewsreview.org/review/la-times-strikes-the-right-balance-by-reporting-evenly-on-both-harms-and-benefits-of-magic-mushrooms-for-cancer-patients/,LA Times strikes the right balance by reporting evenly on both harms and benefits of ‚Äòmagic mushrooms‚Äô for cancer patients,"The story discusses the potential benefits in depth, which is good, but fails to quantify those benefits, which was a weak point.",Ingredient in magic mushrooms is shown to ease anxiety and depression in cancer patients in one dose,story_reviews_00322,4,"['Matt Shipman', 'Michael Bierer MD, MPH', 'Joy Victory']",Cancer,"['hallucinogens', 'mental health', 'psilocybin']",http://www.latimes.com/science/sciencenow/la-sci-sn-magic-mushrooms-cancer-anxiety-20161201-story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Given that this is an illegal substance banned by the U.S. Drug Enforcement Agency, cost as a therapeutic would be difficult to a",Los Angeles Times,The story focuses on two recent studies that find a single application of the hallucinogen psilocybin is effective at providing meaningful relief to cancer patients suffering from severe depression or anxiety. The studies were published in the Journal of ,"https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-502389090-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-502389090.jpg 724w","Depression and other mental health struggles are common and significant among people with cancer, especially terminal cancer. This makes it especially important for reporters to write responsibly about studies like those discussed in this story. You want ",
https://www.healthnewsreview.org/review/stats-roundup-of-allergy-treatment-research-needed-discussion-of-costs/,STAT‚Äôs roundup of allergy treatment research needed discussion of costs,"Parents curious about these forthcoming treatments are likely already wondering if they‚Äôll be affordable, but the story skirts any discussion of pricing.",Allergy treatments enter a new era ‚Äî with a focus on stopping reactions before they start,story_reviews_00323,4,"['Joann Rodgers, MS', 'Alan Schroeder, MD', 'Joy Victory']",STAT,['allergies'],https://www.statnews.com/2016/11/29/allergy-drug-development/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the\xa0story\xa0cites the hundreds of millions of dollars of investment made by drug companies and research institutio",STAT,"The headline on this story from STAT¬†promises to highlight a ‚Äúnew era‚Äù in allergy treatment built around the idea of preventing histamine and other immunologic explosions in our bodies‚Äô mast cells and basophils before they start.
What it delivers i","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-177382750-300x208.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-177382750.jpg 711w","Stories that describe new allergy treatments¬†are likely to have mass audiences, including parents who are hopeful they can ease their child‚Äôs severe food allergies. But will any of these treatments pan out, and one day be widely available and/or afford",
https://www.healthnewsreview.org/review/thorough-wsj-report-on-insomnia-treatments-would-have-benefited-from-cost-comparison/,Thorough WSJ report on insomnia treatments would have benefited from cost comparison,"Because it lacks information on costs, readers can‚Äôt answer an important question: Can I afford it?",Can‚Äôt Get to Sleep? Lay Off the Drugs,story_reviews_00325,4,"['Kim Walsh-Childers, PhD', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",Wall Street Journal,"['cognitive behavioral therapy', 'insomnia', 'sleep problems']",http://www.wsj.com/articles/cant-get-to-sleep-lay-off-the-drugs-1480302360,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Unfortunately, like the earlier Times\xa0story, the WSJ story doesn‚Äôt mention costs, either those associated with taking pres",The Wall Street Journal,"This story explains why those suffering from insomnia should take heed of the American College of Physicians‚Äô recommendation to use¬†cognitive behavioral therapy as a first-line treatment, before turning to prescription or over-the-counter drugs.
Rather","https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock-187086217-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock-187086217.jpg 724w","Lack of sleep is a big concern for many Americans, especially older adults. This story specifically addressed why sleep medications are not ideal for this age group, in terms of potential harms. But it didn‚Äôt dig deep enough into the data on the effecti",
https://www.healthnewsreview.org/review/thorough-and-well-done-ap-story-on-vivitrol-injections-for-inmates-with-opioid-use-disorder/,Thorough and well-done: AP story on Vivitrol injections for inmates with opioid use disorder,This story‚Äôs focus on cautionary aspects of the drug‚Äôs use and marketing does a nice job of illuminating the complexity of drug introductions.,"PRISONS FIGHT OPIOIDS WITH $1,000 INJECTION: DOES IT WORK?",story_reviews_00328,5,"['Sharon Dunwoody, PhD', 'Michael Bierer MD, MPH', 'Joy Victory']",Associated Press,['opioids'],http://www.cbsnews.com/news/prisons-fight-opioids-with-1000-vivitrol-injections-does-it-work/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The high cost of these regular injections is front and center in this story.'}, {'question': 'Does the story adequately quantify th",Associated Press,"
Extended-release naltrexone, which blocks the effects of opioid use, is being increasingly used by prisons in an effort to help¬†prisoners with opioid use disorder stay off drugs once they have been released.
This story tracks that experimental use of th","https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock_93456015_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock_93456015_SMALL-768x513.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201",There is currently¬†a nationwide¬†epidemic of opioid addiction and fatal overdose. A substantial proportion of the prison population is incarcerated in part because of opioid addiction and will be at risk again after their release. One of the periods of h,
https://www.healthnewsreview.org/review/usa-today-gives-solid-overview-on-uncertainties-around-calcium-supplements-and-heart-health/,USA Today gives solid overview on uncertainties around calcium supplements and heart health,"The story offers guidance to readers about the state of research regarding calcium supplements, providing balanced information they can use to make informed decisions about their health.",Calcium supplements and your heart: Researchers send mixed messages,story_reviews_00334,4,"['Matt Shipman', 'Allison Dostal, PhD, RD', 'Joy Victory']",USA Today,"['osteoporosis', 'supplements']",http://www.usatoday.com/story/life/2016/11/06/calcium-supplements-heart/93050736/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not\xa0mentioned. While calcium supplements are not prohibitively expensive for most patients (prices vary, but tend to",USA Today,"The story examines the potential risks and benefits associated with the use of calcium supplements, and discusses two recent studies (found in the Journal of the American Heart Association and the Annals of Internal Medicine) that address the issue.
On th","https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock_80115179_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock_80115179_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Failure to consume an adequate amount of calcium can be a contributing factor to osteoporosis, a condition in which a patient‚Äôs bones become weak and brittle ‚Äî making osteoporosis patients more likely to suffer broken bones. However, there is concern ",
https://www.healthnewsreview.org/review/gastric-balloon-for-weight-loss-healthday-avoids-hot-air-by-balancing-pr-spin-with-skepticism-from-independent-sources/,Gastric balloon for weight loss: HealthDay avoids hot air by balancing PR spin with skepticism from independent sources,It also alerted readers that this sort of medical conference presentation does not go through the peer review process that major journals use.,Balloon-in-a-pill helped obese patients lose weight,story_reviews_00335,4,"['Andrew Holtz, MPH', 'Yoni Freedhoff, MD', 'Joy Victory']",HealthDay,"['gastric balloon', 'weight loss']",https://consumer.healthday.com/vitamins-and-nutrition-information-27/misc-weight-news-704/balloon-in-a-pill-helps-obese-patients-lose-weight-in-study-716556.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While the story notes that the U.S. price of the Obalon intragastric balloon has yet to be announced, the story could have repo",Health Day,"Credit: FDA safety materials on Obalon
This story about a balloon swallowed by people with obesity¬†to help them diet and lose weight is more informative than the associated conference news release we also reviewed.
The overall tone of the story balances ",nan,"Patients want help comparing treatment options. Rather than highlighting results of a trial that merely compared this new weight loss balloon to a placebo, this story could have made more clear that there is no evidence yet that this device is any better ",
https://www.healthnewsreview.org/review/testing-cholesterol-in-toddlers-ap-story-says-it-could-help-but-study-didnt-show-that/,Testing cholesterol in toddlers: AP story says it ‚Äòcould help‚Äô but study didn‚Äôt show that,"The story‚Äôs framing takes the stance that finding a¬†risk factor very early on in life leads to an overall benefit. That may well be prove to be true, but neither the story nor the study being reported on provide evidence of that.","Testing cholesterol in toddlers, even younger? Study says it could help",story_reviews_00337,4,"['Alan Cassels', 'Karen Carlson, MD', 'Joy Victory']",Associated Press,"['cholesterol', 'statins']",https://www.statnews.com/2016/10/26/cholesterol-test-kids/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This was a strong point for the story, which did provide some information on cost. ‚ÄúThe study did not address whether screening i",Associated Press,"
This is a story looking at a study that found¬†familial hypercholesterolemia was more common than previously thought. This condition is associated with an increased risk of heart disease and heart attacks in adults under 40. As a result, researchers are ","https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_100530029_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_100530029_MEDIUM-768x511.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads","Parents want to do everything they can to make sure their children have a long and healthy life, and so a story about a genetic condition being more common than previously thought is likely to be read widely. Unfortunately, the story‚Äôs framing takes the",
https://www.healthnewsreview.org/review/pulsepoint-app-for-cardiac-victims-ap-story-left-us-with-more-questions-than-answers/,PulsePoint app for cardiac arrest: AP story left us with more questions than answers,What research was conducted to show this app is beneficial? And how solid was that research?,APP HELPS SAVE SEATTLE CARDIAC PATIENT,story_reviews_00341,4,"['Harold J. DeMonaco, MS', 'Dave Mosher', 'Joy Victory']",Associated Press,['cardiac arrest'],http://abcnews.go.com/Technology/wireStory/app-helps-save-seattle-cardiac-patient-42934393,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes how\xa0the PulsePoint Foundation‚Äôs\xa0app\xa0is available for free download\xa0for\xa0both iOS and Android. We th",Associated Press,"This is a story¬†about the use of an app called PulsePoint in the care of a Seattle victim of sudden cardiac arrest.
In the process of telling a patient story that ended well, the reader is provided with information on the app‚Äôs development, its current","https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_100611055_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_100611055_MEDIUM-768x511.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads","An American Heart Association report released in 2015 noted that there are approximately 326,000 cases of out-of hospital-cardiac arrests in the United States. The survival rate with good neurologic function is approximately 8%. Importantly, just about on",
https://www.healthnewsreview.org/review/experimental-cancer-treatment-for-kids-with-leukemia-gets-balanced-coverage-by-washington-post/,Experimental immunotherapy for kids with leukemia gets balanced coverage by Washington Post,"Readers get the full sense of how experimental this treatment is, and how it‚Äôs a last-resort option.", This 8-year-old is free of cancer ‚Äî for now ‚Äî after a ‚Äòbreakthrough‚Äô treatment,story_reviews_00349,5,"['Matt Shipman', 'Deanna Attai, MD, FACS', 'Joy Victory']",Washington Post,['immunotherapy'],https://www.washingtonpost.com/national/health-science/tantalizing-counterattack-offers-breakthrough-hope-for-children-with-leukemia/2016/09/30/cf19b15a-663a-11e6-be4e-23fc4d4d12b4_story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The CAR T-cell therapy is currently available only in clinical trials, where costs presumably aren‚Äôt an issue (a point the story ",The Washington Post,"The story focuses on on the use of an experimental immunotherapy technique called CAR T-cell therapy to treat children who have been diagnosed with acute lymphoblastic leukemia (ALL) and who are no longer responding to conventional cancer treatments.
The ","https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_73573053_SMALL-300x210.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_73573053_SMALL-768x537.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","The NIH estimates that there will be approximately 6,590 new cases of ALL diagnosed in the U.S. this year. The majority of those diagnosed with ALL (57%) are under the age of 20, with a median age of 15. Sixty-eight¬†percent of those diagnosed survive at ",
https://www.healthnewsreview.org/review/nprs-story-on-benefits-of-walking-for-older-adults-missed-an-important-cautionary-detail/,Benefits of walking for older adults: NPR story missed a cautionary detail,We also wanted to see more specifics on the benefits measured by the study.,"Walking Fends Off Disability, And It's Not Too Late To Start",story_reviews_00353,4,"['Earle Holland', 'Yoni Freedhoff, MD', 'Joy Victory']",NPR,['exercise'],http://www.npr.org/sections/health-shots/2016/09/26/495477531/walking-fends-off-disability-and-its-not-too-late-to-start,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We‚Äôll rate this\xa0category as non-applicable since the thrust of the story and the project it reports about is for elderly per",NPR,"This story focuses on a study showing that elderly persons recovering from a disability get back to normal 25 percent sooner if they participate in a program of physical activity including ‚Äú150 minutes of aerobic activity as well as strength, flexibilit","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_86877621_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_86877621_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","The story points out that the Centers for Disease Control and Prevention say that ‚Äújust 28 percent of those 75 and up meet the recommendation for aerobic activity, and only 8 percent also did the suggested amount of strength training.‚Äù¬† It says that ",
https://www.healthnewsreview.org/review/new-radiation-guidelines-for-breast-cancer-theres-enough-evidence-healthday-story-tells-us-but-skirts-specifics/,"New radiation guidelines for breast cancer: There‚Äôs ‚Äòenough‚Äô evidence, HealthDay story states, skirting specifics","The story also needed a discussion around costs of radiation therapy, which can be pricey.","More Breast Cancer Patients Should Consider Radiation, New Guidelines Say",story_reviews_00357,4,"['Matt Shipman', 'Deanna Attai, MD, FACS', 'Joy Victory']",Cancer,['breast cancer'],https://consumer.healthday.com/cancer-information-5/breast-cancer-news-94/new-guidelines-say-more-breast-cancer-patients-should-get-radiation-715062.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not addressed in the story. That‚Äôs problematic because, as the American Cancer Society notes, ‚Äútreating cancer with",Health Day,"National Cancer Institute
The story addresses new guidelines from the American Society of Clinical Oncology, the American Society for Radiation Oncology and the Society of Surgical Oncology, which say that that some breast cancer patients who would have b",nan,"Breast cancer is the most common cancer among women in the United States. According to the CDC, more than 230,000 women (and more than 2,000 men) were diagnosed with breast cancer in 2013 alone. New recommendations related to breast cancer treatment, part",
https://www.healthnewsreview.org/review/battling-super-lice-wsj-story-gives-solid-overview-on-the-treatment-options/,Battling ‚Äòsuper lice:‚Äô WSJ story provides solid overview on the treatment options,We were pleased to see how the story pointed out any potential conflicts of interest among the sources.,New Ways to Fight Super Lice,story_reviews_00362,5,"['Joann Rodgers, MS', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",Wall Street Journal,['lice'],http://www.wsj.com/articles/new-ways-to-fight-super-lice-1473701572,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article does a good job of noting the cost of the combing salons, as well as\xa0cost of the medicinal shampoos and other drug t",The Wall Street Journal,"The treatment of childhood cases of head lice infestations is a popular news media perennial at the start of the school year, and this Wall Street Journal story¬†falls into that category. ¬†It covers the usual elements ‚Äî prevalence of the infestations a","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_88442153_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_88442153_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","As the article itself makes clear, head lice infestation¬†is¬†a widespread, unpleasant, and disruptive ‚Äî albeit relatively benign ‚Äî condition that costs millions of families money, aggravation and time in efforts to prevent and treat. ¬†Adding to the ",
https://www.healthnewsreview.org/review/healthday-does-a-good-job-reporting-on-study-of-long-term-weight-loss-after-bariatric-surgery/,HealthDay does a good job reporting on study of long-term weight loss after bariatric surgery,This quick story on a new study looking at long-term prospects for keeping weight off after bariatric surgery touched on most key points readers would be curious about.,Weight-Loss Surgery Sheds Pounds Long Term,story_reviews_00367,4,"['Sharon Dunwoody, PhD', 'Yoni Freedhoff, MD', 'Joy Victory']",HealthDay,['bariatric surgery'],https://consumer.healthday.com/vitamins-and-nutrition-information-27/weight-loss-surgery-bariatric-1005/weight-loss-surgery-achieves-long-term-weight-loss-for-many-714392.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not a component of this story.\xa0 That is an issue, as the story compares three weight-loss surgical options for morbi",Health Day,"Bariatric surgeries have been identified as perhaps the most successful means for people who are morbidly obese to lose weight, and use of these procedures is increasing, according to the American Society for Metabolic and Bariatric Surgery. Information a","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_43438554_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_43438554_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Obesity is a major health issue in the United States, and the use of bariatric surgical procedures is being used increasingly for those who are morbidly obese. Knowing how long people keep the weight off‚Äìand by how much‚Äîis useful for those deciding wh",
https://www.healthnewsreview.org/review/unlike-many-other-news-sites-npr-resists-over-hyping-results-of-alzheimers-study/,"Unlike many other news sites, NPR resists overstating results of Alzheimer‚Äôs study",This story smartly explains that we don‚Äôt know yet if amyloid reduction equals reduced risk of disease.,Test Of Experimental Alzheimer's Drug Finds Progress Against Brain Plaques,story_reviews_00368,4,"['Kevin Lomangino', 'Dan Mayer, MD', 'Joy Victory']",Alzheimer's,['beta amyloid'],http://www.npr.org/sections/health-shots/2016/08/31/491941518/test-of-experimental-alzheimers-drug-finds-progress-against-brain-plaques,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story doesn‚Äôt mention costs. However, the piece is clear that this is early-stage research that might not pan out, so we th",NPR,This NPR story discusses early studies on an experimental amyloid-reducing drug that researchers hope may prevent Alzheimer‚Äôs disease. It does a good job of balancing the promise of the drug with realistic assessments about the early stage of the resear,"https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_32711818_SMALL-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_32711818_SMALL-768x576.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Many stories suggest that reducing amyloid deposits in the brain is the same thing as reducing Alzheimer‚Äôs risk. But that‚Äôs never been proven, and some studies suggest that reducing amyloid may not have any effect on the disease symptoms that people c",
https://www.healthnewsreview.org/review/bloombergs-story-on-virtual-reality-for-pain-control-was-a-little-too-rosy/,Bloomberg‚Äôs story on virtual reality for pain control was a little too rosy,"This story did a lot of things right, but it didn‚Äôt go deep enough into a discussion of what research has found so far about the treatment.",Hospitals Try Giving Patients a Dose of VR,story_reviews_00371,4,"['Matt Shipman', 'Harold J. DeMonaco, MS', 'Joy Victory']",Bloomberg,"['pain', 'virtual reality']",http://www.bloomberg.com/news/articles/2016-08-29/hospitals-try-giving-patients-a-dose-of-vr,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes the cost of specific VR headsets (from $599 to $799) and says that users would also need to have a computer (costin",Bloomberg,The story focuses on the potential use of virtual reality (VR) headsets as clinical tools for helping patients deal with pain by distracting them. The impetus for the story appears to be the fact that the field of VR technology is experiencing rapid growt,"https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_87315781_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_87315781_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","According to the National Center for Complementary and Integrative Health, more than 25 million U.S. adults experience chronic, or daily, pain. And ‚Äúnearly 40 million adults (17.6 percent) experience severe levels of pain.‚Äù Those are big numbers, and ",
https://www.healthnewsreview.org/review/powerful-patient-video-in-stats-story-overshadows-realities-of-new-treatment-for-essential-tremor/,Powerful patient video anecdote in STAT‚Äôs story overshadows realities of new treatment for essential tremor,It‚Äôs hard to think about the potential negative consequences of this treatment after watching a woman‚Äôs remarkable recovery¬†in the accompanying video.,New treatment offers some hope for an unshakable tremor,story_reviews_00372,4,"['Mary Chris Jaklevic', 'Dan Mayer, MD', 'Joy Victory']",STAT,[],https://www.statnews.com/2016/08/24/treatment-essential-tremor/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not say how much this new procedure costs or compare it with existing treatments for patients who don‚Äôt respon",STAT,"This¬†story¬†describes a recently FDA-approved device to treat essential tremor in patients who have not responded to medication. The ExAblate Neuro, made by Dallas-based InSightec, uses magnetic resonance images taken during the procedure to deliver focu",nan,"While not life threatening, essential tremor can be debilitating, especially affecting people in their advanced years. The ExAblate Neuro, which the FDA calls the first focused ultrasound device to treat essential tremor in patients who have not responded",
https://www.healthnewsreview.org/review/a-pat-on-the-back-to-vox-com-for-excellent-reporting-on-melatonin/,A pat on the back to Vox for excellent reporting on melatonin,"This in-depth, well-research story hit all the right notes.",What is melatonin and can it help me sleep?,story_reviews_00374,5,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",Vox,['melatonin'],http://www.vox.com/2016/4/25/11425856/what-is-melatonin-sleep,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes that melatonin can be bought in ‚Äúa corner drug store‚Ä¶for just $6.‚Äù It is widely available, not only in drugst",Vox,"The story offers a broad overview of the hormone melatonin and its use as a supplement to help people get more, or better, sleep. The story looks at a number of meta-analyses of melatonin-sleep research studies, acknowledges the difficulties in assessing ","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_72508823_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_72508823_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Sleep is important. According to the CDC, more than a third of U.S. adults do not get enough sleep, and lack of sleep poses significant public health problems ‚Äî whether from automobile crashes and workplace accidents or increased risk of diseases from d",
https://www.healthnewsreview.org/review/healthday-story-misleads-by-making-osteoporosis-study-sound-like-it-compared-two-drugs/,HealthDay story misleads by making osteoporosis study sound like it compared two drugs,Here‚Äôs a case where the primary endpoints should have been closely paid attention to when reporting on the findings.,Injected Drug May Help Fight Osteoporosis in Women,story_reviews_00376,4,"['Susan Wei, PhD', 'James Rickert, MD', 'Joy Victory']",HealthDay,['osteoporosis'],https://consumer.healthday.com/bone-and-joint-information-4/osteoporosis-news-514/injected-drug-may-help-fight-osteoporisis-in-women-713938.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Although it is not known how much abaloparatide will cost at this stage, the article does discuss\xa0the cost\xa0of its would-be co",Health Day,"The story reports on research published in the Journal of the American Medical Association studying an experimental drug known as abaloparatide¬†and its ability to prevent a¬†new vertebral fracture in postmenopausal women with osteoporosis.
A standout pos","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_4489014_SMALL-300x233.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_4489014_SMALL-768x596.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/","Given the prevalence of osteoporosis, paired with the few treatment options, a new safe, effective medication would be welcomed. Accurate distillation of the research is essential in news coverage.",
https://www.healthnewsreview.org/review/guardians-reporting-on-side-effects-of-drugs-for-bipolar-disorder-hits-many-key-points/,Guardian‚Äôs reporting on side effects of drugs for bipolar disorder hits many key points,Just more discussion around costs and the quality of the evidence was needed.,"Lithium should be more widely used for bipolar disorder, researchers say",story_reviews_00378,4,"['Harold J. DeMonaco, MS', 'Susan Molchan, MD, MA', 'Joy Victory']",The Guardian,"['bipolar disorder', 'lithium']",https://www.theguardian.com/society/2016/aug/14/lithium-should-be-more-widely-used-for-bipolar-disorder-researchers-say,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story did not address costs. Because this ran in the U.S. edition of The Guardian, this is important and useful information",The Guardian,"This story is about a study on¬†the frequency of different side effects¬†of four¬†drugs used in the treatment of bipolar disorders. The researchers conclude that lithium should be used more widely, given its lower rate of side effects.
The story notes tha","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_186879_SMALL-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_186879_SMALL-768x575.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/08","Bipolar disorder, previously known as manic depressive disorder, is relatively common with a lifetime prevalence of about 3% in general population. Understanding the side effect profile of the drugs used to treat this disease, along with their relative ef",
https://www.healthnewsreview.org/review/in-just-a-few-short-paragraphs-reuters-story-covers-a-lot-of-ground-on-asthma-pill/,"In just a few short paragraphs, Reuters story covers a lot of ground on asthma pill","The story does an admirable job of describing how this pill fits into a climate of innovation in asthma treatment, but would have benefitted from independent perspective.",Novartis asthma pill shows promise in small trial,story_reviews_00381,4,"['Mary Chris Jaklevic', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",Reuters,['asthma'],http://www.reuters.com/article/us-health-asthma-novartis-idUSKCN10H075,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not address how much fevipiprant might cost and how it might compete with currently available treatments. A 2013",Reuters,"This brief story is one of two we‚Äôre reviewing this week about a clinical trial for fevipiprant, an asthma pill under development by Novartis Pharmaceuticals.
The piece refrains from the puffery of a similar story in Medical Daily which we also reviewed","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_13548664_SMALL-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_13548664_SMALL-768x510.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","The possibility of taking a pill instead of using an inhaler to control symptoms would surely be welcome news to millions of asthma patients. One in 12 Americans ‚Äî 17.7 million adults and 6.3 million children ‚Äî has asthma, according to the Centers for",
https://www.healthnewsreview.org/review/an-excellent-report-from-fivethirtyeight-on-why-at-home-screening-tests-for-colon-cancer-are-just-as-good-as-colonoscopy/,Excellent job by FiveThirtyEight on why at-home colon cancer tests are a good screening option,"This write-up provided an excellent assessment of the at-home screening¬†options for colon cancer, and why they‚Äôre a safe alternative to colonoscopy.",You Could Skip Your Colonoscopy If You‚Äôre Willing To Collect Your Poop,story_reviews_00383,5,"['Earle Holland', 'Dan Mayer, MD', 'Joy Victory']",Cancer,"['colon cancer', 'uspstf']",http://fivethirtyeight.com/features/you-could-skip-your-colonoscopy-if-youre-willing-to-collect-your-poop/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôll give this story a Satisfactory rating in this category since it does mention the $1,000 cost of a colonoscopy and that one ",FiveThirtyEight,"
This story points out that, based on available data, two at-home screening tests appear to be equally effective compared to the more traditional, and more invasive, sigmoidoscopy and colonoscopy.
We have only minor quibbles with the story‚Äìoverall, it p","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_17272992_SMALL-1-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_17272992_SMALL-1-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads","Given that the public has reservations about aspects of the invasive screening methods, information suggesting that they might be adequately replaced by non-invasive approaches is important to the public‚Äôs health. All too often, colonoscopy is promoted ",
https://www.healthnewsreview.org/review/can-exercise-undo-sedentary-harms-ap-story-makes-observational-data-sound-definitive-healthnewsreview-org/,Can exercise ‚Äòundo‚Äô sedentary harms? AP story makes observational data sound definitive,The research at hand couldn‚Äôt prove one way or another if exercise can counteract sitting all day‚Äìand the story should have made that clearer.,"To reverse damage of sitting, take a brisk, hour-long walk",story_reviews_00386,4,"['Kevin Lomangino', 'Yoni Freedhoff, MD', 'Joy Victory']",Associated Press,['exercise'],http://www.usnews.com/news/business/articles/2016-07-27/to-reverse-damage-of-sitting-take-a-brisk-hour-long-walk,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There‚Äôs no direct cost to walking an hour a day, so we won‚Äôt ding the story for omitting discussion of cost. However, there i",Associated Press,"This story reports on a large meta-analysis of observational studies looking at the association between sedentary behavior (sitting and TV-watching), exercise, and risk of dying prematurely.
Its main take-home message is ‚Äúit takes about 60 to 75 minutes","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_000084938027_Small-300x143.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_000084938027_Small-768x367.jpg 768w, https://www.healthnewsreview.org/wp-content/upl","Every day, readers are bombarded with health news messages from observational studies such as this one relating to diet, exercise, and other lifestyle issues. Because this type of research is not definitive, it is liable to be contradicted by the next stu",
https://www.healthnewsreview.org/review/usa-today-adds-a-vital-dose-of-scrutiny-to-story-on-dry-needling-for-pain/,USA Today injects a vital dose of scrutiny to story on ‚Äòdry needling‚Äô for pain,The story is a tidy¬†overview of the evidence ‚Äî and lack of evidence ‚Äî around an alternative technique for treating pain known as ‚Äúdry needling.‚Äù,Dry needling' for pain therapy is under scrutiny,story_reviews_00392,4,"['William Heisel', 'James Rickert, MD', 'Joy Victory']",USA Today,[],http://www.usatoday.com/story/life/2016/07/17/dry-needling-acupuncture-pain/86940278/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story nicely calls out different questions that readers might have, including whether insurance will pay for the therapy. It an",USA Today,"This is a story about an alternative therapy known as ‚Äúdry needling.‚Äù It involves inserting needles into the skin, similarly to acupuncture.
The story leads with an anecdote that comes dangerously close to being a promotional advertisement for an unpr","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_92061463_SMALL-300x198.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_92061463_SMALL-768x508.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Dry needling has become increasingly popular despite questionable evidence for the procedure. ¬†A pertinent question, which the story attempts to address, is whether or not it is acupuncture in disguise.",
https://www.healthnewsreview.org/review/kudos-to-wsj-for-giving-thorough-look-at-devices-for-choking-victims/,Kudos to WSJ for giving thorough look at ‚ÄòHeimlich alternative‚Äô devices for choking victims,"While the story¬†doesn‚Äôt fully answer the question posed by its own headline, it makes an admirable presentation that is clear and balanced, checking off all of our criteria.",Can New Devices Match Heimlich to Stop Choking?,story_reviews_00394,5,"['Susan Wei, PhD', 'Dan Mayer, MD', 'Joy Victory']",Wall Street Journal,['medical devices'],http://www.wsj.com/articles/can-new-devices-match-heimlich-to-stop-choking-1468242002,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article provides prices on both devices:\nBoth the Dechoker, $89.95, and the LifeVac, $69.95, have a plastic mask that provides",The Wall Street Journal,"This is a story that looks at two devices that purport to be alternatives to the Heimlich maneuver for choking victims.
While the story¬†doesn‚Äôt fully answer the question posed by its own headline, it makes an admirable presentation that is clear and ba","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_78258113_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_78258113_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201",A¬†widely accepted¬†practice to help choking victims is the Heimlich maneuver. The article discusses two devices currently¬†on the market that claim to provide backup options should the Heimlich maneuver fail. The devices have not been tested in people‚Äì,
https://www.healthnewsreview.org/review/cavity-fighting-liquid-for-kids-nice-story-but-what-does-the-medical-evidence-show/,"Cavity-fighting liquid for kids: Nice story, but what does the medical evidence show?","As with¬†medical¬†stories, it‚Äôs vital that dental¬†stories take a look at the research/evidence for a particular intervention and discuss it with readers, and¬†this one didn‚Äôt.",A Cavity-Fighting Liquid Lets Kids Avoid Dentists‚Äô Drills,story_reviews_00397,4,"['Matt Shipman', 'Dan Mayer, MD', 'Joy Victory']",New York Times,['dentistry'],http://www.nytimes.com/2016/07/12/health/silver-diamine-fluoride-dentist-cavities.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health&region=rank&module=package&version=highlights&contentPlacement=2&pgtype=sectionfront,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story addresses cost in multiple places. One dentist notes that using SDF ‚Äúcomes out to pennies per tooth.‚Äù Elsewhere, the ",The New York Times,"The story focuses on the use of silver diamine fluoride (SDF) to treat and prevent dental cavities, particularly in children. The story does a good job of addressing cost, discussing benefits in context, and drawing on input from a variety of independent ","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_87986611_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_87986611_MEDIUM-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2","According to the CDC, cavities are extremely common in young children: 19.5 percent of children aged 2-5, and 20 percent of children aged 5-11, have cavities. SDF offers a relatively faster, less painful, low-cost alternative to the traditional ‚Äúdrillin",
https://www.healthnewsreview.org/review/far-more-scrutiny-needed-in-stats-story-on-postpartum-depression-drug/,STAT‚Äôs story on postpartum depression drug‚Äì ‚Äòa paradigm shift‚Äô that needed more scrutiny,The news coverage of the study findings was great for the drug company‚Äìits stock price soared‚Äìbut the benefit to women remains unknown.,Experimental drug shows promise for quick treatment of postpartum depression,story_reviews_00398,4,"['Andrew Holtz, MPH', 'Susan Molchan, MD, MA', 'Joy Victory']",Depression,['postpartum depression'],https://www.statnews.com/2016/07/12/postpartum-depression-drug/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The drug is still in early experiments, but it would have been nice to give readers some indication of how the eventual price of ",STAT,"
This is story about a small, early test of a new type of drug to treat postpartum depression.
The story is careful to note the preliminary nature of the findings and that the only source is company statements, since the study report has not been submitte","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_61328670_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_61328670_MEDIUM-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2","This story reports some positive early hints about an experimental drug tested in a few women with the symptoms of major depression. But with phrases like ‚Äúparadigm shift,‚Äù readers could easily get the impression that the results are far more reliable",
https://www.healthnewsreview.org/review/ap-takes-pains-to-point-out-lack-of-long-term-data-for-new-dissolvable-stent/,AP takes pains to point out lack of long-term data for new dissolvable stent,We were pleased to see this story‚Äôs important cautions that¬†FDA approval of a new dissolving stent comes with important unknowns.,FDA approves first dissolving stent for US patients,story_reviews_00400,4,"['Sharon Dunwoody, PhD', 'Saurabh Jha, MBBS', 'Joy Victory']",Associated Press,['dissolvable stent'],http://www.foxnews.com/health/2016/07/05/fda-approves-first-dissolving-stent-for-us-patients.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This piece does an admirable job of providing cost information in the face of reluctance by Abbott Labs, the stent‚Äôs designer, to",Associated Press,FDA approval of a dissolvable stent sets the stage for wide use of a device that may‚Äîemphasis on the ‚Äúmay‚Äù‚Äîreduce complications in heart disease patients whose blocked arteries are treated with more typical metal stents.¬† This story offers us tha,"https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_56842416_MEDIUM-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_56842416_MEDIUM-768x510.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2","Metal stents have safety concerns, primarily higher risks of blood clots that could lead to heart attack.¬† If dissolvable stents serve to minimize that subsequent risk, they would indeed constitute an improvement over current metal stents. But no one kno",
https://www.healthnewsreview.org/review/wsj-story-on-prostate-cancer-treatment-test-leaves-us-wondering-why-no-independent-viewpoints/,WSJ story on prostate cancer treatment test leaves us wondering: Why no independent viewpoints?,A nod to conflicts of interest and the inclusion of independent experts would have provided crucial balance to a story dominated by commercial concerns.,Test Aids Prostate Cancer Treatment,story_reviews_00401,4,"['Susan Wei, PhD', 'Joy Victory']",Wall Street Journal,['prostate cancer'],http://www.wsj.com/articles/test-aids-prostate-cancer-treatment-1467864061?cb=logged0.13244635775178315,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Excellent job here. The costs of treatment are a core aspect of the story. The opening paragraph describes how the blood test in qu",The Wall Street Journal,This story describes the upcoming commercialization by Genomic Health and Epic Sciences of a diagnostic blood test¬†which could help determine whether men with advanced prostate cancer should receive¬†new-generation drugs or chemotherapy. The test detects,"https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_19637558_MEDIUM-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_19637558_MEDIUM-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/2","Prostate cancer is one of the most¬†common types¬†of cancer. While new drugs have significantly extended survival times for men in the late stages of the disease, for some men traditional chemotherapy is a better option, so a diagnostic test that would en",
https://www.healthnewsreview.org/review/cnn-cant-resist-lure-of-early-phase-als-stem-cell-research-but-keeps-tone-moderate/,"CNN can‚Äôt resist lure of early-phase ALS stem cell research, but keeps tone moderate",This story is another example of an experimental stem cell therapy receiving news coverage while the research is still preliminary.,"Stem cell study for ALS patients shows promise, yet causes pain",story_reviews_00403,4,"['Mary Chris Jaklevic', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",CNN,"['ALS', 'stem cell therapies']",http://www.cnn.com/2016/06/29/health/als-stem-cell-research/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There‚Äôs no mention\xa0of how much this procedure costs. Though this is still in its earliest stages, one could simply mention",CNN,"A man with ALS participates in a fundraiser for research in New York City.
This story describes a small Phase 2 safety-focused trial of stem cell injections to treat amyotrophic lateral sclerosis (ALS), also known as¬†Lou Gehrig‚Äôs disease. The trial inv",nan,"ALS is a rapidly progressive, fatal disease that attacks the nerve cells that control muscles. It‚Äôs relatively rare, with¬†3.9 cases in every 100,000 Americans, according to the National Institutes of Health. Most people with ALS die from respiratory fa",
https://www.healthnewsreview.org/review/comical-critical-might-even-help-lose-weight/,Bloomberg story on fiber benefits hinges on unpublished data from a private fitness app,,It‚Äôs Comical. It‚Äôs Critical. It Might Even Help You Lose Weight.,story_reviews_00404,4,"['Matt Shipman', 'Yoni Freedhoff, MD', 'Joy Victory']",Bloomberg,[],http://www.bloomberg.com/news/articles/2016-06-28/it-s-comical-it-s-critical-it-might-even-help-you-lose-weight,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story doesn‚Äôt specifically address costs, but it does discuss some of the most common types of fiber-rich food ‚Äî such as fr",Bloomberg,"This story urges people to make sure they‚Äôre eating enough dietary fiber, with a focus on fiber‚Äôs role in promoting healthy weight loss. And, overall, it does a fairly good job ‚Äî though giving a high-profile to unpublished data from a privately-owne","https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_60904904_SMALL-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/iStock_60904904_SMALL-768x510.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","Fiber‚Äìespecially from whole fruits and vegetables‚Äìis an important part of a healthy diet, with institutions from the Mayo Clinic to Harvard‚Äôs T.H. Chan School of Public Health outlining the myriad ways that a fiber-rich diet reduces health risks. An",
https://www.healthnewsreview.org/review/texting-to-prevent-heart-attacks-wsj-overstated-scope-of-study/,Texting to ‚Äòprevent heart attacks:‚Äô WSJ overstates scope of study,"The story serves up an important reminder that we can‚Äôt say something ‚Äúprevents a heart attack‚Äù for research of this nature, where rates of heart attacks weren‚Äôt actually measured. Instead, surrogate markers, such as lipid levels, were used.",How to Prevent a Heart Attack: Text Patients on Healthy Habits,story_reviews_00405,4,"['Sharon Dunwoody, PhD', 'Yoni Freedhoff, MD', 'Joy Victory']",heart disease,['text messaging'],http://www.wsj.com/articles/how-to-prevent-a-heart-attack-text-patients-on-healthy-habits-1466992860,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the peer-reviewed study on which this story seems to have been based on makes the point that text messages could offer",The Wall Street Journal,"This is a story about a now year-old study looking at whether a program of semi-personalized mobile phone text messages supporting healthy lifestyle choices led to significant differences in cholesterol¬†levels, systolic blood pressure, and BMI in a group","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_66245007_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_66245007_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","According to the story, more than 25% of all heart attacks in the United States are ‚Äúrepeat‚Äù events, making treatment‚Äîboth medication and lifestyle elements‚Äîof heart attack victims once they have returned home important. Social media and text mess",
https://www.healthnewsreview.org/review/its-never-ok-to-use-groundbreaking-treatment-for-strokes-when-its-never-been-tested-in-people/,It‚Äôs never OK to use ‚Äògroundbreaking treatment for strokes‚Äô when it‚Äôs never been tested in people,"We question why a national news outlet would consider it newsworthy to report on an approach before human trials begin, and then call it an ‚Äúexclusive‚Äù and ‚Äúgroundbreaking.‚Äù",Exclusive: Doctors to Test a Groundbreaking Treatment for Strokes,story_reviews_00406,4,"['Earle Holland', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",TIME,"['deep brain stimulation', 'stroke']",http://time.com/4382200/deep-brain-stimulation-for-stroke/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While this story admittedly is announcing a new procedure never tried in human stroke patients, it conveniently glosses over th",Time,"This story explains that researchers at the Cleveland Clinic are searching for a first patient for a trial testing whether deep brain stimulation (DBS) might be helpful in improving the outcome of physical therapy in disabled stroke patients.
It provides ","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_38213504_SMALL-300x204.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_38213504_SMALL-768x523.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","As this Time Magazine story points out, around 800,000 Americans suffer strokes each year and half of those are disabled by these events.¬† A procedure that might improve their quality of life would be a boon to public health. ¬†DBS carries significant ri",
https://www.healthnewsreview.org/review/u-s-news-world-report-story-on-proton-beam-radiation-left-out-the-evidence/,U.S. News & World Report story on proton beam radiation left out the evidence,"Although the¬†story offers precious little quantitative data or clinical trial results, it does a good job (from the headline to the end) of describing the pros and cons, costs and benefits of the treatment.",The Promise (and Limits) of Pediatric Proton Radiation,story_reviews_00410,4,"['Joann Rodgers, MS', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",Cancer,['proton beam radiation'],http://health.usnews.com/health-news/best-childrens-hospitals/articles/2016-06-21/the-promise-and-limits-of-pediatric-proton-radiation?int=98e708,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article does an exemplary job of reporting details of access, insurance coverage, and direct costs. It cites a December 2015 jo",US News & World Report,"This magazine feature story falls firmly in the category of what science and medical journalists call an ‚Äúexplainer,‚Äù a relatively intensely reported effort to put context and common sense around an emerging and sometimes controversial discovery or tr","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_88423029_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_88423029_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","For a parent with a child suffering from a life-threatening cancer, identifying the best new treatment regardless of cost or convenience would be the normal expectation. So that a new treatment, such as proton beam therapy, that sounds so reasonable‚Äìthe",
https://www.healthnewsreview.org/review/nbc-news-takes-level-headed-approach-covering-jimmy-carter-drug-for-lung-cancer/,NBC News takes level-headed approach covering ‚ÄòJimmy Carter drug‚Äô for lung cancer,This news story shows how you can capture the excitement in the scientific community around a new treatment while still providing important context.,Lung Cancer Trial Stopped After Jimmy Carter Drug Shrinks Tumors,story_reviews_00411,4,"['William Heisel', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",NBC News,"['jimmy carter', 'Keytruda']",http://www.nbcnews.com/health/cancer/lung-cancer-trial-stopped-after-jimmy-carter-drug-stops-tumors-n593726,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes the costs and puts the costs in perspective, too. It says, ‚ÄúKeytruda, approved October last year for lung cancer ",NBCNews.com,"Former U.S. President Jimmy Carter and former first lady Rosalynn Carter on stage during the 2008 Democratic National Convention.
This is a story about a lung cancer clinical trial for a drug known as Keytruda. As the story explains, Keytruda ‚Äúworked at",nan,"Lung cancer is a common malignancy and the number one cause of cancer deaths in the U.S. Traditionally treatment includes surgery, radiation, and standard chemotherapy, but most patients who have lung cancer that is not very early stage will die of their ",
https://www.healthnewsreview.org/review/colon-cancer-screening-news-healthdays-story-missed-opportunity-to-go-beyond-news-release/,Colon cancer screening news: HealthDay‚Äôs story missed opportunity to go beyond news release,HealthDay‚Äôs take on the U.S. Preventive Service Task Force‚Äôs colon cancer screening news last week would have been stronger if it had delved into specifics such as¬†costs and risks.,Expert Panel Reaffirms Need for Colon Cancer Screen Beginning at Age 50,story_reviews_00412,4,"['Andrew Holtz, MPH', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",HealthDay,"['colon cancer', 'US Preventive Services Task Force']",https://consumer.healthday.com/cancer-information-5/colon-cancer-news-96/expert-panel-reaffirms-need-for-colon-cancer-screen-beginning-at-50-712009.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The costs of screening vary dramatically, not only by test but also by the terms of a person‚Äôs health care insurance coverage",Health Day,This story about updated colon cancer screening recommendations offers readers a reasonably faithful summary of the key conclusions of the U.S. Preventive Services Task Force (USPSTF). The key point of the new guidelines is that several methods of screeni,"https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_17272992_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_17272992_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","While cancer screening doesn‚Äôt always produce clear benefits, the USPSTF concludes colon cancer screening does offer substantial benefits for most people between the ages of 50 and 75. Given the high rates of colon cancer in the U.S., this is important ",
https://www.healthnewsreview.org/review/independent-source-and-costs-all-thats-missing-from-otherwise-solid-reuters-story-on-victoza/,Independent source and costs: All that‚Äôs missing from otherwise solid Reuters story on Victoza,This investor-focused story does a mostly solid job of covering the findings from a new trial looking at heart risk reductions from a type 2 diabetes drug.,Novo diabetes drug cuts heart risks by less-than-hoped 13 percentage,story_reviews_00413,4,"['Steven J. Atlas, MD, MPH', 'Joy Victory']",Reuters,['diabetes'],http://www.reuters.com/article/us-health-diabetes-novo-nordisk-idUSKCN0YZ2F7,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of the costs of Victoza.\xa0This would have been easy to include\xa0given\xa0the drug is widely prescribed ",Reuters,"The story reports on findings from a clinical trial of Novo Nordisk‚Äôs diabetes drug Victoza published in the New England Journal of Medicine. The trial was designed to measure whether Victoza (generic name liraglutide), which is given by injection, was ","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_58425488_SMALL-300x170.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_58425488_SMALL-768x436.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201",Diabetes is one of the most common chronic conditions in the world and its rate is increasing along with higher rates of obesity and an aging population. Treatment of diabetes seeks to modify the risk factors that increase diabetes-associated complication,
https://www.healthnewsreview.org/review/thorough-story-on-underuse-of-new-ovarian-cancer-tests-needed-a-few-more-numbers/,Thorough story on underuse of new ovarian cancer tests needed a few more numbers,"The story says new blood tests for ovarian cancer are being underused because experts fear that the tests could lead to unnecessary surgery or, on the other hand, delayed diagnosis. But we‚Äôre not told: What is the evidence¬†for these concerns?","Ovarian cancer blood tests: Available, not widely used",story_reviews_00416,4,"['Sharon Dunwoody, PhD', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",Philadelphia Inquirer,"['ovarian cancer', 'screening tests']",http://www.philly.com/philly/health/cancer/20160612_Ovarian_cancer_blood_tests__Available__not_widely_used.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Costs are mentioned reasonably\xa0early in the story, and with specificity. This was good\xa0to see.'}, {'question': 'Does the stor",The Philadelphia Inquirer,This is a story about the apparent underuse of two blood tests‚ÄîROMA and OVA1‚Äîthat are FDA approved to help clinicians decide whether surgery to¬†investigate¬†abnormal growths¬†should be performed by a gynecologic oncologist (‚Äúgyn-onc‚Äù) trained to ,"https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_21762177_SMALL-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_21762177_SMALL-768x576.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201","As the story notes, surviving ovarian cancer is an uphill battle‚Äìit is often a deadly disease caught too late.¬† Any procedure that increases the probability of survival is worth careful consideration.",
https://www.healthnewsreview.org/review/thorough-and-informative-vox-story-on-stem-cell-therapy-for-multiple-sclerosis/,Thorough and informative: Vox‚Äôs story on stem cell therapy for multiple sclerosis,"This is a well-reported story, covering many of the factual and contextual bases. The addition of infographics help readers visually understand the study findings, and a plethora of independent sources add credence to the claims.",This isn‚Äôt hype: Canadian doctors just reversed severe MS using stem cells,story_reviews_00418,5,"['Joann Rodgers, MS', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",Vox,"['Multiple sclerosis', 'stem cell therapy', 'stem cells']",http://www.vox.com/2016/6/9/11898512/multiple-sclerosis-stem-cell-chemo,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article mentions a cost of $50,000 to $65,000. However, to us, that sounds on the low end, given the need to first knock out a ",Vox,"One of the graphics used in the Vox story.
This lengthy story describes the results of a small, long-term, proof-of-principle trial of a ‚Äúlast-resort‚Äù risky but promising chemo-plus-stem cell transplant treatment designed for a limited sub-set of peop",nan,"MS is a progressive autoimmune disorder that attacks and damages nerve sheaths in the central nervous system, and is estimated to affect about 400,000 in the U.S. and perhaps 2.5 million worldwide (not 20 million as cited in the article), with prevalence ",
https://www.healthnewsreview.org/review/well-done-stat-story-on-extending-aromatase-a-breast-cancer-drug-treatment/,Well done: STAT story on extended use of aromatase inhibitors for breast cancer,"This story hit all the important marks for reporting on a medical story. A solid, strong effort.",Breast cancer treatment shows benefit to extended treatment with aromotase inhibitors ,story_reviews_00419,5,"['Susan Wei, PhD', 'Mandy Stahre, PhD', 'Joy Victory']",STAT,"['aromatase inhibitors', 'breast cancer']",https://www.statnews.com/2016/06/05/breast-cancer-aromatase-inhibitors/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentions costs. Letrozole, the aromatase inhibitor used in the trial, is available as a generic for less than $100 a mont",STAT,"This is a story about a new study on whether extending the use of letrozole (brand name Femara), a type of drug known as an aromatase inhibitor, reduces recurrence in breast cancer survivors.
Women who have undergone treatment for hormone-receptor positiv","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_21712082_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_21712082_SMALL.jpg 848w",Continuing aromatase inhibitors beyond the standard five years is already a choice undertaken by some women and their doctors. This study is the first to rigorously address whether this is beneficial.,
https://www.healthnewsreview.org/review/better-data-needed-in-healthday-story-on-lowering-catheter-associated-urinary-tract-infection-rates/,More succinct data needed in HealthDay story on lowering catheter-associated urinary tract infection rates,"The story nicely breaks down the research team‚Äôs effort to attack catheter-caused UTIs with a program called ‚ÄúStop CAUTI.‚Äù However, the discussion of the findings needed more succinct details on actual benefits seen when using the program.",Program Cut Catheter-Associated Urinary Tract Infections,story_reviews_00422,4,"['Dave Mosher', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",HealthDay,"['catheter-caused UTI', 'patient safety']",https://consumer.healthday.com/infectious-disease-information-21/urinary-tract-infection-news-686/program-may-cut-catheter-associated-urinary-tract-infections-711562.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We‚Äôre told that, each year, catheters in hospitals cause 250,000 infections and cost $250 million to treat. That‚Äôs important ",Health Day,"HealthDay highlights a national effort to help reduce an uncomfortable and costly problem: hospital-acquired urinary tract infections (UTIs), and specifically those caused by indwelling catheters. These devices¬†are tubes that snake up the urethra into a ","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_32643486_SMALL-300x214.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_32643486_SMALL.jpg 819w","Indwelling catheters are very common sights at hospitals, since nurses can insert them once and they rarely slip out (a balloon at the end holds them in place). However, about 75% of UTIs are caused by such catheters, according to the CDC, and more than t",
https://www.healthnewsreview.org/review/wsjs-look-at-apps-and-wearables-for-text-neck-takes-well-measured-approach/,WSJ‚Äôs look at apps and wearables for ‚Äòtext neck‚Äô takes a measured approach,The story is very up front about an important thing: There is no evidence that either device actually works.,A Cure for Digital Addicts‚Äô ‚ÄòText Neck‚Äô?,story_reviews_00428,4,"['Matt Shipman', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",Wall Street Journal,"['computer app', 'medical devices', 'text neck', 'texting']",http://www.wsj.com/articles/a-cure-for-digital-addicts-text-neck-1464019660,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This is a toss-up, since the story tells readers that the wearable device (named Alex) costs $99, but doesn‚Äôt tell readers how mu",The Wall Street Journal,"The story describes two products ‚Äî a smartphone app and a wearable device ‚Äî designed to improve posture and, theoretically, reduce neck pain, headaches and other ailments.
The story is very up front about one thing: There is no evidence that either de","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000065995387_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000065995387_Small.jpg 849w","Neck pain is a fairly common occurrence. According to The Economic Costs of Pain in the United States, published by the Institute of Medicine, ‚ÄúData from the 2009 National Health Interview Survey indicate that during a 3-month period‚Ä¶15 percent [of ad",
https://www.healthnewsreview.org/review/new-surgical-method-for-uterine-fibroids-gets-thorough-look-by-inquirer/,New surgical method for uterine fibroids gets thorough look by Inquirer,"The story relies heavily on an anecdote, tracking one patient‚Äôs experience with the experimental procedure, but provides a good overview of the surgical treatment options available for women with uterine fibroids.",Doctors test new device for uterine fibroids,story_reviews_00430,4,"['Matt Shipman', 'Karen Carlson, MD', 'Joy Victory']",Philadelphia Inquirer,"['fibroids', 'Sonata', 'sonography-guided transcervical ablation']",http://www.philly.com/philly/health/womenshealth/20160522_Doctors_test_new_device_for_uterine_fibroids.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story pulls off a difficult trick: addressing cost in a meaningful way when it‚Äôs not clear what the price tag will be. The st",The Philadelphia Inquirer,"The story focuses on treatment options available for women who are experiencing health problems related to uterine fibroids, with a particular focus on a technique called Sonata, or sonography-guided transcervical ablation.
The story relies heavily on an ","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000079810179_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000079810179_Small.jpg 849w","According to the National Institutes of Health, ‚ÄúMost American women will develop fibroids at some point in their lives‚Äù ‚Äî but many will be unaware that they even have them. But because they are so common, if even a small percentage of women with fi",
https://www.healthnewsreview.org/review/cancer-drug-keytruda-keeps-patients-alive-3-years/,"Except for presidential anecdote, NBC story on new melanoma drug was well-balanced","By including a discussion of costs, harms, and alternatives, readers are left with a pretty good idea of what this new intervention is about.",Cancer Drug Keytruda Keeps Some Patients Alive For 3 Years,story_reviews_00431,5,"['Dave Mosher', 'Harold J. DeMonaco, MS', 'Joy Victory']",NBC News,"['cancer treatments', 'immunotherapy', 'jimmy carter', 'Keytruda', 'melanoma', 'monoclonal antibody drugs']",http://www.nbcnews.com/health/cancer/cancer-drug-keytruda-keeps-some-patients-alive-3-years-n576376,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The video claims the cost is about $150,000 a year and is ‚Äúcovered by insurance.‚Äù The text story notes how pricey it is and sta",NBCNews.com,"Former president Jimmy Carter announced in August 2015 that he had melanoma skin cancer that spread to his liver and brain. Months later, he shocked the world again by releasing a statement teasing he was in remission. He said a bit more before a videotap","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000046237340_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000046237340_Small.jpg 849w","Melanoma is an increasingly common form of cancer, likely due to the rise of tanning‚Äôs popularity and other risk factors. But it‚Äôs also the most lethal form of skin cancer, according to the American Cancer Society, killing more than 10,000 of 76,000 p",
https://www.healthnewsreview.org/review/healthday-story-wisely-discusses-harms-of-new-nocturia-drug-but-overlooked-data-on-benefits/,HealthDay story wisely includes harms of nocturia drug for older adults,"This story carefully pointed out the known harms of the intervention, but could have been more specific on¬†costs and alternatives.",Could Nasal Spray Curtail Nighttime Bathroom Trips?,story_reviews_00441,4,"[""A'ndrea Elyse Messer, MS, PhD"", 'Dan Mayer, MD', 'Joy Victory']",HealthDay,"['desmopressin', 'frequent urination', 'nocturia', 'urology', 'vasopressin']",https://consumer.healthday.com/sexual-health-information-32/prostate-problem-news-559/will-nasal-spray-curtail-nighttime-bathroom-breaks-710736.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The price or potential price of this drug is not discussed. Since there is mention of the drug already being ‚Äúcommonly‚Äù use",Health Day,"This story is about a proposed new drug for nocturia, which is defined as having to urinate two or more times during a¬†normal night of sleep. The story also briefly mentions another study linking increased physical activity with a smaller number of peopl","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000031493192_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000031493192_Small.jpg 849w","Older adults often make more trips to urinate during the night.¬† This is especially true of men with prostate problems, and this can dramatically interrupt sleep. A safe, effective treatment for this problem would be beneficial for severe sufferers‚Äìif ",
https://www.healthnewsreview.org/review/vox-knocks-it-out-of-the-park-with-well-done-story-on-new-device-for-menstrual-pain/,Vox knocks it out of the park with well-done story on new device for menstrual pain,"With a dose of healthy skepticism, this story provides the reader with a complete discourse on the merits of this new device.","This new device claims to be the ""off switch for menstrual pain."" And it might actually work.",story_reviews_00443,5,"['Harold J. DeMonaco, MS', 'Kathleen Fairfield, MD, DrPH', 'Joy Victory']",Vox,"['livia', 'menstrual pain', 'pain relief']",http://www.vox.com/2016/5/3/11518058/livia-period-pain-reliever-review,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We were pleased to\xa0see cost discussed\xa0in the story. The story points out that the projected retail cost of the Livia device (",Vox,"This is a story about a new device coming to market for menstrual pain. The story is a great example of how the media should deal with claims made about new devices. With a dose of healthy skepticism, the story provides the reader with a complete discours","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000051951024_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000051951024_Small.jpg 849w","Perimenstrual pain is a¬†common problem affecting most premenopausal women. ¬†So, the availability of a device that is safe and effective in relieving symptoms would be welcomed.",
https://www.healthnewsreview.org/review/personal-anecdotes-overwhelm-cautionary-details-in-wsj-story-on-ayahuasca-a-peruvian-hallucinogenic-concoction/,"Personal anecdotes overwhelm cautionary details in WSJ story on ayahuasca, a Peruvian hallucinogenic concoction",At least one personal account of the harms would have brought the story into better balance.,Is Peru‚Äôs Psychedelic Potion a Cure or a Curse?,story_reviews_00446,4,"['Mary Chris Jaklevic', 'Michael Bierer MD, MPH', 'Joy Victory']",Wall Street Journal,"['anecdotes over evidence', 'ayahuasca', 'controlled substances', 'hallucinogens', 'mental illness']",http://www.wsj.com/articles/is-perus-psychedelic-potion-a-cure-or-a-curse-1461944415,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says foreigners are ‚Äúpaying up to $2,500 a week to drink the elixir,‚Äù though it does not say whether this is typical.",The Wall Street Journal,"An ayahuasca ceremony in Peru. Credit: Flickr user brindle95.
This story describes a growing industry of foreigners traveling to Peru‚Äôs Amazonian jungle to drink ayahuasca, a psychedelic brew of local plants that proponents claim can open up the mind an",nan,"A wave of overwhelmingly positive media coverage of ayahuasca has stoked a booming unregulated industry of ayahuasca tourism in Peru that may be putting travelers at risk. In 2013 LA Weekly declared it ‚Äúexceedingly trendy,‚Äù running a cover story and a",
https://www.healthnewsreview.org/review/philly-physician-qa-hits-many-key-points-on-newer-allergy-treatments/,Philly physician Q&A hits many key points on newer allergy treatments,"Although it‚Äôs missing any hard quantitative research data, the story hits a good number of high notes and benchmarks in the ‚Äúnews you can use‚Äù category.","More than shots, there's new help for allergy sufferers ",story_reviews_00454,4,"['Joann Rodgers, MS', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",Philadelphia Inquirer,"['allergies', 'immunotherapy']",http://www.philly.com/philly/health/20160417_More_than_shots__there_s_new_help_for_allergy_sufferers.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Although the physician-expert interviewed for the article works at an academic medical center‚Äìwhere there is conceivably a vested",The Philadelphia Inquirer,"This is a Q&A¬†with a physician¬†about allergy treatments. It offers a mostly¬†solid if standard review of what allergies are, what treatment alternatives are available, and some information about costs. It‚Äôs a ‚Äúsole-source‚Äù consumer health story of","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000021205161_Medium-1-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000021205161_Medium-1-1024x682.jpg 1024w","Allergies are a common cause of sometimes debilitating and clearly miserable symptoms, affecting millions of men, women, and children. Health agency statistics worldwide support the point‚Äìalso made in the piece‚Äìthat prevalence has been consistently ri",
https://www.healthnewsreview.org/review/buzzfeed-oversells-benefits-of-experimental-device-for-paralyzed-man/,BuzzFeed oversells benefits of experimental technology used on paralyzed man,"By saving important details for the end, and skipping over some facts entirely, this story may leave readers with an unrealistic impression of what this new technology does.",A Paralysed Man Can Play ‚ÄúGuitar Hero‚Äù Using A Computer That Reads His Thoughts,story_reviews_00456,4,"['Andrew Holtz, MPH', 'Harold J. DeMonaco, MS', 'Joy Victory']",BuzzFeed,"['device', 'neurology', 'paralysis', 'spinal cord injuries']",http://www.buzzfeed.com/kellyoakes/a-paralysed-man-can-play-guitar-hero-using-a-computer#.sy5pkwooQ,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'It is too early in the development of this experimental technology to begin talking about what the price of such a system might b",BuzzFeed,"This is a story¬†about a case study involving one man with a specific type of partial paralysis, who regained some motion via an experimental device implanted in his brain and connected to a device worn on his arm.
The case¬†study is undoubtedly newsworth","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000066107321_Medium-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000066107321_Medium-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/u",Be amazed. Be disappointed. That‚Äôs the cycle that stories like this put us through. The achievement presented by these researchers is remarkable; they demonstrated that this line of work may someday produce something of benefit to some people with certa,
https://www.healthnewsreview.org/review/solid-effort-by-nbc-on-saturated-fat-study-though-story-lacked-hard-numbers-on-findings/,"Solid effort by NBC on saturated fat study, though story lacked hard numbers on findings","This story does a good job explaining the study‚Äôs design, and the complex issues surrounding dietary habits and heart disease. Its weak¬†point¬†was¬†not quantifying the study‚Äôs findings.",Using Vegetable Oils to Lower Cholesterol May Not Improve Longevity,story_reviews_00457,5,"['Sally James', 'Dan Mayer, MD', 'Joy Victory']",Cardiovascular disease,"['British Medical Journal', 'heart attacks', 'prevention', 'saturated fats']",http://www.nbcnews.com/health/diet-fitness/using-vegetable-oils-lower-cholesterol-may-not-improve-longevity-n554936,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Since this is about affordable and widely available cooking oils, this is N/A.'}, {'question': 'Does the story adequately quantif",NBCNews.com,"This story is about new evidence that may diminish the importance of limiting animal fats in people‚Äôs diets to reduce risk of deaths from heart disease. A new group of researchers re-examined a 45-year-old randomized controlled study of 9,000 people who","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000045966686_Medium-resize-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000045966686_Medium-resize.jpg 900w","Diet appears to play a role in dozens of chronic diseases, including heart disease. Research that helps tease out which fats are truly better for people¬†helps us further understand the issue, though it is complex¬†and evolving. News coverage should not o",
https://www.healthnewsreview.org/review/aspirin-report-from-cbs-doesnt-go-much-beyond-the-news-release/,Aspirin report from CBS doesn‚Äôt go much beyond the news release,"Several missed opportunities in this story, including a lack of hard data.",Should you be taking daily low-dose aspirin for heart health?,story_reviews_00459,4,"['Alan Cassels', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",CBS News,"['aspirin', 'heart attacks', 'heart disease', 'stroke', 'uspstf']",http://www.cbsnews.com/news/new-guidelines-daily-low-dose-aspirin-heart-health-cancer-prevention/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'It is universally known that aspirin is cheap, sold widely and in a manner where its cost will not be a barrier to consumption, s",CBSNews.com,"This is a short report on the recent U.S. Preventive Services Task Force (USPSTF) recommendation statement on the use of aspirin, one of two stories we reviewed on this topic. (Here‚Äôs the other, from STAT News.)
The story includes sufficient¬†details on","https://www.healthnewsreview.org/wp-content/uploads/2015/04/aspirin-204x300.jpg 204w, https://www.healthnewsreview.org/wp-content/uploads/2015/04/aspirin-697x1024.jpg 697w, https://www.healthnewsreview.org/wp-content/uploads/2015/04/aspirin.jpg 1024w","Aspirin is widely prescribed or purchased over-the-counter for aches and pains, and increasingly used to prevent cardiovascular events, such as heart attack and stroke, over the long term. Better public understanding of the benefits and harms of aspirin, ",
https://www.healthnewsreview.org/review/an-array-of-experts-make-this-stat-story-on-aspirin-study-very-strong/,An array of sources make this STAT story on aspirin task force recommendations very strong,"With a wide array of independent sources, and a thorough discussion of the evidence quality, this story from STAT stands out for¬†hitting all the important marks.",Experts debate: Do healthy people need an aspirin a day?,story_reviews_00460,5,"['Alan Cassels', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",STAT,"['aspirin', 'heart attacks', 'heart disease', 'stroke', 'uspstf']",https://www.statnews.com/2016/04/11/aspirin-primary-prevention/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'It is universally known that aspirin is cheap, sold widely and in a manner where its cost will not be a barrier to consumption, s",STAT,"This is a detailed report on the recent U.S. Preventive Services Task Force (USPSTF) recommendation statement on the use of aspirin, one of two stories we reviewed on this topic (here‚Äôs the other, from CBSNEWS.com). It is a relatively thorough discussio","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000001333551_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000001333551_Medium-1024x681.jpg 1024w","Aspirin is widely prescribed or purchased over-the-counter for aches and pains, and increasingly used to prevent cardiovascular events, such as heart attack and stroke, over the long term. Better public understanding of the benefits and harms of aspirin, ",
https://www.healthnewsreview.org/review/reuters-story-covers-most-of-the-bases/,Stem cell therapy for heart failure: Reuters story covers most of the bases,"Privately funded studies on stem cell therapies are a hot topic, and prone to misleading coverage. This story avoids the biohype, though it would have been stronger if it had independent sources.",Vericel stem cell heart failure therapy cuts deaths: study,story_reviews_00462,4,"['Jill U. Adams', 'Yoni Freedhoff, MD', 'Joy Victory']",Reuters,"['heart failure', 'stem cell research', 'stem cell therapy', 'stem cells']",http://www.reuters.com/article/us-health-heart-vericel-idUSKCN0X11NE,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Stem cell therapy is assumed to be quite expensive, yet there is no mention of potential cost to the patient or health care sys",Reuters,"
This investor-minded story looks at a Vericel-funded study on the potential benefits of a new stem cell therapy for advanced heart failure patients. Even though its audience was financial folks, the story included a lot of key details that a general stor","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000062354770_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000062354770_Medium-1024x682.jpg 1024w","According to the American Heart Association, of the 5.7 million Americans living with heart failure, 10 percent of them have advanced heart failure. Although the condition can be managed, over time there can be serious consequences. Due to advanced heart ",
https://www.healthnewsreview.org/review/wapo-story-on-meditation-and-back-pain-relies-heavily-on-news-release/,WaPo leans hard on news release for story on meditation and back pain,"This story thoroughly¬†described the design and results of a new JAMA study on mind-body methods for back pain, but otherwise lacked original reporting.","Mindful meditation may be the answer to relieving chronic back pain, study suggests",story_reviews_00466,4,"['Matt Shipman', 'Ishani Ganguli, MD, MPH', 'Joy Victory']",Washington Post,"['back pain', 'JAMA', 'meditation', 'mindfulness']",https://www.washingtonpost.com/news/to-your-health/wp/2016/03/22/could-meditation-be-the-answer-to-relieving-back-pain-study-shows-surprising-results/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story doesn‚Äôt address costs for any of the treatment options discussed. Is MBSR comparable to CBT? Does insurance cover e",The Washington Post,This story focuses on a JAMA study¬†investigating whether¬†mindfulness-based stress reduction (MBSR) is as effective as cognitive behavior therapy (CBT) and standard treatment at helping patients reduce lower back pain. The story does a good job of quanti,"https://www.healthnewsreview.org/wp-content/uploads/2015/07/back-pain-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/back-pain.jpg 849w","Lower back pain is an extremely common problem around the world. For example, a 2012 paper reported that lower back pain was responsible for more than three percent of all emergency room visits in the United States. An earlier paper found that health care",
https://www.healthnewsreview.org/review/cold-turkey-coverage-from-la-times-lacked-independent-sources/,"Quitting cold turkey‚Äìstrong coverage from LA Times, except for lack of independent sources","Is going cold turkey better than gradually cutting back on cigarettes? The LA Times does a good job explaining a new study examining this question, but the story lacked comments from an independent source‚Äìor even one of the researchers.","To quit smoking, it's best to go cold turkey, study finds",story_reviews_00469,4,"['Euna Bodner, MS', 'Steven J. Atlas, MD, MPH', 'Joy Victory']",Los Angeles Times,"['cold turkey', 'nicotine addiction', 'smoking cessation research']",http://www.latimes.com/science/sciencenow/la-sci-sn-to-quit-smoking-total-abstinence-20160314-story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Both groups in this study used smoking cessation products, and so it would have been helpful to know how much they cost, even i",Los Angeles Times,"This story looks at a¬†study that investigated¬†whether going cold turkey (quitting abruptly) is more effective than cutting back gradually.¬†The article does a good job quantifying the benefits, and informing readers of the quality¬†of the research. We a","https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000010749851_Medium-Page-300x218.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000010749851_Medium-Page.jpg 440w","Well-designed research on smoking cessation is¬†vital to helping¬†smokers overcome their addiction. The media‚Äôs role is important, too‚Äìreaders eager to quit smoking are not likely to be reading medical journals, but they are reading the news. Therefor",
https://www.healthnewsreview.org/review/no-drill-dentistry-fluoride-treatments-can-prevent-cavities-adults/,NPR trend piece on fluoride treatments in adults should have drilled into hard evidence,"This ‚Äúbetter safe than sorry‚Äù story about the advantages of more intensive measures to prevent tooth decay is thick with promises, but thin with evidence about who might benefit and by how much.",No-Drill Dentistry: Fluoride Treatments Can Prevent Cavities In Adults,story_reviews_00470,4,"['Andrew Holtz, MPH', 'Doug Campos-Outcalt, MD, MPA', 'Joy Victory']",NPR,"['cavities', 'dentistry', 'oral health']",http://www.npr.org/sections/health-shots/2016/03/14/469959427/no-drill-dentistry-fluoride-treatments-can-prevent-cavities-in-adults,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does include a discussion of price, reporting that a fluoride varnish treatment can cost $23 to $55, while a filling can ",NPR,"This ‚Äúbetter safe than sorry‚Äù story about the advantages of more intensive measures to prevent tooth decay in adults is thick with promises, but thin with evidence about who might benefit and by how much.
The strong points: The reporter did a good job","https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000067247857_page-version-300x252.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000067247857_page-version.jpg 440w","Prevention is appealing as a concept, but stories about preventive strategies should give readers hard facts about how much benefit is likely and at what cost. While this story did report typical costs for a single fluoride treatment and for a single toot",
https://www.healthnewsreview.org/review/cbs-report-needed-more-details-on-stem-cell-surgery-study/,CBS story on stem cell surgery for cataracts kept hype in check but lacked key study details,"This story had a lot going for it‚Äìincluding a multitude of independent sources‚Äìbut¬†it¬†would have been stronger if it had better quantified the results of the study, and explained how the¬†researchers measured the success of this new surgical method.",First-of-its-kind cataract surgery using stem cells shows promise,story_reviews_00472,4,"['Earle Holland', 'Dan Mayer, MD', 'Joy Victory']",CBS News,"['cataracts', 'congenital cataracts', 'stem cell research', 'stem cell therapies', 'stem cells', 'vision loss']",http://www.cbsnews.com/news/cataract-surgery-using-stem-cells-shows-promise-in-babies/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story doesn‚Äôt discuss\xa0costs for this new approach. One web source points to an average cost of $3,400 per eye for conv",CBSNews.com,"This story describes the findings of a study published in Nature that involved a new approach to correcting congenital cataracts in infants using the patient‚Äôs own stem cells to grow new lenses in the eye, versus the more standard approach of using arti","https://www.healthnewsreview.org/wp-content/uploads/2016/03/istock-baby-eye-edit-300x204.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/03/istock-baby-eye-edit.jpg 546w","While not a common eye disease, congenital cataracts can be devastating to a child‚Äôs vision and normal development. The current treatment option‚Äìsurgery and insertion of artificial lenses‚Äìusually restores vision, but it often requires multiple surge",
https://www.healthnewsreview.org/review/informative-intelligent-coverage-of-osteoporosis-drug-tradeoffs/,"Informative, intelligent coverage of osteoporosis drug tradeoffs",In-depth reporting on an important issue that covers almost all the angles solidly. We had a few modest suggestions for improvement.,More support for osteoporosis drugs,story_reviews_00478,5,"['Matt Shipman', 'Dan Mayer, MD', 'Kevin Lomangino']",Osteoporosis,['bisphosphonates'],http://www.wsj.com/articles/more-support-for-osteoporosis-drugs-1455575920,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story is clear on this point, stating: ‚ÄúAll the bisphosphonates are now available in generic form, for as little as $5 a mont",The Wall Street Journal,"This thorough, well-researched story focuses on the debate over how and whether bisphosphonates should be used to treat osteoporosis, and provides a general overview of the related risks and potential benefits. The story does many things well ‚Äî and addr","https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000010084757_Small-300x223.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000010084757_Small.jpg 804w","Osteoporosis is not uncommon. Estimates of osteoporosis occurrence (and severity) vary, but a 2014 study estimated that more than 10 million people in the U.S. have osteoporosis. Osteoporosis increases the risk of bone injuries, such as hip fractures, tha",
https://www.healthnewsreview.org/review/acupuncture-may-help-ease-fibromyalgia-pain-study-finds/,Acupuncture for fibromyalgia: a few small details would‚Äôve improved a strong story,"Good story on an interesting, well-conducted study. Our reviewers had only a couple of items on their wish list.","Acupuncture May Help Ease Fibromyalgia Pain, Study Finds",story_reviews_00479,4,"['Earle Holland', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",HealthDay,"['acupuncture', 'fibromyalgia', 'pain']",http://consumer.healthday.com/alternative-medicine-information-3/acupuncture-news-5/acupuncture-may-help-ease-fibromyalgia-pain-study-finds-708085.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story offers an estimate of the cost of an acupuncture session at $125. The study participants received nine separate sessions,",Health Day,This HealthDay story reports on a study of fibromyalgia patients who received acupuncture as a supplemental treatment for pain. Their results were compared to those of another group of patients receiving only sham treatments. The story says that after 10 ,"https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000003033679_Small-300x201.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000003033679_Small.jpg 847w","Fibromyalgia is a poorly understood condition in which pain is present in multiple body regions. It is unclear what is the cause of the pain and whether other symptoms that can accompany the pain ‚Äì depression, fatigue, sleep issues ‚Äì are caused by the",
https://www.healthnewsreview.org/review/independent-voices-bolster-coverage-of-potential-opioid-addiction-treatment/,Independent voices boost coverage of potential opioid addiction treatment,"Lots of solid reporting on an important topic in this story. The main problems with the piece are the primitive click-bait headline and a lack of hard data from published, peer-reviewed studies.",Could This Opioid Implant Really End The Opioid Epidemic?,story_reviews_00482,4,"['Joann Rodgers, MS', 'Michael Bierer MD, MPH', 'Kevin Lomangino']",BuzzFeed,"['addiction', 'opioid drugs']",http://www.buzzfeed.com/danvergano/the-opioid-implant,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Hardly\xa0a word is written about costs in any realm of this story: the costs to the economy of lost productivity; the cost of ",BuzzFeed,"This substantially reported article¬†mostly reviews and updates the politics, marketing and use of opioid medications‚Äìnotably buprenorphine‚Äìin various forms and drug combinations‚Äìto treat opioid addiction. The piece is thoroughly researched, contain","https://www.healthnewsreview.org/wp-content/uploads/2016/01/opioid-drugs-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/opioid-drugs.jpg 849w","Data from a variety of sources make a good case that addiction to heroin and opioid painkillers is a growing problem in rural and suburban communities, as well as poor urban ones. Partly as a result, efforts to combat the increased rate of lethal overdose",
https://www.healthnewsreview.org/review/outside-commentary-adds-clarity-to-story-on-jet-lag-therapy/,Outside commentary adds clarity to story on potential jet lag therapy,This Reuters piece scores well for bringing needed balance through comments from an outside expert.,"Flashing night-lights may help lessen jet lag, circadian problems",story_reviews_00483,5,"['Alan Cassels', 'Susan Molchan, MD, MA', 'Kathlyn Stone']",Reuters,"['jet lag', 'light therapy']",http://www.reuters.com/article/us-health-circadian-light-flashes-idUSKCN0VH20X,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'While no costs were discussed, the suggestion that the device might be expensive was made: ‚ÄúThe night flashes require special tec",Reuters Health,"This study of flashing light therapy enrolled¬†39 people, and exposed 31 of them to a series of two-millisecond light flashes with changing intervals while sleeping. The other eight were exposed to 60 minutes of continuous bright light. Those who experien","https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000030770624_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000030770624_Small.jpg 849w","Jet lag is a significant concern for many people who have to travel distances that span¬†multiple time zones, where their¬†ability to work effectively is compromised as the body struggles to adjust to a¬†new time zone. This means a simple, but effective l",
https://www.healthnewsreview.org/review/transferring-moms-bacteria-to-c-section-babies-but-what-if-the-bugs-arent-all-friendly/,Transferring Mom‚Äôs bacteria to C-section babies ‚Äî but what if the bugs aren‚Äôt all friendly?,Generally solid coverage that was too quick to declare this procedure ‚Äúsafe‚Äù based on experience with only four babies.,Bacteria From Mother May Colonize Cesarean Births,story_reviews_00486,5,"['Ishani Ganguli, MD, MPH', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",New York Times,"['babies', 'c-section', 'gut bacteria']",http://well.blogs.nytimes.com/2016/02/01/post-cesarean-bacteria-transfer-could-change-health-for-life-study-shows/?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The article does not discuss the costs associated with inoculation. However, it‚Äôs implied that vaginal microbial transfer is ve",The New York Times,"This is a well-articulated but incomplete story about a proof-of-principle study suggesting that when babies born by C-section are swabbed with their mother‚Äôs vaginal fluids, they have a microbiome more closely approximating¬†those of their vaginally-bo","https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000070337539_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000070337539_Small.jpg 849w","Emerging research suggests that the types and patterns¬†of natural bacteria growing on our bodies are important for healthy immune, digestive, and metabolic systems. Babies born by C-section do not have the benefit of being colonized by the natural¬†bacte",
https://www.healthnewsreview.org/review/sexy-but-not-sensational-stat-strikes-the-right-balance-on-stem-cell-diabetes-approach/,Sexy but not sensational: STAT strikes the right balance on stem cell diabetes approach,"This excellent, cautious examination of a pair of lab studies gives readers everything they need to know without hyping the potential for diabetes treatment.",Cell therapy in protective bubble offers hope for diabetes fix,story_reviews_00489,4,"['William Heisel', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']","""cure""","['stem cell therapy', 'stem cells', 'type 1 diabetes']",http://www.statnews.com/2016/01/25/diabetes-cell-therapy/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Part of the caution in this story is not linking the research too closely to a potential on-the-shelf treatment. The story says i",STAT,"This article does a really nice job of explaining the science behind two studies and appropriately depicting the pace of scientific process. With other news coverage talking about the research getting us ‚Äúclose to a cure‚Äù for diabetes, this story took","https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000040323594_Small-300x242.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000040323594_Small.jpg 771w","Type I Diabetes is a relatively common illness that takes significant time and expense to manage and is associated with major complications. For years it has seemed we are on the verge of a major breakthrough, but, even with better treatments, this condit",
https://www.healthnewsreview.org/review/saturday-sleep-ins-help-prevent-diabetes-small-preliminary-study-got-more-attention-than-it-deserved/,"Saturday sleep-ins help prevent diabetes? Small, preliminary study got more attention than it deserved","A decent enough job of reporting on a small observational study, but our reviewers questioned whether the study was worth covering at all.",Sleeping in on weekends may help reduce diabetes risk,story_reviews_00491,4,"['Joann Rodgers, MS', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Diabetes,['sleep problems'],http://www.reuters.com/article/us-health-sleep-diabetes-idUSKCN0UW2BN,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of the ‚Äòintervention‚Äô (catching up on sleep) is what is at issue here, and that is ‚Äòfree‚Äô. So we‚Äôll rule this ",Reuters Health,"This article describes results of a very small observational study¬†suggesting some tantalizing links between sleep and¬†diabetes risk. But it‚Äôs probably fair to say that this article, although it pretty accurately reflects the proffered data and does a","https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000045582316_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000045582316_Small.jpg 849w","Type 2 diabetes is indeed reaching epidemic proportions in the U.S., along with its major risk factors, obesity and metabolic syndrome. Readers of health news stories will in large numbers therefore be looking for anything that will help them prevent or r",
https://www.healthnewsreview.org/review/just-add-water-student-weight-loss-strong-cbs-report-missed-costs-study-limitations/,‚ÄúJust add water‚Äù for student weight loss? Strong CBS report missed on costs and study limitations,CBS covers a lot of ground in this short report on water coolers in schools but missed some key details.,School water coolers may help kids lose weight,story_reviews_00492,4,"['Euna Bodner, MS', 'Yoni Freedhoff, MD', 'Kevin Lomangino']",CBS News,['weight loss'],http://www.cbsnews.com/news/school-water-coolers-may-help-kids-lose-weight/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The CBS article does not mention any costs associated with the installation of a water dispenser. The JAMA Pediatrics article s",CBSNews.com,"Despite it being a fairly short report, CBS covers a lot of ground: it quantifies the benefits in absolute terms, outlines the study design and weighs the advantages of modern water dispensers against ‚Äúold-fashioned‚Äù water fountains. But in other area","https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000031268340_Small-200x300.jpg 200w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000031268340_Small.jpg 566w",Childhood obesity is a health concern that is on the minds of many parents and policymakers. The Centers for Disease Control and Prevention (CDC) estimates childhood obesity has more than doubled in children and quadrupled in adolescents in the past 30 ye,
https://www.healthnewsreview.org/review/panel-reasserts-mammogram-advice-triggered-breast-cancer-debate/,"Thorough, thoughtful coverage of Task Force‚Äôs final mammogram recommendations",Exemplary reporting on a complicated issue that affects millions of women.,Panel Reasserts Mammogram Advice That Triggered Breast Cancer Debate,story_reviews_00495,5,"['Matt Shipman', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Cancer,"['mammography', 'US Preventive Services Task Force']",http://www.nytimes.com/2016/01/12/health/mammogram-breast-cancer-screen-advice-guidance.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does a good job of explaining how the USPSTF recommendations may affect insurance coverage of mammography screening ‚",The New York Times,"The story provides an excellent overview of new recommendations from the U.S. Preventive Services Task Force (USPSTF) on when, and how often, women should receive mammograms to screen for breast cancer. The story discusses the long-running debate over mam","https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000044046496_Small-214x300.jpg 214w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000044046496_Small.jpg 585w","Breast cancer screening is a big deal. As the CDC notes, ‚ÄúNot counting some kinds of skin cancer, breast cancer in the United States is the most common cancer in women, no matter your race or ethnicity.‚Äù In 2012 alone, 41,150 women died of the disease",
https://www.healthnewsreview.org/review/new-breast-cancer-screening-guidelines-odds-congress/,Informative report on mammogram recommendations could have quantified lives saved,A very good report that lacked a few details found in ,New breast cancer screening guidelines at odds with Congress,story_reviews_00496,4,"['Matt Shipman', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Cancer,"['mammography', 'US Preventive Services Task Force']",https://www.washingtonpost.com/news/to-your-health/wp/2016/01/11/when-should-women-get-mammograms-congress-and-some-key-experts-disagree/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does address how the USPSTF recommendations may affect insurance coverage of mammography screening, as well as relate",The Washington Post,"The story provides a good overview of new recommendations from the U.S. Preventive Services Task Force (USPSTF) on when, and how often, women should receive mammograms to screen for breast cancer. The story summarizes the long-running debate over mammogra","https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000017528988_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000017528988_Small.jpg 849w","Breast cancer screening is a big deal. As the CDC notes, ‚ÄúNot counting some kinds of skin cancer, breast cancer in the United States is the most common cancer in women, no matter your race or ethnicity.‚Äù In 2012 alone, 41,150 women died of the disease",
https://www.healthnewsreview.org/review/tortillas-may-hold-key-healthier-babies/,Tacos and neural tube defects: NPR deftly explains the connection,This story gives readers most of what they need to know about a proposal to fortify corn flour with folic acid as a means of preventing birth defects.,Why Tortillas May Hold The Key To Healthier Babies,story_reviews_00500,4,"['Sally James', 'Karen Carlson, MD', 'Kevin Lomangino']",Diet studies,"['FDA', 'folic acid', 'Hispanic', 'March of Dimes', 'neural tube defects']",http://www.npr.org/sections/thesalt/2016/01/04/456278520/why-tortillas-may-hold-the-key-to-healthier-babies,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not talk about any costs. There are a few places where cost might have been valuable. The story could have discu",NPR,"In this story, the FDA is weighing a request to add folic acid to corn flour in order to possibly prevent neural tube defects¬†during pregnancy. Hispanic women are at higher risk of giving birth to babies with these issues. Corn flour is often consumed mo","https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000041935272_Small-300x216.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000041935272_Small.jpg 816w","Prevention gets short shrift in most health stories, so it is great to read this one about how some prevention (adding folic acid to corn flour) might decrease the number of babies born with neural tube defects. We would have liked the story to discuss al",
https://www.healthnewsreview.org/review/new-class-blood-pressure-meds-effective-old-analysis-shows/,A gloss over costs in coverage of competing blood pressure meds ‚Äî but also some strengths,This story dug deeper than ,"New class of blood pressure meds as effective as old, analysis shows",story_reviews_00502,4,"['Earle Holland', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Cardiovascular disease,"['drug costs', 'high blood pressure']",https://www.washingtonpost.com/news/to-your-health/wp/2016/01/04/new-class-of-blood-pressure-meds-as-effective-as-old-analysis-shows/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'While the story could have been a bit more specific, it gets points for stating that most ACE inhibitor drugs, and many ARB drugs, ",The Washington Post,"This Washington Post story reports the findings of a study that compared the efficacy of two classes of drugs available to treat cardiovascular disease (CVD) ‚Äî angiotensin converting enzyme, or ACE, inhibitors versus newer angiotensin receptor blockers,","https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000017329510_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/01/iStock_000017329510_Small.jpg 849w","For patients with high blood pressure, there are numerous studies that demonstrate medications to lower blood pressure are associated with decreased rates of heart attacks, strokes and to a lesser extent, kidney failure. Given the number of different choi",
https://www.healthnewsreview.org/review/got-yoga-times-carefully-scrutinizes-possible-bone-health-benefits/,Got yoga? Generally thorough Times report doesn‚Äôt quantify size of bone health benefits,"This report never really says how much people‚Äôs bone density improved with daily yoga, but the coverage includes some important caveats about the research.",12 Minutes of Yoga for Better Bone Health,story_reviews_00503,4,"['Alan Cassels', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",New York Times,['yoga'],http://well.blogs.nytimes.com/2015/12/21/12-minutes-of-yoga-for-stronger-bones/?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'While the article did not specifically state how much it costs to do a 12 minute yoga session everyday, one can assume it is rela",The New York Times,"This is a thorough and balanced report of research into the effects of yoga on bone density. While yoga provides a range of potential health benefits including increased flexibility, balance and strength (all factors which can help prevent falls and fract","https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000055009642_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000055009642_Small.jpg 849w","Yoga is hugely popular and growing in importance, so understanding the specific effects of daily practice of yoga could influence¬†current thinking about its role in disease prevention and health promotion. ¬†If a specific effect of yoga on bone density i",
https://www.healthnewsreview.org/review/c-sections-best-little-labor-study-says/,Times overstates risks of planned vs. unplanned C-sections,"Despite a 4-star score, this story lets readers down in some important ways, first by not adequately explaining the small size of the effect and by not addressing some key limitations.","C-Sections Are Best With a Little Labor, a Study Says",story_reviews_00504,4,"['Sally James', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",New York Times,"['birth', 'c-section', 'labor', 'obesity', 'public health']",http://well.blogs.nytimes.com/2015/12/14/c-sections-are-best-with-a-little-labor-a-study-says/?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article does not include any discussion of costs. We believe that information could have added a further dimension to the t",The New York Times,"In this story, we hear about a long-term comparison of three kinds of birth in Scotland: planned C-section, unplanned C-section and vaginal delivery. This enormous observational study included more than 320,000 children, and followed their health for many","https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000019586925_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000019586925_Small.jpg 849w","As the story points out, almost one-third of babies born in the United States are born by C-section. This rate is higher than many other countries. Some of those deliveries are determined by medical conditions that require a C-section, and some are more r",
https://www.healthnewsreview.org/review/marijuana-oil-and-epilepsy-healthday-underscores-perils-of-uncontrolled-studies/,"Marijuana oil and epilepsy: HealthDay underscores perils of uncontrolled, unblinded studies","Our reviewers questioned whether this preliminary study was worth reporting on. But given that it was, they thought the coverage was informative and balanced.",Marijuana Chemical Shows Promise for Hard-to-Treat Epilepsy in Kids,story_reviews_00506,4,"['Sharon Dunwoody, PhD', 'Susan Molchan, MD, MA', 'Kevin Lomangino']",HealthDay,"['Epilepsy', 'marijuana']",http://consumer.healthday.com/cognitive-health-information-26/epilepsy-news-235/medical-marijuana-shows-promise-for-hard-to-treat-epilepsy-in-kids-705896.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not mentioned.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure",Health Day,Efficacy and safety studies of a marijuana-derived oil on children for whom existing drugs fail to control epileptic seizures support moving cannabidiol into clinical studies. That‚Äôs good news. Less cheery is encountering stories about the effects of th,nan,"When a child suffers, little else matters. Parents of epileptic kids whose seizures are not responsive to anti-seizure medicines will be on the lookout for alternatives. Some have apparently already begun to treat their children with marijuana-derived oil",
https://www.healthnewsreview.org/review/post-lays-out-limitations-of-study-showing-longer-survival-with-breast-cancer-surgery/,Post lays out limitations of study showing longer survival with breast cancer surgery,A large retrospective study suggests surgery could help stage 4 breast cancer patients survive longer. The Post evaluates this claim thoroughly.,"Women with Stage 4 breast cancer survive longer if they have surgery, study shows",story_reviews_00507,4,"['Euna Bodner, MS', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Cancer,"['breast cancer', 'surgery']",https://www.washingtonpost.com/news/to-your-health/wp/2015/12/02/women-with-stage-4-breast-cancer-survive-longer-if-they-have-surgery-study-shows/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of breast surgery in the US varies widely depending on the type, hospital and region, and so we acknowledge that it wo",The Washington Post,"This story is about a large retrospective study that was published this week in the journal JAMA Surgery. The research suggests women who opted for surgery to treat their breast cancer had better survival rates than those who didn‚Äôt, even though the num","https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000018536284_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000018536284_Small.jpg 849w","Though current screening recommendations for breast cancer are intended to identify cancers at an earlier, more curable stage of disease, women still present with metastatic disease (cancer that has spread to other parts of the body). This can occur becau",
https://www.healthnewsreview.org/review/panic-disorder-treatment-breath-fresh-air/,A device to help people with panic attacks breathe easier? Inquirer gives readers the low-down,"A wide range of opinions, good explanations of availability¬†and nice context about¬†the quality of the evidence give readers nearly everything they need to know about this unproven treatment for panic attacks.", Panic disorder treatment could be breath of fresh air ,story_reviews_00510,5,"['William Heisel', 'Susan Molchan, MD, MA', 'Kevin Lomangino']",Devices,['panic disorder'],http://www.philly.com/philly/health/mental-health/20151129_Panic_disorder_treatment_could_be_breath_of_fresh_air.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Not only does the story discuss the costs, it explains that ‚Äúno other insurance companies are covering Freespira‚Äôs $500-a-month",The Philadelphia Inquirer,"We would have questioned the decision to write about a device with so little evidence to back up its use, but with a huge health insurer considering whether to back this device as a panic attack treatment, it makes a lot of sense to examine it from multip",nan,"As the article states, several million people in the U.S. have panic disorder, and millions more experience panic attacks that bring them to the emergency room or for a visit to a doctor. The disorder may significantly limit people‚Äôs lives. It is very t",
https://www.healthnewsreview.org/review/light-therapy-effective-treating-depression-not-just-winter-blues/,Should light therapy be recommended for depression in general ‚Äî not just in winter?,"Although this story checked 6 out of 9 of our boxes to earn a 4-star score, the misses were notable because they dealt with benefits, harms, and quality of evidence ‚Äî all extremely important.","Light therapy effective for treating depression, not just winter blues",story_reviews_00511,4,"['Sally James', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",Depression,"['antidepressants', 'depression', 'light therapy', 'psychiatry', 'seasonal affective disorder']",https://www.washingtonpost.com/news/to-your-health/wp/2015/11/18/light-therapy-effective-for-treating-depression-not-just-winter-blues/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story squeaks by on this with mention that light therapy is ‚Äúcheap‚Äù and easy to use. We would have preferred some numbers g",The Washington Post,"This brief story gives a tantalizing glimpse into a small study of 122 people with major depression, but it leaves us wanting a bit more.
The randomized controlled study divided patients into groups with some receiving light therapy alone, some receiving ",nan,"Major depression is the second-ranked cause of disability in the world, and estimates say it strikes 1 in 20 people in the United States. If light therapy, which is relatively low-cost, could improve the treatment of major depression it would help million",
https://www.healthnewsreview.org/review/will-drinking-coffee-extend-life/,Will drinking coffee extend your life? STAT delivers a 5-star answer,"This story on the latest coffee study delivers an appropriate evidence-based message, and manages to do so while keeping readers engaged and entertained.",Will drinking coffee extend your life? ,story_reviews_00513,5,"['Joann Rodgers, MS', 'Susan Molchan, MD, MA', 'Kevin Lomangino']",limits of observational studies,"['coffee', 'relative vs. absolute risk']",http://www.statnews.com/2015/11/16/coffee-extend-life/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Arguably, most people know how much their java habit costs them every day, and neither this STAT story nor the competing CNN cove",STAT,"This STAT story does an exemplary job of describing, and putting into context,¬†yet another observational study of the possible links between coffee consumption and health, this one concluding that overall, whether decaf or regular, coffee is associated w","https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000048278610_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000048278610_Small.jpg 849w","Readers and viewers of mass media have been nearly whiplashed by claims and counterclaims related to the benefits and risks of coffee drinking. A few studies over the past several decades have concluded that, at least in large amounts, coffee can be ‚Äúto",
https://www.healthnewsreview.org/review/healthday-carefully-describes-link-between-breastfeeding-and-preemie-eye-disease/,HealthDay carefully describes link between breastfeeding and preemie eye disease,"This story is clear on the big picture, even if certain details of the coverage could have been presented a bit more sharply.",Breast-Feeding Linked to Reduced Risk of Preemie Eye Problem,story_reviews_00514,5,"['Susan Wei, PhD', 'Earle Holland', 'Kevin Lomangino']",HealthDay,"['baby formula', 'breastfeeding']",http://consumer.healthday.com/women-s-health-information-34/breast-feeding-news-82/breastfeeding-reduces-risk-of-preemies-eye-problems-705253.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Cost is not a relevant criterion in this case as the comparison is made between breast milk and formula. Both feeding methods ent",Health Day,"
This article consists overall of balanced reporting. There are a few missteps in presenting the quantitative evidence but some very strong points are present as well, including the acknowledgement¬†that the studies under consideration are all observation","https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000019788450_Small-200x300.jpg 200w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000019788450_Small.jpg 566w","Retinopathy of prematurity (ROP) is a potentially blinding eye disorder. The article reports on a meta-analysis examining whether human breast milk, compared with formula, is associated with protection against developing ROP.",
https://www.healthnewsreview.org/review/get-paid-to-take-your-pills-strong-inquirer-report-covers-all-the-ins-and-outs/,Get paid to take your pills? Strong Inquirer report covers all the ins and outs,This story aced all 10 criteria and we only had a few suggestions for improvement. Exemplary reporting.,Penn study: Pay patients to take their pills ,story_reviews_00517,5,"['Sally James', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Drug costs,"['behavior', 'cholesterol', 'pills', 'public health', 'rewards', 'statins']",http://www.philly.com/philly/health/20151109_Penn_study__pay_patients_to_take_their_pills.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story discusses costs in a very interesting way ‚Äì because the point of the research was modifying human behavior by paying ‚Ä",The Philadelphia Inquirer,"Researchers studied about 1,500 patients with blood cholesterol levels that put them at risk for heart disease and stroke to try to encourage them (via cash) to take their medicines ‚Äì statins. Results were mixed, but the doctor-and-patient pairs who bot","https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000040924400_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000040924400_Small.jpg 849w","Solving behavioral issues that prevent patients from taking their medications is an important challenge. Even in this study, even with rewards, fewer than half the patients treated for high cholesterol levels kept taking their medication as prescribed. Ma",
https://www.healthnewsreview.org/review/better-diets-saved-one-million-people-dying/,Have better diets ‚Äúsaved more than one million people from dying‚Äù?,"Though it has many strengths, this story should have pushed back against the the claim that one million lives have been saved by better diets. This type of study can‚Äôt tell us that.",Better Diets May Be Extending Americans' Lives ,story_reviews_00518,4,"['Joann Rodgers, MS', 'Yoni Freedhoff, MD', 'Kevin Lomangino']",Diet studies,"['diabetes', 'heart disease', 'limits of observational studies', 'obesity', 'weight loss']",http://consumer.healthday.com/cardiovascular-health-information-20/dieting-to-control-cholesterol-health-news-190/better-diets-may-be-extending-americans-lives-704834.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We are content to declare this Not Applicable, but it wouldn‚Äôt have hurt to note the financial burden and potential financial s",Health Day,This news story ably describes a Harvard research team‚Äôs¬†effort to evaluate the quality of American diets over time using a composite index of food choices that reflect adherence ‚Äî or lack thereof¬†‚Äî to diets predicted to lower the population risk ,"https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000044816870_Small-300x247.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000044816870_Small.jpg 764w","Efforts to slow or stem the rising or persistent epidemics of obesity, diabetes, cancer and¬†heart disease depend substantially on an educated public, ample healthy food choices and public policies that clarify and encourage healthy diets. One huge¬†probl",
https://www.healthnewsreview.org/review/happens-try-prevent-every-single-suicide/,Textured look at one health system‚Äôs relentless suicide prevention efforts,"A solid exploration of one health system‚Äôs suicide prevention program, although it may overstate the role of that program in causing the dramatic drop in suicides reported.",What Happens If You Try To Prevent Every Single Suicide?,story_reviews_00520,4,"['Matt Shipman', 'Michael Bierer MD, MPH', 'Kevin Lomangino']",Depression,['suicide'],http://www.npr.org/sections/health-shots/2015/11/02/452658644/what-happens-if-you-try-to-prevent-every-single-suicide,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'At issue in the story is the health system‚Äôs so-called ‚Äúperfect depression care,‚Äù which incorporates depression screening int",NPR,"The story looks at an attempt by the Henry Ford Health System in Detroit, Mich., to eliminate suicide in its patients by taking a proactive approach to identifying and treating depression. The program, which was launched in 2001, is associated with a sign","https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000034116272_Small-300x236.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/iStock_000034116272_Small.jpg 782w","Suicide is a tragedy. In addition to taking the life of an individual, it can have profound and lasting impacts on friends and family who have lost a loved one to suicide. According to the CDC, the suicide rate in the U.S. was 12.6 per 100,000 people in 2",
https://www.healthnewsreview.org/review/is-sugar-definitely-toxic/,Is sugar ‚Äúdefinitely toxic‚Äù?,"There was room for improvement, but readers who make it the end of this piece should come away with a reasonably thorough understanding of this study‚Äôs findings and what they might mean.","Sugar Is Definitely Toxic, a New Study Says",story_reviews_00522,5,"['Joann Rodgers, MS', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Diet studies,"['diabetes', 'Dr. Robert Lustig', 'sugar', 'weight loss']",http://time.com/4087775/sugar-is-definitely-toxic-a-new-study-says/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Many sugar-rich packaged and prepared foods are more expensive than home-made foods.But the study was not designed to compare the",Time,"This news story reports¬†that a diet study, conducted on 43 overweight minority children and teenagers,¬†is believed by the researchers who did it to definitively prove that sugar ‚Äî in and of itself ‚Äî is metabolically toxic regardless of how much or l","https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000060114824_Small-215x300.jpg 215w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000060114824_Small.jpg 587w","It‚Äôs hard to imagine that any American family could be completely uninformed about the health-related risks of consuming high fructose corn syrup and table sugar (sucrose), major components of sweet drinks, and a supermarket full of processed foods. But",
https://www.healthnewsreview.org/review/times-examines-underuse-of-long-term-contraceptives/,Thorough look at underuse of long-term reversible contraceptives,This Jane Brody column takes a pretty careful look at an important women‚Äôs health issue.,IUDs and Hormonal Implants Remain Underused Contraceptives,story_reviews_00523,5,"['Sally James', 'Karen Carlson, MD', 'Kevin Lomangino']",Devices,"['contraceptives', 'drug costs', 'health costs', 'IUD', 'Pregnancy', 'teens', ""women's health""]",http://well.blogs.nytimes.com/2015/10/26/iuds-and-hormonal-implants-remain-underused-contraceptives/?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We applaud the way this story examines what may be the ‚Äúunder use‚Äù of devices and clearly explains some of the nuance about up-",The New York Times,"Hormonal and copper IUDs.
Changes in the behavior of doctors could make a big difference in how many women opt for using long-acting reversible contraceptives (LARCs). This Jane Brody column reports on a committee‚Äôs strong argument urging obstetricians ",nan,Preventing unwanted pregnancies could work much better if the doctors who see women recommended better options known as long-acting reversible contraceptives or LARCs more often.¬†Some of the resistance to LARCs is likely among older docs who remember the,
https://www.healthnewsreview.org/review/framing-not-quite-balanced-in-coverage-of-drug-to-reduce-blood-transfusions/,Evidence overstated in coverage of drug to reduce blood transfusions,"Strong on independent sources, this story fell short in the way that it quantified the benefits of this study and in how it framed the evidence.","Could an Inexpensive, Underused Drug Reduce Blood Loss During Surgery? Study finds tranexamic acid reduces the need for blood transfusions during joint replacement procedures.",story_reviews_00526,4,"['Susan Wei, PhD', 'James Rickert, MD', 'Kevin Lomangino']",U.S. News & World Report,"['knee replacement', 'surgery']",http://health.usnews.com/health-news/patient-advice/articles/2015/10/20/could-an-inexpensive-underused-drug-reduce-blood-loss-during-surgery?int=98e708,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The piece does a good job of highlighting the low-cost advantage of TXA over blood transfusions. An expert independent from the ori",US News & World Report,"A large retrospective observational study was conducted to see if encouraging patients to elect tranexamic acid (TXA) therapy in joint replacement surgery was associated with a reduction in costly blood transfusions. Based on this observational study, the","https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000026196320_Small-300x178.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000026196320_Small.jpg 899w","Blood transfusions, though generally safe, are quite expensive when they are required in joint replacement surgery. TXA could be a low-cost alternative for eligible¬†patients undergoing the procedure.",
https://www.healthnewsreview.org/review/times-captures-impact-of-new-less-drug-intensive-schizophrenia-treatment/,Times explores impact of integrated care model for schizophrenia treatment,A generally solid story about an important new study of schizophrenia treatment. Readers will get most of what they need to know from this coverage.,Talk Therapy Found to Ease Schizophrenia,story_reviews_00527,4,"['Sally James', 'Susan Molchan, MD, MA', 'Kevin Lomangino']",Harms of medical treatment,"['anti-psychotic drugs', 'mental illness', 'schizophrenia', 'talk therapy']",http://www.nytimes.com/2015/10/20/health/talk-therapy-found-to-ease-schizophrenia.html?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not touch on costs for the more comprehensive treatment ‚Äî including educating families and providing more coun",The New York Times,"
Update: The Times has issued a correction to this story. The correction states that the story erroneously claimed that the experimental approach in the study used lower drug dosages. ‚ÄúThough it studied a program intended to reduce medication dosages, t","https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000023606303_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000023606303_Small.jpg 849w","Psychiatric treatment in the U.S. has become very drug focused. Other countries are ahead of us on using more integrated care models like the one described in this story, so it‚Äôs great to see its success ‚Äúproven‚Äù with a randomized trial. With solid ",
https://www.healthnewsreview.org/review/how-good-is-the-flu-shot-vox-delivers-an-exemplary-answer/,How good is the flu shot? Vox delivers an exemplary answer,The ‚ÄúDear Julia‚Äù column hits a home run with this assessment of the flu shot.,How well do flu shots work? Here‚Äôs what the science says.,story_reviews_00528,5,"['Earle Holland', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",Vox,"['flu shot', 'vaccines']",http://www.vox.com/2015/10/14/9521807/flu-shot-vaccine-effectiveness,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'While the story only touches on the costs of flu shots in passing, saying that they‚Äôre relatively cheap, we‚Äôll give them the be",Vox,"This story asks a simple, straightforward question that annually affects much of the population ‚Äî do flu vaccines work, and how well?¬† The story looks at the evidence offered from a host of studies, giving a fair appraisal of what the data does and doe","https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000010863371_Small-300x201.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000010863371_Small.jpg 847w","Outbreaks of influenza come as regularly as the leaves changing color in the fall.¬† And like the autumn colors, the effectiveness of the flu vaccine can change year to year.¬† This story both explains why there is such variability and answers the questio",
https://www.healthnewsreview.org/review/why-double-knee-replacement-might-be-best/,Careful look at tradeoffs involved with double knee replacement,A 5-star effort that covers most of what we think readers need in a news story. See the complete review for a couple of¬†suggestions as to what could have been done better.,Why Double Knee Replacement Might Be Best ,story_reviews_00530,5,"['Matt Shipman', 'James Rickert, MD', 'Kevin Lomangino']",Harms of medical treatment,['knee replacement'],http://www.wsj.com/articles/why-double-knee-replacement-may-be-best-1444664583,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This is an essential part of the story, since cost is presented as one of the most significant benefits of performing bilateral kne",The Wall Street Journal,"A patient profiled in this WSJ story awaits double knee replacement. Credit: Pete Hausler/The Wall Street Journal
This installment of the Wall Street Journal‚Äôs ‚ÄúInformed Patient‚Äù feature looks at the risks and benefits of bilateral knee replacement ",nan,"A 2012 paper in the Journal of Bone & Joint Surgery reported that the number of knee replacements performed each year in the United States increased by 134 percent between 1999 and 2008, with 615,050 replacements done in 2008. And the number appears to st",
https://www.healthnewsreview.org/review/kids-after-cancer-treatment-healthday-breaks-down-evidence-on-ovarian-transplant-procedure/,Kids after cancer treatment? HealthDay breaks down evidence on ovarian transplant procedure,This 4-star story benefits from several borderline ‚Äúsatisfactory‚Äù ratings. Our review details what could have been done better.,Ovarian Tissue Transplant Can Help Some Women Have Kids After Cancer Treatment Researchers in Denmark report a success rate of about 30 percent,story_reviews_00531,4,"['Sally James', 'Karen Carlson, MD', 'Kevin Lomangino']",Cancer,"['fertility', 'freezing', 'IVF', 'ovarian cancer', 'ovaries']",http://consumer.healthday.com/cancer-information-5/mis-cancer-news-102/ovarian-tissue-transplant-can-help-women-have-kids-after-cancer-treatment-703957.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Surgery to remove a healthy ovary,\xa0storage of that tissue for as long as a decade,\xa0and surgical reimplantation all involv",Health Day,"A small European study showed 31 percent of cancer patients had successful pregnancies after they received transplants of their own (once removed and frozen) ovarian tissue. A substantial number required additional measures, such as in-vitro fertilization","https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000060373600_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000060373600_Small.jpg 849w","Having children is an emotional and cultural touchstone for both men and women. Cancer patients have long suffered infertility because of harsh drugs and radiation therapies. This study raises hopes that by taking some ovarian tissue before treatment, som",
https://www.healthnewsreview.org/review/nice-balance-of-competing-views-on-value-of-ct-heart-scans/,Optimal balance of competing views on value of CT heart scans,Could heart scans help identify people who don‚Äôt need to take statins? This well-written story checks most of our boxes and provides an optimal blend of optimism and skepticism regarding this approach.,Heart Scan Can Fine-Tune Risk Estimate for Patients Considering Statins,story_reviews_00533,4,"['Andrew Holtz, MPH', 'Saurabh Jha, MBBS', 'Kevin Lomangino']",Cardiovascular disease,"['Dr. Harlan Krumholz', 'statins']",http://www.nytimes.com/2015/10/06/health/heart-scan-can-fine-tune-risk-estimate-for-patients-considering-statins.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story reports that a CT scan looking for calcium in coronary arteries ‚Äútypically costs between $75 and $100. Still, it is gen",The New York Times,"Credit NHLBI.
This story hits almost all the high points we look for in a news report. It gives readers not only the basic summary of an analysis of how CT scan results showing levels of calcium deposits in coronary arteries are associated with 10-year ra",nan,"Too often, stories about medical tests fall into the ‚Äúwhy not‚Äù category. This story lays out the potential benefits reported by researchers, but it also provides readers clear and useful explanations of the nuances and potential pitfalls of this sort ",
https://www.healthnewsreview.org/review/deep-dive-into-the-ethics-and-evidence-underlying-genetic-testing-in-psychiatry/,Deep dive into the ethics and evidence underlying genetic testing in depression treatment,This is a solid look at an emerging and important topic.,"Genetic tests for psychiatric drugs spur hope, doubts",story_reviews_00534,5,"['Matt Shipman', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Boston Globe,"['antidepressants', 'genetic testing']",https://www.bostonglobe.com/metro/2015/10/03/genetic-screening-for-mental-health-grows-rapidly-despite-little-evidence-tests-work/Hak26cUCK38R4hMJK2wlZK/story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'While the story looks at genetic tests for prescribing psychiatric drugs broadly, it also uses one test in particular as a focal po",The Boston Globe,"This story, originally reported¬†by the New England Center for Investigative Reporting and published in partnership with the Boston Globe, describes the history and ethical implications of a loophole allowing genetic tests to bypass FDA approval before do","https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000009097535_Small-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000009097535_Small.jpg 850w","According to the CDC, approximately 25 percent of U.S. adults have some form of mental illness. Finding the right drug and dose for treating a mental illness can be time-consuming ‚Äî and mentally, physically and emotionally exhausting for both patients a",
https://www.healthnewsreview.org/review/home-birth-vs-hospital-strong-wsj-evaluation-new-uk-guidelines/,Home birth vs. hospital: Strong WSJ evaluation of new UK guidelines,Our main suggestion for this otherwise strong story is to quantify the difference in risk seen between hospital and home births.,"New Support for Home Births U.K. board NICE, in a surprise, rules having a baby at home is safer than a hospital in some low-risk pregnancies",story_reviews_00536,4,"['Matt Shipman', 'Karen Carlson, MD', 'Kevin Lomangino']",Harms of medical treatment,['birth'],http://www.wsj.com/articles/new-support-for-home-births-1443460410,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not address cost at all. The story is focused primarily on childbirth practices in the U.K., which has a signifi",The Wall Street Journal,"The story looks at guidance from the UK‚Äôs National Institute for Health and Care Excellence (NICE) ‚Äî and related research¬†‚Äî to pregnant women. Specifically, the guidance says home births pose fewer risks than hospital births for woman with low-risk","https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000046032846_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000046032846_Small.jpg 849w","Giving birth is an intensely personal experience, and therefore the decision about where to give birth is an extremely personal decision. It‚Äôs also a decision that can affect the health and well-being of both mother and child. More than 3.9 million chil",
https://www.healthnewsreview.org/review/a-test-identifies-women-with-breast-cancer-who-can-skip-chemo-ap-report-thoroughly-evaluates-the-claim/,A test that identifies women with breast cancer who can ‚Äúskip chemo‚Äù? AP thoroughly analyzes the claim,This Associated Press story does a pretty thorough job addressing our criteria ‚Äî especially under a tight deadline.,"Some with early-stage breast cancer can skip chemo, study says",story_reviews_00537,5,"['Euna Bodner, MS', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Associated Press,['genetic testing'],https://www.bostonglobe.com/lifestyle/health-wellness/2015/09/28/some-with-early-stage-breast-cancer-can-skip-chemo-study-says/rcSTHaktuEI9hBGfsYZBdO/story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states the Oncotype gene test costs $4,175 and adds that many insurers, as well as Medicare, cover it.'}, {'question': 'D",Associated Press,"A¬†study in the New England Journal of Medicine (NEJM) looked into the most common type of breast cancer ‚Äì early stage, without spread to lymph nodes and hormone positive, meaning the tumor‚Äôs growth is promoted by estrogen and/or progesterone. Accordi","https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing.jpg 410w","In the US, breast cancer is the second most common cancer in women after skin cancer, with about 230,000 new cases diagnosed in women each year, according to the National Cancer Institute. Cancer treatments usually involve chemotherapy, which results in a",
https://www.healthnewsreview.org/review/texting-your-way-to-heart-health-npr-thoroughly-examines-the-evidence/,Texting your way to heart health? NPR thoroughly examines the evidence,Adding some numbers to the description of benefits would‚Äôve filled in this otherwise complete picture of the study.,"Text Reminders Help People Lower Cholesterol, Blood Pressure",story_reviews_00541,5,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Cardiovascular disease,['text messaging'],http://www.npr.org/sections/health-shots/2015/09/22/442518139/text-reminders-help-people-lower-their-heart-disease-risk,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This is a tricky one. The story does not explicitly address cost, except to call text messaging ‚Äúa scalable and affordable approa",NPR,The story focuses on a JAMA study that found coronary heart disease patients who received four health-related text messages per week for six months were more likely to take steps to reduce their risk of heart-related health problems ‚Äî and saw correspond,"https://www.healthnewsreview.org/wp-content/uploads/2015/09/iStock_000004992558_Small-201x300.jpg 201w, https://www.healthnewsreview.org/wp-content/uploads/2015/09/iStock_000004992558_Small.jpg 567w","According to the CDC, heart disease is the leading cause of death in the United States for both men and women, and coronary heart disease is the most common form of heart disease ‚Äî killing more than 370,000 people annually. In short, the odds are good t",
https://www.healthnewsreview.org/review/ginger-for-allergies-pretty-good-brief-about-a-mouse-study-is-missing-a-few-key-elements/,Ginger for allergies? Pretty good brief about a mouse study is missing a few key elements,"Clocking in at just over 350 words, this Wall Street Journal brief didn‚Äôt provide much context, but it covered the basics pretty well.",Powdered Ginger May Ease Seasonal Allergy Symptoms,story_reviews_00543,4,"['Sally James', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Wall Street Journal,"['allergies', 'ginger', 'mice studies', 'rhinitis']",http://www.wsj.com/articles/powdered-ginger-may-ease-seasonal-allergy-symptoms-1442853656,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story did not talk about the cost of adding a daily dose of ginger to one‚Äôs diet. But since that cost can‚Äôt be very signi",The Wall Street Journal,A mouse study from Japan showed that rodents that had been fed powdered ginger responded with fewer sneezes and had a lower level of immune response to an allergen. This short piece about the research earns praise for stating clearly in the subheadline an,"https://www.healthnewsreview.org/wp-content/uploads/2015/09/iStock_000013398712_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/09/iStock_000013398712_Small.jpg 849w","Allergies strike as many as 10-30 percent of the world population, according to the American Academy of Allergy, Asthma and Immunology. And this article suggests that a readily available food product may alleviate these irritating symptoms felt by million",
https://www.healthnewsreview.org/review/thorough-npr-report-on-aspirin-would-have-benefited-from-more-numbers/,"Strong overall, NPR report on aspirin for heart protection would have benefited from more numbers","Solid reporting overall. But without some numbers attached to the benefits and harms of aspirin, readers don‚Äôt receive the full story.","Panel Says Aspirin Lowers Heart Attack Risk For Some, But Not All",story_reviews_00545,4,"['Sharon Dunwoody, PhD', 'Susan Wei, PhD', 'Kevin Lomangino']",Cardiovascular disease,"['aspirin', 'Dr. Steven Nissen', 'US Preventive Services Task Force']",http://www.npr.org/sections/health-shots/2015/09/15/440337151/panel-says-aspirin-lowers-heart-attack-risk-for-some-but-not-all,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Cost is not a component of this story, but it does not appear to be as relevant an issue to this piece compared with other storie",NPR,A federal task force has issued a recommendation to limit the daily ingestion of low-dose aspirin among Americans to individuals with a clear risk of heart attack or stroke. ¬†This story delivers that message effectively but lacks the quantitative specifi,"https://www.healthnewsreview.org/wp-content/uploads/2015/08/baby-aspirin-300x214.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/baby-aspirin.jpg 821w","Many individuals with low risk of heart attack or stroke now take daily, low-dose aspirin in preventive mode.¬† If such a practice is‚Äîat best‚Äîuseless or‚Äîat worst‚Äîharmful, folks need to know that. ¬†This story makes a solid effort to inform.",
https://www.healthnewsreview.org/review/vitamin-d-supplements-panacea-placebo-something/,Nuanced portrait of evidence on prevention benefits of vitamin D,A nice deep dive into existing research on vitamin D and the questions that some large new trials on the supplement are expected to resolve.,"Vitamin D supplements: Panacea, placebo or something in between?",story_reviews_00546,5,"['Sally James', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Depression,"['depression', 'diabetes', 'nutrition', 'prevention', 'supplements', 'Vitamin D']",https://www.washingtonpost.com/national/health-science/vitamin-d-supplements-panacea-placebo-or-something-in-between/2015/09/14/662699d2-469d-11e5-846d-02792f854297_story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'A brief mention of cost would have improved an already strong article.\xa0While it can be argued that most people have a rough ",The Washington Post,"This story examines the history of controversy over whether vitamin D has any preventive role in a laundry list of conditions including diabetes, depression and multiple sclerosis. There‚Äôs no controversy over its role in bone health. Different studies h","https://www.healthnewsreview.org/wp-content/uploads/2015/07/vitamin-D-300x242.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/vitamin-D.jpg 771w","Because many Americans love the idea that a pill will improve their health, we are again faced with a ‚Äòwonder vitamin‚Äô situation where the public believes the conclusions of select limited studies rather than comprehensive assessments of the evidence.",
https://www.healthnewsreview.org/review/over-the-top-headline-aside-cnn-frames-resveratrolalzheimers-study-in-cautious-accurate-language/,"Over-the-top headline aside, CNN frames resveratrol/Alzheimer‚Äôs study in cautious, accurate language","After some early missteps, this story recovers to provide readers most of what they need to know about resveratrol‚Äôs possible effects on Alzheimer‚Äôs disease.","For Alzheimer's patients, resveratrol brings new hope",story_reviews_00548,5,"['Matt Shipman', 'Susan Molchan, MD, MA', 'Kevin Lomangino']",Alzheimer's,['resveratrol'],http://www.cnn.com/2015/09/11/health/resveratrol-hope-for-alzheimers-patients/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story does not address cost at all.\xa0But as with the competing Time coverage, we‚Äôll rule this Not Applicable since the st",CNN,"Resveratrol is an antioxidant compound found in grapes and red wine.
Like a competing Time story, this CNN piece overreaches in its description of a randomized controlled trial of resveratrol‚Äôs effects on biomarkers associated with Alzheimer‚Äôs disease",nan,"Alzheimer‚Äôs affects more than 5 million people in the United States, and that number is expected to double over the next 35 years. It is the sixth leading cause of death in the United States. And while the number of patients diagnosed is great, the numb",
https://www.healthnewsreview.org/review/bloomberg-liquid-biopsy-story-nods-to-skepticism-in-headline/,Bloomberg ‚Äúliquid biopsy‚Äù story nods to ‚Äúskepticism‚Äù in headline,"We liked the headline on this story and it features some good restraining comments, but it fell short on discussion of harms and alternatives.",Consumer Blood Test to Detect Cancer Hits Market Amid Skepticism,story_reviews_00549,4,"['William Heisel', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",Bloomberg,"['liquid biopsy', 'Pathway Genomics']",http://www.bloomberg.com/news/articles/2015-09-10/consumer-blood-test-to-detect-cancer-hits-market-amid-skepticism,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story broke down the costs of the test to provide a fuller picture than a competing Reuters story. It shows how costs can range",Bloomberg,"The bottom-line message from this story is a good one, and the fact that ‚Äúskepticism‚Äù is mentioned prominently in the headline makes up for the lack of some important details in the body text. While the story overall is strong and it did a decent job ","https://www.healthnewsreview.org/wp-content/uploads/2015/09/pathway-liquid-biospy-300x247.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/09/pathway-liquid-biospy.jpg 400w","Genomic testing of healthy people is going to cost this country a lot of money, and the proposed benefits of such testing haven‚Äôt been proven at all.",
https://www.healthnewsreview.org/review/reuters-pour-some-cold-water-on-direct-to-consumer-liquid-biopsy/,Reuters adds some cold water to direct-to-consumer ‚Äòliquid biopsy‚Äô,"This story wasn‚Äôt dazzled by the novelty of a liquid biopsy and provided enough cautionary notes, more so than a competing Bloomberg story.",Pathway launches 'liquid biopsy' to find cancer in healthy people,story_reviews_00550,5,"['William Heisel', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",Cancer,"['liquid biopsy', 'Pathway Genomics']",http://www.reuters.com/article/2015/09/10/us-genomics-pathway-biopsy-idUSKCN0RA0NU20150910,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentioned the cost of the test, but the competing Bloomberg story gave a more detailed breakdown of costs. There was\xa0n",Reuters,This story did a very nice job of examining the premise behind ‚Äúliquid biopsies‚Äù and pointing out the lack of supporting evidence ‚Äî a slightly more thorough look than was given by a strong competing story from Bloomberg. While the story could have h,"https://www.healthnewsreview.org/wp-content/uploads/2015/09/pathway-liquid-biospy-300x247.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/09/pathway-liquid-biospy.jpg 400w","Genomic testing of healthy people is going to cost this country a lot of money, and the proposed benefits of such testing haven‚Äôt been proven at all.",
https://www.healthnewsreview.org/review/single-patient-anecdote-manages-to-convey-complexity-of-t-cell-therapy-for-leukemia/,"With focus on one patient, story manages to convey complexity of T-cell therapy for leukemia","We were pleasantly surprised by this story‚Äôs ability to inform, despite relying on a single patient‚Äôs experience to frame the narrative.",T-cell therapy results more modest than hoped for chronic leukemia,story_reviews_00552,4,"['Sally James', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",Cancer,"['cancer', 'immunotherapy', 'leukemia', 'University of Pennsylvania']",http://www.philly.com/philly/health/20150907_T-cell_therapy_results_more_modest_than_hoped_for_chronic_leukemia.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although this therapy only exists for patients in clinical trials, we still think cost should have received more than a single ",The Philadelphia Inquirer,"Patient Bill Ludwig is the focus of this story on a leukemia therapy.
Early results of T-cell therapy raised hopes for some leukemia patients, but immunotherapy for chronic lymphocytic leukemia is proving helpful only for a minority of those who receive i",nan,This story about the emerging science of immunotherapy provides a vivid look inside the near-death complications for one man and the disappointment that only a minority of chronic lymphocytic leukemia patients go into remission after the experimental ther,
https://www.healthnewsreview.org/review/aspirin-day-years-may-keep-colon-cancer-away/,"Harms, limitations explored in Reuters Health‚Äôs aspirin/colon cancer coverage",A very effective report that gives readers most everything they need to know about the study.,An aspirin a day ‚Äì for years ‚Äì may keep colon cancer away,story_reviews_00557,5,"['Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",Cancer,"['aspirin', 'colon cancer']",http://www.reuters.com/article/2015/08/24/us-health-colorectalcancer-prevention-idUSKCN0QT2CV20150824,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'No mention was made of costs, but anyone who has been to a drugstore knows that aspirin is cheap.'}, {'question': 'Does the story",Reuters Health,"A strong story that describes in clear terms the findings as well as the strengths and weaknesses of this study. It covered potential biases that could not be controlled, mentioned harms, and was overall very cautious. It would have been even stronger had","https://www.healthnewsreview.org/wp-content/uploads/2015/08/baby-aspirin-300x214.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/baby-aspirin.jpg 821w","Though evidence has long indicated that low-dose aspirin was associated with a reduced incidence of the disease, this is the first report to say how long the regimen needs to be followed.",
https://www.healthnewsreview.org/review/wsj-fills-holes-left-by-incomplete-news-release-on-beta-blockers-and-ovarian-cancer/,WSJ fills holes left by incomplete news release on beta-blockers and ovarian cancer,This story provides some context that was missing from an MD Anderson news release about the same study.,Heart Drug Linked to Extra Years for Cancer Patients,story_reviews_00558,5,"['Kathlyn Stone', 'Earle Holland', 'Kevin Lomangino']",Cancer,"['beta-blockers', 'ovarian cancer']",http://www.wsj.com/articles/heart-drug-linked-to-extra-years-for-cancer-patients-1440388800,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story mentions that beta-blockers are available as generics but doesn‚Äôt specifically mention costs. As a class, beta bloc",The Wall Street Journal,"This Wall Street Journal article nicely summarizes the findings of a retrospective study of 1,400 cases of women with ovarian cancer; some of whom had been prescribed beta-blockers for high blood pressure and appeared to have better outcomes than those no","https://www.healthnewsreview.org/wp-content/uploads/2015/04/Sheep-following-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/04/Sheep-following-1024x683.jpg 1024w","We often say that news releases can set the tone for subsequent media coverage of new research, and that a poor news release can lead to a great deal of misinformation reaching the public. We‚Äôve compared this phenomenon to sheep following one another. H",
https://www.healthnewsreview.org/review/reader-question-on-otc-pain-relievers-sparks-thorough-evidence-based-response/,"Reader question on OTC pain relievers generates thorough, evidence-based response",This story provides an evidence-based response to a reader question on commonly used over-the-counter pain relievers. The details may come as a surprise to those who think these pain relievers are interchangeable.,"Should you take Tylenol, Advil, or aspirin for pain? Here's what the evidence says.",story_reviews_00559,5,"['Kathlyn Stone', 'Kevin Lomangino']",Vox,"['aspirin', 'ibuprofen', 'pain', 'Tylenol']",http://www.vox.com/2015/8/17/9165189/best-painkiller-tylenol-aspirin-advil,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story doesn‚Äôt mention costs but since these over-the-counter medications have been widely available for a long time it does",Vox,"In this installment of ‚ÄúDear Julia,‚Äù Vox health reporter Julia Belluz takes on a reader question about pain medications. The reader wants to know which over-the-counter (OTC) pain reliever is the best for treating pain ‚Äì Tylenol, Advil or aspirin. T","https://www.healthnewsreview.org/wp-content/uploads/2015/08/ibuprofen-300x214.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/ibuprofen.jpg 820w","Americans spent $4.4 billion on OTC analgesics in 2014, according to the Consumer Healthcare Products Association. Despite wide use and efforts by public health efforts to inform consumers about safety issues, there‚Äôs still a lot of confusion about whic",
https://www.healthnewsreview.org/review/strong-report-on-study-of-broader-multigene-breast-cancer-testing/,Strong report on study of broader multigene breast cancer testing,A pretty solid report on a study of multi-gene cancer test panels. We had a few modest suggestions for improvement.,Testing for more breast cancer genes offers useful information,story_reviews_00563,5,"['Ranit Mishori, MD, MHS, FAAFP', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Cancer,"['BRCA', 'breast cancer', 'genetic testing']",http://www.reuters.com/article/2015/08/13/us-health-cancer-multigene-tests-idUSKCN0QI28B20150813,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article mentions that the tests themselves ‚Äúare not more expensive than testing for the BRCA mutations alone,‚Äù but it d",Reuters Health,This story does a nice job of describing a recent study that looked at the clinical validity of several cancer genetic test panels. The study looked at a group of women who were very high risk for breast cancer but tested negative for the BRCA1/2 genes an,"https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/DNA-gene-testing.jpg 410w","About 5-10% of breast cancer cases in the US are linked to hereditary genetic mutations, the two best-known mutations being BRCA1 and BRCA2. Mutations in dozens of other genes have been studied and identified as possible risk factors for breast cancer.
My",
https://www.healthnewsreview.org/review/high-score-healthday-coverage-scoring-system-colonoscopy-candidates/,High score for HealthDay coverage of ‚Äúscoring system‚Äù for colonoscopy candidates,Strong effort featuring two outside perspectives. Looking at alternatives would have opened up another fruitful avenue of inquiry for the coverage.,'Scoring System' May Spot Those in Greatest Need of Colonoscopy; But one expert cautions that even 'low risk' patients can still develop suspicious polyps,story_reviews_00565,4,"['Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Cancer,"['colon cancer', 'colonoscopy']",http://consumer.healthday.com/cancer-information-5/colon-cancer-news-96/scoring-system-might-spot-those-at-highest-need-of-colonoscopy-702042.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The question of cost is cited in the final line of the story, which suggests that the scoring system can ‚Äúaddress escalating ",Health Day,"Can a new scoring system help some people avoid a colonoscopy?
This is an important story that touches on all sorts of issues involved in public health, including how to best to screen for a disease that takes a terrible toll, how to determine who is at h",nan,The concept of ‚Äúrisk stratification‚Äù ‚Äî which is what this story and the related research paper address ‚Äî is difficult for physicians and patients alike. Risk prediction tools are often created and then not used by physicians because they are cumbe,
https://www.healthnewsreview.org/review/wsj-gives-no-green-light-red-palm-oil-health-aid/,WSJ gives no green light for red palm oil as health aid,"In a time when new supplements and ‚Äúsuperfoods‚Äù are constantly marketed to consumers who have a general sense that something is ‚Äúgood for you,‚Äù this piece delivers the goods with a review of the evidence, or lack thereof, for red palm oil.",A Green Light for Red Palm Oil as Health Aid? Manufacturers cite healthy antioxidants and heart benefits,story_reviews_00569,5,"['Andrew Holtz, MPH', 'Kathleen Fairfield, MD, DrPH', 'Gary Schwitzer']",health food claims,"['antioxidants', 'red palm oil']",http://www.wsj.com/articles/a-green-light-for-red-palm-oil-as-health-aid-1438621978,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentions some specific brands and prices.'}, {'question': 'Does the story adequately quantify the benefits of the treatme",The Wall Street Journal,"The ‚ÄúVerdict‚Äù of this story on red palm oil may not be what marketers want to read, but this overview story packs a delicious and nutritious serving of information for consumers trying to see through swirling health claims. The story covers a lot of g","https://www.healthnewsreview.org/wp-content/uploads/2015/08/organic-virgin-red-palm-oil-410x273-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/organic-virgin-red-palm-oil-410x273.jpg 410w","Like a solid review article that provides clinicians with an overview of the body of evidence about a condition or treatment, a well done consumer advice article such as this one helps busy readers get the big picture quickly. With a broad scope, the stor",
https://www.healthnewsreview.org/review/well-newly-approved-weight-loss-balloon-work-expert-notes-will-probably-effective-short-term-weight-loss/,"Solid reporting, but broader ethical/medical questions not addressed","This was a reasonably thorough report on a temporary implantable weight loss balloon procedure. ¬†But the intervention raises all sorts of questions about the role of a temporary device, with limited benefits and known harms, for a non-medically necessary",How Well Does the Newly Approved Weight-Loss 'Balloon' Work? Expert notes it will probably only be effective for short-term weight loss,story_reviews_00571,4,"['Sally James', 'Yoni Freedhoff, MD', 'Gary Schwitzer']",Devices,"['obesity', 'ReShape', 'weight loss']",http://consumer.healthday.com/public-health-information-30/food-and-drug-administration-news-315/how-does-the-newly-approved-weight-loss-balloon-device-work-701796.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does discuss costs. The discussion would be better if it included the cost of implanting the device. The story only told ",Health Day,"This story describes a device, ReShape, inserted inside the patient‚Äôs stomach that appears to help with weight loss on a short-term temporary basis. Besides the gastric ulcers that struck more than one-third of patients in the study group, we think this","https://www.healthnewsreview.org/wp-content/uploads/2015/08/Weight-scale-wbelt-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/Weight-scale-wbelt-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/W","The story did a good job outlining¬†some of the harms of the device, but the list of potential harms could have been even longer. If¬†someone who is not ‚Äúmedically‚Äù obese pays for this device and this procedure¬†and is exposed¬†to risks for only a lim",
https://www.healthnewsreview.org/review/how-fast-should-you-run/,"Can you jog away from an early grave? This story gives a well-supported, evidence-based answer",How fast should you run to live longer? This story provides clear answer based on the best available evidence.,What‚Äôs The Optimal Speed For Exercise? ,story_reviews_00576,4,"['Matt Shipman', 'Kevin Lomangino']",FiveThirtyEight.com,['exercise'],http://fivethirtyeight.com/features/whats-the-optimal-speed-for-exercise/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story does not go into the costs associated with running or moderate jogging, but there are few costs that are explicitly ass",FiveThirtyEight,The story looks at several studies to address how much time an individual needs to devote to cardiovascular exercise each week in order to significantly reduce their risk of death in a given year. The story also attempts to address whether it is better wa,"https://www.healthnewsreview.org/wp-content/uploads/2015/07/jogging-300x229.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/jogging.jpg 794w","Staving off death is, naturally, an issue of widespread interest. The story focuses on walking, jogging, and running as ways to keep in shape and reduce the risk of mortality in a given year. And jogging and running are incredibly popular in the United St",
https://www.healthnewsreview.org/review/thoughtful-thorough-coverage-prenatal-tests-ability-find-cancer-mothers/,Thoughtful and thorough coverage on prenatal tests‚Äô ability to find cancer in mothers,"Going beyond the individual stories of the women whose cancers were detected by prenatal testing, this WSJ piece explores the underlying study data as well as the ethical and social issues raised by the research.",Prenatal Blood Tests Could Detect Cancer in Mothers,story_reviews_00579,5,"['Joann Rodgers, MS', 'Karen Carlson, MD', 'Kevin Lomangino']",Cancer,['prenatal testing'],http://www.wsj.com/articles/prenatal-blood-tests-could-detect-cancer-in-mothers-1436818819,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the story does not explicitly note the cost of the two commercially available tests, it does provide substantial conte",The Wall Street Journal,This Wall Street Journal story offers a thoughtful and thorough summary of a presentation (and related study in JAMA)¬†about the ability of commercial prenatal blood tests to also uncover hidden cancers in pregnant women.¬†The story makes clear that the s,"https://www.healthnewsreview.org/wp-content/uploads/2015/07/prenatal-blood-test-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/prenatal-blood-test.jpg 849w",There is increasing demand by physicians and pregnant women to perform noninvasive prenatal blood tests as a safer means of establishing¬†fetal risk for Down Syndrome and other serious genetic abnormalities. Although professional guidelines suggest that o,
https://www.healthnewsreview.org/review/costs-and-risks-spelled-out-clearly-in-nbc-report-on-statins/,Costs and risks spelled out clearly in NBC report on statins,"Great explanation of costs, risks, and benefits. We would have liked to have seen a deeper examination of the quality of the evidence and more voices from outside the study.","More People Should Get Statins, Report Says",story_reviews_00581,4,"['William Heisel', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",heart disease,"['cholesterol', 'statins']",http://www.nbcnews.com/health/heart-health/more-people-should-get-statins-report-finds-n391936,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'While the New York Times skipped the cost question, NBC gave readers the numbers they needed to know. It said that ‚ÄúStatins, whic",NBCNews.com,"We always cheer when we see a story take the rare step of spelling out the costs of a treatment as clearly as this one did. We also love the use of hard numbers in talking about the potential benefits of wider statin use and the space devoted to risks, es","https://www.healthnewsreview.org/wp-content/uploads/2015/07/doctor-pills-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/doctor-pills.jpg 849w","Cardiovascular disease is the leading cause of death in the USA. The percentage of adults who might be recommended for statins is quite high, and so the costs and effectiveness of these drugs are vitally important to understand both at an individual level",
https://www.healthnewsreview.org/review/comprehensive-coverage-of-two-new-statin-studies/,Comprehensive coverage of two new statin studies,This was an excellent story that covers nearly all our criteria.,2 Studies Back Guidelines for Wider Use of Statins,story_reviews_00582,5,"['William Heisel', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",heart disease,"['cholesterol', 'statins']",http://www.nytimes.com/2015/07/15/health/broader-statin-use-gets-support-from-2-new-studies.html?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We were surprised to see that a story that covered as much ground as this one did somehow missed costs. The competing story by ",The New York Times,"The consensus around wider statin use has been building, but significant questions remain about costs, long-term risks, and the quality of the evidence supporting wider use. This story focuses on two new studies that address these issues (see here and her","https://www.healthnewsreview.org/wp-content/uploads/2015/07/doctor-pills-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/doctor-pills.jpg 849w","Cardiovascular disease is the leading cause of death in the USA. The number of adults who could potentially be taking statins is very large, and the costs involved very high.",
https://www.healthnewsreview.org/review/f-d-approves-heart-drug-entresto-said-cut-death-risk-20/,"Business story on Entresto, newly approved heart failure drug, capably covers most of the health implications","Strong overall, this story from the New York Times business section could have used some input from health experts to round out the coverage.",F.D.A. Approves Heart Drug Entresto Said to Cut Death Risk by 20%,story_reviews_00584,5,"['Matt Shipman', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",heart disease,"['entresto', 'heart failure', 'Novartis']",http://www.nytimes.com/2015/07/08/business/international/fda-approves-heart-drug-entresto-after-promising-trial-results.html?ref=health&_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does an excellent job here. Not only does it provide the predicted daily and annual cost of the drug ($12.50 and $4,500, ",The New York Times,"The story focuses on FDA‚Äôs approval of a drug called Entresto for use by patients with certain types of heart failure, and discusses the potential profits the drug may accrue for pharmaceutical company Novartis. This story from the business section is a",nan,"According to the CDC, more than 5 million people in the United States have heart failure, which was responsible for one out of nine deaths in 2009. And a 2013 report from the American Heart Association estimated the economic burden of heart failure to be ",
https://www.healthnewsreview.org/review/effectiveness-of-breast-cancer-screening/,Strong report questions effectiveness of breast cancer screening ‚Äî but needed a discussion of study limitations,A capable summary of a study suggesting that increased breast cancer screening doesn‚Äôt reduce mortality rates. There were a couple of deficiencies in the coverage.,Here's new evidence that widespread breast cancer screening isn't effective,story_reviews_00588,4,"['Mandy Stahre, PhD', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Cancer,"['mammography', 'overdiagnosis', 'overscreening']",http://www.vox.com/2015/7/6/8900751/breast-cancer-overdiagnosis,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs in this story or of insurance coverage for mammography. While many readers may understand that",Vox,"This story reports on a new study looking at breast cancer screening rates across hundreds of counties in the United States. It found that while higher breast cancer screening rates were associated with increased rates of breast cancer detection, more scr","https://www.healthnewsreview.org/wp-content/uploads/2015/07/breast-cancer-diagnosis-graph-234x300.jpg 234w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/breast-cancer-diagnosis-graph-798x1024.jpg 798w, https://www.healthnewsreview.org/wp-co","A growing body of evidence suggests that screening mammography is not as beneficial as once thought. But information questioning the benefits of screening mammography usually receives widespread criticism from screening advocates, which adds to confusion ",
https://www.healthnewsreview.org/review/report-on-stroke-clot-removal-guidelines-emphasizes-careful-patient-selection-need-for-care-coordination/,"Report on stroke clot-removal guidelines emphasizes need for careful patient selection, care coordination",This generally solid story about new guidelines for clot removal during strokes would have benefited from a few statistics describing the benefits.,"Heart Association's Stroke Guidelines Support Clot-Removing Device If clot-busting drugs don't work, device can be used to pull the blockage out through the artery",story_reviews_00591,4,"['Sally James', 'Karen Carlson, MD', 'Kevin Lomangino']",HealthDay,"['American Heart Association', 'Boston Scientific', 'Medtronic']",http://consumer.healthday.com/cardiovascular-health-information-20/misc-stroke-related-heart-news-360/new-heart-association-guidelines-recommend-blood-vessel-procedure-700846.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article does not mention, even generally, what removing a clot using these devices might cost. In a broader way, we would h",Health Day,"A Medtronic device used to remove clots during stroke.
This brief article explains why a certain subset of people who have strokes may be treated more effectively with a new procedure than with existing alternatives. The new procedure sends a thin wire tu",nan,"Implementation of these guidelines will require much more systematic coordination of stroke care than currently exists. Currently, smaller community hospitals can quickly assess a patient, get an imaging study, and start tPA (clot-busting medication deliv",
https://www.healthnewsreview.org/review/compelling-tale-of-heart-innovation-would-have-benefited-from-a-few-more-details/,Compelling tale of heart innovation would have benefited from a few more details,"This story documents the labored development of catheter-based aortic stenosis treatment, but seems to harbor few if any doubts about the future success of this approach.",Building a Better Valve ,story_reviews_00600,4,"['Ishani Ganguli, MD, MPH', 'Harold J. DeMonaco, MS', 'Andrew Holtz, MPH']",heart disease,"['Gina Kolata', 'TAVR']",http://www.nytimes.com/2015/06/22/health/heart-failure-aortic-valve-disease-tavr.html?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôll award a Satisfactory here with some reservations. Although the article addresses the cost of the procedure, and in particul",The New York Times,"Henry Kissinger‚Äôs experience is one of several positive anecdotes presented in the story.
This article takes an in-depth look at transcatheter aortic valve replacement (TAVR), a method for replacing narrowed valves in patients too sick or old for surger",nan,"TAVR is an increasingly mainstream option to treat aortic stenosis, a debilitating and eventually fatal condition (usually of old age) for which the only other option has been open heart surgery. This is an important story about how new technology develop",
https://www.healthnewsreview.org/review/surgery-free-option-appendicitis-become-norm/,1st half of story over promotes surgery-free appendicitis option,"Story touts ‚Äúsurgery-free option for appendicitis‚Äù, but readers must dig deep to learn that far more study is needed.",Surgery-free option for appendicitis could become the norm,story_reviews_00601,4,"['Harold J. DeMonaco, MS', 'Andrew Holtz, MPH']",Appendicitis,['antibiotics'],http://www.cnn.com/2015/06/16/health/no-surgery-appendicitis/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While the story does mention cost, it passes along a claim that isn‚Äôt necessarily true. The only mention of costs was the pot",CNN,"The story gets generally good marks from us with a couple of provisos.¬† We liked the balanced discussion of the results and the physician comments in the story.¬† Unfortunately, the headline is overly enthusiastic in its description of the study results.","https://www.healthnewsreview.org/wp-content/uploads/2015/06/Appendicitis-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/Appendicitis-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/Appendicitis.","The gold standard treatment for appendicitis has been appendectomy. In recent years, the laparoscopic (minimally invasive) approach has largely replaced the open surgery.¬† As a result, most patients leave the hospital the day after laparoscopic surgery a",
https://www.healthnewsreview.org/review/story-on-speculative-metformin-health-benefits-needed-a-nod-to-potential-harms/,Story on speculative metformin health benefits needed a nod to potential harms,An interesting and important topic. But the enthusiasm of this story‚Äôs intro may overwhelm subsequent cautions and caveats.,An old-line diabetes drug may have new uses against diseases of aging,story_reviews_00602,4,"['Sharon Dunwoody, PhD', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Alzheimer's,['metformin'],http://www.washingtonpost.com/national/health-science/an-old-line-diabetes-drug-may-have-new-uses-against-diseases-of-aging/2015/06/15/6a16e83c-0a0f-11e5-9e39-0db921c47b93_story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Part of why this topic is exciting is that metformin is relatively cheap, but the story doesn‚Äôt put a price tag on the drug. ",The Washington Post,"Researchers are exploring the potentially broader utility of a well-known drug, metformin, which has traditionally been employed to control type 2 diabetes. Studies are under way to test the impact of the drug on everything from type 1 diabetes to dementi","https://www.healthnewsreview.org/wp-content/uploads/2015/06/metformin-on-ipad2-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/metformin-on-ipad2.jpg 1024w","Though metformin has been around for a long time, it is only in the last 20 years or so that it has become the backbone of medical therapy for patients with type 2 diabetes mellitus ‚Äî that is, diabetes due to insulin resistance in the tissues rather tha",
https://www.healthnewsreview.org/review/a-first-person-account-of-insomnia-therapy-focusing-on-data-not-pills/,"A first-person account of insomnia therapy focusing on ‚Äúdata, not pills‚Äù","Using his own story as a jumping off point, the author provides a very helpful and readable overview of the evidence on insomnia treatments.",The Evidence Points to a Better Way to Fight Insomnia ,story_reviews_00604,4,"['Sally James', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",New York Times,"['cognitive behavioral therapy', 'insomnia', 'Lunesta', 'Restoril', 'systematic review']",http://www.nytimes.com/2015/06/09/upshot/the-evidence-points-to-a-better-way-to-fight-insomnia.html?_r=0&abt=0002&abg=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We wish this story comparing effectiveness of different therapies for insomnia had compared costs as well. How often is cogniti",The New York Times,"This story describes the step-by-step path of an individual patient/author seeking information to compare drugs to cognitive behavioral therapy (CBT) in treating his own insomnia. It isn‚Äôt a news story about research, although it draws from a recent Ann","https://www.healthnewsreview.org/wp-content/uploads/2015/06/insomnia-300x215.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/insomnia.jpg 819w","Insomnia is very common complaint to primary care physicians. ¬†Many patients specifically request a sleeping pill, believing them to be more effective than non-pharmacologic approaches. This story provides value by emphasizing the effectiveness of these ",
https://www.healthnewsreview.org/review/inquirer-emphasizes-alternatives-brain-games-like-lumosity/,Inquirer emphasizes alternatives to brain games like Lumosity,"This story explores how so-called ‚Äúbrain games,‚Äù like Lumosity, stack up against other habits that can help you stay mentally sharp.",Can brain games change behaviors long term?,story_reviews_00606,4,"['Earle Holland', 'Kevin Lomangino']",Philadelphia Inquirer,"['cognitive decline', 'Lumosity']",http://www.philly.com/philly/health/20150607_Can_brain_games_change_behaviors_long_term_.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story doesn‚Äôt mention the costs for such brain games. It mentions the product Lumosity specifically at several points but",The Philadelphia Inquirer,"This story raises the issue of whether so-called ‚Äúbrain games,‚Äù like Lumosity, actually do what they‚Äôre advertised as doing ‚Äî improving brain function. The story includes comments from sources both supporting and opposing these games and cites aut","https://www.healthnewsreview.org/wp-content/uploads/2015/06/brain-fitness-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/brain-fitness-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/brain-fitne","The idea that a computer-driven game can enhance cognition and brain function is enticing and, to some extent, seems to make sense. Mental exercises would seem to strengthen the brain.¬† But the brain isn‚Äôt a muscle and, so far, it isn‚Äôt known whether",
https://www.healthnewsreview.org/review/in-search-of-better-back-pain-treatment-npr-guides-us-to-the-right-destination-with-a-few-detours/,In search of better back pain treatment: NPR guides us to the right destination (with a few detours along the way),This story about the ‚ÄúGokhale Method‚Äù for reducing back pain delivers the right bottom-line message but could‚Äôve done so much sooner in the story.,Lost Posture: Why Indigenous Cultures Don't Have Back Pain,story_reviews_00607,4,"['Matt Shipman', 'James Rickert, MD', 'Kevin Lomangino']",Back pain,"['Dr. Praveen Mummaneni', 'Gokhale Method', 'Pilates', 'yoga']",http://www.npr.org/sections/goatsandsoda/2015/06/08/412314701/lost-posture-why-indigenous-cultures-dont-have-back-pain,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story doesn‚Äôt mention cost at all. And cost could be a significant factor for anyone interested in pursuing the Gokhale M",NPR,"Will adopting the posture of indigenous peoples help reduce rates of lower back pain?
The story discusses a technique called the ‚ÄúGokhale Method‚Äù for reducing back pain by focusing on exercises that can help to improve posture. It‚Äôs clear that a lot",nan,"The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) reported in 2010 that up to 80 percent of Americans experience lower back pain in their lifetime, with up to 20 percent experiencing ‚Äúprotracted‚Äù pain and as many as 8 p",
https://www.healthnewsreview.org/review/wsj-shines-light-on-harms-of-whole-brain-radiation-for-cancer-that-spreads-to-the-brain/,WSJ shines light on harms of whole-brain radiation for cancer that spreads to the brain,Whole-brain radiation treatment can have side-effects ‚Äî such as seizures and memory loss ‚Äî that outweigh the potential survival benefits.,New Study Questions Use of Whole-Brain Radiation to Treat Cancer,story_reviews_00610,5,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Cancer,"['ASCO', 'brain cancer', 'quality of life', 'radiation therapy']",http://www.wsj.com/articles/new-study-questions-use-of-whole-brain-radiation-to-treat-cancer-1433107097,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story doesn‚Äôt mention cost. It‚Äôs a missed opportunity to discuss the costs associated with whole brain radiation and the ",The Wall Street Journal,"
The story reports on a study that found the use of ‚Äúwhole-brain‚Äù radiation therapy in conjunction with targeted radiation therapy to treat cancer in the brain has more adverse side effects and no appreciable benefits over the use of targeted radiatio","https://www.healthnewsreview.org/wp-content/uploads/2015/06/radiation-therapy-300x201.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/radiation-therapy.jpg 846w","We are entering an era of medical research where we no longer only focus on survival, but on patient-centered outcomes such as quality of life. Cancer that has spread to the brain can be particularly difficult to treat, and whole-brain radiation treatment",
https://www.healthnewsreview.org/review/waiting-to-clamp-the-umbilical-cord-npr-carefully-balances-discussion-of-benefits-and-harms/,Waiting to clamp the umbilical cord ‚Äî NPR carefully balances discussion of benefits and harms,Inclusion of potential harms and more expert context elevate this story above the competing ,Delayed Umbilical Cord Clamping May Benefit Children Years Later,story_reviews_00613,4,"['Sally James', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",NPR,"['anemia', 'birth', 'fine motor skills', 'iron deficiency', 'premature infants', 'social skills', 'umbilical cord clamping']",http://www.npr.org/sections/health-shots/2015/05/26/409697568/delayed-umbilical-cord-clamping-may-benefit-children-years-later,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The difference of slowing down the clamping of the newborn‚Äôs umbilical cord does not seem to add any cost to care for a deliver",NPR,This story does a better job than a competing USA Today story at explaining why a delay in cutting the umbilical cord between newborn and Mom might give a modest boost to a child‚Äôs development four years later. Both stories describe a journal article th,"https://www.healthnewsreview.org/wp-content/uploads/2015/05/newborn-with-umbilical-cord-clamp-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/newborn-with-umbilical-cord-clamp-150x150.jpg 150w, https://www.healthnewsreview.or","Estimates are that one out of six babies born in the US suffers some anemia, or a low level of iron in their blood. Delaying of clamping the umbilical cord between mother and child might be a way to prevent that. It is already recommended for premature in",
https://www.healthnewsreview.org/review/coverage-of-delayed-umbilical-cord-clamping-omits-possible-harms-to-baby-important-study-limitation/,Coverage of delayed umbilical cord clamping omits possible harms to baby and an important study limitation,Not a bad effort ‚Äî but not quite as thorough as a ,Waiting a few minutes to cut umbilical cord helps baby,story_reviews_00614,4,"['Sally James', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",premature babies,"['anemia', 'fine motor skills', 'iron', 'iron deficiency', 'premature babies', 'umbilical cord']",http://www.usatoday.com/story/news/2015/05/26/umbilical-cord-clamping/27790669/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The difference of slowing down the clamping of the newborn‚Äôs umbilical cord does not seem to add any cost to care for a deliver",USA Today,"
Despite its four-star score, this story has the potential to lead casual readers astray, since it‚Äôs not quite as careful as a competitor NPR story in describing the potential benefits and harms of leaving newborns‚Äô umbilical cords attached to Mom lon","https://www.healthnewsreview.org/wp-content/uploads/2015/05/newborn-with-mother-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/newborn-with-mother.jpg 851w","Estimates are that one out of six babies born in the US suffers some anemia, or a low level of iron in their blood. Delaying of clamping the umbilical cord between mother and child might be a way to prevent that. It is already recommended for premature in",
https://www.healthnewsreview.org/review/balanced-complete-evaluation-of-study-on-vitamin-supplement-for-skin-cancer-prevention/,"Balanced, complete evaluation of study on vitamin supplements for skin cancer prevention",The story wasn‚Äôt content simply to repeat the information that was spoonfed to reporters in a conference call.,Study: Vitamin B3 may help prevent certain skin cancers,story_reviews_00620,5,"['Dave Mosher', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",Associated Press,"['nonmelanoma skin cancer', 'vitamin B3']",http://abcnews.go.com/Health/wireStory/study-vitamin-b3-prevent-skin-cancers-31024391,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story informs us\xa0online\xa0retailers sell\xa0nicotinamide ‚Äúfor prices ranging from a nickel to a dollar a tablet.‚Äù That‚",Associated Press,"It‚Äôs an attractive¬†idea: Take a cheap, harmless, over-the-counter pill twice¬†a day and lower your chance of developing skin cancer. But as this well-balanced Associated Press (AP) news¬†story¬†illustrates, the results of a new¬†study of Australian can",nan,"Skin cancer affects about 5 million people in the U.S. each year, making it one of the most common forms of cancer, and rates¬†have been on the rise for the past three decades (probably because¬†people are living longer, getting more sun exposure, and enj",
https://www.healthnewsreview.org/review/mediterranean-diet-boosts-brain-power-clinical-study-finds/,Mediterranean diet and cognitive function: Solid WSJ report would‚Äôve benefited from cost info,The main deficiency of this otherwise strong report is that it didn‚Äôt caution readers about the cost of buying some 50 liters of olive oil annually to replicate this diet.,"Mediterranean Diet Boosts Brain Power, Clinical Study Finds",story_reviews_00621,4,"['Susan Molchan, MD, MA', 'Kevin Lomangino']",Diet studies,"['cognitive decline', 'Mediterranean diet', 'olive oil', 'walnuts']",http://www.wsj.com/articles/mediterranean-diet-boosts-brain-power-study-finds-1431356748?mod=mktw,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story mentions neither of two costs that merited discussion: the cost of following a Mediterranean diet and the cost of the",The Wall Street Journal,This story does a nice job describing why a study delving into the impact of various versions of the Mediterranean diet on cognitive function is more rigorous than previous efforts. And its provision of strong comments from an independent expert help read,"https://www.healthnewsreview.org/wp-content/uploads/2015/05/olive-oil-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/olive-oil.jpg 849w",This study offers clinical randomized trial evidence suggesting that a healthy Mediterranean-style diet supplemented with olive oil or nuts may help slow the cognitive decline associated with aging. That‚Äôs pretty big news! Diet is implicated in¬†so many,
https://www.healthnewsreview.org/review/balanced-insightful-report-on-tradeoffs-of-treating-premature-babies-at-edge-of-survival/,"Balanced, insightful report on tradeoffs of treating premature babies at edge of survival",A thorough Wall Street Journal report on a new study that explores the relationship between active medical intervention and survival ‚Äî a topic considered to be controversial among pediatric experts.,Premature Babies May Benefit From Intensive-Care Treatment,story_reviews_00623,5,"['Euna Bodner, MS', 'Karen Carlson, MD', 'Kevin Lomangino']",Shared decision-making,"['premature babies', 'shared decision-making']",http://www.wsj.com/articles/premature-babies-may-benefit-from-intensive-care-treatment-1430995819,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Especially in the WSJ, we would expect some mention of the extraordinarily high health care costs that can result from intensiv",The Wall Street Journal,"
When a baby is born at the edge of viability, the question of what action to take is a difficult and controversial one. The risks of poor outcomes are high, even if the baby survives. The Wall Street Journal highlights a new study that explores the relat","https://www.healthnewsreview.org/wp-content/uploads/2015/05/premature-baby-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/premature-baby.jpg 850w","This cohort study examined what happens to babies born at extremely low gestational age, providing valuable new information on the likelihood of health outcomes that matter to parents. Those outcomes are also of importance to society from the standpoint o",
https://www.healthnewsreview.org/review/medicare-assessing-value-lung-cancer-screening/,The Times offers informative breakdown on the value of lung cancer screening,"Thorough, informative reporting on the risks and benefits of participating in a new lung cancer screening program.",On Medicare and Assessing the Value of Lung Cancer Screening,story_reviews_00625,5,"['Sharon Dunwoody, PhD', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Cancer,"['low-dose CT', 'lung cancer', 'National Lung Screening Trial']",http://www.nytimes.com/2015/05/12/health/on-medicare-and-assessing-the-value-of-lung-cancer-screening.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story describes the case of one patient who paid $95 out of pocket for a lung cancer screen in 2013. But while the story do",The New York Times,"
Is the opportunity for Medicare recipients who are heavy smokers to receive yearly low-dose CT scans a boon or a problem? This New York Times analysis not only provides a little history about the recent Medicare decision to fund the procedure, which seek","https://www.healthnewsreview.org/wp-content/uploads/2015/05/lung-cancer-xray-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/lung-cancer-xray.jpg 849w","Among the illnesses caused by smoking, lung cancer is a big one. It is the number one cause of cancer death in the U.S. and most lung cancers occur in smokers. So short of stopping smoking, what can be done to decrease the risk of dying from lung cancer? ",
https://www.healthnewsreview.org/review/penn-study-questions-lariat-device-prevent-stroke-heart-patients/,Philadelphia Inquirer highlights FDA ‚Äúloophole‚Äù allowing use of heart device without testing,A solid piece of reporting that focuses on the safety of a medical device used to prevent strokes. Its discussion of FDA rules governing device approvals is valuable.,Penn study questions Lariat device to prevent stroke in heart patients,story_reviews_00626,5,"['Sally James', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Devices,"['atrial fibrillation', 'Lariat', 'stroke', 'University of Pennsylvania', 'Watchman']",http://www.philly.com/philly/health/hearthealth/20150505_Penn_study_questions_Lariat_device_to_prevent_stroke_in_heart_patients.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This is an unusual story, not directly about a therapy that patients choose or buy. But we still think the price of the device ",The Philadelphia Inquirer,"Atrial fibrillation (AF) is a common cause of rapid, irregular heartbeat that puts people at increased risk for stroke. Approving new devices or surgical techniques to help reduce risk for these patients is important, and so this story is important for he","https://www.healthnewsreview.org/wp-content/uploads/2015/05/lariat-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/lariat.jpg 600w","This story discusses the application of a device that closes off the atrial appendage, a part of the heart where blood can pool in patients with atrial fibrillation, causing clots to form. The device was initially developed for use during open heart surge",
https://www.healthnewsreview.org/review/ox-story-points-to-key-limitations-of-study-on-massage-therapy-for-infertility-but-misses-65-study-dropout-rate/,"Fox story points to key limitations of study on massage therapy for infertility, but misses high study dropout rate",This story did a reasonable job of reporting on a study about the use of massage to treat infertility. It would‚Äôve been stronger had it pointed out the study‚Äôs high dropout rate.,Can massage therapy treat infertility?,story_reviews_00627,4,"['Alan Cassels', 'Karen Carlson, MD', 'Kevin Lomangino']",Fox News,"['Clear Passage', 'infertility', 'IVF', 'massage']",http://www.foxnews.com/health/2015/05/01/can-massage-therapy-treat-infertility/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story tells us that the Clear Passage Therapy costs $6,000, takes about 20 hours of massage, and may be covered by some insurer",FoxNews.com,"This story reports on a retrospective study looking at a form of massage therapy that is designed to treat infertility, with the claim that it is an alternative to surgery¬†or in-vitro fertilization (IVF)¬†in dealing with blocked fallopian tubes. The theo","https://www.healthnewsreview.org/wp-content/uploads/2015/05/Clear-Passage-treatment-300x160.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/Clear-Passage-treatment.jpg 600w","Couples who experience infertility are sometimes desperate for solutions, so having an alternative, less invasive form of treatment is very attractive. If massage works¬†to increase fertility ‚Äî and it‚Äôs not clear that this report of a study can adequa",
https://www.healthnewsreview.org/review/new-helmet-technology-helping-patients-tackle-baldness/,Fox story fails to dent dubious hair-growth helmet claims,"Despite its 4-star score, this story failed to provide any critical analysis of the suspect claims made by the manufacturer of this baldness remedy.",New helmet technology helping patients tackle baldness,story_reviews_00630,4,"['Euna Bodner, MS', 'Kevin Lomangino']",Fox News,"['baldness remedies', 'cosmetic procedures', 'Theradome']",http://www.foxnews.com/health/2015/04/26/helmet-to-regrow-hair/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states that Theradome costs $895. That‚Äôs accurate, and the helmet can be purchased online.'}, {'question': 'Does the st",FoxNews.com,"This story describes a fairly new laser device that is said to promote hair growth. Although other laser products for this purpose exist, this is the first of its kind to be wearable. This may make it more likely that those with hair loss will continue us","https://www.healthnewsreview.org/wp-content/uploads/2015/05/theradome-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/theradome.jpg 640w","Millions of people experience hair loss, according to the American Academy of Dermatology. The causes of hair loss are numerous, and not all treatments work for all people. Some people, especially women, experience low self-esteem with hair loss. Thus, a ",
https://www.healthnewsreview.org/review/times-shines-in-coverage-of-new-injection-for-double-chins/,The Times shines in coverage of new injection for double chins,This 5-star effort features more original reporting and detail than the , Injection Offers Option to Slim Down Double Chin Without Surgery,story_reviews_00631,5,"['Harold J. DeMonaco, MS', 'Kevin Lomangino']",New York Times,"['cosmetic procedures', 'double chins', 'Kybella', 'Kythera']",http://www.nytimes.com/2015/05/01/health/injection-kybella-double-chin.html?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes that the price has not yet been set, which we‚Äôll call good enough for a Satisfactory rating. It could have noted ",The New York Times,This story demonstrates why it‚Äôs so important to seek out independent perspectives in health news. Readers of the competing Post coverage on this story ‚Äî which featured no such perspective ‚Äî will come away with a fairly superficial understanding of ,nan,"Like it or not, lifestyle drugs are big business. So it is not surprising that a ‚Äútreatment‚Äù for double chins has been developed. The FDA approved Kybella based in part on the recommendation of its dermatologic drugs advisory committee. Critical to th",
https://www.healthnewsreview.org/review/color-genomics-sells-249-breast-cancer-gene-test-masses/,Potential harms missing in coverage of Color Genomics cancer test,The failure to discuss potential harms of more widespread testing in more than a general way is a significant omission in this story.,Color Genomics Sells $249 Breast Cancer Gene Test to Masses,story_reviews_00635,4,"['Earle Holland', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Bloomberg,"['BRCA', 'breast cancer', 'color genomics', 'genetic testing']",http://www.bloomberg.com/news/articles/2015-04-21/color-genomics-brings-245-breast-cancer-risk-test-kit-to-masses,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Since the primary news value of this story is the lower-than-normal cost of the new test, the story rates a satisfactory for this c",Bloomberg,"
This story describes a newly available genetic test intended to indicate if a person has a BRCA1 or BRCA2 mutation that signals a susceptibility to breast cancer, as well as mutations linked to ovarian cancer.¬† While tests for these mutations are alread",nan,"It has been estimated that there are approximately 222,000 unaffected (not diagnosed with cancer) BRCA 1/2 mutation carriers in the United States and only 5-6% of them have been identified. In addition, estimates suggest that over 35,000 breast cancer pat",
https://www.healthnewsreview.org/review/new-skin-cancer-radiation-treatment-5-star-story-but/,"New skin cancer radiation treatment ‚Äì 5 star story, but‚Ä¶.","This is a case where the body text of the story sends one message, but the headline and photos send a different one.",Skin Cancer Removal With Miniaturized Radiation,story_reviews_00640,5,"['Sharon Dunwoody, PhD', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",skin cancer/sun protection,[],http://www.wsj.com/articles/skin-cancer-removal-with-miniaturized-radiation-1428358712,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This was a strong point of the piece. The story contrasts the much higher cost of eBx relative to standard skin cancer treatments, ",The Wall Street Journal,"This was a strong overall story about an increasingly popular radiation treatment for non-melanoma skin cancers. Importantly, it cautions readers about the absence of long-term safety data, as well as the high costs of the treatment relative to more stand",nan,"Non-melanoma skin cancers are very common, but rarely represent a serious health concern. They only spread locally and don‚Äôt metastasize to organs or structures where damage could be life threatening. For cancers not on the face or in other hard-to-reac",
https://www.healthnewsreview.org/review/learning-to-say-no-to-dialysis/,Learning to Say No to Dialysis,"This story questions the orthodoxy around dialysis, especially for seniors, and calls for a more involved and deliberative decision-making process prior to its use.",Learning to Say No to Dialysis,story_reviews_00643,4,"['Alan Cassels', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Kidney Disease,['Dialysis'],http://www.nytimes.com/2015/03/31/health/learning-to-say-no-to-dialysis.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article could have included some quick facts about the cost of dialysis, as well as the costs of transportation, hospital t",The New York Times,"This thoughtful article about dialysis for older people with kidney disease captures the dilemma that many elderly patients must go through: whether they wish to endure the often difficult, inconvenient, and unpleasant task of frequent trips to a renal ce",nan,"This piece describes the reality of a common, costly, and time-intensive medical intervention, then identifies a major flaw in its execution: many patients don‚Äôt understand what they‚Äôre getting into, and wouldn‚Äôt proceed if they did. The emphasis on",
https://www.healthnewsreview.org/review/experts-back-angelina-jolie-pitt-in-choices-for-cancer-prevention/,Experts Back¬†Angelina Jolie Pitt in Choices for Cancer Prevention,Celebrities can be a force for knowledge or nonsense when it comes to health care. This New York Times piece fact checks an op-ed by Angelina Jolie Pitt against the recommendations of several experts.,Experts Back¬†Angelina Jolie Pitt in Choices for Cancer Prevention,story_reviews_00646,4,"['Harold J. DeMonaco, MS', 'Kevin Lomangino']",Cancer,"['Angelina Jolie', 'BRCA', 'breast cancer', 'ovarian cancer']",http://www.nytimes.com/2015/03/25/science/experts-back-angelina-jolie-pitt-in-choices-for-cancer-prevention.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Since the story focuses on the story of Ms. Jolie Pitt, a woman with financial resources beyond those of most women, we think d",The New York Times,"This well-written story provides a compelling narrative on Ms. Jolie-Pitt‚Äôs, Ms. Krances‚Äô and Ms Zelenske‚Äôs journey along with supportive comments by three experts in the field. The story does a nice job in describing the different approaches and th",nan,"In our celebrity-obsessed culture, health recommendations from famous people carry more weight than they should. And so when someone like Angelina Jolie Pitt goes public to describe her health care decision-making, the news media need to be ready to compa",
https://www.healthnewsreview.org/review/e-cigarettes-helping-smokers-quit-or-fueling-a-new-addiction/,"E-cigarettes: Helping smokers quit, or fueling a new addiction?","While this story about e-cigarettes checks most of our boxes, its 4-star score conceals some significant gaps in the coverage. Read the complete review for details.","E-cigarettes: Helping smokers quit, or fueling a new addiction?",story_reviews_00650,4,"['Sally James', 'Michael Bierer MD, MPH', 'Kevin Lomangino']",CNN,['e-cigarettes'],http://www.cnn.com/2015/03/23/health/e-cigarettes-smoking-addiction-nicotine/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We are disappointed that the story did not give any direct costs for tobacco cigarettes, e-cigarettes, or smoking cessation aid",CNN,"This story summarizes arguments on the benefits and harms of e-cigarettes, also called ‚Äúelectronic nicotine delivery systems‚Äù or ENDS,¬†as gleaned from a recent conference in Abu Dhabi. While it effectively communicates the opinions of a number of exp",nan,"The growing popularity of e-cigarettes presents society with opportunities as well as risks. First, relying on ENDS instead of traditional cigarettes may well be the lesser of two evils¬†(as suggested by this report from the UK government)¬†for those who ",
https://www.healthnewsreview.org/review/non-prescription-allergy-relief-what-you-need-to-know/,Non-prescription allergy relief: what you need to know,"This USA Today story is easy-to-read and has many consumer-friendly details, but it missed the mark on a few important points.",Non-prescription allergy relief: what you need to know,story_reviews_00651,4,"['Euna Bodner, MS', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",USA Today,['allergy'],http://www.usatoday.com/story/news/2015/03/22/non-prescription-allergy-treatment/24845259/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story goes above and beyond our standard here. There is a whole section on costs, which tells consumers to ‚Äúexpect to pay mor",USA Today,We congratulate this story for its thorough and nuanced discussion of the costs of different allergy medications ‚Äî a rarity in health news today. But if a story is going to call certain medications ‚Äúthe single most effective drug class for treating na,nan,"March is the beginning of spring and allergy season. It is estimated that 50 million people in the US, or 30 percent of adults, are affected by nasal allergies. There are a variety of treatment options, such as antihistamines and decongestants, as well as",
https://www.healthnewsreview.org/review/breast-biopsy-accuracy-is-questioned-in-experimental-study/,Breast biopsy accuracy is questioned in experimental study,A solid job overall reporting on a study that suggests pathologists frequently misdiagnose conditions that fall short of invasive breast cancer.,Breast biopsy accuracy is questioned in experimental study,story_reviews_00653,4,"['Christine K. Norton, MA', 'Kevin Lomangino']",Associated Press,['breast cancer'],http://tucson.com/news/science/health-med-fit/breast-biopsy-accuracy-is-questioned-in-experimental-study/article_f2d6e47d-bbf0-5684-8539-f6b859ba96c6.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Since the first sentence of the piece focuses on ‚Äúanother reason for getting a second medical opinion,‚Äù readers would have ",AP Associated Press,"Having acknowledged the overall quality of the coverage, we‚Äôd note that our wish list for this story includes a couple of contextual details. Since the story advocates for a second opinion from a pathologist, it would‚Äôve been helpful to explain how it",nan,"Each year nearly 1.6 million women in the United States undergo a breast biopsy. ¬†Clinicians and patients depend on an accurate pathology report to decide whether treatment is necessary, determine the future frequency of screening, and choose the right s",
https://www.healthnewsreview.org/review/manual-clot-removal-after-heart-attack-may-not-help-could-harm/,"Manual Clot Removal After Heart Attack May Not Help, Could Harm","This story did an efficient job of checking off most of our boxes. We applaud the 5-star score, but we can never resist the temptation to offer a few suggestions for improvement.","Manual Clot Removal After Heart Attack May Not Help, Could Harm",story_reviews_00654,5,"[""A'ndrea Elyse Messer, MS, PhD"", 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",HealthDay,"['Blood clots', 'heart attack']",http://consumer.healthday.com/cardiovascular-health-information-20/angioplasty-news-26/manual-clot-removal-after-heart-attack-may-not-help-could-harm-697481.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not discuss the cost of angioplasty, or whether that cost would be affected if routine practice regarding clot r",HealthDay,Removing clots during angioplasty to open up a blocked coronary artery has become a common practice.¬† This study of a large number of randomly selected patients showed that there was little difference between those patients who had only angioplasty and t,nan,"Angioplasty is common after a cardiac event and manual clot removal is considered routine practice.¬† If this practice has no practical clinical value and has negative implications for strokes within 30 days after treatment, then perhaps this routine prac",
https://www.healthnewsreview.org/review/can-personal-air-purifiers-keep-cold-and-flu-bugs-away/,Can Personal Air Purifiers Keep Cold and Flu Bugs Away?,This is another quality installment of health news from the Wall Street Journal‚Äôs ‚ÄúAches and Claims‚Äù column ‚Äî this time on the dubious benefits of personal air purifiers. Check out ,Can Personal Air Purifiers Keep Cold and Flu Bugs Away?,story_reviews_00655,4,"['Earle Holland', 'Matt Shipman', 'Kevin Lomangino']",Devices,['Clean air'],http://www.wsj.com/articles/can-personal-air-purifiers-keep-cold-and-flu-bugs-away-1426523645,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does mention that the two devices discussed each cost around $150,\xa0a fairly steep price for a device that offers no cl",The Wall Street Journal,"This story asks whether personal air purifiers provide some protection from pathogen-caused illnesses and mentions lab tests that suggest some efficacy in avoiding inhalation of small particles. It also explains the limitations of these lab studies, and n",nan,"It‚Äôs a messy world out there, especially on public transport. Passengers in planes, trains, and buses (among myriad other public spaces) will come into contact with pathogenic microbes, so any device that can help prevent infection would be most welcome",
https://www.healthnewsreview.org/review/studies-boost-hopes-for-new-class-of-cholesterol-medicines/,Studies boost hopes for new class of cholesterol medicines,"The strongest part of this AP story was the quantification of worrisome side effects in patients who took these experimental drugs. But the article fell short in other areas, failing to go into detail about costs and giving an exaggerated estimate of bene",Studies boost hopes for new class of cholesterol medicines,story_reviews_00656,4,"['Euna Bodner, MS', 'Kevin Lomangino']",Associated Press,['cholesterol'],http://www.philly.com/philly/health/hearthealth/20150315_ap_04e14045cafa4111b1207602f3df6198.html#SdPp3l24qqyHpT7K.99,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Unlike the competing article in The New York Times, the AP story did not attempt to estimate costs for this class of drugs.'}, ",AP Associated Press,"This AP story was strong overall, and did a great job discussing the drugs‚Äô side effects and putting these new trials into perspective with older studies. However, the story was also¬†shorter than the competing New York Times article and, consequently, ",nan,"Lipid-lowering drugs, such as statins, are used to help people lower their cholesterol levels, which doctors believe may reduce the risk for heart attacks and strokes. But some people may not get their cholesterol into the recommended range with statins a",
https://www.healthnewsreview.org/review/tests-of-cholesterol-drugs-offer-hope-of-reducing-heart-attacks-and-strokes/,Tests of Cholesterol Drugs Offer Hope of Reducing Heart Attacks and Strokes,This New York Times story did a thorough job explaining the benefits and shortcomings of a series of trials looking into a class of cholesterol drugs. We especially liked how the piece addressed limitations and costs. More informative than the ,Tests of Cholesterol Drugs Offer Hope of Reducing Heart Attacks and Strokes,story_reviews_00657,5,"['Euna Bodner, MS', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",New York Times,"['cholesterol', 'heart attack', 'stroke']",http://www.nytimes.com/2015/03/16/business/tests-of-cholesterol-drugs-offer-hope-of-reducing-heart-attacks-and-strokes.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'It‚Äôs difficult to estimate costs for drugs that haven‚Äôt yet been approved by the Food and Drug Administration, so we feel this ",The New York Times,This piece did an excellent job addressing all of our criteria and fully merited a 5-star rating. We particularly liked how the independent experts quoted in the story provided a more critical and balanced view of the studies‚Äô findings. Our only signifi,nan,"Lipid-lowering drugs, such as statins, are used to help people lower their cholesterol levels, which doctors believe may reduce the risk for heart attacks and strokes. But some people may not get their cholesterol into the recommended range with statins a",
https://www.healthnewsreview.org/review/stress-test-or-3-d-scan-and-the-best-heart-exam-is/,Stress Test or 3-D Scan? And the Best Heart Exam Is ‚Ä¶,"This otherwise well-reported story is thrown off course by a misleading anecdote at the end. The story should have pushed back against a patient‚Äôs unfounded prognostications, or better yet, left them out of the coverage entirely.",Stress Test or 3-D Scan? And the Best Heart Exam Is ‚Ä¶,story_reviews_00658,4,"['Sharon Dunwoody, PhD', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",heart disease,"['CTAs', 'Stress Testing']",http://www.nbcnews.com/health/heart-health/stress-test-or-3-d-scan-best-heart-exam-n323316,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs do not surface in this story.\xa0 Since one would assume that a CT scan would be considerably more expensive than traditi",,"A comparison of two diagnostic tests ‚Äî traditional stress tests and newer heart CTA (computed tomography angiogram) scans ‚Äî among more than 10,000 heart patients found no difference in those patients‚Äô incidence of subsequent heart attacks and relate",nan,"The arrival of new diagnostic procedures always seems to promise more effective treatment.¬† But effectiveness is an empirical question, and this study‚Äôs findings suggest that the familiar stress tests work just as well as heart CT scans. That result co",
https://www.healthnewsreview.org/review/the-gentle-cesarean-more-like-a-birth-than-an-operation/,The Gentle Cesarean: More Like A Birth Than An Operation,"The family-centered or ‚Äúgentle‚Äù cesarean is an interesting concept and newsworthy for its innovation. This engaging NPR piece conveys much of what readers would want to know, but leans a bit too heavily on the opinions of advocates for our liking.",The Gentle Cesarean: More Like A Birth Than An Operation,story_reviews_00663,4,"['Euna Bodner, MS', 'Karen Carlson, MD', 'Kevin Lomangino']",NPR,['Cesarean'],http://www.npr.org/blogs/health/2015/03/09/390977656/the-gentle-cesarean-more-like-a-birth-than-an-operation,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story said hospitals aren‚Äôt charging more for the family-centered cesarean. We‚Äôll judge this nod in the direction of costs ",NPR,"This NPR story was a pleasure to listen to, as well as read. It was full of color, anecdotes and scenes, at least in the audio piece. But the two mothers who are proponents of so-called family-centered C-sections ran the whole show, and there were no coun",nan,"Almost a third of babies are delivered via C-section in the United States, and many mothers are not happy with their cesarean birth experience, preferring the natural delivery method instead. The family-centered cesarean holds the potential to improve som",
https://www.healthnewsreview.org/review/walk-a-little-faster-to-get-the-most-out-of-your-exercise-time/,Walk A Little Faster To Get The Most Out of Your Exercise Time,"How much is ‚Äúenough‚Äù when it comes to exercise, and is more always better? This NPR story tackles those difficult questions through coverage of a new exercise trial.",Walk A Little Faster To Get The Most Out of Your Exercise Time,story_reviews_00664,4,"['Sally James', 'Mandy Stahre, PhD', 'Kevin Lomangino']",NPR,['exercise'],http://www.npr.org/blogs/health/2015/03/02/390230746/walk-a-little-faster-to-get-the-most-out-of-your-exercise-time,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Fitting exercise time into a life can be tricky if you are in poverty, working two jobs, or don‚Äôt have a safe neighborhood. T",NPR,"This is a solid look at a study of the effects of exercise at different intensities and durations in obese people who were sedentary at the start of the study. The explanation of what the researchers did and what they found is careful, and the take-home m",nan,"Many overweight, out-of-shape people want to begin exercise programs and are looking for guidance on how much is enough. This story highlights findings showing that exercising a bit harder and longer leads to a modest improvement in one risk factor for he",
https://www.healthnewsreview.org/review/should-pregnant-women-eat-more-tuna/,Should Pregnant Women Eat More Tuna?,A good overview of why government nutrition authorities are considering a revision on their guidance for tuna consumption during pregnancy.,Should Pregnant Women Eat More Tuna?,story_reviews_00669,4,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",New York Times,"['Omega-3', 'Pregnancy']",http://well.blogs.nytimes.com/2015/03/02/should-pregnant-women-eat-more-tuna/?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The gist of this story is to compare the health effects of tuna vs. other types of fish during pregnancy. We don‚Äôt think there‚",The New York Times,"The story provides an overview of the debate on whether pregnant women and nursing mothers should eat tuna ‚Äî which is high in omega-3 fatty acids and other nutrients that are important to prenatal and infant development, but which can also contain relat",nan,Few subjects are as emotionally loaded as those pertaining to what a mother could or should do to protect the health of her children during and after pregnancy. And there is a great deal of (often conflicting) guidance for new and expecting mothers on wha,
https://www.healthnewsreview.org/review/app-trains-your-brain-to-see-better/,App ‚Äòtrains‚Äô your brain to see better,This story improves upon other recent Fox News efforts by including an independent expert perspective ‚Äî the lack of which we commented on in ,App ‚Äòtrains‚Äô your brain to see better,story_reviews_00671,4,"['Harold J. DeMonaco, MS', 'Kevin Lomangino']",Fox News,['vision'],http://www.foxnews.com/health/2015/02/26/app-trains-your-brain-to-see-better/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story clearly outlines the costs of the app, initially and on an ongoing basis: ‚ÄúThe app is free to download, but the basic 3",,"This story is a rehash of a similar story that Fox News posted in January 2014. It‚Äôs also basically the same story that appeared in a Fox Business video segment in January 2015. Unlike previous versions, the new story thankfully doesn‚Äôt claim that the",nan,"While we can‚Äôt countenance Fox‚Äôs repeated coverage of this specific product, we acknowledge that the topic may hold interest for some readers, including several of our more senior reviewers. Presbyopia is a bit of a nuisance for most over the age of 5",
https://www.healthnewsreview.org/review/phone-support-can-help-ease-postpartum-depression/,Phone support can help ease postpartum depression,A generally complete report on a study of peer phone counseling for postpartum depression.,Phone support can help ease postpartum depression,story_reviews_00673,4,"['Joann Rodgers, MS', 'Karen Carlson, MD', 'Kevin Lomangino']",Reuters Health,['postpartum depression'],http://www.reuters.com/article/2015/02/24/us-postpartum-depression-phone-support-idUSKBN0LS2LS20150224,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We want to rule this satisfactory. The story notes that the peer phone counseling is run by volunteers with nurses on call, and",Reuters Health,This story reports on a small study suggesting that peer counseling by telephone can be helpful for some mothers experiencing postpartum depression. The story is thoroughly reported. It includes perspectives from two experts not affiliated with the resear,nan,"The American Psychiatric Association estimates that 9 to 16 percent of first time mothers experience postpartum depression (PPD), defined as a ‚Äúserious mental health problem‚Äù marked by a prolonged period of emotional disturbance that affects the abili",
https://www.healthnewsreview.org/review/lay-off-the-mega-doses-of-vitamin-d/,Lay off the mega-doses of Vitamin D,"Many consumers and health care providers continue to hope that a pill, including a seemingly harmless one like vitamin D, will be the solution to a host of chronic diseases. This story explains why that thinking has a lot of holes in it.",Lay off the mega-doses of Vitamin D,story_reviews_00674,4,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Supplements,['Vitamin D'],http://www.washingtonpost.com/news/to-your-health/wp/2015/02/24/lay-off-the-mega-doses-of-vitamin-d/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not discuss the price of vitamin D supplements (a quick online search indicates that supplements can range in pr",The Washington Post,"The story urges readers to be cautious about consuming vitamin D supplements ‚Äî particularly in high doses, which can increase a variety of health risks. The story stems from a recent commentary in the Journal of the American Medical Association, which e",nan,"Vitamin D use has increased significantly over the past 15 years;¬†Consumer Reports reported that sales of vitamin D supplements rose from $40 million in 2001 to $425 million in 2009. While some articles, including the recent one in JAMA, have tied this i",
https://www.healthnewsreview.org/review/mindfulness-may-help-ease-sleep-problems-for-seniors/,‚ÄòMindfulness‚Äô May Help Ease Sleep Problems for Seniors,"Our review offers a few suggestions for how this story could have been improved, but honestly, we couldn‚Äôt come up with much.",‚ÄòMindfulness‚Äô May Help Ease Sleep Problems for Seniors,story_reviews_00678,5,"['William Heisel', 'Dave Mosher', 'Kevin Lomangino']",HealthDay,['sleep problems'],http://consumer.healthday.com/alternative-medicine-information-3/meditation-news-467/mindfulness-may-help-older-adults-sleep-problems-696519.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of costs. There were a few good opportunities to introduce costs here. For one, the meditation therapy requ",HealthDay,"With a few dollar signs, this story could have been a perfect example of how to write about a small study with interesting findings.
¬†",nan,"Everyone sleeps, most of us have trouble with it at some point, and the options to remedy the problem can be overwhelming and costly. Drugs have side effects and cognitive behavioral therapy is not always readily available. Mindfulness meditation presents",
https://www.healthnewsreview.org/review/gradual-smoking-cessation-may-be-possible-with-nicotine-addiction-pill/,Gradual smoking cessation may be possible with nicotine addiction pill,"This story carefully characterized the participants enrolled in a Pfizer-sponsored smoking cessation study that involved the drug Chantix. And for that reason, we‚Äôd give it a slight edge over ",Gradual smoking cessation may be possible with nicotine addiction pill,story_reviews_00679,4,"['Matt Shipman', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",Reuters,['nicotine addition'],http://www.reuters.com/article/2015/02/18/us-smoking-nicotine-cessation-idUSKBN0LL1ZD20150218,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not tell us how much the smoking cessation drug costs or whether insurance companies will pay for it.'}, {'quest",Reuters,"The story is an overview of a recent study that found the use of the smoking cessation drug Chantix (varenicline) increased the likelihood that smokers would be able to quit smoking, even if the drug treatment regimen was begun before the smoker had set a",nan,"As we noted in our review of the New York Times story, smoking is a major health problem in the United States. The CDC reports that approximately one in five deaths in the United States is tied to smoking-related health effects. Smoking is linked to a sig",
https://www.healthnewsreview.org/review/medicine-given-even-before-smokers-are-ready-to-quit-is-found-to-help-them/,Medicine Given Even Before Smokers Are Ready to Quit Is Found to Help Them,This was an informative and engaging summary in which we were pleased to see cost information ‚Äî a feature missing from ,Medicine Given Even Before Smokers Are Ready to Quit Is Found to Help Them,story_reviews_00680,4,"['Matt Shipman', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",New York Times,['smoking cessation'],http://www.nytimes.com/2015/02/18/health/pills-found-to-help-chances-of-quitting-smoking-in-the-future.html?_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story makes clear that Chantix costs approximately $250 per month. The story also notes that some insurance companies would not",The New York Times,This story covers a Pfizer-sponsored study that compared Chantix (varenicline)¬†to placebo in a group of smokers who were willing to gradually reduce their cigarette consumption ‚Äî with the goal being smoking cessation. ¬†The headline is somewhat mislead,nan,Smoking is a major health problem in the United States. The CDC reports that approximately one in five deaths in the United States is tied to smoking-related health effects. Smoking is linked to a significant increase in health risks related to heart dise,
https://www.healthnewsreview.org/review/alcohol-good-for-your-heart-evidence-is-evaporating/,Alcohol good for your heart? Evidence is evaporating,"A new study has cast doubt on the proposed benefits of moderate alcohol consumption. Using the results as a jumping off point, this story skeptically assesses the evidence and explores concerns about the alcohol/heart health hypothesis.",Alcohol good for your heart? Evidence is evaporating,story_reviews_00683,4,"['Euna Bodner, MS', 'Kevin Lomangino']",USA Today,['Alcohol'],http://www.usatoday.com/story/news/2015/02/15/alcohol-heart-cardiovascular-health/23109823/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Cost was not an issue here. People generally know what a bottle of wine or other alcohol costs.'}, {'question': 'Does the story a",USA Today,This reader-friendly piece successfully conveyed the main point of a new study: science linking alcohol consumption to heart health is inconclusive. Featuring¬†plenty of independent sources and bolded bullet points addressing key caveats about alcohol-rel,nan,"Many people are familiar with the notion that drinking moderate amounts of alcohol, particularly red wine, could be good for the heart. And so, many people clink glasses and drink to ‚Äúone‚Äôs health.‚Äù But as an an editorial that accompanied the study ",
https://www.healthnewsreview.org/review/chemoprevention-works-against-breast-cancer-but-these-drugs-are-not-popular/,"Chemoprevention works against breast cancer, but these drugs are not popular",This is a thorough look at the pros and cons of taking certain drugs that have been shown to reduce the risk of breast cancer. The five stars are well deserved.,"Chemoprevention works against breast cancer, but these drugs are not popular",story_reviews_00684,5,"['Sally James', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Cancer,['breast cancer'],http://www.washingtonpost.com/national/health-science/chemoprevention-works-against-breast-cancer-but-these-drugs-are-not-popular/2015/02/16/8c58a702-9ce9-11e4-a7ee-526210d665b4_story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentions that these drugs are ‚Äúcovered‚Äù by the Affordable Care Act, and that ‚Äúwomen with a high risk for breast can",The Washington Post,"Drugs exist to lower the risk of breast cancer in high-risk women, but they aren‚Äôt getting used as often as one might expect. This story does an excellent job of exploring the disparity between research showing the drugs‚Äô effectiveness and the lack of",nan,"This story asks deep questions about perceptions of risk, and why health care providers may not be having nuanced discussions about breast cancer prevention options with their patients. The voices missing from this story are the voices of real patients wh",
https://www.healthnewsreview.org/review/its-hard-to-know-where-gluten-sensitivity-stops-and-the-placebo-effect-begins/,It‚Äôs Hard To Know Where Gluten Sensitivity Stops And The Placebo Effect Begins,"Strong where it counts, this FiveThirtyEight story does a fine job of explaining the research on¬†‚Äúnon-celiac gluten sensitivity‚Äù in simple, clear terms. A couple of minor additions would‚Äôve completed the picture for readers.",It‚Äôs Hard To Know Where Gluten Sensitivity Stops And The Placebo Effect Begins,story_reviews_00685,4,"['Matt Shipman', 'Karen Carlson, MD', 'Kevin Lomangino']",Diet studies,['Gluten'],http://fivethirtyeight.com/features/its-hard-to-know-where-gluten-sensitivity-stops-and-the-placebo-effect-begins/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While the story does mention that there are now a broad range of gluten-free foods on the market, it does not discuss the incre",FiveThirtyEight,"‚ÄúNon-celiac gluten sensitivity‚Äù (NCGS) is a condition in which people report gastrointestinal problems related to consuming gluten ‚Äî even though they do not have either celiac disease or a wheat allergy. The story concludes that, at most, 1 in 30 of",nan,"According to a 2013 survey cited in the story, more than 29 percent of people in the U.S. are trying to reduce or eliminate their gluten consumption, presumably due to concerns over NCGS. This can have a significant economic impact on consumers. A 2007 st",
https://www.healthnewsreview.org/review/for-most-strokes-clot-retrieval-device-boosts-effectiveness-of-drug-treatment/,"For most strokes, clot-retrieval device boosts effectiveness of drug treatment","This story delivers most of what readers need to know about four new studies of stroke treatment ‚Äî even if it does, at times, get a bit caught up in the excitement surrounding the results.","For most strokes, clot-retrieval device boosts effectiveness of drug treatment",story_reviews_00686,4,"['Harold J. DeMonaco, MS', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Devices,[],http://www.latimes.com/science/sciencenow/la-sci-sn-stroke-treatment-better-20150211-story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We aren‚Äôt provided with any numbers, but the story does speak to the issue of cost. ‚ÄúBut many centers, citing mixed findings on",Los Angeles Times,This is an example of good medical reporting. This 865-word document provides the reader with sufficient background information to appreciate why the four studies (two published in the NEJM) are important and how they differ from previous studies. The eco,nan,"Stroke is a leading cause of morbidity and mortality in the US, accounting for about 1 out of every 20 deaths. In addition to the death toll, stroke is a leading cause of disability among survivors. The treatment of stroke changed radically decades ago wi",
https://www.healthnewsreview.org/review/10-million-wisdom-teeth-are-removed-each-year-that-might-be-way-too-many/,10 million wisdom teeth are removed each year. That might be way too¬†many.,Congratulations to Vox for a strong debut at HealthNewsReview.org. This was a¬†4-star effort that questions a very common and costly dental practice.,10 million wisdom teeth are removed each year. That might be way too¬†many.,story_reviews_00692,4,"['Kathlyn Stone', 'Harold J. DeMonaco, MS', 'Kevin Lomangino']",Vox,"['surgery', 'wisdom teeth']",http://www.vox.com/2015/1/13/7539983/wisdom-teeth-necessary,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This article talks about the overall costs of removing wisdom teeth ‚Äî $3 billion annually, according to the American Public Healt",,"This story explores a simmering debate among dentists and oral surgeons over the wisdom of preventative wisdom tooth removal. This issue primarily affects 17-25 year olds, since that is the age when the third molars typically appear and when they are leas",nan,"Preventative removal of wisdom has been an accepted standard of care for decades. Absent universal agreement among doctors and oral surgeons on how to treat non-symptomatic wisdom teeth, it‚Äôs very important that young adults understand that there is no ",
https://www.healthnewsreview.org/review/placebo-effect-influenced-by-perceived-cost-study-finds/,"Placebo effect influenced by perceived cost, study finds",A pretty good overview of an interesting study on placebos. It had one significant omission.,"Placebo effect influenced by perceived cost, study finds",story_reviews_00698,4,"[""A'ndrea Elyse Messer, MS, PhD"", 'Kevin Lomangino']",Los Angeles Times,"[""Parkinson's""]",http://www.latimes.com/science/sciencenow/la-sci-sn-expensive-placebos-work-better-20150127-story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The cost of sugar pills is not in question. But the story does explore the cost implications of developing more effective placebos.",Los Angeles Times,"This story summarizes a study that tested responses to two placebos ‚Äî one cheap and one expensive ‚Äî in patients with Parkinson‚Äôs disease. The expensive placebo seemed to work better, but the effect was small. The study itself was also tiny ‚Äî just ",nan,"This study suggests that, as with hair shampoo, people believe that pricier drugs are better. This is a challenge to attempts to deliver more effective treatments for less money. Better means to communicate drug efficacy may be needed to help offset this ",
https://www.healthnewsreview.org/review/trial-finds-gsk-ebola-shot-is-safe-and-provokes-immune-response/,Trial finds GSK Ebola shot is safe and provokes immune response,"With a condition as panic-inducing as Ebola infection has been, stories might be tempted to get over-enthusiastic about the potential for an experimental vaccine. This story didn‚Äôt.",Trial finds GSK Ebola shot is safe and provokes immune response,story_reviews_00699,4,"['Harold J. DeMonaco, MS', 'Sally James', 'Kevin Lomangino']",Reuters,['Ebola'],http://www.reuters.com/article/2015/01/28/us-health-ebola-vaccine-idUSKBN0L12MC20150128,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although accurate cost information is unlikely to be available at this point, cost will undoubtedly become an issue for success",Reuters,"This is a well-balanced, well-written story that lacked only a few minor details. We thought that a few words about cost and some discussion of other potential prevention/treatment approaches would have been ideal. Although independent sources were not in",nan,"The world has been transfixed with the outbreak of Ebola in West Africa and the enormous humanitarian crisis it has caused. ¬†The return of American health care workers from West Africa, both infected and non-infected, brought the reality of Ebola home to",
https://www.healthnewsreview.org/review/dna-blood-test-gives-women-a-new-option-for-prenatal-screening/,DNA Blood Test Gives Women A New Option For Prenatal Screening,Prenatal screening tests should not be confused with diagnostic tests. This story explains why.,DNA Blood Test Gives Women A New Option For Prenatal Screening,story_reviews_00705,4,"['Mandy Stahre, PhD', 'Karen Carlson, MD', 'Kevin Lomangino']",NPR,['prenatal testing'],http://www.npr.org/blogs/health/2015/01/26/368449371/dna-blood-test-gives-women-a-new-option-for-prenatal-screening,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story mentioned that insurance coverage of the new tests varies, but no indication of an actual dollar amount was given.'},",NPR,"This story reports on several newer, noninvasive prenatal screening tests called cell-free DNA tests. These tests work by examining pieces of fetal DNA from a blood sample taken from the mother. Although more accurate than traditional screening tests (blo",nan,"The new prenatal screening tests discussed in this story are not diagnostic tests, and patients may not understand the difference between¬†the certainty of a diagnostic test and¬†the uncertainties of a¬†screening test. Solid health reporting can help wome",
https://www.healthnewsreview.org/review/day-tripping-benefits-seen-in-psychedelics/,Day Tripping: Benefits Seen in Psychedelics,An initial version of this story had a trippy quote from one of the study researchers. We‚Äôre glad that this sensational language and other deficiencies were addressed in subsequent editing. The revised version is much better.,Day Tripping: Benefits Seen in Psychedelics,story_reviews_00706,4,"['Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Newsweek,"['mental health', 'psychedelics']",http://www.newsweek.com/day-tripping-benefits-seen-use-psychedelics-301847,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'No costs were cited, perhaps because the drugs are not legally available in the United States. We‚Äôll rate this Not Applicable.'",Newsweek,"The story does a nice job of reviewing previous research on psychedelic drugs and mental illness, and it does eventually address what science views at the major limitation of the observational study being reported on ‚Äî the fact that it can‚Äôt tell us w",nan,"Depression is a widespread illness with large impacts on morbidity and mortality in the United States, so it is important to explore new potential treatments. The article also touches on an important tension between public health efforts to reduce psyched",
https://www.healthnewsreview.org/review/researchers-in-italy-found-bergamot-lowered-blood-cholesterol/,Researchers in Italy Found Bergamot Lowered Blood Cholesterol,"Meeting most of our criteria for quality health journalism, this solid Wall Street Journal ‚ÄúAches and Claims‚Äù column helps readers sort out research on a potential cholesterol-lowing supplement.",Researchers in Italy Found Bergamot Lowered Blood Cholesterol,story_reviews_00709,5,"['Kathleen Fairfield, MD, DrPH', 'Dave Mosher', 'Kevin Lomangino']",health food claims,['cholesterol'],http://www.wsj.com/articles/researchers-in-italy-found-bergamot-lowered-blood-cholesterol-1421703338,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There are bergamot supplements on the market, but the price was not discussed. The cost of statins is also excluded.'}, {'quest",The Wall Street Journal,"This story describes a potential cholesterol-lowering herbal supplement derived from the bitter citrus fruit, bergamot, found in Italy. It explains that four human studies have been published on the subject, and that all of these studies involved a cardio",nan,"With the introduction of new cholesterol guidelines last year, a large proportion of the public will be recommended to take a statin for primary prevention of heart disease. Many patients experience side effects from statins or prefer herbal/natural produ",
https://www.healthnewsreview.org/review/mohs-surgery-minimal-scars-vs-high-cost/,Mohs surgery: Minimal scars vs. high cost,This insightful piece explores the cost-benefit tradeoffs of Mohs surgery ‚Äî a procedure that involves excising cancerous skin tumors and immediately examining them with a microscope to confirm that the entire tumor is removed. But it‚Äôs a bit one-sided,Mohs surgery: Minimal scars vs. high cost,story_reviews_00711,4,"['Euna Bodner, MS', 'Kevin Lomangino']",Philadelphia Inquirer,['Mohs surgery'],http://www.philly.com/philly/health/20150118_Mohs_surgery__Minimal_scars_vs__high_cost.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The main focus of the story is the higher cost of Mohs surgery, which is quoted to be around $1,100 per case, compared to about $90",The Philadelphia Inquirer,"The use of Mohs surgery¬†has skyrocketed over the past few years ‚Äì 248 percent from 1996 to 2008, according to Medicare data. The procedure is heralded as being the ‚Äúpreferred treatment‚Äù for certain types of skin cancer and boasts a cure rate of 98 ",nan,"Skin cancer is becoming increasingly common with the global aging population and the thinning of the Earth‚Äôs ozone. In an era when policymakers talk about curbing spiraling health care costs, the average number of adults being treated for skin cancer is",
https://www.healthnewsreview.org/review/vitamin-d-may-boost-colon-cancer-survival-study-finds/,"Vitamin D May Boost Colon Cancer Survival, Study Finds",We applaud the clear effort to solicit several different independent expert perspectives ‚Äì a strong point with this story.,"Vitamin D May Boost Colon Cancer Survival, Study Finds",story_reviews_00716,5,"['Joann Rodgers, MS', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Cancer,"['colon cancer', 'Vitamin D']",http://consumer.healthday.com/cancer-information-5/colon-cancer-news-96/vitamin-d-may-boost-colon-cancer-survival-study-finds-695421.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This story does not discuss cost. However, most people generally understand that vitamin supplements are affordable, so we‚Äôll r",HealthDay,This story reports the results of research presented at a symposium showing that metastatic colon cancer patients who had higher levels of vitamin D in their blood before undergoing chemo- and biological therapies survived substantially longer on average ,nan,"For advanced cancer patients, the possibility that going into treatment with higher but still normal vitamin D levels might extend the time to disease progression by a couple of months on average ‚Äî and on average extend their lives by ¬†7 to 8 month ‚Äî",
https://www.healthnewsreview.org/review/new-drugs-improve-options-for-melanoma-patients/,New drugs improve options for melanoma patients,It‚Äôs difficult to do an overview of melanoma drug research in a relatively brief story.¬† But this story did a solid job.,New drugs improve options for melanoma patients,story_reviews_00728,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Cancer,['melanoma'],http://www.usatoday.com/story/news/nation/2013/05/29/melanoma-drugs-fda/2370007/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Ballpark costs are mentioned in the final take home quote from the executive director of the Melanoma Research Foundation: ‚Äú‚ÄùIf",USA Today,"This story demonstrated how to present context and broad perspective even in advance coverage of big meetings like the American Society of Clinical Oncology (ASCO) meeting.
¬†",nan,"The ending of a story may be the take-home message that readers remember.¬† Often that‚Äôs a glowing patient anecdote.¬† This quote, from the executive director of the Melanoma Research Foundation, presented an appropriate and necessary final perspective:",
https://www.healthnewsreview.org/review/new-drug-may-help-some-asthmatics-study-finds/,"New Drug May Help Some Asthmatics, Study Finds",Better than a competing piece ,"New Drug May Help Some Asthmatics, Study Finds",story_reviews_00729,4,"['William Heisel', 'Harold J. DeMonaco, MS']",New York Times,['asthma'],http://www.nytimes.com/2013/05/22/business/dupilumab-a-new-drug-may-help-some-asthmatics.html?_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story fails to discuss costs. Given that this drug is apparently meant to be taken in addition to other drugs, it likely wi",The New York Times,"Key details are provided by the Times that were not provided by a competing Reuters story, making the promise of this new asthma drug seem a little more distant. We wish that cost information, risk of harm information, and a better comparison to alternati",nan,"The vast majority of people with asthma can control their symptoms with a combination of inhaled corticosteroids and long acting beta agonist drugs.¬† Unfortunately, there is a small population of people whose asthma proves to be more resistant.¬† Drugs t",
https://www.healthnewsreview.org/review/wireless-pacemaker-shows-promise-in-early-study/,Wireless Pacemaker Shows Promise in Early Study,"While this story adequately addressed 7 of our 10 criteria, the 3 on which it missed were significant omissions, yet could have been easily addressed.",Wireless Pacemaker Shows Promise in Early Study,story_reviews_00732,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",HealthDay,['pacemaker'],http://consumer.healthday.com/Article.asp?AID=676197,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explains that this is in the ‚Äúearly testing‚Äù phase, so it‚Äôs understandable that a cost estimate might not be given.",HealthDay,"Strong points:¬† appropriate caveats about the limitations of this early stage of testing, amplified by input from independent experts.
Weak points:
¬†",nan,The population of Americans over age 65 years is increasing and along with it comes an increase in the numbers of people with heart rate irregularities.¬† Pacemakers have become an important tool in the control of allowing people to live normal lives.¬†¬†,
https://www.healthnewsreview.org/review/gene-test-may-help-guide-prostate-cancer-treatment/,Gene test may help guide prostate cancer treatment,"Solid medical conference reporting, with many expert interviews and good context provided.¬† Goes far beyond the conference presentation itself.",Gene test may help guide prostate cancer treatment,story_reviews_00733,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Associated Press,['prostate cancer'],http://www.usatoday.com/story/news/nation/2013/05/08/gene-test-prostate-cancer/2142643/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The cost of the new test ‚Äì and of one that recently came on the market ‚Äì were listed (> $3,000 each). And the story explained i",AP Associated Press,"The story employed very careful presentation of both the promise and the potential limitations of two new prostate cancer gene tests.
Until recently, the PSA test was routinely used as a screening instrument for prostate cancer resulting in millions of me",nan,"One line from the story captures the essence of why this matters:
‚ÄúDoctors say tests like these have the potential to curb a major problem in cancer care ‚Äî overtreatment.‚Äù",
https://www.healthnewsreview.org/review/implanted-device-may-predict-epilepsy-seizures-study-suggests/,"Implanted Device May Predict Epilepsy Seizures, Study Suggests","Overall, a fairly thorough report that addressed almost all of our criteria satisfactorily.","Implanted Device May Predict Epilepsy Seizures, Study Suggests",story_reviews_00734,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Devices,"['Epilepsy', 'seizures']",http://consumer.healthday.com/Article.asp?AID=676009,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'It seems that some cost estimate could have been projected by the device manufacturer which also funded the study.\nBut given the",HealthDay,"We appreciate how the story placed appropriate caveats up high in the first and second sentences of the story, and followed that with cautious language from both the author (‚ÄúWe just wanted to see if this is feasible‚Ä¶‚Äù) and an independent expert.
¬†",nan,This was not a bad model for how to report on research looking at new devices in small studies. The story provided cautions and some necessary context.,
https://www.healthnewsreview.org/review/are-pricey-computer-aided-mammograms-worth-it/,Are Pricey Computer-Aided Mammograms Worth It?,This story addressed most of our criteria. The ones it missed could have been easily addressed.,Are Pricey Computer-Aided Mammograms Worth It?,story_reviews_00736,4,"['Christine K. Norton, MA']",HealthDay,['mammography'],http://consumer.healthday.com/Article.asp?AID=675407,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story points out that Medicare pays an additional $11 for mammography readings that use CAD. \xa0It would also be useful for re",HealthDay,"This story summarizes the results of a study of 409,000 mammograms done with computer-aided detection (CAD) & without CAD among women aged 67-89.¬† The headline and most of the content of the story point out that CAD may not provide overall value. ¬†Use o",nan,"CAD is used with 75% of mammography readings. ¬†In addition to increasing the cost of a mammogram, its use leads to increased costs due to false positives and over-diagnosis of DCIS. ¬†This over-diagnosis causes many older women to have unnecessary tests ",
https://www.healthnewsreview.org/review/stomach-ct-scans-may-help-find-osteoporosis-study/,Stomach CT scans may help find osteoporosis ‚Äì study,"Good details in reporting on the study, and valuable additional context and perspectives.",Stomach CT scans may help find osteoporosis ‚Äì study,story_reviews_00737,5,"['Gary Schwitzer', 'Karen Carlson, MD']",Osteoporosis,[],http://www.reuters.com/article/2013/04/15/us-health-ctscsn-osteoporosis-idUSBRE93E15G20130415,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explained the cost of DXA tests and CT scans.'}, {'question': 'Does the story adequately quantify the benefits of the tre",Reuters Health,"This story rose above simply rehash-reporting of what the study found and added important perspectives to help readers understand the possibilities but the limitations of looking at CT scans for signs of osteoporosis.
¬†",nan,As new technologies are added to medicine‚Äôs arsenal ‚Äì and existing technologies are applied to new uses ‚Äì it is important that people understand the tradeoffs that may occur as a result:¬† the potential for tradeoffs of some good but some harm.¬† Th,
https://www.healthnewsreview.org/review/therapy-often-as-good-as-surgery-for-knees-study-finds/,"Therapy often as good as surgery for knees, study finds","A solid report that touched on most of our suggested 10 story criteria.¬† Despite the two unsatisfactory scores, the story did a good job capturing the essence and importance of the study.","Therapy often as good as surgery for knees, study finds",story_reviews_00746,4,"['Gary Schwitzer', 'Kevin Lomangino']",Associated Press,"['Knees', 'surgery', 'therapy']",http://vitals.nbcnews.com/_news/2013/03/19/17371367-therapy-often-as-good-as-surgery-for-knees-study-finds?lite,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story included researcher estimates: ‚ÄúSurgery costs about $5,000, compared with $1,000 to $2,000 for a typical course of phys",AP Associated Press,"The story quoted two patients who had different treatment paths.¬† A quote from an editorial writer added a strong perspective.
(Disclosure:¬† The lead author, Dr. Jeffrey Katz, has reviewed stories for us on HealthNewsReview.org.¬† He was not consulted b",nan,"The author of the editorial in the New England Journal of Medicine wrote: ‚Äúmillions of people are being exposed to potential risks associated with a treatment that may or may not offer specific benefit, and the costs are substantial.‚Äù
That‚Äôs why thi",
https://www.healthnewsreview.org/review/folic-acid-in-pregnancy-tied-to-lower-autism-risk/,Folic acid in pregnancy tied to lower autism risk,This story about possible links between folic acid supplements and reduced autism risk tries to include enough caveats to put the study results in the proper perspective. Compared to an ,Folic acid in pregnancy tied to lower autism risk,story_reviews_00749,4,"['Andrew Holtz, MPH', 'Karen Carlson, MD', 'Gary Schwitzer']",Autism,"['folic acid', 'Pregnancy']",www.reuters.com/article/2013/02/12/us-folic-acid-pregnancy-idUSBRE91B1HO20130212,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The story didn‚Äôt discuss costs, but since folic acid supplement pills cost only a few cents each, the omiss",Reuters Health,The body of this story clearly makes the point that these researchers went to great lengths to rule out alternative explanations for the data showing that Norwegian women who took folic acid supplements before or early in pregnancy were less likely to hav,nan,"Stories that may encourage millions of people to change behavior in order to possibly, but not certainly, affect a small risk, should proceed with caution. But since folic acid supplementation is already strongly recommended to reduce the risk a baby may ",
https://www.healthnewsreview.org/review/folic-acid-linked-to-reduced-risk-of-autism-spectrum-disorders/,Folic acid linked to reduced risk of autism spectrum disorders,"Like a Reuters Health story we also reviewed, this story has an enticing headline about an apparent link between folic acid supplements and reduced risk of autism. But it then explains to readers how to put the results in perspective.",Folic acid linked to reduced risk of autism spectrum disorders,story_reviews_00750,4,"['Andrew Holtz, MPH', 'Karen Carlson, MD', 'Gary Schwitzer']",Autism,"['folic acid', 'Pregnancy']","http://www.latimes.com/health/boostershots/la-heb-autism-folic-acid-20130212,0,495631.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 No discussion of costs, but since folic acid supplement pills cost only a few cents each, the omission is not",Los Angeles Times,"This story includes appropriate caution about jumping to conclusions that folic acid can indeed prevent some cases of autism, as well as the size of any potential effect. It does a better job than the Reuters Health story of explaining why a study of wome",nan,"Stories that may encourage millions of people to change behavior in order to possibly, but not certainly, affect a small risk, should proceed with caution. But since folic acid supplementation is already strongly recommended to reduce the risk a baby may ",
https://www.healthnewsreview.org/review/long-awaited-stroke-studies-show-hopeful-new-treatment-no-better-than-older-one/,Long-awaited stroke studies show hopeful new treatment no better than older one,Excellent job on a story that received very little mainstream news media attention.,Long-awaited stroke studies show hopeful new treatment no better than older one,story_reviews_00753,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Stroke,[],http://www.washingtonpost.com/national/health-science/long-awaited-stroke-studies-show-hopeful-new-treatment-no-better-than-older-one/2013/02/08/cf3b90f4-7142-11e2-ac36-3d8d9dcaa2e2_story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Nice job on this.\xa0 The story reported:\n‚ÄúInsurance companies and Medicare, the health insurer for the elderly, already cover t",The Washington Post,"History, context, costs, evidence ‚Äì all were covered in this story.¬† But the reporter also introduces the nagging question of whether ‚Äútrue believer‚Äù physicians will ignore the findings.
¬†",nan,"Embolic stroke can have devastating consequences for the patient and family.¬† Many have assumed that aggressive management, including clot retrieval was important to improving outcomes.¬† The three studies now put this assumption into serious question.¬†",
https://www.healthnewsreview.org/review/drug-is-shown-to-help-pancreatic-cancer-cases/,Drug Is Shown to Help Pancreatic Cancer Cases,A business story that is just as meaningful to patients and their family members as it is to investors.,Drug Is Shown to Help Pancreatic Cancer Cases,story_reviews_00759,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Cancer,['pancreatic cancer'],http://www.nytimes.com/2013/01/23/business/pancreatic-cancer-drug-found-to-extend-life.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story reported that Abraxane ‚Äúwill cost $6,000 to $8,000 a month‚Äù for pancreatic cancer patients. And then placed the cost ",The New York Times,"The only one of our 10 criteria that was not addressed was the potential harms of Abraxane.¬† Other than that, a very complete job of reporting.
¬†",nan,"As the story makes clear, pancreatic cancer ‚Äúis a disease that gave oncology a bad name‚Ä¶a notoriously difficult disease.‚Äù¬† Better treatment options are needed.¬† This story reported on new trial results with a calm, clear, contextual delivery.",
https://www.healthnewsreview.org/review/fda-approves-1st-skin-patch-to-combat-migraines/,FDA Approves 1st Skin Patch to Combat Migraines,"In fewer than 500 words, this story managed to satisfactorily address 7 of our 10 criteria.",FDA Approves 1st Skin Patch to Combat Migraines,story_reviews_00760,4,"['Kevin Lomangino', 'Steven J. Atlas, MD, MPH']",HealthDay,['migraine'],http://consumer.healthday.com/Article.asp?AID=672713,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story says it‚Äôs ‚Äúnot clear‚Äù how much the new patch will cost, which is accurate, but Bloomberg was able to provide a ",HealthDay,"Strong points included the perspective of two independent experts. Weaker points:¬† incomplete discussion of costs, insufficient analysis of the evidence, and some questions bordering on disease-mongering.
¬†",nan,Migraine headaches are a common cause of pain and debility in people who suffer from them. Fortunately there are good medications to treat the range of frequency and severity seen in clinical practice. This new product probably will fill a small but poten,
https://www.healthnewsreview.org/review/the-other-incontinence/,The other incontinence,"It is rare that we see a story include so much in one package:¬† educational background on the condition (fecal incontinence), interviews with 5 sources, some discussion of at least a half dozen treatment options.¬† Our critique includes a few bits of con",The other incontinence,story_reviews_00761,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Philadelphia Inquirer,['fecal incontinence'],http://www.philly.com/philly/health/20130121_The_other_incontinence.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story mentions what Medicare pays for the pacemaker InterStim device and treatment.\nBut no cost estimate was given for Sol",The Philadelphia Inquirer,"In a generally very complete story, we only wish that full costs and known harms of the options discussed had been reported.¬† It would have been pretty easy to include that information.
¬†",nan,"As the story explains, fecal incontinence is a problem that bothers many people and people who have it don‚Äôt like to talk about it.¬† This review of treatment options makes clear that none is perfect.¬†¬† Overall, a well-done story.",
https://www.healthnewsreview.org/review/women-with-a-berry-snacking-habit-may-have-healthier-hearts/,Women With A Berry-Snacking Habit May Have Healthier Hearts,Best story out of the three reviewed on berries and heart attacks. NPR quotes an independent expert who talks about the study‚Äôs limitations ‚Äì something that the ,Women With A Berry-Snacking Habit May Have Healthier Hearts,story_reviews_00762,4,"['Euna Bodner, MS', 'Kathleen Fairfield, MD, DrPH']",Diet studies,"['blueberries', 'strawberries']",http://www.npr.org/blogs/thesalt/2013/01/14/169323332/women-with-a-berry-snacking-habit-may-have-healthier-hearts,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 Costs not mentioned but we think most people know the ballpark cost of berries.'}, {'question': 'Does the sto",NPR,"Even though it was better than the two competitors we also reviewed, the NPR story could have clarified a few points in its online version.
For example, although anthocyanin seems to be the likely component in reducing the risk for heart attacks, research",nan,"Reporting food stories can be difficult, especially when results are not crystal clear. But NPR, to its credit, does seem to have a more balanced view of the study than the other two articles, instead of just touting the benefits of berries.¬† The public ",
https://www.healthnewsreview.org/review/energy-drinks-promise-edge-but-experts-say-proof-is-scant/,"Energy Drinks Promise Edge, but Experts Say Proof Is Scant","We found no glaring problems with the reporting of this valid story, so it gets a top 5-star score.¬† But we question whether the subject matter warranted front-page attention¬†in a 2,000-word article. ","Energy Drinks Promise Edge, but Experts Say Proof Is Scant",story_reviews_00769,5,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",New York Times,['Energy drinks'],http://www.nytimes.com/2013/01/02/health/scant-proof-is-found-to-back-up-claims-by-energy-drinks.html?ref=health&_r=0,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes that energy drinks are expensive compared with other sources of caffeine, such as coffee or caffeine tablets. A 16-",The New York Times,"We‚Äôre not in the habit of criticizing news organizations for devoting too much space to stories that debunk dubious health claims. But¬†with so many important health stories screaming for attention, we think it‚Äôs legitimate to question the Times‚Äôs i",nan,What to cover is arguably as important as how to cover it. There are countless products and treatments that lack¬†strong supporting evidence for health claims.¬†We applaud the Times‚Äôs impulse to look skeptically at one of these categories in substantial,
https://www.healthnewsreview.org/review/new-test-could-help-diagnose-alzheimers-disease-in-live-patients/,New test could help diagnose Alzheimer‚Äôs disease in live patients,"This is one of the finest, most complete health care news stories we‚Äôve reviewed in a long time.¬† The fact that its topic was a sensitive, confusing, controversial one adds to our appreciation of the journalism.",New test could help diagnose Alzheimer‚Äôs disease in live patients,story_reviews_00770,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Alzheimer's,[],http://www.philly.com/philly/health/20121218_New_test_could_help_diagnose_Alzheimer_s_disease_in_live_patients.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story reports, ‚ÄúLack of coverage for the $3,000 test is the biggest barrier.‚Äù'}, {'question': 'Does the story adequately qu",The Philadelphia Inquirer,"Please read our entire review.¬† Top to bottom, beginning to end, this story sparkled with the kind of context, clarity, and completeness rarely seen in health care journalism today.
¬†
¬†",nan,"If you do a search of our past reviews,¬† you‚Äôll find many stories in a littered landscape of good, bad and ugly stories on Alzheimer‚Äôs tests.¬† This story was one of the best.",
https://www.healthnewsreview.org/review/in-girls-last-hope-altered-immune-cells-beat-leukemia/,"In Girl‚Äôs Last Hope, Altered Immune Cells Beat Leukemia",This ,"In Girl‚Äôs Last Hope, Altered Immune Cells Beat Leukemia",story_reviews_00774,4,[],,[],http://www.nytimes.com/2012/12/10/health/a-breakthrough-against-leukemia-using-altered-t-cells.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The study addresses costs nicely,\xa0noting that any commercial treatment resulting from this research will probably be very expens",The New York Times,"The story was peppered with¬†sensational descriptions (‚Äúamazing,‚Äù ‚Äúphenomenal,‚Äù ‚Äúfantastic,‚Äù etc. ) that attest to the¬†electrifying possibilities of the new treatment, which involves infusing patients with a virus that will reprogram¬†their i",nan,"The experimental treatment being reported on here, which recruits the patient‚Äôs own immune system to selectively target cancer cells, represents an interesting new area of research with exciting preliminary results in a few patients with untreatable can",
https://www.healthnewsreview.org/review/bigger-role-seen-for-breast-cancer-drug/,Bigger Role Seen for Breast Cancer Drug,"An excellent story, addressing most major points of extended tamoxifen breast cancer treatment research while incorporating clear, clean writing.¬† Better than the competing ",Bigger Role Seen for Breast Cancer Drug,story_reviews_00778,5,[],,[],http://www.nytimes.com/2012/12/06/health/extended-use-of-breast-cancer-drug-suggested.html?ref=health&_r=0&pagewanted=print,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Clearly stated.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answer",The New York Times,"Also longer than the competing AP and USA Today stories, coming in at more than 1,000 words ‚Äì an increasingly rarer but appreciated treat in journalism these days.
The story makes a good point missing from the USA Today article ‚Äì that many women who a",nan,"Scientific evidence should be the basis of decision-making in breast cancer treatment; good practice can only follow good science, and this study adds to the body of treatment evidence.",
https://www.healthnewsreview.org/review/longer-tamoxifen-use-cuts-breast-cancer-deaths/,Longer tamoxifen use cuts breast cancer deaths,"Solid story, better than the competing ",Longer tamoxifen use cuts breast cancer deaths,story_reviews_00779,5,[],,[],http://www.denverpost.com/fitness/ci_22128646/longer-tamoxifen-use-cuts-breast-cancer-deaths,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Price is a significant issue with such a long-term medication and this story covered the issue well.'}, {'question': 'Does the stor",AP Associated Press,"The USA Today story was actually a bit longer than the Associated Press story, so this was not a matter of word count limitations.¬† In the end, it was a matter of which words were used and how the space was allocated.¬† But the New York Times story was l",nan,"Once initial treatment for breast cancer is finished, there is a sense of loss of direction for many survivors. There are limited ways to reduce recurrence risk and mortality in the hope of a normal life span. ¬†This research adds to the evidence needed t",
https://www.healthnewsreview.org/review/is-a-breath-test-for-colon-cancer-possible/,Is a Breath Test for Colon Cancer Possible?,An¬†informative take on the value of a new breath test for detecting colon cancer. Better than the ,Is a Breath Test for Colon Cancer Possible?,story_reviews_00781,5,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",Cancer,['colon cancer'],http://consumer.healthday.com/Article.asp?AID=671303,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Costs were not mentioned, but since this test is in an early stage of development, it would be difficult to provide an accurate c",HealthDay,This story addressed many of the issues that we like to see covered in discussion of¬†experimental¬†diagnostic tests.¬†It explained that this test is not ready for prime time and probably won‚Äôt be any time soon. It emphasized that the results of a small,nan,"In any story about diagnostic testing or screening, the discussion has to go beyond how many people with the disease were correctly identified. We also need to hear about how many people without the disease were incorrectly identified (i.e. false positive",
https://www.healthnewsreview.org/review/experimental-insomnia-drug-shows-promise/,Experimental Insomnia Drug Shows Promise,This story did a lot of things admirably.¬† The use of independent experts was the most important factor in the story.,Experimental Insomnia Drug Shows Promise,story_reviews_00784,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",HealthDay,['insomnia'],http://consumer.healthday.com/Article.asp?AID=671066,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of costs.\xa0 If the drug has been submitted to the FDA for marketing approval, as the story states, you know tha",Health Day,"We thought the explanation of results was handled awkwardly.¬† But for the most part, this story addressed most of our criteria and deserves a four-star score.
¬†",nan,"When a study author is a paid employee of the drug company reporting on its own drug, it is crucial that independent experts be called on to analyze the evidence.¬† This story did a good job of that.",
https://www.healthnewsreview.org/review/probiotics-benefits-may-be-more-than-a-gut-feeling/,Probiotics‚Äô Benefits May Be More Than a Gut Feeling,An extensive and¬†well-written overview of some of the health claims that are being made about probiotics. A few more specifics would have been helpful.,Probiotics‚Äô Benefits May Be More Than a Gut Feeling,story_reviews_00786,4,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",Supplements,['Probiotics'],http://online.wsj.com/article/SB10001424127887324784404578143402702878118.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story tells us that probiotics sales totaled $770 million last year, but it doesn‚Äôt break\xa0that figure\xa0down as far a",The Wall Street Journal,"The story would have been improved by some¬†effort to quantify the¬†benefits that are attributed to probiotics. We also would like to have¬†seen¬†cost figures attached to some of the products that are mentioned. Overall, though, we were impressed by the s",nan,"Probiotics are clearly helpful for preventing and treating some forms of diarrhea.¬†However, that doesn‚Äôt mean that they will prove to be helpful in the many other areas that marketers are touting benefits. Articles like this one can help consumers diff",
https://www.healthnewsreview.org/review/meditation-might-cut-risk-of-heart-attack-stroke-in-blacks/,"Meditation Might Cut Risk of Heart Attack, Stroke in Blacks","Thanks largely to the inclusion of an independent perspective, this HealthDay piece was much stronger than its counterpart from ","Meditation Might Cut Risk of Heart Attack, Stroke in Blacks",story_reviews_00789,4,"['Kevin Lomangino', 'Harold J. DeMonaco, MS']",HealthDay,['meditation'],http://consumer.healthday.com/Article.asp?AID=670657,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'According to the story, ‚ÄúAn initial 10-hour course runs about $1,500 when taught by nonprofit groups, and there is continued life",Health Day,"Though neither story¬†picked up on the troubled history of this study (addressed here and here and in our¬†review of the competing story from from TIME), HealthDay at least featured a reality check on the evidence high up in the story.¬†Citing an independ",nan,"For the second time in as many weeks, an NIH-funded study of an alternative medical treatment has been published under murky circumstances.¬†For reasons that aren‚Äôt entirely clear, the two studies have received¬†markedly different receptions¬†in the med",
https://www.healthnewsreview.org/review/doctors-debate-value-of-fringe-heart-treatment/,Doctors debate value of ‚Äòfringe‚Äô heart treatment,AP‚Äôs story included a few good details that were missing from the competing ,Doctors debate value of ‚Äòfringe‚Äô heart treatment,story_reviews_00796,5,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH', 'Gary Schwitzer']",Associated Press,[],http://www.denverpost.com/fitness/ci_21928391/doctors-debate-value-fringe-heart-treatment,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'According to the story: ‚ÄúTreatments cost $90 to $150 apiece, usually are done weekly for 30 weeks and then less often, and are no",Associated Press,"This AP story gave us many of the same reasons that USA Today cited for not trusting the results of this study. But there were a few more enlightening touches, including the fact that a number of the study investigators were convicted felons, and that dro",nan,"This is good reporting on marginal research on a complementary/alternative medicine approach that is funded by the NIH.¬† Journalists need to ensure that they are as critical of mainstream research findings, particularly when presented at research confere",
https://www.healthnewsreview.org/review/researchers-raise-concerns-over-chelation-heart-study/,Researchers raise concerns over chelation heart study,This story reports on a troubled NIH-funded study of chelation therapy.¬† The cited experts are extremely strong in their statements that this not be adopted into clinical practice. The ,Researchers raise concerns over chelation heart study,story_reviews_00797,5,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH', 'Gary Schwitzer']",Diabetes,['chelation therapy'],http://www.usatoday.com/story/news/nation/2012/11/04/chelation-therapy-heart-disease/1678251/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says that chelation therapy costs about $5000 out of pocket.'}, {'question': 'Does the story adequately quantify the bene",USA Today,There‚Äôs no question that this story looked thoroughly at the evidence being presented. The story makes many legitimate points about limitations in the study and why it should be interpreted very cautiously. Even if some may feel that the story skirts th,nan,"While¬†we applaud the aggressiveness with which some stories like this one punched holes in this study, we pause to point out that many of the complaints being made here¬†‚Äî marginal benefit, lots of dropouts, possibly biased investigators, etc., etc. ‚Ä",
https://www.healthnewsreview.org/review/the-berry-essence-of-fat-burning/,The Berry Essence of Fat Burning?,"Maintaining¬†an objective tone, this WSJ piece managed to communicate the¬†silliness of¬†claims being made about raspberry ketone supplements.",The Berry Essence of Fat Burning?,story_reviews_00799,5,"['Kevin Lomangino', 'Gary Schwitzer']",Diet studies,"['raspberries', 'weight loss']",http://online.wsj.com/article/SB10001424052970204840504578084811010354082.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story gives pricing information for some of the supplements mentioned ‚Äî $3.79 for a month‚Äôs supply of one ketone\xa0capsule",The Wall Street Journal,"Turning to three different experts in the areas¬†of weight loss counseling, natural remedies, and obesity research, this story brought home the point that there is virtually no evidence to support the use of raspberry ketones for weight loss. Even the hyp",nan,"Despite an almost total lack of supporting evidence, raspberry ketones have somehow emerged as the hot new weight loss supplement. It‚Äôs a testament to the¬†influence of hucksters like Dr. Oz, who has shamelessly plugged the supplements as a ‚Äúmiracle f",
https://www.healthnewsreview.org/review/study-multivitamins-may-lower-cancer-risk-in-men/,Study: Multivitamins may lower cancer risk in men,"Details matter, and this AP story provided more of them than the ",Study: Multivitamins may lower cancer risk in men,story_reviews_00803,5,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",Associated Press,"[""men's health"", 'multivitamins']",http://www.usatoday.com/story/news/nation/2012/10/17/multivitamins-cancer-risk-men/1638929/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 Most people know that multivitamins are inexpensive.'}, {'question': 'Does the story adequately quantify the ",Associated Press,"In lots of little ways, this AP piece exemplifies the difference between very good and outstanding health reporting. Compared with the solid effort from Reuters, the AP‚Äôs take was just a little more thorough in its evaluation of the evidence and its imp",nan,"Current¬†evidence is unclear as to whether¬†vitamin supplements help prevent chronic diseases,¬†and they‚Äôve been shown to cause harm in some cases. That‚Äôs why, with the exception of people suffering from a vitamin deficiency, most of us are advised to",
https://www.healthnewsreview.org/review/daily-multivitamin-shown-to-help-ward-off-cancer-in-men/,Daily multivitamin shown to help ward off cancer in men,"A solid effort, but readers of this Reuters piece may not appreciate just how small the benefits in this study were. The ",Daily multivitamin shown to help ward off cancer in men,story_reviews_00804,4,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",Cancer,"[""men's health"", 'multivitamins']",http://www.reuters.com/article/2012/10/17/us-cancer-vitamins-idUSBRE89G11U20121017,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable. The story didn‚Äôt mention costs, but most people know that a daily multivitamin isn‚Äôt very expensive.'}, {'que",Reuters Health,"This story did a good job of delivering the right take-home messages about¬†this study: Basically, that the research should be considered trustworthy, but that the benefits¬†seen were so small as to raise doubts about their importance. The story could hav",nan,"Current evidence is unclear as to whether vitamin supplements help prevent chronic diseases, and they‚Äôve been shown to cause harm in some cases. That‚Äôs why, with the exception of people suffering from a vitamin deficiency, most of us¬†are advised¬†to ",
https://www.healthnewsreview.org/review/cervical-cancer-vaccine-in-early-stages/,Cervical cancer vaccine in early stages,This story outperformed the competing coverage by the ,Cervical cancer vaccine in early stages,story_reviews_00808,4,"['Mandy Stahre, PhD', 'Karen Carlson, MD']",Cancer,"['Cervical cancer', 'HPV']",http://thechart.blogs.cnn.com/2012/10/10/cervical-cancer-vaccine-in-early-stages/?hpt=he_c2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Not applicable; too early in development process to discuss costs.'}, {'question': 'Does the story adequately quantify the bene",CNN,"In either case, we question the newsworthiness of a Phase I study in 18 women. At least the Philadelphia story had the local angle.¬† Are we going to start reporting on all Phase i lab results with samples sizes this small?
¬†",nan,"We usually think of vaccines to prevent diseases, not treat them. That‚Äôs the premise behind existing cervical cancer vaccines, which prevent infection with HPV strains known to cause cancer. It‚Äôs interesting to hear that a vaccine that¬†might treat¬†e",
https://www.healthnewsreview.org/review/tomato-helps-cut-the-risk-of-a-stroke-study-shows/,"Tomato Helps Cut the Risk of a Stroke, Study Shows","The score may not show it, but this WSJ report was the weakest of the three competing stories on the same study. ","Tomato Helps Cut the Risk of a Stroke, Study Shows",story_reviews_00811,4,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",health food claims,['Tomatoes'],http://online.wsj.com/article/SB10000872396390444897304578044680394134430.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of tomatoes, or other sources of lycopene, is not in question.'}, {'question': 'Does the story adequately quantify the b",The Wall Street Journal,"This story went into pretty fine detail on the best food sources of lycopene, an effort that would have been better directed toward critical evaluation of the study methods and findings. Although it did manage to provide readers with the absolute risks se",nan,For years we‚Äôve been hearing about the benefits of this or that ‚Äúsuperfood‚Äù with the most antioxidants. But the reality is that there‚Äôs no strong evidence to support the health benefits of any particular fruit or vegetable over any other. All frui,
https://www.healthnewsreview.org/review/tomatoes-may-help-reduce-stroke-risk/,Tomatoes may help reduce stroke risk,This otherwise well-reported story fell into some of the obvious traps we¬†implore journalists to avoid. It still managed to best the competing coverage from the ,Tomatoes may help reduce stroke risk,story_reviews_00812,4,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",CNN,['Tomatoes'],http://thechart.blogs.cnn.com/2012/10/08/tomatoes-may-put-the-brakes-on-stroke/?hpt=he_c2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of tomatoes, or other food sources of lycopene, is not in question.'}, {'question': 'Does the story adequately quantify ",CNN,"This story about lycopene for the prevention of¬†stroke¬†had two glaring problems: It provided relative instead of absolute risk numbers, and had a headline that was more forceful than the underlying evidence can support.
But the rest of the story had a w",nan,For years we‚Äôve been hearing about the benefits of¬†this or that ‚Äúsuperfood‚Äù with the most antioxidants. But the reality is that there‚Äôs no strong evidence to support the health benefits of any particular fruit or vegetable over any other. All fru,
https://www.healthnewsreview.org/review/tomatoes-may-lower-your-risk-for-stroke/,Tomatoes May Lower Your Risk for Stroke,This WebMD story made¬†a key point that the competing ,Tomatoes May Lower Your Risk for Stroke,story_reviews_00813,4,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",health food claims,['Tomatoes'],http://www.webmd.com/stroke/news/20121008/tomatoes-may-lower-your-risk-stroke,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of tomatoes, or other sources of lycopene, is not in question.'}, {'question': 'Does the story adequately quantify the b",WebMD,There was enough effort here to earn a 5-star score: plenty of original reporting and critical evaluation of the study. The deficiencies have to do with how the results were reported‚Äìlanguage that wasn‚Äôt quite careful or detailed enough to¬†convey the,nan,For years we‚Äôve been hearing about the benefits of this or that ‚Äúsuperfood‚Äù with the most antioxidants. But the reality is that there‚Äôs no strong evidence to support the health benefits of any particular fruit or vegetable over any other. All frui,
https://www.healthnewsreview.org/review/a-new-course-for-concussions/,A new course for concussions,An important story on an important topic ‚Äì kids and concussions.,A new course for concussions,story_reviews_00814,4,['Gary Schwitzer'],Philadelphia Inquirer,['Concussion'],http://www.philly.com/philly/health/20121009_A_new_course_for_concussions.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'As one of the experts in the story points out, ‚Äúthe treatment needs to be individualized.‚Äù\xa0 All therapies have costs.\xa",The Philadelphia Inquirer,"This engaging article highlights the serious problem of concussions in children and how to treat them. The issue is presented from a mother‚Äôs point of view, with input from the treating physician and other experts. The symptoms, treatment, and outcome a",nan,"Concussions are a very common injury in children, and are most likely underreported. Though sports-related concussions get most of the attention (and they occur in all sports), any activity that can shake the brain can cause concussion. There are clear gu",
https://www.healthnewsreview.org/review/alzheimer-drug-shows-some-promise-in-mild-disease/,Alzheimer drug shows some promise in mild disease,Readers of this AP report are more likely than those who see only the ,Alzheimer drug shows some promise in mild disease,story_reviews_00815,5,"['Andrew Holtz, MPH', 'Harold J. DeMonaco, MS']",Alzheimer's,['dementia'],http://www.denverpost.com/fitness/ci_21725322/alzheimer-drug-shows-some-promise-mild-disease,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Even though it is too early in the research process to have a firm price, the story notes that that this sort of drug is likely to ",Associated Press,"Starting with a lead sentence that describes the potential effect of this experimental drug for Alzheimer‚Äôs disease as modest, to a basic description of the measurement scale used by the researchers that makes clear that the differences were probably to",nan,"Alzheimer‚Äôs disease is a debilitating and devastating disease for patients, families and for society in general.¬† No adequate treatment exist to either stem the progressive decline in memory and cognitive function or to treat the symptoms.¬† Reporting ",
https://www.healthnewsreview.org/review/alzheimers-drug-slows-memory-decline/,Alzheimer‚Äôs Drug Slows Memory Decline,"This WebMD report on the results of experiments with a drug to treat Alzheimer‚Äôs disease covers the basics, but readers are likely to perceive a bigger research advance than those who see ",Alzheimer‚Äôs Drug Slows Memory Decline,story_reviews_00816,4,"['Andrew Holtz, MPH', 'Harold J. DeMonaco, MS']",Alzheimer's,['dementia'],http://www.webmd.com/alzheimers/news/20121008/alzheimers-drug-slows-memory-decline,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Though it is too early to have a firm price, the story notes that similar drugs can cost hundreds of dollars per month. This price ",WebMD,"This story meets almost all of our criteria. However, the AP story we also reviewed does a better job overall of describing the research results. That said, the WebMD story included a clear disclaimer about the preliminary nature of medical meeting announ",nan,"Alzheimer‚Äôs disease is a debilitating and devastating disease for patients, families and for society in general.¬† No adequate treatment exists to either stem the progressive decline in memory and cognitive function or to treat the symptoms.¬† Reporting",
https://www.healthnewsreview.org/review/drug-shows-promise-in-treating-a-type-of-muscular-dystrophy-in-boys/,Drug Shows Promise in Treating a Type of Muscular Dystrophy in Boys,A reasonably well written report on an early trial of a promising drug with just enough provisos to put the study into perspective.¬† We would have liked to have seen some additional information about potential harms (available in the company‚Äôs press re,Drug Shows Promise in Treating a Type of Muscular Dystrophy in Boys,story_reviews_00817,4,['Gary Schwitzer'],New York Times,['muscular dystrophy'],http://www.nytimes.com/2012/10/04/business/drug-shows-promise-in-treating-type-of-muscular-dystrophy.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable. The drug is in early stages of development and as such, identifying the potential cost is premature'}, {'question",The New York Times,"The approach to Duchenne muscular dystrophy described in the story is new and offers a potential approach to a host of genetic disorders.
Because the science is new and has not been studied in great detail, there are no guarantees that the approach will w",nan,Reporting of clinical trial results should always be balanced and in context.¬† This is even more important when reporting about possible treatments for devastating diseases like Duchenne muscular dystrophy.,
https://www.healthnewsreview.org/review/benefits-seen-in-hormone-use-early-in-menopause/,Benefits Seen In Hormone Use Early In Menopause,The AP story did a much better job than ,Benefits Seen In Hormone Use Early In Menopause,story_reviews_00818,4,"['Euna Bodner, MS', 'Karen Carlson, MD']",Associated Press,['menopause'],http://www.huffingtonpost.com/2012/10/03/benefits-seen-in-hormone-_0_n_1935931.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the article details the manufacturers of the low-dose estrogen pills and low-dose estrogen skin patches, it does not g",Associated Press,"A new trial called the Kronos Early Estrogen Prevention Study (KEEPS) contradicts findings from the well-known Women‚Äôs Health Initiative (WHI). Despite the new study‚Äôs limitations of being ‚Äútoo small and too short,‚Äù it still is fresh research that",nan,"Hormone therapy was a popular way to combat menopausal symptoms for decades. But when the WHI suggested that estrogen and progesterone treatments may increase risks for heart attacks and strokes, prescriptions for these hormones fell. The WHI established ",
https://www.healthnewsreview.org/review/study-placebo-or-not-acupuncture-helps-with-pain/,"Study: Placebo or not, acupuncture helps with pain",AP tops ,"Study: Placebo or not, acupuncture helps with pain",story_reviews_00825,5,"['Kevin Lomangino', 'Harold J. DeMonaco, MS']",Associated Press,['acupuncture'],http://www.usatoday.com/news/story/2012/09/10/study-placebo-or-not-acupuncture-helps-with-pain/57735412/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes that sessions cost $60 to $100 and are covered by some private insurance, but not Medicare.'}, {'question': 'Does t",Associated Press,"In contrast with the¬†competing Reuters coverage, this AP story¬†explained how the study‚Äôs methodology differed from that of previous studies, and why the conclusions are likely to be stronger. It also featured comments from experts not involved with st",nan,"The results of many previous studies suggest that acupuncture is as¬†at least as effective,¬†and possibly more effective,¬†than other¬†treatments that are commonly used for chronic pain. However,¬†before it can wholeheartedly endorse a new treatment, the ",
https://www.healthnewsreview.org/review/circumcision-pluses-outweigh-risks-pediatricians/,Circumcision pluses outweigh risks: Pediatricians,"Even if the American Academy of Pediatrics didn‚Äôt quantify benefits and harms in its statement, we still wish news stories about the statement would.",Circumcision pluses outweigh risks: Pediatricians,story_reviews_00829,4,"['Mandy Stahre, PhD', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",Associated Press,['circumcision'],http://www.denverpost.com/fitness/ci_21407043/circumcision-pluses-outweigh-risks-pediatricians,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Cost estimates from CDC are given.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/p",Associated Press,"Still, this was a reasonable report on the AAP policy statement, emphasizing the role of parents‚Äô shared decision-making on this issue up high in the second sentence.
¬†",nan,Parents still have to make decisions and news stories could help them by providing the best evidence on how large is the scope of potential benefit and how large is the scope of potential harm ‚Äì actual numbers.,
https://www.healthnewsreview.org/review/pediatricians-decide-boys-are-better-off-circumcised-than-not/,Pediatricians Decide Boys Are Better Off Circumcised Than Not,A reasonable report on a new policy statement by the American Academy of Pediatrics.,Pediatricians Decide Boys Are Better Off Circumcised Than Not,story_reviews_00830,4,"['Mandy Stahre, PhD', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",NPR,['circumcision'],http://www.npr.org/blogs/health/2012/08/27/159955340/pediatricians-decide-boys-are-better-off-circumcised-than-not,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost was mentioned as a barrier for some people but no actual cost estimates were given in the story.\xa0 AP‚Äôs story gave a C",NPR,"This story adequately addressed most of our criteria; exceptions were actual costs and better discussion of potential harms.
¬†",nan,"Circumcision has been on the decline in the country although the American Academy of Pediatrics‚Äô examination of the evidence suggests that long-term health benefits from this procedure may outweigh risks associated with circumcision, a stance they have ",
https://www.healthnewsreview.org/review/walnuts-may-improve-sperm-quality-in-healthy-men/,Walnuts May Improve Sperm Quality in Healthy Men,"Not unlike walnuts themselves, medical studies often come with a protective shell of claims that make their actual findings difficult to interpret. This story wasn‚Äôt quite strong enough to crack things open for readers.",Walnuts May Improve Sperm Quality in Healthy Men,story_reviews_00831,4,"['Kevin Lomangino', 'Gary Schwitzer']",health food claims,"['fertility', 'walnuts']",http://www.webmd.com/infertility-and-reproduction/news/20120815/walnuts-may-improve-sperm-quality-healthy-men,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Costs aren‚Äôt mentioned, but the price of walnuts\xa0isn‚Äôt\xa0a major concern.'}, {'question': 'Does the story adequately quan",WebMD,"The story didn‚Äôt hype the findings excessively,¬†and it did a reasonable job of communicating the results as interpreted by the researchers. But it needed to ask a few more pointed questions to make the results meaningful for readers. Specifically:
¬†",nan,"As the story points out, male reproductive issues contribute to fertility problems in many couples. Dietary changes ‚Äì if proven effective ‚Äì would be a convenient and inexpensive way to address these issues.",
https://www.healthnewsreview.org/review/can-daily-aspirin-help-ward-off-cancer/,Can daily aspirin help ward off cancer?,We appreciate the clear caveats about limitations starting in the second sentence of the story and continuing throughout ‚Äì even discussing ‚Äúdetection bias.‚Äù,Can daily aspirin help ward off cancer?,story_reviews_00832,5,"['Gary Schwitzer', 'Kathleen Fairfield, MD, DrPH']",Cancer,['aspirin'],http://www.reuters.com/article/2012/08/10/us-aspirin-cancer-idUSBRE87914Z20120810,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of aspirin is not in question.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/pr",Reuters Health,"The story was clear about what the new study suggests but what the limitations of the evidence are.¬† As a result, readers get a clear message ‚Äì clearer than in the competing WebMD story.
¬†",nan,We can begin to do a better job of educating news consumers about the quality of evidence ‚Äì what studies show and what they may not show.¬† This story does a good job of making the distinctions clear.,
https://www.healthnewsreview.org/review/daily-aspirin-may-reduce-risk-of-cancer-death/,Daily Aspirin May Reduce Risk of Cancer Death,The story‚Äôs language swings back and forth in a confusing way over whether this is an association or a cause and effect finding.¬† ,Daily Aspirin May Reduce Risk of Cancer Death,story_reviews_00833,4,"['Gary Schwitzer', 'Kathleen Fairfield, MD, DrPH']",Cancer,['aspirin'],http://www.webmd.com/cancer/news/20120812/aspirin-may-cut-risk-of-cancer-death,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of aspirin is not in question.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/pr",WebMD,"As strongly suggestive as a large, long-term observational study may be ‚Äì and as important as the research may be as a piece of the puzzle of answering research questions ‚Äì such a study cannot establish cause and effect.¬† So news stories that use cau",nan,"It matters because we need to start educating the public that not all studies are equal. Also, people are exhausted by (and suspicious of) the constant stream of information about what will make them healthier and thinner, only to find out later that the ",
https://www.healthnewsreview.org/review/u-m-oversees-cutting-edge-trial-that-offers-hope-in-fight-against-lou-gehrigs-disease/,U-M oversees cutting-edge trial that offers hope in fight against Lou Gehrig‚Äôs disease,A beautifully written two-part report for which we offer only a few thoughts of constructive criticism.,U-M oversees cutting-edge trial that offers hope in fight against Lou Gehrig‚Äôs disease,story_reviews_00834,5,"['William Heisel', 'Steven J. Atlas, MD, MPH', 'Gary Schwitzer']",Detroit Free Press,"['ALS', ""Lou Gehrig's disease""]",http://www.freep.com/apps/pbcs.dll/article?AID=2012308050233,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does talk about the cost of the trial.\xa0 It says, ‚ÄúThe company has shelled out about $2.5 million for the first phase",Detroit Free Press,"Some excellent reporting and writing is demonstrated in this piece. The patient stories are beautifully drawn, and the science, for the most part, is well explained. It provides a range of viewpoints on the treatments, gives cost information for the trial",nan,Our main constructive criticism is that the story repeatedly talks about how the stem cell technique ‚Äúmay provide hope‚Äù for ALS sufferers. Should such stories emphasize a frame of hope?¬† Or simply report on the evidence and let readers decide how muc,
https://www.healthnewsreview.org/review/magnetic-stimulation-helps-some-people-with-treatment-resistant-depression/,Magnetic stimulation helps some people with treatment-resistant depression,This was a very thorough assessment of a new technology for treating patients whose depression does not respond to medication. Balanced story that addressed many key issues.,Magnetic stimulation helps some people with treatment-resistant depression,story_reviews_00835,5,['Kevin Lomangino'],Washington Post,['depression'],http://www.washingtonpost.com/national/health-science/magnetic-stimulation-helps-some-people-with-treatment-resistant-depression/2012/08/03/66922da8-d672-11e1-b2d5-2419d227d8b0_print.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The costs of rTMS, and the market forces that work to encourage or restrain use of this technology, are well described.'}, {'questi",The Washington Post,"This Kaiser Health News story published in the Washington Post delivered the core of what we expect from any article about a new treatment approach ‚Äî a balanced, evidence-based look at how well the treatment works, with appropriate attention to costs an",nan,"Although¬†repetitive transcranial magnetic neurostimulation (rTMS)¬†is approved by the FDA, evidence suggests that it offers modest clinical benefit for patients with depression. It is also much more expensive and arguably less effective than existing tre",
https://www.healthnewsreview.org/review/hormone-boosts-mental-function-in-small-study/,Hormone boosts mental function in small study,Better than the competing ,Hormone boosts mental function in small study,story_reviews_00836,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",mental health,"['GHRH', 'hormone-releasing hormone']",http://in.reuters.com/article/2012/08/06/us-hormone-mental-function-idINBRE8751BD20120806,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Not only did the story estimate cost ‚Äì $700 for a single shot ‚Äì but it put it up high in the 5th paragraph along with caveats a",Reuters Health,"A good example of how to report on potentially promising new interventions while curbing enthusiasm with context and clearly-stated limitations.
¬†",nan,Earlier studies have suggested that GHRH and IGF-1 play important roles in the cognitive decline associated with normal aging and in patients with Alzheimer‚Äôs disease.¬† Recent studies in otherwise healthy older adults have suggested that supplementatio,
https://www.healthnewsreview.org/review/study-psa-testing-cuts-worst-prostate-cancers/,Study: PSA Testing Cuts Worst Prostate Cancers,Better than ,Study: PSA Testing Cuts Worst Prostate Cancers,story_reviews_00838,4,"['William Heisel', 'Gary Schwitzer']",Cancer,['prostate cancer'],http://www.webmd.com/prostate-cancer/news/20120730/study-psa-testing-cuts-worst-prostate-cancers,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no cost information in the story, and this is a big gap seen in other stories that covered the topic ‚Äì in TIME.com a",WebMD,"The story made an important attempt to evaluate the quality of the evidence, explaining that ‚Äústudies looking back at cancer trends in a population are very unreliable when it comes to showing what caused those trends.‚Äù This doesn‚Äôt make up for some",nan,"This story says that the new study ‚Äúseems to make a powerful argument in favor of PSA testing‚Äù. It‚Äôs true that retrospective studies can be powerful tools for understanding health trends, but they are not created equal. This study raises more questi",
https://www.healthnewsreview.org/review/abandoning-psa-screening-could-cost-lives-study/,Abandoning PSA Screening Could Cost Lives: Study,We‚Äôre told that researchers constructed a model ‚Äì but there is no critical evaluation of that model.,Abandoning PSA Screening Could Cost Lives: Study,story_reviews_00839,4,"['William Heisel', 'Gary Schwitzer']",Cancer,['prostate cancer'],http://health.usnews.com/health-news/news/articles/2012/07/30/abandoning-psa-screening-could-cost-lives-study,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We reviewed three stories that covered this new retrospective study on PSA screening. None of them discussed the costs involved",Health Day,"HealthDay‚Äôs story didn‚Äôt make an attempt to critically evaluate the statistical modeling study as WebMD and TIME.com did.¬† This is a critical flaw in such a story.
¬†",nan,PSA screenings are one of the most talked about and written about facets of cancer care. Readers ‚Äì especially men in 40 and older ‚Äì can be easily confused by what seem to be conflicting studies about the benefits and harms of PSA tests. After reading ,
https://www.healthnewsreview.org/review/immune-disorder-drug-shows-promise-for-alzheimers-2/,Immune-Disorder Drug Shows Promise for Alzheimer‚Äôs,"There were many strong elements in this story:¬† cautious language early and often, strong input from independent experts, and concerns stated about off-label use.¬† Nice job.",Immune-Disorder Drug Shows Promise for Alzheimer‚Äôs,story_reviews_00841,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Alzheimer's,[],http://online.wsj.com/article/SB10001424052702303754904577532833079592486.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explained that the cost can be more than $50K/year.'}, {'question': 'Does the story adequately quantify the benefits of t",The Wall Street Journal,"The constructive criticism we raise below is relatively minor in the overall assessment of this well done story.
¬†",nan,"Immunoglobulin infusions have been used to treat a variety of presumed immunologic conditions.¬† So it is not surprising that attempts have been made to treat neurologic conditions such as Guillain-Barre syndrome, multiple sclerosis and Alzheimer‚Äôs Dise",
https://www.healthnewsreview.org/review/nutrient-drink-might-boost-memory-in-early-alzheimers-study/,Nutrient Drink Might Boost Memory in Early Alzheimer‚Äôs: Study,"Despite some cautious caveats, the story leaves readers‚Äô heads spinning:¬† Is this a product that ‚Äúmight boost memory‚Äù or is it too ‚Äúdifficult to make a clear cut statement about the value of the product‚Äù?¬† The story says both. It also leaves u",Nutrient Drink Might Boost Memory in Early Alzheimer‚Äôs: Study,story_reviews_00844,4,"['Gary Schwitzer', 'Kathleen Fairfield, MD, DrPH']",Alzheimer's,[],http://consumer.healthday.com/Article.asp?AID=666520,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states ‚ÄúThere are no plans to market Souvenaid, so the cost hasn‚Äôt been established.‚Äù'}, {'question': 'Does the sto",Health Day,"This was a story about an industry-funded study with many of the quotes coming from an inventor from an institution that holds the patent on the product.
The quotes from the VP of medical and scientific affairs at the Alzheimer‚Äôs Association were import",nan,It‚Äôs Alzheimer‚Äôs Disease ‚Äì that‚Äôs why it matters.¬† And when you put ‚Äúdrink might boost memory‚Äù in the headline and let the inventor say existiing data now suggests that it may be possible to receive something that will sustain cognition‚Äù ‚Ä,
https://www.healthnewsreview.org/review/a-new-treatments-tantalizing-promise-brings-heartbreaking-ups-and-downs/,A New Treatment‚Äôs Tantalizing Promise Brings Heartbreaking Ups and Downs,"This thoughtful, carefully worded story explains exploratory cancer research with all the caveats intact. (Part of a series.)",A New Treatment‚Äôs Tantalizing Promise Brings Heartbreaking Ups and Downs,story_reviews_00845,5,"['William Heisel', 'Harold J. DeMonaco, MS']",Cancer,['blood cell cancer'],http://www.nytimes.com/2012/07/09/health/new-frontiers-of-cancer-treatment-bring-breathtaking-swings.html?_r=1&ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Even while writing about an experimental treatment being tried in just one patient, this story weaves a discussion of costs through",The New York Times,"This moving story about one son‚Äôs quest to cure his mother‚Äôs cancer manages to explain to readers quite a lot about the broader issue of the limitations of genome sequencing, the difficulty in pinpointing the cause for certain cancers, and, perhaps mo",nan,Genome sequencing and cancer research are two areas that often cause journalists to lose their critical faculties. This story provides a great model for how to write about interesting new research while not creating too much hype ‚Äì or hope ‚Äì about the,
https://www.healthnewsreview.org/review/botox-may-help-multiple-sclerosis-tremors/,Botox may help multiple sclerosis tremors,Satisfactory grades on 9 of our 10 criteria.¬† Nice job.,Botox may help multiple sclerosis tremors,story_reviews_00848,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Reuters Health,"['Botox', 'Multiple sclerosis']",http://www.reuters.com/article/2012/07/03/us-botox-sclerosis-idUSBRE8611AJ20120703,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explains: ‚Äúthe cost could range from $500 to $1,000 Australian dollars, which are roughly equal to U.S. dollars. In the",Reuters Health,"Especially noteworthy were the caveats and discussion of limitations.
¬†",nan,People with MS might understandably leap at any news of progress.¬† This story was strong on evidence and caution and appropriately low key on excitement.,
https://www.healthnewsreview.org/review/newer-second-line-diabetes-drug-may-outperform-older-meds/,Newer ‚ÄòSecond-Line‚Äô Diabetes Drug May Outperform Older Meds,This diabetes drug story hits most of the marks but may leave readers wanting more data.,Newer ‚ÄòSecond-Line‚Äô Diabetes Drug May Outperform Older Meds,story_reviews_00850,4,['William Heisel'],Diabetes,"['heart attack', 'stroke']",http://consumer.healthday.com/Article.asp?AID=666147,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We were glad to see the story at least mentioned the cost issues, although we would have preferred some actual dollar figures. It s",HealthDay,"This tightly written comparison of the side effects from a new diabetes drug compared to the most popular drugs on the market answers most of our questions but should have provided more hard numbers to address benefits, harms and costs.
¬†",nan,"Diabetes rates are climbing throughout the world, and effective treatments are needed to address the core problem and to minimize side effects. Because these drugs are for chronic conditions, they can carry a high price tag. To help readers understand whe",
https://www.healthnewsreview.org/review/not-all-calories-equal-study-shows/,"Not All Calories Equal, Study Shows",No caveats or independent perspective in this Wall Street Journal post. The competing ,"Not All Calories Equal, Study Shows",story_reviews_00851,4,"['Kevin Lomangino', 'Harold J. DeMonaco, MS']",Diet studies,['weight loss'],http://online.wsj.com/article/SB10001424052702304458604577490943279845790.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Although diets with more animal protein (e.g. Atkins) are likely to cost more, we don‚Äôt think that‚Äôs a major consideration wi",The Wall Street Journal,"This story laid out the basic facts about a study that compared the metabolic effects of diets containing differing amounts of fat, protein, and carbohydrate. But we think it started off on the wrong foot.¬† The headline is scientifically incorrect.¬† All",nan,"Many people want to lose weight both for health reasons and to look better. However, achieving long-term weight loss is extraordinarily difficult, and consumers receive lots of conflicting advice about what they should be eating to maximize chances for su",
https://www.healthnewsreview.org/review/low-carb-diet-burns-the-most-calories-in-small-study/,Low-carb diet burns the most calories in small study,This story rebounded quickly from an opening sentence flub to provide a more balanced and thorough report than the competing ,Low-carb diet burns the most calories in small study,story_reviews_00852,5,"['Kevin Lomangino', 'Harold J. DeMonaco, MS']",Diet studies,['weight loss'],http://www.usatoday.com/news/health/story/2012-06-27/calories-low-carb-weight-loss/55843134/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of these diets is not really in question. We‚Äôll call it not applicable.'}, {'question': 'Does the story adequately qua",USA Today,"An incorrect opening sentence in the original version of the story (apparently corrected later) was the only significant flaw we found with this story.
¬†",nan,People want to believe that there‚Äôs a diet that will make it easier for them to shed pounds and keep them off over the long term. And this JAMA study does provide some evidence to support the superiority of diets with lower carbohydrate content and more,
https://www.healthnewsreview.org/review/seaweed-supplement-may-aid-weight-loss-study/,Seaweed supplement may aid weight loss: study,"There are so many ways a story about seaweed for weight loss could have been hyped.¬† This story, though, artfully dodged all of those ways, stuck to the evidence, and gave a thorough report. Interesting sidenote:¬† written by an intern.¬† Off to a great ",Seaweed supplement may aid weight loss: study,story_reviews_00854,5,"['Gary Schwitzer', 'Kevin Lomangino']",Diet studies,['weight loss'],http://www.reuters.com/article/2012/06/13/us-seaweed-weightloss-idUSBRE85C1DD20120613,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explained that alginate as an aid to weight loss is already available in pill form, selling for around $45 for a seven-da",Reuters Health,"This was a very complete analysis of an intriguing, but limited, research finding.¬† The story addressed all 10 of our criteria.¬† The strong caveat in the second sentence ‚Äì and others later ‚Äì leaves no doubt in the reader‚Äôs mind.
¬†",nan,It‚Äôs OK to report on preliminary findings when you question the quality of the evidence as clearly as this story did.,
https://www.healthnewsreview.org/review/type-1-diabetes-stem-cell-treatment-shows-promise/,Type 1 Diabetes Stem Cell Treatment Shows Promise,In a short piece ‚Äì fewer than 500 words ‚Äì this story addressed most of our criteria.,Type 1 Diabetes Stem Cell Treatment Shows Promise,story_reviews_00856,4,['Gary Schwitzer'],Diabetes,['stem cells'],http://diabetes.webmd.com/news/20120611/stem-cells-type-1-diabetes,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No estimate was given of the cost of this ‚Äúcocktail treatment.‚Äù'}, {'question': 'Does the story adequately quantify the ben",WebMD,"Caveats appeared up high in the story.¬† Potential harms adequately explained.
But the story may have overstated the benefits of nonmyeloablative stem cell therapy for Type 1 diabetes, because this procedure has only been effective when tried in the first",nan,"We wish some estimate had been given of cost.¬† It can‚Äôt be inexpensive to use the autologous stem cell transplant method used in the study.¬† But the results ‚Äì from this tiny study ‚Äì are interesting, as they reproduce other results from different p",
https://www.healthnewsreview.org/review/study-dark-chocolate-may-lower-heart-disease-and-stroke-risks/,Study: Dark Chocolate May Lower Heart Disease and Stroke Risks,We don‚Äôt see how readers are helped by another story about ‚Äúthe benefits of chocolate‚Äù ‚Äì especially one that jerks readers‚Äô heads back and forth about whether this is terribly flawed research or ‚Äúwonderful news.‚Äù,Study: Dark Chocolate May Lower Heart Disease and Stroke Risks,story_reviews_00860,5,"['Gary Schwitzer', 'Kevin Lomangino']",health food claims,['chocolate'],http://www.webmd.com/heart-disease/news/20120531/will-dark-chocolate-day-keep-doctor-away,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The study included a cost-effectiveness analysis and the story reported on it.\xa0 Unfortunately, it didn‚Äôt offer any critical an",WebMD,We remind journalists and consumers that you should always read our commentary rather than simply glancing at the grade or star score given a story ‚Äì because this is an example of a story that addressed most of our criteria yet ‚Äì in our opinion ‚Äì fa,nan,We fear that this is the kind of story that leaves the American public numb to the kind of research news that they should care about.¬† That‚Äôs why this matters.,
https://www.healthnewsreview.org/review/common-painkillers-may-help-prevent-skin-cancer-study/,Common Painkillers May Help Prevent Skin Cancer: Study,"Four stars but with some notable flaws. This story pumps up the notion that ‚Äúmore NSAID use is better‚Äù for skin cancer prevention, but doesn‚Äôt mention well known harms ‚Äì and ‚Äì except for the final line, inappropriately uses cause-and-effect lang",Common Painkillers May Help Prevent Skin Cancer: Study,story_reviews_00862,4,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH', 'Gary Schwitzer']",Cancer,['NSAIDs'],http://consumer.healthday.com/Article.asp?AID=665168,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of NSAIDs is not in question.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/pro",Health Day,"This is another one of those stories that will leave readers‚Äô heads spinning. In the opening sentence, we learn that takings NSAIDs ‚Äúappears to significantly lower the risk for developing several major forms of skin cancer.‚Äù And throughout the story",nan,"It would be great if we could add skin cancer prevention to the list of benefits associated with regular use of anti-inflammatory pain drugs. These drugs are cheap, widely available, and many people are already taking them for prevention of cardiovascular",
https://www.healthnewsreview.org/review/drastic-method-targets-hard-to-treat-hypertension/,Drastic method targets hard-to-treat hypertension,A good example of how to report on new technologies with caution and balance.,Drastic method targets hard-to-treat hypertension,story_reviews_00863,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Associated Press,['hypertension'],http://www.msnbc.msn.com/id/47590752/ns/health-health_care/#.T8TL6b_D78A,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story noted, ‚ÄúIn Europe, Medtronic‚Äôs hypertension procedure costs about $14,000, sticker shock compared with the generic pr",Associated Press,"The story allows both the enthusiasm and the reservations to be perfectly clear to the reader.¬† Nice job.
¬†",nan,"The story estimates that more than 7 million Americans have hypertension that is resistant to drug therapy.¬† That resistance may be the result of inadequate drug dosing, incorrect drug combination, poor compliance and adherence or underlying physiology.¬",
https://www.healthnewsreview.org/review/long-lasting-birth-control-cuts-pregnancy-rate/,Long-Lasting Birth Control Cuts Pregnancy Rate,"Overall, a good story, but women trying to make decisions would have been helped by a few more comparative details.",Long-Lasting Birth Control Cuts Pregnancy Rate,story_reviews_00864,4,"['Karen Carlson, MD', 'Gary Schwitzer']",Wall Street Journal,['contraceptives'],http://online.wsj.com/article/SB10001424052702304707604577422553757669354.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no discussion of the costs of long-acting methods (IUDs, implants, and long-acting injections) compared to alternative",The Wall Street Journal,"Many currently available birth control methods are effective, but only when they are actually used. A new study shows that methods such as the IUD and hormonal implants, which require no further attention once they are in place, are substantially more eff",nan,"Preventing unwanted pregnancy is a¬†critical health issue, for¬†women,¬†men,¬†and¬†the society at large, with current estimates of 3 million unplanned pregnancies per year in the U.S., of which half result from failure of birth control methods.¬† Women ha",
https://www.healthnewsreview.org/review/chinese-herb-kudzu-may-help-drinkers-cut-down/,Chinese Herb Kudzu May Help Drinkers Cut Down,"A pretty good example of how to handle a small, early study of a new treatment. Benefits nicely quantified, good attention to limitations, and quotes were well calibrated.",Chinese Herb Kudzu May Help Drinkers Cut Down,story_reviews_00866,4,"['Kevin Lomangino', 'Michael Bierer MD, MPH']",health food claims,['Alcohol'],http://www.webmd.com/mental-health/alcohol-abuse/news/20120517/chinese-herb-kudzu-may-help-drinkers-cut-down?page=2&print=true,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The reader is likely to come away confused on this point. The story states that currently available kudzu supplements cost abou",WebMD,"We especially enjoyed the comments of the independent expert quoted in the story, who identified important reasons to be cautious about the study and described himself as ‚Äúhopeful but skeptical‚Äù about the new therapy. This strikes as a good perspectiv",nan,"Excessive alcohol use is associated with many health problems, including liver disease and cancer. It‚Äôs also a major cause of preventable death from violence and motor vehicle accidents. We might be able to reduce this toll by helping those drinking abo",
https://www.healthnewsreview.org/review/prep-free-virtual-colonoscopy-could-be-as-effective-as-scope-procedure/,Prep-free virtual colonoscopy could be as effective as scope procedure,This Boston Globe blog post gave its audience a more thorough understanding of an emerging approach to virtual colonoscopy than the ,Prep-free virtual colonoscopy could be as effective as scope procedure,story_reviews_00869,5,"['William Heisel', 'Gary Schwitzer']",Boston Globe,"['colon cancer', 'colonoscopy']",http://www.boston.com/Boston/dailydose/2012/05/prep-free-virtual-colonoscopy-could-effective-scope-procedure/WgEstvjqpsR3sShkUbOdoI/story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentioned costs and insurance coverage, while the Wall Street Journal story on the same topic mentioned neither. The Glob",The Boston Globe,Look at the way the Boston Globe approached this story compared to the Wall Street Journal. The difference is subtle but important. The Journal focused too narrowly on the idea that patients might be able to avoid cleansing their colons before going in to,nan,"The Globe rightly points out that colonscopy is not the only option for people hoping to catch cancer early. This is crucial for readers to have a clear understanding of screening and prevention options.¬†The Wall Street Journal got the news out first, bu",
https://www.healthnewsreview.org/review/marijuana-may-ease-multiple-sclerosis-symptoms/,Marijuana may ease multiple sclerosis symptoms,"On a subject that is easily sensationalized, this story was measured and analytical in its reporting of a very preliminary study.",Marijuana may ease multiple sclerosis symptoms,story_reviews_00872,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Reuters Health,"['marijuana', 'Multiple sclerosis']",http://www.reuters.com/article/2012/05/14/us-marijuana-sclerosis-idUSBRE84D0RS20120514,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Somebody had to pay for the marijuana used in the study.\xa0 And somebody would have to pay something if it were used therapeut",Reuters Health,"For every claim there was a caution.
And an independent perspective delivered caveats and limitations that were important for reader understanding.
¬†",nan,Additional treatments for MS symptoms are needed and are an important element in the MS Society 2011-2015 strategic response. Stories about treatments for MS symptoms are going to get a lot of attention from patients and families dealing with that diagnos,
https://www.healthnewsreview.org/review/mens-fertility-test-available-for-home/,Men‚Äôs fertility test available for home,An interesting and fairly informative piece about male infertility with a news hook based on a new fertility test.,Men‚Äôs fertility test available for home,story_reviews_00873,5,"['William Heisel', 'Harold J. DeMonaco, MS']",Chicago Tribune,"['home testing', 'infertility']","http://www.chicagotribune.com/health/ct-x-at-home-sperm-test-20120502,0,4880709.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says, ‚ÄúThe test costs about $40; the average cost of a semen analysis in a doctor‚Äôs office is about $100.‚Äù As a com",Chicago Tribune,This is a fairly thorough and thoughtful analysis of the reasons for male infertility and the pros and cons of this particular home fertility test for men. Our one wish was that there was a little more consideration given to the science behind the test it,nan,"The story is bookended by the idea that the burden for addressing fertility issues is born mostly by women. If the statistics in the story are to be believed, men should be taking fertility issues just as seriously. This story provides ample information t",
https://www.healthnewsreview.org/review/mixed-message-on-antidepressant-for-hot-flashes/,Mixed message on antidepressant for hot flashes,Well balanced piece about whether antidepressants are really effective in treating hot flashes in menopausal women.,Mixed message on antidepressant for hot flashes,story_reviews_00875,5,"['Mandy Stahre, PhD', 'Karen Carlson, MD']",Reuters Health,"['antidepressants', 'hot flashes']",http://www.reuters.com/article/2012/04/23/us-mixed-message-antidepressant-idUSBRE83M15020120423,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article does discuss how much Lexapro ‚Äì the antidepressant mentioned in the article ‚Äì costs.'}, {'question': 'Does the stor",Reuters Health,This article presents the results of several studies examining whether antidepressants are effective in reducing hot flashes in menopausal women. ¬†The article avoids overstating the results of these studies and provides information from skeptics that man,nan,"For some women hot flashes can impede on quality of life during menopause. ¬†Since many doctors and women are leery about using hormone replacement therapy to alleviate hot flashes, other drugs are being investigated.",
https://www.healthnewsreview.org/review/preventive-medicines-can-help-migraine-sufferers/,Preventive medicines can help migraine sufferers,This story about new migraine prevention guidelines didn‚Äôt mention the industry conflicts that pervade the writing committee that issued the recommendations.,Preventive medicines can help migraine sufferers,story_reviews_00876,4,"['Kevin Lomangino', 'Harold J. DeMonaco, MS']",USA Today,['migraine'],http://www.usatoday.com/news/health/story/2012-04-20/migraine-guidelines/54489780/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs were not discussed. As the guidelines state, ‚Äúoverall cost is a consideration when prescribing medications; cost may in",USA Today,"However, we were pleased to see that story raised some appropriately skeptical concerns about the potential harms of headache prevention drugs. We also applaud the story‚Äôs inclusion of an unconventional patient anecdote ‚Äî someone who tried multiple me",nan,"In recent years, government panels and medical societies have come under fire for issuing treatment guidelines that favor the drug industry. There has been a call for these groups to recruit more members who do not have industry conflicts and whose recomm",
https://www.healthnewsreview.org/review/surgery-for-migraines-help-or-hokum/,Surgery for migraines: Help or hokum?,"The use of ‚Äúhokum‚Äù in a headline always makes us smile, but despite the fact that the story met many of our criteria, we weren‚Äôt all smiles after reading it.",Surgery for migraines: Help or hokum?,story_reviews_00878,4,"['William Heisel', 'Steven J. Atlas, MD, MPH', 'Gary Schwitzer']",Philadelphia Inquirer,"['Botox', 'migraine', 'surgery']",http://www.philly.com/philly/health/20120421_Surgery_for_migraines__A_big_help_or_hokum_.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does talk about costs and the fact that the procedure is not covered by many insurers. We would like to find any insurer ",The Philadelphia Inquirer,"While, in the end, the story injects some appropriate caution and skepticism, it carries so many unproven assumptions that it is hard to tease them all out. In the first two sentences alone, we are told, unequivocally, that a forehead lift ended a patient",nan,The problem with this story is that it is just that ‚Äì a story. A ‚Äúgood‚Äù (Dr. Guyuron) vs. ‚Äúevil‚Äù (the medical establishment) or an ‚Äúinnovator‚Äù vs. ‚Äúestablishment‚Äù is the tone of this piece. But the evidence is so shaky as to make the new,
https://www.healthnewsreview.org/review/early-study-hints-that-breast-cancer-vaccine-might-work/,Early Study Hints That Breast Cancer Vaccine Might Work,"Key quote found too late in the story: ‚ÄúUntil the vaccine is linked to an actual survival benefit or improvement in tumor status, no one can say if it helps patients in a meaningful way.‚Äù",Early Study Hints That Breast Cancer Vaccine Might Work,story_reviews_00887,4,"['Mandy Stahre, PhD', 'Gary Schwitzer']",Cancer,"['breast cancer', 'vaccines']",http://consumer.healthday.com/Article.asp?AID=663304,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Costs weren‚Äôt discussed, but since this was an early report on an experimental vaccine, that is understandable.'}, {'question':",Health Day,"The current article discussed some very preliminary results of an experimental vaccine for HER-2 breast cancer.
Our key concerns:
A better explanation of what type of response the subjects in the study experienced may have helped to better frame the findi",nan,"There are several breast cancer vaccine trials underway with a significant amount of time and money invested. Before stories start to appear hinting that any of these vaccines ‚Äúmight work,‚Äù more concrete evidence on more meaningful endpoints needs to ",
https://www.healthnewsreview.org/review/bypass-less-risky-than-stent-use-over-long-term/,Bypass Less Risky Than Stent Use Over Long Term,This thoroughly reported and clearly written piece came out on top compared to competing stories by the ,Bypass Less Risky Than Stent Use Over Long Term,story_reviews_00890,5,"['William Heisel', 'Harold J. DeMonaco, MS']",heart disease,['surgery'],http://online.wsj.com/article/SB10001424052702303404704577307684080395176.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Like its counterparts, this story fails to say a word about costs of the two procedures.\xa0 Based on our calculations, the two",The Wall Street Journal,"Readers needed a thoughtful look at what at first glance appeared to be a massive amount of evidence supporting a more invasive approach to heart treatment. This story carefully put the findings in perspective. Unlike competing coverage, the story did not",nan,"Patients with coronary artery disease are faced with important treatment decisions.¬† Whether to rely on medical treatment, coronary artery bypass surgery or coronary angioplasty requires some detailed information about the pluses and minuses of each appr",
https://www.healthnewsreview.org/review/study-sees-lower-death-risk-with-bypass-surgery-versus-angioplasty-for-older-heart-patients/,Study sees lower death risk with bypass surgery versus angioplasty for older heart patients,"Solid reporting, but we thought the ",Study sees lower death risk with bypass surgery versus angioplasty for older heart patients,story_reviews_00891,4,"['William Heisel', 'Harold J. DeMonaco, MS']",Associated Press,['surgery'],http://www.washingtonpost.com/national/health-science/study-sees-lower-death-risk-with-bypass-surgery-versus-angioplasty-for-older-heart-patients/2012/03/27/gIQAhbTDeS_story.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This story, the NPR story and the Wall Street Journal story we reviewed all failed to mention costs.\nThe cost of the two appro",Associated Press,"The story provides a lot of good information and gathered a variety of views from doctors. But the story only hinted at harms and costs, without quantifying these. We‚Äôre not sure that readers got a clear, overall assessment of what to do with this evide",nan,"Patients with coronary artery disease are faced with important treatment decisions.¬† Whether to rely on medical treatment, coronary artery bypass surgery or coronary angioplasty requires some detailed information about the pluses and minuses of each appr",
https://www.healthnewsreview.org/review/bypass-surgery-edges-stents-for-heart-treatment/,Bypass Surgery Edges Stents For Heart Treatment,The story provides some solid information about pros and cons but could have provided more on costs and harms.,Bypass Surgery Edges Stents For Heart Treatment,story_reviews_00892,4,"['William Heisel', 'Harold J. DeMonaco, MS']",heart disease,['surgery'],http://www.npr.org/blogs/health/2012/03/27/149458849/bypass-surgery-edges-stents-for-heart-treatment?ps=sh_sthdl,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This story, along with the Associated Press and Wall Street Journal stories we reviewed, did not include information about cost",NPR,"This clear and concise piece touches on many of our criteria, but only lightly. A competing Wall Street Journal piece explained more fully how this study differs from the gold standard of a clinical trial and how this study in particular could have missed",nan,"When the evidence to support one treatment over another is so marginal, reporters have a duty to full explore all the implications of¬†a more invasive and more costly procedure over the standard treatment. Most coverage of this retrospective, observationa",
https://www.healthnewsreview.org/review/experimental-cholesterol-drug-results-called-game-changing/,Experimental cholesterol drug results called ‚Äògame changing‚Äô,Emphasizing ‚Äúdramatic‚Ä¶breakthrough‚Ä¶and game-changing‚Äù about results of a Phase I clinical trial is troubling.,Experimental cholesterol drug results called ‚Äògame changing‚Äô,story_reviews_00895,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",CNN,['cholesterol'],http://thechart.blogs.cnn.com/2012/03/22/experimental-cholesterol-drug-results-called-game-changing/?hpt=he_c2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story noted that two editorial writers ‚Äúcaution that it will remain unclear how important this\xa0class of drugs will be.",CNN Health,"The story was generally fairly complete.¬† But the cheerleading drowned out the caveats in our view.
¬†",nan,"It strikes us as a silly and empty projection to state in the story‚Äôs 2nd sentence:
If these initial results pan out in larger trials, the drug could prove to be¬†more effective than statins, the widely prescribed drugs which have been very successful i",
https://www.healthnewsreview.org/review/less-invasive-hernia-procedure-easier-on-patients-study/,Less Invasive Hernia Procedure Easier on Patients: Study,Overall this story did enough to meet our expectations for quality health journalism. But we couldn‚Äôt help wishing for a few more salient details on key questions.,Less Invasive Hernia Procedure Easier on Patients: Study,story_reviews_00896,4,"['Kevin Lomangino', 'Steven J. Atlas, MD, MPH', 'Gary Schwitzer']",HealthDay,['surgery'],http://consumer.healthday.com/Article.asp?AID=662912,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We‚Äôll give credit to the story for attempting to compare the relative costs of the two procedures, but we thought the languag",Health Day,"This study could have easily been reported as a clear case of new technology besting the old way of doing things. Thankfully, this story avoided that simplistic narrative by reaching out to an independent expert, who explained that the traditional approac",nan,"Innovation in medicine almost always means higher costs, but sometimes it doesn‚Äôt lead to higher quality or better outcomes. Good studies are needed to confirm the benefits of new approaches compared with the existing standard.
Most surgical studies com",
https://www.healthnewsreview.org/review/study-suggests-overall-benefit-from-antidepressants/,Study suggests overall benefit from antidepressants,We applaud the concise and detailed explanation of the study‚Äôs results and offer just a few suggestions for improvement.,Study suggests overall benefit from antidepressants,story_reviews_00901,4,['Gary Schwitzer'],Depression,['antidepressants'],http://www.reuters.com/article/2012/03/07/us-study-antidepressants-idUSTRE82623V20120307,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The costs of antidepressants weren‚Äôt discussed, but perhaps that is understandable in this kind of broad overview of a meta-ana",Reuters Health,"Reporters usually don‚Äôt write the headlines, but we wish someone would have changed the headline on this story.¬† The body of the story conveyed important questions ‚Äì about the number needed to treat ‚Äì and about differences in treating the elderly ‚",nan,"The story tried to capture why this is important in its opening sentence:
Despite recent debate about how well antidepressants really work in people with only mild or moderate depression, a new analysis of drug studies suggests they may have some benefit ",
https://www.healthnewsreview.org/review/researchers-report-progress-in-cancer-immunotherapy/,Researchers report progress in cancer immunotherapy,"In general, this was a carefully researched and written piece. But we longed for a bit of historical perspective.",Researchers report progress in cancer immunotherapy,story_reviews_00903,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Cancer,"['immunotherapy', 'melanoma']","http://www.latimes.com/health/la-he-cancer-immunotherapy-20120305,0,6643402.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'An early experiment of immunotherapy against melanoma may be too early to allow for a cost estimate.'}, {'question': 'Does the st",Los Angeles Times,"The piece felt top-heavy with words of ‚Äúprogress‚Ä¶more effective‚Ä¶complete remission (in one patient)‚Ä¶hopes,‚Äù etc.
Half-way through came this line: ‚ÄúSeveral independent researchers said the study results were promising. But they also noted that ",nan,"We were urged to review this by breast cancer advocate Jody Schoger, who wrote on Facebook, ‚ÄúThis seems like announcing a new chemo regimen that extends survival by one or two months‚Ä¶. I do appreciate that hope and optimism ‚Äì I always prefer that it",
https://www.healthnewsreview.org/review/can-herbs-fight-asthma/,Can Herbs Fight Asthma?,This was a reasonable story on an intriguing herbal approach to treating asthma. Cautious.¬† Concise,Can Herbs Fight Asthma?,story_reviews_00904,4,"['Gary Schwitzer', 'Kathleen Fairfield, MD, DrPH']",health food claims,['asthma'],http://www.webmd.com/asthma/news/20120305/can-herbs-fight-asthma,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of the cost of kampo, nor of any comparison with current asthma medications.'}, {'question': 'Does the story adeq",WebMD,"The story addressed most of our criteria. The few flaws (cost, availability, novelty) could be fixed easily.
¬†",nan,Another tool to help control asthma would be attractive.¬† This story was appropriately cautious in its evaluation of the research report.,
https://www.healthnewsreview.org/review/robotic-surgeries-costlier-but-safer-study/,Robotic surgeries costlier but safer: study,"This story gets 4 stars for addressing most of our criteria, but missed some of the meat and misgivings of what was readily available in the written words of the researchers‚Äô conclusion and of the editorial accompanying the study.",Robotic surgeries costlier but safer: study,story_reviews_00905,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Reuters Health,['surgery'],http://www.reuters.com/article/2012/03/05/us-robots-surgery-idUSTRE82405320120305,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Much of the focus of the piece was on costs.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test",Reuters Health,"We don‚Äôt think the story conveyed the conclusion of the researchers, nor that of the the editorial writer.
The researchers concluded:
‚ÄúWhile robotic assisted and laparoscopic surgery are associated with fewer deaths, complications, transfusions and sh",nan,"What are the outcomes that readers/patients should really care about?¬† That‚Äôs the question the editorial raised ‚Äì or that many other independent observers would raise about this study.¬† While the story was functional, it could have helped readers be",
https://www.healthnewsreview.org/review/vitamin-a-may-slash-melanoma-risk/,Vitamin A may slash melanoma risk,This ,Vitamin A may slash melanoma risk,story_reviews_00907,4,"['Gary Schwitzer', 'Kevin Lomangino']",Cancer,"['melanoma', 'vitamins']",http://vitals.msnbc.msn.com/_news/2012/03/01/10548491-vitamin-a-may-slash-melanoma-risk,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The cost of Vitamin A is not in question, although the amount we collectively spend on supplements ‚Äî most o",MSNBC,"Using language like this is simply not appropriate nor accurate to describe the findings from an observational study:
‚Äúslash risk‚Äù‚Ä¶‚Äùreduce the risk‚Äù‚Ä¶‚Äùreduced risk was more pronounced in women than in men‚Äù‚Ä¶‚Äùprotective effect‚Äù‚Ä¶‚Äùmel",nan,Stories like this may simply become part of the background noise that overwhelms news consumers in the daily drumbeat of health care news coverage.¬† That‚Äôs why this matters.,
https://www.healthnewsreview.org/review/omega-3-fatty-acids-may-protect-the-aging-brain/,Omega-3 Fatty Acids May Protect the Aging Brain,This was the best of three stories we reviewed about a study of omega-3 fatty acids and the aging brain. The difference: a clear and detailed description of the limitations of observational research.,Omega-3 Fatty Acids May Protect the Aging Brain,story_reviews_00908,4,"['Kevin Lomangino', 'Kathleen Fairfield, MD, DrPH']",health food claims,"['dementia', 'Omega-3']",http://consumer.healthday.com/Article.asp?AID=662183,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of fish is not in question, although a word about the cost of fish oil supplements would not have been inappropriate.'},",Health Day,"This story made the key point that CNN and the Washington Post failed to communicate in their competing coverage: ‚ÄúThis study ‚Ä¶ did not prove that omega-3 fatty acids prevent mental decline, merely that there may be an association between consumption ",nan,"Consumers have only so much capacity to implement behavior changes to improve their health. By critically evaluating the evidence, stories can help consumers focus on the changes that are most likely to be beneficial.
We know that people get easily overwh",
https://www.healthnewsreview.org/review/vitamin-d3-might-ease-menstrual-cramps/,Vitamin D3 Might Ease Menstrual Cramps,"Overall, a serviceable story with a few flaws that could be easily addressed.",Vitamin D3 Might Ease Menstrual Cramps,story_reviews_00911,4,"['Mandy Stahre, PhD', 'Karen Carlson, MD']",HealthDay,['Vitamin D'],http://consumer.healthday.com/Article.asp?AID=662184,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story did explain that ‚ÄúThe cost of vitamin D supplements would be roughly comparable with (NSAIDS or birth control pills).‚Ä",Health Day,"We wished for more on benefits, harms, and on context about the dose used in the study.¬†¬† See our comments on those criteria below.
¬†",nan,"Most women experience some sort of menstrual cramps and only rarely are the instances of these cramps debilitating.¬† This study, done in a sample of women with already low levels of Vitamin D and with a dosage beyond that recommended or available to most",
https://www.healthnewsreview.org/review/experimental-drug-shows-promise-against-type-2-diabetes/,Experimental Drug Shows Promise Against Type 2 Diabetes,It‚Äôs challenging to distill a complicated study into a short space. HealthDay managed to capture much of the essential information of this preliminary clinical trial but missed two of the most important elements: a clear explanation of the benefits and ,Experimental Drug Shows Promise Against Type 2 Diabetes,story_reviews_00912,4,"['William Heisel', 'Gary Schwitzer']",Diabetes,[],http://consumer.healthday.com/Article.asp?AID=662137,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'It‚Äôs too early to discuss costs for this specific drug, although some mention of the costs of competing drugs would have been h",Health Day,"This story explains that the results are preliminary and gives readers the right basic information about the study, but the study‚Äôs findings and its limitations warranted more explanation.
¬†",nan,"As the story notes, we have been down this road before with diabetes drugs. Avandia was promoted as a breakthrough for people with diabetes until 2010 when it was found to cause heart attacks. Because diabetes affects so many people worldwide, it is espec",
https://www.healthnewsreview.org/review/mammograms-can-save-lives-of-women-in-their-40s-study/,Mammograms Can Save Lives of Women in Their 40s: Study,"It‚Äôs interesting to note that many leading news organizations chose not to write about this new study.¬† Did this story do anything to clarify the decision-making process for women in their 40s? Oh, well, better than ",Mammograms Can Save Lives of Women in Their 40s: Study,story_reviews_00915,4,"['Mandy Stahre, PhD', 'Gary Schwitzer']",Cancer,"['breast cancer', 'mammography']",http://consumer.healthday.com/Article.asp?AID=661968,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of costs regarding mammograms. \xa0Stories should not assume that every woman in the 40s who chooses to get a mam",Health Day,"Although the article presents some interesting new findings regarding mammogram for women in their 40s, the article lacks a strong critical analysis to point out the weaknesses with the current study.
¬†",nan,"Since the U.S. Preventive Services Task Force published their revised recommendations in November of 2009, many women between the ages of 40-49 have continued to be confused about what the evidence shows and what they should do.
News organizations that co",
https://www.healthnewsreview.org/review/the-healthy-skeptic-probiotics-could-help-in-cold-and-flu-season/,The Healthy Skeptic: Probiotics could help in cold and flu season,The Healthy Skeptic column does its usual fine job evaluating claims ‚Äì this time about probiotic products.,The Healthy Skeptic: Probiotics could help in cold and flu season,story_reviews_00918,5,"['Gary Schwitzer', 'Kevin Lomangino']",animal research,"['common cold', 'Probiotics']","http://www.latimes.com/health/la-he-skeptic-probiotic-immunity-20120220,0,4314012.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story includes the cost of several of the products mentioned.'}, {'question': 'Does the story adequately quantify the benefits ",Los Angeles Times,"The marketing message of ‚Äúimproving overall immune health‚Äù deserves to be scrutinized whenever and wherever it appears.
¬†",nan,"We‚Äôve reviewed more than a half dozen stories on probiotics in recent years.¬† Hype lives on.¬† So there‚Äôs room for healthy skepticism, as in this LA Times column.",
https://www.healthnewsreview.org/review/patients-own-stem-cells-help-heal-heart-early-research-shows/,"Patient‚Äôs own stem cells help heal heart, early research shows",CNN avoided the easy Valentine‚Äôs Day tie-in for this heart story and gave readers a clear picture of both the study‚Äôs importance and its limitations. Better than ,"Patient‚Äôs own stem cells help heal heart, early research shows",story_reviews_00922,4,"['William Heisel', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",CNN,"['heart attack', 'stem cells']",http://thechart.blogs.cnn.com/2012/02/13/patients-own-stem-cells-help-heal-heart-early-research-shows/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'It‚Äôs too early to have a meaningful discussion of costs.\n\xa0'}, {'question': 'Does the story adequately quantify the benefits",CNN Health,"The story did a better job than a competing WebMD story in covering most of the necessary ground to give readers a realistic assessment of this stem cell study. It described the actual study with an appropriate level of detail. However, it missed two impo",nan,The use of autologous stem cells to repair damaged heart muscle has been studied previously with mixed results.¬† This phase 1 study (designed to determine the safety of the stem cell infusions) was conducted in a small group of patients who had previousl,
https://www.healthnewsreview.org/review/tiny-electrical-shocks-to-the-brain-enhance-memory-study/,Tiny electrical shocks to the brain enhance memory: study,As with the ,Tiny electrical shocks to the brain enhance memory: study,story_reviews_00925,4,"['Andrew Holtz, MPH', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",Alzheimer's,['Epilepsy'],http://www.reuters.com/article/2012/02/08/us-brain-stimulation-idUSTRE8172G320120208,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This line of research is so preliminary that we don‚Äôt think it‚Äôs necessary that stories report specific cost estimates. This st",Reuters Health,"This story does a bit better job than the other one we reviewed of describing electrical brain stimulation treatment as it is used in other types of patients, and pointing out that it is ‚Äúvery invasive.‚Äù Still, it could have been more specific about t",nan,The terrible effects of Alzheimer‚Äôs disease and the lack of effective treatments create desperate desires for new options. Stories that report on this line of research should emphasize the caveats and cautions in order to take into account the power of ,
https://www.healthnewsreview.org/review/electrical-brain-stimulation-may-strengthen-memory-study-says/,"Electrical Brain Stimulation May Strengthen Memory, Study Says",The readers of this story and the other one we reviewed ,"Electrical Brain Stimulation May Strengthen Memory, Study Says",story_reviews_00926,4,"['Andrew Holtz, MPH', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",Alzheimer's,['Epilepsy'],http://consumer.healthday.com/Article.asp?AID=661597,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This line of research is so preliminary that we won‚Äôt criticize a story for omitting cost estimates. However, as the story note",Health Day,This story gives readers a good sense of the tentative nature of this research. It points out that the results seen in patients with epilepsy might not be replicated in those with Alzheimer‚Äôs disease. But the story should have done more to point out the,nan,The terrible effects of Alzheimer‚Äôs disease and the lack of effective treatments create desperate desires for new options. Stories that report on this line of research should emphasize the caveats and cautions in order to take into account the power of ,
https://www.healthnewsreview.org/review/study-clouds-evidence-on-soy-and-menopause/,Study clouds evidence on soy and menopause,Five-star story on small study that tries to counter large body of evidence on soy supplements for hot flashes.,Study clouds evidence on soy and menopause,story_reviews_00932,5,"['Mandy Stahre, PhD', 'Karen Carlson, MD', 'Gary Schwitzer']",Reuters Health,"['hot flashes', 'menopause']",http://www.reuters.com/article/2012/01/30/us-soy-menopause-idUSTRE80T1WV20120130,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Soy supplements are over the counter so the price may vary.\xa0 Story cites estimate.'}, {'question': 'Does the story adequately qu",Reuters Health,"Overall, this story addressed our criteria.
The big picture is that this is a small study, funded by pharma that showed a benefit for soy.¬† Put in the context of the many randomized clinical trials that have looked at this issue over the past decade, the",nan,"Many women may not feel comfortable taking hormone replacement therapy to relieve symptoms of menopause, but are interested in something to reduce uncomfortable symptoms. ¬†However, studies of supplements or over-the-counter remedies need to be conducted ",
https://www.healthnewsreview.org/review/magnesium-rich-diet-may-lower-stroke-risk-study/,Magnesium-rich diet may lower stroke risk: study,Very nice summary in just a 400-word story. Only the headline gave us pause.,Magnesium-rich diet may lower stroke risk: study,story_reviews_00936,5,"['Gary Schwitzer', 'Kathleen Fairfield, MD, DrPH']",Reuters Health,[],http://www.reuters.com/article/2012/01/16/us-stroke-idUSTRE80F03L20120116,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The cost of such a diet is not in question.'}, {'question': 'Does the story adequately quantify the benefits ",Reuters Health,"Except for the headline, the story was carefully framed to avoid overstating the findings. This story is a good example of how to report on an observational meta-analysis.
We know how headlines are almost always written by someone other than the reporter.",nan,"Stroke is a major cause of death and disability in the aging population.¬† We can decrease stroke risk by treating hypertension and taking aspirin.¬† If dietary interventions decrease risk further, this is important public health information.¬† People nee",
https://www.healthnewsreview.org/review/nicotine-patch-may-improve-memory/,Nicotine Patch May Improve Memory,Slightly better on more counts than the competing ,Nicotine Patch May Improve Memory,story_reviews_00939,4,"['William Heisel', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",TIME,['mild cognitive impairment'],http://healthland.time.com/2012/01/09/nicotine-patch-may-improve-memory/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story didn‚Äôt mention cost. The nicotine patch is readily available over the counter.\xa0 We found a range of prices onlin",Time,"This was an ambitious piece for such a short amount of space. The story tries to cover all the relevant ground and give readers enough context to make sense of the findings. While we applaud some of the conflict of interest information it provides, it doe",nan,"As we age, one of the things that worries us most is memory loss. So a drug that promises to restore¬† memory to nearly half of what it used to be is certain to be gain a lot of interest and attention.¬† The most important line in the story is the caveat ",
https://www.healthnewsreview.org/review/nicotine-replacement-treatments-may-not-work-long-term/,Nicotine Replacement Treatments May Not Work Long-Term,"We reviewed three stories on this study, and WebMD graded better than the ",Nicotine Replacement Treatments May Not Work Long-Term,story_reviews_00940,5,"['William Heisel', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",Smoking,[],http://www.webmd.com/smoking-cessation/news/20120109/study-nicotine-replacement-treatments-may-not-work-long-term,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This story discussed costs in the context of overall sales figures. ‚ÄúDeciding how best to get smokers to quit for good is a publi",WebMD,"This story managed to address nearly all of our criteria in this clearly written piece. We always wish stories had a little more detail about costs, and this one, like the other two reviewed, also missed information about harms. The main drawback to this ",nan,"As this story points out, the research on nicotine therapy has been evolving. Because of the strength of so many clinical trials, people assume that patches, gum and other nicotine products work, but this study indicates that under real world conditions, ",
https://www.healthnewsreview.org/review/nicotine-gum-and-skin-patch-face-new-doubt/,Nicotine Gum and Skin Patch Face New Doubt,"Of the 3 stories we reviewed, this clearly written and well reported piece provided some of the best context for why these findings matter.",Nicotine Gum and Skin Patch Face New Doubt,story_reviews_00941,4,"['William Heisel', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",New York Times,[],http://www.nytimes.com/2012/01/10/health/study-finds-nicotine-gum-and-patches-dont-help-smokers-quit.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'All three stories at least mentioned the total amount of money being spent on nicotine replacement products or the growth in that s",The New York Times,We applaud the writer for being the only one of the three to find comments from researchers not connected to the makers of nicotine products. But we wish that the independent commentary had been used to better effect to actually help readers understand th,nan,This story was the only one to note that the clinical trials that are mentioned in all three stories have been the basis for federal guidelines that recommend the use of nicotine replacement products as aids for quitting smoking. One of the surest ways to,
https://www.healthnewsreview.org/review/the-healthy-skeptic-is-caffeine-an-effective-weight-loss-aid/,The Healthy Skeptic: Is caffeine an effective weight-loss aid?,In contrast with ,The Healthy Skeptic: Is caffeine an effective weight-loss aid?,story_reviews_00943,5,"['Gary Schwitzer', 'Kathleen Fairfield, MD, DrPH']",Los Angeles Times,['weight loss'],"http://www.latimes.com/health/la-he-skeptic-weight-loss-caffeine-20120109,0,2780189.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The column includes a cost estimate for the products mentioned.\xa0 This column is consistently good about including cost informati",Los Angeles Times,"Timely consumer information ‚Äì analyzing claims made about weight loss products just as many New Year‚Äôs resolutions start to hit their second week.
In typical Healthy Skeptic fashion, clear language cuts through the claims:
¬†",nan,Why does it matter for a major newspaper to take on weight loss claims like this?¬† Because overweight people are vulnerable to claims of a quick fix ‚Äì a pop-a-pill solution.¬† The $50-or-so per month cost of the products could go toward a fitness cente,
https://www.healthnewsreview.org/review/debate-over-who-needs-a-thyroid-check-in-pregnancy/,Debate over who needs a thyroid check in pregnancy,"Overall, the story does an excellent job weighing the pros and cons of thyroid screening and treatment in pregnant women.",Debate over who needs a thyroid check in pregnancy,story_reviews_00947,5,"['Euna Bodner, MS', 'Karen Carlson, MD', 'Gary Schwitzer']",Associated Press,['Pregnancy'],http://yourlife.usatoday.com/parenting-family/pregnancy/story/2012-01-02/Debate-over-who-needs-a-thyroid-check-in-pregnancy/52336108/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states that a $25 blood test can identify someone with a thyroid disorder. The costs associated with daily hormone therap",Associated Press,"The article gives extensive context to the recent Journal of Clinical Endocrinology & Metabolism study and refers to other research done in the field.
¬†",nan,The article effectively breaks down and explains a complex debate in the physician community ‚Äì whether all pregnant women should be screened for thyroid function and whether women with milder cases of hypothyroidism should be diagnosed and treated. The ,
https://www.healthnewsreview.org/review/spinal-manipulation-home-exercise-may-ease-neck-pain/,"Spinal Manipulation, Home Exercise May Ease Neck Pain",This story about a neck-to-neck comparison of treatments clearly states the main findings. It includes good context and independent sources.,"Spinal Manipulation, Home Exercise May Ease Neck Pain",story_reviews_00948,4,"['Andrew Holtz, MPH', 'Steven J. Atlas, MD, MPH', 'Gary Schwitzer']",HealthDay,"['exercise', 'pain']",http://consumer.healthday.com/Article.asp?AID=660294,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'It‚Äôs too bad this story didn‚Äôt mention costs. Considering that the trial found only small differences in the effectiveness ",Health Day,"When researchers randomized 272 neck pain patients to receive either spinal manipulation, medication, or instructions on home exercises, they found some differences that were statistically significant. But the big picture is that all the patients tended t",nan,"News reports should always distinguish between study results that really mean something to people dealing with illnesses and those that are merely statistically significant, but clinically underwhelming. This story reports key findings about measured diff",
https://www.healthnewsreview.org/review/spinal-tap-may-predict-alzheimers-years-ahead/,Spinal tap may predict Alzheimer‚Äôs years ahead,"Thorough job, addressing all of our criteria except for the potential cost implications of such a test.",Spinal tap may predict Alzheimer‚Äôs years ahead,story_reviews_00949,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Alzheimer's,['dementia'],http://thechart.blogs.cnn.com/2012/01/02/spinal-tap-may-predict-alzheimers-years-ahead/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of costs.\xa0 Yes, we know that it‚Äôs too early to use this in clinical settings, but the story makes the case t",CNN,"This story is a good example of what an independent expert‚Äôs perspective can bring to a piece.
¬†
¬†",nan,"Stories about predictive tests for Alzheimer‚Äôs Disease may play with the emotions of affected families.¬† This story appropriately evaluated evidence, so that the current state of this research ‚Äì what it might mean and what it does not yet mean ‚Äì wa",
https://www.healthnewsreview.org/review/study-looks-at-deep-brain-stimulation-in-bipolar-patients/,Study Looks at Deep Brain Stimulation in Bipolar Patients,Strong point:¬† caveats up high in the story.¬† Weaker points: confusing presentation of data.,Study Looks at Deep Brain Stimulation in Bipolar Patients,story_reviews_00950,4,"['William Heisel', 'Harold J. DeMonaco, MS', 'Gary Schwitzer']",Depression,['bipolar disorder'],http://consumer.healthday.com/Article.asp?AID=660311,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We would have liked to have seen a little more information on costs, but we are glad that costs are mentioned up high. In the third",Health Day,"This solid story on a very small study of deep brain stimulation gives readers a lot of the information they need, but it also likely will lead to some confusion about what the study found. With a little more work clarifying the potential benefits of the ",nan,"Deep brain stimulation has been touted for a number of disorders, including Parkinson‚Äôs disease. Because it is expensive and invasive, studies typically only include a few patients at a time, making it difficult to draw broad conclusions from any one st",
https://www.healthnewsreview.org/review/statins-tied-to-lower-risk-of-fatal-prostate-cancer/,Statins tied to lower risk of fatal prostate cancer,Touch ‚Äôem all.¬† This story neatly addressed all 10 of our criteria.,Statins tied to lower risk of fatal prostate cancer,story_reviews_00952,5,"['Gary Schwitzer', 'William Heisel']",Cancer,"['prostate cancer', 'statins']",http://www.reuters.com/article/2011/12/29/us-statins-prostate-cancer-idUSTRE7BS10L20111229,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Cost range estimates for statins are given in the story.'}, {'question': 'Does the story adequately quantify the benefits of the tr",Reuters Health,"It really isn‚Äôt that difficult to address our criteria, as this story demonstrates.
You can report on studies that suggest a benefit, but you can also then educate readers about why this may not be the case.
This one was a good model for how to report o",nan,"Some journalists become statin-crazy. Statins have been touted as beneficial for people with dementia, arthritis, and pneumonia, just to name a few. More statin cheerleading could have happened with this story.¬† Instead, the reporter stopped to evaluate ",
https://www.healthnewsreview.org/review/brain-stimulation-may-help-some-stroke-patients/,Brain stimulation may help some stroke patients,"Thoroughly reported and engagingly written, this Reuters story about a new approach to stroke rehabilitation edged out the ",Brain stimulation may help some stroke patients,story_reviews_00955,5,"['Kevin Lomangino', 'Steven J. Atlas, MD, MPH', 'Gary Schwitzer']",Reuters Health,[],http://www.reuters.com/article/2011/12/14/us-brain-stimulation-idUSTRE7BD2CV20111214,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states that the transcranial magnetic stimulation\xa0(TMS) machine costs about $50,000, but it could also have noted ‚Äî ",Reuters Health,The major difference is that Reuters attempted to put the study‚Äôs main finding ‚Äî a 23% improvement with the new treatment on a¬†test of cognitive abilities ‚Äî into meaningful terms for¬†readers. And¬†although¬†WebMD quoted more sources (four independ,nan,It is telling that researchers with¬†this study really couldn‚Äôt say whether the results they observed would matter to patients.¬†It‚Äôs a reminder¬†that benefits¬†deemed ‚Äúsignificant‚Äù in research studies may¬†not always¬†lead to improvements¬†that a,
https://www.healthnewsreview.org/review/magnet-therapy-may-help-stroke-survivors-recover/,Magnet Therapy May Help Stroke Survivors Recover,This was¬†a reasonable story on a preliminary study of a new technique called transcranial magnetic stimulation (TMS) to treat post-stroke disability. It wouldn‚Äôt have taken much to address our suggestions for improvement. ,Magnet Therapy May Help Stroke Survivors Recover,story_reviews_00956,4,"['Kevin Lomangino', 'Steven J. Atlas, MD, MPH', 'Gary Schwitzer']",Stroke,[],http://www.webmd.com/stroke/news/20111213/magnet-therapy-may-help-some-stroke-survivors-recover,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story notes that TMS equipment is expensive and requires specialized training. However, this story didn‚Äôt put a dollar fi",WebMD,"Low-hanging fruit this story could have snatched include:
With that being said, we thought the story overall offered an¬†informative account of the study and excelled at providing context. We wish more stories about new treatments made the effort to quote",nan,"Brain damage caused by stroke affects millions of patients and their caregivers. These people need accurate, unbiased information when making decisions about care and rehabilitation. Journalists can help provide that information by carefully vetting studi",
https://www.healthnewsreview.org/review/parents-latest-pick-herbal-shampoos-to-keep-away-lice/,Parents‚Äô Latest Pick: Herbal Shampoos to Keep Away Lice,The money quote in this story: ‚ÄúThese companies might as well claim that their products repel alligators.‚Äù,Parents‚Äô Latest Pick: Herbal Shampoos to Keep Away Lice,story_reviews_00957,5,"['Gary Schwitzer', 'Kathleen Fairfield, MD, DrPH']",Wall Street Journal,[],http://online.wsj.com/article/SB10001424052970203430404577094362860652858.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story includes the cost of some of the products in question.'}, {'question': 'Does the story adequately quantify the benefits o",The Wall Street Journal,"Excellent piece, putting the ‚Äúproblem‚Äù of head lice in perspective and raising questions about efficacy of preventive shampoos.
One company spokeswoman asks, if the products didn‚Äôt work, ‚Äúwhy would we have such a large following of repeat customer",nan,"$150 million in annual sales for products of unknown effectiveness:¬† that‚Äôs why this matters.¬† If these products were proven effective, it might be another story.",
https://www.healthnewsreview.org/review/treatment-for-blood-disease-is-gene-therapy-landmark/,Treatment for Blood Disease Is Gene Therapy Landmark,"Overall, this story provided a clear, contextual explanation of what was done in this research and what its impact may be.",Treatment for Blood Disease Is Gene Therapy Landmark,story_reviews_00958,4,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",New York Times,[],http://www.nytimes.com/2011/12/11/health/research/hemophilia-b-gene-therapy-breakthrough.html?_r=1&ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does a good job noting the possible costs of this approach ($30,000 for a single treatment) and places it in the context ",The New York Times,"We were struck by how well the story was organized, structured and written.¬† Very easy to follow.
¬†",nan,The use of viral vectors (in this case and adenovirus) to deliver missing genes to patients with genetic disorders has been attempted for many years.¬† Hemophilia Type B is a genetic debilitating disorder caused by an inability to produce a protein (facto,
https://www.healthnewsreview.org/review/gene-test-could-spare-women-from-unnecessary-radiation/,Gene test could spare women from unnecessary radiation,"This story on a new version of a gene test meant to help women with small breast tumors make treatment decisions provides good context, but it may have obscured a key limitation of the study.",Gene test could spare women from unnecessary radiation,story_reviews_00960,4,"['Andrew Holtz, MPH', 'Karen Carlson, MD', 'Gary Schwitzer']",Cancer,[],http://yourlife.usatoday.com/health/medical/breastcancer/story/2011-12-06/Gene-test-could-spare-women-from-unnecessary-radiation/51678050/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story reports that the existing version of this test costs over $4,000. It puts this cost in context by reporting that one of t",USA Today,Women diagnosed with small breast tumors known as ductal carcinoma in situ (DCIS) often have to make treatment decisions (including whether to add radiation therapy after surgery) without being certain about how much risk of a recurrence they really face.,nan,Predicting risk is one thing. Knowing which treatment is most likely to produce the best outcome for a patient with a certain risk level is a different question. People often confuse the two; so news reports about risk assessment should take special care ,
https://www.healthnewsreview.org/review/prozac-may-reduce-symptoms-of-autism-in-adults/,Prozac May Reduce Symptoms of Autism in Adults,"This was a well-explained, well-written piece on a small, short-term study of an antidepressant to treat adult autism.",Prozac May Reduce Symptoms of Autism in Adults,story_reviews_00961,5,"['William Heisel', 'Gary Schwitzer']",TIME,"['antidepressants', 'Prozac']",http://healthland.time.com/2011/12/05/prozac-may-reduce-symptoms-of-autism-in-adults/print/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'It‚Äôs\xa0 not that costs are high, it‚Äôs just that they weren‚Äôt discussed. The costs of Prozac are well known and could hav",Time,"This story covers a study that adds to prior research.¬† A quick PubMed search finds an astonishing lack of randomized clinical trials evaluating antidepressants for autism.¬† Although the study is small, it is a randomized clinical trial and addresses a ",nan,"The autism community is active, motivated and passionate about finding treatment solutions for their children and themselves. There is a huge amount of debate about the benefits of medication and whether some forms of autism need be treated as a medical d",
https://www.healthnewsreview.org/review/eating-fish-may-be-good-for-brain-health/,Eating Fish May Be Good for Brain Health,Slightly better than the ,Eating Fish May Be Good for Brain Health,story_reviews_00965,4,"['Gary Schwitzer', 'Euna Bodner, MS']",Alzheimer's,[],http://www.webmd.com/alzheimers/news/20111130/eating-fish-may-be-good-for-brain-health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of fish is not in question.\n '}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/pr",WebMD,"The story allows the researcher to say, ‚ÄúMore fish, more brain, less Alzheimer‚Äôs.‚Äù¬†¬† Pithy.¬† Quotable.¬† But simplistic and not proven by this study.
 
¬†",nan,"At least the competing HealthDay story interviewed an independent source who wondered about other possible confounding factors in the research and stated, ‚ÄúFor now, the connection must be viewed as an association, rather than a cause-and-effect.‚Äù
So e",
https://www.healthnewsreview.org/review/microwave-technique-fights-lung-tumors/,Microwave Technique Fights Lung Tumors,"Overall, this tightly-written story covers a lot of ground in only 380 words.",Microwave Technique Fights Lung Tumors,story_reviews_00966,4,"['William Heisel', 'Gary Schwitzer']",WebMD,['lung disease'],http://www.webmd.com/lung-cancer/news/20111128/microwave-technique-may-fight-lung-tumors,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says that the procedure ‚Äúcosts about $2,000, takes about an hour, and the patient is typically kept overnight in the ho",WebMD,"We would have liked to have seen a little more detail about the following:
¬†",nan,"Yes, this approach is being studied for lung, bone, liver and kidney cancers, but it can‚Äôt be emphasized enough how preliminary are these findings from this one Italian study that was reported.¬† And a US audience was given no perspective on how/whether",
https://www.healthnewsreview.org/review/the-healthy-skeptic-promise-of-chromagen-lenses-for-dyslexia-a-bit-blurry/,The Healthy Skeptic: Promise of ChromaGen lenses for dyslexia a bit blurry,The LA Times‚Äô Healthy Skeptic column clears up some fuzzy claims about an approach to dyslexia.,The Healthy Skeptic: Promise of ChromaGen lenses for dyslexia a bit blurry,story_reviews_00967,5,"['Gary Schwitzer', 'Harold J. DeMonaco, MS']",Los Angeles Times,[],"http://www.latimes.com/health/la-he-skeptic-dyslexia-lenses-20111128,0,7298705.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explains the cost of the glasses and lenses and that the lens costs could be recurring.\xa0 It did not explain if insuran",Los Angeles Times,"The column allows a manufacturer to make its claims but then turns to a literature search and four sources to examine the evidence.
¬†",nan,"Reading is an essential tool in a child‚Äôs development.¬† Given the economic, social, and and academic impact of poor reading skills, it is not surprising that parents will seek out opportunities to improve their child‚Äôs skills.
Because dyslexia is ‚Äú",
https://www.healthnewsreview.org/review/4424/,"Study: Vaccine for Breast, Ovarian Cancer Has Potential","<span style=""font-size: small;"">Although this story gets 4 stars for how it addressed many of our criteria, it relies too much on one study, one patient and, for the most part, one source.</span>","Study: Vaccine for Breast, Ovarian Cancer Has Potential",story_reviews_00973,4,[],Cancer,"['breast cancer', 'ovarian cancer', 'vaccines']",http://www.WebMD.com/breast-cancer/news/20111108/study-vaccine-for-breast-ovarian-cancer-has-potential,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does discuss costs, but the framing is problematic. The story, based on a conversation with one source, the study‚Äôs lea",WebMD,"While the story does many things well, the overall framing of the story is that the vaccine ‚Äúshows promise,‚Äù when the evidence actually points in the other direction. Because only one patient in the study remains cancer free and because that patient m",nan,"Right now, there more than 10,000 cancer-related clinical trials recruiting patients. Cancer has foiled scientists repeatedly with treatments that initially seemed promising in the laboratory or in a very small group of people and later proved unworkable ",
https://www.healthnewsreview.org/review/4408/,New device uses light to screen for melanoma,"<span style=""font-size: small;"">This nicely written, thoroughly reported piece by the Associated Press is a very good example of how to report on new medical devices.</span>",New device uses light to screen for melanoma,story_reviews_00976,5,[],Associated Press,['melanoma'],http://www.foxnews.com/health/2011/11/03/new-device-uses-light-to-screen-for-melanoma.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story takes the rare step of talking about costs from three different angles. The cost to the physician. The cost to the patien",Associated Press,"It puts both the potential benefits and potential harms of this scanner used to detect cancerous skin lesions in the proper context. It explains that, while new to the market, the device is not a medical breakthrough. It provides cost information, for bot",nan,"Despite the well-known risks of excessive sun exposure, many Americans remain ‚Äúsun worshipers.‚Äù Rates of skin cancer, specifically melanoma, have been on the rise. While most skin cancers represent local disease and do not risk distant spread, melanom",
https://www.healthnewsreview.org/review/4407/,Study Weakens Case for Preventive Mastectomy,"<span style=""font-size: small;"">This was a solid report on a new study about genetic testing for breast cancer, confirming that current guidelines are reasonable. </span>",Study Weakens Case for Preventive Mastectomy,story_reviews_00977,5,[],Cancer,"['BRCA', 'breast cancer']",http://online.wsj.com/article/SB10001424052970204528204577010180419303576.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story did not discuss the cost of the BRCA test, which according to the National Cancer Institute can range from several hu",The Wall Street Journal,"But our reviewers were troubled by the story‚Äôs headline and lead sentence, which they felt overreached with its suggestion that the study results ‚Äúweaken the case for preventive mastectomy‚Äù in women who test negative for certain cancer mutations,¬†b",nan,"Inheriting a mutation in BRCA1 or BRCA2¬†can greatly¬†increase a woman‚Äôs lifetime risk of breast cancer,¬†but there is some uncertainty about whether close relatives of BRCA carriers also have a higher risk even if they test negative.¬†These new data ar",
https://www.healthnewsreview.org/review/4402/,The Healthy Skeptic: Seeing through skin supplements‚Äô claims,"<span style=""font-size: small;"">The Healthy Skeptic column can usually be counted on to drive home to consumers the need for evidence to back up health care product claims. It succeeded in that once again this time. </span>",The Healthy Skeptic: Seeing through skin supplements‚Äô claims,story_reviews_00980,4,[],Los Angeles Times,[],"http://www.Los Angeles Times.com/health/la-he-skeptic-skin-20111031,0,3342182.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The Healthy Skeptic column ‚Äì as it usually does ‚Äì included cost information.'}, {'question': 'Does the story adequately quantif",Los Angeles Times,"We only wish the column had added a brief note about concerns about harms from antioxidants and a bit more about why the evidence cited by manufacturers is so inconclusive.
¬†",nan,‚ÄúFountain of youth‚Ä¶anti-aging‚Ä¶youthful skin‚Äù product claims demand scrutiny.¬† They got it in this column.¬† We wish this same approach would be applied more often to the broad range of health care products and claims.,
https://www.healthnewsreview.org/review/4361/,"Robotic surgery grows, but so do questions","<span style=""font-size: small;"">In a balanced way ‚Äì¬† ‚Äúnot anti-robot‚Äù ‚Äì this was solid journalism raising questions about proliferation of uNPRoven technology ‚Äì uNPRoven, at least, about what difference it makes to patients. </span>","Robotic surgery grows, but so do questions",story_reviews_00993,5,[],Los Angeles Times,['surgery'],"http://www.Los Angeles Times.com/health/la-he-robotic-surgery-20111017,0,3304377.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Good analysis of cost impact of use of robotics ‚Äì for patients and health care institutions.'}, {'question': 'Does the story adeq",Los Angeles Times,"It‚Äôs a rare story that counters all of the claims made for robotic surgery.¬† This story scores so well because, one by one, it addresses our criteria in a way we expect stories about new technologies to analyze claims.
This was a story that had consume",nan,"Robotic surgery has increasingly gained acceptance recently despite the fact that the true benefits of the device may be minimal. Given the expense of the device and the per case costs of the disposables, a story that looks hard at the existing evidence i",
https://www.healthnewsreview.org/review/4370/,"HPV test more sensitive than Pap, questions remain","<span style=""font-size: small;"">A sophisticated job of explaining the large review of four clinical trials involving 140,000 women, and why there remain questions that require further study.</span>","HPV test more sensitive than Pap, questions remain",story_reviews_00994,4,[],Reuters Health,['HPV'],http://www.Reuters.com/article/2011/10/17/us-hpv-idUSTRE79G6QW20111017,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This story does not mention the cost of any procedure, nor does it tackle the societal cost of changes in screening frequency o",Reuters Health,"Questions remain ‚Äì even though a large review was done to try to decide if women should get more than the typical cervical cancer screening, known as a Pap test. This story does justice to the sometimes volatile topic of screening for cancer by laying o",nan,"The way Pap tests are done has changed a great deal over the past decade, with the advent of new ‚Äúliquid-based‚Äù testing technology that allows concurrent tests for human papillomavirus (HPV). Some strains of HPV promote cervical cancer. Although the H",
https://www.healthnewsreview.org/review/4347/,"Chocolate lovers have fewer strokes, study finds","<span style=""font-size: small;"">Overall, this was a far superior job of reporting on this study than the competing <a href=""https://www.healthnewsreview.org/review.html?review_id=4348"" target=""_blank"">WebMD coverage</a>.</span>","Chocolate lovers have fewer strokes, study finds",story_reviews_00996,5,[],health food claims,['chocolate'],http://www.Reuters.com/article/2011/10/10/us-chocolate-strokes-idUSTRE7995O620111010,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We‚Äôll rule this not applicable because, in general, most people have ballpark knowledge of how much chocolate costs.\xa0 The st",Reuters Health,"Starting with¬†the headline, this story is careful to¬†explain¬†that the study observed fewer strokes in those who ate more chocolate; it doesn‚Äôt suggest that¬†the chocolate prevented strokes. It also features excellent use¬†of¬†statistics, a more expli",nan,"Some journalists may balk at our insistence that stories about observational studies include appropriate discussion of the limitations of the evidence.¬† In only 378 words, this story provides another example that this can be done ‚Äì and it doesn‚Äôt req",
https://www.healthnewsreview.org/review/4346/,New Alzheimer‚Äôs Drug Shows Early Promise,"<span style=""font-size: small;"">Although this story barely outscores its <a href=""https://www.healthnewsreview.org/review.html?review_id=4349"" target=""_blank"">WebMD competition</a>, we wish that both stories would learn from competitors‚Äô different stron",New Alzheimer‚Äôs Drug Shows Early Promise,story_reviews_00998,5,[],Alzheimer's,[],http://consumer.Healthday.com/Article.asp?AID=657729,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 It‚Äôs understandable that costs wouldn‚Äôt be discussed in such early research.'}, {'question': 'Does the st",HealthDay,"Overall, a solid job of reporting.
Several criticisms:
¬†",nan,"There is always the risk of fostering false hope in reporting on Alzheimer‚Äôs drug stories.¬† Except for its headline, this story did a very good job of putting the research results into an appropriately cautious context for readers.",
https://www.healthnewsreview.org/review/4349/,Drug May Reduce Plaque in Brains of Alzheimer‚Äôs Patients,"<span style=""font-size: small;"">In comparing this story with its </span>",Drug May Reduce Plaque in Brains of Alzheimer‚Äôs Patients,story_reviews_00999,4,[],Alzheimer's,[],http://www.WebMD.com/alzheimers/news/20111010/drug-may-reduce-plaque-in-alzheimers-patients,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 It‚Äôs understandable that costs wouldn‚Äôt be discussed at this early stage of research.'}, {'question': 'Do",WebMD,"We applaud the restraint the WebMD headline writer employed with ‚ÄúDrug May Reduce Plaque in Brains of Alzheimer‚Äôs Patients.‚Äù¬† That‚Äôs about all you can say at this point, and the body text of the story explains why.¬† In that regard, this story go",nan,"This story was better in quantifying harms, but the HealthDay competition was better in explaining the history of this area of research and what else is now being investigated.
It would not have required much more effort or space for either news organizat",
https://www.healthnewsreview.org/review/4313/,The Healthy Skeptic: Products make testosterone claims,"<span style=""font-size: small;"">We almost always applaud the LA Times‚Äô Healthy Skeptic column, although sometimes it just pushes us to push the paper to do more with it. We give it a 5-star score but it could have easily been even better. </span>",The Healthy Skeptic: Products make testosterone claims,story_reviews_01003,5,[],Los Angeles Times,['testosterone'],"http://www.Los Angeles Times.com/health/la-he-skeptic-testosterone-supplements-20110912,0,111750.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'As it usually does, the Healthy Skeptic column itemized costs of the products in question.'}, {'question': 'Does the story adequate",Los Angeles Times,"The disease-mongering of Low T (low testosterone) could have been an important subtheme of this column, yet it was barely mentioned. As our medical editor on this review wrote, ‚ÄúLow T syndrome reflects a cure in search of a disease.‚Äù
The column was so",nan,What does ‚Äúfeeling manly‚Äù mean?¬† What does ‚Äúvirility‚Äù mean?¬† Does a 1% per year decline in testosterone levels for most men mean they have a condition that requires treatment?¬† There are conditions attributable to low testosterone that warrant ,
https://www.healthnewsreview.org/review/4302/,"Rare surgery brings more weight loss, more risks",This story portrays the controversy in treating chronic obesity by clearly explaining the delicate balance of risk and benefit surrounding weight-loss surgery.,"Rare surgery brings more weight loss, more risks",story_reviews_01007,5,[],Reuters Health,"['obesity', 'surgery', 'weight loss']",http://www.Reuters.com/article/2011/09/06/us-surgery-weightloss-idUSTRE7855YR20110906,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No mention in this lengthy story of the costs of the two procedures or insurance coverage. Readers need this information, and t",Reuters Health,"While the story begins with a small research study about two different methods of weight-loss surgery, it expands and includes context about wider debate over whether shedding pounds improves health and life expectancy. We do wish it had included cost and",nan,"Size matters. Today‚Äôs obese Americans face higher risks of heart disease, diabetes and stroke because of their weight. But in this story, important questions are raised about the risks posed by one type of weight-loss surgery ‚Äì known as duodenal switc",
https://www.healthnewsreview.org/review/4267/,New Blood Thinner May Outperform Warfarin for Irregular Heartbeat,"<span style=""font-size: small;"">Slightly better than its <a href=""https://www.healthnewsreview.org/review.html?review_id=4272"" target=""_blank"">NY Times competition</a> because it provided the absolute risk reduction figures (however it gave the number of ",New Blood Thinner May Outperform Warfarin for Irregular Heartbeat,story_reviews_01011,5,[],HealthDay,['atrial fibrillation'],http://consumer.Healthday.com/Article.asp?AID=656337,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentioned that apixabane would cost more than warafarin, and included a quote from a company spokesperson to indicate tha",Health Day,"This is a story about an experimental new blood thinner for use by people who have atrial fibrillation. ¬†This story delivers a sound presentation of why this drug may have benefit over the commonly used warfarin.
¬†",nan,The need for medication to reduce clotting risk from atrial fibrillation is common and there is long-standing interest in eliminating the need for routine monitoring that the current treatment with warfarin requires.,
https://www.healthnewsreview.org/review/4272/,Trial Shows Blockbuster Potential for Blood Clot Pill,"<span style=""font-size: small;"">We would have liked to have seen absolute risk reduction figures ‚Äì not just relative ‚Äì and a more complete discussion of potential harms.¬† The <a href=""https://www.healthnewsreview.org/review.html?review_id=4267"" targe",Trial Shows Blockbuster Potential for Blood Clot Pill,story_reviews_01012,4,[],New York Times,"['Blood clots', 'pills']",http://www.nytimes.com/2011/08/28/business/trial-shows-potential-for-blood-clot-pill-eliquis.html?scp=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentioned that it was expected that the drug reported on would cost $8/day as compared with <$1/day for warfarin.\nOne as",The New York Times,This is a story about a large clinical trial that found a new medication to be more effective though more expensive than the current medication used to reduce the chance of blood clot formation in individuals with atrial fibrillation. ¬†The story did a go,nan,The risk of hemorrhagic stroke is a concern to those who use warfarin as part of their treatment for atrial fibrillation. ¬†The availability of a medication that reduces that risk and is a more effective treatment for their condition will be of interest t,
https://www.healthnewsreview.org/review/4250/,Less-invasive appendix surgery shines in new study,"<span style=""font-size: small;"">This is our 1600th story reviewed on this site and it‚Äôs a good lesson for others.¬† It shows again that you CAN satisfy our criteria in fewer than 500 words. </span>",Less-invasive appendix surgery shines in new study,story_reviews_01016,5,[],Appendicitis,['surgery'],http://www.Reuters.com/article/2011/08/22/us-appendix-surgery-idUSTRE77L6QP20110822,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Nice job on this.\xa0 The story states:\n‚ÄúFor uncomplicated cases of appendicitis, in which the appendix is still intact, the tab",Reuters Health,"It‚Äôs also noteworthy that this reporter‚Äôs work consistently scores high in our reviews.¬† The commitment to excellence is evident.
This is a clear, concise explanation of a journal article‚Äôs findings.
¬†",nan,Elective appendectomy is a common surgical procedure that is now routinely performed using minimally invasive techniques. The question of whether laparoscopic appendectomy is safe and cost effective for a ruptured appendix has been an unresolved question.,
https://www.healthnewsreview.org/review/4232/,Doctors screen for cervical cancer too often: study,"<span style=""font-size: small;"">A lack of clarity may mislead readers about the screening recommendation ‚Äì marring an otherwise high-scoring story on an important topic for women‚Äôs health. </span>",Doctors screen for cervical cancer too often: study,story_reviews_01017,5,[],Cancer,['Cervical cancer'],http://www.Reuters.com/article/2011/08/18/us-cervical-cancer-screen-idUSTRE77H0XD20110818,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story referred to ‚Äúextra costs women may incur to get childcare and make it to the doctor‚Äôs office ‚Äî plus the costs to a ",Reuters Health,"This story was generally clearly written and delivered an important reminder to women that screening too often isn‚Äôt harmless ‚Äì and that there‚Äôs a reason for evidence-based screening guidelines.
Unfortunately, the story is confusing in a way that co",nan,"The story ended with some sound advice for women: ‚ÄúWe need to shift toward the wellness visit as opposed to, ‚ÄòYou have to come in here every year for a Pap,'‚Äù (one expert) said. There are other important preventive interventions that happen during a",
https://www.healthnewsreview.org/review/4229/,Dogs Sniff Out Lung Cancer in Humans,"<span style=""font-size: small;"">The story ends with an appropriate quote:¬†‚Äú‚ÄùThe dogs show that it can be done. We need to find out what the dogs are sniffing so we can do it in a more scientific manner.‚Äù</span>",Dogs Sniff Out Lung Cancer in Humans,story_reviews_01019,4,[],Cancer,['lung cancer'],http://www.WebMD.com/lung-cancer/news/20110817/dogs-use-their-noses-to-detect-lung-cancer,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention costs. At the very least, what does it cost to train dogs?\xa0If you can let someone call this the ‚",WebMD,"Other than the too-simple headline, this story about four dogs in Europe finding 71 out of 100 lung cancers is pretty responsible. For readers who get all the way to the end, it will be clear that the dog-detection system is far from available now and mig",nan,"The US spends an estimated $10 billion on treatment for patients with lung cancer. ¬†It is the second most common form of cancer in the US, and the leading cause of cancer death. An estimated 220,000 people will be diagnosed this year and about 157,000 wi",
https://www.healthnewsreview.org/review/4211/,"Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts","<span style=""font-size: small;"">This story provides an excellent look at the controversies related to a new form of treatment and the role of manufacturers in pushing its acceptance.<br/>
</span>","Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts",story_reviews_01024,5,[],New York Times,['chemotherapy'],http://www.nytimes.com/2011/08/12/business/heated-chemotherapy-bath-may-be-only-hope-for-some-cancer-patients.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Good job on this, stating ‚ÄúThe cost of the surgery and Hipec, including hospitalization, ranges from $20,000 to more than $100,00",The New York Times,"This story opens readers‚Äô eyes to a debate that flared up before attendees of a recent meeting of the American Society of Clinical Oncology ‚Äì but a debate that most of us wouldn‚Äôt know about.
The sidebar story, ‚ÄúSome Stealth Marketing by a ‚ÄòHot ",nan,"This is an important piece of enterprise journalism.
The ‚Äúchemo bath‚Äù approach has been around for many years, but the use of heated solutions is relatively new and has limited data to support it use. Despite the limited evidence, the approach is gain",
https://www.healthnewsreview.org/review/4202/,Gene therapy shown to destroy leukemia tumors,"<span style=""font-size: small;"">This story ‚Äì and one <a href=""https://www.healthnewsreview.org/review.html?review_id=4205"" target=""_blank"">by WebMD</a> ‚Äì were better <a href=""https://www.healthnewsreview.org/blog/2011/08/striking-contrasts-of-hype-ver",Gene therapy shown to destroy leukemia tumors,story_reviews_01026,4,[],Cancer,"['gene therapy', 'leukemia']",http://www.Reuters.com/article/2011/08/10/us-leukemia-genetherapy-idUSTRE7795NT20110810,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'While WebMD missed the cost component, Reuters smartly raised this issue and discussed how future research will be funded. ‚ÄúAll o",Reuters Health,¬†,nan,"As both stories note, researchers have been trying to find a way to use genetically engineered cells to fight cancer for 20 years, making even a small study like this interesting news. Both stories sounded some cautionary notes, but Reuters could have mor",
https://www.healthnewsreview.org/review/4205/,Gene Therapy Cures Adult Leukemia,"<span style=""font-size: small;"">Somebody at WebMD must take responsibility for a headline that says ‚Äúcure‚Äù after one year‚Äôs experience in 3 patients. Cure used to be defined in 5 year terms.¬† Is WebMD redefining the term? </span>",Gene Therapy Cures Adult Leukemia,story_reviews_01027,4,[],"""cure""","['gene therapy', 'leukemia']",http://www.WebMD.com/cancer/news/20110810/gene-therapy-cures-adult-leukemia,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Unlike the Reuters story, this story did not discuss costs.'}, {'question': 'Does the story adequately quantify the benefits of",WebMD,¬†,nan,"As noted by both of the stories we reviewed, researchers have been trying to find a way to use genetically engineered cells to fight cancer for 20 years, making even a small study like this interesting news. Both stories sounded some cautionary notes, but",
https://www.healthnewsreview.org/review/4194/,"Test Can Tell Fetal Sex at 7 Weeks, Study Says","<span style=""font-size: small;"">It struck our reviewers that this piece had more consumer-helpful information than a </span>","Test Can Tell Fetal Sex at 7 Weeks, Study Says",story_reviews_01028,4,[],New York Times,"['blood tests', 'Pregnancy']",http://www.nytimes.com/2011/08/10/health/10birth.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story quotes one price estimate of about $250 for the testing. We would have liked more detail about whether new details on acc",The New York Times,The story outlines how new research about an existing family of consumer blood tests shows accuracy at seven weeks into pregnancy for determining the sex of a fetus. What the story also tells is the complicated weighing of risks and benefits that parents ,nan,"Earlier sex-determination in pregnancy could lead to parents choosing (or trying to choose) the gender they prefer. Internationally, it is already clear that some parents in China and India are deliberately choosing male babies, and aborting female fetuse",
https://www.healthnewsreview.org/review/4197/,Mother‚Äôs blood test reveals baby‚Äôs sex,"<span style=""font-size: small;"">Both this story by Reuters and a <a href=""https://www.healthnewsreview.org/review.html?review_id=4194"" target=""_blank"">competing story by the New York Times</a> did a reasonable job in reporting on this research ‚Äì and bet",Mother‚Äôs blood test reveals baby‚Äôs sex,story_reviews_01029,4,[],Reuters Health,['blood tests'],http://www.Reuters.com/article/2011/08/09/us-mothers-blood-test-idUSTRE77860Q20110809,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentions the estimated cost of test, but does not note that consumers can get the test without a doctor‚Äôs involvement i",Reuters Health,"Reuters reports on a new survey, published in the Journal of the American Medical Association, which reinforces the accuracy of a certain blood test for determining the sex of a fetus as early as seven weeks along in pregnancy. We like how the Reuters sto",nan,"Earlier sex-determination in pregnancy could lead to parents choosing (or trying to choose) the gender they prefer. Internationally, it is already clear that some parents in China and India are deliberately choosing male babies, and aborting female fetuse",
https://www.healthnewsreview.org/review/4178/,Urine Test May Help Predict Prostate Cancer,"<span style=""font-size: small;"">Let the data dictate the merits of the test.¬† Describing it as a ‚Äúpainless urine test‚Äô in the lede is cheerleading.¬† Besides tests requiring catheterization, most urine tests are <em><strong>painfree!</strong></em></s",Urine Test May Help Predict Prostate Cancer,story_reviews_01032,4,[],Cancer,['prostate cancer'],http://www.WebMD.com/prostate-cancer/news/20110803/urine-test-may-help-predict-prostate-cancer,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the story included price estimates for prostate biopsy, it did not include a ball park estimate for the cost to assay ",WebMD,This is a story about a potential new test that may improve the ability to determine when a man with elevated circulating PSA levels has prostate cancer and perhaps better predict if the prostate cancer that a man has is aggressive or not. ¬†While mention,nan,Having tools that better predict whether a prostate cancer is aggressive would be useful for helping men avoid treatment that isn‚Äôt needed. ¬†Whether this test will prove to be useful in this regard remains to be demonstrated.,
https://www.healthnewsreview.org/review/4180/,Blood Test May Spot Alzheimer‚Äôs Before Symptoms Appear,"<span style=""font-size: small;"">So many stories about so many Alzheimer‚Äôs tests fall short in explaining why sensitivity and specifity is so important in such test ‚Äì and why some may choose not to be tested.¬† This story wasn‚Äôt bad but we point out ",Blood Test May Spot Alzheimer‚Äôs Before Symptoms Appear,story_reviews_01033,4,[],Alzheimer's,['blood tests'],http://www.WebMD.com/alzheimers/news/20110803/blood-test-may-spot-alzheimers-before-symptoms-appear,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\n\n\nThe story includes a tentative estimate of what this sort of blood test might cost if it is approved.'}, {'question': 'Does t",WebMD,"



So many reports of potential tests for Alzheimer‚Äôs Disease have been announced recently that one might wonder what exactly is newsworthy about yet another announcement of a small study proclaiming preliminary results, particularly when the source is",nan,"






Memory loss with aging causes tremendous fear in our society ‚Äì often for good reason. Alzheimer‚Äôs is particularly challenging because it can be hard to diagnose in its early stages and because there are no effective treatments that meaningfully",
https://www.healthnewsreview.org/review/4173/,Stool test good for catching colon cancer: study,"<span style=""font-size: small;"">This is an important story ‚Äì and well executed ‚Äì about an approach to colon cancer screening that arguably doesn‚Äôt get enough public attention. </span>",Stool test good for catching colon cancer: study,story_reviews_01035,5,[],Cancer,['colon cancer'],http://www.Reuters.com/article/2011/08/02/us-colon-cancer-idUSTRE7714ZR20110802,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Costs of FOBT and of colonoscopy were included.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/t",Reuters Health,"Maybe somebody is paying attention to our criteria checklist. As you read this story, one by one, they are addressed (except for one). 
¬†",nan,It is important to remind consumers that there is good evidence for what stool tests ‚Äì especially the newer versions ‚Äì can accomplish.¬† From a public health perspective ‚Äì looking at population-wide benefits ‚Äì they make a great deal of sense becau,
https://www.healthnewsreview.org/review/4161/,Women who eat lots of fiber have less breast cancer,"<span style=""font-size: small;"">In less than 500 words, this story covered a big study but drove home the limitations of its findings. </span>",Women who eat lots of fiber have less breast cancer,story_reviews_01039,5,[],Cancer,"['breast cancer', 'Fiber']",http://www.Reuters.com/article/2011/07/28/us-fiber-breast-cancer-idUSTRE76R6YM20110728,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The cost of fiber in the diet is not in question.'}, {'question': 'Does the story adequately quantify the ben",Reuters Health,"It‚Äôs not often you see a story that so simply explains possible confounders in research.¬† This story hammered the point:
¬†",nan,nan,
https://www.healthnewsreview.org/review/4143/,A Rubber Twist On Treating Tennis Elbow Pain,"<span style=""font-size: small;"">4-star review but this brief blog post on a new tennis elbow treatment double-faulted in two key areas ‚Äì on scope of benefit and limitations of the evidence. </span>",A Rubber Twist On Treating Tennis Elbow Pain,story_reviews_01042,4,[],NPR,['tennis elbow'],http://www.NPR.org/blogs/health/2011/07/25/138614357/a-rubber-twist-on-treating-tennis-elbow-pain,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states that the FlexBar costs between $16 and $33. It could have compared this cost with that of some other treatment opt",NPR,The story said that a study showed the new treatment improved strength and decreased pain from tennis elbow ‚Äî but it never said by how much or how this improvement was measured.¬†We also never learn about important limitations in the study design that s,nan,"As this story points out, tennis elbow isn‚Äôt confined to the country club set and can do a lot more than throw off your serve. It¬†can also directly threaten the livelihood of painters and other manual laborers whose movements are restricted by debilita",
https://www.healthnewsreview.org/review/4130/,Experimental Drug Might Help Fight Alzheimer‚Äôs After All,"<span style=""font-size: small;"">Huge disconnect between the headline (which focuses on benefit) and the body of the story (which focuses only on safety).¬† As one expert said, ‚ÄúWe‚Äôll have to wait‚Ä¶to comment on this as a potential therapy.‚Äù¬† So, t",Experimental Drug Might Help Fight Alzheimer‚Äôs After All,story_reviews_01044,4,[],Alzheimer's,[],http://consumer.Healthday.com/Article.asp?AID=655012,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'As the drug is still under development, there was no discussion of costs.\nThis is a humanized monoclonal antibody and the story ",Health Day,"This story reports on a drug in development for people with Alzheimer‚Äôs disease. ¬†While providing a lot of detailed information about the molecule under study and how the drug is better tolerated at lower doses, this story failed to provide any insight",nan,"The graying of the population means that the concern about Alzheimer‚Äôs disease looms large ‚Äì ¬†for the elderly, people who care for elders, and those paying the bills.",
https://www.healthnewsreview.org/review/4121/,The shallow waters of dolphin therapy claims,"<span style=""font-size: small;"">The column adroitly addresses the age-old defense of lack of evidence ‚Äì ‚ÄúIf there‚Äôs no science behind it, how can you say that it doesn‚Äôt work?‚Äù</span>",The shallow waters of dolphin therapy claims,story_reviews_01046,4,[],Los Angeles Times,['therapy'],"http://www.Los Angeles Times.com/health/la-he-skeptic-dolphin-therapy-20110718,0,1273996.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes the costs of several of the therapy sessions offered. ‚ÄúA five-day program costs $2,200 and includes about 20 minu",Los Angeles Times,"Another strong entry in this regular Healthy Skeptic column by the LA¬†Times, this story provides readers with nearly everything they need to know about dolphin therapy treatment centers. We especially liked how the story showed that different claims are ",nan,"People with hard-to-treat conditions or people who have children with autism or other disorders want badly to find something to improve their lives. Getting a chance to swim with dolphins, as this story points out, has a romantic, fantasy-like appeal that",
https://www.healthnewsreview.org/review/4118/,"For Some Prostate Cancer Patients, Combo Treatment Improves Survival","<span style=""font-size: small;"">This was a generally well done story.¬† </span>","For Some Prostate Cancer Patients, Combo Treatment Improves Survival",story_reviews_01049,4,[],Cancer,['prostate cancer'],http://consumer.Healthday.com/Article.asp?AID=654857,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs.\xa0 Over and over again ‚Äì more than 70& of >1,500 stories we‚Äôve reviewed fail to adequate",Health Day,"This story details the outcomes of a recent study examining whether the addition of male hormone therapy to radiation therapy improves outcomes for men with prostate cancer, and that the risk level of the man‚Äôs prostate cancer ¬†determines whether short",nan,It is important for men to understand that prostate cancer is not a monolith and that various therapies benefit specific groups of patients. ¬†It is not a one size fits all prospect. ¬†The lack of benefit of combined therapy for low-risk patients should b,
https://www.healthnewsreview.org/review/4100/,Folic acid tied to better grades in Swedish teens,"In fewer than 500 words, this story did a good job explaining what a study found and putting that observation into context. Better than ",Folic acid tied to better grades in Swedish teens,story_reviews_01052,5,[],Reuters Health,['folic acid'],http://www.Reuters.com/article/2011/07/11/us-folic-acid-idUSTRE76A0S320110711,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 Costs weren‚Äôt mentioned, but we didn‚Äôt think that was a necessity in this case.'}, {'question': 'Does the",Reuters Health,This is a story about a recent study published in the journal Pediatrics which found an association between folic acid levels and school grades in a cohort of Swedish teens. ¬†This story did a reasonable job of describing this cohort study. ¬†It¬†explaine,nan,Understanding how to interpret study results and knowing the appropriate questions to ask in order to understand how those results might be applicable is a valuable skill. ¬†Helping people think about studies of nutrition in context and whether they might,
https://www.healthnewsreview.org/review/4090/,Study Questions Chiropractic‚Äôs Impact on Back Pain,"<span style=""font-size: small;"">This story touched on an important truth about the treatment of chronic back pain‚Äîeven if it missed some key points along the way. </span>",Study Questions Chiropractic‚Äôs Impact on Back Pain,story_reviews_01054,4,[],Back pain,[],http://consumer.Healthday.com/Article.asp?AID=654498,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article did attempt to offer information on the costs of manipulation by consulting a spokesman for the American Chiropract",Health Day,"
The article focused on a recent systematic review of the effectiveness of spinal manipulation for chronic low back pain.¬† The Cochrane Collaboration review found that this popular treatment leads to rapid short-term pain relief and improvement in functi",nan,Spinal manipulation is one of the most popular treatments for low back pain in the United States and many other nations. ¬†The 2007 National Health Interview Survey concluded that roughly 8.6% of U.S. adults‚Äîclose to 20 million individuals‚Äîutilized ch,
https://www.healthnewsreview.org/review/4095/,Study Shows Chest Pain From Heart Disease Can Be Treated With Stem Cell Therapy,"<span style=""font-size: small;"">This is a generally well done and thoughtful story. But it assumes that readers understand the different phases of trials. </span>",Study Shows Chest Pain From Heart Disease Can Be Treated With Stem Cell Therapy,story_reviews_01055,4,[],heart disease,['stem cell therapy'],http://www.WebMD.com/heart-disease/news/20110707/stem-cell-treatment-may-relieve-angina,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of cost.\xa0 A ballpark could have been given.'}, {'question': 'Does the story adequately quantify the benefits o",WebMD,Our main constructive criticism is that the story should have emphasized what a Phase 2 study shows and doesn‚Äôt show.¬† It says that a Phase 3 study is being planned ‚Äì but never defines what a Phase 3 study is.¬† These are important concepts for reade,nan,"Fascinating research, worthy of news coverage.",
https://www.healthnewsreview.org/review/4081/,Heart Treatment Overused,"<span style=""font-size: small;"">This was an excellent story. Some stories framed this study as nothing but good news.¬† But this story put ‚Äúoverused‚Äù in the headline, put the $20,000 cost in the first sentence, and explained the ‚Äúreassuring‚Äù and t",Heart Treatment Overused,story_reviews_01056,5,[],Wall Street Journal,[],http://online.wsj.com/article/SB10001424052702304760604576428323005864648.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The $20,000 procedure cost is in the first sentence. Many stories never get there at all.'}, {'question': 'Does the story adequatel",The Wall Street Journal,"Terrific context ‚Äì reminding readers of the North American Spine Society‚Äôs publication last week of a study showing conflicts of interest in a spinal procedure, and stating that ‚ÄúAs health-care costs continue to soar, reaching $2.5 trillion in the U",nan,"The story not only establishes the troublesome overtreatment.¬† It goes further upstream to overscreening.¬† It quotes one expert:
‚ÄúWe suspect that part of the [problem] may be driven by a huge push for screening patients who don‚Äôt have symptoms but h",
https://www.healthnewsreview.org/review/4088/,Review raises questions over benefits of cutting salt,"<span style=""font-size: small;"">Good context, good sourcing. Independent perspectives added a great deal to the story. </span>",Review raises questions over benefits of cutting salt,story_reviews_01057,5,[],Reuters Health,[],http://www.Reuters.com/article/2011/07/06/us-salt-hypertension-idUSTRE76476E20110706,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 Costs not in question in this context.'}, {'question': 'Does the story adequately quantify the benefits of th",Reuters Health,This is a story about the information published in a recent Cochrane reviewing what has been shown to result from the reduction of dietary salt intake along with the opinions of several diverse thought leaders in the field about the review. ¬†The review f,nan,Cardiovascular disease is the leading cause of death worldwide and it is therefore of interest to know what lifestyle changes are effective in reducing this risk. ¬†Salt restriction is currently considered an important public health measure for reducing t,
https://www.healthnewsreview.org/review/4074/,Who should get screened for lung cancer?,"<span style=""font-size: small;"">In ending with an expert‚Äôs summary that lung CT scanning is ‚Äúnot a home run‚Äù with clear limitations, this story touches ‚Äôem all and hits its own home run in addressing our criteria. </span>",Who should get screened for lung cancer?,story_reviews_01059,5,[],Cancer,['lung cancer'],http://www.Reuters.com/article/2011/07/01/us-lung-cancer-idUSTRE7602ZN20110701,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story emphasizes cost several times, including the estimate of a few hundred dollars per scan.'}, {'question': 'Does the story ",Reuters Health,"In the same week that new data were published by the US National Lung Screening Trial ‚Äì subject of some badly flawed national news coverage ‚Äì here‚Äôs a story on a different lung screening trial in Japan.
To those journalists who are challenged by scr",nan,"Costs, harms and limitations of the evidence ‚Äì issues often left out of many screening stories ‚Äì were emphasized in this one.",
https://www.healthnewsreview.org/review/4056/,Research shows promise in reversing Type 1 diabetes,"<span style=""font-size: small;"">It would be so easy to hype the extremely preliminary results of this research.¬† To its credit, this story did none of that. </span>",Research shows promise in reversing Type 1 diabetes,story_reviews_01063,5,[],Los Angeles Times,['type 1 diabetes'],"http://www.Los Angeles Times.com/health/la-he-bcg-diabetes-20110625,0,6341862.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Not applicable.\xa0 Costs were not discussed, which is understandable at this early stage of research which the story emphasized.'}",Los Angeles Times,"Responsible reporting of a promising, but very preliminary finding in diabetes research.
The caveats and context were all there.
Nice job.
¬†",nan,"As one of the independent experts was quoted saying, ‚Äù If this is reproducible and correct, it could be a phenomenal finding.‚Äù¬† The story emphasized that this is still a big IF.",
https://www.healthnewsreview.org/review/4044/,Olive oil lovers show lower stroke risk,"<span style=""font-size: small;"">This story devoted almost as many words to the limitations of such an observational study as the entire <a href=""https://www.healthnewsreview.org/review.html?review_id=4047"" target=""_blank"">LA Times blog piece</a> did to th",Olive oil lovers show lower stroke risk,story_reviews_01064,5,[],Reuters Health,['olive oil'],http://www.Reuters.com/article/2011/06/16/us-olive-oil-idUSTRE75E66L20110616,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The cost of olive oil is not in question.'}, {'question': 'Does the story adequately quantify the benefits of",Reuters Health,"This story explored the nature of an observational study about the stroke-reducing risks of olive oil. The story appropriately discussed other possible reasons for the findings and why a clinical trial is stronger evidence.
¬†",nan,"With so much news coverage touting an apparent benefit from olive oil in this study (CBS had a headline about ‚Äúhuge decline in stroke risk‚Äù), it is refreshing to see so much time and space given to a clear-eyed evaluation of the evidence as this story",
https://www.healthnewsreview.org/review/4042/,"Sleeptime Head-Cooling Cap Eases Insomnia, Study Finds","<span style=""font-size: small;"">It is striking how easily such preliminary pilot trial results garner news attention.</span>","Sleeptime Head-Cooling Cap Eases Insomnia, Study Finds",story_reviews_01065,4,[],HealthDay,['insomnia'],http://consumer.Healthday.com/Article.asp?AID=653882,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 No discussion of costs but that‚Äôs understandable at this early stage of development.'}, {'question': 'Does ",Health Day,"This is an interesting story about interesting research for a common problem.¬† We appreciate the caveat at the end of the story ‚Äì ‚ÄúBecause this study was extremely small and presented at a medical meeting, the data and conclusions should be viewed as",nan,"As the story indicates, ‚ÄúChronic insomnia ‚Äî which the American Academy of Sleep Medicine attributes to about one out of every 10 Americans ‚Äî can be difficult to treat.‚Äù",
https://www.healthnewsreview.org/review/4045/,Olive Oil Linked to Reduced Stroke Risk,"<span style=""font-size: small;"">Better than its <a href=""https://www.healthnewsreview.org/review.html?review_id=4047"" target=""_blank"">LA Times competition</a> largely because 3 independent experts‚Äô perspectives drove home the potential limitations of th",Olive Oil Linked to Reduced Stroke Risk,story_reviews_01066,5,[],Stroke,['olive oil'],http://www.WebMD.com/healthy-aging/news/20110615/olive-oil-linked-to-reduced-stroke-risk,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The cost of olive oil is not in question.'}, {'question': 'Does the story adequately quantify the benefits of",WebMD,"An added nice touch was the discussion of the possible etiology of the olive oil effect (e.g., inflammation).
Overall, a solid summary.
¬†",nan,"When an observational study points to a statistical association between one factor and one outcome, it is important to explain why that doesn‚Äôt necessarily mean that one factor caused that one outcome.¬† This story did a better job of that than its LA T",
https://www.healthnewsreview.org/review/4037/,"‚ÄòHoney, It‚Äôs Your Turn‚Ä¶‚Äô","<span style=""font-size: small;"">The story delivers a very clear summary of the challenges to finding a safe and effective approach to a male contraceptive, and a clear-eyed summary of some of the leading research candidates.</span>","‚ÄòHoney, It‚Äôs Your Turn‚Ä¶‚Äô",story_reviews_01068,5,[],Wall Street Journal,['contraceptives'],http://online.wsj.com/article/SB10001424052702303848104576383730320049892.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 Cost not discussed but since the article clearly stated that the methods discussed are ‚Äúat least years away",The Wall Street Journal,"We are curious about a couple of things.
Why and how were the three methods chosen as ‚Äúmost promising‚Äù among a dozen methods mentioned?
Is it coincidence that in the past week many stories have popped up about male contraceptive research, including a ",nan,"The story‚Äôs concluding line summarizes why this matters:¬†¬† ‚Äúgiven that roughly half of all pregnancies in the U.S. are unplanned, ‚Äòwe need to have more options for couples to be able to plan their lives.‚Äô ‚Äú",
https://www.healthnewsreview.org/review/4032/,Extracting the facts about pomegranate pills,"<span style=""font-size: small;"">One of the best examples we have seen reporting on the evidence (or lack of it) regarding a supplement for very specific health claims.</span>",Extracting the facts about pomegranate pills,story_reviews_01069,5,[],Los Angeles Times,[],"http://www.Los Angeles Times.com/health/la-he-pomegranate-extract-pills-20110613,0,7151568.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story includes the cost of pomegranate pills.'}, {'question': 'Does the story adequately quantify the benefits of the treatment",Los Angeles Times,"This was not one of the LA Times‚Äô Healthy Skeptic columns, but it may as well have been.¬† As that column often does, this story dampened the hype surrounding claims for pomegrante juice and pills.
We especially appreciate the point-by-point analysis of",nan,"A cardiologist quoted in the story said, ‚ÄúIf people want to take them, that‚Äôs fine, but it‚Äôs not based on any scientificallly valid information‚Ä¶.There‚Äôs no definitive clinical trial demonstrating a beneficial effect of pomegranate fruit, juice o",
https://www.healthnewsreview.org/review/4008/,Jury Still Out on Radiation for Early Prostate Cancer,"<span style=""font-size: small;"">Perhaps because of all of the excitement coming out of the American Society of Clinical Oncology conference in Chicago, relatively few news organizations picked up on this important paper in the Annals of Internal Medicine.",Jury Still Out on Radiation for Early Prostate Cancer,story_reviews_01071,5,[],Cancer,['prostate cancer'],http://consumer.Healthday.com/Article.asp?AID=653598,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The only discussion of cost was one phrase deep in the story ‚Äì ‚Äù proton beam therapy in particular is expensive‚Äù ‚Äì but ",Health Day,This 750 word story provided readers with a good synopsis of the study results and did so in plain and straightforward terms providing definitions for the average reader. We liked the fact that the story linked the study results to a reasonable set of rec,nan,News stories in recent years have so often breathlesslly promoted new radiation therapy approaches such as proton beam therapy and intensity modulated radiation therapy.¬† It is important to bring the public reviews of the evidence that show ‚Äúcurrently ,
https://www.healthnewsreview.org/review/3992/,Drugs Show Promise Slowing Advanced Melanoma,"<span style=""font-size: small;"">Much better than the competing stories by CNN.com and Reuters in a number of small but significant ways ‚Äì most notably in discussing potential harms and costs.¬† </span>",Drugs Show Promise Slowing Advanced Melanoma,story_reviews_01073,5,[],Cancer,['melanoma'],http://www.nytimes.com/2011/06/06/health/research/06melanoma.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The significant costs of both drugs were mentioned.\xa0 Nice job.'}, {'question': 'Does the story adequately quantify the benefits ",The New York Times,"The story made strong, clear attempts to report in a restrained manner, using terms/phrases such as:
¬†",nan,Stories about cancer ‚Äì perhaps especially melanoma because of its treatment challenges ‚Äì should balance promise with realistic context.¬† This story did a better job of that than the competitors‚Äô efforts we reviewed.,
https://www.healthnewsreview.org/review/4001/,Hormone-blocking drug reduces breast cancer risk,"<span style=""font-size: small;"">A solid job reporting on a study presented at the American Society of Clinical Oncology conference.¬† Contrast this effort with </span>",Hormone-blocking drug reduces breast cancer risk,story_reviews_01076,5,[],Associated Press,['breast cancer'],http://www.The Denver Post.com/fitness/ci_18211043,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'According to the story, brand-name aromatase inhibitors cost between $340 and $420 a month, but the story also points out that lowe",Associated Press,"This story reports on results from a double-blind, placebo-controlled, randomized trial, which found that the aromatase inhibitor, exemestane, is an effective option for preventing breast cancer in higher risk, postmenopausal women.¬† The story does a nic",nan,There are significant side effects associated with tamoxifen and raloxifene and many women feel these potential harms outweigh the potential benefit of reducing their risk of developing cancer. Aromatase inhibitors have fewer side effects and may be a mor,
https://www.healthnewsreview.org/review/4005/,Two new drugs extend survival for melanoma patients,"<span style=""font-size: small;"">The difference between a 4-star story and a 5-star score may be bigger than what first glance offers. </span>",Two new drugs extend survival for melanoma patients,story_reviews_01077,4,[],Cancer,['melanoma'],http://www.CNN.com/2011/HEALTH/06/05/melanoma.drugs/index.html?hpt=he_c2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Not a word about costs ‚Äì difficult to comprehend given the estimates the New York Times provided of $120,000 per course of tr",CNN,"More broadly, the story contained none of the restrained context provided by the Times.¬†¬† Read and compare.
¬†",nan,Stories about cancer ‚Äì perhaps especially melanoma because of its treatment challenges ‚Äì should balance promise with realistic context.¬† This story fell short in comparison with the competing New York Times story.,
https://www.healthnewsreview.org/review/4007/,New melanoma drugs improve chances of survival,"<span style=""font-size: small;"">Despite the four-star score, there were at least two significant shortcomings in this story ‚Äì yet both could be easily addressed. </span>",New melanoma drugs improve chances of survival,story_reviews_01078,4,[],Cancer,['melanoma'],http://www.Reuters.com/article/2011/06/05/us-cancer-melanoma-idUSTRE7542AM20110605,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of costs ‚Äì only of potential sales volume.\nIsn‚Äôt the significant cost of both drugs worth at least one line ",Reuters Health,"No discussion of drug costs ‚Äì which are substantial.
And the story didn‚Äôt explain, as the New York Times did, that 38% of vemurafenib trial participants had to stop taking the drug or lower the dose because of side effects. And there wasn‚Äôt a word a",nan,"The competing New York Times story used clear restraint in describing the findings:
But this story had none of that.¬† Instead, readers only read about:
A better balance was possible.",
https://www.healthnewsreview.org/review/3979/,Study Suggests Special MRI Might Help Diagnose Autism,"<span style=""font-size: small;"">This story asks most of the right questions and provides many good answers.</span>",Study Suggests Special MRI Might Help Diagnose Autism,story_reviews_01082,4,[],Autism,['MRI'],http://consumer.Healthday.com/Article.asp?AID=653349,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story deserves high marks for noting the high costs of an MRI. ‚ÄúThis test costs no more than a standard MRI, which runs aroun",Health Day," If it had spent a little more time quantifying the potential benefits of this screening, and if it had discussed any of the potential harms, it would have earned a higher rating.
¬†",nan,"MRIs are being touted as a breakthrough screening for a range of conditions, with promises that ‚Äúearly intervention‚Äù will save lives and eliminate suffering. For this to be true, studies have to be properly designed and have to¬†target the right popul",
https://www.healthnewsreview.org/review/3962/,Limits of New Screen for Heart Disease,"<span style=""font-size: small;"">The story addressed most of our criteria and was a technically competent story.¬† But it lacked the clarity on significance and the punch that a competing </span>",Limits of New Screen for Heart Disease,story_reviews_01085,4,[],heart disease,[],http://online.wsj.com/article/SB10001424052702304066504576341601457555690.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story provided information about the costs for the test.'}, {'question': 'Does the story adequately quantify the benefits of th",The Wall Street Journal,"This story reported on a study which found that using coronary CT angiography to screen for heart disease did not result in improved outcomes for patients during the 18 months in which they were studied.
It could have emphasized that neither this CT test ",nan,"The story offered the context that ‚ÄúThe study of CCTA screening comes as medical experts are re-evaluating the frequency and usefulness of other types of health screening, including mammographies for women and PSA testing for prostate cancer in men.‚Äù",
https://www.healthnewsreview.org/review/3966/,Heart scans tied to ‚Äúevidence-free‚Äù treatment: study,"<span style=""font-size: small;"">While both this story and a competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3962"" target=""_blank"">Wall Street Journal story</a> scored well, Reuters delivered context and significance more clearly ",Heart scans tied to ‚Äúevidence-free‚Äù treatment: study,story_reviews_01086,5,[],heart disease,[],http://www.Reuters.com/article/2011/05/23/us-heart-scans-idUSTRE74M6NI20110523,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Costs were reported.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'a",Reuters Health,"This story summarized the study and its significance clearly in the first sentence ‚Äì ‚ÄúWhen symptom-free people have heart scans to look for clogged arteries, they can end up with overtreatment and side effects.‚Äù
¬†",nan,The story delivered powerful quotes from experts to put the findings into context for readers:,
https://www.healthnewsreview.org/review/3946/,Pills Offer Easier Way to Treat MS,"<span style=""font-size: small;"">Good job giving perspective on new pills that could replace shots for some patients with multiple sclerosis. </span>",Pills Offer Easier Way to Treat MS,story_reviews_01088,4,[],Wall Street Journal,"['Multiple sclerosis', 'pills']",http://online.wsj.com/article/SB10001424052748704681904576319662989399214.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This story lists both the costs of the newest drug ‚Äì Gilenya ‚Äì and the costs of existing injectable treatments. This is a great",The Wall Street Journal,"While the headline makes it sound easy, the story gives useful context on just how different patients respond to different medications ‚Äì both oral and injected. Managing multiple sclerosis is a complex balance in which each patient has to find the drugs",nan,"Multiple sclerosis is a chronic disease for a lifetime for the estimated 400,000 sufferers in the United States. As a chronic disease with no cure, the managment of it becomes key to helping patients minimize the disability they suffer. Accurate reporting",
https://www.healthnewsreview.org/review/3953/,HPV test beats Pap for cervical cancer screening,"<span style=""font-size: small;""><span style=""line-height: 115%;"">Rarely do we see so much information gathered and presented in such a clear, compelling way, giving readers appropriate context to understand the evidence on various cancer screenings. </spa",HPV test beats Pap for cervical cancer screening,story_reviews_01089,5,[],Associated Press,"['Cervical cancer', 'HPV', 'pap smears']",http://www.foxnews.com/health/2011/05/19/hpv-test-beats-pap-cervical-cancer-screening/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does not list the costs of all the screenings mentioned, but we give it a passing grade for at least addressing the issue",Associated Press,"¬†By using clear language, the story tells readers exactly what they need to know saying, for example, ‚ÄúScreening women with no symptoms for ovarian cancer with a blood test and an ultrasound exam is harmful‚Äù and ‚ÄúCervical cancer is easy to prevent.",nan,"Screening for diseases seems like a win-win, and advocates for early screening often present it as an inviolable law that screenings save lives. As this story shows, evidence is mounting that not all screenings do save lives and that some, in fact, can do",
https://www.healthnewsreview.org/review/3939/,Selenium Supplements Might Give Modest Benefit Against Cholesterol,"<span style=""font-size: small;"">¬†Overall, a good job.¬† Just not quite as complete as a competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3940"" target=""_blank"">Reuters story</a> on the same study. </span>",Selenium Supplements Might Give Modest Benefit Against Cholesterol,story_reviews_01090,4,[],HealthDay,['cholesterol'],http://consumer.Healthday.com/Article.asp?AID=652914,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of selenium supplements probably isn‚Äôt a big issue for most individual consumers, but across our society the costs a",Health Day,"This story about selenium‚Äôs effects on cholesterol points out some key limitations in a new study. It explains¬†that the¬†trial was conducted in Britain, where people generally have lower selenium intakes than in the U.S. ‚Äî so the results may not¬†app",nan,Selenium is a component of multivitamins taken by millions of Americans on a daily basis. Selenium supplements are also taken¬†individually in the hope that they will ward off¬†chronic diseases such as¬†cancer and heart disease. While there isn‚Äôt much e,
https://www.healthnewsreview.org/review/3940/,Can selenium lower cholesterol?,"<span style=""font-size: small;"">¬†This story about selenium‚Äôs effects on cholesterol met more of our criteria in fewer words than¬†the competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3939"" target=""_blank"">HealthDay story</a>.</",Can selenium lower cholesterol?,story_reviews_01091,5,[],Reuters Health,['cholesterol'],http://www.Reuters.com/article/2011/05/16/us-selenium-cholesterol-idUSTRE74F80M20110516,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says a month‚Äôs supply of selenium costs about $2. But many people may be getting selenium in\xa0their daily multivitami",Reuters Health,"While both stories managed to deliver the correct bottom line about selenium supplements, Reuters did a better job explaining the costs and availability of selenium supplements and reporting the data¬†presented in the study.
¬†",nan,Selenium is a component of multivitamins taken by millions of Americans on a daily basis. Selenium supplements are also taken¬†individually in the hope that they will ward off¬†chronic diseases such as¬†cancer and heart disease. While there isn‚Äôt much e,
https://www.healthnewsreview.org/review/3929/,"Dessert, Laid-Back and Legal","<span style=""font-size: small;"">Stories about these products are spreading all over the Internet.¬† So it‚Äôs important that the <em>New York Times</em> weighs in with a closer look at the claims.</span>","Dessert, Laid-Back and Legal",story_reviews_01093,5,[],New York Times,['melatonin'],http://www.nytimes.com/2011/05/15/us/15lazycakes.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story includes some pricing estimates for these products.'}, {'question': 'Does the story adequately quantify the benefits of t",The New York Times,The story offers good context ‚Äì starting with a recollection of over-the-counter melatonin claims that were ‚Äúthe rage‚Äù among frequent fliers back in the ‚Äô90s.¬† And reminding readers that ‚Äúpromoters of these are appealing to people who think it‚,nan,It can be a public service to do this kind of reporting when new fad products are promoted without evidence of safety or effectiveness.,
https://www.healthnewsreview.org/review/3918/,"Celebrex may curb colon cancer, but with caveats","<span style=""font-size: small;"">We applaud the generally restrained take on the results, with ‚Äúcaveats‚Äù right in the headline and some discussion of the study‚Äôs¬†limitations. Solid explanation of how one might balance benefits and harms of treatment","Celebrex may curb colon cancer, but with caveats",story_reviews_01094,5,[],Cancer,['colon cancer'],http://www.Reuters.com/article/2011/05/11/us-celebrex-cancer-idUSTRE74A5SB20110511,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story manages to work costs into the discussion: ‚ÄúAt a cost of several dollars per day, depending on dosage, [Celebrex]\xa0is",Reuters Health,This story about Celebrex‚Äôs potential to prevent colorectal cancer satisfied¬†most of our criteria and gives readers the correct bottom line on this study. The story should have taken a bit more care to explain that the investigators were¬†looking at a ,nan,"As the story points out, screening via colonoscopy does not always catch¬†polyps before they have a chance to progress to¬†cancer. Drugs that can¬†reduce the number of polyps that¬†develop in the first place (e.g. Celebrex and aspirin) might therefore hav",
https://www.healthnewsreview.org/review/3920/,New drug advances the fight against pancreatic cancer,"<span style=""font-size: small;"">It‚Äôs difficult to cover both the hope and the potential ‚Äì and the caveats and context ‚Äì as well as this story did in fewer than 400 words.</span>",New drug advances the fight against pancreatic cancer,story_reviews_01095,4,[],Cancer,['pancreatic cancer'],http://yourlife.USA Today.com/health/medical/cancer/story/2011/05/An-advance-in-fighting-pancreatic-cancer/47064942/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of cost.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure",USA Today,"This story succinctly captures the important take-aways of the new study in terms of survival advantage and quality of life, while employing two key experts for perspective.
¬†",nan,Pancreatic cancer is typically such a poor-prognosis tumor that research like this is newsworthy.,
https://www.healthnewsreview.org/review/3916/,Lung scans may lead to overdiagnosis: study,Overall good job in summarizing an important analysis in only 456 words.,Lung scans may lead to overdiagnosis: study,story_reviews_01099,4,[],Reuters Health,['overdiagnosis'],http://www.Reuters.com/article/2011/05/10/us-lung-scans-idUSTRE74971L20110510,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No mention of cost ‚Äì a signficant issue in the context of alleged overdiagnosis.'}, {'question': 'Does the story adequately q",Reuters Health,"We identified three shortcomings ‚Äì all easily addressed.
¬†",nan,"Putting hard numbers to concerns about overdiagnosis and overtreatment is a vital health policy issue ‚Äì and important for journalists to track, as Reuters did with this story.",
https://www.healthnewsreview.org/review/3907/,Significant Number of Medicare Patients Getting Too-Frequent Colonoscopies,"<span style=""font-size: small;"">This was a smart, concise blog post that captured the essence of the important new analysis accurately and adequately. ¬†</span>",Significant Number of Medicare Patients Getting Too-Frequent Colonoscopies,story_reviews_01100,4,[],Screening,['colonoscopy'],http://blogs.wsj.com/health/2011/05/09/significant-number-of-medicare-patients-getting-too-frequent-colonoscopies/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story didn‚Äôt discuss costs.\xa0 And cost is a significant issue here.\xa0 The AP story, by comparison, reported that ‚Äúc",The Wall Street Journal,"Its few shortcomings could have been overcome easily with a little more space:
(Also fixing the typo in the final paragraph where colonoscopy was used when they meant colon cancer.¬† We make ‚Äôem, too.)
¬†",nan,The story‚Äôs interview quotes nailed the issue:,
https://www.healthnewsreview.org/review/3908/,Study: Many elderly get colon screening too often,"<span style=""font-size: small;"">Just a bit better than the competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3907"" target=""_blank"">Wall Street Journal health blog story</a> because AP discussed costs and mentioned what some of the ",Study: Many elderly get colon screening too often,story_reviews_01101,5,[],Associated Press,['colonoscopy'],http://www.forbes.com/feeds/ap/2011/05/09/general-us-med-needless-colonoscopies_8457614.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story stated: ‚ÄúColonoscopy costs vary widely but typically exceed $1,000. While Medicare rules say the government won‚Äôt pay",Associated Press,"As the WSJ blog did, this story‚Äôs interview quotes provided important perspectives:
¬†",nan,This was a well done story about a very well done study with important practice and policy implications.,
https://www.healthnewsreview.org/review/3893/,New Stratagems in the Quest for Hair,"<span style=""font-size: small;"">Overall, the story hit many of our marks, but it could have provided a deeper look at the evidence for these products, quantified harms and benefits and made better use of independent experts.</span>",New Stratagems in the Quest for Hair,story_reviews_01103,4,[],New York Times,[],http://www.nytimes.com/2011/05/05/fashion/05SKIN.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story\xa0provided a more\xa0thorough discussion of costs than we have seen in many stories about cosmetic products.\xa0It says,",The New York Times,"We appreciated that the story took the opportunity¬†opened by¬†new interest in an experimental hair-loss product, Latisse, to take a broader look at hair loss medicine. We especially liked the section on costs.
¬†",nan,"Hair loss is one of the elusive golden eggs for drug companies. There are two main products on the market now, but both of them come with significant side effects and questions about long term efficacy.
Any new entrant in the hair loss field tends to gene",
https://www.healthnewsreview.org/review/3899/,Swedish Study Finds Surgery For Prostate Cancer Better Than Waiting,"<span style=""font-size: small;"">This relatively short blog piece contains a lot of critical pieces of information and caveats such as ‚Äúdon‚Äôt leap to any conclusions‚Äù about this study</span>",Swedish Study Finds Surgery For Prostate Cancer Better Than Waiting,story_reviews_01104,4,[],Cancer,['prostate cancer'],http://www.NPR.org/blogs/health/2011/05/04/135995705/swedish-study-finds-surgery-for-prostate-cancer-better-than-waiting,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs. Costs would include treating the double digit rates of incontinence and erectile dysfunction ",NPR,"Great ending quote from an independent expert about how ‚Äúthere will always be questions, and an ongoing need to individualize therapy.‚Äù The story could have mentioned shared decision making as a solution here when men and their doctors are looking to ",nan,Individuals with early stage prostate cancer struggle to understand how to best make use of study outcomes to make a decision about whether to pursue active intervention to treat prostate cancer and this story helped provide some context for being able to,
https://www.healthnewsreview.org/review/3888/,"Low-Salt Diet Ineffective, Study Finds. Disagreement Abounds.","<span style=""font-size: small;"">A slam dunk win for the New York Times in comparison with a competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3887"" target=""_blank"">USA Today story</a>. </span>","Low-Salt Diet Ineffective, Study Finds. Disagreement Abounds.",story_reviews_01105,5,[],Diet studies,[],http://www.nytimes.com/2011/05/04/health/research/04salt.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': ''}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answer': 'Satisfact",The New York Times,"Two stories we reviewed on this study about salt intake showed how two well meaning journalists could come to very different conclusions about how to present this information. The New York Times story took the most cautious approach, weighing the preponde",nan,"For years, high salt intake has been suggested as a cause of heart disease and early death. Researching the impact of salt, or any dietary factor, on health can be tricky, as both of these stories explain, and this study attempted to provide a deeper look",
https://www.healthnewsreview.org/review/3895/,Study: Prostate cancer surgery helps younger men,"<span style=""font-size: small;"">By a hair, the best of the three stories we reviewed on this Swedish study of prostate cancer surgery in younger men.¬† </span>",Study: Prostate cancer surgery helps younger men,story_reviews_01106,5,[],Associated Press,"['prostate cancer', 'surgery']",http://www.The Denver Post.com/fitness/ci_17992092,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no information about the respective financial costs of the treatments for prostate cancer discussed.\xa0 Costs would ",Associated Press,This story did a good job describing the results of a recently published study which continues to follow a large group of men in Sweden who either had immediate surgery to remove their prostate or waited until they had evidence of that their prostate canc,nan,Helping men understand when there may be and when there may not be benefit from aggressive immediate treatment of prostate cancer is valuable for those diagnosed with early stage disease.,
https://www.healthnewsreview.org/review/3897/,Aggressive Treatment May Be Beneficial for Early Prostate Cancer,"<span style=""font-size: small;"">The headline is potentially misleading for readers.¬† Otherwise this is a reasonably well done story. </span>",Aggressive Treatment May Be Beneficial for Early Prostate Cancer,story_reviews_01107,5,[],Cancer,['prostate cancer'],http://consumer.Healthday.com/Article.asp?AID=652625,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs. Costs would include treating the double digit rates of incontinence and erectile dysfunction ",Health Day,"As with the NPR and AP stories we also reviewed, this story helped frame this issue in the first few lines rather than burying it at the end as so often is the case. To have an expert not involved in study quoted in the second paragraph saying ‚Äúfindings",nan,"Decisions about what, if anything, to do when facing a diagnosis of early stage prostate cancer is difficult and this story provided readers with useful information to consider.",
https://www.healthnewsreview.org/review/3883/,Quest for Vaccines to Treat Addiction,"<span style=""font-size: small;"">This story hooks readers with an¬†anecdote that sets an overly optimistic tone about this exciting¬†area of¬†substance abuse¬†research. We were relieved as we read further to find a more tempered assessment of the field. Ov",Quest for Vaccines to Treat Addiction,story_reviews_01108,4,[],Wall Street Journal,['addiction'],http://online.wsj.com/article/SB10001424052748704436004576298980739463392.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Although there was no discussion of costs, the article was clear in stating that vaccines are\xa0for the most part\xa0in an early",The Wall Street Journal,"Through its well-sourced coverage, the story conveys¬†that vaccines probably won‚Äôt¬†cure addictions¬†as successfully¬†as they¬†prevent¬†polio.¬†There‚Äôs also a nice explanation¬†of the science behind this technology and a¬†summary of the¬†challenges¬†t",nan,"The search for an easy fix to addictions ‚Äî a silver bullet ‚Äî has a long, venerable, and disappointing history. The most effective treatments so far are substitution therapies, such as methadone, buprenorphine, and varenicline.¬†‚ÄúBlocking‚Äù therapie",
https://www.healthnewsreview.org/review/3878/,"Fewer mammograms being done, studies show","<span style=""font-size: small;"">We could split hairs about the overall balance in the piece, but generally this was a good job ‚Äì far better than the competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3877"" target=""_blank"">Denver P","Fewer mammograms being done, studies show",story_reviews_01112,4,[],CNN,['mammography'],http://www.CNN.com/2011/HEALTH/05/02/mammogram.study/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'At some point, costs must enter into this discussion.\xa0 But this story never got there.'}, {'question': 'Does the story adequ",CNN,We give the story credit for highlighting the main point ‚Äî that the benefit is small and that women should be informed and given a choice. The piece could have ended with that. it also would have been good to comment more on the science of the studies w,nan,"Demonstrating far more balance than some other stories, this report allowed the chair of the US Preventive Services Task Force to explain their recommendations:
But still missing in the piece was any recognition of the possibility that a decline in mammog",
https://www.healthnewsreview.org/review/3884/,Tailored medicine could prevent more heart attacks,"<span style=""font-size: small;"">Interesting story on an important area of research ‚Äì individualized medicine driven by computerized risk calculators that might someday be embedded in electronic health record systems. </span>",Tailored medicine could prevent more heart attacks,story_reviews_01113,4,[],heart disease,['heart attacks'],http://www.Reuters.com/article/2011/05/02/us-tailored-medicine-heart-attacks-idUSTRE7417DW20110502,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Couldn‚Äôt Dr. Eddy have commented on the projected cost of implementing his idea?\xa0 And certainly the projected cost saving ",Reuters Health,"The story addressed most of our criteria, but we felt it could have been improved a bit by even brief mention of the cost impact of implementing such a system, and a little more context on the Archimedes system and related research.
Overall, though, good ",nan,Finding more cost effective and more efficient means of treating people with high blood pressure has great potential for health policy ‚Äì as does the broader approach of using risk calculators in electronic medical records.,
https://www.healthnewsreview.org/review/3861/,Potential Parkinson‚Äôs Treatment Explored,"<span style=""font-size: small;"">We applaud the appropriately cautious tone and context provided in this story ‚Äì a good example of how health care business stories can address most of our criteria. </span>",Potential Parkinson‚Äôs Treatment Explored,story_reviews_01114,5,[],Wall Street Journal,"[""Parkinson's""]",http://online.wsj.com/article/SB10001424052748704729304576287272953759718.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 There was no discussion of costs but that is understandable at this early stage.'}, {'question': 'Does the st",The Wall Street Journal,Reporters of some business stories we‚Äôve evaluated say that our criteria aren‚Äôt fair to or shouldn‚Äôt be applied to business stories ‚Äì that some health care industry business announcements may be incomplete but are still newsworthy.¬† We have no di,nan,"Parkinson‚Äôs disease is a progressive degenerative disease. While there are newer treatment options including newer drugs and deep brain stimulation, a definitive treatment remains elusize. Newer approaches, such as the delivery of a treatment directly t",
https://www.healthnewsreview.org/review/3866/,Test of Eye Drug Is Said to Show Success in Elderly,"<span style=""font-size: small;"">Don‚Äôt just read the star score for this story.¬† The real story here is one of ‚Äúinside baseball‚Äù ‚Äì and how journals, embargoes, industry interests and the drive to get scoops in journalism often rule the day.¬† So r",Test of Eye Drug Is Said to Show Success in Elderly,story_reviews_01115,4,[],New York Times,[],http://prescriptions.blogs.nytimes.com/2011/04/27/test-of-eye-drug-shows-success-in-elderly/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Costs are the heart of this story.\n'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product",The New York Times,"This NYT blog piece broke the story of a trial of one company‚Äôs $50 drug versus its $2,000 drug for the same problem ‚Äì age-related macular degeneration.
The piece provides a lot of good flesh about the study, but it should‚Äôve slapped a bigger warnin",nan,"It‚Äôs an interesting preview of the debates that may become more frequent in the era of comparative effectiveness research, with devils in the details. The study itself, however, is a preview of a preview: it‚Äôs information from anonymous investigators ",
https://www.healthnewsreview.org/review/3850/,Experimental Test May Warn of Premature Births,"Not a bad summary of a new study, written clearly and succinctly. But could have made the point more emphatically about lack of interventions to stop preterm birtheven if the test works.",Experimental Test May Warn of Premature Births,story_reviews_01120,4,[],HealthDay,['birth'],http://consumer.Healthday.com/Article.asp?AID=652094,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story included an estimate that ‚ÄúThe test may cost $150 to $250.‚Äù'}, {'question': 'Does the story adequately quantify the b",Health Day,But we wish it had given even a little context of what‚Äôs done to help predict prematurity now instead of the vague quote from the researcher saying ‚Äúthe test ‚Äòshould be an important tool for an obstetrician who currently has no clue‚Äô if premature ,nan,"Most of our criteria were addressed in this story, yet more context and more independent expert perspective focusing on the data reported in the study would have been helpful. The most challenging fact ‚Äì which wasn‚Äôt addressed ‚Äì is that we lack inte",
https://www.healthnewsreview.org/review/3852/,"Aspirin cuts heart attacks, not deaths or strokes","<span style=""font-size: small;"">This was a good example of explaining limitations, caveats and context to a consumer audience. </span>","Aspirin cuts heart attacks, not deaths or strokes",story_reviews_01121,5,[],Reuters Health,['aspirin'],http://www.Reuters.com/article/2011/04/20/us-aspirin-heartattacks-idUSTRE73J7KG20110420,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôll accept the brief mention ‚Äì at the very end of the story about aspiring being ‚Äúcheap‚Äù and ‚Äúcost effective for men ov",Reuters Health,"This story demonstrates a careful and contextual analysis of the evidence, making clear what the study did show and what it didn‚Äôt.
¬†",nan,"The trials aren‚Äôt long enough to show downstream effects on mortality, which is, unfortunately, a problem with most primary prevention trials. The real question here (which is not answered but is discussed) is what is the balance of benefits and harms.",
https://www.healthnewsreview.org/review/3839/,"Women Taking Calcium Supplements May Risk Heart Health, Researchers Say","<span style=""font-size: small;"">¬†This story makes a good effort to neatly summarize the growing body of evidence around the relationship between calcium and heart health.</span>","Women Taking Calcium Supplements May Risk Heart Health, Researchers Say",story_reviews_01123,4,[],HealthDay,['heart health'],http://consumer.Healthday.com/Article.asp?AID=652081,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story makes no mention of costs. Given that calcium supplementation can last for decades, we think costs would have been im",Health Day,It‚Äôs a difficult task given the sheer volume of research and the differences between the studies in question. The story mostly succeeds and deserves praise for taking a cautious tone. We would have liked to have seen more of the evidence presented in ab,nan,"As with many of the findings coming out of the landmark Women‚Äôs Health Initiative study, research related to calcium and heart health can leave consumers confused and even scared. Does calcium in a regular, balanced diet raise a person‚Äôs risk of havin",
https://www.healthnewsreview.org/review/3843/,"Alzheimer‚Äôs Redefined, But Changes Mean Little For Patients","<span style=""font-size: 10pt; font-family: Arial;"">Too often stories about tests for Alzheimer‚Äôs disease gloss over uncertainties and limitations, so it is heartening to see a news report that (like the AP story we also reviewed) tells readers the stark","Alzheimer‚Äôs Redefined, But Changes Mean Little For Patients",story_reviews_01124,5,[],Alzheimer's,[],http://www.NPR.org/blogs/health/2011/04/19/135547952/alzheimers-disease-gets-redefined-but-changes-mean-little-for-patients,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': '\n\n\nThe story clearly points out that brain scans and biomarker tests are ‚Äúare to be used only for research, and not for diag",NPR,"



This story serves readers by acknowledging the news about revised definitions for Alzheimer‚Äôs disease diagnosis can be confusing‚Ä¶ and for highlighting the potential to sow worry about ‚Äúpreclinical Alzheimer‚Äôs‚Äù.
A shortcoming of this story (a",nan,"



Alzheimer‚Äôs is a terrible disease. Patients and families are desperate for hope of progress, so stories about tests or treatments should follow the model of this story by giving readers a sober and realistic assessment of developments.",
https://www.healthnewsreview.org/review/3845/,New guidelines define pre-Alzheimer‚Äôs disease,"<span style=""font-size: 10pt; font-family: Arial;"">Like the NPR story we also reviewed, this story about revised guidance on diagnosing Alzheimer‚Äôs disease does a nice job of clearly distinguishing what is relevant to readers and what is of interest onl",New guidelines define pre-Alzheimer‚Äôs disease,story_reviews_01125,5,[],Alzheimer's,[],http://www.The Denver Post.com/fitness/ci_17878970,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': '\n\n\nThe story clearly points out that brain scans and biomarker tests are not ready for clinical use. Since there are no recomm",Associated Press,"



This report tells readers the stark reality, that lab tests and brain scans for Alzheimer‚Äôs are not ready for clinical use and even when the tests are validated, they will have limited value to patients until effective treatments are developed.
This",nan,"



It is more than just validation of the new diagnostic approaches being described that will be needed before these can influence clinical practice. All of the diagnostic test characteristics will need to be examined, including the ability of the test r",
https://www.healthnewsreview.org/review/3818/,Screening Prostates at Any Age,"<span style=""font-size: small;"">A strength of the story was the input from experts in the field to help readers understand the concept of why finding and then treating prostate cancer may not always benefit a man.</span>",Screening Prostates at Any Age,story_reviews_01129,4,[],New York Times,['prostate cancer'],http://www.nytimes.com/2011/04/12/health/12prostate.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs, either in terms of the actual dollar value involved in routine PSA testing or for follow-up b",The New York Times,"This was a well-written, informative story that identifies the challenges to implementing a rational approach to prostate cancer screening.
But we thought the two closing patient profiles ‚Äì the only patients profiled in the piece ‚Äì wrapped up the stor",nan,This is a useful piece to help readers understand the notion that testing is not an isolated intervention and that thinking ahead can be helpful in having medical care that matches one‚Äôs personal values and interests.,
https://www.healthnewsreview.org/review/3812/,Diet drug Qnexa: Don‚Äôt get too carried away by new study,"<span style=""font-size: small;"">This story gets a 4-star score as its </span>",Diet drug Qnexa: Don‚Äôt get too carried away by new study,story_reviews_01131,4,[],Los Angeles Times,['diet'],"http://www.Los Angeles Times.com/health/boostershots/diet-weight/la-heb-diet-drug-20110410,0,4618610,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 There was no discussion of costs, but the entire story was about the troubled path of a drug that was denied ",Los Angeles Times,"We applaud the degree and clarity of the context and explanations provided by this story ‚Äì about how this is not new info, how the FDA had problems with this kind of data when it reviewed it earlier, and how there were financial ties between the study a",nan,This is the kind of explanatory journalism we appreciate:¬† seeing through the headlines and the trumpeting of benefits that may come through even in journal articles and their news releases.,
https://www.healthnewsreview.org/review/3820/,New Pill for MS Shows Promise in Clinical Trial,"<span style=""font-size: small;"">This story about a possible new oral medication for treating multiple sclerosis (MS) packs a lot of good information into a tight and clearly written story.</span>",New Pill for MS Shows Promise in Clinical Trial,story_reviews_01132,4,[],HealthDay,"['Multiple sclerosis', 'pills']",http://consumer.Healthday.com/Article.asp?AID=651645,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Multiple sclerosis is a chronic illness requiring ongoing treatment. So, cost of treatment is an important consideration. This ",Health Day,"Readers are well served by information on the study‚Äôs design, the preliminary nature of the research, the industry-funding behind the work and the strength of the study‚Äôs findings. The story also took the additional step of making it clear to readers ",nan,"Relapsing-remitting multiple sclerosis is one form of the disease. It is characterized by a waxing and waning of symptoms with no disease progression. Treatment has been aimed at the immune system and has included injectable drugs (interferons, glatiramer",
https://www.healthnewsreview.org/review/3813/,Study: Weight-loss combo pill shows promise,"<span style=""font-size: small;"">This story bit on the ‚Äúsignificant promise‚Äù reported in a new study, but thereby lacked some of the cautionary context provided by a competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3812"" target",Study: Weight-loss combo pill shows promise,story_reviews_01133,4,[],CNN,"['pills', 'weight loss']",http://thechart.blogs.CNN.com/2011/04/10/study-weight-loss-combo-pill-shows-promise/?hpt=C2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The story didn‚Äôt discuss cost, but the story was clear that is a drug that has been slowed in its path to m",CNN,"Perhaps if we had not compared the CNN.com story with the LA Times piece, our comments might be more glowing.¬† It covered a lot of the bases ‚Äì addressing most of our criteria.
But the Times story was framed completely differently, delivering healthy sk",nan,"This story delivered a key summary line from an independent expert:¬† ‚Äú‚ÄùThis might be a good tool in the short term to get someone motivated, and that‚Äôs great. But unless it‚Äôs paired with aggressive lifestyle changes, it may not be great in the lo",
https://www.healthnewsreview.org/review/3806/,Vaginal gel reduces preterm births in some women,"<span style=""font-size: small;"">This story laid out the evidence in a more clear and compelling way than its <a href=""https://www.healthnewsreview.org/review.html?review_id=3811"" target=""_blank"">competition on the Los Angeles Times blog</a>.</span>",Vaginal gel reduces preterm births in some women,story_reviews_01135,5,[],Associated Press,['birth'],http://www.The Denver Post.com/fitness/ci_17783037,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story addresses costs in a much more straight forward way than the LA Times blog piece. It says, ‚ÄúAlthough the company didn‚Ä",Associated Press,"Both stories hit many of our marks, but this one provided much needed independent commentary, provided a better explanation of the evidence and gave readers cost information and information about possible clinical applications that were either missing or ",nan,"Preterm births can lead to serious complications for both the chlidren and the mothers and are a leading cause of neonatal death. So far, treatments to prevent preterm birth have had limited success. This study indicates that there is a superior intervent",
https://www.healthnewsreview.org/review/3791/,"More Options Before Bypass Surgery, Study Finds","<span style=""font-size: small;"">This story is a good example of how to explain shared decision-making issues to a broad audience.</span>","More Options Before Bypass Surgery, Study Finds",story_reviews_01137,5,[],heart disease,['surgery'],http://online.wsj.com/article/SB10001424052748704587004576243112786712844.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not talk about costs, which was disappointing. The costs of intensive medical therapy can easily be identified. ",The Wall Street Journal,"The piece gave readers some powerful information to help them sort through the range of factors that should be considered for any medical intervention. The only weakness our reviewers found with the story is the lack of comment about cost.
¬†",nan,"Too often stories present medical options as false choices of best versus worst. They don‚Äôt take into consideration the very real differences between patients‚Äô medical histories, diagnoses and expectations. This story should be applauded for giving re",
https://www.healthnewsreview.org/review/3796/,Estrogen Lowers Breast Cancer and Heart Attack Risk in Some,"<span style=""font-size: small;"">Careful reporting of a medical journal article that gives consumers plenty of nuance to chew over.</span>",Estrogen Lowers Breast Cancer and Heart Attack Risk in Some,story_reviews_01140,4,[],New York Times,"['breast cancer', 'heart attacks']",http://well.blogs.nytimes.com/2011/04/05/estrogen-lowers-risk-of-heart-attack-and-breast-cancer-in-some/?pagemode=print,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not touch on costs.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/produ",The New York Times,"The New York Times provides vital context for this discussion of estrogen use after menopause. Kudos for the¬† parsing of risk and including skepticism about the value of these results from outside researchers.
¬†",nan,"



Millions of women have already taken hormone replacement, and more are poised in the delicate transition where such therapy may be considered. The medical confusion is tricky for them, and this story will be widely read. Giving a true picture of this ",
https://www.healthnewsreview.org/review/3784/,New heart valve replacement procedure hailed,A reasonably complete story ‚Äì and better than some of the early stories we‚Äôve seen flooding out of the week‚Äôs big cardiology conference.,New heart valve replacement procedure hailed,story_reviews_01142,4,[],heart disease,[],"http://www.Los Angeles Times.com/health/la-he-heart-valve-replacement-20110404,0,7843825,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story indicated that the device costs around $30,000; and that combined with the costs of surgery, it works out to around $50,2",Los Angeles Times,"But benefits and harms seen in the trial weren‚Äôt adequately quantified to our liking, making it difficult for readers to judge the true scope of each as seen in the study.
Instead, a lot of space was given to exuberant quotes about ‚Äúgame changer‚Ä¶one",nan,"As the story mentions, aortic stenosis is common among the elderly population and information about a potential additional treatment option for those at the greatest risk is important.¬† The real question will be whether the benefit-harm tradeoff for the ",
https://www.healthnewsreview.org/review/3783/,Can painkillers prevent melanoma?,"<span style=""font-size: small;"">We shuddered when we saw this headline, ‚ÄúCan painkillers prevent melanoma?‚Äù, dreading what might come next. </span>",Can painkillers prevent melanoma?,story_reviews_01145,5,[],Reuters Health,['melanoma'],http://www.Reuters.com/article/2011/04/01/us-painkillers-melanoma-idUSTRE7305ZR20110401,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Costs aren‚Äôt discussed, but everyone should know the costs of aspirin, ibuprofen or related painkillers.'}, {'question': 'Does ",Reuters Health,"Instead, this story clearly and efficiently reported what was found and why:
We were a bit puzzled, though, why the story never mentioned that the study in question also looked at statins and found ‚Äúno significant protective effect was observed with sta",nan,A story that could have been hyped was saved by an important independent expert perspective in the piece.,
https://www.healthnewsreview.org/review/3775/,Patients May Benefit From New Heart Device,"<span style=""font-size: small;"">While this story earned four stars by an honest application of our 10 criteria, the three on which it was judged unsatisfactory are worth noting.¬† Read on. </span>",Patients May Benefit From New Heart Device,story_reviews_01146,4,[],Devices,[],http://online.wsj.com/article/SB10001424052748704471904576230671702390088.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We were happy to see some attention to the potential cost of the stent and in comparison to the existing drug eluting stents.\xa0In",The Wall Street Journal,¬†,nan,"The pace of innovation in the interventional management of coronary artery disease has been impressive.¬†First generation interventions included balloon angioplasty, quickly followed by angioplasty and placement of a stent to hold the vessel open.¬†The th",
https://www.healthnewsreview.org/review/3772/,"Less Stress, Better Sleep May Help You Lose Weight","<span style=""font-size: small;"">Better than its <a href=""https://www.healthnewsreview.org/review.html?review_id=3769"" target=""_blank"">LA Times competition</a> because it provided more context. But it committed the same fundamental flaw in failing to evalu","Less Stress, Better Sleep May Help You Lose Weight",story_reviews_01149,4,[],HealthDay,['weight loss'],http://consumer.Healthday.com/Article.asp?AID=651334,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answ",Health Day,"The story provided the important viewpoint that it may make sense to manage a chronic health condition such as obesity in a holistic setting that goes beyond consideration of just caloric intake and energy expenditure. ¬†However, the insight that those ob",nan,Results of an observational study should not be confused as ‚Äì or communicated as ‚Äì strategies for obtaining an outcome.¬† The research is important.¬† But it has limitations that were not adequately explained.,
https://www.healthnewsreview.org/review/3765/,No Good Evidence That Folk Remedies Ease Colic,"<span style=""font-size: small;"">We found a stunning contrast between this story and another on the same study reported on the <a href=""https://www.healthnewsreview.org/review.html?review_id=3767"" target=""_blank"">MSNBC site‚Äôs ‚ÄúToday Moms‚Äù feature</a>",No Good Evidence That Folk Remedies Ease Colic,story_reviews_01152,4,[],HealthDay,['babies'],http://consumer.Healthday.com/Article.asp?AID=651268,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story did not discuss costs. Some of the products described could end up being quite costly, and chiropractic treatment wou",Health Day,"HealthDay breaks down the evidence in a clear, concise way for readers, emphasizing high in the story that there still is not much evidence that any form of therapy works to quell colic. We wish it had spent a little more time quantifying the benefits tha",nan,Colic is frightening for parents and the cause of much angst. Stories that discuss treatment options need to make plain the amount of evidence supporting these options and avoid championing a therapy just for the sake of having something ‚Äúnew‚Äù to attr,
https://www.healthnewsreview.org/review/3754/,3-D breast scan seen as breakthrough,This one met most of our measures but could leave readers with more questions than answers about yet another technological twist on cancer screening.,3-D breast scan seen as breakthrough,story_reviews_01157,4,[],Imaging studies,[],http://www.philly.com/philly/health_and_science/20110322_3-D_breast_scan_seen_as_breakthrough.html?viewAll=y,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The article says that upgrading an existing 2-D system made by Hologics to 3-D can be accomplished with the purchase of $150,000 wo",The Philadelphia Inquirer,"We are pleased when we see a major newspaper willing to devote 1300 words to an important story about breast cancer screening. This in-depth Philadelphia Enquirer piece about a new 3-D mammogram puts the extra column space to¬†reasonably good use, but it ",nan,"Screening for breast cancer remains an important public health issue given the prevalence of the disease and the fact that cancers detected earlier are easier to treat. The problem of false positive testing in mammography is a big one, and new technology ",
https://www.healthnewsreview.org/review/3752/,40% of Gastric Banding Patients Have Complications,A solid story that provides readers with good information about a very popular surgical procedure. We only wish it had taken a harder look at the underlying evidence and given readers some information on associated costs.,40% of Gastric Banding Patients Have Complications,story_reviews_01160,4,[],HealthDay,[],http://consumer.Healthday.com/Article.asp?AID=651049,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although not discussed in the study precipitating the story, the costs for gastric banding and appropriate follow-up care are r",Health Day,This is a story reporting on a study detailing the long-term outcomes observed in a group of patients more than a decade after having gastric banding to help with weight management. ¬†The story provided some useful insight about how gastric banding and ga,nan,Obesity is an¬†increasingly common and increasingly serious risk factor for disease and early death. Providing readers with realistic expectations about the benefits of gastric banding is useful for those making decisions about what approach to take to he,
https://www.healthnewsreview.org/review/3753/,Study: Poor Results From Lap-Band Surgery,"This story hit about as many of our¬† marks as a competing HealthDay story on the same gastric banding study. But neither story provided readers any cost information, and only this story revealed one study author‚Äôs conflicts of interest.",Study: Poor Results From Lap-Band Surgery,story_reviews_01161,4,[],WebMD,['surgery'],http://www.WebMD.com/diet/weight-loss-surgery/news/20110321/study-poor-results-from-lap-band-surgery,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'As with the HealthDay story we reviewed, there was no discussion of costs of the banding procedure nor for regular office visit",WebMD,"This story detailed the long-term outcomes at one institution for obese individuals who had gastric banding surgery.¬†¬†The story was clear about the drawbacks inherent in the study. For example, that the data were obtained from a relatively small number ",nan,Obesity is a significant public health issue and impacts up to one third of American adults. Diet and exercise are still the preferred approach. Drug therapy for obesity remains elusive as evidenced by the recent refusal of the FDA to approve Qnexa. Incre,
https://www.healthnewsreview.org/review/3733/,Hormones may be better than soy for hot flashes,"<span style=""font-size: small;"">This was a solid summary, delivered in only 423 words, and addressing our criteria in almost all cases. </span>",Hormones may be better than soy for hot flashes,story_reviews_01164,5,[],Reuters Health,"['hot flashes', 'Soy']",http://www.Reuters.com/article/2011/03/15/us-hormones-be-better-than-soy-hot-flash-idUSTRE72E7P820110315,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We were pleased to see that the story included cost estimates of both soy supplements and of hormone replacement therapy pills.'}, ",Reuters Health,"One of the only suggestions we would make is that the story could have quantified potential harms.¬† It didn‚Äôt quantify harms of estrogen (about which there is a great deal of evidence) nor of soy (for which there is a scant evidence base). However, the",nan,"Hot flashes are such a hot button issue for so many women.¬† It is refreshing to see a clear, straightforward daily news report that delivers most of the information women need to evaluate a new study.",
https://www.healthnewsreview.org/review/3734/,A Touch of Massage Therapy: Reiki Used for Cancer Patients,"<span style=""font-size: small;"">The repeated statements about ‚Äúbenefit‚Ä¶healing‚Ä¶treatment‚Ä¶positive effect‚Äù in this column seemed to outweigh the statements about lack of evidence. </span>",A Touch of Massage Therapy: Reiki Used for Cancer Patients,story_reviews_01165,4,[],Wall Street Journal,['massage'],http://online.wsj.com/article/SB10001424052748704893604576200502111578620.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We give the story high marks here for at least addressing the costs at a couple of centers. It says, ‚ÄúAt Memorial Sloan-Kettering",The Wall Street Journal,We give the online version of this column credit for being merely descriptive in its headline:¬†‚ÄúReiki used for cancer patients.‚Äù Yes.¬†This method of¬†light massage¬†is indeed being used for cancer patients. But there isn‚Äôt much evidence to support,nan,Cancer patients often are in extreme pain and can feel deep depression about their condition. Stories about alternative therapies to relieve anxiety or pain need to present real evidence with a more clear focus on the weight of the evidence or lack thereo,
https://www.healthnewsreview.org/review/3722/,A Dutch therapy that stimulates the senses seems to soothe dementia patients,"<span style=""font-size: small;"">Interesting story on an innovative approach.¬† Particularly good sourcing.¬† We just wish it had spent a bit more time¬†analyzing¬†the new study that is the basis for the article and pointing out its limitations.</span>",A Dutch therapy that stimulates the senses seems to soothe dementia patients,story_reviews_01166,4,[],Philadelphia Inquirer,"['dementia', 'therapy']",http://www.philly.com/philly/health_and_science/20110314_A_Dutch_therapy_that_stimulates_the_senses_seems_to_soothe_dementia_patients.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'According to the story, a basic sensory room costs $15,000, and a portable cart with Snoezelen devices\xa0is\xa0sold\xa0for under\x",The Philadelphia Inquirer,"This story is about¬†‚ÄúSnoezelen‚Äù rooms that¬†include flashing lights, bubble tubes, disco balls, and other stimulations that are meant to soothe patients with cognitive¬†impairment.
Our main suggestions for improvement:
¬†
¬†",nan,"Innovative methods are needed to treat behavioral problems associated with dementia and many other medical conditions. The Snoezelen rooms are innovative,¬†but we need evidence that there is a benefit before large scale investments can be made.¬†Money for",
https://www.healthnewsreview.org/review/3714/,FDA approves first new drug for lupus in 56 years,"<span style=""font-size: small;"">A well-balanced summary of this historic new drug approval. </span>",FDA approves first new drug for lupus in 56 years,story_reviews_01169,4,[],,[],http://www.stltoday.com/business/national-and-international/article_ca6920f9-64f4-54fb-8b88-56eca25cea0b.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of the drug wasn‚Äôt mentioned ‚Äì a big oversight.\xa0 Other news stories pegged it at about $35,000 a year. '}, {'qu",AP Associated Press,"Good caveats, including in the patient profiled, who said, ""It‚Äôs a bittersweet thing for me because I have friends with lupus for whom this drug won‚Äôt work. There‚Äôs no one-size-fits-all for lupus and I‚Äôm just extremely fortunate that my lupus is m",nan,"As the story explained, this was not only the first new lupus drug approved in 56 years, but it could be ""a milestone that medical experts say could prompt development of other drugs that are even more effective in treating the debilitating immune system ",
https://www.healthnewsreview.org/review/3710/,Could gene tests tell if kids can be sports stars?,"<span style=""font-size: small;""><span style=""font-family: Arial;"">Nice job summarizing the potential ethical and psychological impact of home gene testing kits and provides an appropriately cautious tone regarding the evidence surrounding a particular gen",Could gene tests tell if kids can be sports stars?,story_reviews_01170,4,[],Associated Press,[],http://news.yahoo.com/s/ap/20110308/ap_on_sp_ot/us_med_sports_gene_tests,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\xa0According to the story, the testing kit costs about $170. \xa0\n'}, {'question': 'Does the story adequately quantify the benefi",Associated Press,"¬†A recent commentary published in the Journal of the American Medical Association (JAMA) calls attention to the potential harms associated with testing children for genes associated with sports performance. 
What differentiates the results reported in th",nan,"Since the entire human genome was sequenced and reported over a decade ago to great fanfare, the public has been waiting to see the practical benefits of applying this knowledge. So far, there has been little for them to see. A number of commercial enterp",
https://www.healthnewsreview.org/review/3701/,Why to Eat Like a Greek,"<span style=""font-size: small;"">This story focused more clearly on results from a newly published study than its <a href=""https://www.healthnewsreview.org/review.html?review_id=3707"" target=""_blank"">CNN.com competition</a> ‚Äì and got at the risk reductio",Why to Eat Like a Greek,story_reviews_01171,4,[],Diet studies,[],http://online.wsj.com/article/SB10001424052748703883504576186970964603198.html?mod=googlenews_wsj,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable. There was no discussion of costs, i.e. how consumption of a ‚ÄòMediterranean diet‚Äô compared to more typical die",The Wall Street Journal,"For decades, health benefits that may be derived from consuming a¬†‚ÄòMediterranean diet‚Äô have been reported on.¬† This remains of general interest to readers. ¬†This story reported the results of a recent meta-analysis which pooled the results from 50 ",nan,"We wish the story had emphasized more strongly that the impact was on risk factors, not necessarily end organ endpoints.¬† And it could have explained that metabolic syndrome itself is not a disease.",
https://www.healthnewsreview.org/review/3693/,New Chemo Drug May Benefit Some Breast Cancer Patients,"<span style=""font-size: small;"">There‚Äôs only so much you can do in 385 words but this was a balanced and fairly complete report of the key issues for¬†the new drug, eribulin, that was recently approved for patients with metastatic breast cancer.¬† </spa",New Chemo Drug May Benefit Some Breast Cancer Patients,story_reviews_01179,4,[],Cancer,"['breast cancer', 'chemotherapy']",http://consumer.Healthday.com/Article.asp?AID=650463,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no discussion of cost in the article.'}, {'question': 'Does the story adequately quantify the benefits of the treatmen",Health Day,"The article clearly details the survival benefit of eribulin, but it fails to tell readers that the drug has been approved in the United States.¬† It also fell short because it did not explain how much the drug costs or how often harms occurred in the stu",nan,Metastatic breast cancer becomes progressively more difficult to treat as various therapies become less effective.¬† This study suggests that eribulin¬†is the first single-agent chemotherapy that¬†extended the survival time of¬†women with metastatic breas,
https://www.healthnewsreview.org/review/3686/,Gene therapy raises hope for a future AIDS cure,"<span style=""font-size: small;"">Almost as important as the questions it answered were the unanswered questions the story listed at the end. Kudos for this kind of muted, responsible journalism. If only it hadn‚Äôt used the word ‚Äúcure‚Äù 12 times.¬†</spa",Gene therapy raises hope for a future AIDS cure,story_reviews_01181,5,[],"""cure""","['gene therapy', 'HIV/AIDS']",http://www.washingtonpost.com/wp-dyn/content/article/2011/02/28/AR2011022803737_pf.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We like this story‚Äôs approach.\xa0 The story could have easily stated that it‚Äôs just too early to know ‚Äì end of story.\xa0 In",Associated Press,"Our one criticism is for the headline writer, who had to frame it as ‚Äúhope for a future AIDS cure‚Äù despite these caveats in the body of the story:
A competing MedPage Today story had this headline: ‚ÄúHIV-Resistant T Cells on Horizon.‚Äù That story sa",nan,It is possible to report on very preliminary research ‚Äì even involving only six people ‚Äì and even on a topic like HIV/AIDS ‚Äì and to do so in a reasonable way.¬† This story achieved that goal ‚Äì despite the repeated use of ‚Äúcure‚Äù.,
https://www.healthnewsreview.org/review/3677/,Study: PSA rise not good prostate cancer predictor,"<span style=""font-size: small;"">Shorter than its </span>",Study: PSA rise not good prostate cancer predictor,story_reviews_01183,4,[],Associated Press,['prostate cancer'],http://yourlife.USA Today.com/health/medical/cancer/story/2011/02/Study-PSA-rise-not-good-prostate-cancer-predictor/44135930/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of costs ‚Äì not of PSA testing nor of subsequent biopsies.\xa0 These are big cost issues that warranted at least",Associated Press,"It did a better job quantifying harms, but a weaker job in evaluating the evidence.¬† It also never addressed the option of not having PSA tests at all.
Neither story addressed costs ‚Äì a big issue given the evidence about unnecessary biopsies.
¬†",nan,"This story focused on the study results, evaluating the value of tracking rising PSA levels.¬† But it never dropped back to the big picture and never reminded men that NOT having a PSA test at all.¬† The competing HealthDay story did, giving it a small bu",
https://www.healthnewsreview.org/review/3678/,Rapid Rise in PSA Levels a Poor Predictor of Prostate Cancer: Study,"<span style=""font-size: small;"">Generally good job reporting on an important study that raises more questions about what rising PSA levels mean or don‚Äôt mean. And reminds readers that NOT having PSA tests is a viable option as well.¬† Slightly better th",Rapid Rise in PSA Levels a Poor Predictor of Prostate Cancer: Study,story_reviews_01184,4,[],Cancer,['prostate cancer'],http://consumer.Healthday.com/Article.asp?AID=650257,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story did not discuss the costs of PSA tests or provide estimates of the costs for following up an increase in PSA with a b",Health Day,"This story did a few things better than its AP competition:
But AP did a better job quantifying harms.
Neither story discussed the costs of PSA tests or provided estimates of the costs for following up an increase in PSA with a biopsy. These are significa",nan,"PSA velocity was initially recommended to help men with abnormal PSA values (> 4) make decisions about whether to undergo biopsy because most of these men don‚Äôt have cancer. Because most elevated PSA values are false positives, PSA velocity could help m",
https://www.healthnewsreview.org/review/3679/,Pill That Hits A Cause Of Cystic Fibrosis Beats Expectations,"<span style=""font-size: small;"">A short (369-word) blog piece still is able to address most of our criteria, doing a good job covering a promising announcement ‚Äì complete with caveats.</span>",Pill That Hits A Cause Of Cystic Fibrosis Beats Expectations,story_reviews_01185,4,[],NPR,"['cystic fibrosis', 'pills']",http://www.NPR.org/blogs/health/2011/02/24/133995182/pill-that-hits-a-cause-of-cystic-fibrosis-beats-expectations,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'More explicitly than some other stories we saw, this blog included an estimate that the drug ‚Äúwould command a very high price, pe",NPR,"Noteworthy is how the short piece still included:
¬†",nan,"This story is important for a couple of reasons.¬†New CF treatments are needed. Desperately. The announcement of positive results for a new mode of therapy is sure to cause great excitement among patients, providers, and investors.¬† The cystic fibrosis g",
https://www.healthnewsreview.org/review/3668/,Trial Shows Cystic Fibrosis Drug Helped Ease Breathing,"<span style=""font-size: small;""><span style=""font-family: Arial;"">An excellent article overall. Had it used an independent source, it would‚Äôve swept our criteria.</span></span>",Trial Shows Cystic Fibrosis Drug Helped Ease Breathing,story_reviews_01186,5,[],New York Times,['cystic fibrosis'],http://prescriptions.blogs.nytimes.com/2011/02/23/vertex-says-cystic-fibrosis-drug-helped-patients-breathe-easier/?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'It discusses the drug‚Äôs costs, which are expected to be substantial.\xa0Given the relatively small population that the drug might",The New York Times,¬†,nan,"This story is important for a couple of reasons.¬†New CF treatments are needed. Desperately. The announcement of positive results for a new mode of therapy is sure to cause great excitement among patients, providers, and investors. This blog on the health",
https://www.healthnewsreview.org/review/3670/,Drugs To Prevent Weak Bones Linked To Unusual Fractures In Women,"<span style=""font-size: small;"">Good job of explaining a potentially confusing study. Extra points for including discussion of relative vs. absolute risk. Extra points for explaining a ‚Äúthigh‚Äù fracture that is not near the hip.</span>",Drugs To Prevent Weak Bones Linked To Unusual Fractures In Women,story_reviews_01187,5,[],NPR,[],http://www.NPR.org/blogs/health/2011/02/23/133972189/osteoporosis-drugs-linked-to-unusual-fractures-in-women,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story gives no cost information. We wish the story had given the yearly cost of at least one of these therapies, and even s",NPR,"There was a very clear explanation of the difference between relative and absolute risk.¬† And a very clear summary statement: ‚ÄúThat‚Äôs obviously a lot more benfit than risk.‚Äù
The story ends with another strong point: discussing some of the issues th",nan,"This study has the potential to confuse readers and listeners.¬† But the story addresses the seemingly contradictory elements well. Women over 65, who face most of the risk from osteoporosis, will have to question their providers as each new bit of eviden",
https://www.healthnewsreview.org/review/3667/,Fungus Got Your Toes? Zap It,"<span style=""font-size: small;"">Any American who hasn‚Äôt seen an ad for a local toenail fungus laser treatment center probably has other fungal issues of greater concern after living under a rock. If there must be more news coverage, this one was pretty ",Fungus Got Your Toes? Zap It,story_reviews_01191,5,[],Wall Street Journal,[],http://online.wsj.com/article/SB10001424052748704476604576158351630076320.html?mod=WSJ_0_0_WP_2715_RIGHTTopCarousel_1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Costs of one treatment course is estimated at $750-1,500 and the story says that some may need one one to four treatments.\xa0 So u",The Wall Street Journal,"Balanced, generally complete, evidence-based, with clear language:
¬†",nan,We have a limited pot of money to spend on health care.¬† Do we want insurance plans to reimburse for toenail fungus treatments that don‚Äôt have a solid evidence base?¬† This story helps educate readers about what they might not get for a sizeable invest,
https://www.healthnewsreview.org/review/3669/,Mammograms May Not Be Fool-Proof at Catching Second Cancers,"<span style=""font-size: small;"">Gets off to a bad start with misleading headline: ‚ÄúMammograms May Not Be Fool-Proof at Catching Second Cancers.‚Äù¬† No type of screening for breast cancer is fool-proof whether it is for an initial diagnosis or for a sec",Mammograms May Not Be Fool-Proof at Catching Second Cancers,story_reviews_01192,4,[],Cancer,['mammography'],http://consumer.Healthday.com/Article.asp?AID=650149,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article does not include information about the psychological and financial costs\xa0of biopsies for\xa0women with a false p",Health Day,"Although the story addressed most of our criteria satisfactorily, it didn‚Äôt:
¬†
¬†",nan,"Women already diagnosed with breast cancer are at risk of developing a second breast cancer.¬† Breast cancer survivors would benefit from evidence of the accuracy of screening mammography in detecting second breast cancers.¬† In addition, this evidence is",
https://www.healthnewsreview.org/review/3671/,"More unusual, fewer usual breaks with bone drugs",Good job of reporting on a new study‚Äôs conclusion on the tradeoffs involved in the use of bisphosphonate drugs for osteporosis.,"More unusual, fewer usual breaks with bone drugs",story_reviews_01193,5,[],Reuters Health,['osteoporosis'],http://www.Reuters.com/article/2011/02/22/us-bone-drugs-idUSTRE71L7JK20110222,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of a year‚Äôs treatment should have been included. The story only says the drug are ‚Äúcheap.‚Äù\xa0 Cheap to one woma",Reuters Health,"Strong points:
Room for improvement:
¬†",nan,"



An estimated 10 million people in the United States have the diagnosis of osteoporosis, a bone-weakening disease. Most of those are women. While millions are taking the widely prescribed drugs for this condition, the medical community is still evaluat",
https://www.healthnewsreview.org/review/3657/,Trying brain pacemakers to zap psychiatric disease,This was an interesting and balanced overview of deep brain stimulation for some old and some new uses.,Trying brain pacemakers to zap psychiatric disease,story_reviews_01194,4,[],Associated Press,[],http://www.washingtonpost.com/wp-dyn/content/article/2011/02/21/AR2011022101866_pf.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We give the story credit for at least citing a $30,000 cost for the ‚Äúsurgeries‚Äù but wish it had explained what that included an",Associated Press,"We especially appreciate the lack of hype in this story.¬† The reporter clearly worked hard to stick to the evidence ‚Äì not merely to promote the potential.
¬†",nan,"About 65-70 percent of patients with major depressive disorder improve substantially with 1 to 2 course of standard treatment (medication, psychotherapy or combinations). Subsequent treatment options have progressively lower rates of treatment response. T",
https://www.healthnewsreview.org/review/3664/,"Gastric Bypass Best for Weight Loss, Study Finds","<span style=""font-size: small;"">The headline &amp; lead paragraph overstate the¬†strength of the evidence ‚Äî a problem we also flagged in the <a href=""https://www.healthnewsreview.org/review.html?review_id=3662"" target=""_blank"">competing LA Times coverag","Gastric Bypass Best for Weight Loss, Study Finds",story_reviews_01195,4,[],HealthDay,"['surgery', 'weight loss']",http://consumer.Healthday.com/Article.asp?AID=650137,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes that the average cost of weight loss\xa0surgery is about $30,000. It would have been helpful to include a compariso",Health Day,"This story also was¬†better than the LA Times story in other small but tangible ways, including its handling of the statistics¬†on benefits and harms and its¬†discussion of costs. More¬†context on the previous research that has been conducted in this fiel",nan,"Most Americans today are either overweight or obese, and all that fat is taking a serious toll on our health and our economy. With manyt of us seemingly unable or unwilling to change our diets and exercise more, surgery remains one of the few options that",
https://www.healthnewsreview.org/review/3644/,Drug Shows Promise For Newborn Blindness,"<span style=""font-size: small;""><span style=""font-family: Arial;"">A multifaceted evaluation of this study and its context. But despite the high score, we have a full wish list</span></span>",Drug Shows Promise For Newborn Blindness,story_reviews_01196,4,[],Wall Street Journal,"['babies', 'eye disease']",http://online.wsj.com/article/SB10001424052748703961104576148692383748796.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'It gets credit for discussing the costs of Avastin.\nIn this review, we‚Äôll keep coming back to the lack of context for the compar",The Wall Street Journal,"
¬†",nan,"The study presents important evidence that could help many babies in the future and will likely lead to future studies. The article got the gist, yet there were some lapses in its presentations of the benefits, harms, and comparator treatments. We think t",
https://www.healthnewsreview.org/review/3632/,Women on bone drugs have less colon cancer: study,"<span style=""font-size: small;"">The difference between this story and the <a href=""https://www.healthnewsreview.org/review.html?review_id=3634"" target=""_blank"">HealthDay story</a> we reviewed on the same topic can be see in the first quotes each story cho",Women on bone drugs have less colon cancer: study,story_reviews_01203,4,[],Cancer,['colon cancer'],http://www.Reuters.com/article/2011/02/14/us-colon-cancer-idUSTRE71D6LS20110214,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Unlike the HealthDay story, this one mentions cost. It says that the drug in question, Fosamax, ‚Äúcosts around $10 per month in th",Reuters Health,"Reuters Health quoted Eric Jacobs from the American Cancer Society saying, ‚ÄúThe lower risk of colorectal cancer risk seen among bisphosphonate users in this study is intriguing‚Ä¶.However, these results should be interpreted with caution and require con",nan,"As this story notes, colorectal cancer is the third leading cause of cancer deaths in the United States and affects roughly 1 out of every 20 people. If there is already a relatively inexpensive preventative measure on the market, this could prove benefic",
https://www.healthnewsreview.org/review/3629/,Can relaxation drinks put you to sleep?,"<span style=""font-size: small;"">In reporting on a new wave of products, the story‚Äôs major shortcoming was the lack of discussion about lifestyle/behavior changes, which are the long term solutions for insomnia.</span>",Can relaxation drinks put you to sleep?,story_reviews_01205,4,[],Washington Post,['insomnia'],http://www.washingtonpost.com/wp-dyn/content/article/2011/02/14/AR2011021405988.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'These beverages don‚Äôt come cheap, but you wouldn‚Äôt know it\xa0from reading the story, which had no information on costs.\xa",The Washington Post,"This story reported on¬†so-called ‚Äúrelaxation drinks‚Äù¬†that contain melatonin, valerian, and other supplements that marketers say will help put¬†you to sleep. While we hand it to the reporting team for ferreting¬†out this¬†interesting new trend and pr",nan,"The ability to get a good night‚Äôs sleep, while taken for granted by many, is¬†something that a¬†large number of Americans struggle with on a daily¬†basis. There are reports that 40 to 70 million Americans, or about 20 percent of the population, suffer r",
https://www.healthnewsreview.org/review/3601/,Lymph Node Study Shakes Pillar of Breast Cancer Care,"<span style=""font-size: small;"">This thoughtful, reasoned story walked readers carefully through the new findings on lymph node removal following a breast cancer diagnosis and also provided a great Q&amp;A with the reporter answering questions from reader",Lymph Node Study Shakes Pillar of Breast Cancer Care,story_reviews_01209,5,[],Cancer,['breast cancer'],http://www.nytimes.com/2011/02/09/health/research/09breast.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Clearly, the costs involved in cancer treatment already are high. By removing a layer of treatment from an estimated 40,000 pat",The New York Times,"We do wish that the story had provided a few more hard numbers, especially in regard to cost. And the story could have made it clear higher up that this study does not mean that lymph nodes should never be removed.
But, overall, this story earns a top fiv",nan,"The story says it all: ‚ÄúThe discovery turns standard medical practice on its head. Surgeons have been removing lymph nodes from under the arms of breast cancer patients for 100 years, believing it would prolong women‚Äôs lives by keeping the cancer from",
https://www.healthnewsreview.org/review/3604/,Breast-cancer study questions lymph node removal,"<span style=""font-size: small;"">This &lt;500 word story did a solid job of reporting on the new findings.¬† However, the effort is surpassed by the 3,500-word job </span>",Breast-cancer study questions lymph node removal,story_reviews_01210,4,[],Cancer,['breast cancer'],http://www.washingtonpost.com/wp-dyn/content/article/2011/02/08/AR2011020806420.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs.\xa0 The article does refer to an editorial that accompanied the paper.\xa0 The editorial obse",The Washington Post,"Room for improvement:
¬†",nan,"Women who have an axillary lymph node dissection (ALND) following a diagnosis of breast cancer, sometimes develop infections at the surgery site or lymphedema.¬† Depending on its severity, lymphedema can be painful, disfiguring, and expensive to treat.¬† ",
https://www.healthnewsreview.org/review/3606/,Early breast cancers may need less lymph node surgery,"<span style=""font-size: small;"">Good job in a short story, but for more depth and decision-making help, women would get more out of the 3,500-word </span>",Early breast cancers may need less lymph node surgery,story_reviews_01213,4,[],Cancer,"['breast cancer', 'surgery']",http://yourlife.USA Today.com/health/medical/cancer/story/2011/02/Early-breast-cancers-may-need-less-lymph-node-surgery/43476410/1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article didn‚Äôt discuss any differences in the financial cost of the two approaches.\xa0 Nor did it discuss whether insure",USA Today,"Improved quality of life, with no reduction in survival. This story hits the high points of an important study looking at overall survival in some breast cancer patients who face lymph node dissection of multiple nodes with¬†its not infrequent life-long c",nan,"Until now, if a patient has a positive node on a sentinel node biospy they then have additional lymph node surgery.¬†Based on this study, which suggests¬†there is no overall ¬†or disease-free survival benefit to ¬†ALND for the patients named above, there ",
https://www.healthnewsreview.org/review/3595/,FDA Approves First Drug To Prevent Preterm Births,"Cost was the only one of our 10 criteria not addressed by this solid, tight reporting on a new drug approval.",FDA Approves First Drug To Prevent Preterm Births,story_reviews_01216,5,[],NPR,"['birth', 'FDA']",http://www.NPR.org/blogs/health/2011/02/05/133505087/fda-approves-first-drug-to-prevent-preterm-births,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of costs, something we always look for and wish would be provided.'}, {'question': 'Does the story adequately qua",NPR,"Given that 50% of care is covered by Medicaid and 49% by private payors, the costs for this drug are invisible to the individual. It is administered in clinic or by home health nurses and does not typically have a co-pay structure although patients will s",nan,"News of new drug approvals can be washed over with giddy hype.¬† But not in this story, which offered perspective, context and restraint.",
https://www.healthnewsreview.org/review/3574/,CDC To Doctors: Anti-HIV Pill No Magic Bullet Against Virus,"<span style=""font-size: small;"">In just 432 words, this story earns its 5-star score.¬† This should be a lesson for other health journalists.¬† Most of our ten criteria can be easily addressed ‚Äì even in a short story, even on deadline.¬† </span>",CDC To Doctors: Anti-HIV Pill No Magic Bullet Against Virus,story_reviews_01225,5,[],NPR,['HIV/AIDS'],http://www.NPR.org/blogs/health/2011/01/27/133280476/cdc-to-doctors-anti-hiv-pill-no-magic-bullet-against-virus,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Strong point.\xa0 The story said, ‚ÄúThere‚Äôs one other thing, the CDC says. Make sure patients understand that warding off HIV is",NPR,"Clear, succinct, and important reporting that tones down some of the celebratory tone that greeted a drug‚Äôs ‚Äúlandmark study‚Äù from a few months ago.
¬†",nan,The story notes that there was a lot of celebrating when news came out in November that taking a pill can reduce the risk of getting HIV.¬† But the story delivered a clear dose of evidence and caution ‚Äì important journalism.,
https://www.healthnewsreview.org/review/3575/,"Extra calcium, vitamin D no bone booster for men",A solid 4-star story that was just a few facts and lines away from earning 5 stars.,"Extra calcium, vitamin D no bone booster for men",story_reviews_01226,4,[],Reuters Health,['Vitamin D'],http://www.Reuters.com/article/2011/01/27/us-extra-calcium-idUSTRE70Q8V020110127,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'It is rare to see a story include costs of what might be viewed as inexpensive supplements, but this story included the costs ‚Äì a",Reuters Health,"This was a very clean and efficient story summarizing what the evidence showed and what it didn‚Äôt.
¬†",nan,Consumers may want to believe that supplements can‚Äôt hurt ‚Äì they can only help.¬†¬† It‚Äôs worth it for journalists to report on studies that show that good diet and exercise works to prevent bone-thinning ‚Äì but that supplements may not add any prot,
https://www.healthnewsreview.org/review/3567/,Short-term pill-free therapy may help insomniacs,A generally well done report on a very preliminary study.¬† We would only have hoped for a few more caveats.,Short-term pill-free therapy may help insomniacs,story_reviews_01232,4,[],Reuters Health,['insomnia'],http://www.Reuters.com/article/idUSTRE70N71L20110124,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\nAlthough this trial was a preliminary experiment, the proposed intervention is clearly defined as two office visits and t",Reuters Health,"



There is a lot to like about the possibility of a treatment for insomnia that doesn‚Äôt rely on sleeping pills or intense and expensive counseling by specialists. While this story paints a reasonably fair picture of a small test of a brief behavioral ",nan,"



Insomnia affects many people. And we are all subjected to a relentless flood of ads for sleeping pills. News of research into relatively simple approaches that don‚Äôt rely on drugs is understandably welcome, but stories about small, preliminary trial",
https://www.healthnewsreview.org/review/3549/,Antidepressant May Help Ease Hot Flashes,"<span style=""font-size: small;"">This story about using the antidepressant Lexapro to treat hot flashes was better than the competing coverage from a Washington Post blog.</span>",Antidepressant May Help Ease Hot Flashes,story_reviews_01238,4,[],WebMD,"['antidepressants', 'hot flashes']",http://www.WebMD.com/menopause/news/20110118/antidepressant-may-help-ease-hot-flashes?print=true,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article did not\xa0include information about the cost of this medication.\xa0According to recent Consumer Reports data, Lex",WebMD,"In contrast with the poorly sourced blog post, this story¬†includes comments from two experts who provide¬†valuable context about the findings of a recent trial. And while the discussion of¬†harms was still¬†inadequate, this story did at least mention the",nan,"We need more treatment options for women with¬†disruptive menopausal symptoms. Although hormone treatment is effective, many women are reluctant to take hormones because of the increase in potentially serious adverse effects associated with their use. Eme",
https://www.healthnewsreview.org/review/3540/,Alternative treatments for diabetes ‚Äî do they work?,"<span style=""font-size: small;"">The column attempted to evaluate the quality of the evidence but relied on a dueling quotes approach that did not actually provide readers with much analysis. Because so much of the story is spent on the herbal remedy maker",Alternative treatments for diabetes ‚Äî do they work?,story_reviews_01240,4,[],Diabetes,[],"http://www.Los Angeles Times.com/health/la-he-skeptic-diabetes-drinks-20110117,0,1538564,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The ‚ÄúHealthy Skepticism‚Äù column is usually good about reporting costs and they did it again this time. ‚ÄúSugar Crush isn‚Äôt y",Los Angeles Times,"¬†We applaud the way this ‚ÄúThe Healthy Skeptic‚Äù column raised some critical issues in this piece about the alleged therapeutic benefits of herbal drinks for diabetics. We wish, though, that this piece had done more than just raise issues and ask quest",nan,"Diabetes is a chronic disease that affects more than 200 million people worldwide. It requires careful modulation of blood sugar through diet, exercise and other lifestyle changes, and sometimes by a medication regimen that can be costly and mentally taxi",
https://www.healthnewsreview.org/review/3531/,"Antibiotics Defeat Ear Infections In Little Kids, Studies Find","<span style=""font-size: small;"">A clear, well-written summary of new research ‚Äì both on the NPR blog and on the air. </span>","Antibiotics Defeat Ear Infections In Little Kids, Studies Find",story_reviews_01242,4,[],NPR,['antibiotics'],http://www.NPR.org/blogs/health/2011/01/13/132869336/antibiotics-defeat-ear-infections-in-little-kids-studies-find,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Neither the blog post nor the radio piece discussed specific costs, although the blog post did describe the antibiotic in quest",NPR,"This well written blog post accompanied a fairly thorough on-air discussion of two new studies showing the benefits of vaccines for treating middle ear infections in young children.
¬†",nan,"A child with an ear infection can lead to a frightening and frustrating experience for parents. Because so many doctors are now used to the wait-and-see approach and other doctors are willing to give a child antibiotics just to make the parents happy, stu",
https://www.healthnewsreview.org/review/3532/,"Antibiotics speed up recovery from ear infections in young children, studies show","<span style=""font-size: small;"">Better than any of the other three stories we reviewed on this study on the important angle of the conversation parents should now have with their pediatricians. </span>","Antibiotics speed up recovery from ear infections in young children, studies show",story_reviews_01243,4,[],CNN,['antibiotics'],http://pagingdrgupta.blogs.CNN.com/2011/01/13/antibiotics-speed-up-recovery-from-ear-infections-in-young-children-studies-show/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This story did not discuss the costs of antibiotic prescriptions to the individual or costs of policies on our health care syst",CNN,"Of four stories we reviewed on this study (Washington Post blog, NPR, Los Angeles Times as well), two were blog pieces ‚Äì this one and the Washington Post entry.¬† This CNN effort was better in most ways than the¬†opinionated blog from the Washington Pos",nan,Wanting the best for a child with an ear infection doesn‚Äôt necessarily mean opting for the most aggressive treatment.¬†As¬†Dr Richard Rosenfeld¬† puts it in this story:¬†‚ÄúMedicine is about gray zones and balancing the risks and benefits.¬†Parents and ,
https://www.healthnewsreview.org/review/3528/,New studies say antibiotics are good for infants with confirmed ear infections,"<span style=""font-size: small;"">Overall, a credible job in telling the story of the latest chapter of the long saga of debate over treatment options for common childhood ear infections. </span>",New studies say antibiotics are good for infants with confirmed ear infections,story_reviews_01244,4,[],Los Angeles Times,"['antibiotics', 'babies']","http://www.Los Angeles Times.com/health/boostershots/la-heb-otitis-media-01122011,0,6449187,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The writer did not give a typical cost for a couple of office visits and buying the antibiotic for otitis media treatment. The ",Los Angeles Times,Two studies published in the New England Journal of Medicine show slight decrease in recurrence of ear infections in children under 2 if antibiotics are given. The story quotes one expert saying the studies are ‚Äúsubstantial‚Äù but also quotes a second e,nan,"Otitis media is the most common illness in children under 3 in the US. (75 percent of all children experience once by age 3.) Parents suffer, children suffer, and money is spent. If the treatment is only marginally effective, it would save parents and soc",
https://www.healthnewsreview.org/review/3523/,Progress Toward Blood Test for Down Syndrome,"<span style=""font-size: small;"">Independent expert perspectives were key elements in this story, explaining the ‚Äúnot yet ready for prime time‚Äù stage of this research and putting its potential for future use into context. </span>",Progress Toward Blood Test for Down Syndrome,story_reviews_01247,5,[],WebMD,"['blood tests', 'Downs Syndrome']",http://www.WebMD.com/baby/news/20110111/progress-toward-blood-test-for-down-syndrome,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôll give the story the benefit of the doubt for again leaning on an independent expert who says the technology is likely prohib",WebMD,"This thoroughly reported and carefully written story avoids giving pregnant women false hope of an easier way to detect genetic anomalies while still presenting some compelling information about a new blood test.
¬†",nan,"Pregnancy can be anxiety inducing because of the sheer number of tests already required of women: frequent blood tests, ultrasounds, and amniocentesis in many cases. Add to that the barrage of stories about the way diet and environmental conditions may be",
https://www.healthnewsreview.org/review/3525/,Shingles Vaccine Looks Like a Safe Bet for Seniors: Study,Best of three stories we reviewed on this study (see reviews of WebMD and Reuters stories as well). We invite your comparison.,Shingles Vaccine Looks Like a Safe Bet for Seniors: Study,story_reviews_01249,5,[],HealthDay,['vaccines'],http://consumer.Healthday.com/Article.asp?AID=648741,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\n\n\nThe story reports that the vaccine can cost a couple of hundred dollars and that cost can put the vaccine out of reach for so",Health Day,"



This story about a study of how the shingles vaccine performs in regular clinical use does a nice job of putting the pros and cons of the vaccine in a larger context. We also applaud how this story addresses the potential harms of the vaccine. This st",nan,"



Shingles is a terribly painful condition caused by the chicken pox virus. It often reemerges late in life. Although a large clinical trial demonstrated that a vaccine could reduce the risk of shingles attacks and postherpetic neuralgia under idealized",
https://www.healthnewsreview.org/review/3526/,Shingles Vaccine Cuts Disease Risk 55%,"<span style=""font-size: small;"">There was a lot of good detail in this story, but it failed to address the limitations of the observational study.¬† And it didn‚Äôt address the shared decision-making option of NOT¬†getting vaccinated, making the shot soun",Shingles Vaccine Cuts Disease Risk 55%,story_reviews_01250,4,[],WebMD,['vaccines'],http://www.WebMD.com/skin-problems-and-treatments/shingles/news/20110110/shingles-vaccine-cuts-disease-risk-55-percent,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\n\n\nThis story includes a comment that ‚Äúvaccine expense is another barrier for some‚Äù and that not all insurance plans cover t",WebMD,"



This story about how the shingles vaccine performs in the real world takes a somewhat different tack from the HealthDay and Reuters stories we also reviewed. It includes discussion of a second study documenting low usage rates of the vaccine, but the ",nan,"



When this story discusses the study documenting low usage rates, it states that ‚Äúdoctors may not be aware of the new recommendation.‚Äù It could be argued that many doctors have been aware of the recommendations, but have had a healthy skepticism of",
https://www.healthnewsreview.org/review/3503/,"Antibiotic eases common stomach pain, studies find","<span style=""font-size: small;"">AP‚Äôs story was better than the competing </span>","Antibiotic eases common stomach pain, studies find",story_reviews_01255,4,[],Associated Press,['antibiotics'],http://www.MSNBC.msn.com/id/40932529/ns/health-health_care/#,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Hooray! Unlike the WebMD story, this story includes cost information. ‚ÄúThe price for IBS treatment hasn‚Äôt been determined, he s",Associated Press,"AP included cost information, and this is a significant factor that should not have been ignored by other stories.
At the same time, the lack of independent experts was a flaw. This is underscored by¬†an unrepresentative anecdote from a glowing patient su",nan,"Because IBS treatment has been a frustrating experience for so many, even a modest improvement in symptoms that lasts a few months may be worthwhile for some. This appears to be a novel way of treating IBS, and the fact that symptoms improved at all is of",
https://www.healthnewsreview.org/review/3504/,Experimental Drug Helps Fight Aggressive Breast Cancer: Report,"<span style=""font-size: small;"">A generally well-done story that unfortunately had a disconnect between the headline ‚Äì ‚Äúdrug helps fight aggressive breast cancer‚Äù ‚Äì (imagine the impact this might have on some women in that state) and the appropria",Experimental Drug Helps Fight Aggressive Breast Cancer: Report,story_reviews_01256,4,[],Cancer,['breast cancer'],http://consumer.Healthday.com/Article.asp?AID=648557,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of the potential cost of the drug.\xa0 Since the story briefly discusses ‚Äúa similar drug‚Äù it could ",Health Day,This article reports on a study and accompanying editorial published in The New England Journal of Medicine.¬† The piece details the results of a Phase 2 trial for the experimental cancer drug Iniparib which was developed to treat¬†triple-negative breast ,nan,"Metastasized triple-negative breast cancer is difficult to treat.¬† If¬†the results of this study hold up in already ongoing larger¬†trials, PARP inhibitors may be a new class of drugs that might be more effective than current therapies.¬† The story deser",
https://www.healthnewsreview.org/review/3486/,New Breast Cancer Drug Found Deep In the Sea,"<span style=""font-size: small;"">An interesting and generally well-written story about fascinating research.¬† However, for the main drug profiled, there weren‚Äôt enough details to satisfy several of our key criteria.¬† </span>",New Breast Cancer Drug Found Deep In the Sea,story_reviews_01257,4,[],Cancer,['breast cancer'],http://online.wsj.com/article/SB10001424052748704111504576059772498413328.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While the drug manufacturer speculates that sales will top $1 billion, the story gives no indication of what the cost is for th",The Wall Street Journal,¬†,nan,nan,
https://www.healthnewsreview.org/review/3491/,Study finds overuse of implanted defibrillators,"<span style=""font-size: small;"">¬†A generally solid story that would have been stronger if it picked up on issues addressed in an editorial accompaying the journal article on which the story is based. </span>",Study finds overuse of implanted defibrillators,story_reviews_01259,4,[],Devices,['defibrillators'],"http://www.Los Angeles Times.com/health/la-he-heart-device-20110105,0,5729049.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Both stories we reviewed discussed costs, but the LA Times provided more details. ‚ÄúThey can be lifesaving in appropriate patients",Los Angeles Times,"This story about a study on the overuse of implanted defibrillators packs in more information than many competing stories and hits nearly all of our marks, giving readers good context and a clear understanding of the study and its implications.¬†We would ",nan,"The study in question examined data collected from a national registry on over 100,000 patients and concluded that 1/5 of the implants were outside existing guidelines. This number is troubling at face value but the story appears to be a bit more complica",
https://www.healthnewsreview.org/review/3485/,J&J joins development of blood test that can spot 1 cancer cell in a billion healthy ones,"<span style=""font-size: small;"">This story squeaked by on several of our criteria.¬† But our reviewers‚Äô overall impression was that the story gushed far too much enthusiasm without a sufficient dose of caution, analysis and perspective. </span>",J&J joins development of blood test that can spot 1 cancer cell in a billion healthy ones,story_reviews_01262,4,[],Associated Press,['blood tests'],"http://www.Los Angeles Times.com/health/sns-ap-us-med-cancer-blood-test,0,463860,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôll give the story a minimally passing grade on this criterion as well, because it does note that an earlier version of a test ",Associated Press,"This story about a business deal to support development of a test that can detect extremely low levels of cancer cells circulating in a person‚Äôs blood stream hits most of the points we want to see, yet our reviewers felt that readers are left with an ov",nan,Cancer is a leading cause of death. No disease incites greater fear. There is great demand for tests that could improve cancer outcomes. Stories about potential advances in this area should be careful not to stoke desperate hopes.,
https://www.healthnewsreview.org/review/3479/,More signs lung cancer screening could save lives,"<span style=""font-size: small;"">The meat of the story was well done, making up for the headline, lead sentence and concluding section that were a bit raw around the edges. </span>",More signs lung cancer screening could save lives,story_reviews_01263,4,[],Cancer,['lung cancer'],http://uk.Reuters.com/article/idUKTRE6BR3E720101228,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\n\nThe story reports that this sort of scan costs about $300. The story also notes that if screening is effective, the sca",Reuters Health,"



We were on high alert when reviewing this story about CT screening and lung cancer deaths, because of questions about the methods used in the study and the advocacy history of the lead researcher. The headline, lead sentence and concluding section‚Ä¶ ",nan,"


 
Lung cancer is the leading cancer killer of men and women in US. While the most effective response is reducing smoking (which also reduces the heart disease and other smoking-related ailments that kill and disable far more people than lung cancer), e",
https://www.healthnewsreview.org/review/3473/,Don‚Äôt Stay Up Waiting For A Pill To Fight Jet Lag,"<span style=""font-size: small;"">Good health news blog example.¬† Solid context and history ‚Äì especially given blog post brevity. </span>",Don‚Äôt Stay Up Waiting For A Pill To Fight Jet Lag,story_reviews_01265,4,[],NPR,['jet lag'],http://www.NPR.org/blogs/health/2010/12/27/132361885/dont-stay-up-waiting-for-a-pill-to-fight-jet-lag,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of cost, which we wish had been included.'}, {'question': 'Does the story adequately quantify the benefits of the",NPR,Only 250 words but with 5 links to offer more context to the discerning reader.,nan,nan,
https://www.healthnewsreview.org/review/3462/,Study: Stroke deaths higher where fried fish aplenty,"<span style=""font-size: small;"">While other stories by other news organizations used headlines such as ‚Äúeating fried fish may boost stroke risk‚Äù ‚Äì something this study could not establish, this USA Today story did a solid job of explaining how assoc",Study: Stroke deaths higher where fried fish aplenty,story_reviews_01267,5,[],Stroke,[],http://www.USA Today.com/yourlife/food/diet-nutrition/2010-12-23-friedfish23_ST_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story doesn‚Äôt discuss the cost of fried fish, but we think this is common knowledge. Not applicable in this case.'}, {'ques",USA Today,"This story could have been botched so easily.¬† Instead, this story covered the study and sought multiple independent perspectives which provided important analysis of the possible limitations of the research and the questions remaining.
¬†",nan,"Association does not equal causation, and this story nailed that point, explaining it clearly for readers.¬† Nice job.¬† To others who still don‚Äôt understand the difference, see our primer on this topic.",
https://www.healthnewsreview.org/review/3453/,Dyslexia: Scanning the brain for clues,Better by far than the stories by Reuters and WebMD that we also reviewed.¬† Read and compare.,Dyslexia: Scanning the brain for clues,story_reviews_01268,4,[],CNN,[],http://www.CNN.com/2010/HEALTH/12/21/dyslexia.kids/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\nNone of the stories we reviewed gave readers sufficient information on the cost of the research scans used in the study. ",CNN,"



This story is the best of the three we reviewed about a study indicating that brain scans may help researchers understand brain structure and function in people who have dyslexia. It refrains from claiming that the work has near-term clinical implicat",nan,"



Good reading skills are fundamental to educational, social and financial success. Dyslexia is a type of reading disability characterized by difficulties in word recognition, spelling and decoding. Most studies suggest early intervention is important, ",
https://www.healthnewsreview.org/review/3445/,Vaginal steam bath finds a place among Southern California spa options,"<span style=""font-size: small;"">Was it the ability to put ‚Äúvaginal steam bath‚Äù¬†in a headline that sold a major newspaper on this story?¬† We couldn‚Äôt find much else.¬†</span>",Vaginal steam bath finds a place among Southern California spa options,story_reviews_01270,4,[],Los Angeles Times,['vaginal'],"http://www.Los Angeles Times.com/health/la-he-v-steam-20101220,0,6205138,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes the price ‚Äúper squat‚Äù at various spas and the cost of a do-it-yourself Internet kit.'}, {'question': 'Does the ",Los Angeles Times,"We liked that this story points out early on that there is zero evidence to support the health benefits of herbal steam baths for the vagina, which are known in traditional Korean medicine as chai-yok. But we became¬†confused¬†when the story explained¬†th",nan,There are limited journalistic resources to cover the seemingly limitless number of treatments that are out there.¬†So we‚Äôd prefer to see journalists pursuing stories¬†that¬†aid¬†the decision-making of¬†a significant number of health care consumers.¬†A ,
https://www.healthnewsreview.org/review/3442/,FDA rejects Avastin as breast cancer therapy,"<span style=""font-size: small;"">Overall we commend this story for navigating some tricky issues issue pretty squarely down the middle. However we point out a few ways it could‚Äôve been improved.</span>",FDA rejects Avastin as breast cancer therapy,story_reviews_01276,4,[],CNN,"['breast cancer', 'FDA']",http://www.CNN.com/2010/HEALTH/12/16/avastin.fda/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The several facets of costs are addressed, including the rationing charge. The story gets a shout out for talking about both sides ",CNN,"Strong points:
Weaker points:
¬†",nan,"Withdrawing a drug can be a tricky business. Like with Vioxx, some people currently taking a drug may be deriving benefit from it and tolerating it fine, but others may be harmed by it. As is clear from this article, the problem isn‚Äôt that Avastin doesn",
https://www.healthnewsreview.org/review/3439/,German doctors declare ‚Äúcure‚Äù in HIV patient,"This report on an extreme treatment that may have eliminated HIV from one person in an almost unique situation included a wealth of caution, which is warranted, since standard antiretroviral therapy offers decades of good quality life to people with HIV.",German doctors declare ‚Äúcure‚Äù in HIV patient,story_reviews_01277,4,[],"""cure""",['HIV/AIDS'],http://www.Reuters.com/article/idUSTRE6BE68220101215,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story makes no mention of costs.\xa0With an estimated cost of $150,000 to 200,000, the cost of a allogenic bone marrow tran",Reuters Health,"The quote marks around the word ‚Äúcure‚Äù in the headline were a sign of the cautious approach of this story. Instead of allowing a sense of hyperbole to permeate, as we saw in other coverage of the same study, we were glad to see many of the appropriate",nan,"The word cure, even when surrounded by quote marks certainly gets one‚Äôs attention. Applied to a story about HIV and AIDS, it is an attention-grabber. Despite the arguable hyperbole on the part of the German researchers, the story is interesting because ",
https://www.healthnewsreview.org/review/3424/,Bone Drug Zometa Flops Overall as Breast Cancer Treatment,"<span style=""font-size: small;""><span style=""font-family: Arial;"">When something doesn‚Äôt work, say so. That‚Äôs what this story did, unlike the Los Angeles Times story we also reviewed about the negative results from the AZURE trial that looked for surv",Bone Drug Zometa Flops Overall as Breast Cancer Treatment,story_reviews_01282,5,[],Cancer,['breast cancer'],http://consumer.Healthday.com/Article.asp?AID=647266,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We won‚Äôt require a discussion of costs in this story because the use of zoledronic acid for early stage breast cancer is still up",Health Day,"This story offered a solid, informative overview of a randomized controlled trial called AZURE‚Äîwhich assessed the benefits and risks of zoledronic acid as a treatment for early stage breast cancer. Its clarity, and cautious interpretation of this clinic",nan,"Zoledronic acid and other bone-density enhancing bisphosphonates have been employed as treatments for osteoporosis and to prevent skeletal complications among women with metastatic breast cancer. However, their role in the prevention of recurrence among w",
https://www.healthnewsreview.org/review/3413/,Baby aspirin linked to reduced cancer deaths,This story gives readers enough information about the limitations of this latest study of aspirin and cancer in order to understand why leading experts recommend waiting for more evidence before¬†putting too much faith in the common headache remedy.,Baby aspirin linked to reduced cancer deaths,story_reviews_01283,4,[],Cancer,['aspirin'],"http://www.Los Angeles Times.com/news/science/la-he-aspirin-cancer-20101207,0,4251936,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of aspirin is not in question. Nevertheless, a broad recommendation to begin taking aspirin daily in middle age would li",Los Angeles Times,This story about the apparent cancer reducing effect of daily low-dose aspirin seen in an analysis of data from a collection of earlier heart disease trials provides a more thorough discussion of the limitations of the latest study and its methods than so,nan,"Cancer is the second leading cause of death in the United States behind heart disease, and there are few proven methods for reducing one‚Äôs risk of developing the disease. The study discussed in this story provides fairly convincing evidence that a daily",
https://www.healthnewsreview.org/review/3414/,A daily aspirin to prevent cancer? Maybe.,"This story comes close to clinching a balanced presentation of evidence from a meta-analysis of the cancer prevention potential of aspirin. Readers get a sense of what‚Äôs new about the study results, while also being cautioned not to take it as the final",A daily aspirin to prevent cancer? Maybe.,story_reviews_01284,4,[],Cancer,['aspirin'],http://www.NPR.org/blogs/health/2010/12/07/131873139/study-aspirin-cuts-deaths-from-wide-variety-of-cancers,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This story does not discuss the cost of daily aspirin intake. Because the cost to individuals is low and well-known, we won‚Äôt i",NPR,"This story about aspirin‚Äôs potential benefits in cancer prevention does a better job than some others we reviewed, yet this story still left a lot of gaps in the picture. The overall tone couched the potential benefits in cautious statements about the p",nan,"Aspirin‚Äôs benefits to reduce cardiovascular problems are well established, but there appears to be a growing body of evidence about its strengths in preventing certain cancers, too. If aspirin turns out to be a simple solution to preventing cancer with ",
https://www.healthnewsreview.org/review/3415/,"Aspirin may cut cancer deaths, but caution urged",No story did any better than this one when it comes to delivering the news about the latest study of aspirin and cancer along with clear cautions against acting prematurely on what is still a hotly-debated scietific question.,"Aspirin may cut cancer deaths, but caution urged",story_reviews_01285,5,[],Associated Press,['aspirin'],http://www.The Mercury News.com/latest-health-news/ci_16797613?nclick_check=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': '\n\n\nAlthough the story does not discuss costs, the price of aspirin is low and well-known. Yet it would be helpful for stories ",Associated Press,"From the appropriate title to the last precautionary sentence, this story provides the readers with a balanced perspective and places the study into context. This story gives readers key facts and a range of expert reactions and context about a study that",nan,Cancers of all types are second only to heart disease as the cause of death in developed countries. A number of observational studies have suggested that the kind of low-dose aspirin regimen recommended for some people at risk of heart disease may also ha,
https://www.healthnewsreview.org/review/3410/,Gene Therapy Corrected Rare Bleeding Disorder: Study,"On a point-by-point basis, this story about a very early gene therapy experiment meets many of our criteria‚Ä¶ and yet readers may be left a bit befuddled. The story doesn‚Äôt include any comments from the researchers, some of the quotes are confusing, an",Gene Therapy Corrected Rare Bleeding Disorder: Study,story_reviews_01291,4,[],HealthDay,['gene therapy'],http://consumer.Healthday.com/Article.asp?AID=646941,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We think it‚Äôs too early to guess at what any therapy based on this technique would cost, so we won‚Äôt flag the story for not m",Health Day,This story relayed the findings of a very preliminary study¬†on a new treatment for Wiskott-Aldrich syndrome ‚Äî a rare genetic disorder that leads to serious immune system deficiencies and problems with blood clotting.¬†While¬†the story did convey some¬†,nan,"Because of its devastating effects on the immune system,¬†Wiskott-Aldrich syndrome puts sufferers¬†at increased risk of death from infections and cancer. Although bone marrow transplants can be an effective and durable¬†treatment, many children have probl",
https://www.healthnewsreview.org/review/3386/,U.S. panel triples Vitamin D intake guideline,"<span style=""font-size: 10pt; font-family: Arial;"">A flawed headline and lead sentence undermine the overall good quality of this story about an Institute of Medicine report on recommended intake of vitamin D and calcium.</span>",U.S. panel triples Vitamin D intake guideline,story_reviews_01295,4,[],Philadelphia Inquirer,['Vitamin D'],http://www.philly.com/inquirer/health_science/daily/20101130_U_S__panel_triples_Vitamin_D_intake_guideline.html?page=2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\n\n\nAlthough this story does not specifically report the cost of Vitamin D supplements, it does note that Americans spent $425 mi",The Philadelphia Inquirer,"




Most readers would take the headline ‚ÄúU.S. panel triples Vitamin D intake guideline‚Äù to mean that people should seek to increase their consumption, when in fact the committee concluded that while recommending a higher daily intake of vitamin D th",nan,"




The huge national spending on vitamin D supplements shows that people are interested in the potential health benefits. While this story does a generally good job on the details of the Institute of Medicine report and reactions to it, casual readers w",
https://www.healthnewsreview.org/review/3387/,Report Questions Need for 2 Diet Supplements,"<span style=""font-size: small;"">This story wasn‚Äôt afraid to pass judgment on lesser quality evidence. It confidently explained why an expert Institute of Medicine panel didn‚Äôt buy into the idea, promoted¬†shamelessly over¬†the past few years in variou",Report Questions Need for 2 Diet Supplements,story_reviews_01296,5,[],New York Times,"['limits of observational studies', 'Vitamin D']",http://www.nytimes.com/2010/11/30/health/30vitamin.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Most people know roughly what a bottle of vitamin D supplements might cost them, so the lack of information on cost is not a signif",The New York Times,"In one particularly effective passage, the story quoted a representative of a supplement industry group who disagreed with the report, saying that higher¬†levels of vitamin D could be beneficial.¬†But it then segued¬†immediately¬†into an explanation of wh",nan,"Vitamin D is¬†the latest in a long¬†line of ‚Äúmiracle‚Äù nutrients that people have turned¬†to in the hope of improving¬†their health.¬†As we‚Äôve¬†learned¬†from copious¬†previous experience, these supplements rarely work as advertised and¬†can sometimes",
https://www.healthnewsreview.org/review/3390/,"Report: A bit more vitamin D is good, not too much","<span style=""font-size: 10pt; font-family: Arial;"">This story concisely summarizes the overall recommendation of an Institute of Medicine committee about the intake of vitamin D that appears to support bone health. It pointedly contrasts the recommendatio","Report: A bit more vitamin D is good, not too much",story_reviews_01297,5,[],Associated Press,['Vitamin D'],http://www.The Denver Post.com/fitness/ci_16740302,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\nThe story does not address costs. While the price of a supplement pill is typically just a few cents, this story would ha",Associated Press,"




¬†The story includes multiple voices that explain the rationale for the new recommendation, as well as comments from prominent experts who dissent with some of the committee‚Äôs recommendation. The story does not give readers any information about wh",nan,"




People may want clear and final answers about nutrition and health, but the reality of health research is usually more complex and less conclusive. This story manages to summarize and explain the Institute of Medicine recommendations on vitamin D and",
https://www.healthnewsreview.org/review/3389/,Robotic assist eases less-invasive hysterectomies,"<span style=""font-size: small;"">Explaining the results of a meta analysis of observational studies is a daunting task and we applaud this story for a credible job. We would have liked a bit more information about the study design and the inherent difficul",Robotic assist eases less-invasive hysterectomies,story_reviews_01300,4,[],Reuters Health,['surgery'],http://www.Reuters.com/article/idUSTRE6AS59H20101129?pageNumber=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story only cites the researchers‚Äô statement that the robotic approach adds ‚Äúa few thousand more dollars to the procedur",Reuters Health,It‚Äôs complicated for journalists who have to explain data from a systematic review of eight studies comparing three different surgical approaches to endometrial cancer.¬† This story gave an adequate overview.¬† But we would have hoped for a stricter eva,nan,"About 600,000 women will undergo surgical removal of their uterus for a variety of medical reasons. The proliferation of robotic surgery facilities is a trend that demands an analysis of the evidence. Unfortunately there is little chance that we will ever",
https://www.healthnewsreview.org/review/3378/,Pill shows a drop of up to 70% in HIV infection risk,"<span style=""font-size: small;"">The impressive-sounding 70% relative risk reduction figure in the headline is finally tempered a bit deep in this story about an important drug trial for HIV prevention in high risk men. </span>",Pill shows a drop of up to 70% in HIV infection risk,story_reviews_01302,4,[],Los Angeles Times,['HIV/AIDS'],"http://www.Los Angeles Times.com/health/la-he-hiv-prevention-20101123,0,3820799,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The lack of cost information was disappointing because the best results in the study came from people who consistently took the",Los Angeles Times,"We could hear the champagne glasses clinking when we read the headline and the top of this story about the potential for a drug to prevent HIV infections. The rest of the story, though, strikes the appropriate cautionary notes and, for the most part, prov",nan,"The world has been promised a cure for AIDS for almost as long as the disease has been with us, and yet scientists have not been able to crack the code. They have, however, made dramatic progress in helping people control the HIV virus and prevent its tra",
https://www.healthnewsreview.org/review/3370/,Pomegranate juice could help kidney patients,"<span style=""font-size: small;"">If you‚Äôre going to report on health claims made for stuff like pomegranate juice, this story is almost a model of how to do so.</span>",Pomegranate juice could help kidney patients,story_reviews_01304,5,[],Diet studies,[],http://www.Reuters.com/article/idUSTRE6AL3C120101122?pageNumber=2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story included a price estimate for one brand of pomegranate juice ‚Äì about $4 for a 16 oz. bottle.'}, {'question': 'Does the ",Reuters Health,"Early and frequent caveats such as:
It also made excellent use of two independent and skeptical experts.
It also appropriately used absolute risk reduction figures, not just the more impressive-sounding relative risk reductions.
¬†",nan,There‚Äôs been so much hype of pomegranate juice.¬† It is refreshing and important to see a journalist tell the story but to do with facts and data ‚Äì and with independent perspectives ‚Äì rather than becoming a marketing arm of the juice industry.,
https://www.healthnewsreview.org/review/3355/,Next big thing? Big cholesterol drop with new drug,"<span style=""font-size: small;"">Better than competing stories by </span>",Next big thing? Big cholesterol drop with new drug,story_reviews_01310,4,[],Associated Press,['cholesterol'],http://www.The Denver Post.com/fitness/ci_16636091,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'As with the competing USA Today coverage, this story didn‚Äôt mention costs. We feel that some discussion of this issue was war",Associated Press,This AP story reports on a new study presented at a cardiology meeting and published online via the New England Journal of Medicine. The research is particularly newsworthy because of the dramatic effects on both LDL (‚Äúbad‚Äù) and HDL (‚Äúgood‚Äù) chole,nan,"Cardiovascular disease remains number one cause of death in the US and other developed countries. And many people still suffer heart attacks despite being treated with high doses of statin drugs, which lower bad cholesterol. So researchers are looking for",
https://www.healthnewsreview.org/review/3358/,Experimental Drug Raises Good Cholesterol Levels in Early Trial,"<span style=""font-size: small;"">Better than CNN‚Äôs story on this same study, HealthDay <span style=""font-family: Arial;"">clearly framed the story around the safety concerns about this new class of drugs that are designed to alter how the body manages cho",Experimental Drug Raises Good Cholesterol Levels in Early Trial,story_reviews_01311,4,[],HealthDay,['cholesterol'],http://consumer.Healthday.com/Article.asp?AID=646067,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Because this story clearly points out that the drug is only part way through the clinical trial process and still has a long way ",Health Day,"
¬†Beginning with the lead and continuing throughout, the story reminded readers of the limitations of this trial and that questions about health benefits will have to wait for the next round of experimentation. However, although this story gives readers ",nan,"When a trial is designed to test safety, stories about the results should focus on that question without wandering off into speculation about health benefits that have yet to be put to the test. That‚Äôs what this story does.
Over 20 million Americans cur",
https://www.healthnewsreview.org/review/3347/,Experimental drug could replace burdensome anti-stroke treatment warfarin,This is the longest of three stories we reviewed on rivaroxaban and has many appealing features. Unfortunately the story fell short on costs and harms and only relative risk reduction information was provided.,Experimental drug could replace burdensome anti-stroke treatment warfarin,story_reviews_01313,4,[],Los Angeles Times,[],"http://www.Los Angeles Times.com/news/science/la-he-blood-thinners-20101116,0,3652934,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'It is an interesting paradox that the story didn‚Äôt provide an estimate of how much consumers will have to pay for the drug, b",Los Angeles Times,"Cost information is discussed inadequately, incompletely or not at all in 70% of the stories we review. It is an interesting paradox that this story didn‚Äôt provide an estimate of how much consumers will have to pay for the drug, but it did estimate the ",nan,"While the story was well done overall, the things that were missing were vital, and could have been addressed with just a few more words.",
https://www.healthnewsreview.org/review/3349/,The Downside of a Cancer Study Extolling CT Scans,One of the best such columns to appear in the ,The Downside of a Cancer Study Extolling CT Scans,story_reviews_01314,5,[],Cancer,[],http://well.blogs.nytimes.com/2010/11/15/the-downside-of-a-cancer-study-extolling-ct-scans/?pagemode=print,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Good job on this.\xa0 The story stated:\n\xa0However, it could have also included at least a line about the costs of following test",The New York Times,"These were some of the special elements of this column:
¬†",nan,"It can be better to be late and more complete than to be first and incomplete and imbalanced.¬† Or it at least makes sense to do a next-day or next-week followup to provide context you couldn‚Äôt give on the day the news broke.
Many stories that reported ",
https://www.healthnewsreview.org/review/3335/,Heart Device Cuts Death Rate,"<span style=""font-size: small;"">Better in several subtle but significant ways than its Los Angeles Times competition on this story. </span>",Heart Device Cuts Death Rate,story_reviews_01316,5,[],Devices,['heart disease'],http://online.wsj.com/article/SB10001424052748704327704575614530026680288.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This story was more precise on costs than the LA Times, saying, ‚ÄúThe devices cost up to $35,000, versus the roughly $25,000 cost ",The Wall Street Journal,This piece asked more tough questions than the story in the LA Times. It also provided readers with more of the hard data than the other story. It broke down a complicated topic and allowed readers to view the evidence from multiple vantage points. Ultima,nan,"Defibrillators are a significant investment, and their success as a clinical intervention depends in part on whether their widespread use will be funded. Both stories discuss the broad scope of the problem ‚Äî 22 million people with heart failure worldwid",
https://www.healthnewsreview.org/review/3343/,New pill prevents strokes with less bleeding risk for atrial fib patients,"The body of the story is reasonably balanced. The headline is a bit over the top. While it is perhaps true, the study findings have yet to be completely analyzed and have not been subjected to peer review.",New pill prevents strokes with less bleeding risk for atrial fib patients,story_reviews_01317,4,[],Stroke,[],http://www.USA Today.com/yourlife/health/medical/heartdisease/2010-11-15-stroke-rivaroxiban_N.htm?loc=interstitialskip,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story mentioned that the price of rivaroxaban would likely be significantly greater than coumadin.\xa0 But it could have be",USA Today,"The story did a good job providing information about the study, the potential for benefit and the possible side effects associated with this medication.¬† Good comparison with coumadin, the effective, though challenging, medication used to treat atrial fi",nan,"The story ended with a terrific quote indicating that ‚Äúwe‚Äôre left with a question of cost versus convenience.‚Äù The ending quote goes right to the heart of the issue (pun intended). In reality, there was no signficant difference in outcomes between c",
https://www.healthnewsreview.org/review/3350/,Study: New blood thinner works as well as Coumadin,"<span style=""font-size: small;"">Overall, a solid report.¬† Could have been improved with more specific information on costs and harms.¬† And it should have reminded readers about the limitations of drawing conclusions from talks at scientific meetings. </",Study: New blood thinner works as well as Coumadin,story_reviews_01318,4,[],Associated Press,[],http://news.yahoo.com/s/ap/20101115/ap_on_he_me/us_med_blood_thinner,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story provides some information on the cost of Coumadin and the recently approved Pradaxa. Although the price for Xarelto h",Associated Press,"The story is based on a preliminary report presented at a scientific meeting. The results of the study in question have not been analyzed completely and have not been subjected to peer review. Although the study results appear to be good news, we really w",nan,Sometimes journalists on deadline at a scientific conference with hundreds and hundreds of papers being presented may forget to remind readers that there are limitations to the conclusions that can be drawn from talks presented at meetings because they ha,
https://www.healthnewsreview.org/review/3332/,Special Infant Formula Might Help Shield Babies from Type 1 Diabetes,"Strongest point:¬† inclusion of several independent experts‚Äô perspectives. Weakest point:¬† use of only relative, not absolute, risk reduction stats.",Special Infant Formula Might Help Shield Babies from Type 1 Diabetes,story_reviews_01323,4,[],HealthDay,"['baby formula', 'type 1 diabetes']",http://consumer.Healthday.com/Article.asp?AID=645775,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story notes that the extensively hydrolyzed formula is more expensive than standard formula; however, the authors should ha",Health Day,"There are many options when weaning an infant from breast milk.¬† The story discusses a recently published NEJM study which compared extensively hydrolyzed formula with regular infant formula in infants from 6-8 months, and followed these children for 10 ",nan,"Particularly important is the statement from the co-director of the Diabetes Center of Excellence at the University of Massachusetts, that there are quite a few steps between preventing one of two diabetes-causing antibodies in at-risk children via a spec",
https://www.healthnewsreview.org/review/3321/,Vitamin B and its role in improving memory,"We wish more claims of simple cures were the subject of stories this thoughtful and cautious. It didn‚Äôt hit all of our marks, but it performed an excellent service for readers wondering whether upping their B vitamin intake could help them stop memory l",Vitamin B and its role in improving memory,story_reviews_01326,4,[],Los Angeles Times,['vitamins'],"http://www.Los Angeles Times.com/health/la-he-nutrition-lab-b-vitamins-20101108,0,273827,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs. Were people to begin taking B vitamins in the quantities necessary to show improvement along ",Los Angeles Times,"This story provided insightful information about whether there exists an associations between the intake of specific ¬†B vitamins, including B6, folic acid (B9), and B12 (cobalamin), and chance of developing dementia or Alzheimer‚Äôs disease, this story i",nan,"As the population ages, we are feeling the effects of cognitive decline in large numbers of people. Most families have been affected in some way by Alzheimer‚Äôs or a similar condition. A simple solution like B vitamins would provide hope for many, and st",
https://www.healthnewsreview.org/review/3325/,"Topical rub eases kids‚Äô cold symptoms, study says","This story packed in a lot of great information, but it also fell a little short when characterizing the strength of the results. Reporters should always take a hard look at the statistics being used to tout a study‚Äôs findings, especially when the resea","Topical rub eases kids‚Äô cold symptoms, study says",story_reviews_01327,4,[],CNN,['common cold'],http://pagingdrgupta.blogs.CNN.com/2010/11/08/topical-rub-eases-kids-cold-symptoms-study-says/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\n\nOne could say that the cost of VapoRub is not an important factor, but given how easy it would be to note the price of ",CNN,"



This story of a clinical trial of a generations-old cough and congestion remedy hits almost all the key points that we would expect of a report on even the most aggressive intervention for a life-threatening condition. Where it falls short is in descr",nan,"



Just because something is statistically significant does not always mean that people can sense a real difference. The big question left unanswered here is whether a one-point shift on a seven-point scale is meaningful.",
https://www.healthnewsreview.org/review/3308/,"CT Scans Can Reduce Lung Cancer Deaths, Study Finds","<span style=""font-size: small;"">As solid as this story was, we wish it had reported that 300 needed to be scanned in order for one life to be extended.¬† That means that 299 had to be scanned, run the risks, run up the costs of scanning and unnecessary fo","CT Scans Can Reduce Lung Cancer Deaths, Study Finds",story_reviews_01328,4,[],Cancer,['lung cancer'],http://www.nytimes.com/2010/11/05/health/research/05cancer.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\nMixed bag and, in the end, not specific enough to warrant a satisfactory score. \nThe story does say that a nationwide lu",The New York Times,"



This story concisely reports the announcement that the long-anticipated National Lung Screening Trial indicates that heavy smokers who were offered a certain type of CT scan were less likely to die of lung cancer than similar smokers who were offered ",nan,"



Putting a spotlight on relative differences in rates usually magnifies the effects of an intervention. Absolute numbers ‚Äì and the number of people that need to undergo the intervention in order for at least one to benefit ‚Äì should get at least equ",
https://www.healthnewsreview.org/review/3311/,"Special CT scans cut lung cancer deaths in major study, but questions remain about screening","<span style=""font-size: small;"">Perhaps AP‚Äôs rush ‚Äì as a major wire service ‚Äì to get something published on this major trial prevented them from getting independent perspectives, but that omission is bothersome. Otherwise a generally solid report. <","Special CT scans cut lung cancer deaths in major study, but questions remain about screening",story_reviews_01330,4,[],Associated Press,['lung cancer'],http://www.cbsnews.com/stories/2010/11/04/health/main7022144.shtml,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\n\n\nThe story reports that these scans typically cost $300-400 and are not generally covered by insurance. The story would have b",Associated Press,"



It‚Äôs clear that this story worked very hard to avoid hyping the results of the National Lung Screening Trial, which found that heavy smokers who were offered certain CT scans were less likely to die of lung cancer than those who were offered chest x",nan,"



News reports on medical trials must give readers a balanced perspective. But journalists should seek out independent sources, so that they are not dependent on the sponsor or lead researcher to provide that balance.",
https://www.healthnewsreview.org/review/3302/,MRI Images May Pinpoint Time of Stroke,"<span style=""font-size: small;"">A fairly good overview of an interesting study.¬† But failing to discuss the availability of MRI for the urgent use proposed ‚Äì and then the cost of that use ‚Äì were two significant oversights. </span>",MRI Images May Pinpoint Time of Stroke,story_reviews_01334,4,[],HealthDay,['MRI'],http://consumer.Healthday.com/Article.asp?AID=645251,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs ‚Äì not for the individual and not for health planners and society. As we discussed in the ‚Äú",Health Day,This is a story about the possible use of MRI scans to help determine the onset time of stroke. ¬†It provided a clear explanation about how this can be an issue for people who awaken to find that they have had a stroke sometime while sleeping or someone w,nan,"It was noteworthy that this story largely avoided hype, injecting caution about further research that is needed, while clearly showing what the potential impact of this research could be.",
https://www.healthnewsreview.org/review/3296/,Train The Brain: Using Neurofeedback To Treat ADHD,"The story‚Äôs premise is that there is ‚Äúgrowing evidence‚Äù that neurofeedback can help people with ADHD. However, the story¬†never follows up¬†with a description of even a single¬†study¬†which backs up this bold contention. We think¬†a story should alw",Train The Brain: Using Neurofeedback To Treat ADHD,story_reviews_01337,4,[],NPR,['ADHD'],http://www.NPR.org/templates/story/story.php?storyId=130896102,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story sidebar estimates that a full course of treatment can cost $3000 or more. It could have added that this treatment is unli",NPR,"The story did accurately portray the overall state of the evidence on neurofeedback for ADHD and emphasized the lack of well controlled studies supporting its effectiveness. It also provided useful information about how to avoid untrained therapists, and ",nan,"For many parents, medication is not an appealing option for treating a child‚Äôs ADHD symptoms. The availability of better non-pharmacologic alternatives would therefore be an important and welcome development.¬†Journalists have to be careful about how th",
https://www.healthnewsreview.org/review/3284/,Do Cortisone Shots Actually Make Things Worse?,"The story brought clarity to a complicated and confusing topic. It offered important take-home messages for patients and healthcare providers alike‚Äîat least in the area of tennis elbow, where the evidence is most compelling.",Do Cortisone Shots Actually Make Things Worse?,story_reviews_01343,5,[],New York Times,[],http://well.blogs.nytimes.com/2010/10/27/do-cortisone-shots-actually-make-things-worse/?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\nThe New York Times article did not discuss the costs of steroid injections or other treatments. It would have been useful if ",The New York Times,"A New York Times article asks the provocative question ‚ÄúDo steroid injections actually make things worse?‚Äù‚Äîreferring to the treatment of chronic tendon problems such as tennis elbow, rotator cuff symptoms, jumper‚Äôs knee, and pain in the Achilles t",nan,"
Modern medicine is slowly emerging from a long period of misunderstanding about the nature of chronic tendon problems such as tennis elbow, rotator cuff ‚Äútendinitis‚Äù, and pain at the Achilles tendon.
For decades, researchers and healthcare providers ",
https://www.healthnewsreview.org/review/3286/,POM-boozled: Do health drinks live up to their labels?,This Health.com story (not reported by but simply republished by CNN.com) did an excellent job of picking apart the¬†claims made by POM Wonderful pomegranate juice and other beverages that are promoted as health products.,POM-boozled: Do health drinks live up to their labels?,story_reviews_01344,4,[],CNN,[],http://www.CNN.com/2010/HEALTH/10/27/health.pom.drink.labels/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says a bottle of POM costs $4, meeting our standard for a satisfactory. It could have specified that\xa0the $4 cost refer",CNN,"As the story points out, these claims are usually based on very thin evidence from manufacturer-funded studies. The story also included some good background information on why food manufacturers are so tempted to stretch the truth when making these claims",nan,"The ability to make health claims is a very important marketing¬†tool for food companies.¬†Unfortunately, though,¬†nobody seems to have much authority to regulate these claims or tell us which are based on sound science. The result¬†is that¬†we get compan",
https://www.healthnewsreview.org/review/3288/,More not always better with in vitro fertilization,"<span style=""font-size: small;"">The story did a good job of covering what is new here: more is not more. It was a thoughtful, well-researched story. </span>",More not always better with in vitro fertilization,story_reviews_01345,4,[],Associated Press,['in vitro fertlization'],"http://www.Los Angeles Times.com/health/chi-ap-us-med-fertilitysucc,0,3307196,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Important information about costs is provided here.'}, {'question': 'Does the story adequately quantify the benefits of the treatme",Associated Press,"Although the story did not hit all our marks, it did provide some important context for readers, especially patients who are considering fertility options. We wish most of all that it had spent more time with a few independent experts to provide some stro",nan,"The world of fertility medicine can be maddening ‚Äî both for patients and reporters. Costs are high. New techniques are being touted with some frequency. And even though there appears to be a wealth of data about outcomes, the information is incomplete a",
https://www.healthnewsreview.org/review/3280/,"Science working to create workable, safe blood substitutes","<span style=""font-size: small;"">This wonderfully written piece serves as both a profile of one of the most important components of our bodies ‚Äî blood ‚Äî and a glimpse into the future of what blood transfusions may become.</span>","Science working to create workable, safe blood substitutes",story_reviews_01347,4,[],,[],"http://www.Los Angeles Times.com/health/la-he-in-the-works-blood-20101025,0,4281865,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This is a big omission in the story. Given the ongoing shortages of blood, the costs to healthcare delivery systems continue to",Los Angeles Times,"It does not delve as deeply into the evidence behind some of these blood substitutes as we would have liked. Nor does it always identify conflicts of interest where appropriate. Overall, though, it is a balanced and thoughtful look at the topic.
¬†",nan,"As the story notes, blood shortages can magnify the effects of a disaster like the tsunami and volcano eruption in Indonesia this month. A recent¬†study in Prehospital &¬†Disaster Medicine found that if there were a major earthquake to hit Tehran ‚Äî one ",
https://www.healthnewsreview.org/review/3257/,Fish Oil Study Finds Little Benefit for Pregnant Women,Slightly better than the competing ,Fish Oil Study Finds Little Benefit for Pregnant Women,story_reviews_01351,4,[],,[],http://online.wsj.com/article/SB10001424052702303550904575562053166893846.html#printMode,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of costs and we always think there should be ‚Äì even if inconsequential. '}, {'question': 'Does the st",The Wall Street Journal,"Some important questions the story didn‚Äôt address: how did researchers measure development/intelligence at 18 months?¬† What effect size were they hoping for?¬†
¬†",nan,"In a few small but significant ways, this story used language that explained the findings more clearly than the competing New York Times story. But both stories whiffed on some important questions.¬† Read both full reviews to learn more. ",
https://www.healthnewsreview.org/review/3247/,Experimental Therapy For Sore Heels Has Skeptics,A solid piece about which we have only a few reservations.¬† We have no doubt that most listeners and readers were smarter after hearing/reading this piece. ,Experimental Therapy For Sore Heels Has Skeptics,story_reviews_01353,4,[],,[],http://www.NPR.org/templates/story/story.php?storyId=130573337,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Cost is a major part of the story here and NPR doesn‚Äôt gloss over it.\xa0The cost of shockwave treatment\xa0can range anywhere fr",NPR,"This story is about the use of shockwaves to treat a condition called plantar fasciitis that causes heel pain.¬†The story drives home the¬†point that there¬†are conflicting studies and opinions as to the¬†effectiveness of this treatment, but¬†we wish it h",nan,"There‚Äôs no question that we need better treatment options¬†for¬†plantar fasciitis‚Äìa common, bothersome problem which is a nuisance for most people but can be a real pain for some.¬†However, tough questions must be asked about a treatment that can cost",
https://www.healthnewsreview.org/review/3256/,Study: Vitamin B12 may help ward off Alzheimer‚Äôs,This Health.com story that was picked up by CNN.com did a considerably better job than ,Study: Vitamin B12 may help ward off Alzheimer‚Äôs,story_reviews_01358,4,[],,[],http://www.CNN.com/2010/HEALTH/10/18/health.vitamin.b12.alzheimers/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': ''}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answer': 'Not Sat",CNN Health,¬†,nan,This story is important because of the large burden of Alzheimer‚Äôs  disease and because we do not have effective ways to prevent it  currently.,
https://www.healthnewsreview.org/review/3231/,Hormone Replacement for Men? Perhaps,"As well as this story scored on our criteria, the failure to address costs and the potential for conflict of interest in a source can‚Äôt be overlooked. (Several of the satisfactory scores were close calls.¬† Read the full review.)",Hormone Replacement for Men? Perhaps,story_reviews_01365,4,[],,[],http://www.nytimes.com/2010/10/12/health/12brody.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Given the controversies about the benefit of testosterone replacement treatment in andropausal men, the costs of care are an im",The New York Times,We wish there were more¬†stories like this one which take a broad¬†view of the evidence¬†on a given treatment and aren‚Äôt simply reactions to a press release about a new study.¬†This column on testosterone therapy¬†rightly emphasizes the limited and conf,nan,"There is evidence that some men suffer from a real problem with¬†testosterone deficiency, and that¬†testosterone¬†replacement can be helpful for these¬†men.¬†¬†However, it is difficult to distinguish pathological deficiency from the normal drop in testost",
https://www.healthnewsreview.org/review/3236/,"Erbitux may help fight breast cancer, claims study","<span style=""font-size: small;"">The story could have been much more clear on the real take-home point:¬†<span style=""font-family: Arial;"">Women in this trial only lived an additional two¬†months without the disease getting worse but </span>without a discu","Erbitux may help fight breast cancer, claims study",story_reviews_01367,4,[],,[],http://www.Reuters.com/article/idUSTRE69B3HO20101012,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'According to the story, sales for this drug were $1.7 billion last year; however, we don‚Äôt know how much an individual person",Reuters Health,Results from a Phase II¬†clinical trial presented at a medical meeting suggest that¬†the drug Erbitux¬†may be useful for treating a type of breast cancer that does not respond to hormone therapy or other targeted treatments.¬†The fact that these data were,nan,"Although triple negative breast cancer is very difficult to treat, this drug does not seem all that impressive. Erbitux does not seem to be effective in lung or bowel cancer. Is this a drug searching for another cancer market?¬† ",
https://www.healthnewsreview.org/review/3229/,Doctors study osteoporosis screening and treatment choices to lessen risk of fractures,"Superb job of identifying major uncertainties surrounding the prevention, diagnosis, and treatment of osteoporosis. In doing so, it cut through the fog of misinformation‚Äîsome would say ‚Äúhype‚Äù‚Äîthat often surrounds this topic.",Doctors study osteoporosis screening and treatment choices to lessen risk of fractures,story_reviews_01370,4,[],,[],http://www.boston.com/news/health/articles/2010/10/11/sorting_through_advice_on_osteoporosis/?p1=Upbox_lead,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article did not discuss the costs of various management approaches. A simple statement about the costs of screening and the",The Boston Globe," 
The scientific evidence in this area seems to be changing by the month‚Äîand those at potential risk of fractures need to stay informed about key developments. The Boston Globe article clearly gave women and men enough information to at least start a di",nan,"Osteoporosis is both a serious and controversial condition. As much as 50% of the U.S. population older than 50 will be at risk for osteoporotic fractures over the course of their lifetimes, according to a recent report from the U.S. Preventive Services T",
https://www.healthnewsreview.org/review/3223/,Study O.K.‚Äôs Light Drinking During Pregnancy. Too Good to Be True?,A thoughtful story on a highly-charged topic that provides informative context. This story is the better of the two we reviewed.,Study O.K.‚Äôs Light Drinking During Pregnancy. Too Good to Be True?,story_reviews_01372,4,[],,[],http://healthland.time.com/2010/10/06/study-o-k-s-light-drinking-during-pregnancy-too-good-to-be-true/print/#ixzz11awTwgM4,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This does not seem to apply.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/proce",TIME,"You can almost hear the assignment desk with this one: ""Give me 15 inches on this study that says babies and alcohol mix."" The study itself is a little more complicated, and this story does a nice job of exploring the study‚Äôs limitations and the broader",nan,"With most clinicians in the United States recommending that women abstain entirely from alcohol while pregnant, there is a heightened anxiety around the effects drinking might have on a child. As the story notes, ""for those women who drink before finding ",
https://www.healthnewsreview.org/review/3225/,Colonoscopy may miss more than 7 percent of cancers,A well-written and thoughtful piece about a large study on colonoscopies that generated some surprising findings about what clinicians have long thought to be a definitive test.,Colonoscopy may miss more than 7 percent of cancers,story_reviews_01373,4,[],,[],http://www.Reuters.com/article/idUSTRE6955LI20101006,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not discuss costs and should have. If colonscopy is not providing that value that people once thought, it should",Reuters Health,The story puts the numbers right in the headline and follows up with more numbers in the lead.¬†The story hits most of our marks and does an especially good job making use of independent voices. We would have liked to see more use of absolute numbers to h,nan,"As the story notes, colon cancer is the second leading killer among all cancers in the US. Detecting it early can save thousands of lives. If there are flaws in the way these screenings are being applied, they need to be documented and remedied. This stor",
https://www.healthnewsreview.org/review/3226/,Seizure and Pain Drug May Treat Hot Flashes,"This story notes the preliminary nature of presentations at medical meetings, but it also leaves several key questions unanswered.",Seizure and Pain Drug May Treat Hot Flashes,story_reviews_01374,4,[],,[],http://www.WebMD.com/menopause/news/20101006/seizure-and-pain-drug-may-treat-hot-flashes,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': ''}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answer': 'Not Sat",WebMD,¬†,nan,nan,
https://www.healthnewsreview.org/review/3217/,Neurofeedback Gains Popularity and Lab Attention,"This story is mostly a ""he-said-she-said"" exchange that gives equal billing to proponents and skeptics of neurofeedback treatment for a dizzying array of ailments. Readers deserve stories that make clear the state of the evidence about medical treatments.",Neurofeedback Gains Popularity and Lab Attention,story_reviews_01375,4,[],,[],http://www.nytimes.com/2010/10/05/health/05neurofeedback.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\xa0The story provided cost estimates for a couple of neurofeedback treatment regimens. \xa0It also indicated euphemistically that ",The New York Times,"This is a story about a purported surge in the popularity of neurofeedback to treat a host of neurological ills, despite a chronic lack of large, well-controlled trials to provide reliable evidence about benefits and harms. The existence of a single, smal",nan,¬†This story matters because it lends credence to a treatment modality in the absence of documentation. ¬†,
https://www.healthnewsreview.org/review/3221/,Some Doctors Question New Cancer Treatment,"When ads tout ""real hope,"" journalists should ask ""how real?"" and ""what‚Äôs the evidence?"" That‚Äôs what this story does.",Some Doctors Question New Cancer Treatment,story_reviews_01376,5,[],,[],http://online.wsj.com/article/SB10001424052748704029304575525832837346848.html#printMode,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says that each machine ""costs as much as $300,000."" It does not provide a per-treatment cost, which would have been nice.",The Wall Street Journal,"This story shows how ""a shortcut the Food and Drug Administration allows for granting regulatory approval to certain medical devices"" has allowed the NanoKnife, an experimental treatment with very limited evidence, to be touted as the latest cure for canc",nan,This device is the type one might see advertised on the side of a bus or in the back pages of of a weekly tabloid. Health reporters often ignore these claims to focus on the higher profile blockbuster drugs being sold by major drug companies or some break,
https://www.healthnewsreview.org/review/3213/,"Surgery For Sinus Misery: Better, But Still No Cure","Sometimes you can get away with breaking the rules. This story revolves around the experience of a single patient, but the specific patient and the way her tale was handled make all the difference.","Surgery For Sinus Misery: Better, But Still No Cure",story_reviews_01378,4,[],,[],http://www.NPR.org/templates/story/story.php?storyId=130242857,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'A comment about the overall cost of endoscopic sinus surgery, as well as insurance coverage and likely out-of-pocket expenses f",NPR,"While we typically wouldn‚Äôt advise reporters to focus exclusively on a single patient‚Äôs experience, as this story about¬†endoscopic surgery for treating sinus infections¬†did, the result¬†here is a winner thanks to¬†the patient‚Äôs¬†familiarity with t",nan,"Chronic sinusitis is a common problem that has a significant impact on quality of life.¬†Chronic sinus infections can be painful, result in significant medical expenditures,¬†and lead to¬†lost productivity due to work absences. 
Although endoscopic sinus ",
https://www.healthnewsreview.org/review/3203/,Mammogram Benefit Seen for Women in Their 40s,"<span style=""font-size: larger;""><span style=""font-family: Arial;"">Although we gave the story a generally favorable review, we don‚Äôt understand why the New York Times afforded this important issue only 471 words when it deserved a much more thorough ana",Mammogram Benefit Seen for Women in Their 40s,story_reviews_01382,4,[],,[],http://www.nytimes.com/2010/09/30/health/research/30mammogram.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\n      \n\n \n \nThe story does not discuss the costs of annual mammography screening, or even provide a range of costs.\x",The New York Times,"



 
This story includes strong comments from independent experts that can help readers get a broader understanding of the results of a study that compared breast cancer death rates among women in their 40s who lived in areas of Sweden that did or did no",nan,"


 
People commonly overestimate the risk of breast cancer death among women in their 40s. By not including any information about the absolute numbers of deaths among women in this study or in the population at large, the story misses an opportunity to c",
https://www.healthnewsreview.org/review/3193/,IUD Proposed to Treat Uterine Cancer,"<span style=""font-size: small;"">¬†This story earns a five-star rating with clear caveats and interpretation for readers.¬† </span>",IUD Proposed to Treat Uterine Cancer,story_reviews_01383,5,[],,[],http://consumer.Healthday.com/Article.asp?AID=643680,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention any costs of the IUD or other treatments.'}, {'question': 'Does the story adequately quantify the be",HealthDay,"This story carefully reports on these results, with appropriate caveats that emphasize the small size of the study, the preliminary nature of the results and narrow patient population (those with pre-cancerous lesions or early-stage cancer). It quotes sev",nan,"The progestin-containing IUD (brand name Mirena) is a highly effective, well-tolerated form of birth control. Pathology studies have also shown that the IUD can cause reversal of cellular changes, known as hyperplasia, in the lining of the uterus (enodmet",
https://www.healthnewsreview.org/review/3204/,Swedish mammography study sows more confusion about screening for breast cancer,"<span style=""font-size: small;"">In the first paragraph the story included the perspective of critics who ""charged that the study was poorly designed and potentially vastly misleading""¬†and that it ""made no attempt to weigh the risks of mammography against",Swedish mammography study sows more confusion about screening for breast cancer,story_reviews_01384,5,[],,[],"http://www.Los Angeles Times.com/health/boostershots/la-heb-mammography-20100929,0,3749619,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\n\n\nThe story only said once that ""the costs are high"" referring to screening and the risks of false positives and invasive proce",Los Angeles Times,"


 
This story about a study of mammography in Swedish women in their 40s puts the findings in the context of other recent reports and highlights the critiques of independent experts, thus helping readers to see that this is just one more piece of the pu",nan,"


 
A percentage difference that sounds dramatic may look much different when put into the context of the baseline risk and the potential drawbacks of an intervention.",
https://www.healthnewsreview.org/review/3205/,New mammogram study stirs debate for women in 40s,"Clearly and strongly and early (in the 4th graf), the story states that ""the new study has major limitations and cannot account for possibly big differences in the groups of women it compares.""¬† That‚Äôs the kind of statement readers need on a complex is",New mammogram study stirs debate for women in 40s,story_reviews_01385,5,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_MAMMOGRAMS?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\nAlthough the story notes the number of women who would need to be screened to prevent a breast cancer death and the risk ",AP Associated Press,"



 
This story gives readers a balanced view of the benefits and harms of screening mammography among women in their 40s based on the results of study comparing the areas in Sweden that offered routine screening to those that did not. It tells readers n",nan,"


 
The clear description of some of the limitations of mammography helps readers see some of the complexity of decisions about screening.",
https://www.healthnewsreview.org/review/3192/,Simplifying the Decision for a Prostate Screening,"<span style=""font-size: larger;"">We‚Äôre not sure how much this story ‚Äì or the study on which it‚Äôs based ‚Äì will ""simplify"" decision-making for men facing this issue. </span>",Simplifying the Decision for a Prostate Screening,story_reviews_01387,4,[],,[],http://well.blogs.nytimes.com/2010/09/27/simplifying-the-decision-for-a-prostate-screening/?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\xa0There was no discussion of costs, though this doesn‚Äôt seem relevant to this particular discussion.\xa0'}, {'question': 'D",The New York Times,¬†This story reported on a recent study that found that a man‚Äôs PSA level at age 60 was a useful indicator of his risk for developing aggressive prostate cancer within his lifetime. ¬†While initially seeming to indicate that major groups concur that the,nan,"¬†It is important for men to understand that that prostate cancer is not a monolithic condition. ¬†Some prostate cancer is aggressive and much of it is not. ¬†Further, there is value in recognizing that ‚Äòcatching a cancer early and treating‚Äô is not wi",
https://www.healthnewsreview.org/review/3195/,IUDs May Help Treat Endometrial Cancer,"The story addresses most of our criteria ‚Äì¬† but ‚Äì as is often the case, no discussion of costs or potential harms. ",IUDs May Help Treat Endometrial Cancer,story_reviews_01389,4,[],,[],http://www.WebMD.com/cancer/news/20100928/iuds-may-help-treat-endometrial-cancer,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention the costs of the IUD or implantation.'}, {'question': 'Does the story adequately quantify the benefi",WebMD,"The standard treatment for endometrial cancer is hysterectomy, or surgical removal of the uterus.¬† However, some women, including younger women who wish to preserve their fertility, may prefer non-surgical alternatives. A study published in the Annals of",nan,"Endometrial cancer is rare in women under 40. However, for these women, who may wish to preserve their childbearing ability, there have been few alternatives to hysterectomy.",
https://www.healthnewsreview.org/review/3199/,Can lasers help you stop smoking? Check the data,"¬†We don‚Äôt often see¬†subheads like this:¬†""‚ÄôNOT ENOUGH EVIDENCE‚Äô IN SCIENTIFIC TERMS; NOT FDA-APPROVED FOR QUITTING SMOKING; WON‚ÄôT WORK ON EVERYBODY."" Beneath each subhead, the story dismantles the scientific claims of laser therapy proponents pi",Can lasers help you stop smoking? Check the data,story_reviews_01391,5,[],,[],http://www.Reuters.com/article/idUSTRE68S3TM20100929,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explains that the company profiled ""charges $350 for a one-time treatment that takes less than an hour, and offers free e",Reuters Health,"This story does something that few stories accomplish. It takes on a flashy topic ‚Äì lasers to stop people from smoking ‚Äì and deconstructs the science, or lack thereof, being used to sell it. Often stories about buzzworthy treatments focus on the weird",nan,"Smoking causes about one out of every five preventable deaths in the US, and it is one of the toughest addictions to kick. Obviously people with the will to quit would like to be able to do so in one easy visit to a laser spa. By allowing scientific claim",
https://www.healthnewsreview.org/review/3190/,"In Test of Stents, Old Standby Wins Out","<span style=""line-height: 115%; font-family: ; font-size: 10pt"">Stents are a complex topic and this article covers a lot of solid ground, but we‚Äôve pointed out some shakier spots.</span>","In Test of Stents, Old Standby Wins Out",story_reviews_01395,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=643623,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs aren‚Äôt discussed.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/proced",HealthDay,"

¬†",nan,"While coating metal stents with drugs has reduced the odds that the arteries will clog again, they have the downside of requiring much longer courses of dual anti-platelet drugs, which increases the risks of bleeding. And that bleeding risk becomes a part",
https://www.healthnewsreview.org/review/3172/,New study widens debate on the value of mammograms,Good job.¬† ,New study widens debate on the value of mammograms,story_reviews_01396,5,[],,[],http://www.philly.com/inquirer/health_science/daily/20100923_New_study_widens_debate_on_the_value_of_mammograms.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\n\n \nThe story does not mention the cost of mammography (or of follow up tests and treatments) to the individual, or, col",The Philadelphia Inquirer,"



 
This story clearly outlines how a study of mammography screening in Norway feeds into debate about the value of breast cancer screening. It includes the comments of experts who have a variety of perspectives on the latest data.

¬†
¬†",nan,"


 
Women have been whipsawed by often confusing statements and claims about whether and when to get a mammogram. This story lays out how the latest study data points to benefits of screening‚Ä¶ but that the benefits appear to be smaller than most people",
https://www.healthnewsreview.org/review/3181/,Mammograms√¢‚Ç¨‚Ñ¢ Value in Cancer Fight at Issue,Terrific sourcing is the highlight of this story ‚Äì with quotes or excerpts from seven different sources.¬† ,Mammograms√¢‚Ç¨‚Ñ¢ Value in Cancer Fight at Issue,story_reviews_01398,5,[],,[],http://www.nytimes.com/2010/09/23/health/research/23mammogram.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\nThe story does not mention the costs of screening or follow-up tests or treatment ‚Äì to the individual or, collectively,",The New York Times,"



 
This story offers readers a comprehensive overview of the study of screening mammography in Norway. It clearly explains how this study is different from earlier examinations of the effect of mammography, so that readers can get a better understandin",nan,"


 
Readers of this story will see the new results as a useful addition to other evidence on the value of mammography screening. By providing proper context, the story helps readers understand why these researchers concluded that mammography may have sma",
https://www.healthnewsreview.org/review/3174/,Mammograms Less Effective Than Believed,"<span style=""font-size: small;"">The quotes and the statistics provided by Dr. Gilbert Welch, who wrote the editorial in the New England Journal of Medicine, were key in helping to explain the study and put it in perspective for readers. </span>",Mammograms Less Effective Than Believed,story_reviews_01399,5,[],,[],http://www.WebMD.com/breast-cancer/news/20100922/mammograms-less-effective-than-believed,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This story did not mention the cost or insurance coverage for mammograms ‚Äì an unfortunate oversight given the nature of this ",WebMD,¬†,nan,nan,
https://www.healthnewsreview.org/review/3177/,Mammogram benefits more modest than doctors thought,"<span style=""font-size: small;""><span style=""font-family: Arial;"">In a relatively short account (&lt;500 words) of the results of a study of the effects of mammography screening in Norway, this story does a relatively good job communicating the conclusion",Mammogram benefits more modest than doctors thought,story_reviews_01400,4,[],,[],http://www.USA Today.com/yourlife/health/medical/breastcancer/2010-09-23-mammogram23_st_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\n\n\n\nThe story does not mention the cost of mammography (or of follow up tests and treatments) to the individual, or, collec",USA Today,"



 
¬†However, it does not explain to readers what is new or different about this study compared to earlier reports. Also, the final word in the story goes to an expert who touts benefits of mammography screening that clash with what was seen in this st",nan,"


 
By comparing this story with, for example, the Philadelphia Inquirer and WebMD stories, you see how some of the gaps we‚Äôve identified were addressed by competitors, giving readers a more complete and helpful story. ",
https://www.healthnewsreview.org/review/3168/,Some appendicitis cases may not require ‚Äôemergency‚Äô surgery,"<span style=""font-size: small;"">In an efficient and effective little 262-word story, USA Today reported what surprisingly few other news organizations did on a theme of ""More expensive, rushed emergency surgery is not always better.""</span>",Some appendicitis cases may not require ‚Äôemergency‚Äô surgery,story_reviews_01403,5,[],,[],http://www.USA Today.com/yourlife/health/healthcare/hospitals/2010-09-21-appendectomy21_ST_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Although the story didn‚Äôt cite the cost of appendectomy ‚Äì emergency or urgent surgery ‚Äì and we wish it had, we nonetheless wi",USA Today,"We really don‚Äôt understand why only a handful of mainstream news organizations reported this story. (At least in what we found.)
Why is that not a story? 
We applaud USA Today for finding time and space ‚Äì and clearly it didn‚Äôt need to free up much s",nan,"The story explains that as many as 300,000 appendectomies are done each year in the US.¬† That figure alone explains why this is an important study to report. ",
https://www.healthnewsreview.org/review/3162/,New Drugs Stir Debate on Rules of Clinical Trials,This story may evoke many different responses from readers and reviewers.¬† But our reviewers ‚Äì applying our ten criteria fairly ‚Äì give it a five-star score.¬† Concerns? Yes.¬† Overall impression?¬† Strong. ,New Drugs Stir Debate on Rules of Clinical Trials,story_reviews_01405,5,[],,[],http://www.nytimes.com/2010/09/19/health/research/19trial.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story hints at costs, noting, for example, that one phase of the trials for the drug would cost $100 million. It also talks abo",The New York Times,"A powerfully written account of how two cancer patients‚Äô lives track the development of a promising cancer drug, this story does readers a great service by explaining the intricacies and ethical quandries of the clinical trial process. It does not serve",nan,"The newspaper archives are full of stories about promising cancer drugs that went nowhere. As this story rightly points out, early success in reducing a patient‚Äôs symptoms does not mean a drug will increase a patient‚Äôs chance of long-term survival. St",
https://www.healthnewsreview.org/review/3166/,Early Trial Suggests COPD Drug Might Help Some Asthmatics,"<span style=""font-size: small;"">Slightly better than the competing <a href=""https://www.healthnewsreview.org/review.html?review_id=3167"" target=""_blank"">AP story</a> ‚Äì mainly because of the way it emphasized the caveats about this research. </span>",Early Trial Suggests COPD Drug Might Help Some Asthmatics,story_reviews_01406,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=643299,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs aren‚Äôt discussed and should be.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/",HealthDay,"Each tells the tale differently, with different context and subplots. This HealthDay story nicely¬†frames the meaning of this line of research by hammering home its early stage and unanswered questions. 
¬†",nan,"There‚Äôs a need for additional effective, well-tolerated treatment options for uncontrolled asthma, and this study provides early evidence‚Äîto be confirmed in future research‚Äîof a drug that‚Äôs sometimes given to such patients but is not currently app",
https://www.healthnewsreview.org/review/3157/,Looming ruling on breast cancer drug splits patient advocates,"<span style=""font-size: small;"">A 4-star story that, nonetheless, felt imbalanced as it focused on one personal story that missed the issue at hand ‚Äì that on average, the drug is not very effective and causes problems. Where was the anecdote that reflec",Looming ruling on breast cancer drug splits patient advocates,story_reviews_01410,4,[],,[],http://www.CNN.com/2010/HEALTH/09/15/breast.cancer.drug/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': ''}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answer': 'Satisfactor",CNN Health,"



In December, an FDA advisory panel will decide if it should revoke the approval of the drug Avastin for treating metastatic breast cancer based on the results of two major trials suggesting that the serious side effects outweigh the time that patients",nan,Two major trials found¬†that¬†Avastin¬†is not particularly effective for treating metastatic breast cancer and it causes serious side effects. The story missed this main¬†issue by devoting an extraordinary amount of space to just one woman‚Äôs success sto,
https://www.healthnewsreview.org/review/3152/,Drug for Irritable Bowel Achieves Goals in Trial,"If this story had gone the extra step of bringing in some independent experts to analyze the evidence, it would have given readers a much better picture of IBS and its treatment options.",Drug for Irritable Bowel Achieves Goals in Trial,story_reviews_01413,4,[],,[],http://www.nytimes.com/2010/09/14/health/research/14bowel.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story notes that the new drug would likely\xa0cost ""several dollars a day.""\xa0We‚Äôll call this satisfactory since we can‚Äôt ",The New York Times,"This New York Times story about an experimental drug for irritable bowel syndrome (IBS) satisfied most of our criteria. Its few shortcomings, however, were significant and threw the overall story out of balance. First, the¬†story reported on clinical tria",nan,"There are few effective treatments for irritable bowel syndrome, and most of the treatments that are effective bring limited relief to a minority of patients. The prospect of a useful new therapy for this condition is excellent news for patients, but we n",
https://www.healthnewsreview.org/review/3140/,No Cure For Morning Sickness Just Yet,"More stories need to take advantage of Cochrane Library reviews, as this one did in discussing treatments for morning sickness. At the same time, the key components of any good story ‚Äî cost information, hard data and independent voices ‚Äî should not be",No Cure For Morning Sickness Just Yet,story_reviews_01415,4,[],,[],http://www.NPR.org/blogs/health/2010/09/07/129708094/morning-sickness,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There wasn‚Äôt any discussion of\xa0costs of these treatments. The point of the story was tell readers that these treatments co",NPR,"We wish more stories focused their coverage on the lack of good evidence supporting¬†commonly¬†used medical treatments, as this NPR story about remedies for¬†morning sickness did. We also appreciate¬†this story‚Äôs decision to cover a Cochrane¬†Library sy",nan,"Morning sickness is common and can range from a minor annoyance to a life-threatening condition. It takes a significant toll on women and our economy via lost work days,¬†increased anxiety, physical symptoms and reduced overall quality of life. Women who ",
https://www.healthnewsreview.org/review/3139/,Pancreatic Chemo Comparison Finds No Survival Boost,"<font size=""3"">It takes trial and error to find appropriate cancer strategies. We are happy to see reporting on a strategy that failed because failures can ultimately lead to successes. We do wish a few more of important questions were answered.</font>",Pancreatic Chemo Comparison Finds No Survival Boost,story_reviews_01423,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=642851,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs of these chemotherapy agents are not discussed. The study compared a drug available only as a brand name to a regimen con",HealthDay,This story gave balanced coverage and the right tone to an ongoing area of research: chemotherapy for pancreatic cancer. A few more sentences would have plugged the holes and added important context about why the study compared these two regimens in the f,nan,New strategies are needed in the war against pancreatic cancer. The JAMA editorial¬†accompanying the study called such cancers ‚Äúarguably the most challenging of human malignancies.‚Äù An effective new treatment option could offer hope and extended life ,
https://www.healthnewsreview.org/review/3134/,Topical Gel Catches Up With Pills for Relief,"Sometimes the frame can distract from the picture. This rare, clear-eyed assessment of the medical evidence about a pain reliever is upstaged by an overly enthusiastic headline, lead and anecdotal comments.",Topical Gel Catches Up With Pills for Relief,story_reviews_01424,4,[],,[],http://www.nytimes.com/2010/09/07/health/07pain.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '1clip_filelist.xml""/>\n\n\n\nThe story says that the average copayment for a month‚Äôs supply of some of the topical NSAID medicati",The New York Times,"1clip_filelist.xml""/>




This story about topical gels that contain pain relief medication similar to ibuprofen makes a strong showing when examined point-by-point. Nevertheless, readers may end up with a skewed impression because of the personal anecdot",nan,"1clip_filelist.xml""/>




One strongly-worded claim or conclusion can brush aside a page full of facts. This story has a well-constructed middle that is overshadowed by opinions highlighted at both its beginning and end.",
https://www.healthnewsreview.org/review/3123/,Benefits seen for high-risk women in ovary removal,"<span style=""font-size: small;"">THIS is how this study should have been reported! The only five-star story out of four reviewed on a complicated topic that is sure to be hotly debated by researchers and clinicians. It sorted through the evidence carefully",Benefits seen for high-risk women in ovary removal,story_reviews_01428,5,[],,[],http://www.huffingtonpost.com/2010/09/01/benefits-seen-for-highris_n_701915.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\xa0\n\nThe story refers to the costs of both testing and treatments.'}, {'question': 'Does the story adequately quantify the benef",AP Associated Press,"¬†
This story is the best of four we reviewed on a study of women with an elevated risk of cancer connected to mutations in their BRCA1 and BRCA2 genes and the effects of preventive surgery. (See reviews of the Reuters, NPR and HealthDay stories.) In cont",nan,"¬†
The findings of this study are likely to have a strong influence on the advice given to women who have a high risk of breast and ovarian cancer due to BRCA1 and BRCA2 gene mutations. Nevertheless, news reports should try to do what this story did: pres",
https://www.healthnewsreview.org/review/3126/,Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice,Much more complete job than its ,Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice,story_reviews_01431,5,[],,[],http://consumer.Healthday.com/Article.asp?AID=642736,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explains that ""Metformin (originally marketed as Glucophage, though it is now available as an inexpensive generic) has be",HealthDay,"It doesn‚Äôt take much to please us sometimes ‚Äì but putting ""mice""¬†in the headline goes a long way most days.¬† If you‚Äôre going to report this stuff, you better be up front about the level of research.¬† And this story went on to include other caveat",nan,"It is interesting and thought-provoking to consider the potential impact of a widely-available, generally safe and inexpensive generic medicine being used in this new way.¬† But the research ‚Äì and the potential ‚Äì deserve to be wrapped in the caveats t",
https://www.healthnewsreview.org/review/3112/,Low-Dose Omega-3 Fatty Acids Don‚Äôt Protect Heart Patients,"<span style=""font-size: small;"">A reasonably cautious summary of a paper that had not yet been presented at a European conference at the time the story was written. </span>",Low-Dose Omega-3 Fatty Acids Don‚Äôt Protect Heart Patients,story_reviews_01435,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=642547,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable. The margarines used in the study are not commercially available, so we can understand why cost of these formulati",HealthDay,"¬†We were frankly a bit surprised at the number of stories on this study ‚Äì this one even being filed well before the paper was even presented at the Curopean Society of Cardiology Congress in Stockholm.¬† Was it that earth-shattering?¬† However, at leas",nan,"¬†The ending quote is the money quote:¬† ""..this is by no menas the final word.""¬† It never is.¬† ",
https://www.healthnewsreview.org/review/3119/,Pot may provide some chronic pain relief: study,Better than the ,Pot may provide some chronic pain relief: study,story_reviews_01437,4,[],,[],http://www.Reuters.com/article/idUSTRE67T2VA20100830,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'It is less surprising that neither story discussed costs, given that so few stories do. But sample costs could have been obtain",Reuters Health,"The story did a great job evaluating the evidence, providing outside voices, discussing alternatives to marijuana smoking, and presenting both the benefits and the potential harms. It could have done a better job discussing possible costs, availability an",nan,"This topic lends itself to jokey, pun-filled writing, but this story played it straight. Chronic pain can ruin lives, and a breakthrough with an alternative approach would be important news. As this story makes clear, until some larger studies with fewer ",
https://www.healthnewsreview.org/review/3113/,Study: More omega-3 fats didn‚Äôt aid heart patients,"<span style=""font-size: small;"">This is one story that mentioned the increasing number of foods that are promoted for being ""fortified"" with omega-3 fatty acids.¬† It‚Äôs been a hot marketing trend.¬† Maybe this study will make readers question whether su",Study: More omega-3 fats didn‚Äôt aid heart patients,story_reviews_01438,5,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_HEART_HEALTHY_FATS?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': '\xa0As the products used in the study are not commercially available, there was no mention of their presumptive costs.\n(It might",AP Associated Press,"One of 3 stories we reviewed on this study (Reuters and HealthDay were the others), this one did raise some interesting thoughts about why the study failed to show a difference and reported on some of the other types of foods that are now commercially for",nan,¬†Health claims in food marketing require a great deal of scrutiny.¬† This new data casts some doubt on some past marketing practices. We‚Äôll see how and if that changes ‚Äì and if consumer behavior and health care advice changes at all. As a quote in th,
https://www.healthnewsreview.org/review/3115/,Omega-3 margarines fail to help in heart study,"<span style=""font-size: small;"">One of three stories we reviewed on this paper in the NEJM. (Also see the <a href=""https://www.healthnewsreview.org/review.html?review_id=3113"" target=""_blank"">AP</a> and <a href=""https://www.healthnewsreview.org/review.htm",Omega-3 margarines fail to help in heart study,story_reviews_01439,5,[],,[],http://www.Reuters.com/article/idUSTRE67S07W20100829,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable; the product in question is not commercially available. But why didn‚Äôt the story give us some range for comparis",Reuters Health,¬†This story reports on a study published in the New England Journal of Medicine that found little impact from the use of omega-3 supplemented margarine. ¬†The outcomes of the study were interpreted as suggesting that a population using optimal medical th,nan,"¬†The key quote in the story was this: 
""It will be viewed as a largely negative study and people who are enthusiasts for omega fatty acids will continue to be enthusiasts and people who are skeptics will continue to be skeptics,"" said Scott Wright of the",
https://www.healthnewsreview.org/review/3110/,"Gaining on death, cooling therapy catches on slowly","Reuters Health digs deep and wide on this one, affords the story a lot of space, and delivers readers a very good story. ","Gaining on death, cooling therapy catches on slowly",story_reviews_01440,5,[],,[],http://www.Reuters.com/article/idUSTRE67P4HT20100826,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '1clip_filelist.xml""/>\n\n\n\nThe story does a good job in articulating the expense associated with universal adoption of cooling me",Reuters Health,"1clip_filelist.xml"" rel=""File-List""/>



 
This in-depth (3400 word) report on cooling patients after cardiac arrest in order to reduce the risk of brain damage offers readers a wealth of detail on therapeutic hypothermia, the available evidence of its ef",nan,"1clip_filelist.xml"" rel=""File-List""/>



 
The likelihood of surviving and thriving after an out of hospital cardiac arrest has been low for a host of reasons.¬† As the story notes approximately 300,000 Americans suffer a heart attack outside the hospital",
https://www.healthnewsreview.org/review/3101/,"‚ÄòBreakthrough‚Äô melanoma drug shrinks tumors, may prolong life*","<span style=""font-size: small;"">This story was well done and deserves a high 4-star rating.¬† But the online version (at least) delivered key caveats and context in the sidebar, not in the main text, and these key points may have been missed. (See reviews","‚ÄòBreakthrough‚Äô melanoma drug shrinks tumors, may prolong life*",story_reviews_01441,4,[],,[],http://www.USA Today.com/news/health/2010-08-26-1Amelanoma26_ST_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This was the only\xa0one of the three competing stories we reviewed which mentioned costs. While an accurate estimate of the new dr",USA Today,"Clearly, in the big picture, we liked this story.¬† It addressed most of our criteria.¬† Our negative comments are about structure not the reporting. We found the story online.¬† We didn‚Äôt see the print version.¬† The sidebar could have been easily miss",nan,"The prospect of a new therapy¬†for advanced melanoma ‚Äî a¬†deadly condition that resists almost all¬†efforts at treatment ‚Äì is, indeed, exciting. But we think it‚Äôs important not to let this excitement feed false hope for desperate patients and their ",
https://www.healthnewsreview.org/review/3102/,Biosynthetic Corneas Show Promise in Transplants,There were some strengths in this story that did not appear in the other two we reviewed (,Biosynthetic Corneas Show Promise in Transplants,story_reviews_01442,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=642463,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This is the only story of the three reviewed to discuss costs. As for cost, Griffith said the biosynthetic corneas ""in theory"" shou",HealthDay,This story establishes the small scope of the story up high. It brings in one outside¬†voice and is more cautious than the other two stories in describing the number of people affected by corneal conditions. It also is the only story to use a dollar figur,nan,"This story was similar to the Reuters story but packed in more information and did not rely largely on the press release. It shows that even with limited space and time, a reporter can pull together the relevant facts to present readers with most of the c",
https://www.healthnewsreview.org/review/3104/,First Biosynthetic Corneas Implanted,"<span style=""font-size: small;"">Of the three stories we reviewed on this same study, this one did the best job of placing the study into the correct context and sharing with readers most of the details necessary to help them decide how to evaluate this pr",First Biosynthetic Corneas Implanted,story_reviews_01444,5,[],,[],http://www.WebMD.com/eye-health/news/20100825/first-biosynthetic-corneas-implanted,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'One of the few ways this story fell down. Because donor corneas and plastic corneas are already on the market, at least a range",WebMD,"The story could have discussed costs and done a better job quantifying how many people might actually benefit from this treatment. All in all, though, the story was far more complete than the other two.
¬†",nan,"Blindness is a serious public health concern, especially in developing countries, and any potential advance that would increase the number of corneas would be good news. People in the U.S. who are struggling with vision loss are anxious for treatment prog",
https://www.healthnewsreview.org/review/3107/,"In Early Trial, Targeted Therapy Fights Advanced Melanoma","<span style=""font-size: small;"">Of the three competing stories we reviewed on this topic, this¬†HealthDay piece¬†did the best job of clearly laying out the limitations of the new research. (Also see reviews of <a href=""https://www.healthnewsreview.org/rev","In Early Trial, Targeted Therapy Fights Advanced Melanoma",story_reviews_01446,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=642479,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story didn‚Äôt mention costs, which is somewhat understandable given the early phase of research.\xa0 But the competing USA",HealthDay,"Importantly, it was the only story¬†to explain that we don‚Äôt yet know whether the new drug prolongs the survival of patients with metastatic melanoma.¬†Somewhat surprisingly given the story‚Äôs attention to these details, it failed to describe¬†or make ",nan,"Messages promoting cancer screening are ubiquitous but not always evidence based.¬†As one of our reviewers completed his work, New England Patriots owner Robert Kraft is urging women not to be afraid of false-positive mammograms during the halftime of a p",
https://www.healthnewsreview.org/review/3079/,Tai chi may ease fibromyalgia pain,"Only 400 words long, this story deserves a four-star score.¬† Succinct, but not dry, with some appropriate caveats. ",Tai chi may ease fibromyalgia pain,story_reviews_01451,4,[],,[],http://www.USA Today.com/yourlife/health/medical/alternative/2010-08-19-taichi19_st_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This is the only of the five stories to actually put a dollar figure on the classes. ""Even the cost of a class, which can top $50 a",USA Today,"The story does two things better than all the other stories. It puts a dollar figure to the cost of tai chi therapy, and it gives people a better sense of how popular tai chi is. It could have done a better job evaluating the evidence and providing some a",nan,"Why not just give the absolute numbers? How many out of how many? Why make the reader do the math? ""79% of tai chi participants said their symptoms had improved, compared with 39% of those in the educational class‚Ä¶Even three months after the classes end",
https://www.healthnewsreview.org/review/3081/,Tai Chi Reported to Ease Fibromyalgia,The best of the five stories we reviewed on the same study.¬† Read why. ,Tai Chi Reported to Ease Fibromyalgia,story_reviews_01452,4,[],,[],http://www.nytimes.com/2010/08/19/health/19taichi.html?_r=1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\xa0At a minimum, the reporter could have found out how much the master used in the study typically charges and how much the DVD co",The New York Times,¬†This is a well considered look at a limited study of an unusual approach to a disorder that has stumped clinicians for decades. It is the only one of the five stories we reviewed that quoted a patient about her experience. This has pluses and minuses. T,nan,"With a sensational topic like tai chi for a debilitating syndrome it is important to write even more clearly and dispassionately as possible. Whether clinicians really have a handle on what causes fibromyalgia remains to be seen, but the truth is that man",
https://www.healthnewsreview.org/review/3088/,Study shows value of quality-of-life cancer care,Of the four competing stories we reviewed (also see review of stories by ,Study shows value of quality-of-life cancer care,story_reviews_01453,4,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_CANCER_PALLIATIVE_CARE?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'While it could have been more detailed about the actual numbers involved,\xa0this story explained that the cost of palliative care ",AP Associated Press,"The story was¬†marred, however,¬†by a failure to discuss any limitations of the research or to properly quantify the benefits. In addition, its sourcing included only experts likely to hold a favorable view of palliative medicine. ¬†
¬†",nan,"We cannot¬†tackle the health care crisis without¬†looking at¬†the costs of care at the end of life. Medicare¬†spends about $50 billion dollars per year on care during the last two months of life. 
Decreasing the suffering and improving the quality of life",
https://www.healthnewsreview.org/review/3083/,"Palliative Care Extends Life, Study Finds",An important description of palliative care emphasizing shared decision-making.¬† Kudos to the NYT for framing it this way.,"Palliative Care Extends Life, Study Finds",story_reviews_01455,4,[],,[],http://www.nytimes.com/2010/08/19/health/19care.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although it touches on reimbursement, this story never addresses the key issues that most readers will be interested in ‚Äî how",The New York Times,Our reviewers were split on one distinctive feature of this story ‚Äì the discussion of the health care reform bill¬†brought Glenn Beck and Sarah Palin into the story. One reviewer thought that had an uncertain effect and that the space could¬†have been b,nan,We can‚Äôt know if palliative care is a good thing if we don‚Äôt know what it means. The Times description is good enough to be quoted at length: ,
https://www.healthnewsreview.org/review/3073/,Obesity Surgery Helps Diabetic Patients Kick Medicines,"<span style=""font-size: medium;"">This brief (~300 words) blog post was relatively complete and balanced.¬† But we call for even greater scrutiny of the evidence ‚Äì even within the limitations of a brief blog.¬†</span>",Obesity Surgery Helps Diabetic Patients Kick Medicines,story_reviews_01460,4,[],,[],http://www.NPR.org/blogs/health/2010/08/17/129250036/obesity-surgery-helps-diabetic-patients-kick-meds,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '1clip_filelist.xml""/>\n\n\n\n1clip_filelist.xml""/>\n\n\n\nHealth care spending before and after the surgery is a key point in this ",NPR,"1clip_filelist.xml""/>



1clip_filelist.xml""/>



As you‚Äôll see, our critique of just the ""Evidence"" criterion was almost as long as the entire blog story, but we think the points we raise about evidence are essential ‚Äì no matter the story format or i",nan,"1clip_filelist.xml""/>



 
Obesity and diabetes are major public health problems, and interventions that may reduce the impact of these conditions deserve the public‚Äôs attention.
",
https://www.healthnewsreview.org/review/3069/,"For diabetics, taking the sting out of insulin","If more stories took a step back the way this one did, there may be far less public confusion about medicine. This story used the ""news"" as a jumping off point for a deeper exploration of the topic. ","For diabetics, taking the sting out of insulin",story_reviews_01463,4,[],,[],"http://www.Los Angeles Times.com/health/la-he-insulin-delivery-20100816,0,2517032,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This is the one big hole in the story. The one nod to costs in the story comes toward the end, where\xa0it\xa0says, ""Further, h",Los Angeles Times,"This story explains in plain language¬†that there might indeed be¬†a better way on the¬†horizon for diabetics tied to the daily routine of regular insulin injections. It could have benefited from more outside expertise, some cost information and a¬†more¬†",nan,"As the story notes, there are potentially 70 million people in the United States who stand to benefit from an improved insulin delivery system. Writing about how a medicine is consumed is never as sexy as writing about a brand new cure or an oddball alter",
https://www.healthnewsreview.org/review/3071/,Oral alternative to allergy shots improves hay fever,"A balanced, cautious story that earns a four-star score ‚Äì nothing to sneeze at.¬† But it wouldn‚Äôt have taken much to boost this to a more complete story and a top score. ",Oral alternative to allergy shots improves hay fever,story_reviews_01464,4,[],,[],http://www.Reuters.com/article/idUSTRE67F37Q20100816,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '1clip_filelist.xml"" rel=""File-List""/>1clip_themedata.thmx"" rel=""themeData""/>1clip_colorschememapping.xml"" rel=""colorSchemeMapping""/",Reuters Health,"1clip_filelist.xml"" rel=""File-List""/>1clip_themedata.thmx"" rel=""themeData""/>1clip_colorschememapping.xml"" rel=""colorSchemeMapping""/>



 
This story reports on a recent meta-analysis that suggests immunotherapy tablets and drops that dissolve under the to",nan,"1clip_filelist.xml"" rel=""File-List""/>1clip_themedata.thmx"" rel=""themeData""/>1clip_colorschememapping.xml"" rel=""colorSchemeMapping""/>



 
Allergic rhinitis (hay fever) won‚Äôt kill you, but it can make you quite  uncomfortable.  Allergy sufferers have bee",
https://www.healthnewsreview.org/review/3066/,"Burger and a statin to go? Or hold that, please?",A reasonably balanced news story in response to an unusual article published in a medical journal.¬† ,"Burger and a statin to go? Or hold that, please?",story_reviews_01466,5,[],,[],http://www.Reuters.com/article/idUSTRE67C2GE20100813,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'In this context, the cost discussion works, even though it is only a passing reference. The authors are trying to argue that statin",Reuters Health,¬†,nan,nan,
https://www.healthnewsreview.org/review/3064/,Should belly fat prompt early colon cancer screens?,"We‚Äôve stated before that how you end a piece is important framing because it may be the take-home message readers remember.¬† This one ended appropriately, with a US Preventive Services Task Force member saying this study alone would not lead the task f",Should belly fat prompt early colon cancer screens?,story_reviews_01467,4,[],,[],http://www.Reuters.com/article/idUSTRE67A4TE20100811,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention costs of screening colonoscopy. Costs of screening a younger population is especially important give",Reuters Health,This story outlines both the potential benefits and drawbacks of screening clearly and concisely. It quotes several independent experts who provide valuable perspectives for the reader. The story could have been improved by mentioning that this study was ,nan,"Overweight and obesity is associated with an increased risk for colon cancer. Recent research suggests that abodominal fat in particular may increase colon cancer risk ‚Äì http://www.cancer.gov/cancertopics/factsheet/Risk/obesity#r4. However, in the absen",
https://www.healthnewsreview.org/review/3054/,Effectiveness of statins is called into question,"This story does a masterful job of explaining how statins have become such a dominant force despite some of the conflicting evidence about their benefits. Good breakdown of difference between ""primary"" and ""secondary prevention."" ",Effectiveness of statins is called into question,story_reviews_01472,4,[],,[],"http://www.Los Angeles Times.com/news/science/la-he-statins-20100809,0,7651756,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story doesn‚Äôt discuss the costs to consumers (or the health system). It does a great job, though, of tallying the sales a",Los Angeles Times,"Recent research suggests that patients who are on statins may not be seeing the benefits promised them. If true, this would mean that the majority of the 24 million Americans taking statins are only contributing to record sales for a very profitable class",nan,"Statins have been touted as one of modern medicine‚Äôs greatest breakthroughs, and statin makers have been trying to build on the success of the drugs as a potential cure for heart disease by expanding their scope into Alzheimer‚Äôs, arthritis, cancer and",
https://www.healthnewsreview.org/review/3052/,Some evidence vitamin D might fight colds,"<span style=""font-size: 10pt; font-family: Arial;"">This story about a test of whether vitamin D supplements could reduce the risk of colds and other respiratory illnesses would have scored higher if the careful and cautious body of the piece had not been ",Some evidence vitamin D might fight colds,story_reviews_01474,4,[],,[],http://www.Reuters.com/article/idUSTRE67444320100805,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '1clip_filelist.xml"" rel=""File-List""/>\n\n\n\n\n \nThis story does not mention cost. Sure, vitamin pills cost only pennies a day",Reuters Health,"1clip_filelist.xml"" rel=""File-List""/>



 
The story points out that the results of the study provided only weak support for the idea that vitamin D has a protective effect and that in fact for the main outcome of this trial there was no statistically sig",nan,"1clip_filelist.xml"" rel=""File-List""/>



When trial results are not statistically significant, headlines shouldn‚Äôt tease readers. And ‚Äì as always ‚Äì we wish there had been an independent expert voice offering perspective on this study. ",
https://www.healthnewsreview.org/review/3049/,Phys Ed: How Much Does Knee Surgery Really Help?,"<span style=""font-size: larger;"">Excellent coverage overall, chock full of subtleties. </span>",Phys Ed: How Much Does Knee Surgery Really Help?,story_reviews_01475,5,[],,[],http://well.blogs.nytimes.com/2010/08/04/phys-ed-how-much-does-knee-surgery-really-help/?pagemode=print,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The author briefly mentions that the operation ""can be expensive."" A little more detail about the costs and economic forces wou",The New York Times,"The author took the time to dig into many facets of the evidence and explain their meaning for someone considering ACL surgery. As this is a topic of interest to many readers, including ""weekend warrior"" recreational athletes, it was good that the reporte",nan,"This study provides compelling evidence that for many patients, physical treatment alone without surgery leads to excellent outcomes in terms of pain, as well as function in both usual activities and sports-related ones. For someone who isn‚Äôt financiall",
https://www.healthnewsreview.org/review/3050/,Castration Drug Used as Autism Therapy,"Here‚Äôs a well-deserved five-star rating for an important piece of public service, hard-nosed, evaluate-the-evidence health care journalism. ",Castration Drug Used as Autism Therapy,story_reviews_01479,5,[],,[],http://articles.sun-sentinel.com/2010-08-03/health/fl-autism-treatment-20100803_1_castration-drug-autism-therapy-lupron,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says that Lupron costs about $5,000 a month but is seldom covered by insurance. Good job to address both points. '}, {'qu",Sun-Sentinel,"A new and uNPRoven approach to autism pops up in a local community.¬† A reporter and his newspaper have several choices: 
Thankfully, this reporter and this paper chose #3.¬† 
¬†",nan,"The story quotes the mother of two developmentally disabled children saying:¬† ""These people are preying on the fears of parents. We cannot be using these children who are so vulnerable as guinea pigs in a medical experiment.""
And it quotes a developmenta",
https://www.healthnewsreview.org/review/3039/,In the Works: Immunotherapy for food allergies,"This had the potential to be yet another ""miracle cure"" tale based on flimsy evidence and a few overheated anecdotes. Instead,¬†it presented a balanced, nuanced look at a potentially important but uNPRoven technique for desensitizing individuals with life",In the Works: Immunotherapy for food allergies,story_reviews_01480,4,[],,[],"Los Angeles Times.com/news/health/la-he-allergies-immunotherapy-20100802,0,6451436.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The article notes that traditional immunotherapy requires frequent office visits for the administration of shots. One can imagi",Los Angeles Times,"From the uncertainty of its¬†opening headline to its thorough examination of¬†concerns raised by¬†national experts and local docs and their patients, this story nicely conveys the complexity that¬†so often accompanies new medical research.¬†A bit more det",nan,Families of children with food allergies¬†often live in terrible fear of accidental exposure to allergenic foods. And recent positive reports about immunotherapy are¬†making more patients and familes wonder if this option¬†is available to them. While the ,
https://www.healthnewsreview.org/review/3037/,Costly New Prostate Cancer Drug Works In Mysterious Ways,Let us count the ways we liked this story. It chose a difficult angle and excelled at it.¬† It raises tough questions.¬† It has surprising depth for a <500 word story. Earns its five star score. ,Costly New Prostate Cancer Drug Works In Mysterious Ways,story_reviews_01483,5,[],,[],http://www.NPR.org/blogs/health/2010/07/29/128851922/costly-new-prostate-cancer-drug-works-in-mysterious-ways,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story itself only says ""it‚Äôs pretty pricey.""\xa0 But those words provide a hyperlink to another NPR\xa0story that discloses t",NPR,"The story had a primary focus of evaluating the evidence, raising some of the ""mysterious ways"" this drug works even in the headline.¬† And saying ""It does work, sort of"" ‚Äì in the third paragraph.¬† But its strength is in how it educates readers about w",nan,Put this one on a shelf and pull it down anytime you need proof that journalists can scrutinize evidence (and get a 5-star score from us) in less than 500 words.¬† Show this to journalism students.¬† ,
https://www.healthnewsreview.org/review/3029/,Is a Colonoscopy More Effective in High-Def?,"A solid story that could have strayed into ""gee whiz"" territory. Instead, the writer places this new entry in the colonscopy device market ‚Äî high definition cameras ‚Äî¬†into the proper context.",Is a Colonoscopy More Effective in High-Def?,story_reviews_01485,4,[],,[],http://online.wsj.com/article/SB10001424052748704700404575391240651319552.html?mod=WSJ_0_0_WP_2715_RIGHTTopCarousel_1,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story devotes a few sentences to costs, without actually providing dollar figures. Still, the effort is far stronger than in mo",The Wall Street Journal,"More outside sources, hard analysis of the data, use of absolute (not relative) data and better specifics about costs could have made the story even better.
¬†",nan,"Ever since Katie Couric broadcast her colonscopy in 2002, the procedure has become an unlikely media darling. Stories like this one lower the hype volume and give readers a fuller picture of this evolving technology. Newer isn‚Äôt always better. But for s",
https://www.healthnewsreview.org/review/3027/,The big thaw,"Very well done.¬† ¬†This story piles up questions about an expensive and uNPRoven fertility approach, emphasizing the costs, the uncertainties, and the unknowns.¬† Another five-star story today! ",The big thaw,story_reviews_01488,5,[],,[],http://www.boston.com/news/health/articles/2010/07/26/freezing_human_eggs_is_gaining_in_popularity_and_the_science_behind_it_is_making_strides_as_well/?page=2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Excellent.\xa0 Estimate of $10,000 or more per procedure and states that insurance usually doesn‚Äôt cover it. '}, {'question': 'Do",The Boston Globe,"This story delivers a clear conclusion:¬† ""Bottom line, a woman who wants to conceive a child at some point in the future should carefully consider the options ‚Äî the risks, costs, and unknowns.""
¬†",nan,"In the face of a practice ""gaining in popularity,""¬† this story did a public service by explaining how much is not known about the practice of freezing eggs, and by issuing a clear caveat to consumers.¬† This method could be applied to many health news st",
https://www.healthnewsreview.org/review/3028/,Tiny Eye Telescope Brings Back A World Of Sight,"A near model story for how to report on surgical developments, this piece only had a few missing elements and earns a five-star rating. ¬†",Tiny Eye Telescope Brings Back A World Of Sight,story_reviews_01489,5,[],,[],http://www.NPR.org/templates/story/story.php?storyId=128668304,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This sounds like a lengthy and involved procedure that would require expensive technical expertise during surgery. The device i",NPR,"The story starts with a gee whiz hook but then gives readers the necessary context. It also uses independent voices, spends nearly as much time talking about the potential harms as the benefits and provides a solid exploration of the alternatives to surge",nan,"Everyone starts to lose some vision as they age, and macular degeneration, in particular, affects millions of people. This story serves as both a nice piece of hope for a subset of these people and as a reminder to everyone else that there are multiple¬†w",
https://www.healthnewsreview.org/review/3025/,What ‚Äúclinically proven‚Äù means for a beauty product,"This was a fine piece of journalism, a troubling ",What ‚Äúclinically proven‚Äù means for a beauty product,story_reviews_01490,5,[],,[],http://www.Reuters.com/article/idUSTRE66M4EK20100723,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs not discussed and it could have been frosting on this story. '}, {'question': 'Does the story adequately quantify the ben",Reuters Health,"A five-star review for this ""buyer beware"" on an allegedly ""clinically proven"" product.¬† 
¬†",nan,"There may be an inclination for some to look the other way when it comes to claims for personal care products. After all, come on, what‚Äôs the harm? Well, we can think of many.¬†¬† Especially with all the hype for products that supposedly protect the ski",
https://www.healthnewsreview.org/review/3014/,New Pill Found to Cut Weight With Few Side Effects: Study,"This is the best of the three stories reviewed on lorcaserin, but it‚Äôs not without flaw. (See reviews of other stories by ",New Pill Found to Cut Weight With Few Side Effects: Study,story_reviews_01498,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=641132,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is a passing reference to costs, which is more than the other two stories provided. But it would not have taken much effo",HealthDay,"The story does a good job placing this drug into the context of the current competition to bring a new blockbuster weight-loss pill to market, and it brings in a critical, independent voice, albeit late in the story. But it doesn‚Äôt provide enough detail",nan,"The story focuses too much on the drugs and not enough on whether this drug (or any drug) is a viable remedy for obesity.
The story ‚Äì and the issue ‚Äì is a big deal because obesity is such a big deal in the US, with major impacts on morbidity, mortalit",
https://www.healthnewsreview.org/review/3004/,Higher vitamin E intake tied to lower dementia risk,"A refreshingly¬†restrained take on a new observational study of vitamin E and the risk of dementia.¬†The story maintained a cautious tone throughout and never slipped¬†into the ""may reduce risk""¬†language¬†so prevalent in other reports of observational st",Higher vitamin E intake tied to lower dementia risk,story_reviews_01501,4,[],,[],http://www.Reuters.com/article/idUSTRE66B6I020100713,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The costs of foods containing vitamin E is not really in question, so we‚Äôll call this one not applicable.'}, {'question': 'Does",Reuters Health,¬†While the story has a¬†few notable deficiencies ‚Äî no independent comment and insufficient statistical¬†detail regarding the magnitude¬†of the¬†effect ‚Äî readers will undoubtedly come away with the right¬†bottom line¬†message about this study: Interes,nan,"Dementia will place a¬†growing¬†burden¬†on individuals and our society as the population ages, yet there are currently no effective¬†ways to prevent or treat this condition.¬†Instead of offering false hope about strategies that have little chance of makin",
https://www.healthnewsreview.org/review/2997/,All kids should have cholesterol tests: study,"<span style=""font-size: 10pt; font-family: Arial;"">This story is a mixed bag. It is the shortest yet the best of the three reports </span>",All kids should have cholesterol tests: study,story_reviews_01504,4,[],,[],http://www.Reuters.com/article/idUSTRE66B0RG20100712,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '1clip_filelist.xml"" rel=""File-List""/>\n\n\n\nThe story says universal screening would be expensive, but it does not provide any",Reuters Health,"1clip_filelist.xml""/>



 
 Yet there was still a key oversight. The lead sentence implies that more thorough screening would lead to improved health outcomes, even though the study did not examine that question. On the other hand, this story contains the",nan,"1clip_filelist.xml"" rel=""File-List""/>



 
Testing for cholesterol or other risk factors is useful only when it helps to reduce disease. We hope readers got the point that the evidence is sketchy and that statin treatment in kids is controversial. 
",
https://www.healthnewsreview.org/review/2991/,Fish Oil Supplements Linked to Lower Risk of Breast Cancer: Study,HealthDay improved on two measures with this story:¬† touching on the limitations of observational studies and getting an important independent perspective.¬† But some flaws still require attention.,Fish Oil Supplements Linked to Lower Risk of Breast Cancer: Study,story_reviews_01509,4,[],,[],http://www.businessweek.com/lifestyle/content/Healthday/640917.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 No discussion of costs, but we think it‚Äôs common knowledge that these supplements are inexpensive. '}, {'qu",HealthDay,"You can read the full review below.¬† But we don‚Äôt want to overlook what a big thing it is to see improvement in the two areas already noted.¬† Keep it up, HealthDay. 
¬†",nan,Breast cancer risk is not a one-size-fits-all story.¬† It‚Äôs age-dependent.¬† And this story should have pushed the researchers for age-specific breakdowns.¬† ,
https://www.healthnewsreview.org/review/2992/,Fish Oil Linked to Lower Breast Cancer Risk,"Four sources were interviewed ‚Äì a strength of this story ‚Äì delivering appropriate caveats. But, like its HealthDay competitor, it‚Äôs a 4-star story with some remaining ‚Äì but easily fixed ‚Äì flaws. ",Fish Oil Linked to Lower Breast Cancer Risk,story_reviews_01510,4,[],,[],http://www.WebMD.com/breast-cancer/news/20100708/fish-oil-linked-to-lower-breast-cancer-risk,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 Not discussed, but it should be general knowledge that they‚Äôre relatively inexpensive. '}, {'question': 'Do",WebMD,The story missed an opportunity to explain the inherent limitations in drawing conclusions from such an observational study.¬† And its use of relative risk reduction figures is bothersome.¬† Why not just give the absolute numbers from each group in the st,nan,"There could be boilerplate language that stories could use to start to educate readers about what observational studies CAN‚ÄôT PROVE.¬† In fact, we suggest some in a primer elsewhere on this site.¬† ",
https://www.healthnewsreview.org/review/2986/,FDA clears first implantable telescope for vision,"This was a short, solid story of less than 450 words that addressed all but one of our criteria.",FDA clears first implantable telescope for vision,story_reviews_01512,5,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_EYE_IMPLANT?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explains that ""is seeking Medicare coverage for the surgery and rehab costs, a package that it calls CentraSight. The com",AP Associated Press,"A very careful report on progress for this vision problem, emphasizing potential harms, the limited subset of people who might benefit, and costs. Nice job. 
¬†",nan,This is a fresh example of how stories about new technologies can address our criteria of what we think it‚Äôs important for consumers to know ‚Äì and to do so in a reasonably short story. ,
https://www.healthnewsreview.org/review/2983/,‚ÄúMind-body‚Äù therapy shows promise for fibromyalgia,This was¬†a¬†thorough and well balanced review¬†of an emerging psychotherapy technique known as affective self-awareness therapy that is used to treat fibromyalgia pain.,‚ÄúMind-body‚Äù therapy shows promise for fibromyalgia,story_reviews_01513,4,[],,[],http://www.Reuters.com/article/idUSTRE6614LQ20100705,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Chronic pain\xa0takes a huge financial toll in terms of\xa0direct medical costs and lost productivity,\xa0but the\xa0story didn",Reuters Health,The story gets high marks for its evaluation of the¬†evidence and especially for pointing out the limitations of¬†psychotherapy studies that use a waiting list as a control group. The story would have been improved by the inclusion¬†of some truly independ,nan,"Because of the controversy¬†that has surrounded the diagnosis of fibromyalgia for decades (and which still persists today),¬†researchers have been slow to develop new therapies for treating the condition. The new approach discussed here is especially welc",
https://www.healthnewsreview.org/review/2972/,Statins May Lower Rates of Prostate Cancer Recurrence,"The headline is troubling because such a study can‚Äôt support causal language such as ""may lower recurrence.""¬† But there were enough qualifiers later to make up for that false start. Better story than its WebMD competitor. ",Statins May Lower Rates of Prostate Cancer Recurrence,story_reviews_01517,5,[],,[],http://www.businessweek.com/lifestyle/content/Healthday/640594.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story says statins can cost $5 a day or more. '}, {'question': 'Does the story adequately quantify the benefits of the treatmen",HealthDay,"A relatively clear breakdown of the unclear picture of whether statins may help in this specific area of research. 
¬†",nan,One thing that made this story better than its WebMD competition was the expert source who put this study in the context of other studies that have been done and raised questions about statistical problems in the study (although we wish we‚Äôd heard more ,
https://www.healthnewsreview.org/review/2968/,Cholesterol drugs for the healthy still debatable,"Given all the previous hype about statin drugs for otherwise apparently healthy people, it is important that journalists bring consumers the latest scientific doubts about this approach ‚Äì and this story generally did a very good job of that. ",Cholesterol drugs for the healthy still debatable,story_reviews_01518,4,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_CHOLESTEROL_DRUGS?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story included Crestor sales figures but did not tell readers how much it cost consumers.\xa0 Unlike some of the other stat",AP Associated Press,"¬†This story raises insightful questions about the use of a particular statin medication, Crestor, in a patient population without elevated cholesterol levels. ¬†The story mentioned that a company financed study demonstrated benefit from the use of this d",nan,"¬†The final quote of the story is the take-home point:¬† ""We just don‚Äôt know what the balance of benefits and harms are for people who are going to take this for a lifetime.""¬† ",
https://www.healthnewsreview.org/review/2953/,Coffee may cut risk for some cancers,"Better than the WebMD story on the same study because CNN discussed potential harms and had several sources. But this is one instance where the 4-star score based on our 10 criteria seems too high.¬† When you get the basics wrong, you got the story wrong.",Coffee may cut risk for some cancers,story_reviews_01527,4,[],,[],http://pagingdrgupta.blogs.CNN.com/2010/06/22/coffee-may-cut-risk-for-some-cancers/?eref=time_health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable ‚Äì the cost of coffee is not in question.'}, {'question': 'Does the story adequately quantify the benefits of the",CNN Health,"What basics are wrong? The on-air and online stories still used terms like ""benefit"" and ""lowers risk"" ‚Äì sometimes with the qualifier ""may cut risk"" which still doesn‚Äôt cover up the inaccuracy of using causal language to explain results that can‚Äôt p",nan,Some of the online comments on the CNN website provide a glimpse of how readers react to such stories:¬† ,
https://www.healthnewsreview.org/review/2936/,‚ÄòLiberation procedure‚Äô for multiple sclerosis sparks debate,"While the article is bookended by optimistic anecdotes and sometimes its tone overreaches the available evidence, it charts a mostly cautious course through a tricky debate, calling out many caveats to balance the preliminary hope.",‚ÄòLiberation procedure‚Äô for multiple sclerosis sparks debate,story_reviews_01530,4,[],,[],http://www.philly.com/inquirer/health_science/daily/20100616__Liberation_procedure__for_multiple_sclerosis_sparks_debate.html#axzz0r1JgAB44,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We read that Paulette O‚ÄôLeary (of Toronto) paid $13,000 for the procedure at a US medical center. However, as it seems the proced",The Philadelphia Inquirer,"The article‚Äôs tone mimics the roller-coaster nature of these debates: stories of miraculous recoveries, ""groundbreaking"" research by mavericks, yet also caution by skeptical experts, conflicting evidence, and calls for more trials. It could‚Äôve navigat",nan,"Our favorite line, and maybe the heart of the issue, is when it shows Dr. Bonn citing the need for rigorous studies, while understanding patients‚Äô frustration, their suffering, and the roller coaster ride they‚Äôve been on. It expresses empathy without ",
https://www.healthnewsreview.org/review/2931/,Generic Drug Could Save Many Trauma Patients,"In just 245 words, this NPR blog brief packed almost as much information as two longer stories we reviewed about the same study of the drug tranexamic acid (TXA).",Generic Drug Could Save Many Trauma Patients,story_reviews_01531,4,[],,[],http://www.NPR.org/blogs/health/2010/06/15/127852843/generic-drug-could-save-thousands-of-trauma-patients,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'TXA costs $10 per treatment, according to the story. Although this cost is characterized as low, the story could have noted that th",NPR,"While it earns credit for presenting the benefits in absolute terms and for including the number-needed-treat to save a life, this was the only¬†story of the three that failed to include¬†an independent perspective on the results. A good effort considerin",nan,"Even in a brief such as this, there needs to space for an independent take on the issue.",
https://www.healthnewsreview.org/review/2927/,"The pros and cons of Prolia, Amgen‚Äôs new osteoporosis drug",Overall a well done and informative story ‚Äì although it did not always use the absolute risk/benefit statistics that we prefer. ,"The pros and cons of Prolia, Amgen‚Äôs new osteoporosis drug",story_reviews_01535,5,[],,[],"http://www.Los Angeles Times.com/news/health/la-he-closer-20100614,0,674971,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\xa0This story not only mentions the cost for this drug but also for other treatments for osteoporosis as well.'}, {'question': 'Do",Los Angeles Times,"The story detailed what is known about the impact of this drug on various types of bone fractures associated with osteoporosis, how its mode of action is someone different than other osteoporosis treatments, its administration and how the costs compare wi",nan,"¬†The gestalt about osteoporosis is that women should live in fear of bone breaks. While the story provided very good information about this new treatment, it did not provide much context about the problem. And its inconsistent use of relative vs. absolut",
https://www.healthnewsreview.org/review/2930/,Drug That Stops Bleeding Could Save Lives,"Like its competitors (we reviewed 3 such stories), HealthDay communicated the¬†basic facts¬†but failed to challenge some of the more optimistic claims regarding the lifesaving potential of the drug TXA.",Drug That Stops Bleeding Could Save Lives,story_reviews_01536,4,[],,[],http://consumer.Healthday.com/Article.asp?AID=640122,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story notes that TXA is cheap, but we wish it had put\xa0a dollar amount on it the way competing coverage did. The cost of ",HealthDay,"The story also should have done more to examine whether the results of this international study are applicable to patients in the United States and other Western countries.
¬†",nan,"Bleeding from trauma represents a significant cause of death espeicially in developing countries.¬† So, the availability of an inexpensive and easy to administer drug that could reduce blood loss in patients with trauma would be welcomed.¬† The results of",
https://www.healthnewsreview.org/review/2932/,Cheap drug could save tens of thousands,"One clear strength and some clear weaknesses in this, one of¬†the three stories we reviewed about a study of the¬†clot-promoting drug tranexamic acid (TXA) for trauma patients. ",Cheap drug could save tens of thousands,story_reviews_01537,4,[],,[],http://hosted.ap.org/dynamic/stories/E/EU_MED_STOP_BLEEDING_DRUG?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'TXA costs $4.50/gram, according to the story,\xa0and a typical dose is 2 grams. However, a brief comment on the relative costs of t",AP Associated Press,"This was the¬†only¬†one of the three stories we reviewed to explain that the¬†benefits would be seen¬†mainly in developing world countries where trauma care is often limited. On the downside, the story nevertheless claimed, without providing any supportin",nan,"Even when a clinical trial¬†is large and well conducted, the results need to be greeted cautiously when they are first and only data showing a benefit from¬†an intervention. While the data from this study suggest that TXA is an important lifesaving¬†treat",
https://www.healthnewsreview.org/review/2925/,Portland cancer center among those offering experimental immune therapy ipilimumab,"You can look all over this story for hype, but there isn‚Äôt any.¬† Just the facts, in a calm, restrained local angle to a national news story. No cures, no breakthroughs, no ""seismic shifts.""¬† ",Portland cancer center among those offering experimental immune therapy ipilimumab,story_reviews_01538,5,[],,[],http://www.oregonlive.com/health/index.ssf/2010/06/portland_cancer_center_among_t.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No discussion of costs.\xa0 Is this OK because this is still experimental?\xa0 We don‚Äôt think so, not when the drug company i",The Oregonian,"It‚Äôs really refreshing to see a local newspaper localize a national story and to do so in a responsible way.¬† Sure, the story led with its personal anecdote.¬† But the personal trials of being in a trial came through in that anecdote.¬† And sure, there",nan,"After a week‚Äôs worth of news out of the American Society of Clinical Oncology meeting, and some published concerns about how that news was covered by bigger national news organizations, it was good to see this local paper‚Äôs measured efforts. ",
https://www.healthnewsreview.org/review/2912/,"In melanoma patients, immune therapy may boost survival","We admire the precision and restraint shown in this story ‚Äì especially when compared with NBC reports that used sensational language like ""breakthrough‚Ä¶revolutionary‚Ä¶a seismic shift"" to describe the same study results.","In melanoma patients, immune therapy may boost survival",story_reviews_01541,5,[],,[],http://www.USA Today.com/news/health/2010-06-07-melanoma07_ST_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 Costs not discussed but we understand that at this point in the research.\xa0 Nonetheless, we wish the story ",USA Today,"In just 310 words, this story covered key points of study results clearly, concisely and without hyperbole. It used terms like ""may boost survival‚Ä¶may provide a new way‚Ä¶modest success"" instead of overstating.
¬†",nan,"It is a difficult balance reporting on promising study results for a terrible disease and doing so without sensationalism.¬† This story found that balance nicely.¬† It proves that in only 310 words, health news stories can do a reasonable job addressing o",
https://www.healthnewsreview.org/review/2904/,Low-dose combination of Avandia and metformin decreases progression to diabetes by two-thirds with few side effects,A 5-star story that packs a lot into a tight 445-word package. ,Low-dose combination of Avandia and metformin decreases progression to diabetes by two-thirds with few side effects,story_reviews_01544,5,[],,[],http://Los Angeles Timesblogs.Los Angeles Times.com/booster_shots/2010/06/lowdose-combination-of-avandia-and-metformin-decreases-progression-to-diabetes-by-twothirds-with-few.html?utm_source=feedburner,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs and the cost-effectiveness of this strategy are not discussed.\xa0Any discussion of a preventive strategy should include ",Los Angeles Times,"A well-constructed, balanced story that was missing just one piece of information: cost. Had the article discussed¬†the price tag of this approach, it would‚Äôve aced our criteria.
¬†",nan,"In addition to summarizing the key points of the study, the article provides some important nuggets of context, describing how rosiglitazone is in the hot seat now, even mentioning that some feel clinical trials with it are unethical. Rosi is undergoing a",
https://www.healthnewsreview.org/review/2906/,New Drug Spray May Help Premature Ejaculation,"One of three stories we reviewed on this same study.¬† It was the most detailed of the three ‚Äì which should be helpful to men trying to make sense of the company‚Äôs claims for its product.¬† Of course, this story was posted a day later than the other t",New Drug Spray May Help Premature Ejaculation,story_reviews_01546,5,[],,[],http://men.WebMD.com/news/20100602/new-drug-spray-may-help-premature-ejaculation,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story explains that ""No price has been set.""\xa0 We give it credit for thinking about cost and addressing it ‚Äì even if the an",WebMD,"There was a lot we liked about this story.¬† Appropriate caveats. Even the headline said ""may help"" instead of hyping results.¬† Lots of detail on the evidence. Maybe WebMD is starting to listen to us? 
¬†",nan,"The story ended with this note which we had not seen before on a WebMD story: 
We applaud this addition.¬†",
https://www.healthnewsreview.org/review/2896/,Trial Help for Sex Problems,"A reasonable job of reporting on two small studies of a spray used to delay ejaculation. The results have not been peer-reviewed or published, but they are being used by the company involved in the research to drum up interest in the spray in the run up t",Trial Help for Sex Problems,story_reviews_01547,4,[],,[],http://online.wsj.com/article/SB10001424052748704596504575272621430624744.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The company behind the product undoubtedly has done market research about\xa0how much of this product it might sell and at what",The Wall Street Journal,"The one thing we didn‚Äôt like in the story was letting the independent urologist get away with his claim that the findings were ""clinically significant.""¬† We liked the way one observer put it in an online comment posted after the WSJ online story:¬†
¬†",nan,"Sexual dysfunctions can be serious and life altering, and there is a steady parade of therapies being offered both through the standard scientific process and through outright hucksterism. It is important for reporters not to be blinded by the glare of se",
https://www.healthnewsreview.org/review/2884/,Does do-it-yourself colon cleansing really improve health?,Regular readers of this site know that we admire the LA Times‚Äô Healthy Skeptic column.¬† This is another example why. We wish more news orgs would do something like this.¬† ,Does do-it-yourself colon cleansing really improve health?,story_reviews_01553,5,[],,[],"http://www.Los Angeles Times.com/news/health/la-he-skeptic-20100524,0,5823363.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This column always does a good job discussing costs ‚Äì and raising questions of cost-effectiveness.\xa0 So why do more than 70% of",Los Angeles Times,"Starting with a dry comment about how obsessed some people are with their digestive tracts, and what a boon this is for the alternative medicine industry, this story goes on to evaluate the claims in a way we only wish would be applied more often to more ",nan,"Punch line to this story:¬† claims that colon cleansing supplements can somehow detoxify the colon and improve overall health ""have no basis in science."" ",
https://www.healthnewsreview.org/review/2874/,Finding a ‚Äúsilent killer‚Äù,"This story reports on one of only 6 studies highlighted by the American Society of Clinical Oncology out of more than 4,000 abstracts posted online a month in advance of its annual meeting.¬† This story ‚Äì while still employing some hyperbole such as ‚Äú",Finding a ‚Äúsilent killer‚Äù,story_reviews_01555,5,[],,[],http://www.chron.com/disp/story.mpl/metropolitan/7015523.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story does mention how much the blood test and ultrasound cost. The story could have raised the question of whether this might ",The Houston Chronicle,Cancer Antigen 125 (CA-125) is a protein found on the surface of certain types of ovarian cancer cells. The CA-125 test is used to monitor and guide treatment for ovarian cancer but has not been shown to be an effective screening test for average-risk wom,nan,"Key perspective in the story from Dr. Len Lichtenfeld of the American Cancer Society: ‚ÄúMore research and refining needs to be done before it should be implemented. I can remember when doctors all rushed to adopt the Prostate Specific Antigen test, and w",
https://www.healthnewsreview.org/review/2869/,Special diet doesn‚Äôt help kids with autism in small study,"This was a solid, succinct report on an issue that has received ‚Äì and will undoubtedly continue to generate ‚Äì a lot of attention, including a lot of misinformation. ",Special diet doesn‚Äôt help kids with autism in small study,story_reviews_01556,5,[],,[],http://www.USA Today.com/news/health/2010-05-20-autism20_ST_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Not applicable.\xa0 The story didn‚Äôt discuss costs of the diet, but that doesn‚Äôt seem particularly vital. '}, {'question': 'D",USA Today,"Even in a short (491-word) story, there was a good explanation of how the research was done ‚Äì with appropriate caveats about how small was the study sample. 
¬†",nan,There have been so many claims made about an autism-diet link.¬† It is important to report on new evidence in this field. ,
https://www.healthnewsreview.org/review/2867/,‚ÄòFemale Viagra‚Äô May Treat Low Sexual Desire,"A story that early and often reminds readers of the controversies surrounding the diagnosis and treatment of so-called hypoactive sexual desire in women.¬† Unfortunately the headline promotes the tired old ""female Viagra"" label. ",‚ÄòFemale Viagra‚Äô May Treat Low Sexual Desire,story_reviews_01558,5,[],,[],http://www.WebMD.com/sexual-conditions/news/20100518/female-viagra-may-treat-low-sexual-desire,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost data for flibanserin is not provided.\xa0 Some projection of cost should be available for any drug this far along in Phase",WebMD,"This story reports on a investigational drug, flibanserin, that is being developed to treat what is a controversial diagnosis¬†called ""hypoactive sexual desire"" in women. The popular press has dubbed this drug ""Female Viagra"" despite that fact that it has",nan,"Good reminders that this is a controversial diagnosis and that ""some experts see it as the medicalization of what is for many women a relationship issue."" ",
https://www.healthnewsreview.org/review/2853/,Under-Skin Defibrillators Seen Closer to Reality,"<span style=""font-size: 10pt; font-family: Arial;"">This story on a new type of implantable heart defibrillator is a couple of hundred words longer than the other story on the same research that we reviewed. The additional length is put to good use.</span>",Under-Skin Defibrillators Seen Closer to Reality,story_reviews_01561,5,[],,[],http://www.nytimes.com/2010/05/13/business/13device.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\nThe story notes that the cost of the device would be similar to that of existing devices, but that implantation is simpler, which",The New York Times,"
 This story includes an independent source and details about the underlying concept of the new device and its limitations that help readers put the research into the proper perspective. Aside from including more pertinent information, this story did a be",nan,"
Until two treatments are directly compared, it is usually inappropriate to claim that one is superior to the other. This story does a good job of explaining the results of research into this new device without implying that the preliminary trials produce",
https://www.healthnewsreview.org/review/2854/,Sleeping Pill May Treat Fibromyalgia Pain,"A generally solid review of this research, but patching a few holes would‚Äôve made it even more seaworthy.",Sleeping Pill May Treat Fibromyalgia Pain,story_reviews_01562,4,[],,[],http://www.WebMD.com/fibromyalgia/news/20100512/sleeping-pill-may-treat-fibromyalgia-pain,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Costs of the regimen used in narcolepsy are discussed.'}, {'question': 'Does the story adequately quantify the benefits of the trea",WebMD,"A well written and well constructed story that has two major flaws. ¬†The story is based on the results of a presentation at a national meeting and the results have not been subjected to peer review. ¬†In addition, the lack of disclosure concerning the pr",nan,"Fibromyalgia is a somewhat controversial yet important disorder.¬† Due in large measure to the lack of a clear cause of the disorder and the myriad of symptoms, treatments for fibromyalgia have been few and far between.¬† So, the early report of a new dru",
https://www.healthnewsreview.org/review/2856/,Below-the-skin defibrillator restores heartbeat,"<span style=""font-size: 10pt; font-family: Arial;"">The shorter of two stories we reviewed that report the results of trials of a new type of implantable heart defibrillator. Although the story reports many of the key points readers need to know, a few ele",Below-the-skin defibrillator restores heartbeat,story_reviews_01563,4,[],,[],http://www.Reuters.com/article/idUSTRE64B5WL20100512,"[{'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answer': 'Satisfactory', 'explanation': '\n\n\nThe story says that it is hoped the new device may be as effective as existing devices while potentia",Reuters Health,"

 Readers are told that further trials are needed, but while key potential benefits of the new type of device are outlined, the story does not mention problems that the researchers encountered in these early trials. The most important missing element in ",nan,"5clip_filelist.xml""/>


 



While it would have been helpful to name a dollar figure, the story did say that the new device costs roughly the same as existing implantable defibrillators. However, the story also includes claims that associated costs will ",
https://www.healthnewsreview.org/review/2833/,Weight Loss Pill Also Lowers Blood Pressure,"An overall fairly complete story that fell a bit short on explaining the blood pressure benefit, and quantifying harms. ",Weight Loss Pill Also Lowers Blood Pressure,story_reviews_01565,4,[],,[],http://www.WebMD.com/diet/news/20100504/weight-loss-pill-also-lowers-blood-pressure?page=2,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\xa0There was no discussion of costs.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/pr",WebMD,"Although highlighting the effect of this product on blood pressure, the story did not explain how much blood pressure dropped.¬† 
The story also didn‚Äôt say how common the side effects are or how often people have to discontinue the medication due to sid",nan,Obesity and high blood pressure are very common conditions. ¬†There are few treatment for obesity that have been demonstrated to be enable people to lose weight and maintain that loss.¬† ,
https://www.healthnewsreview.org/review/2821/,Drug Reverses Diabetes-Related Vision Loss,Better than the news release re-write of HealthDay but not as sharp as the New York Times piece on the same study.,Drug Reverses Diabetes-Related Vision Loss,story_reviews_01573,4,[],,[],http://diabetes.WebMD.com/news/20100428/drug-reverses-diabetes-related-vision-loss,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story covers cost in the very last two lines. '}, {'question': 'Does the story adequately quantify the benefits of the treatmen",WebMD,The key difference between this and the NYT story was that WebMD didn‚Äôt reflect on the question of why Genentech didn‚Äôt test its cheaper Avastin against the much more expensive Lucentis. The important issue of corporate sponsorship of a clinical trial,nan,You want to talk about comparative effectiveness research?¬† This would have been a good place for it. ,
https://www.healthnewsreview.org/review/2808/,A Genentech Eye Treatment Is Found to Help Prevent Vision Loss in Diabetics,Best of the three stories we reviewed on this study because it raised important questions about corporate sponsorship of clinical trials.¬† What does the company know about its cheaper drug versus its more expensive one? ,A Genentech Eye Treatment Is Found to Help Prevent Vision Loss in Diabetics,story_reviews_01574,5,[],,[],http://www.nytimes.com/2010/04/28/health/research/28eye.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\xa0Kudos! \xa0This story reported on the costs of the drug Lucentis as well as the less expensive Avastin.'}, {'question': 'Does t",The New York Times,"This story reports on the results of a newly published phase III trial demonstrating the benefits of the drug Lucentis for vision in those with diabetic macular edema. ¬† While including pertinent information about the possible benefits, harms, and costs,",nan,With promising results attributable to the more expensive medication it becomes almost impossible for government and commercial payors to not cover it.¬† It is precisely these sorts of studies that have driven health care costs in our country beyond a sus,
https://www.healthnewsreview.org/review/2804/,Trendy fizzy drink is mushrooming,Strong consumer column from registered dietitian.,Trendy fizzy drink is mushrooming,story_reviews_01578,5,[],,[],http://www.MSNBC.msn.com/id/36571884/ns/health-diet_and_nutrition/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Story says it costs $3-5 a bottle'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/pr",MSNBC,"If kombucha drinks are as hot a trend as the column suggests, then it‚Äôs worth the space to put claims and beliefs to the test, which this column did nicely. 
¬†",nan,"As the story explains: ""When celebrities like Reese Witherspoon were spotting carrying bottles of kombucha, it was inevitable that the exotic brew‚Äôs popularity would, well, mushroom.""¬† So it‚Äôs helpful to have an expert column shoot down some of the h",
https://www.healthnewsreview.org/review/2794/,Experimental Drug May Treat Hepatitis C,More focused and realistic in its assessment of a new study than the competing story by HealthDay news service. ,Experimental Drug May Treat Hepatitis C,story_reviews_01580,4,[],,[],http://www.WebMD.com/hepatitis/news/20100421/experimental-drug-may-treat-hepatitis-c,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'SInce the test drug is in the very early stages of development, this criterion is technically not applicable.\xa0However, the pre",WebMD,"While still needing some improvement, this WebMD story does a better job than a competing HealthDay piece of covering¬†an¬†experimental new treatment for hepatitis-C. The major difference is that this story¬†stayed focused on the study at hand, while the¬",nan,nan,
https://www.healthnewsreview.org/review/2780/,Lung Cancer Screening Often Raises False Alarm,"Accurate, informative and concise.¬† Solid five-star story. ",Lung Cancer Screening Often Raises False Alarm,story_reviews_01581,5,[],,[],http://www.NPR.org/blogs/health/2010/04/lung_cancer_screening_often_ra.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story clearly states the cost of a CT scan. The story could have commented on the fact that insurance may not cover it as a scr",NPR,An article published in the Annals of Internal Medicine¬† adds new fuel to the debate over the utility of lung cancer screening. The ongoing results of the National Lung Screening Trial from the National Cancer Institute are highly anticipated and many ho,nan,Both CT scans and x-rays generate significant numbers of false positive results when used to screen for lung cancer. Patients should carefully consider the consequences of these tests before initiating screening.,
https://www.healthnewsreview.org/review/2776/,Study: 2 good choices to prevent breast cancer,"More balanced than the competing story from USA Today ‚Äì with an expert quote saying ""I¬†don‚Äôt see a clear winner"" ‚Äì quite different than the researcher‚Äôs line in the other story that this ""suggests more high-risk women should consider taking ralox",Study: 2 good choices to prevent breast cancer,story_reviews_01583,5,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_BREAST_CANCER_DRUGS?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story specifically points out that generic tamoxifen costs 30 cents a day and Evista costs $3 a day.'}, {'question': 'Does the ",AP Associated Press,"This story reports on results from a recently updated randomized trial, which found that tamoxifen and raloxifene (Evista) are both effective options for preventing breast cancer in high-risk, postmenopausal women; however, as the writer notes, there are ",nan,The story emphasized choice and weighing of tradeoffs ‚Äì essential points in looking at this topic and this study. ,
https://www.healthnewsreview.org/review/2763/,Drug for Immune Disorders Helps Alzheimer‚Äôs,"Even though the story addressed many of our criteria, we‚Äôre left wondering how newsworthy is a study in which only 16 people got the active treatment.¬† Especially when the headline makes a definitive statement that the drug ""helps."" ",Drug for Immune Disorders Helps Alzheimer‚Äôs,story_reviews_01586,4,[],,[],http://www.WebMD.com/alzheimers/news/20100414/drug-for-immune-disorders-helps-alzheimers,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The approach is described as ""expensive ‚Äî about $2,000 to $3,000 per treatment. And patients in the study received infusions up t",WebMD,The biggest weakness was its failure to put the study results into any meaningful context for readers.¬† It describes points on a symptom scale without telling us the significance of these changes.¬† And it describes slowing the rate of brain shrinkage in,nan,"We applaud the independent perspective sought from the Mayo Alzheimer‚Äôs expert and its reminder ‚Äì ""In the past few years alone, several Alzheimer‚Äôs drugs that made it to this stage failed to pan out in further testing."" ",
https://www.healthnewsreview.org/review/2738/,Health claim: Weight loss shot dissolves fat,"At a time when so many news stories hype fat or weight loss interventions, it‚Äôs refreshing to see more space devoted to the evidence. ",Health claim: Weight loss shot dissolves fat,story_reviews_01590,4,[],,[],http://featuresblogs.chicagotribune.com/features_julieshealthclub/2010/04/health-claim-weight-loss-shot-dissolves-fat.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs weren‚Äôt mentioned and we wish they had been to help drive home the point of questionable cost effectiveness. '}, {'ques",Chicago Tribune,"The newspaper says this column was part of an ongoing series looking at the reality behind health claims. We love such efforts.¬† Of course, it‚Äôs what we do every day on this site! 
¬†",nan,"Efforts like Jeremy Singer-Vine‚Äôs Research Report column in the Wall Street Journal, the LA Times‚Äô Healthy Skeptic column, the Consumer Reports AdWatch series, and this Chicago Tribune series could be a model for other news organizations for devoting ",
https://www.healthnewsreview.org/review/2710/,Study: Riskier surgeries for back pain raise costs,"Apt quote from the story:¬†""""It certainly looks like there‚Äôs more complex surgery being done than we have very good evidence to support.""",Study: Riskier surgeries for back pain raise costs,story_reviews_01593,5,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_BACK_SURGERY?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story deal with cost very early in the story:\xa0\n""You have one kind of operation that could cost $20,000 and another that cou",AP Associated Press,"Thorough report, including a glance at how marketing and financial conflict of interest may have influenced the rise in costly, complex surgeries. 
¬†",nan,"The story ends with an important quote from a spine surgeon:¬† ""Too much fusion surgery is done in this country and often for inappropriate reasons"" and patients ""should not hesitate to get a second opinion.""",
https://www.healthnewsreview.org/review/2716/,‚ÄòElectronic Nose‚Äô Sniffs Out Asthma,This story about an experimental¬†technique for diagnosing asthma was refreshingly light on hype and included quite a few caveats and qualifiers.,‚ÄòElectronic Nose‚Äô Sniffs Out Asthma,story_reviews_01594,5,[],,[],http://Healthday.com/Article.asp?AID=637800,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Since this device is\xa0experimental,\xa0we can accept the fact that the story didn‚Äôt put a specific price tag\xa0on the technolo",HealthDay,"The new test looks for volatile organic compounds that are presumably uniquely exhaled by people with asthma.¬†When used in combination with a somewhat standard test, the new process may provide somewhat greater ability to diagnose asthma.¬†The story righ",nan,"Asthma is a relatively common disease that appears to be increasing in its frequency.¬†In its classic form, asthma is relatively easy to diagnose. However many patients present with atypical symptoms and require more extensive testing, including provocati",
https://www.healthnewsreview.org/review/2692/,Avodart May Lower Prostate Cancer Risk,"A fairly thorough review, covering costs, benefits (with a stab at absolute risk reduction), and harms.¬† Caveats and uncertainties were emphasized. ",Avodart May Lower Prostate Cancer Risk,story_reviews_01601,5,[],,[],http://men.WebMD.com/prostate-enlargement-bph/news/20100331/avodart-may-lower-prostate-cancer-risk,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'At the end of the story, an expert is quoted accurately describing the cost of the drug as $4 a day, which is expensive given that ",WebMD,"This week in The New England Journal of Medicine is the second of two major studies showing a reduction in prostate cancer incidence from a drug in the 5-alpha-reductase inhibitor class. The drug Avodart, commonly used to treat enlarged prostates, was sho",nan,"There‚Äôs a big push for so-called ""chemoprevention"" of prostate cancer.¬† But evidence ‚Äì not intuition ‚Äì must guide that push. This story did a decent job explaining the controversies.",
https://www.healthnewsreview.org/review/2676/,Liver supplements don√¢‚Ç¨‚Ñ¢t seem to offer protection,"<span style=""font-size: small;"">Another nice job by the paper‚Äôs Healthy Skeptic column, citing good sources, although perhaps a little light on the evidence. </span>",Liver supplements don√¢‚Ç¨‚Ñ¢t seem to offer protection,story_reviews_01602,5,[],,[],"http://www.Los Angeles Times.com/features/health/la-he-skeptic-20100329,0,5452330,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': ''}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedure?', 'answer': 'Satisfactor",Los Angeles Times,"
¬†",nan,"The market for herbal supplements is huge, but the marketing is largely unregulated and fueled by dubious claims. This piece does a nice job of explaining why one supplement may not live up to the hype.",
https://www.healthnewsreview.org/review/2679/,Are We Overselling The Sunshine Vitamin?,"Good story pointing out that we have incomplete evidence about the health effects of vitamin D supplementation, and we are uncertain whom should be tested, and how much people should take. ¬†Even the experts are at odds about it.",Are We Overselling The Sunshine Vitamin?,story_reviews_01604,5,[],,[],http://www.NPR.org/templates/story/story.php?storyId=125226703,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The cost of testing for vitamin D levels was provided.\xa0 No information about the costs of vitamin D supplements, but we‚Äôll giv",NPR,This story helps temper some of the rampant health claims made for vitamin D with information about the nature of the studies giving rise to the enthusiasm. ¬†It is a step in the right direction for helping readers discern between health claims supported ,nan,¬†People are bombarded with health claims and learning to question their basis ‚Äì¬† how strong is the evidence supporting the claim ‚Äì is helpful for people so that they can make more informed decisions. ,
https://www.healthnewsreview.org/review/2672/,"Study adds evidence that bone drugs work, are safe",This is a solid review of a study examining¬†the risk of¬†thigh-bone fractures in women with osteoporosis taking bisphosphonate drugs.,"Study adds evidence that bone drugs work, are safe",story_reviews_01605,5,[],,[],http://www.NPR.org/templates/story/story.php?storyId=125143433,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Treatment costs for both Fosamax and Reclast\xa0are provided.'}, {'question': 'Does the story adequately quantify the benefits of t",AP Associated Press,"Although these drugs are supposed to strengthen bone, some reports have raised the possibility that they actually may¬†increase¬†the likelihood of an unusual type of fracture for¬†some¬†women.¬†For the most part, this story provides a¬†thorough¬†look¬†at ",nan,"Hip fractures are a common and often devastating result of osteoporosis. While bisphosphonates are proven to help prevent osteoporotic fractures, recent reports have raised concern about whether¬†a rare type of thigh fracture might be more common in women",
https://www.healthnewsreview.org/review/2636/,Triumph for Drug to Straighten Clenched Fingers,"Five-star effort: A main story and a sidebar that deliver facts, cautious optimism, and balancing issues of costs and potential harms.¬† ",Triumph for Drug to Straighten Clenched Fingers,story_reviews_01613,5,[],,[],http://www.nytimes.com/2010/03/16/business/16hand.html?src=twt,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The main story estimates a course of treatment will cost\xa0about $5400,\xa0and the sidebar helpfully compared this amount to some ",The New York Times,This story is about the long journey to approval of¬†a new drug called Xiaflex used¬†to treat Dupuytren‚Äôs contracture‚Äìa condition in which cords of collagen cause fingers to clench involuntarily. While the main story focuses mostly on the financial ma,nan,A drug‚Äôs approval by the FDA is often accompanied by excessive hype regarding the new therapy‚Äôs¬†benefits¬†but little scrutiny of potential downsides. It‚Äôs nice to see an approval story that balances excitement about benefits with sober analysis of ,
https://www.healthnewsreview.org/review/2640/,Salsalate May Help Treat Type 2 Diabetes,A 429-word story that had a definite edge over a 240-word HealthDay story we also reviewed.¬† You can pack a lot more detail and context into those 189 words.¬† ,Salsalate May Help Treat Type 2 Diabetes,story_reviews_01614,4,[],,[],http://diabetes.WebMD.com/news/20100315/salsalate-may-help-treat-type-2-diabetes,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs are not discussed explicitly.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/prod",WebMD,"This is the better of two articles we reviewed¬†about a newly¬†published study. It was quite balanced overall, although it misinterpreted the key result and would‚Äôve benefited much from soliciting an outside expert‚Äôs opinion on the study.
¬†",nan,"Despite a few shortcomings, this article has substantially more balance, critical analysis, and thoughtful framing than the HealthDay story we reviewed on this same study. ",
https://www.healthnewsreview.org/review/2634/,Newer Genetic Test for Autism More Effective,"The concluding quote was important: ""(This test) is better, but it‚Äôs not great. The vast majority of children who have autism have no identifiable genetic markers that will help in genetic counseling for future pregnancies. That is very frustrating.""",Newer Genetic Test for Autism More Effective,story_reviews_01616,4,[],,[],http://Healthday.com/Article.asp?AID=636945,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story did not mention specific costs of the CMA test; however, it did indicate that not all insurance will cover this test.",HealthDay,"This¬†piece reports on a study, which found that a newer genetic test is better at detecting abnormalities linked to autism when compared to the standard tests. This was a well-referenced piece that met many of our criteria, but it would have been improve",nan,This is a story about an emerging diagnostic test for a childhood disorder that appears to have increasing prevalence.¬†Knowledge of genetic predisposition to this disease is important. ,
https://www.healthnewsreview.org/review/2635/,Medtronic atrial fibrillation system shines in study,"Overall, this was a balanced report but we wish it had included independent perspectives ‚Äì maybe even someone who could compare this device with another already on the market.",Medtronic atrial fibrillation system shines in study,story_reviews_01617,4,[],,[],http://www.Reuters.com/article/idUSTRE62E3M420100315?type=globalMarketsNews,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\xa0There was no discussion of costs.'}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/pr",Reuters Health,"This story reports on results from a preliminary study for a device in development to treat atrial fibrillation.¬† Although it appears to be intended as a business story, we think shareholders would care about cost and comparisons with existing alternativ",nan,"Since the story acknowledged that a competing device was already on the market, it wouldn‚Äôt have required much more work to do some comparative analysis ‚Äì especially if our call for an independent expert‚Äôs perspective was heeded. ",
https://www.healthnewsreview.org/review/2588/,Study Finds Stents Effective in Preventing Strokes,"Two procedures. Two studies. Two very different outcomes. In competing coverage of¬†a complicated story, both the¬†",Study Finds Stents Effective in Preventing Strokes,story_reviews_01628,4,[],,[],http://www.nytimes.com/2010/02/27/health/27stroke.html?pagewanted=print,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although it hints at potential implications of expanded Medicare coverage for stents, this story doesn‚Äôt make any explicit re",The New York Times,"Immediately ‚Äì in the second sentence ‚Äì this story raised doubts about the North American study more forcefully than the LA Times story ever did. And it immediately offered the perspective that these ""disparate findings‚Ä¶could help determine whether M",nan,"While we don‚Äôt want our¬†health coverage to devolve into¬†""he said, she said"" between research camps,¬†good reporting¬†has to present opposing views when reasonably justified by the evidence.¬†¬†¬†¬†",
https://www.healthnewsreview.org/review/2570/,Acupuncture May Ease Depression During Pregnancy,A generally well-done piece with appropriate context and caveats. ,Acupuncture May Ease Depression During Pregnancy,story_reviews_01631,4,[],,[],http://Healthday.com/Article.asp?AID=636244,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story makes no mention of costs or insurance coverage for acupuncture in the context of partum depression. Costs could be a",HealthDay,"This story reports on the results of a randomized, controlled trial comparing a specific type of acupuncture to ""sham"" acupuncture (acupuncture using different pressure points), and massage. The study found that the group of women who received customized ",nan,"Depression during pregnancy may be difficult to recognize because many of the normal changes (such as change in appetite and sleep and lower energy levels) during pregnancy are similar to the symptoms of depression. However, untreated and undiagnosed depr",
https://www.healthnewsreview.org/review/2573/,Zapping fibroids with heat in hunt for new options,"The treatment of uterine fibroids is starting to feel like the ""device wars"" seen in treatment of other conditions.¬† This story did a reasonably good job of discussing the options that women face ‚Äì and some of the pros and cons. ",Zapping fibroids with heat in hunt for new options,story_reviews_01632,4,[],,[],http://hosted.ap.org/dynamic/stories/U/US_MED_HEALTHBEAT_FIBROIDS?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Treatment for uterine fibroids represents a\xa0big cost burden\xa0for our health care system and\xa0for individual patients. Ho",AP Associated Press,"This story¬†covers less-invasive alternatives to¬†hysterectomy for the treatment of uterine fibroids. One of the techniques‚Äìradio frequency (RF) ablation‚Äìis an experimental¬†method in early clinical testing, whereas the two other approaches‚Äìuterine ",nan,"There are¬†a number of different¬†treatments for fibroids that are less invasive than hysterectomy. However,¬†there is very little good research¬†to tell us which approach is most effective for which patients. Add to this the financial incentives that dev",
https://www.healthnewsreview.org/review/2562/,"Aspirin might reduce recurrence risk for breast cancer survivors, study finds",It is so easy to get a story like this wrong.¬† But this story mostly got it right.¬† ,"Aspirin might reduce recurrence risk for breast cancer survivors, study finds",story_reviews_01636,5,[],,[],"http://www.Los Angeles Times.com/news/nation-and-world/la-sci-aspirin17-2010feb17,0,1751303,print.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Cost of aspirin is not in question.\xa0 Not applicable. '}, {'question': 'Does the story adequately quantify the benefits of the ",Los Angeles Times,"Appropriate discussion of possible limitations of the research.¬† Good context.¬† Appropriate warnings to women being treated for breast cancer NOT¬†to start taking aspirin.
¬†",nan,"As one expert said in the story, ""If true, it would certainly be a relatively easy, inexpensive, potentially safe intervention for women who have had breast cancer.""¬† But the story made clear that‚Äôs a big IF. ",
https://www.healthnewsreview.org/review/2558/,‚ÄòBonding‚Äô Hormone Might Help Some With Autism,This story is the best of the three we reviewed about the¬†,‚ÄòBonding‚Äô Hormone Might Help Some With Autism,story_reviews_01640,5,[],,[],http://Healthday.com/Article.asp?AID=636049,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although this is a very preliminary study, some mention of costs should have been included, even if simply to note that the cos",HealthDay,"Overall this 633-word story captures the essence of the study and places the test results into a reasonable context.
¬†",nan,"This small study supports the hypothesis that oxytocin is involved in the social behaviors associated with high-functioning autism spectrum disorders, and it suggests a potential therapeutic role for oxytocin in people with such disorders.
  ",
https://www.healthnewsreview.org/review/2534/,Insulin Study Could Lead to New Dosage Devices,The best of three stories we reviewed on the same study. ,Insulin Study Could Lead to New Dosage Devices,story_reviews_01644,4,[],,[],http://www.nytimes.com/2010/02/05/business/05diabetes.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Like its competitors, the Times did not discuss costs‚Äìan\xa0omission\xa0which perhaps is more acceptable in this story since ",The New York Times,"With its balanced coverage of an experimental system for managing blood glucose in type 1 diabetes, the Times demonstrates why it is¬†often a cut above most other health media outlets. Of the three competing stories¬†we looked¬†at, the Times‚Äò was the on",nan,The study covered here represents a potentially important advance on the road to an automated system for managing blood sugar in patients with type 1 diabetes. By laying out the potential of such a system in sober terms and pointing out the many obstacles,
https://www.healthnewsreview.org/review/2533/,Zap or Chill? Targeting Fat Without Surgery,"News on devices to cool-treat ""offending jiggle""¬† or to ""zap your belly, flanks and hips."" ¬† Reasonable balance, but doesn‚Äôt emphasize potential harms and the total lack of evidence for health benefits. ",Zap or Chill? Targeting Fat Without Surgery,story_reviews_01645,4,[],,[],http://www.nytimes.com/2010/02/04/fashion/04SKIN.html?ref=health,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states the price for the Zerona device: $1,700 to $3,800 for six sessions. The price of Zeltiq is also reported but is no",The New York Times,This story does a solid job describing two newish treatments purported to dissolve targeted fat‚Äìthe Zeltiq cooling system and the Zerona laser. The story manages to deliver the most important facts while maintaining some tongue-in-cheek distance. This i,nan,The idea of losing visible fat quickly is sufficiently compelling that consumers spend many millions of dollars on treatments ranging from surgical removal of fat to topical creams. With two new technologies with plausible scientific validity entering the,
https://www.healthnewsreview.org/review/2536/,Hormone replacement tied to lower colon cancer risk,We see so many stories that make unfounded claims about observational studies. It is refreshing to see one that put findings in perspective so well. ,Hormone replacement tied to lower colon cancer risk,story_reviews_01647,5,[],,[],http://www.Reuters.com/article/idUSTRE6134XJ20100204,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The cost of hormone replacement therapy is not in question.\xa0 '}, {'question': 'Does the story adequately quantify the benefits",Reuters Health,"In only 546 words, this story covered most of the bases ‚Äì providing absolute data from a big trial, saying that the findings support earlier theories, but warning that this does not change earlier advice about HRT. 
¬†",nan,This story was judicious and cautious ‚Äì two important characteristics in discussing hormone replacement therapy and colon cancer. ,
https://www.healthnewsreview.org/review/2517/,Industrial chemical OSR#1 used as autism treatment,This paper continues its excellent series of stories on autism controversies with this report. ,Industrial chemical OSR#1 used as autism treatment,story_reviews_01650,5,[],,[],"http://www.Los Angeles Times.com/features/health/la-he-autism-chemical1-2010feb01,0,1654619.story?page=2","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story mentions that 30 capsules of\xa0OSR#1 cost $60. It would have been nice had the story also included\xa0information about ",Chicago Tribune,"The product known as OSR #1 contains a chemical originally intended for clean-up of toxic waste at industrial sites.¬†This story by the Chicago Tribune (which was republished by the Los Angeles Times) examines¬†how,¬†despite a total lack of any research¬†",nan,Autism is a serious disorder which affects a growing number of children and their families and for which there are few good¬†treatment options.¬†¬†This¬†is a¬†situation ripe for abuse by overzealous advocates and¬†unscrupulous marketers¬†of uNPRoven thera,
https://www.healthnewsreview.org/review/2518/,Face time with MyClyns anti-germ spray,We appreciate the Healthy Skeptic column in this paper.¬† And this is another fine example of why we feel that way.,Face time with MyClyns anti-germ spray,story_reviews_01651,4,[],,[],"http://www.Los Angeles Times.com/features/health/la-he-skeptic1-2010feb01,0,692239.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Explicit.\xa0 $9-10 for a fifth-of-an-ounce spray bottle. '}, {'question': 'Does the story adequately quantify the benefits of the ",Los Angeles Times,"Take water, add sodium chloride, zap it with an electric charge.¬† And then sell it for ten bucks a bottle as an anti-germ spray.¬† That‚Äôs the story the LA Times tells with this column.
Good as this column was, though, it could have been much stronger i",nan,"With all of the anti-microbial marketing bombarding us like an attack on our immune system these days, it‚Äôs good to have a newspaper evaluate the claims and the evidence for us. ",
https://www.healthnewsreview.org/review/2523/,Can fish oil help guard against schizophrenia?,¬†A generally well done story that let the researcher get away with making some projections that should have been challenged.¬† That‚Äôs why we look for independent expert voices in such stories. ,Can fish oil help guard against schizophrenia?,story_reviews_01652,4,[],,[],http://www.Reuters.com/article/idUSTRE6105QQ20100201,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention costs.\xa0 Fish oil supplements are relatively inexpensive and can cost as little as $0.25 per day f",Reuters Health,"This story does a good job of reporting on the research methods and findings.¬† However, the research itself has some methodological concerns that could have been addressed in the story.¬† For example, one might¬†question the plausibility¬†that the¬†benef",nan,"This story should have challenged the author‚Äôs comments that fish oil ""could also potentially be used to prevent or delay the onset of chronic depression, bipolar illness, and substance abuse disorder ‚Äî all of which are far more common than psychotic ",
https://www.healthnewsreview.org/review/2524/,Fish Oil May Fight Psychosis,"Some minor, but significant, caveats in this story. Still, why no independent perspectives? ",Fish Oil May Fight Psychosis,story_reviews_01653,4,[],,[],http://www.WebMD.com/schizophrenia/news/20100201/fish-oil-vs-psychosis,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no mention of the cost of dietary fish oil supplements.\xa0 '}, {'question': 'Does the story adequately quantify the ",WebMD,"This news story reports on results from a recent randomized trial, which found that taking fish oil capsules reduces the risk of psychosis in high-risk teens. While the results of this study¬†seem exciting, this story tempers this¬†excitement by indicatin",nan,nan,
https://www.healthnewsreview.org/review/2525/,Fish oil shows promise in preventing psychosis,"A generally good job that, nonethless, did not raise questions about study methodology that we would have raised.¬† Our sense is that the story reports on something that is too good to be true.",Fish oil shows promise in preventing psychosis,story_reviews_01654,4,[],,[],http://www.MSNBC.msn.com/id/35186424/ns/health-mental_health/,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Estimated costs of fish oil supplements, approximately $0.40 per day, are provided.'}, {'question': 'Does the story adequately quan",AP Associated Press,"This story does a good job of reporting on the research methods and findings.¬† However, the research itself has some methodological concerns that could have (should have?) been examined more closely in the story.¬† For example, one might¬†question the pl",nan,"Schizophrenia-like illnesses can be devastating especially if untreated so the use of a dietary supplement that is widely available could be quite helpful.¬†¬†¬†If replicated in a larger study, this would be quite a boon for such high-risk youth.¬† The ey",
https://www.healthnewsreview.org/review/2512/,New morning-after pill works for up to 5 days,"Overall good job, except that it didn‚Äôt discuss specific costs or harms. ",New morning-after pill works for up to 5 days,story_reviews_01656,4,[],,[],http://hosted.ap.org/dynamic/stories/E/EU_MED_MORNING_AFTER_PILL?SITE=AP,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention costs of either drug, other than to describe the costs of ellaOne as ""three times the price of Plan ",AP Associated Press,"In 1999, the FDA first approved the prescription-only Plan B (two high dose pills of Levonorgestrel, a hormone commonly found in many birth control pills).¬† In 2006, Plan B was made available without a prescription to women over the age of 18, however th",nan,"In short, taking these pills is not a pleasant experience but nonetheless is far safer than abortion.",
https://www.healthnewsreview.org/review/2510/,Ultrasound may cut deaths in high-risk pregnancies,A 555-word story that covered most of the bases.¬† A few more words on costs and some from an independent source and we‚Äôd be looking at a five-star story. ,Ultrasound may cut deaths in high-risk pregnancies,story_reviews_01659,4,[],,[],http://www.Reuters.com/article/idUSTRE60Q55J20100127,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '1clip_filelist.xml"" rel=""File-List""/>\n\n\n\nThe story does not give any estimate of the cost of Doppler ultrasound examination",Reuters Health,"1clip_filelist.xml"" rel=""File-List""/>



 
This story clearly explains that a new review of the available evidence from published trials backs the use of Doppler ultrasound to monitor high-risk pregnancies. Notably, the story reports the absolute risk cal",nan,"1clip_filelist.xml"" rel=""File-List""/>



When there is concern about potential problems with a pregnancy, Doppler ultrasound is a commonly recommended test used to help make decisions about cesarean section, induced labor or other interventions; thus misu",
https://www.healthnewsreview.org/review/2494/,"MS pills show promise and risk, studies say","This AP story was much better than one that appeared on the LA Times blog.¬† Of course, it ran 786 words as opposed to 305 on the blog.¬† But this review is one piece of evidence calling for more words, more context and more balance in such stories.","MS pills show promise and risk, studies say",story_reviews_01664,4,[],,[],http://www.The Denver Post.com/fitness/ci_14231453#ixzz0dFtUwcPw,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer",AP Associated Press,"Nice job explaining harms and benefits ‚Äì including putting the potential risks/harms right in the headline.¬† 
¬†",nan,"¬†The appeal of an oral drug for MS is clear.¬† The risks emphasized in this story, though, raise important questions",
https://www.healthnewsreview.org/review/2495/,MS Patients May Soon Bypass Painful Injections,Excitement but caution captured in the same story ‚Äì including a strong patient quote about being careful about jumping on new and uNPRoven ideas.,MS Patients May Soon Bypass Painful Injections,story_reviews_01665,4,[],,[],http://www.NPR.org/templates/story/story.php?storyId=122774705,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No cost was discussed. '}, {'question': 'Does the story adequately quantify the benefits of the treatment/test/product/procedur",NPR,The online story (we listened to the radio version as well) did some nice things that other stories didn‚Äôt do ‚Äì including providing a direct link to an editorial in the New England Journal of Medicine ‚Äì when many news organizations surprisingly fail,nan,This story was a nice little example of how a short radio piece and web article can provide appropriate context on a research story.,
https://www.healthnewsreview.org/review/2491/,Should HPV Test Replace the Pap Smear?,"Overall good job, but didn‚Äôt discuss costs or give any evidence to support a ""cost-effective"" claim made in the story. ",Should HPV Test Replace the Pap Smear?,story_reviews_01666,4,[],,[],http://Healthday.com/Article.asp?AID=635110,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not discuss the costs of the tests or mention the costs of the additional colposcopies that result from the high",HealthDay,"Human Papilloma Virus (HPV) is the most common sexually transmitted disease and can cause cell changes that lead to cervical cancer. Each year around 12,000 women are diagnosed with cervical cancer in the US, however this number has declined significantly",nan,"It is clear that screening with HPV DNA tests will result in observing and treating more women at an earlier point in the progression from cell changes to cervical cancer. However, what is less clear is if the additional testing and treatment is worth it,",
https://www.healthnewsreview.org/review/2477/,New Anticlotting Drug Beats Plavix,"This entire story on treatment of ""acute coronary syndrome"" never defined that for readers.¬† Are they expected to know? ",New Anticlotting Drug Beats Plavix,story_reviews_01669,4,[],,[],http://www.WebMD.com/heart-disease/news/20100113/new-anti-clotting-drug-beats-plavix,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': '\xa0There was no discussion of costs, although the story did mention that the twice a day dosing of the drug would be required.",WebMD,¬†This story reported on the results of a recently published study that found a new anti-clotting medication (which is not yet FDA approved) had better outcomes than the currently available medication used to treat people with acute coronary syndrome.¬† W,nan,"While predicting that FDA approval is likely, the story never gives a cost estimate.¬† How much will it cost to get a 1.1% reduction in death? ",
https://www.healthnewsreview.org/review/2478/,Blood Test for Lung Cancer in the Works,Solid job reporting on the results of a¬†preliminary¬†study to develop a new diagnostic blood test for lung cancer ‚Äì not a new population screening test. ,Blood Test for Lung Cancer in the Works,story_reviews_01670,5,[],,[],http://www.WebMD.com/lung-cancer/news/20100113/blood-test-for-lung-cancer-in-the-works,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Costs are not discussed, as this is an investigational procedure.'}, {'question': 'Does the story adequately quantify the benefit",WebMD,"¬†We would have liked to see more independent assessment of the specific results presented at this scientifiic meeting.¬† Ideally, the story should have touched on the limitations of drawing conclusions from results presented at scientific meetings ‚Äì re",nan,"A validated non-invasive test for lung cancer could offer several benefits. The current protocol to diagnose lung cancer frequently includes an X-ray and then a biopsy or other invasive procedure to investigate any X-ray abnormalities, which are common. B",
https://www.healthnewsreview.org/review/2474/,Some Blood Pressure Drugs May Stave Off Dementia,"Important area of research.¬† But this story had some important gaps ‚Äì no context of prior research, benefits framed only in relative terms (",Some Blood Pressure Drugs May Stave Off Dementia,story_reviews_01671,4,[],,[],http://Healthday.com/Article.asp?AID=634898,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of the drugs was not mentioned.\xa0 And the possible cost-effectiveness ramifications of the research were not mention",HealthDay,"Generally well done though the story may have been, we‚Äôre troubled when a story talks about ""a small but protective effect¬†"" and uses active verbs to say the drugs ""may stave off dementia"" when it also states in the story this is not convincing proof o",nan,This is an important and intriguing area of research.¬† But stories that make it sound as though cause-and-effect has been proven ‚Äì when it hasn‚Äôt ‚Äì don‚Äôt do a service to public understanding.¬† See how¬† blogger Emlly DeVoto wrote about the same ,
https://www.healthnewsreview.org/review/2461/,"Debate over cognitive, traditional mental health therapy","Kudos to this newspaper for exploring an important professional debate ‚Äì one that raises questions about whether evidence-based, tested therapies are being ignored too often. ","Debate over cognitive, traditional mental health therapy",story_reviews_01672,4,[],,[],"http://www.Los Angeles Times.com/features/health/la-he-psychotherapy11-2010jan11,0,3973704.story","[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not discuss the cost of CBT compared to other therapies. The\xa0story notes it is seen as a cost-effective treat",Los Angeles Times,This is an important enterprise story examining the debate among mental health professionals over cognitive behavioral therapy versus traditional psychoanalysis. This is not a story that was done simply in reaction to a news release or a journal article o,nan,"Should we base treatments/interventions on science, on science tailored to the individual, or on experential approaches? ¬†(The middle option is best.)
Are clinicians paying attention to the latest science or walking to their own drumbeat ‚Äì not listenin",
https://www.healthnewsreview.org/review/2463/,"Robot prostate surgery has downsides, needs more data",A rare story that appropriately focuses on the downsides of an expensive medical procedure! ,"Robot prostate surgery has downsides, needs more data",story_reviews_01673,4,[],,[],http://www.Reuters.com/article/idUSTRE60A4RY20100111,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': '\xa0The story indicated that the robotic procedure was more expensive than a standard surgical prostatectomy. In addition, it inclu",Reuters Health,"This is a story about a study examining the costs, harms and the impact of doctor experience¬†associated with¬†the use of robotic prostatectomy. The story raised some important issues that are not ordinarily broached during patient ‚Äì doctor conversation",nan,¬†This story is provides an example for consumers to consider about the value in knowing about both the benefits as well as the harms associated with whatever treatment option they are considering. ¬†Further ‚Äì the story raises the point that newer or se,
https://www.healthnewsreview.org/review/2464/,More Aggressive Treatment for Weekend Stroke,"In comparing this HealthDay story with a Reuters story on the same study, the latter is slightly better for small but significant reasons.¬† Read both story reviews for a comparison. ",More Aggressive Treatment for Weekend Stroke,story_reviews_01674,4,[],,[],http://health.msn.com/health-topics/first-aid/articlepage.aspx?cp-documentid=100252352,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not discuss the costs or potential savings associated with the use of this drug. \xa0On the cost side,\xa0there ",HealthDay,¬†,nan,nan,
https://www.healthnewsreview.org/review/2465/,Weekend stroke care more aggressive but not better,This story from Reuters did a slightly better job¬†than a competing report from HealthDay. ,Weekend stroke care more aggressive but not better,story_reviews_01675,4,[],,[],http://www.Reuters.com/article/idUSTRE60A5C020100111,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'As with the HealthDay report, this article did not mention costs.'}, {'question': 'Does the story adequately quantify the benef",Reuters Health,"To its credit, this story noted early and prominently that the study found no decrease in the death rate among patients with stroke who were admitted on the weekends compared with those admitted during the week. However, it shared many of the shortcomings",nan,"As the story points out,¬†when you suffer a stroke on a Saturday or Sunday, ""waiting until Monday for aggressive treatment is not an option.""¬†¬†¬†",
https://www.healthnewsreview.org/review/2432/,"Study: Ginkgo biloba has no effect on Alzheimer‚Äôs, dementia","The story summed it up succinctly ‚Äì ""largest and longest study"" and it found no protective effect.¬† ","Study: Ginkgo biloba has no effect on Alzheimer‚Äôs, dementia",story_reviews_01683,4,[],,[],http://www.USA Today.com/news/health/2009-12-30-ginkgo30_ST_N.htm?loc=interstitialskip,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story states that US sales for the product hit $99 million in 2008.\xa0 But it never explained the cost to the individual. ",USA Today,"In fewer words than its HealthDay competitor (404 words vs. 740), this story did a slightly better job on providing context and balance. 
¬†",nan,Americans spend about $100 million a year on this stuff. ,
https://www.healthnewsreview.org/review/2412/,Stem cell therapies for hearts inching closer to wide use,"Overall, a good wrapup of progress on cardiac stem cell research. ",Stem cell therapies for hearts inching closer to wide use,story_reviews_01690,5,[],,[],http://www.CNN.com/2009/HEALTH/12/18/stem.cells.heart/index.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The story reports that harvesting enough stem cells for infusion is difficult and costly, though it fails to cite specific costs.",CNN Health,"The story does a solid job of explaining that the current research, a Phase I study, can establish only that the procedure is safe, not that it is effective. The reader learns about the differences among the three phases of studies the FDA requires. The r",nan,"Despite advances in diagnostics and therapies, heart attack and its consequences represent a significant problem. ¬†This report highlights the results of an early phase 1 trial comparing a placebo infusion to an infusion of processed adult stem cells in p",
https://www.healthnewsreview.org/review/2402/,Giving a Heart a Hand,"How nice to see a newspaper that still devotes more than 1,500 words to a story about research that could have an impact on many.¬† Overall, a strong story. ",Giving a Heart a Hand,story_reviews_01691,4,[],,[],http://online.wsj.com/article/SB10001424052748703954904574596252025375352.html,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story states that the LVAD device costs $80,000, and that the total cost, including implant surgery, is over $150,000. '}, {'qu",The Wall Street Journal,"As the ratings show, for the most part the story follows best practices regarding potential harms and benefits, sourcing and context. The story veers toward the sensational with its second satisfied-patient anecdote. But taken as a whole the story provide",nan,"As more Americans survive heart attacks, more of them deal with heart failure later on. A device that treats people with advanced chronic heart failure could prolong many lives. For now, whom to treat and when to treat with these devices remains an area o",
https://www.healthnewsreview.org/review/2393/,Radiation From CT Scans May Raise Cancer Risk,Well done story on an important topic.¬† Important discussion about the wide range of doses of radiation exposure among different hospitals. ,Radiation From CT Scans May Raise Cancer Risk,story_reviews_01692,4,[],,[],http://www.NPR.org/templates/story/story.php?storyId=121436092,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story does not mention costs of CT scans, which are substantial. '}, {'question': 'Does the story adequately quantify the b",NPR,"Computed Tomography (CT) scans produce incredibly detailed high-resolution pictures of the body, making them invaluable tools for the detection and treatment of disease.¬†However as doctors rely on them more and more for diagnosis and monitoring and patie",nan,Consumers should be aware that they may be exposed to more radiation than they think and should discuss this risk with their doctor before undergoing CT scanning.,
https://www.healthnewsreview.org/review/2389/,"More evidence coffee, tea could prevent diabetes",This story gave more context and more caveats and in fewer words than a WebMD story on the same study. ,"More evidence coffee, tea could prevent diabetes",story_reviews_01695,4,[],,[],http://www.Reuters.com/article/idUSTRE5BD50N20091214,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': '\xa0There was no discussion of costs, but most people know what coffee and tea costs.'}, {'question': 'Does the story adequately ",Reuters Health,"In 400 words, this story did a better job than its WebMD competition did in 500 words on the same study, namely: 
Nonetheless, it still:

¬†",nan,¬†The flip side is equally true: the benefits may not turn out to be real and that advice may be groundless.¬†,
https://www.healthnewsreview.org/review/2382/,Studies: Bone drugs may help prevent breast cancer,A generally well-done story.¬† But the story lacked the reservations or skepticism expressed in a competing ,Studies: Bone drugs may help prevent breast cancer,story_reviews_01699,4,[],,[],http://www.USA Today.com/news/health/2009-12-10-breast-cancer-drugs_N.htm,"[{'question': 'Does the story adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This story informs the reader of the cost range for some generic and brand name drugs.\xa0 It states that a 3-month supply of alend",AP Associated Press,"This story covers the results of preliminary findings of two large observational studies presented at the San Antonio Breast Cancer Symposium which suggest that bisphosphonates, for example Fosamax,¬†Boniva and Actonel,¬†may play a role in reducing the ri",nan,"Breast cancer is the second leading cause of cancer-related death in women, following lung cancer.¬† Currently, there are no preventive measures for women of average risk.¬† The research results reported in this story add to other recent studies that have",
https://www.healthnewsreview.org/news-release-review/kudos-for-universitys-restraint-in-promoting-at-home-hpv-tests-for-women/,Kudos for university‚Äôs restraint in promoting at-home HPV tests for women,The release is also very transparent about potential conflicts of interest.,"Mailed HPV tests can help find women at-risk for cervical cancer, study finds",,4,"['Matt Shipman', 'Andrae Vandross, MD', 'Kathlyn Stone']",Screening tests,"['Cervical cancer', 'HPV testing', 'University of North Carolina Lineberger Comprehensive Cancer Center']",https://www.eurekalert.org/pub_releases/2018-11/ulcc-mht110718.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The release does not place a pricetag on HPV screening ‚Äî which would include the test kit, analysis and follow-up clinical",news_reviews_00016,University of North Carolina Lineberger Comprehensive Cancer Center,"The release focuses on a recent ‚Äúproof-in-principle‚Äù study that found it is feasible to use at-home testing kits to screen low income women with limited access to medical care for human papillomavirus (HPV) infection, which can lead to cervical cancer","As the National Cancer Institute notes, virtually all cervical cancers are caused by HPV ‚Äî with most of them being caused by certain strains of HPV. And early diagnosis of HPV infection can help to prevent cancers, or allow patients and healthcare provi","https://www.healthnewsreview.org/wp-content/uploads/2018/11/GettyImages-610752626-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/11/GettyImages-610752626-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/recap-of-some-knee-surgeons-use-of-aspirin-as-a-clot-buster-skims-over-study-limitations/,Recap of some knee surgeons‚Äô use of aspirin as a clot buster skims over study limitations,"Harms from aspirin, including bleeding risk, were not mentioned.",Aspirin alone a good clot buster after knee surgery,,4,"['Andrew Holtz, MPH', 'Harold J. DeMonaco, MS', 'Kathlyn Stone']",Academic medical center news release,"['aspirin', 'clot buster drugs', 'knee surgery', 'Michigan Medicine']",https://www.eurekalert.org/pub_releases/2018-10/mm-u-aaa102018.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The cost differences between aspirin and anticoagulant drugs are listed and the potential savings by using aspirin are highl",news_reviews_00019,Michigan Medicine,"It is certainly welcome news when a study reports that a cheaper, over-the-counter drug produces results about the same as more expensive prescription drugs that are generally trickier to use. However, this release about aspirin performing about the same ",News releases should be clear about when they are referring to the specific design or results of a study and when they are providing general context for readers. This release makes several references to blood clot prevention following knee replacement sur,"https://www.healthnewsreview.org/wp-content/uploads/2015/04/aspirin-204x300.jpg 204w, https://www.healthnewsreview.org/wp-content/uploads/2015/04/aspirin-697x1024.jpg 697w, https://www.healthnewsreview.org/wp-content/uploads/2015/04/aspirin.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/observational-study-cant-prove-surgery-better-than-more-conservative-prostate-cancer-treatment/,Observational study can‚Äôt prove surgery better than more conservative prostate cancer treatment,But the release did a nice job of quantifying what researchers found and describing the harms of more aggressive prostate cancer treatment.,Combo therapy of prostatectomy plus radiotherapy may improve survival in prostate cancer,,4,"['Mary Chris Jaklevic', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Observational studies,['Thomas Jefferson University'],https://www.eurekalert.org/pub_releases/2018-09/tju-cto092418.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of the cost of any of these treatments. One survey\xa0from 2014 found uninsured patients were ch",news_reviews_00029,,"This news release describes an observational study that compared two common ‚Äúcombination‚Äù therapies for locally advanced prostate cancer ‚Äî that is, cancer that is growing but has not spread to other parts of the body. The findings were published in ","Questions linger about how to best treat men with high-risk forms of prostate cancer. However, observational data from studies like this one cannot answer the question of which course of treatment is most effective.¬†The problem is that patients and docto","https://www.healthnewsreview.org/wp-content/uploads/2018/05/prostate-screening-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/05/prostate-screening.jpg 400w"
https://www.healthnewsreview.org/news-release-review/ties-to-drugmaker-left-out-of-postpartum-depression-drug-study-recap/,Ties to drugmaker left out of postpartum depression drug study recap,"This news release would have been stronger had it mentioned costs, and gone into more detail on harms and benefits.","Newly Published Results Show Investigational Treatment Brexanolone Consistently Reduced Depressive Symptoms Across Three Postpartum Depression Trials, Supporting Submission for FDA Approval",,4,"['Sally James', 'Kathleen Fairfield, MD, DrPH', 'Kathlyn Stone']",Academic medical center news release,"['brexanolone', 'post-partum depression', 'University of North Carolina Health Care System']",https://www.newswise.com/articles/newly-published-results-show-investigational-treatment-brexanolone-consistently-reduced-depressive-symptoms-across-three-postpartum-depression-trials-supporting-submission-for-fda-approval,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The news release does not mention costs. While a new therapy may not have an established price, the release could have s",news_reviews_00037,University of North Carolina Health Care,"An injectable drug, brexanolone, showed some effectiveness in treating postpartum depression in two phase 3 double-blind randomized controlled trials including 247 women from 30 different research centers, according to research led by the University of No","The American Psychological Association estimates that up to one-in-seven women in the US suffer from some form of postpartum depression, and this disorder can linger for some of them and interfere with their bonding with their child. Existing treatments, ","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-522778346-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-522778346.jpg 724w"
https://www.healthnewsreview.org/news-release-review/breastfeeding-for-stroke-prevention-kudos-to-heart-association-for-clarifying-that-study-doesnt-show-cause-and-effect/,Breastfeeding for stroke prevention? Kudos to heart association for clarifying that study doesn‚Äôt show cause-and-effect,The release would have been even stronger had it told readers about the ,Breastfeeding may help protect mothers against stroke,,4,"['Matt Shipman', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Association/Society news release,"['American Heart Association', 'breastfeeding', 'stroke']",https://www.eurekalert.org/pub_releases/2018-08/aha-bmh081718.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Breastfeeding is not an option for all mothers, whether because of medical/physical limitations or because of socioeconomi",news_reviews_00041,American Heart Association,"The release focuses on a prospective cohort study, one of the strongest types of observational studies,¬†that identified a correlation between breastfeeding and stroke. Specifically, the study reported that women who nursed at least one child were less li","Although the incidence and mortality from stroke has been in decline, stroke remains a significant health problem in the United States, affecting hundreds of thousands of men and women every year. Therefore, new information that could help people make lif","https://www.healthnewsreview.org/wp-content/uploads/2018/08/GettyImages-171275753-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/08/GettyImages-171275753-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/nih-brings-balance-to-recap-of-study-on-blood-test-for-gestational-diabetes/,NIH brings balance to recap of study on blood test for gestational diabetes,Some discussion on the cost considerations of widespread screening for gestational diabetes would have made the release stronger.,Blood test may identify gestational diabetes risk in first trimester,,4,"['Joann Rodgers, MS', 'Virginia A. Moyer, MD', 'Kathlyn Stone']",Government agency news release,"['blood test', 'gestational diabetes', 'National Institutes of Health (NIH)']",https://www.nih.gov/news-events/news-releases/blood-test-may-identify-gestational-diabetes-risk-first-trimester,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The absence of cost information is unfortunate in this release. \xa0In general, the public has little experience of or u",news_reviews_00043,National Institutes of Health,"This release accurately describes an observational study using second-hand data¬†from another¬†study¬†¬†which found that a relatively inexpensive blood test (HbA1c or A1C for short), commonly used to monitor diabetes, might help identify women at risk for",Public health and obstetrical associations estimate that 1 to 15% of all pregnant women in the U.S. develop gestational diabetes and no doubt a greater percentage worries they might. There are potentially serious health consequences to gestational diabete,"https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000014169059_Small-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000014169059_Small.jpg 851w"
https://www.healthnewsreview.org/news-release-review/recap-of-robotic-surgery-study-shows-useful-comparison-with-standard-surgery-but-sidesteps-cost/,"Recap of robotic surgery study shows useful comparison with standard surgery, but sidesteps cost","While robotic surgery may be ‚Äúnot inferior‚Äù to standard therapy for bladder cancer, it does have added costs and a longer procedure time.",Robotic surgery as effective as open surgery for bladder cancer,,4,"['Andrew Holtz, MPH', 'Dan Mayer, MD', 'Kathlyn Stone']",,"['bladder cancer', 'Loyola University Health System', 'robotic surgery']",https://www.eurekalert.org/pub_releases/2018-07/luhs-rsa071118.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no discussion of cost in this release. The journal article says several institutions refused to provide their p",news_reviews_00055,Loyola University Health System,"This news release about a trial that randomly assigned people with bladder cancer to either robot-assisted or open surgery buried the real news under a weak lead that garbles the findings. The news here is that, contrary to assertions of many proponents o","The final sentence of the release, a quote from a researcher, should have been the lead: ‚ÄúIt is important to conduct these trials before widespread adoption of technology, as has been the case with robotic prostatectomy (removal of the prostate).‚Äù¬† W","https://www.healthnewsreview.org/wp-content/uploads/2018/07/GettyImages-857730242-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/07/GettyImages-857730242-768x576.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/newsworthy-vitamin-d-research-accurately-and-cautiously-explained-by-the-american-cancer-society/,"Newsworthy vitamin D research, accurately and cautiously explained by the American Cancer Society",This is a balanced and carefully¬†written report on a newly published study linking vitamin D levels and colorectal cancer risk.,Large international study links blood vitamin D levels to colorectal cancer risk,,4,"['Alan Cassels', 'Kathleen Fairfield, MD, DrPH', 'Kevin Lomangino']",Association/Society news release,"['american cancer society', 'colorectal cancer']",https://www.eurekalert.org/pub_releases/2018-06/acs-lis061118.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This release is not reporting on vitamin D supplementation but about circulating levels of vitamin D in the body. Although",news_reviews_00063,American Cancer Society,"This news release describes an analysis of data from 17 different studies where blood levels of vitamin D were reported. The main finding: higher circulating vitamin D levels are associated with lower risk of colorectal cancer.
The release provides a care","This is an important study by some of the nation‚Äôs top vitamin D researchers. Its findings have the potential to impact recommendations concerning Vitamin D supplementation.
It‚Äôs worth keeping in mind, however, that there is a growing mountain of rese","https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock-513384794-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock-513384794-768x511.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStoc"
https://www.healthnewsreview.org/news-release-review/janssen-highlights-insignificant-findings-along-with-modest-results-in-esketamine-nasal-spray-trials/,Janssen highlights insignificant findings along with modest results in esketamine nasal spray trials,One of the studies (in elderly patients aged 65 and older with treatment-resistant depression) showed no statistical significance but the release says the drug had ‚Äúmeaningful effects‚Äù compared to placebo.,New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression ,,4,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Kathlyn Stone']",industry/commercial news releases,"['depression', 'esketamine nasal spray', 'Janssen']",https://www.prnewswire.com/news-releases/new-phase-3-data-show-esketamine-nasal-spray-demonstrated-rapid-improvements-in-depressive-symptoms-in-patients-with-treatment-resistant-depression-300643208.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs are not addressed and they should be. While esketamine spray is a newer version of ketamine, which has been in use",news_reviews_00078,Janssen Pharmaceutical Companies of Johnson & Johnson,"This news release focuses on two phase 3 clinical trials that evaluated the use of a drug called esketamine to treat depression. Both trials focused on patients who had not responded to at least two antidepressant drugs, and both trials used esketamine as","Clinical trials, indeed any medical research, can be extremely complicated. News releases, theoretically, are designed to help reporters (and presumably other members of the public) get a handle on new findings, so that they can determine whether the find","https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-939164198-300x210.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/05/GettyImages-939164198-768x538.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/study-summary-omitted-key-detail-about-acupressure-for-menstrual-pain-relief/,Study summary omitted key detail about acupressure for menstrual pain relief,You have to read the study to learn that acupressure delivered via smart phone app was an add-on therapy and not a replacement for traditional treatments for menstrual pain.,Acupressure for menstrual pain ,,4,"['Joann Rodgers, MS', 'Karen Carlson, MD', 'Kathlyn Stone']",Hospital news release,"['Acupressure', 'Charit√© - Universit√§tsmedizin Berlin', 'menstrual pain']",https://www.eurekalert.org/pub_releases/2018-04/c-ub-afm040418.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release did not mention it, but the app is ‚Äúgratis‚Äù according to the Luna app website (in German). Most apps of ",news_reviews_00091,Charit√© - Universit√§tsmedizin Berlin,"This news release, issued by a university in Berlin, Germany, concludes that use of an app-based acupressure program can achieve a ‚Äúsustained reduction in menstrual pain‚Äù in some women when assessed at 3- and 6-month intervals. The release does a reas","As the release notes, most young women experience cramps, bloating, headaches, backaches, and other discomforts ‚Äî often severe ‚Äî at some point of their lives during their monthly menses. An entire industry, pharmaceutical and otherwise, has grown up a","https://www.healthnewsreview.org/wp-content/uploads/2018/04/GettyImages-123183780-300x196.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/04/GettyImages-123183780-768x503.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/association-delivers-balanced-recap-of-safety-trial-of-targeted-immunotherapy-for-liver-cancer/,Association delivers balanced recap of safety trial of targeted immunotherapy for liver cancer,This release is a measured presentation of findings from a phase 1 safety trial that also acknowledges limitations., Targeted immunotherapy treatment shows promise for treating advanced stage liver tumors ,,4,"['Mary Chris Jaklevic', 'Andrae Vandross, MD', 'Kathlyn Stone']",Cancer,"['immunotherapy', 'liver cancer', 'Society of Interventional Radiology']",https://www.eurekalert.org/pub_releases/2018-03/soir-tit031318.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of how much this therapy might cost. The reported cost of T-VEC for a round of melanoma therapy ",news_reviews_00098,Society of Interventional Radiology,This news release responsibly describes a small safety trial for the use of image-guided injections of an immunotherapy approved for melanoma in advanced liver cancer. The study involving a genetically modified version of the herpes virus called talimogen,"Liver cancer has been on the rise, and it is particularly deadly. Fewer than one in five people diagnosed with liver cancer live more than five years, according to the National Cancer Institute, and the survival rate is lower for people with advanced form","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-489736070-244x300.jpg 244w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-489736070-768x945.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/announcement-on-cavity-prevention-study-acknowledges-high-dropout-rate/,Announcement on cavity prevention study acknowledges high dropout rate,"The cost of dental care, where insurance is inadequate or out-of-reach, is a particular burden for low income people. We‚Äôd like to have seen this tackled in the release.",Cavity prevention approach effectively reduces tooth decay ,,4,"['Sally James', 'Dan Mayer, MD', 'Kathlyn Stone']",University news release,"['cavity prevention', 'tooth decay', 'University of California - San Francisco']",https://www.eurekalert.org/pub_releases/2018-01/uoc--cpa011918.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While the news release says the research is aimed at lowering costs and reducing the burden for low income patients, we ",news_reviews_00118,University of California - San Francisco,"In a study of 460 patients at high risk of dental damage separated into two groups, those who used cavity-prevention products dramatically reduced their risk of cavities compared to the control group, according to researchers at the University of Californ","Dental problems are a plague to people of all income ranges and ages. The cost of dental care, where insurance is inadequate or out-of-reach, is a particular burden for low income people. If specific preventive measures are proven to significantly reduce ","https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-499929704-300x210.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2018/01/GettyImages-499929704-768x539.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/clearly-state-both-the-benefits-and-the-risks-of-using-the-medicinal-cream/,Recap of clinical trial on skin cancer treatment includes both strengths and weaknesses of the findings,The release clearly states benefits and potential harms of using the drug.,"In clinical trial, cream reduces squamous cell carcinoma risk ",,4,"['Earle Holland', 'Dan Mayer, MD', 'Kathlyn Stone']",University news release,"['Brown University', 'fluorouacil', 'skin cancer']",https://www.eurekalert.org/pub_releases/2018-01/bu-ict010318.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release does mention costs twice, by saying that treating these cancers surgically is more costly, and that the use ",news_reviews_00126,Brown University,"Getty Images
This release reports on a large multi-center clinical trial intended to gauge the preventative value of using a cream containing 5 percent fluorouacil as a means of reducing the occurrence of both squamous cell carcinoma and basal cell carcin","These skin cancers ‚Äî squamous cell carcinomas and basal cell carcinomas ‚Äî are among the most common forms of cancer afflicting Americans and to date, the only effective preventative has been the use of sunscreen with varying success. This trial sugges",nan
https://www.healthnewsreview.org/news-release-review/recap-of-hip-fracture-screening-study-takes-balanced-approach-on-a-serious-health-issue/,Recap of hip fracture screening study takes balanced approach on a serious health issue,A discussion of the cost of treating more women as a result of enhanced screening deserved a mention., Screening could prevent a quarter of hip fractures in older women,,4,"['Ann Miller, PhD', 'Richard Hoffman, MD', 'Kathlyn Stone']",Screening tests,"['hip fractures', 'older women', 'University of Birmingham']",https://www.eurekalert.org/pub_releases/2017-12/uob-scp121917.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This release was very thorough in most areas. However, we‚Äôre only told that the proposed screening program is ‚Äúlow c",news_reviews_00131,University of Birmingham,"Getty Images
This news release describes results of a five-year study in which older women in seven areas of Britain were randomly assigned to either go through a screening procedure for osteoporosis called FRAX, or not. Women who were screened were 28% l","In an aging society like Britain, a tool that reduces risk of hip fractures is an important innovation. Hip fractures can be disabling for the elderly, and many older people never fully recover from them. Unfortunately, although the release vaguely sugges",nan
https://www.healthnewsreview.org/news-release-review/time-to-retire-the-pap-test-strong-study-recap-explores-the-trade-offs/,Time to retire the Pap test? Strong study recap explores the trade-offs,More discussion on the potential cost savings would have rounded this release out nicely.,HPV testing is better than the Pap test at detecting cervical cancer ,,4,"['Sally James', 'Steven J. Atlas, MD, MPH', 'Kathlyn Stone']",Journal news release,"['Cervical cancer', 'HPV testing', 'Oxford University Press USA']",https://www.eurekalert.org/pub_releases/2017-11/oupu-hti111317.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release includes the idea of costs, but without using any numbers. The two mentions of cost are here:\n‚ÄúHowever, r",news_reviews_00145,Oxford University Press USA,"In a 12-year study of more than a million women in the Kaiser Permanente of Northern California system, researchers concluded that the HPV screening test alone may be enough to detect the vast majority of cancers and so-called ‚Äúpre-cancers‚Äù without th","Prevention by early detection is a key part of saving lives from cervical cancer. The Pap smear has been widely used in the United States since the 1950s. As a result, the incidence of cervical cancer has dramatically decreased. However, the fact that cer","https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-539279885-300x169.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/11/GettyImages-539279885-768x432.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/props-for-mostly-cautious-description-on-preliminary-study-on-pancreatic-cancer-treatment/,Props for mostly cautious description of preliminary study on pancreatic cancer treatment,This release would have been stronger had it clarified potential availability to patients with pancreatic cancer.,Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer ,,4,"['Ann Miller, PhD', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Cancer,"['pancreatic cancer', 'ViewRay']",https://www.eurekalert.org/pub_releases/2017-10/v-eds101917.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs of the\xa0MRIdian on-table adaptive radiotherapy in comparison to conventional radiotherapy are not discussed. Giv",news_reviews_00154,ViewRay,This news release reports results of a retrospective study comparing conventional radiotherapy for inoperable pancreatic cancer versus an adaptive radiation therapy that allows clinicians to see the tumor in real time and respond to changes on a daily bas,Surgery is an option only for certain less common types of pancreatic cancer. The five-year survival rates for pancreatic cancers that cannot be treated with surgery are 12% to 14% even for those diagnosed in stage I; the five-year survival rate for cance,"https://www.healthnewsreview.org/wp-content/uploads/2017/10/pancreas-298x300.jpg 298w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/pancreas-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/pancreas.jpg 592w"
https://www.healthnewsreview.org/news-release-review/washington-university-offers-strong-recap-of-study-using-genetic-testing-to-determine-safe-dosing-of-warfarin/,Washington University offers strong recap of study using genetic testing to determine safe dosing of warfarin,This release does many things well but may leave readers confused about the genetic test‚Äôs applicability to newer anticoagulants coming into wider use. (It doesn‚Äôt apply.),Genetic testing helps set safe dose of common blood thinner,,4,"['Joann Rodgers, MS', 'Christopher Labos, MD', 'Kathlyn Stone']",Academic medical center news release,"['genetic testing', 'warfarin', 'Washington University School of Medicine']",https://www.eurekalert.org/pub_releases/2017-09/wuso-gth092117.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'Although the release doesn‚Äôt give actual costs of warfarin versus some of the newer drugs, or factor in the cost of the us",news_reviews_00164,Washington University School of Medicine,This news release describes results of a study designed to learn whether testing for the presence of three gene variants could make dosing with the blood thinner warfarin safer for patients given the drug to prevent blood clots after joint replacement sur,Some estimates put the number of Americans regularly taking the clot-preventing blood thinner warfarin and several newer anticoagulants at more than six million. Warfarin (sold under the brand name Coumadin) requires frequent blood testing to address risk,"https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-638852948-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/10/GettyImages-638852948-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/u-of-pittsburgh-recap-of-copd-drug-study-touts-statistically-significant-results-but-are-they-meaningful-to-patients/,"U of Pittsburgh recap of COPD drug study touts ‚Äòstatistically significant‚Äô results, but are they meaningful to patients?","Some discussion of costs, harms and more focus on what the benefits actually represent to patients would have made the release stronger.",Therapy proves effective in subgroup of COPD patients ,,4,"['Earle Holland', 'Dan Mayer, MD', 'Kathlyn Stone']",University news release,"['COPD', 'mepolizumab', 'University of Pittsburgh Schools of the Health Sciences']",https://www.eurekalert.org/pub_releases/2017-09/uops-tpe091117.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of the costs of the drug mepolizumab in the news release. An online search reveals that the price fo",news_reviews_00170,University of Pittsburgh Schools of the Health Sciences,This news release describes two studies published in the New England Journal of Medicine that looked at the benefit of using the drug mepolizumab to treat chronic obstructive pulmonary disease (COPD) patients who had an eosinophilic phenotype ‚Äî an unusu,COPD is a chronic inflammation of the lungs that seriously compromises breathing in these patients. An estimated 40 percent of COPD patients have¬†an eosinophilic phenotype that has limited their successful treatment in the past. Since there is no cure fo,"https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-503332900-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-503332900-768x576.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/md-anderson-gives-proton-therapy-careful-treatment-in-study-recap/,MD Anderson gives proton therapy careful treatment in study recap,Small study size gets overshadowed by survival emphasis in cancer release.,"Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer ",,4,"['William Heisel', 'Steven J. Atlas, MD, MPH', 'Kathlyn Stone']",Academic medical center news release,"['lung cancer', 'M. D. Anderson Cancer Center', 'proton therapy']",https://www.eurekalert.org/pub_releases/2017-07/uotm-ccp072017.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We‚Äôre not talking about a few pills a day here. We are talking about ongoing expensive treatment for five years. The c",news_reviews_00195,University of Texas M. D. Anderson Cancer Center,"lung cancer illustration
We applaud the careful wording in this release and all the caveats provided. At the same time, because cancer effects such an emotional response in audiences, including journalists, there is an even higher standard one must meet t",Lung cancer is strongly associated with cigarette smoking and remains the most common cause of death due to cancer in the United States. This study reports 5-year treatment outcomes of stage 3 non-small cell lung cancer at a single cancer center. Stage 3 ,nan
https://www.healthnewsreview.org/news-release-review/drug-refractory-psoriatic-arthritis-shows-promise-clinical-trial/,"Drug for psoriatic arthritis ‚Äòshows promise‚Äô, but what about cost and harms?","This release covers most of the key questions about this drug, but not its side effects and steep cost.",Drug for refractory psoriatic arthritis shows promise in clinical trial,,4,"['Alan Cassels', 'Andrae Vandross, MD', 'Kathlyn Stone']",Academic medical center news release,"['ixekuzumab', 'psoriatic arthritis', 'Stanford Medicine']",http://med.stanford.edu/news/all-news/2017/05/drug-for-refractory-psoriatic-arthritis-shows-promise-in-clinical-trial.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No cost information was provided, even though the drug is already on the market for another condition. According to Good",news_reviews_00222,Stanford Medicine,This relatively thorough news release summarizes the results of a 24-week randomized trial of the biologic drug ixekizumab (marketed as Taltz) in patients with psoriatic arthritis. While the release hits most of the key points that any journalist might as,"People with psoriatic arthritis often have painful, red, scaly patches on their skin and they may not be effectively treated with TNF inhibitors (drugs commonly used to treat inflammatory conditions). If only half of¬†psoriatic arthritis patients get bett","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_21923587_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_21923587_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/nyu-langone-adds-welcome-nuance-in-recap-of-study-on-cannabidiol-for-severe-epilepsy/,NYU Langone adds welcome nuance in recap of study on cannabidiol for severe epilepsy,The release provides a thorough description of benefits and side effects that were reported from the trial. It also includes cautions and nuance that are missing from many news releases.,Cannabis Derivative Cannabidiol Reduces Seizures in Severe Epilepsy Disorder ,,4,"['Earle Holland', 'Adam Cifu, MD', 'Kathlyn Stone']",Academic medical center news release,"['cannabidiol', 'epilepsy seizures', 'NYU Langone Medical Center']",http://www.prnewswire.com/news-releases/cannabis-derivative-cannabidiol-reduces-seizures-in-severe-epilepsy-disorder-300463552.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no mention of the cost of the drug but the NYT reported last year that Epidiolex could cost from $2,500 to $5,",news_reviews_00224,NYU Langone Medical Center,"This release from the NYU Langone Medical Center describes a randomized placebo controlled clinical trial of children and adolescents with Dravet syndome, an extreme form of epilepsy, who often don‚Äôt respond to other drugs. The release provides a very g","Dravet syndrome is a rare form of epilepsy that generally begins in a child‚Äôs first year but is a life-long condition, according to the Epilepsy Foundation. Currently, treatments for this condition are marginal and new therapies addressing its symptoms ","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-547041904-300x224.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-547041904.jpg 683w"
https://www.healthnewsreview.org/news-release-review/fda-announcement-on-acute-myeloid-leukemia-treatment-needed-a-few-more-details/,Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?,More details on benefits and evidence would have improved this already strong news release.,FDA approves new combination treatment for acute myeloid leukemia ,,4,"['Earle Holland', 'Steven J. Atlas, MD, MPH', 'Kathlyn Stone']",Government agency news release,"['FDA', 'leukemia']",https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm555778.htm,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'There is no mention of the cost of this new drug, Rydapt (midostaurin), or of the cost of the diagnostic tool, the\xa0Leuk",news_reviews_00238,FDA,"acute myeloid leukemia (AML)
This release from the Food and Drug Administration announces approval of a new drug, Rydapt (midostaurin), for the treatment of specific acute myeloid leukemia patients who possess certain genetic FLT3 mutations that affect th","Acute myeloid leukemia (AML) is a serious and often fatal form of blood cancer, and treatments against it have been limited in the past. AML involves the cells that fight infection in the body.¬† Increased understanding of the genetics of this disease has",nan
https://www.healthnewsreview.org/news-release-review/johns-hopkins-gives-nice-snapshot-of-study-on-imaging-test-add-on-for-kidney-tumors/,Johns Hopkins gives nice snapshot of study on imaging test add-on for kidney tumors,This release offers a good summary along with mentioning the need for a larger study to confirm the findings.,Noninvasive Imaging Test Shown Accurate in Ruling Out Kidney Cancers,,4,"['Earle Holland', 'Saurabh Jha, MBBS', 'Kathlyn Stone']",Academic medical center news release,"['Johns Hopkins Medicine', 'kidney cancer']",http://www.newswise.com/articles/noninvasive-imaging-test-shown-accurate-in-ruling-out-kidney-cancers,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This release notes several times that sestamibi SPECT/CT is inexpensive and widely available. It would have been good to",news_reviews_00243,Johns Hopkins Medicine,"This release from Johns Hopkins reports on a small, preliminary trial that shows adding a diagnostic imaging technique called sestamibi SPECT/CT to CT or MRI imaging tests led to more accurate diagnosis of kidney tumors, and subsequently, fewer unnecessar","The ability to better classify tumors of the kidney and prevent unnecessary surgeries for benign tumors would be a boon for patients and the health care system.¬† If these results hold in a planned larger study, the Johns Hopkins radiologists‚Äô research ","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-537645661-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-537645661-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStoc"
https://www.healthnewsreview.org/news-release-review/investigational-dose-oral-interferon-free-treatment-can-cure-hepatitis-c-children/,Kudos to medical group‚Äôs summary of alternative treatment for hepatitis C in children,The release is transparent about potential conflicts of interest and provides a good snapshot of the benefits. The release would have been better if it dialed back on the sensational language and included the cost of this pricey drug.,Investigational dose of oral interferon-free treatment can cure hepatitis C in children,,4,"['Mary Chris Jaklevic', 'Virginia A. Moyer, MD', 'Kathlyn Stone']",Association/Society news release,"['European Association for the Study of the Liver', 'hepatitis c']",https://www.eurekalert.org/pub_releases/2017-04/eaft-ido041117.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There‚Äôs no mention of costs. The manufacturer, Gilead Sciences, has been charging $94,500 for a 12-week regimen of thi",news_reviews_00244,European Association for the Study of the Liver,"This news release from the European Association for the Study of the Liver (EASL) heralding the safety and efficacy of a combination drug therapy for children with hepatitis C does a good job in several areas. It explains the scope of benefits and harms, ","One estimate puts the incidence of chronic hepatitis C infection in U.S. children at between 23,000 and 46,000. Pediatric hepatitis C is usually contracted at birth from mothers with a history of IV drug abuse. More than one-third of infected kids eventua","https://www.healthnewsreview.org/wp-content/uploads/2017/04/GettyImages-612638916-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/04/GettyImages-612638916-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/fda-could-do-a-better-job-sharing-numbers-on-costly-new-eczema-drug/,FDA could do a better job sharing numbers on costly new eczema drug,"We don‚Äôt ding the FDA for omitting the drug‚Äôs cost since their evaluations are made independent of cost, but we do expect some hard facts on benefits.",FDA approves new eczema drug Dupixent,,4,"['Earle Holland', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Government agency news release,"['Dupixent', 'eczema', 'FDA']",https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm549078.htm,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The FDA evaluates drugs without considering costs, which is why they are not discussed in this news release. We rate this ",news_reviews_00256,FDA,"This news release from the FDA announces the agency‚Äôs approval of a new drug, dupilumab (to be marketed as Dupixent), for treating eczema, or atopic dermatitis. It briefly describes the type of clinical trials leading to the approval and identifies the ",Some estimates suggest as many as 18 million Americans suffer from moderate-to-severe eczema ‚Äî and for them it is a miserable disease. A new medication that is potentially effective against this condition would therefore be welcomed. But the enormous co,"https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_87522427_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_87522427_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/evidence-limitations-absent-in-release-on-active-surveillance-for-prostate-cancer/,Vanderbilt PR release on active surveillance for prostate cancer lacks precision,"Since reduced harms from active surveillance is an important topic, we wish the release had provided numbers and context.",Active Surveillance Preserves Quality of Life for Prostate Cancer Patients,,4,"['Sally James', 'Harold J. DeMonaco, MS', 'Kathlyn Stone']",Academic medical center news release,"['active surveillance', 'Vanderbilt University Medical Center']",http://www.newswise.com/articles/view/671560/?sc=sphn,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Typically, we are asking that a release tell us the ‚Äúcost‚Äù of a therapy or drug, but in this case, we wish the relea",news_reviews_00260,Vanderbilt University Medical Center,"A¬†Vanderbilt University news release about an important study on prostate cancer treatments and quality of life¬†left us disappointed: Why so few specifics on the measured benefits?
In this 3-year study of more than 2,500 men with prostate cancer, resear","An estimated 250,000 men are diagnosed with prostate cancer in the United States each year, according to the National Cancer Institute, and about 80 percent of those cancers are localized ‚Äî meaning the disease has not spread from the organ. These patien","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_371304_SMALL-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_371304_SMALL-768x576.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/09"
https://www.healthnewsreview.org/news-release-review/release-on-regional-lung-cancer-screening-initiative-ignores-high-potential-for-over-diagnosis/,Medical center needed more balance in messages about lung cancer screening initiative,"<span class=""Abstract 154656078 0 1"" id=""scm6MainContent_rptSections_lblSection_3""><span class=""Paragraph 154656081 0 1"" id=""scm6MainContent_rptSections_lblSection_6"">Low-dose CT used in the screening program could have a high false-positive rate of more ",Free lung-cancer screening in the Augusta area finds more than double the cancer rate of previous screenings,,4,"['Matt Shipman', 'Saurabh Jha, MBBS', 'Kathlyn Stone']",Academic medical center news release,"['lung cancer screening', 'Medical College of Georgia at Augusta University']",https://www.eurekalert.org/pub_releases/2017-03/mcog-fls030917.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The release clearly states that the relevant screening technique would normally cost between $100 and $250, but was free as ",news_reviews_00266,Medical College of Georgia at Augusta University,"The news release reports on a journal article about a lung cancer screening initiative in the Augusta, Georgia, area. The screening initiative found that eight of 264 ‚Äúhigh-risk‚Äù individuals ‚Äî or 3 percent ‚Äî had lung cancer. The release notes 3 pe","Screening involves tradeoffs and potential harms just like any medical intervention. That‚Äôs not a message we often hear from the news media but it should be communicated more often. We explored some of the harms of lung cancer screening, including the a","https://www.healthnewsreview.org/wp-content/uploads/2017/03/harms-of-cancer-screening-300x204.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/03/harms-of-cancer-screening.jpg 393w"
https://www.healthnewsreview.org/news-release-review/laryngeal-cancer-treatment-pr-release-is-strong-on-context-but-skips-limitations/,Laryngeal cancer treatment: PR release is strong on context but skips limitations,"The release doesn‚Äôt mention that this was a retrospective, observational study, not a clinical trial, which is an important limitation. Correlation doesn‚Äôt equal causation.",The best treatment for laryngeal cancer? This approach helps decide ,,4,"['Matt Shipman', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Academic medical center news release,['laryngeal cancer'],https://www.eurekalert.org/pub_releases/2017-02/mmu-tbt020217.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This is the one area the release fails to address at all. Cost is simply not addressed.'}, {'question': 'Does the news r",news_reviews_00285,Michigan Medicine - University of Michigan,The release focuses on recent research published in the journal JAMA Otolaryngology ‚Äì Head and Neck Surgery. The research assessed the effectiveness of a treatment technique for laryngeal cancer that exposed patients with advanced (stage 3 or 4) cancer ,"People don‚Äôt want to lose the power of speech. Whether it‚Äôs reading bedtime stories to one‚Äôs children or talking about your day with loved ones, speech is an important part of interpersonal communication. Our voices are part of who we are and how we","https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-450534959-300x258.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/02/GettyImages-450534959.jpg 699w"
https://www.healthnewsreview.org/news-release-review/medical-association-puts-laparoscopic-anti-reflux-surgery-for-gerd-in-clear-context/,Medical association puts laparoscopic anti-reflux surgery for GERD in clear context,"Strong on alternatives and costs, the release would have been better with more details on study limitations.",Laparoscopic anti-reflux operation for GERD linked to fewer postoperative complications ,,4,"['Sally James', ""A'ndrea Elyse Messer, MS, PhD"", 'Kathlyn Stone']",Association/Society news release,"['GERD', 'laparoscopic surgery']",https://www.eurekalert.org/pub_releases/2017-01/acos-lao012617.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The story focused on costs, including information about the relative cost comparison between what are called ‚Äúopen‚Äù surg",news_reviews_00287,American College of Surgeons,"A new study by the American College of Surgeons, a professional organization, compared records for 75,000 patients who underwent surgery for GERD, or gastrointestinal esophageal reflux disease. The study looked at two different surgical procedures and fou","Millions of Americans complain of occasional heartburn, sometimes called a burning sensation in the throat from food coming back up from the stomach. But some estimates are that about 20 percent of US adults fit the definition of GERD, which means they su","https://www.healthnewsreview.org/wp-content/uploads/2016/02/heartburn-236x300.jpg 236w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/heartburn.jpg 614w"
https://www.healthnewsreview.org/news-release-review/university-release-on-anti-inflammatory-diet-for-reducing-bone-loss-gets-points-for-balance-restraint/,"University release on anti-inflammatory diet for reducing bone loss gets points for balance, restraint",A mention of specific diets or foods and numbers illustrating the actual benefits would have made the release even better.,Anti-inflammatory diet could reduce risk of bone loss in women ,,4,"['William Heisel', 'Allison Dostal, PhD, RD', 'Kathlyn Stone']",University news release,"['Anti-inflammatory diets', 'bone fractures', 'Ohio State University']",https://www.eurekalert.org/pub_releases/2017-01/osu-adc012617.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release does not discuss costs. This is not a typical intervention but more of a dietary lifestyle choice, but becau",news_reviews_00291,Ohio State University,"This news release describes the results of an observational study that looked at the association of a scoring system called the dietary inflammatory index (DII), which aims to measure the inflammatory potential of certain foods, with risk of bone fracture","Chronic inflammation plays an important role in the development of many chronic diseases and some dietary patterns have been shown to be associated with inflammation. However, the evidence of the association between dietary patterns and inflammation is st","https://www.healthnewsreview.org/wp-content/uploads/2015/11/osteoporosis-questions-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/osteoporosis-questions-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/2"
https://www.healthnewsreview.org/news-release-review/informative-release-on-managing-prehypertension-shouldve-toned-down-the-headline/,Informative release on managing ‚Äòprehypertension‚Äô should‚Äôve toned down the headline,"Aside from an overreaching headline and sub-headline, the news release delivers essential information including costs, harms, availability, and study limitations.",Personalized treatment for those in blood pressure 'gray zone' ,,4,"['Mary Chris Jaklevic', 'Richard Hoffman, MD', 'Kathlyn Stone']",Academic medical center news release,"['blood pressure', 'Johns Hopkins Medicine', 'prehypertension']",https://www.eurekalert.org/pub_releases/2017-01/jhm-ptf011217.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The news release says that coronary artery calcium scans ‚Äúaren‚Äôt usually covered by insurance and can range in cost from",news_reviews_00297,Johns Hopkins Medicine,"This news release describes an analysis of data from the Multi-Ethnic Study of Atherosclerosis (MESA) study showing a link between a buildup of calcium in coronary arteries and heart attacks in patients with borderline high blood pressure, referred to her","Nearly 30 percent of U.S. adults have prehypertension, defined as blood pressure between 120 and 139 for the first number (systolic) and/or 80 to 89 for the second number (diastolic). Preypertension is associated with a higher risk of heart attack as well","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-516257748-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-516257748-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/computer-tablets-for-easing-agitation-in-dementia-patients-hospital-gives-fair-treatment-to-small-pilot-study/,Computer tablets for easing agitation in dementia patients: Hospital gives fair treatment to small pilot study,"More numbers ‚Äî length of the study, cost of the tablets, measures of improvement ‚Äî would have been helpful.",Tablet devices show promise in managing agitation among patients with dementia ,,4,"['Sally James', 'Susan Molchan, MD, MA', 'Kathlyn Stone']",Hospital news release,"['computer tablets', 'dementia', 'McLean Hospital']",https://www.eurekalert.org/pub_releases/2017-01/mh-tds010617.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The news release doesn‚Äôt mention the price of the computer tablet used. It does note that the apps used were free to d",news_reviews_00300,McLean Hospital,"This news release describes a feasibility study of just 36 patients with dementia who were given computer tablets loaded with a variety of apps, and observed by staff members at McLean Hospital in Boston. Without using much measurement, the study conclude","Care for people with dementia ranks as one of the most expensive health care outlays in the United States, according to the National Institute on Aging. It also says between 4 and 5 million Americans have dementia.
Among the U.S.‚Äôs 1.4 million nursing h","https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-488564482-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2017/01/GettyImages-488564482-768x513.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/lancet-release-on-ebola-vaccine-results-delivers-balanced-update-on-trial/,Lancet release on Ebola vaccine results delivers mostly balanced update on trial,A¬†reference to cost¬†and¬†the¬†other¬†Ebola vaccines¬†under concurrent development by major pharmaceutical competitors would have made the release even stronger.,Final trial results confirm Ebola vaccine provides high protection against disease,,5,"['Kim Walsh-Childers, PhD', 'Dan Mayer, MD', 'Kathlyn Stone']",Journal news release,"['Ebola vaccine', 'The Lancert']",https://www.eurekalert.org/pub_releases/2016-12/tl-tlf122116.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The news release provides no information about how much the vaccine is likely to cost.\xa0Cost is especially important i",news_reviews_00310,The Lancet,"This news release discusses the results of a World Health Organization-led study of an experimental Ebola vaccine manufactured by Merck, Sharpe & Dohme. The study tested the effectiveness of the vaccine (currently referred to as rVSV-ZEBOV) among individu","Health organizations worldwide have been scrambling to develop an effective vaccine against Ebola since the 2013-2016 Ebola outbreak in West Africa¬†which killed more than 11,300 people.
Merck received¬†‚ÄúBreakthrough Therapy Designation‚Äù status in 201","https://www.healthnewsreview.org/wp-content/uploads/2016/12/GettyImages-512577665-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/GettyImages-512577665-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/university-pr-release-offers-clear-eyed-summary-of-supplements-potential-to-aid-those-suffering-with-ptsd-and-substance-use-disorder/,University PR release offers clear-eyed summary of supplement‚Äôs potential to aid those suffering with PTSD and substance use disorder,"This news release doesn‚Äôt exaggerate the benefits found in the study, and added helpful caveats about the limitations of the research and the intervention‚Äôs applicability to the general public.",A potential pharmaceutical intervention for co-occurring PTSD and substance use disorder ,,4,"['Alan Cassels', 'Harold J. DeMonaco, MS', 'Kathlyn Stone']",Academic medical center news release,"['Medical University of South Carolina', 'N-acetylcysteine', 'PTSD']",https://www.eurekalert.org/pub_releases/2016-12/muos-app121616.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no discussion of the cost of N-acetylcysteine although it is on the World Health Organization‚Äôs list of essen",news_reviews_00313,Medical University of South Carolina,"This news release describes the outcomes of a small randomized placebo controlled study on the use of N-acetylcysteine, an inexpensive over-the-counter supplement, along with cognitive behavioral therapy in male veterans with PTSD and substance use disord","Post-traumatic stress is a huge problem among veterans who have seen combat, and the effects of PTSD can be lifelong and debilitating. Since PTSD is also found in police officers, firefighters and other emergency personnel, a safe and effective treatment ","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-530428850-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-530428850-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStoc"
https://www.healthnewsreview.org/news-release-review/psilocybin-for-treating-depression-in-cancer-patients-informative-5-star-review-from-johns-hopkins/,Psilocybin for treating depression in cancer patients: Informative 5-star release from Johns Hopkins,"This release is very thorough in addressing benefits, potential side effects and study design in a meaningful way.",Hallucinogenic Drug Psilocybin Eases Existential Anxiety in People with Life-Threatening Cancer ,,5,"['Matt Shipman', 'Harold J. DeMonaco, MS', 'Kathlyn Stone']",Academic medical center news release,"['Johns Hopkins Medicine', 'psilocybin']",http://www.newswise.com/articles/view/665429/?sc=mwhn,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Cost is not addressed at all.\nThe costs associated with cancer treatments has been the topic of discussion for some tim",news_reviews_00323,Johns Hopkins Medicine,"This release focuses on a recent study that found a single application of the hallucinogen psilocybin is effective at providing meaningful relief to cancer patients suffering from severe depression or anxiety. The release is exceptionally thorough, addres","We have done three reviews related to these studies: one on a news story from the LA Times, one on a news release from NYU, and this review on the release from Johns Hopkins. And the core issues involved are similar across all three items. Cancer is a wid","https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-175393859-300x230.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStock-175393859-768x589.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/12/iStoc"
https://www.healthnewsreview.org/news-release-review/university-release-takes-admirably-cautious-approach-in-describing-aml-treatment-response/,University release takes admirably cautious approach in describing leukemia treatment response,"The release makes it abundantly clear that this is a small, preliminary trial result while providing a good description of benefits and an adequate overview of the trial.","In Highly Lethal Type of Leukemia, Cancer Gene Predicts Treatment Response",,4,"[""A'ndrea Elyse Messer, MS, PhD"", 'Dan Mayer, MD', 'Kathlyn Stone']",Academic medical center news release,"['acute myeloid leukemia', 'Decitabine', 'Washington University in St. Louis']",http://www.newswise.com/articles/in-highly-lethal-type-of-leukemia-cancer-gene-predicts-treatment-response,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no discussion of cost in this story. Decitabine is an FDA-approved drug and costs are readily available, but no",news_reviews_00326,Washington University in St. Louis,"acute myeloid leukemia (AML)
Decitabine, a drug usually seen as a milder form of chemotherapy, may be an improved treatment for patients with acute myeloid leukemia (AML) who also have mutations in the TP53 gene, according to this news release from Washin","About 20,000 Americans will be diagnosed with AML this year and about 10,400 will die of the disease, according to the National Cancer Institute‚Äôs surveillance data. Patients with TP53 mutations are considered to have poor prognosis using conventional c",nan
https://www.healthnewsreview.org/news-release-review/novel-urine-test-for-cervical-cancer-strong-but-could-be-better-on-false-negatives/,Novel urine test for cervical cancer: strong but could be better on false negatives,"Under the best of scenarios, the new test gets it wrong 10 in 100 times. That‚Äôs a potential harm that the release didn‚Äôt call out.",Johns Hopkins Scientists Advance a Novel Urine Test to Predict High-Risk Cervical Cancer,,4,"['Sharon Dunwoody, PhD', 'Steven J. Atlas, MD, MPH', 'Kathlyn Stone']",Academic medical center news release,"['Cervical cancer', 'Johns Hopkins Medicine', 'urine test']",http://www.newswise.com/articles/ohns-hopkins-scientists-advance-a-novel-urine-test-to-predict-high-risk-cervical-cancer,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release suggests\xa0that a urine test would be less costly than a Pap test, but it makes no effort to indicate what ",news_reviews_00328,Johns Hopkins Medicine,"In an effort to increase the accuracy of cervical cancer diagnoses, a team of researchers is developing a urine test that looks for methylation (a mechanism used by cells to control gene expression) in four genes and, at this early stage, shows evidence o","Most cases of cervical cancer occur in developing countries, where Pap tests may be less available for cultural or cost reasons. A urine test that costs less than current diagnostic procedures and that provides increased diagnostic accuracy would offer si","https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock-576588098-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock-576588098-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStoc"
https://www.healthnewsreview.org/news-release-review/study-limitations-didnt-make-it-into-otherwise-strong-release-on-male-birth-control-shot/,Study limitations didn‚Äôt make it into otherwise strong release on male birth control shot,This release painted a less-than-complete picture when it omitted the study‚Äôs lack of controls and projected cost of the contraceptive.,Male birth control shots prevent pregnancy ,,4,"['Mary Chris Jaklevic', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Association/Society news release,"['hormonal contraceptive', 'male birth control']",https://www.eurekalert.org/pub_releases/2016-10/tes-mbc102416.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The cost of these hormone injections isn‚Äôt mentioned, and there‚Äôs no assessment of how the cost might compare with o",news_reviews_00338,The Endocrine Society,This news release describes an efficacy and safety study of an injectable hormonal contraceptive for men that involved 320 men in seven countries. The news release quantified benefits and described adverse effects in some detail while emphasizing the need,"The development of new forms of birth control including male hormonal contraceptives has been stalled for years, partly due to lack of interest on the part of drug companies. That‚Äôs despite the fact that many men have indicated a willingness to use horm","https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock_37031112_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/11/iStock_37031112_MEDIUM-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2"
https://www.healthnewsreview.org/news-release-review/jama-release-gives-even-handed-account-of-casting-vs-surgery-for-ankle-fracture-in-older-adults/,JAMA release gives even-handed account of casting vs surgery for ankle fracture in older adults,"A nod to cost, funders and more details on the availability of this modified technique would have made this release stronger.",Modified cast instead of surgery results in similar functional outcomes for ankle fracture in older adults ,,4,"['Alan Cassels', 'James Rickert, MD', 'Kathlyn Stone']",Journal news release,"['ankle fracture treatment', 'JAMA']",https://www.eurekalert.org/pub_releases/2016-10/tjnj-mci100716.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release notes that casting instead of surgery as an initial treatment would result in ‚Äúreduced intervention costs‚",news_reviews_00348,The JAMA Network Journals,This news release reports on the results of a randomized trial of older adults (average age 71) who had ankle fractures that were either treated with ‚Äúclose contact casting‚Äù or with surgery. While the outcomes after six months were similar in both gro,"Ankle fractures are extremely common, and perhaps more common in older people so if one type of lower-tech procedure (close casting) can be proven to be safer, equally effective and less costly than the current standard of care (surgery) this could be a m","https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_88366015_MEDIUM-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/10/iStock_88366015_MEDIUM-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/2"
https://www.healthnewsreview.org/news-release-review/bayers-pr-release-on-newly-approved-iud-for-birth-control-omits-costs-novelty/,"Bayer‚Äôs PR release on newly approved IUD for birth control omits costs, novelty",This release is good on transparency but more data on costs and its comparative advantages (effectiveness and rate of side effects) over existing intrauterine birth control devices would have made it stronger.,FDA Approves Bayer's Kyleena‚Ñ¢ (Levonorgestrel-Releasing Intrauterine System) 19.5 mg for Prevention of Pregnancy for up to Five Years ,,4,"['Matt Shipman', 'Karen Carlson, MD', 'Kathlyn Stone']",industry/commercial news releases,"['Bayer', 'birth control', 'Kyleena']",http://www.prnewswire.com/news-releases/fda-approves-bayers-kyleena-levonorgestrel-releasing-intrauterine-system-195-mg-for-prevention-of-pregnancy-for-up-to-five-years-300330006.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs are not discussed at all. Given that this release was issued by the manufacturer of Kyleena, the oversight is espe",news_reviews_00361,Bayer,"The news release focuses on a forthcoming birth control product called Kyleena. The product is implanted in the uterus¬†and releases the hormone levonorgestrel, which the release says can prevent pregnancy for up to five years. The release does a fair job","According to the CDC, more than 7 percent of U.S. women use long-term, reversible contraceptives ‚Äî i.e., intrauterine systems or implants ‚Äî to avoid unwanted pregnancy. The widespread use of these technologies means that they are both economically imp","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_37081776_SMALL-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_37081776_SMALL-768x510.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/generally-strong-release-on-shingles-vaccine-trial-but-lacking-transparency-on-coi/,Generally strong release on shingles vaccine trial ‚Äì but lacking transparency on COI,GSK‚Äôs release on results of shingles vaccine for the elderly hits some high notes but misses the beat on disclosures.,GSK's candidate shingles vaccine shows high efficacy against shingles and its complications in adults aged 70 years and over in phase III study published in NEJM ,,4,"['Kim Walsh-Childers, PhD', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",industry/commercial news releases,"['GSK', 'shingles vaccine']",http://www.prnewswire.com/news-releases/gsks-candidate-shingles-vaccine-shows-high-efficacy-against-shingles-and-its-complications-in-adults-aged-70-years-and-over-in-phase-iii-study-published-in-nejm-300328369.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The vaccine in question has not yet been submitted to the FDA for approval, so we wouldn‚Äôt expect to have a specific p",news_reviews_00363,GSK,"This news release summarizes the findings of a phase III clinical trial of an investigational vaccine for shingles, a painful skin rash that can affect anyone who has ever had chickenpox. The study, described in a NEJM article, involved 13,900 adults 70 o","Shingles, a virus that results in a painful skin rash, is common in the United States, affecting about one-in-four adults at some point in their lifetime. Caused by varicella zoster, the same virus that causes chickenpox in children, shingles produces a l","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_68479901_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_68479901_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/duke-health-release-earns-applause-for-clear-disclosure-but-we-wanted-more-info-on-harms-and-cost-associated-with-this-eye-treatment/,"Duke Health release earns applause for clear disclosure, but we wanted more info on harms and cost associated with this eye treatment","This news release earns praise for a very forthright disclosure, and solid reporting on the benefits and evidence, but it could have done more to inform readers about associated harms and the price tag for this expensive biologic drug.","Humira Provides Effective, Non-Steroid Alternative for Eye Inflammation ",,4,"['Dave Mosher', 'Susan Molchan, MD, MA', 'Kathlyn Stone']",Academic medical center news release,"['Duke University School of Medicine', 'uveitis']",http://www.newswise.com/articles/view/660259/?sc=mwhn,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'No dollar signs here, which ‚Äî as we discovered ‚Äî is quite an oversight, given the steep costs of adalimumab.\nPredni",news_reviews_00365,Duke Health,"A study of 217 people afflicted with an eye disease called uveitis tried to determine just how well adalimumab, a pricy ‚Äúbiologic‚Äù drug, could stave off frustrating symptoms like inflammation inside the eye, floaters, cloudy vision, and blurred vision","Uveitis, or inflammation of and damage to important structures in the eye, is a relatively rare disease that affects about 43,000 new people a year in the United States, according to the Ocular Immunology and Uveitis Foundation. While treatable, left untr","https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_21762976_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/09/iStock_21762976_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/kudos-to-boston-childrens-hospital-for-release-on-acetaminophen-and-asthma-study/,Kudos to Boston Children‚Äôs Hospital for release on acetaminophen and asthma study,"Overall, an excellent news release on the acetaminophen versus ibuprofen study published in the NEJM.",Acetaminophen does not aggravate children's asthma ,,4,"['Euna Bodner, MS', 'Karen Carlson, MD', 'Kathlyn Stone']",Academic medical center news release,"['acetaminophen', 'asthma', ""Boston Children's Hospital""]",http://www.eurekalert.org/pub_releases/2016-08/bch-adn081716.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Costs are not addressed in the Boston Children‚Äôs Hospital news release. The acetaminophen medication used in the study",news_reviews_00372,Boston Children's Hospital,"This news release by Boston Children‚Äôs Hospital is based on a study published in the New England Journal of Medicine on the first randomized, double-blind, controlled trial comparing acetaminophen to ibuprofen to treat pain and fever in children with as","Acetaminophen is the most commonly used pediatric medication in the United States. Previous observational studies found a correlation between acetaminophen and increased asthma symptoms, as well as decreased lung function. Other analyses found that acetam","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000056289110_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000056289110_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/mcmaster-news-release-on-flu-vaccine-trial-left-out-the-key-finding/,McMaster University news release on flu vaccine trial left out the key data finding,What¬†was the rate of influenza in communities vaccinated with nasal vs injected vaccines over the course of the study?,Flu nasal spray provides similar protection against influenza as flu shot: Study ,,4,"['Earle Holland', 'Karen Carlson, MD', 'Joy Victory']",University news release,"['influenza', 'McMaster University', 'vaccine']",http://www.eurekalert.org/pub_releases/2016-08/mu-fns081116.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This release doesn‚Äôt discuss\xa0costs in its comparison of influenza shots versus nasal sprays, although both modes of",news_reviews_00378,,"This McMaster University news release reports the results of a study looking at effectiveness of two different types of flu vaccine in a Canadian community.
The release refrained from using sensational language to describe the study, and it clearly identi","An important aspect of this study is that previously, a CDC advisory committee had recommended against using the nasal sprays to vaccinate children for the 2016-2017 flu season.¬† If that recommendation was incorrect, then using the spray as well as stand","https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_63462503_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/08/iStock_63462503_SMALL-768x511.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/fda-release-on-hepatitis-c-drug-informs-on-harms-benefits-but-is-light-on-evidence/,"FDA release on hepatitis C drug informs on harms, benefits but is light on evidence",Some background on the clinical trials that led to approval of a new hepatitis C drug and where they can be accessed would make this release more complete.,FDA approves Epclusa for treatment of chronic Hepatitis C virus infection,,4,"['Sally James', ""A'ndrea Elyse Messer, MS, PhD"", 'Kathlyn Stone']",Government agency news release,"['FDA', 'hepatitis C treatment']",http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm508915.htm,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The release does not discuss cost. The FDA evaluates drugs without consideration of cost, so it‚Äôs understandable that th",news_reviews_00400,FDA,"This release announces the approval by the FDA of a new pill, Epclusa, for patients with chronic infections with Hepatitis C virus, also known as HCV. The tablet combines an existing drug, sofosbuvir, with a new drug, velpatasvir, and is the first single ","An estimated 120 million people have HCV infections worldwide, with an upper estimate of 3.9 million in the US alone, according to the Centers for Disease Control and Prevention (CDC).
This new treatment ‚Äî Epclusa ‚Äî has an estimated cost of about $74,","https://www.healthnewsreview.org/wp-content/uploads/2016/07/hepc.jpg 235w, https://www.healthnewsreview.org/wp-content/uploads/2016/07/hepc-150x150.jpg 150w"
https://www.healthnewsreview.org/news-release-review/clarity-is-key-especially-when-release-recommends-strategy-for-reducing-cognitive-dysfunction/,"Clarity is key, especially when release recommends strategy for reducing cognitive dysfunction","Harms, cost and context missing from news release on strategy for reducing cognitive dysfunction following anesthesia.",Simple measures can reduce post-operative cognitive dysfunction in older patients ,,4,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Kathlyn Stone']",Foundation/nonprofit news release,"['anesthesia', 'cognitive dysfunction']",http://www.eurekalert.org/pub_releases/2016-06/fda-smc062216.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release doesn‚Äôt discuss cost at all, which is somewhat surprising given that dexamethasone has been on the market ",news_reviews_00403,Funda√ß√£o de Amparo √† Pesquisa do Estado de S√£o Paulo,"This news release focuses on a recent article published in the journal PLOS ONE, reporting that the use of the corticosteroid dexamethasone and avoiding ‚Äúdeep‚Äù or ‚Äúprofound‚Äù anesthesia during surgery can reduce the incidence of post-operative cogn","POCD is not uncommon. A 2014 literature survey paper found that 41.4 percent of patients age 60 or older who had major surgery (other than cardiac surgery) were exhibiting symptoms of POCD when discharged from the hospital. Three months later, 12.7 percen","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_93271607_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_93271607_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/nyu-langone-brings-balance-to-release-on-hepatitis-b-treatment-for-infected-women-during-pregnancy/,NYU Langone brings balance to release on hepatitis B treatment for infected women during pregnancy,Otherwise carefully written release on hepatitis B treatment omitted cost,Antiviral Treatment During Pregnancy Reduces Mother-to-Child Transmission of Hepatitis B,,4,"['Earle Holland', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Academic medical center news release,"['antiviral', 'Hepatitis B', 'NYU Langone Medical Center', 'tenofovir']",http://nyulangone.org/press-releases/antiviral-treatment-during-pregnancy-reduces-mother-to-child-transmission-of-hepatitis-b,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release makes no mention of the cost of the drug in question, Tenofovir.\xa0 A web search found that the cost for a ",news_reviews_00404,NYU Langone,This news release describes a clinical trial testing whether an antiviral drug given to pregnant women in their third trimester reduces their hepatitis B viral load. The study also examined whether the drug limits the transmission of the virus from mother,"Almost 240 million people are infected with hepatitis B virus and about 780,000 die each year from the disease, according to the World Health Organization. The hepatitis B virus infects the liver and while many recover with treatment, it can become a chro","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_45941434_SMALL-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_45941434_SMALL-768x512.jpg 768w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/release-on-societal-benefits-of-heart-failure-medication-skirts-cost-controversy/,Release on societal benefits of heart failure medication skirts cost controversy,News release claiming the ‚Äúcost effectiveness‚Äù of a new heart failure medication should have provided some cost data.,"Timely use of Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among HFrEF patients, according to an expert analysis in JAMA Cardiology",,4,"['Sally James', ""A'ndrea Elyse Messer, MS, PhD"", 'Kathlyn Stone']",cardiovascular disease,"['Entresto', 'heart failure', 'Novartis']",http://www.prnewswire.com/news-releases/timely-use-of-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-per-year-among-hfref-patients-according-to-an-expert-analysis-in-jama-cardiology-300288694.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release mentions cost-effectiveness several times but does not give any indication of what the price of therapy with",news_reviews_00405,Novartis Pharmaceuticals Corporation,This news release summarizes a study that estimated the benefits of sacubitril/valsartan (marketed as Entresto) vs enalapril (an ACE-inhibitor) in treating heart failure patients with lowered ejection fraction (the amount of blood pumped from the heart). ,"An estimated 6 million people in the United States have heart failure, and about half of those with heart failure also have reduced ejection fraction, so any treatment for them matters for their individual health and for society‚Äôs costs of overall healt","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_16805481_SMALL-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_16805481_SMALL-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/uploads/201"
https://www.healthnewsreview.org/news-release-review/clarity-and-cautions-on-new-multiple-sclerosis-therapy/,Ottawa Hospital release on MS therapy hits the right notes with clarity and cautions,Appropriately cautious release provides most of the right details on multiple sclerosis therapy advance.,MS breakthrough: Replacing diseased immune system halts progression and allows repair ,,4,"['William Heisel', ""A'ndrea Elyse Messer, MS, PhD"", 'Kathlyn Stone']",Hospital news release,['Ottawa Hospital Research Institute'],http://www.eurekalert.org/pub_releases/2016-06/ohri-mbr060816.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of the cost of this therapy. However, it is already used for treating leukemia and some other types ",news_reviews_00409,Ottawa Hospital Research Institute,"This is nearly a textbook example about how a news release can take mixed results from a clinical study and both highlight the promising findings while illuminating the harms and other issues, too. The only glaring omission here was any mention of the cos","As the news release states, ‚ÄúMS affects approximately 2.3 million people around the world, causing symptoms that range from blurred vision to extreme fatigue to partial or complete paralysis.‚Äù¬† This therapy is intended for only those with severe rela","https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000057875156_Medium-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000057875156_Medium-1024x680.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/northwestern-issued-strong-release-on-a-new-psoriasis-treatment-absent-cost/,"Northwestern issued strong release on a new psoriasis treatment, absent cost info","This release gets praise for transparency, quantification and strength of evidence.",New drug clears psoriasis in clinical trials,,4,"['Sally James', 'Kathleen Fairfield, MD, DrPH', 'Kathlyn Stone']",Academic medical center news release,"['ixekizumab', 'Northwestern University', 'psoriasis']",http://www.eurekalert.org/pub_releases/2016-06/nu-ndc060916.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release does not mention cost or whether it‚Äôs covered by private insurance or Medicare, and in this case, it‚Äôs a",news_reviews_00412,Northwestern University,"This release summarizes results from a group of three phase 3 studies that evaluated ixekizumab, a new drug treatment for psoriasis. The clinical trials enrolled nearly 4,000 patients from 21 countries. About 80 percent of the patient volunteers with mode","An estimated 7.5 million people in the United States have psoriasis, an inflammatory auto-immune¬†disorder of the skin and other tissues, according to the American Academy of Dermatology. The positive results being published in a high-level New England Jo","https://www.healthnewsreview.org/wp-content/uploads/2015/07/psoriasis-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/psoriasis.jpg 410w"
https://www.healthnewsreview.org/news-release-review/release-offers-thorough-comparison-of-treatments-for-superficial-skin-cancers/,Release offers thorough comparison of treatments for superficial skin cancers,Journal release offers good overview of topical basal cell carcinoma treatment study but doesn‚Äôt mention that many may still have to seek surgery after trying the non-invasive creams.,Topical skin creams effective to treat superficial basal cell carcinoma: New study ,,4,"['Steven J. Atlas, MD, MPH', 'Kathlyn Stone']",Cancer,"['basal cell carcinoma', 'Elsevier', 'skin cancer']",http://www.eurekalert.org/pub_releases/2016-06/e-tsc060216.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The news release notes that ‚ÄúFluorouracil has the advantage of being less expensive than imiquimod,‚Äù a statement for whi",news_reviews_00415,Elsevier,"This is a news release about a study carried out in the Netherlands that looked at 3-year data from more than 600 patients with¬†superficial basal cell carcinoma (BCC) who were treated topically with non-surgical, noninvasive therapies. The study compares","BCC is the most common form of skin cancer and most of its harm is from local spread. Basal cell carcinomas rarely kill but surgical treatment can be painful and, in certain areas of the face, may be disfiguring. If superficial basal cell carcinomas can b","https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_79213023_SMALL1-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/06/iStock_79213023_SMALL1.jpg 850w"
https://www.healthnewsreview.org/news-release-review/news-release-uses-restraint-in-describing-early-results-of-experimental-cancer-drug-good/,News release uses restraint in describing early results of experimental cancer drug. Good.,How do you describe an experimental cancer drug without losing balance? This release teeters a bit but ends up making the stick.,Investigational CDK4/6 inhibitor abemaciclib is active against a range of cancer types ,,4,"['Andrew Holtz, MPH', 'Steven J. Atlas, MD, MPH', 'Kathlyn Stone']",Association/Society news release,"['abemaciclib', 'American Association for Cancer Research']",http://www.eurekalert.org/pub_releases/2016-05/aafc-ici051916.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While one could say it is far too soon to start talking about the cost of a drug that is only beginning to be tested in ",news_reviews_00425,American Association for Cancer Research,"This release about the first set of tests in patients prescribed an experimental cancer drug, abemaciclib, uses language that mostly hews to the careful tone of the researchers‚Äô journal article. It does not make any premature claims of cure or even exte","People with cancer are on the lookout for any potential new treatment. Writers of news releases about experimental cancer drugs must be careful not to imply benefits that have not been proven. As this release demonstrates, even when there are no claims of","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000045461330_Medium-300x186.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000045461330_Medium-1024x636.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/fda-pr-release-on-bladder-cancer-drug-approval-skirts-lack-of-long-term-benefit-data/,FDA PR release on bladder cancer drug skirts lack of long-term survival data,This news release on regulatory approval of a new bladder cancer drug glosses over lack of long-term survival data.,"FDA approves new, targeted treatment for bladder cancer",,4,"['Sally James', 'Susan Molchan, MD, MA', 'Kathlyn Stone']",Cancer,"['bladder cancer', 'FDA', 'immunotherapy', 'Tecentriq', 'urothelial carcinoma']",http://www.prnewswire.com/news-releases/fda-approves-new-targeted-treatment-for-bladder-cancer-300271014.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The release does not mention cost. The FDA evaluates drugs without consideration of cost, so it‚Äôs understandable that th",news_reviews_00426,U.S. Food and Drug Administration,"The Food and Drug Administration approved a new immunotherapy drug that acts as a ‚Äúcheckpoint‚Äù inhibitor in patients whose bladder cancer (urothelial carcinoma) has not responded to other chemotherapy. The drug, atezolizumab (marketed as Tecentriq), s","The National Cancer Institute (NCI) estimates 76,960 new cases of bladder cancer and 16,390 deaths from this disease in 2016. This approval of a new drug for treating bladder cancer is part of a wider area of research into immunotherapy, in which drugs ta","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000081364273_Medium-300x222.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000081364273_Medium-1024x759.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/strong-effort-in-pr-release-on-new-tb-test-misses-on-funding-harms/,Strong effort in PR release on new TB test misses on funding; harms,This release on a new skin test for tuberculosis provides a good overview of benefits and the study methods but we‚Äôd like to know who sponsored the study.,New easy-to-use TB test achieves accuracy comparable to IGRAs in Phase III trials ,,4,"['Earle Holland', 'Harold J. DeMonaco, MS', 'Kathlyn Stone']",Association/Society news release,"['American Thoracic Society', 'tb test', 'tuberculosis']",http://www.eurekalert.org/pub_releases/2016-05/ats-net051016.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This release provides a very good discussion of costs, stating, ‚ÄúThere is also a dramatic price difference between the two",news_reviews_00428,American Thoracic Society,"This news release summarizes the results of two clinical trials gauging the efficacy of a new test for tuberculosis ‚Äî C-Tb. The study compared the new test with a more complex, and expensive, alternative and measures whether the new test works better in","Tuberculosis is a serious problem worldwide and the World Health Organization (WHO) has a stated goal of controlling, if not eradicating, the disease by 2035.¬† As is noted, the most often used test (TST) is associated with a high false positive rate maki","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000061182244_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000061182244_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/release-suggests-seafood-diet-helps-slow-cognitive-decline-but-didnt-include-study-limitations/,Release suggests seafood diet helps slow cognitive decline ‚Äì but didn‚Äôt include study limitations,This release provides a measured overview of the study but doesn‚Äôt address its weaknesses or quantify benefits.,Stave off cognitive decline with seafood,,4,"['Matt Shipman', 'Ishani Ganguli, MD, MPH', 'Kathlyn Stone']",Academic medical center news release,"['cognitive decline', 'Omega-3 Fatty Acids', 'Rush University Medical Center', 'seafood']",http://www.eurekalert.org/pub_releases/2016-05/rumc-soc051016.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Cost isn‚Äôt discussed. And because it‚Äôs about a widely-consumed food that is a staple for many diets, we‚Äôll rate it n",news_reviews_00429,Rush University Medical Center,"The news release is a recap of a recent journal article published in the journal Neurology, and reports that older adults who eat seafood at least once per week saw slower declines in two specific cognitive areas (semantic memory and perceptual speed) tha","Most people plan on aging; it happens whether we like it or not. And many people have experiences with loved ones whose cognitive abilities ‚Äî such as memory ‚Äî have declined with age. In short, issues regarding cognitive decline associated with aging a","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000088833181_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000088833181_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/solid-pr-release-on-glaucoma-device-shouldve-cautioned-on-study-limitations/,Solid PR release on glaucoma device should‚Äôve cautioned on study limitations,This release is informative in describing an early trial on a new drug delivery device for glaucoma patients. A little more information on potential harms and costs would have made it stronger.,Glaucoma Drug-Dispensing Eye Insert Shows Promise as New Option for Patients Struggling to Take Daily Prescription Eye Drops,,4,"['Mary Chris Jaklevic', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Association/Society news release,"['American Academy of Ophthalmology', 'bimatroprost', 'drug delivery device', 'glaucoma']",http://www.prnewswire.com/news-releases/glaucoma-drug-dispensing-eye-insert-shows-promise-as-new-option-for-patients-struggling-to-take-daily-prescription-eye-drops-300263282.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The news release doesn‚Äôt mention costs, despite the fact that investors would need to recoup the enormous cost of deve",news_reviews_00433,American Academy of Ophthalmology,"This news release reports phase 2 trial results of a silicone ring that slowly releases glaucoma medication onto the surface of the eye, potentially eliminating the need for patients to self-administer eye drops. The study was funded by the developer of t","Patient non-adherence to glaucoma treatment regimens is a serious problem, believed to contribute to glaucoma remaining a leading cause of blindness. Medication to lower eye pressure is generally preferred over traditional surgery and laser surgery becaus","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000056112852_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000056112852_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/cvs-release-on-hospital-vs-home-infusion-provides-useful-info-on-cost-savings-outcomes-and-quality-of-life-not-so-much/,CVS release on hospital vs home infusion provides useful info on cost-savings. Outcomes and quality of life ‚Äì not so much,This look at cost savings from home infusion services as compared to hospital infusions is potentially useful but went far afield by claiming improved outcomes and quality of life. The 13 previous studies that were the basis for the retrospective analysis,CVS Health Research Institute Study Shows that Home Infusion Care Improves Patient Outcomes and Quality of Life While Reducing Overall Costs,,4,"['Sally James', 'Susan Molchan, MD, MA', 'Kathlyn Stone']",Health care costs,"['CVS Health Research Institute', 'home health', 'infusion']",http://www.prnewswire.com/news-releases/cvs-health-research-institute-study-shows-that-home-infusion-care-improves-patient-outcomes-and-quality-of-life-while-reducing-overall-costs-300262614.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The news release includes information about costs. We would have liked a little more context. The release states: ‚ÄúThe cos",news_reviews_00436,CVS Health,This news release describes the cost savings and safety of home infusion services from 13 previously published studies compared with infusion services at a clinic or hospital. Home infusion appears safe and clinically effective while saving money in the s,"Treatments for chronic diseases, which often require drugs administered through infusion, are one of the fastest growing costs in the US health care system. If patients can be served at home, rather than in outpatient clinics or hospitals, it saves both m","https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000025346493_Medium-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/iStock_000025346493_Medium-1024x768.jpg 1024w, https://www.healthnewsreview.org/wp-content"
https://www.healthnewsreview.org/news-release-review/study-on-refining-childhood-leukemia-treatment-protocol-promising-but-release-offers-hazy-data/,Study on refining childhood leukemia treatment protocol promising but release offers hazy data,This news release strikes an optimistic tone in a study showing a small statistical improvement when childhood leukemia patients are given higher doses of standard chemotherapy drugs. The data presentation was a bit confusing.,Relapses of childhood leukemia improve with high doses of common chemo drug ,,4,"['Earle Holland', 'Dan Mayer, MD', 'Kathlyn Stone']",Academic medical center news release,"['chemotherapy', 'childhood leukemia', 'NYU Langone Medical Center']",http://www.eurekalert.org/pub_releases/2016-04/nlmc-roc042516.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'This release makes no mention of the costs of the drugs compared in this study, even though the drugs have been in use f",news_reviews_00439,NYU Langone Medical Center / New York University School of Medicine,This release reports the findings of a large clinical trial testing whether alternative dosing regimens of standard chemotherapeutic drugs can improve the treatment of B-acute lymphoblastic leukemia. The study showed that using high doses of the drug meth,"This form of cancer ‚Äî B-acute lymphoblastic leukemia ‚Äî is the most common cancer in children and a major cause of cancer death in patients under 40 years old. And while the majority of patients survive with appropriate treatment, anywhere from one-fif","https://www.healthnewsreview.org/wp-content/uploads/2016/05/stock-illustration-73392875-leukemia-cancer-blood-leukaemia-disease-concept-vector-300x171.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/05/stock-illustration-73392875-leukem"
https://www.healthnewsreview.org/news-release-review/best-antidepressant-for-overweight-people-release-makes-partial-case/,Best antidepressant for overweight people? Release makes partial case,"This release concludes that buproprion is the best antidepressant for most overweight people, but the claim could have been tempered with the inclusion of some of the study limitations.",One antidepressant shown to control weight during 2-year study ,,4,"['Joann Rodgers, MS', ""A'ndrea Elyse Messer, MS, PhD"", 'Kathlyn Stone']",industry/commercial news releases,"['antidepressants', 'depression', 'obesity']",http://www.eurekalert.org/pub_releases/2016-04/ghri-oas041916.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'A quote from one of the study‚Äôs co-authors\xa0mentions ‚Äúcosts‚Äù and ‚Äúpatient preferences‚Äù as sensible considera",news_reviews_00440,Group Health Research Institute,This news release describes results of a retrospective study by Group Health on the link between antidepressant drugs and weight change over a two-year period in adults with already-diagnosed depression. The results of the study suggest that compared to a,"Depression takes a significant toll on human health, well-being and productivity. It‚Äôs a challenging condition to treat, costs billions every year worldwide, and suicide is a too-frequent outcome.
Antidepressants are among the mostly commonly prescribed","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000084243767_Medium-300x199.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000084243767_Medium-1024x680.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/strong-accounting-of-early-study-on-colorectal-cancer-drug-but-was-a-release-really-warranted/,Strong accounting of early study on colorectal cancer drug ‚Äî but was a release really warranted?,This news release portraying a safety trial of a drug for treating colorectal cancer uses a measured tone in explaining the very preliminary nature of the study.,Experimental drug guadecitabine found safe in patients with colorectal cancer ,,4,"['Matt Shipman', 'Harold J. DeMonaco, MS', 'Kathlyn Stone']",Academic medical center news release,"['colorectal cancer', 'Johns Hopkins']",http://www.eurekalert.org/pub_releases/2016-04/jhm-edg041516.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'We‚Äôll rate this ‚ÄúNot Applicable‚Äù given the very early nature of the study and the fact that guadecitabine is clearly",news_reviews_00445,Johns Hopkins Medicine,The news release discusses the¬†findings of a small study¬†that was designed to assess the safety of the experimental drug guadecitabine for use in conjunction with the conventional drug irinotecan to treat metastatic colorectal cancer. Phase 1 studies ar,"According to the National Cancer Institute, colorectal cancer is the third most common type of cancer in the United States for both men and women. And while 5-year survival statistics are good for colorectal cancer patients who are diagnosed while the can","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000019455710_Medium-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000019455710_Medium-1024x768.jpg 1024w, https://www.healthnewsreview.org/wp-content"
https://www.healthnewsreview.org/news-release-review/release-pairing-lung-ultrasound-vs-chest-x-ray-raised-a-red-flag-over-potential-misdiagnosis/,"Strong on costs, PR release pairing lung ultrasound vs chest X-ray neglected potential for misdiagnosis","Substituting lung ultrasound for chest X-ray in children looks advantageous in this release, but the lack of data on diagnostic accuracy is concerning.",Lung ultrasound may be a safe substitute for chest X-ray when diagnosing pneumonia in children ,,4,"['Earle Holland', 'Dan Mayer, MD', 'Kathlyn Stone']",Hospital news release,"['lung ultrasound', 'pediatric pneumonia']",http://www.eurekalert.org/pub_releases/2016-04/tmsh-lum041116.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'This release earns praise for clearly mentioning the cost savings derived from the use of chest ultrasounds versus chest X-r",news_reviews_00449,The Mount Sinai Hospital / Mount Sinai School of Medicine,"This Mount Sinai news release describes a small study aimed at testing whether chest ultrasounds are as effective at diagnosing pneumonia in children as chest X-rays, the current diagnostic method of choice. Patients were randomized into either a test gro","Pneumonia is the number one killer of children on the planet, according to the World Health Organization (WHO).¬† While chest X-rays are the accepted means of diagnosing pneumonia, WHO points out that in three-quarters of the world, the necessary equipmen","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000056289110_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000056289110_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/nih-release-delivers-most-of-the-goods-on-heart-bypass-surgery-outcomes/,NIH release delivers most of the goods on long-term heart surgery outcomes,This news release delivers good info on heart bypass surgery outcomes but harms and costs were absent.,Heart bypass surgery brings long-term benefits,,4,"[""A'ndrea Elyse Messer, MS, PhD"", 'Ishani Ganguli, MD, MPH', 'Kathlyn Stone']",cardiovascular disease,"['coronary artery disease', 'heart bypass']",http://www.nih.gov/news-events/nih-research-matters/heart-bypass-surgery-brings-long-term-benefits,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no discussion of cost in this release. Perhaps the cost of medical treatment is moot as both groups received th",news_reviews_00450,NIH National Institutes of Health,"This news release describes extended outcomes of a large, randomized controlled trial comparing the effects of coronary artery bypass grafting (CABG) surgery plus medical treatment with those of medical treatment alone on patients with dysfunction or fail","This study offers important information on the positive long-term impact of a widely performed surgery on a population previously thought to be too sick to receive it. As the U.S. population ages, more and more people suffer from cardiovascular disease, a","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000079810501_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000079810501_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/news-release-on-osteoporosis-drug-prominently-notes-funders-and-potential-conflicts-of-interest-kudos/,News release on osteoporosis drug prominently notes funders and potential conflicts of interest. Kudos!,The Endocrine Society put disclosures front and center in this drug trial summary.,Abaloparatide may help prevent fractures in postmenopausal women with osteoporosis ,,4,"['Joann Rodgers, MS', 'Harold J. DeMonaco, MS', 'Kathlyn Stone']",Association/Society news release,"['osteoporosis', 'postmenopausal women']",http://www.eurekalert.org/pub_releases/2016-04/tes-amh040116.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release doesn‚Äôt include any discussion of the financial burden of the disease or estimated costs of treating it. T",news_reviews_00453,The Endocrine Society,"This release from The Endocrine Society describes the results of one of a series of randomized, double-blind comparative clinical trials of abaloparatide-SC, an investigational drug designed to increase bone mineral density and prevent bone fractures in p","Some health organizations estimate more than 200 million women (and men) worldwide have osteoporosis and that in the United States, 43 million adults are at risk for osteoporosis and that the disease is responsible for about 2 million broken bones each ye","https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000076254391_Medium-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000076254391_Medium-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/u"
https://www.healthnewsreview.org/news-release-review/duke-university-offers-strong-data-driven-release-on-lung-cancer-screenings-for-former-smokers/,Duke University offers strong data-driven release on lung cancer screenings for former smokers,News release expertly addresses findings from study on frequency of screening CTs for heavy smokers.,High-risk lung cancer patients may not need annual screenings ,,4,"['Alan Cassels', 'Saurabh Jha, MBBS', 'Kathlyn Stone']",Academic medical center news release,"['low-dose CT', 'lung cancer']",http://www.eurekalert.org/pub_releases/2016-03/dumc-hlc032116.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The release appropriately mentioned that a changed frequency of screening could save millions of dollars in subsequent scree",news_reviews_00455,Duke University Medical Center,"This news release summarizes a study published in Lancet Oncology which looked at the appropriate frequency of screening using low-dose computed tomography (CT) for lung cancer in former smokers. The 7-year study included more than 19,000 individuals with",A re-analysis of the world‚Äôs largest lung cancer screening trial could have major consequences for patients and health systems. This study found that if initial low-dose CT screening is negative then less frequent subsequent screening seems reasonable. ,"https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000082672259_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/04/iStock_000082672259_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/no-study-available-to-back-up-claim-that-the-ipad-may-be-a-cost-effective-alternative-vision-aid/,University can‚Äôt produce vision study that it promotes worldwide in news release,A university asks reporters and the public to accept its claims about a vision study on blind faith; there‚Äôs no indication the claims are based on published or peer-reviewed research.,Can an iPad Help You See? ,,4,"['Sally James', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Academic medical center news release,"['Concordia University', 'macular degeneration', 'tablet computer']",http://www.newswise.com/articles/view/650223/?sc=mwhn,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We are glad to learn, as the release points out, that there may be a less expensive option for seniors needing vision ai",news_reviews_00457,Concordia University,"This news release from Montreal‚Äôs Concordia University focuses on a research study showing that seniors with age-related macular degeneration (AMD) may be able to use iPad tablet computers to help them read, instead of buying more expensive vision aids.","A growing percentage of the population are elderly and likely to have vision impairments of some kind. AMD, which occurred in about half of this small (100 volunteers) study group, is a common eye condition and a leading cause of vision loss among people ","https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000034399362_Medium-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000034399362_Medium-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/pr-release-prematurely-calls-new-chemotherapy-drug-the-new-standard-of-care/,PR release prematurely calls new chemotherapy drug the ‚Äúnew standard of care‚Äù,Promising results presented in this release are overshadowed by the absence of published data.,Celator Announces Phase 3 Trial for VYXEOS‚Ñ¢ (CPX-351) in Patients with High-Risk Acute Myeloid Leukemia Demonstrates Statistically Significant Improvement in Overall Survival ,,4,"['Alan Cassels', 'Dan Mayer, MD', 'Kathlyn Stone']",Cancer,"['acute myeloid leukemia', 'chemotherapy']",http://www.prnewswire.com/news-releases/celator-announces-phase-3-trial-for-vyxeos-cpx-351-in-patients-with-high-risk-acute-myeloid-leukemia-demonstrates-statistically-significant-improvement-in-overall-survival-300235620.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no discussion of the costs of the treatment.'}, {'question': 'Does the news release adequately quantify the be",news_reviews_00464,"Celator Pharmaceuticals, Inc.","Image shows blue-fluorescing Vyxeos nano-liposomes being engulfed by leukemia cells. Credit: Celator Pharmaceuticals
This is a company announcement of the results of a phase 3 trial of its new chemotherapy drug Vyxeos (cytarabine: daunorubicin) Liposome f","AML is¬†a cancer of the myeloid line of blood cells, where¬†abnormal white blood cells grow rapidly and accumulate in the bone marrow, interfering with the production of normal blood cells. Any chemotherapy advance that can extend the lives of patients wi",nan
https://www.healthnewsreview.org/news-release-review/exemplary-explanation-of-study-comparing-diabetic-macular-edema-treatments/,Exemplary explanation of study comparing diabetic macular edema treatments,This release provides just about everything readers need to know about an important study.,Eylea outperforms Avastin for diabetic macular edema with moderate or worse vision loss,,5,"['Kathlyn Stone', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",diabetes,"['comparative effectiveness studies', 'diabetes complications', 'diabetic macular edema']",http://www.nih.gov/news-events/news-releases/eylea-outperforms-avastin-diabetic-macular-edema-moderate-or-worse-vision-loss,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The release states that based on Medicare allowable charges, each injection of Eylea costs $1,850, Lucentis is $1,200 per in",news_reviews_00473,NIH National Institutes of Health,"Results from a two-year comparative effectiveness randomized clinical trial are summarized in this news release from the National Institutes of Health (NIH).¬† The trial compared aflibercept (marketed as Eylea), bevacizumab (Avastin) and ranibizumab (Luce","Patients with diabetes are at risk of developing DME, a consequence of diabetic retinopathy. It causes swelling in an area of the retina called the¬†macula due to fluid build-up. Diabetic retinopathy is responsible for an estimated 12,000 to¬† 24,000 new ","https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000055945450_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/03/iStock_000055945450_Small.jpg 849w"
https://www.healthnewsreview.org/news-release-review/penn-research-fda-approved-alzheimers-drug-help-smokers-quit/,Can an Alzheimer‚Äôs drug help you quit smoking? Penn PR release nicely frames very early research,Generally solid discussion of an early study on repurposing an Alzheimer‚Äôs drug to help with smoking cessation.,Penn research: An FDA-approved Alzheimer's drug could help smokers quit ,,4,"['Kathlyn Stone', 'Susan Molchan, MD, MA', 'Kevin Lomangino']",Academic medical center news release,"['repurposing approved drugs', 'smoking cessation']",http://www.eurekalert.org/pub_releases/2016-02/uop-pra021816.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There is no mention of costs in the release. Some mention of costs would have been useful and could have taken a number ",news_reviews_00477,University of Pennsylvania,This news release describes a report on an ongoing trial of the Alzheimer‚Äôs drug galantamine as a smoking cessation aid. The release also notes that the study on which it‚Äôs based sought to explore whether the drug would have less of an effect on parti,"Simply stated, cigarette smoking has been found to have ill effects on almost every organ of the body. Despite decades of research and laws banning cigarette advertising people still have a hard time giving up this habit. Few people who try to quit are su","https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000060440592_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000060440592_Small.jpg 849w"
https://www.healthnewsreview.org/news-release-review/release-hits-the-right-notes-on-study-comparing-two-antiseptics-used-in-c-sections/,Release hits the right notes on study comparing two antiseptics used in C-sections,This news release comparing antiseptics to prevent post-cesarean section infection covers nearly all the bases. Well done.,"To Prevent Infection After C-Section, Chlorhexidine Better Than Iodine ",,5,"['Sally James', 'Doug Campos-Outcalt, MD, MPA', 'Kathlyn Stone']",Academic medical center news release,"['cesarean', 'infection', 'labor and delivery', 'obstetrics']",http://www.newswise.com/articles/view/647238/?sc=mwhn,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We gave the release a passing grade on cost for including context on the cost of an infection.\n‚ÄúAn estimated 1.3 million ",news_reviews_00486,Washington University in St. Louis,"Women who deliver babies via cesarean section (C-section) surgery may develop infections of the incision, and this news release describes research that shows an alternative combination of skin-cleaning agents prior to surgery may prevent those infections ","Delivering babies via C-section is common in the United States, and an estimated 1.3 million women delivered that way in 2013. Between 5 and 12 percent of those deliveries included an infection. Shortening post-surgical pain and reducing the risk of infec","https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000070373251_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000070373251_Small.jpg 849w"
https://www.healthnewsreview.org/news-release-review/in-depth-merck-release-on-new-hep-c-drug-skirts-some-of-the-basics/,In-depth Merck release on new Hep C drug skirts some of the basics,"This news release seemingly throws out the kitchen sink in terms of sharing data but under scrutiny, we find key information is missing.",Merck Receives FDA Approval of ZEPATIER‚Ñ¢ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review,,4,"['Dave Mosher', 'Dan Mayer, MD', 'Kathlyn Stone']",Health care costs,"['hepatitis c', 'Merck']",http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'We‚Äôre told a 12-week regimen costs $54,600. However, we‚Äôre not clued in as to how much a 16-week treatment costs and tha",news_reviews_00490,Merck,Merck‚Äôs PR release fills us in on its freshly FDA-approved drug ‚Äî Zepatier (elbasvir and grazoprevir) ‚Äî to treat two different forms of hepatitis C and claims to ‚Äúcure‚Äù upwards of 94% of infections based on 12- and 16-week trials. The combinatio,"Hepatitis C is caused by a virus that attacks the liver ‚Äî an organ you can‚Äôt live without because it breaks down toxins, fights infections, helps regulate metabolism, and aids digestion. Infections can be passed down in a variety of ways, including fr","https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000066345329_Small-300x198.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2016/02/iStock_000066345329_Small.jpg 852w"
https://www.healthnewsreview.org/news-release-review/release-on-rare-bleeding-disorder-therapy-gets-points-for-restraint/,Release on potential therapy for rare bleeding disorder gets points for restraint,High marks for this measured news release on an animal study that researchers hope may pave the way for a treatment for a rare bleeding disorder.,Gene therapy for rare bleeding disorder achieves proof-of-concept,,5,"['Sally James', 'Susan Wei, PhD', 'Kathlyn Stone']",Animal research,"['animal research', 'clotting', 'Factor VII', 'gene therapy', 'hematology', 'rare']",http://www.eurekalert.org/pub_releases/2016-01/chop-gtf011916.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The news release does not bring up costs, but we‚Äôll rate this Not Applicable since the release is clear that this is ear",news_reviews_00492,Children's Hospital of Philadelphia,"Credit: UC Davis Comparative Oncology Program
This short news release describes a gene therapy experiment in four dogs that might turn out to help human patients with a rare blood disorder known as Factor VII deficiency. The release does a good job of mak","Gene therapies are emotional minefields for patients and families, especially since so much has been promised and actual successes have been few. One gene therapy offered in Europe has a price tag of $1 million. This release would serve readers better if ",nan
https://www.healthnewsreview.org/news-release-review/magnetic-stimulation-brain-may-help-patients-cocaine-addiction/,Release carefully makes case for magnetic stimulation for cocaine addiction,This news release on magnetic brain stimulation to combat cocaine addiction has something we don‚Äôt often see in releases ‚Äî lots of underscoring of the research limitations.,Magnetic stimulation of the brain may help patients with cocaine addiction,,4,"['Earle Holland', 'Michael Bierer MD, MPH', 'Kathlyn Stone']",Association/Society news release,"['cocaine addiction', 'Magnetic stimulation']",http://www.eurekalert.org/pub_releases/2015-12/econ-mso113015.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While the release clearly labels this work as preliminary, the overall inference of the news is that this is a potential",news_reviews_00509,European College of Neuropsychopharmacology,This release reports the findings from a small pilot study asking whether rTMS (repetitive transcranial magnetic stimulation) to certain parts of the brain in cocaine users can limit their use and affect their cravings for the drug. The results showed a d,"While cocaine abuse is widespread in the developed world, there are no proven therapies for this addiction. Some pharmacologic approaches appear to be helpful but they are still under investigation. Medicines given to such patients are intended to affect ","https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000076117985_Medium-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000076117985_Medium-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/u"
https://www.healthnewsreview.org/news-release-review/promising-new-antimicrobials-fight-drug-resistant-mrsa-infection-study-finds/,New antimicrobials could fight MRSA infection if they make it out of the lab dish,An advance in the struggle against MRSA is welcome news ‚Äî for those who can follow the technical description one might find in a journal article.,"Promising new antimicrobials could fight drug-resistant MRSA infection, study finds",,4,"['Susan Wei, PhD', 'Earle Holland', 'Kathlyn Stone']",University news release,"['antimicroblias', 'Georgia State University', 'MRSA']",http://www.eurekalert.org/pub_releases/2015-11/gsu-pna113015.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Even though it‚Äôs ‚Äúearly days‚Äù for this strategy we‚Äôd like to see some mention of costs, if not for the proposed ",news_reviews_00511,Georgia State University,This news release from Georgia State University reports on a study¬†proposing a novel antimicrobial approach for combating methicillin-resistant Staphylococcus aureus (MRSA). The news release provides a thorough ‚Äúbig picture‚Äù overview of the underlyin,MRSA is a staph bacteria that‚Äôs resistant to many types of antibiotics. In some cases it‚Äôs life-threatening. MRSA has garnered a lot of attention over the last decades because of its presence in hospitals and communities. Community-acquired MRSA tends,"https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000067241787_Small-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/12/iStock_000067241787_Small-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/upl"
https://www.healthnewsreview.org/news-release-review/working-sweat-may-protect-men-lethal-prostate-cancer/,Will diet and exercise protect men from lethal prostate cancer?,"Studies tracking older men who participated in vigorous exercise shows they had a lower risk of lethal prostate cancer, but there‚Äôs no cause and effect data.",Working up a sweat may protect men from lethal prostate cancer ,,4,"['Matt Shipman', 'Dan Mayer, MD', 'Kathlyn Stone']",Academic medical center news release,[],http://www.eurekalert.org/pub_releases/2015-11/uoc--wua111715.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The study evaluated the combined effect of six lifestyle habits on prostate cancer mortality. Those six factors were, as des",news_reviews_00517,University of California - San Francisco,"This release summarizes an article in the Journal of the National Cancer Institute which reports that healthy lifestyle habits, including regular vigorous exercise, are associated with reduced risk of death from prostate cancer. The release does a fine jo","Prostate cancer is costly ‚Äî in both lives and money. It is the most common cancer in U.S. men, according to the Centers for Disease Control and Prevention. In 2012, more than 177,000 men in the U.S. were diagnosed with prostate cancer, and 27,244 died f","https://www.healthnewsreview.org/wp-content/uploads/2015/11/senior-exercise-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/senior-exercise-1024x682.jpg 1024w"
https://www.healthnewsreview.org/news-release-review/lucentis-proves-effective-proliferative-diabetic-retinopathy/,Generally strong description of diabetic retinopathy drug trial ‚Äî but more transparency please,A mostly informative release that describes a possible new treatment option for people with diabetic retinopathy. The advantage here is fewer side effects than the standard treatment.,Lucentis Proves Effective Against Proliferative Diabetic Retinopathy,,4,"['Matt Shipman', 'Kathleen Fairfield, MD, DrPH', 'Kathlyn Stone']",Academic medical center news release,"['eye disease', 'Joslin Diabetes Center', 'Lucentis', 'proliferative diabetic retinopathy']",http://www.newswise.com/articles/view/642967/?sc=swhn,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story doesn‚Äôt mention cost at all. Since Lucentis can cost $2,000 per injection, that‚Äôs a significant oversight.",news_reviews_00520,Joslin Diabetes Center,"This release describes a study¬†published in the Journal of the American Medical Association on the use of the drug ranibizumab (brand name Lucentis) to treat proliferative diabetic retinopathy (PDR), which can damage eyesight and lead to blindness. The c","According to the CDC, 9.3% of the U.S. population¬† ‚Äî 29.1 million people ‚Äî have Type 2 diabetes. The number rises to 16.2% of adults between the ages of 45 and 64. Among them, PDR is an added burden affecting a great many people with diabetes. A 2010","https://www.healthnewsreview.org/wp-content/uploads/2015/11/Eye-anatomy-300x268.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/Eye-anatomy-1024x914.jpg 1024w, https://www.healthnewsreview.org/wp-content/uploads/2015/11/Eye-anatomy.j"
https://www.healthnewsreview.org/news-release-review/botox-to-prevent-heart-bypass-complications-association-carefully-describes-benefits-seen-in-small-study/,Botox to prevent heart bypass complications? Association carefully describes benefits seen in small study,This brief news release packs a lot of useful information about a study of botulinum toxin in the prevention of complications following bypass surgery.,Botox may prevent irregular heartbeat after bypass surgery ,,4,"['Harold J. DeMonaco, MS', 'Ishani Ganguli, MD, MPH', 'Kathlyn Stone']",Association/Society news release,"['American Heart Association', 'atrial fibrillation', 'botulinum toxin']",http://www.eurekalert.org/pub_releases/2015-10/aha-bmp101515.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The story rightly points out that the development of atrial fibrillation after coronary artery bypass surgery has signif",news_reviews_00533,American Heart Association,This concise (393 word) news release from the American Heart Association on a trial that used botulinum toxin to prevent irregular heart rhythms after bypass surgery packs a lot of good information into a small frame. The novel use of botulinum toxin repr,Atrial fibrillation after coronary bypass surgery is a vexing problem. Most patients who develop atrial fibrillation post-procedure do so within a few days of the procedure so an intraoperative or preoperative solution seems reasonable.Atrial fibrillation,"https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000021528750_Small-300x300.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/10/iStock_000021528750_Small-150x150.jpg 150w, https://www.healthnewsreview.org/wp-content/upl"
https://www.healthnewsreview.org/news-release-review/referencing-animal-study-in-headline-nyit-accurately-frames-evidence-on-new-heart-failure-treatment/,"Referencing ‚Äúanimal study‚Äù in headline, NYIT accurately frames evidence on possible new heart failure treatment",We wish more news releases were as up front with readers as this one is.,Animal study suggests treatment that may improve heart function in heart failure ,,4,"['Matt Shipman', ""A'ndrea Elyse Messer, MS, PhD"", 'Kevin Lomangino']",Academic medical center news release,['mice studies'],http://www.eurekalert.org/pub_releases/2015-10/nyio-ass101315.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'This release is reporting on work done in an animal model, far removed from clinical use in humans. As such, it would be v",news_reviews_00539,New York Institute of Technology,"This release focuses on a recently-published study¬†in rats with high blood pressure that are at risk of heart failure, a condition in which the heart does not pump blood as efficiently as it should. The study‚Äôs findings suggest treating the animals wit","Heart failure is a big deal. According to the CDC, more than 5 million people in the United States are diagnosed with heart failure and ‚Äî in 2009 ‚Äî heart failure was a contributing factor in one out of every nine deaths in the U.S. The CDC also notes ","https://www.healthnewsreview.org/wp-content/uploads/2015/06/Mouse-410x273-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/Mouse-410x273.jpg 410w"
https://www.healthnewsreview.org/news-release-review/did-they-get-it-all-news-release-describes-device-that-would-give-real-time-answer-to-cancer-surgeons/,Did they ‚Äúget it all‚Äù? News release describes device that might give real-time answer to cancer surgeons,Pretty good account of an early study about a new device. Addition of cost and potential harms would have completed the picture for readers.,Surgical probe seeks out where cancer ends and healthy tissue begins,,4,"['Joann Rodgers, MS', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Breast cancer,['University of Illinois'],http://www.eurekalert.org/pub_releases/2015-09/uoia-sps091615.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'Although the study was not designed to assess relative costs of gold standard histology and OCT. the release would have ",news_reviews_00547,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,"The experimental light probe. Credit University of Illinois at Urbana-Champaign.
This news release describes the results of a small clinical ‚Äúproof of concept‚Äù trial¬†designed to blind-test the reliability and accuracy (i.e. sensitivity and specificit","During surgery to remove a solid tumor, some tissue around the tumor is also removed. A pathologist takes the tumor with surrounding tissue and stains it with ink so that the outer edges, or margins, can be seen under a microscope. ‚ÄúNegative margins‚Äù ",nan
https://www.healthnewsreview.org/news-release-review/georgetown-carefully-announces-findings-of-preliminary-resveratrolalzheimers-study/,Georgetown carefully announces findings of preliminary resveratrol/Alzheimer‚Äôs study,"Overall, this was a solid news release for a recent phase II trial studying resveratrol and an example for other institutions announcing findings from preliminary studies.",Resveratrol impacts Alzheimer's disease biomarker ,,4,"['Euna Bodner, MS', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Academic medical center news release,"['Georgetown University Medical Center', 'resveratrol']",http://www.eurekalert.org/pub_releases/2015-09/gumc-ri090415.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Although resveratrol is found in some foods, it was tested here as an investigational new drug. This means that it is not ",news_reviews_00548,Georgetown University Medical Center,"Resveratrol is an antioxidant compound found in grapes and red wine.
This news release from Georgetown University Medical Center does a thorough job laying out the main points of a resveratrol phase II clinical trial. It reasonably talks about the study‚Ä","Alzheimer‚Äôs disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. It is a condition associated with aging, since most symptoms appear when people hit their mid-60s. Estimates vary, but experts suggest th",nan
https://www.healthnewsreview.org/news-release-review/mediterranean-diet-and-breast-cancer-risk-informative-jama-news-release-includes-ample-caveats/,Mediterranean diet and breast cancer risk: informative JAMA news release includes ample caveats,A few small additions would have made this informative news release about the Mediterranean diet and breast cancer even more useful.,Mediterranean diet plus olive oil associated with reduced breast cancer risk ,,4,"['Earle Holland', 'Deanna Attai, MD, FACS', 'Kevin Lomangino']",Breast cancer,"['JAMA', 'Mediterranean diet']",http://www.eurekalert.org/pub_releases/2015-09/tjnj-mdp091015.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release makes no mention of the cost of the supplemented diets compared to what might be expected for a normal daily",news_reviews_00549,The JAMA Network Journals,"This news release reports on the findings of a large European study, published in JAMA Internal Medicine, asking whether older women participants following a Mediterranean Diet, supplemented with either extra-virgin olive oil (EVOO) or nuts, experienced a","Breast cancer is the most common cancer in women.¬† If the risk of this disease can be lowered by simply altering one‚Äôs diet, it would represent a safe, non-pharmacological approach to improving the public‚Äôs health.","https://www.healthnewsreview.org/wp-content/uploads/2015/09/iStock_000053662472_Small-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/09/iStock_000053662472_Small.jpg 849w"
https://www.healthnewsreview.org/news-release-review/exemplary-explanation-experimental-test-concussion/,Exemplary explanation of an experimental test for concussion,"Apart from a few minor concerns, this release represents a good model for other organizations on how to report complicated research findings in a way that‚Äôs interesting and accurate.",Eye Tracking Has High Sensitivity as a Biomarker for Concussion; Eye Tracking Detects Concussion with Sensitivity Comparable to that of Blood Tests for Heart Attack,,4,"['Joann Rodgers, MS', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Academic medical center news release,"['concussion', 'sports']",http://www.prnewswire.com/news-releases/eye-tracking-has-high-sensitivity-as-a-biomarker-for-concussion-300125284.html,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release, (surprisingly, given its overall thoroughness) does not supply any information about the estimated costs of",news_reviews_00558,Hennepin County Medical Center,"This news release is a wonderfully detailed summary of a study of a novel eye-tracking measure of brain injury, one with the potential to significantly advance the accuracy of tests to detect the severity of traumatic brain injuries, whose consequences¬†c","Physicians and other medical personnel in emergency rooms, on playing fields, and¬†in offices struggle with diagnosing concussions and determining the severity of the underlying brain injury. While brain imaging can identify patients with fractures, bleed","https://www.healthnewsreview.org/wp-content/uploads/2015/08/concussion-300x197.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/concussion.jpg 856w"
https://www.healthnewsreview.org/news-release-review/good-release-on-cbtanxiety-missed-on-costcomparison-info/,Good release on CBT/anxiety missed on cost/comparison info,"A generally well-done news release on an important research paper. ¬†But information about costs of the approach, and about the¬†degree of differences between the two approaches tested, was missing.",Telephone-Based Cognitive Behavioral Therapy for Anxiety in Rural Older Adults,,4,"['Earle Holland', 'Susan Molchan, MD, MA', 'Gary Schwitzer']",Journal news release,"['anxiety', 'cognitive behavioral therapy']",http://media.jamanetwork.com/news-item/telephone-based-cognitive-behavioral-therapy-for-anxiety-in-rural-older-adults/,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'At no point in the release was cost mentioned.\xa0 Psychotherapy and counseling can be costly, especially for the elderl",news_reviews_00560,The JAMA Network Journals,The news release reports on the outcome of a randomized clinical trial testing how well telephone-based therapy can be used for older rural patients experiencing general anxiety disorder. ¬†It‚Äôs an interesting and important topic. ¬†The release would ha,"The research paper points out that generalized anxiety disorder¬†‚Äúis one of the most common anxiety disorders in older adults‚Äù and is ‚Äúassociated with poor quality of life, increased health care utilization, impaired memory, and potentially increase","https://www.healthnewsreview.org/wp-content/uploads/2015/08/Lonely-old-man-410x273-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/08/Lonely-old-man-410x273.jpg 410w"
https://www.healthnewsreview.org/news-release-review/careful-account-of-vitamin-d-study-closes-with-questionable-recommendation-on-testing/,Careful account of vitamin D study closes with questionable recommendation on testing,An otherwise strong report on a study about vitamin D and inflammation takes a wrong turn at the very end when it encourages readers to inquire about testing their vitamin D levels.,"Weight loss plus vitamin D reduces inflammation linked to cancer, chronic disease",,4,"['Joann Rodgers, MS', 'Richard Hoffman, MD', 'Kevin Lomangino']",Academic medical center news release,"['Fred Hutchinson Cancer Research Center', 'inflammation', 'vitamin D']",http://www.eurekalert.org/pub_releases/2015-06/fhcr-wlp062415.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'There was no mention\xa0of the potential costs of screening women for vitamin D levels (as encouraged in the release in ",news_reviews_00568,FRED HUTCHINSON CANCER RESEARCH CENTER,"This news release describes a randomized, controlled clinical trial designed to learn whether adding vitamin D supplements to substantial weight loss regimens would have a synergistic effect in reducing inflammatory chemicals in the bodies of overweight, ","News releases that include the words ‚Äúdiet,‚Äù ‚Äúoverweight,‚Äù ‚Äúvitamin,‚Äù and ‚Äúcancer‚Äù are almost narrative nuclear events, often guaranteeing an explosion of coverage, souped up vitamin sales pitches, and lots of negative fallout whose half-l","https://www.healthnewsreview.org/wp-content/uploads/2015/07/vitamin-D-300x242.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/07/vitamin-D.jpg 771w"
https://www.healthnewsreview.org/news-release-review/lancet-delivers-key-details-on-a-rapid-new-ebola-test-quantifies-sensitivityspecificity-and-explores-study-limitations/,Lancet delivers key details on a rapid new Ebola test; quantifies sensitivity/specificity and explores study limitations,A thorough summary of a study describing a new test for Ebola virus that would be faster and more convenient than currently available tests.,New rapid diagnostic test for Ebola could be game changer in the fight against the disease,,4,"['Dave Mosher', 'Ishani Ganguli, MD, MPH', 'Kevin Lomangino']",Diagnostic tests,"['Ebola', 'The Lancet']",http://www.eurekalert.org/pub_releases/2015-06/tl-tln062415.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'We don‚Äôt see any dollar signs in this release, either for the new test or RT-PCR. According to a New York Times blog p",news_reviews_00570,The Lancet,"
This release from the The Lancet plays up a first-of-its-kind rapid diagnostic test for Ebola virus disease (EVD). We‚Äôre told the ReEBOV Antigen Rapid Test (made by Corgenix) could be a powerful future tool in detecting, monitoring, and controlling out","On average, the¬†Ebola virus kills about half of the people it infects. Recent outbreaks in Africa have claimed tens of thousands of lives. Although standard diagnostic tests take hours to process, it might take days for samples to reach¬†a lab from remot","https://www.healthnewsreview.org/wp-content/uploads/2015/06/ebola-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/ebola.jpg 800w"
https://www.healthnewsreview.org/news-release-review/with-second-death-risk-study-in-a-month-lancet-displays-better-grip-on-limitations/,"With second death-risk release in a month, Lancet displays better grip on limitations",The current release does a pretty thorough job of explaining the study and quotes from an accompanying editorial to provide some perspective.,Simple score predicts risk of death for middle-aged adults in the UK,,5,"['Sharon Dunwoody, PhD', 'Steven J. Atlas, MD, MPH', 'Kevin Lomangino']",Journal news release,"['Sense About Science', 'The Lancet', 'Ubble Age']",http://www.eurekalert.org/pub_releases/2015-06/tl-tls060215.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'Access to an interactive site for purposes of computing a score predicting one‚Äôs risk of dying will be free. However, th",news_reviews_00579,The Lancet,"For the second time in a month, The Lancet is promoting a ‚Äúsimple‚Äù test that may help predict one‚Äôs risk of death. A few weeks ago it was the notorious death grip study, this time it‚Äôs a questionnaire that predicts your ‚ÄúUbble age.‚Äù
The new te",Predicting what the future may hold is something that is intriguing to everyone. And what is more important to predict than whether you will live or die? So this algorithm that provides an estimate of one‚Äôs risk of death in 5 years is appealing at many ,"https://www.healthnewsreview.org/wp-content/uploads/2015/06/crystal-ball-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/06/crystal-ball.jpg 849w"
https://www.healthnewsreview.org/news-release-review/exemplary-hopkins-new-release-on-an-early-experimental-treatment-for-multiple-myeloma/,"Exemplary Hopkins news release on an early, experimental treatment for multiple myeloma",This release about a new approach to the treatment of multiple myeloma is in many ways a model for other organizations reporting on similar studies.,Pilot clinical trial finds injected immune cells safe in multiple myeloma patients,,5,"['Earle Holland', 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",Academic medical center news release,"['adoptive T cell therapy', 'immunotherapy', 'Johns Hopkins', 'multiple myeloma']",http://www.eurekalert.org/pub_releases/2015-05/jhm-pct051915.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The release, while loaded with information about the research, fails to mention costs related to this new approach at an",news_reviews_00581,JOHNS HOPKINS MEDICINE,"This is a report of a phase I clinical trial testing whether specific immune cells harvested from the bone marrow, grown in the lab and then re-infused into multiple myeloma patients can effectively change the immune environment in the patient and suggest","Multiple myeloma is one of several cancers of the blood and the National Cancer Institute estimates that nearly 27,000 new cases of myeloma will be diagnosed this year. Less than half of patients live as much as five years after their diagnosis, and more ","https://www.healthnewsreview.org/wp-content/uploads/2015/05/cancer-300x225.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/cancer.jpg 800w"
https://www.healthnewsreview.org/news-release-review/release-on-binge-eating-drug-study-raises-questions-on-commercial-influence/,Release on binge-eating disorder study raises questions on commercial influence,This release didn‚Äôt sensationalize the findings of study of a drug to treat binge-eating disorder. But our reviewers noted that binge-eating disorder itself would be considered by some to be an example of disease mongering.,"Clinical trial examines safety, effectiveness of drug to treat binge eating disorder",,4,"['Sharon Dunwoody, PhD', 'Susan Molchan, MD, MA', 'Kevin Lomangino']",Disease mongering,"['binge-eating disorder', 'JAMA', 'Monica Seles', 'Shire Pharmaceuticals', 'Vyvnase']",http://www.eurekalert.org/pub_releases/2015-01/tjnj-cte011215.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'The news release does not discuss costs for drug, lisdexamfetamine (Vyvanse), that is still under patent. All drugs of t",news_reviews_00582,JAMA Psychiatry,"Monica Seles is the face of an industry-sponsored campaign to raise awareness of binge-eating disorder.
A clinical trial in people diagnosed with binge-eating disorder found that a drug of the amphetamine class, also marketed for attention-deficit disorde","Binge-eating disorder became an official psychiatric diagnosis with the publication of DSM-V in 2013. It‚Äôs not just over-eating, but periods (at least 2 days/week for 6 months) of excessive eating with loss of control that causes psychological distress.",nan
https://www.healthnewsreview.org/news-release-review/cracking-open-the-claim-that-walnuts-may-help-slow-colon-cancer-growth/,Cracking open the claim that walnuts ‚Äúmay help slow colon cancer growth‚Äù,A 5-star score and a reasonably solid accounting of mouse study. But the release benefits from several ‚ÄúNot Applicables‚Äù and borderline ‚ÄúSatisfactory‚Äù ratings that could have gone the other way.,"New Harvard research finds walnuts may help slow colon cancer growth A walnut-enriched diet may cause beneficial genetic changes in animal cancer cells, affecting inflammation, blood supply and growth of tumors",,5,"['Sally James', 'Earle Holland', 'Kevin Lomangino']",Animal research,"['colon cancer', 'Harvard', 'walnuts']",http://www.eurekalert.org/pub_releases/2015-05/es-nhr051115.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'In this very narrow discussion of a small study in mice, the suggestion is that someday maybe walnuts (or some nutritional",news_reviews_00588,EDELMAN SEATTLE,Mice are not people. Yet many medical research headlines about mouse studies extend the implicit promise that whatever is discovered may cure diseases in humans. This release tries to correct that by mentioning ‚Äúanimal study‚Äù in the sub-headline and i,"According to the National Cancer Institute, colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer deaths in the United States. If something as simple as eating walnuts could reduce that risk or slow down ",nan
https://www.healthnewsreview.org/news-release-review/delivering-on-key-points-release-on-improved-hpv-vaccine-would-benefit-from-additional-context/,"Delivering on key points, release on improved HPV vaccine would benefit from additional context","Though solid overall, this release about an improved version of the gardasil HPV vaccine would have benefited from the addition of a few key details.",New HPV vaccine offers greater protection against cervical cancer than current vaccine,,4,"['Harold J. DeMonaco, MS', 'Kevin Lomangino']",Academic medical center news release,"['Cervical cancer', 'HPV vaccine', 'New England Journal of Medicine', 'Queen Mary University of London']",http://www.eurekalert.org/pub_releases/2015-02/qmuo-nhv021815.php,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Applicable', 'explanation': 'The release is from the UK and likely written for a UK audience, which would expect the cost of the vaccine to be covered ",news_reviews_00592,Queen Mary University of London,"This news release has several strengths. It carefully describes an important study comparing two forms of human papillomavirus (HPV) vaccine and provides the reader with information on the potential impact of HPV infections. However, it doesn‚Äôt deliver ","HPV infection occurs in just about every sexually active adult. In the vast majority of cases, its presence produces no lasting effects. Depending of the strain of virus and other factors, however, the virus can cause a number of genital conditions includ","https://www.healthnewsreview.org/wp-content/uploads/2015/05/vaccination-with-gardasil-300x200.jpg 300w, https://www.healthnewsreview.org/wp-content/uploads/2015/05/vaccination-with-gardasil.jpg 849w"
https://www.healthnewsreview.org/news-release-review/drugs-activate-brain-stem-cells-may-reverse-multiple-sclerosis/,Exaggeration at the NIH? Mouse study release may go too far in suggesting ‚Äúreversal‚Äù of multiple sclerosis,"Despite its four-star score, this release isn‚Äôt clear about the fact that this was an early-phase animal study.",Drugs that activate brain stem cells may reverse multiple sclerosis,,4,"['Harold J. DeMonaco, MS', ""A'ndrea Elyse Messer, MS, PhD"", 'Kevin Lomangino']",Government agency news release,"['animal research', 'clobetasol', 'miconazole', 'NIH']",http://www.nih.gov/news/health/apr2015/ninds-20.htm,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Not Satisfactory', 'explanation': 'While one could argue that we should give the release a pass given the early stage of the research,\xa0the drugs discuss",news_reviews_00599,NIH,Our review team had a lively debate as to the extent to which this National Institutes of Health news release exaggerates the findings of the study it reports on. We agreed that the release waits far too long to warn readers that this exciting study of po,The lackluster performance of the pharmaceutical industry in developing new treatments has led to coordinated efforts to repurpose existing drugs for new uses. The research highlighted in this NIH news release is important because it represents one of the,nan
https://www.healthnewsreview.org/news-release-review/thorough-summary-of-trial-comparing-drugs-for-diabetic-macular-edema/,Thorough summary of trial comparing drugs for diabetic macular edema,"This news release describes a study testing three drugs for diabetic macular edema with price tags ranging from about $700 to $17,700 for a round of treatment.",Joslin Researchers Conduct First Trial Directly Comparing Drugs for Diabetic Macular Edema and Find All are Effective,,4,"[""A'ndrea Elyse Messer, MS, PhD"", 'Doug Campos-Outcalt, MD, MPA', 'Kevin Lomangino']",Academic medical center news release,"['comparative effectiveness studies', 'diabetes']",http://www.newswise.com/articles/view/629985/?sc=mwhr&xy=10015339,"[{'question': 'Does the news release adequately discuss the costs of the intervention?', 'answer': 'Satisfactory', 'explanation': 'The costs of the three anti-VEGF drugs evaluated in the study were listed as about $1960 for aflibercept (Eylea), $1200 for ",news_reviews_00604,Joslin Diabetes Center,"This release was uncommonly thorough in explaining the results of the study and its implications. Benefits are accurately described in terms that are meaningful to readers. Costs for the different drugs are provided, and the study methodology is clearly c","Vision problems are significant in both type I and type II diabetics and about 750,000 Americans with diabetic retinopathy have diabetic macular edema, which causes blurred vision. The finding that that three drugs work equally well for people with mild v","https://www.healthnewsreview.org/wp-content/uploads/2015/04/iStock_000006252421_Small-200x300.jpg 200w, https://www.healthnewsreview.org/wp-content/uploads/2015/04/iStock_000006252421_Small.jpg 566w"
